[
    {
        "sen": [
            "Four decades ago in 1985, alleles of apolipoprotein E (ApoE) ε2/ε3/ε4 became famous for explaining 16% of genetic variance in low-density lipoprotein cholesterol in the benchmark study of Sing and Davignon (1): total blood cholesterol, low-density lipoprotein cholesterol, and apolipoprotein B were elevated by ApoE ε4 (ApoE4) allele and lowered by ApoE ε2 (ApoE2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Preexisting morbidities increase risk of COVID-19 infections and mortality: for young adults: diabetes and obesity; for older people: diabetes and dementia (14,15)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 also damages the cardiovascular system with atrial fibrillation, ventricular arrhythmia, and disseminated coagulation (16)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These morbidities are also associated with variants in the ApoE gene cluster that we hypothesize are relevant to COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "ApoE4 homozygotes have 2.2-fold higher risk for COVID-19 positivity and 4.3-fold more case-fatality after COVID-19 than ApoE3 homozygotes (17,18)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Heterozygosity (ε3/ε4) was modestly associated with COVID-19 below linear dose dependence."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Strong associations for ε4/ε4 with COVID-19 were not diminished by excluding dementia, hypertension, coronary heart disease (CHD), or type II diabetes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on these associations, Kuo et al. hypothesize that ApoE4 has recessive effects on COVID-19 outcomes and suggest that these effects are independent of these common age-related diseases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We discuss how ApoE allele pleiotropies can mediate COVID-19 infectivity and survival."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We hypothesize that ApoE4 associations with COVID-19 extend to the ApoE gene complex with balancing detrimental and protective effects in haplotypes, and multiple gene-by-gene transcriptional interactions (28)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This approach could identify protective genes for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "ApoE2 also merits consideration in COVID-19, given its benefit to CVD and AD."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Several ApoE cluster genes may interact with COVID-19, for example, NECTIN2 (herpes receptor HHV1) and ApoC1 which, like ApoE, is in the HCV envelope (42)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "ApoE cluster haplotypes associate with the same morbidities from CVD and obesity (43,44) that increase vulnerability to COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The outbreak of COVID-2019 initiated at Wuhan, China has become a global threat by rapid transmission and severe fatalities."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recent studies have uncovered whole genome sequence of SARS-CoV-2 (causing COVID-2019)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also performed functional overrepresentation analysis of interacting proteins to understand their role in COVID-2019 severity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As per the results, Prevotella proteins, but not viral proteins are involved in multiple interactions with NF-kB, which is involved in increasing clinical severity of COVID-2019."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Prevotella may have role in COVID-2019 outbreak and should be given importance for understanding disease mechanisms and improving treatment outcomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The rapid spread of the coronavirus disease 2019 (COVID-19) pandemic has dramatically impacted oncologic care."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Two observational studies suggest that infection rates of COVID-19 may be significantly higher in cancer patients than in the general population (Liang et al., 2020, Yu et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Further analyses suggest that cancer patients may also be at increased risk of severe complications from COVID-19, including hospitalization, respiratory failure, and death (Dai et al., 2020, Liang et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Multiple factors are likely contributing to the increased prevalence and severity of COVID-19 infection seen in cancer patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Compared to the general population, cancer patients tend to be older, are more often smokers, and have more comorbid medical conditions, all of which are reported risk factors for severe COVID-19 infection (Jordan et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of major concern to medical oncologists in particular are antineoplastic therapies, which have a variety of effects that can theoretically be deleterious in the context of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Lymphosuppression and myelosuppression directly caused by cancer itself as well as cytotoxic treatments pose an increased risk of respiratory viral infections (Vento et al., 2008); some cytotoxic agents also cause pulmonary toxicity that may prove harmful in the context of severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Some monoclonal antibodies (for example, anti-CD38 antibodies such as daratumumab and isatuximab) result specifically in NK-cell depletion and increase risk of lower respiratory viral infection, although it is unclear whether this applies to COVID-19 (Nahi et al., 2019)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Early reports have demonstrated a hyperactive, proinflammatory T cell phenotype in severe cases of COVID-19 (Xu et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Some clinicians have accordingly hypothesized that immune checkpoint inhibitors may promote a more severe COVID-19 phenotype and are using these drugs with some hesitation, although the subject is controversial (Bersanelli 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, a significant proportion of cancer patients take corticosteroids for prophylaxis, treatment, and symptom control related to cancer, which might be detrimental in the management of acute respiratory distress syndrome due to COVID-19 (Russell et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Prospective clinical trials of investigational antineoplastic therapy, which drive many advancements in medical oncology, are now faced with additional logistical and practical barriers in the COVID-19 era."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, despite COVID-19-related trials accruing at record pace, no randomized data are yet available to guide practice."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Notably, some antineoplastic treatments may be helpful in mitigating the harmful immune response associated with severe COVID-19 and are under active investigation as repurposed therapies for COVID-19 (Table 1",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Given the above, it is imperative that real-world evidence about the effects of COVID-19 on cancer patients is collected and disseminated rapidly to inform clinical decisions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "CCC19",
            " is a multicenter registry that was created to help bridge the knowledge gap in cancer care caused by the COVID-19 pandemic."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 2959,
                "end": 2964,
                "name": "CCC19"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Participating sites are asked to obtain necessary institutional IRB approval and data transfer and to make the best possible effort to report data on cases of COVID-19 in cancer patients that are treated in both the inpatient and outpatient settings, to ensure data are collected on patients with both mild and severe disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of note, a large global analysis is planned, subsequently fusing ",
            "RedCAP",
            " databases with the ",
            "European Society for Medical Oncology COVID-19 and Cancer Registry (ESMO-CoCARE)",
            " project."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 3481,
                "end": 3487,
                "name": "RedCAP"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 3507,
                "end": 3587,
                "name": "European Society for Medical Oncology COVID-19 and Cancer Registry (ESMO-CoCARE)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "National and international consortia will play a key role in understanding the effects of the coronavirus disease 2019 (COVID-19) pandemic on cancer patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "COVID-19 and Cancer Consortium (CCC19)",
            " aims to collect and analyze observational data at scale to inform clinical practice in real-time."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 3760,
                "end": 3798,
                "name": "COVID-19 and Cancer Consortium (CCC19)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "National and international consortia will play a key role in understanding the effects of the coronavirus disease 2019 (COVID-19) pandemic on cancer patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "COVID-19 and Cancer Consortium (CCC19)",
            " aims to collect and analyze observational data at scale to inform clinical practice in real-time."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 4060,
                "end": 4098,
                "name": "COVID-19 and Cancer Consortium (CCC19)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to the Johns Hopkins University Coronavirus Resource Center and the Daily Technical Statement on New Coronavirus Cases Worldwide (COVID-19) issued by the Secretary of Health of Mexico, as of March 20, 2020, 234,072 confirmed cases have been reported worldwide with 9840 deaths."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At the time of this writing, 768 complete genomic sequences of SARS Cov-2 have been obtained and deposited in the ",
            "GISAID",
            " database, and 10 clades have been defined from phylogenetic studies carried out with these sequences (A1, A1a, A2, A2a, A3, A5, B, B1, B2 and B4) [5]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 402,
                "end": 408,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A diagnostic test for COVID-19 was first conducted at the Instituto Nacional de Enfermedades Respiratorias, Mexico City, on February 27, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The complete genome sequence was assembled using CLC Genomics Workbench 20 (QIAGEN) and SPAdes [9] and mapped against the reference sequence Wuhan-Hu-1 (",
            "GenBank",
            " accession number ",
            "NC_045512.2",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 856,
                "end": 863,
                "name": "GenBank"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 881,
                "end": 892,
                "name": "NC_045512.2"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "The sequence was deposited in the ",
            "GISAID",
            " database [5] under accession ID ",
            "EPI_ISL_412972",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 929,
                "end": 935,
                "name": "GISAID"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 968,
                "end": 982,
                "name": "EPI_ISL_412972"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T4",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "A database was constructed including 178 genomic sequences available on the ",
            "GISAID",
            " platform, obtained from December 31, 2019 to March 05, 2020, reported in 22 countries."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 1060,
                "end": 1066,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A second database of 768 sequences deposited until March 20, 2020, was used to construct a phylogenetic tree."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This finding correlates with the transmission events reported by ",
            "GISAID",
            " [5], which suggest that this strain was first introduced into Belgium, then England, and finally, Italy, where the Mexican patient had been traveling."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Dataset",
                "start": 1329,
                "end": 1335,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Very recently, the outbreak of coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed significant threats to international health [4–9]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The outbreak of coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed significant threats to international health."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "One week later, on January 7, 2020, Chinese health authorities confirmed that they had identified a novel coronavirus (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Chinese Center for Disease Control and Prevention issued an epidemic update and risk assessment of COVID-19 in late January."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Zhou et al showed that COVID-19 shares 79.5% sequence identity with SARS-CoV."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It was also confirmed that COVID-19 uses the same cell entry receptor, angiotensin-converting enzyme 2, as SARS-CoV, which is highly expressed in airway epithelial cells."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Zhu et al also identified and characterized COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 seems to be the seventh member of the family of coronaviruses that infect humans."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Notably, COVID-19 grew more readily in primary human airway epithelial cells than in standard tissue culture cells, unlike SARS-CoV or MERS-CoV, suggesting the potential for increased infectivity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Homology modeling revealed that COVID-19 had some amino acid variations at key residues benchmarked with SARS-CoV."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A familial cluster of pneumonia due to COVID-19 has been reported."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The basic reproductive number of COVID-19 was estimated to be 2.2, lower than that of SARS-CoV (around 3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            " However, host virus interactions may hasten the birth of potential super spreaders, leading to major outbreaks."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first reported patient with COVID-19 infection in the United States was administered remdesivir."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Two randomized controlled trials have been registered to evaluate the safety and efficacy of remdesivir in mild/moderate or severe patients with COVID-19 viral pneumonia."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            " Kirchdoerfer and Ward noticed that nonstructural proteins (nsp)12 polymerase may be a template for the design of novel antiviral therapeutic agents to interrupt the assembly of the SARS-CoV core RNA-synthesis machinery."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 has full-length genome sequences with > 75% nucleotide identity with that of SARS-CoV, which allows the molecular structure information to be used as a model for coronavirus antiviral design."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is of great significance to share what is known of COVID-19 genome sequences, the epidemiology, and clinical features of the illness."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hopefully, the early suggestion that COVID-19 infection is of lower lethality than SARS holds true."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The goal is to break the transmission chain of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Each week a sequence data cutoff is applied across the consortium to give a defined dataset for weekly analysis to report to SAGE, initially focusing on: (1) local transmission versus imported cases, (2) rates of epidemic growth,5, 6 (3) reconstructing spatial movement, (4) chains of transmission, (5) observed genetic changes, and (6) identification of genomic changes potentially affecting common diagnostic tests or direct (eg, chemotherapeutics) or indirect therapies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The World Health Organization (WHO) declared the outbreak of a coronavirus disease of 2019 (COVID-19) as public health emergency of international concern and put in place a series of temporary recommendations on January 30."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The current outbreak of COVID-19 has nearly 3 million confirmed cases worldwide with more than 200,000 deaths, as of April 27, 2020, according to the WHO."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Many researches are now underway to develop effective interventions for controlling and preventing the COVID-19 pandemic, including therapeutic drugs such as inhibitors of the RNA-dependent RNA polymerase or the viral protease, and blockers of virus-cell membrane fusion as well as vaccines, and large scale clinical trials have just begun [6, 7]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Full-length viral nucleotide sequences of SARS-CoV-2 (accession number ",
            "MN908947",
            " and ",
            "MN996527",
            "-",
            "MN996531",
            ") [1, 2], SARS-CoV (accession number ",
            "AY274119",
            ", ",
            "AY278488",
            " and ",
            "AY390556",
            "), bat-derived SARS-like coronavirus (bat-SL-CoV) RaTG13 (accession number ",
            "MN996532",
            "), and MERS-CoV (accession number ",
            "JX869059",
            ") were downloaded from the ",
            "NCBI",
            " ",
            "GenBank",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "AccessionNumber",
                "start": 798,
                "end": 806,
                "name": "MN908947"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 811,
                "end": 819,
                "name": "MN996527"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 820,
                "end": 828,
                "name": "MN996531"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 865,
                "end": 873,
                "name": "AY274119"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 875,
                "end": 883,
                "name": "AY278488"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 888,
                "end": 896,
                "name": "AY390556"
            },
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 971,
                "end": 979,
                "name": "MN996532"
            },
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 1013,
                "end": 1021,
                "name": "JX869059"
            },
            false,
            {
                "id": "T9",
                "type": "Creator",
                "start": 1048,
                "end": 1052,
                "name": "NCBI"
            },
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 1053,
                "end": 1060,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T9",
                "end": "T1"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T9",
                "end": "T2"
            },
            {
                "id": "R6",
                "bool": true,
                "head": "T9",
                "end": "T3"
            },
            {
                "id": "R8",
                "bool": true,
                "head": "T9",
                "end": "T4"
            },
            {
                "id": "R10",
                "bool": true,
                "head": "T9",
                "end": "T5"
            },
            {
                "id": "R12",
                "bool": true,
                "head": "T9",
                "end": "T6"
            },
            {
                "id": "R14",
                "bool": true,
                "head": "T9",
                "end": "T7"
            },
            {
                "id": "R16",
                "bool": true,
                "head": "T9",
                "end": "T8"
            },
            {
                "id": "R1",
                "bool": true,
                "head": "T10",
                "end": "T1"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T10",
                "end": "T2"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T10",
                "end": "T3"
            },
            {
                "id": "R7",
                "bool": true,
                "head": "T10",
                "end": "T4"
            },
            {
                "id": "R9",
                "bool": true,
                "head": "T10",
                "end": "T5"
            },
            {
                "id": "R11",
                "bool": true,
                "head": "T10",
                "end": "T6"
            },
            {
                "id": "R13",
                "bool": true,
                "head": "T10",
                "end": "T7"
            },
            {
                "id": "R15",
                "bool": true,
                "head": "T10",
                "end": "T8"
            }
        ]
    },
    {
        "sen": [
            "Epitope prediction was carried out using the predicted proteins, including S, E, N, M, and ORFs (corresponding to accession numbers ",
            "QHD43415",
            "-",
            "QHD43423",
            ", ",
            "QHI42199",
            ") of the reference SARS-CoV-2_Wuhan-Hu-1 (accession number ",
            "MN908947",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "AccessionNumber",
                "start": 1194,
                "end": 1202,
                "name": "QHD43415"
            },
            false,
            {
                "id": "T12",
                "type": "AccessionNumber",
                "start": 1203,
                "end": 1211,
                "name": "QHD43423"
            },
            false,
            {
                "id": "T13",
                "type": "AccessionNumber",
                "start": 1213,
                "end": 1221,
                "name": "QHI42199"
            },
            false,
            {
                "id": "T14",
                "type": "AccessionNumber",
                "start": 1280,
                "end": 1288,
                "name": "MN908947"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We first aligned each of these SARS-CoV-2 sequences to the reference sequence SARS-CoV-2_Wuhan-Hu-1 (accession number ",
            "MN908947",
            ") using BLAT software [14]."
        ],
        "lab": [
            false,
            {
                "id": "T15",
                "type": "AccessionNumber",
                "start": 1409,
                "end": 1417,
                "name": "MN908947"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "After the alignment, we extracted nucleotide sequences corresponding to individual proteins of SARS-CoV-2, translated them to amino acid sequences, and then compared them to reference amino acid sequences of SARS-CoV-2_Wuhan-Hu-1 (accession numbers ",
            "QHD43415",
            "-",
            "QHD43423",
            ", ",
            "QHI42199",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T16",
                "type": "AccessionNumber",
                "start": 1694,
                "end": 1702,
                "name": "QHD43415"
            },
            false,
            {
                "id": "T17",
                "type": "AccessionNumber",
                "start": 1703,
                "end": 1711,
                "name": "QHD43423"
            },
            false,
            {
                "id": "T18",
                "type": "AccessionNumber",
                "start": 1713,
                "end": 1721,
                "name": "QHI42199"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Genome sequences of SARS-CoV-2_WIV02 (accession number ",
            "MN996527",
            "), SARS-CoV_GZ02 (",
            "AY390556",
            "), and Bat-CoV_RaTG13 (",
            "MN996532",
            ") were compared with SARS-CoV-2_Wuhan-Hu-1 (",
            "MN908947",
            ")",
            "156 amino acid mutations, which were observed at more than 0.5% frequencies in at least one region, were plotted",
            "To control the current COVID-19 pandemic and prevent the second pandemic in the near future, the development of new drugs and vaccines, and the establishment of tools investigating the immune responses in patients or silently-infected individuals are urgent issues."
        ],
        "lab": [
            false,
            {
                "id": "T19",
                "type": "AccessionNumber",
                "start": 1779,
                "end": 1787,
                "name": "MN996527"
            },
            false,
            {
                "id": "T20",
                "type": "AccessionNumber",
                "start": 1805,
                "end": 1813,
                "name": "AY390556"
            },
            false,
            {
                "id": "T21",
                "type": "AccessionNumber",
                "start": 1836,
                "end": 1844,
                "name": "MN996532"
            },
            false,
            {
                "id": "T22",
                "type": "AccessionNumber",
                "start": 1888,
                "end": 1896,
                "name": "MN908947"
            },
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, several reports have suggested that a subset of patients with severe COVID-19 might have a cytokine release syndrome [19, 20]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These HLA-oligomers might be useful to predict and monitor acute T-cell responses in COVID-19 patients who cause these life-threatning symptoms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To control and prevent the current COVID-19 pandemic, the development of novel vaccines is an emergent issue."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "An outbreak of novel coronavirus disease 2019 (COVID-19) spread from China worldwide since December 2019 (Zhu et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, most COVID-19 patients require hospitalization or isolated observation, but large numbers of patients could overwhelm healthcare systems globally."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is important for us to avoid an increasing number of COVID-19-related deaths by early detection of the high-risk group."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The inclusion criteria were mild/moderate symptoms of COVID-19 when hospitalized, serum collection on the first day of hospitalization, and serial serum collection during hospitalization."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For a screening experiment, a total of 28 patients with COVID-19 who were eligible based on the study’s criteria participated."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To confirm the discrimination ability of the predictive markers between the COVID-19 severe population and other diseases, 114 patients with several common diseases, who were negative for SARS-CoV-2 RNA (Supplemental Information and Supplemental Table 3), were enrolled."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, IP-10, CXCL9, and CCL17 levels were specifically associated with the COVID-19 severe/critical group."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Laboratory data showing significant associations with the development of severe/critical symptoms (Supplemental Table 1) were compared between COVID-19 and common diseases (Supplemental Fig. 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ranges of all laboratory data except for CRP overlapped between COVID-19 and common diseases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To validate the predictive power of CCL17, independent samples from COVID-19 patients were added, and CCL17 levels at an early phase of hospitalization were determined."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Approximately 80% of COVID-19 patients have mild or moderate disease and recover within a few weeks, but as previously reported, the remaining COVID-19 patients develop severe or critical symptoms (Guan et al., 2020, Wu and McGoogan, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "ALB, LDH, CRP, and neutrophil counts were associated with the development of severe pneumonia (Gong et al., 2020, Mo et al., 2020, Wang et al., 2020a, Zhang et al., 2020a), and COVID-19 patients with hypertension were also significantly more likely to develop severe disease (Wu et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In COVID-19, the CCL17 expression range was very narrow in the severe/critical group."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This feature might explain why many more children with COVID-19 have mild symptoms than adult patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Dysfunction of Treg cells in the lung could induce severe/critical pneumonia in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The mechanism of CCL17 suppression in COVID-19 is unknown."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "High expression of IP-10 was associated with severe disease in COVID-19 (Ma et al., 2020, Runfeng et al., 2020, Xiong et al., 2020, Yang et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interestingly, there were no associations for both IFN-λ1 and 2 in COVID-19, and IFN-λ1 or 2 genes were not associated with response to interferon-α (IFN-α) treatment for CHC (Ge et al., 2009)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, clinical trials of IFN-α treatment for COVID-19 that classified patients by SNP type showed that it could provide good results (Li and De Clercq, 2020, Wang et al., 2020b)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The present data showed for the first time that IFN-λ3 itself is a key molecule for the development of severe pneumonia, and the natural course of IFN-λ3 in COVID-19 patients was shown using serial serum samples."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The association of IL-6 with COVID-19 has been previously reported (Chen et al., 2020a, Gao et al., 2020, Zhang et al., 2020c)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The present data suggest that COVID-19 patients with RA have high levels of IL-6 without severe/critical symptoms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These data suggest that the SNP type of individuals should be considered to understand the profiles of predictive markers, in addition to COVID-19 outcomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, Yang et al. reported that CXCL9 levels were elevated during disease progression of COVID-19, but they were not useful as predictive markers (Yang et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Highlights     •  CCL17, IFN- l 3, IL-6, IP-10, and CXCL9 were predictor for COVID-19 prognosis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The downregulation of CCL17 could be unique in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19, a novel coronavirus-related illness, has spread worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, almost all COVID-19 patients require hospitalization, which can reduce limited medical resources in addition to overwhelming medical facilities."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To identify predictive markers for the development of severe pneumonia, a comprehensive analysis of serum chemokines and cytokines was conducted using serial serum samples from COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Low expression of CCL17 was specifically observed in pre-severe COVID-19 patients compared with other common diseases, and the predictive ability of CCL17 was confirmed in validation samples of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We successfully typed a total of 77 HRV strains representing all three HRV species (",
            "GenBank",
            " accession numbers ",
            "MH824434",
            "‐",
            "MH824510",
            "), whereas 16 HRV strains could not be typed."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 84,
                "end": 91,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 110,
                "end": 118,
                "name": "MH824434"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 119,
                "end": 127,
                "name": "MH824510"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T1",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "I am an instructor at Mount Sinai, meaning I am still an early-career researcher, and COVID-19 has negatively affected my career development, my research work and our hospital."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The outbreak of COVID-19 has stalled both the basic, clinical and non-COVID medical research."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This Editorial describes an early-career researcher's experience and highlights how after efficiently contributing to ‘flattening the curve’ of COVID-19 infections, the research community has an opportunity for growth and re-structuring."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 outbreak has created a global health crisis that is profoundly affecting early-career scientists."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease 2019 (COVID-19) caused by a novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide as a severe pandemic (Callaway et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Currently, no validated therapeutics against virus-target interactions are available for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Convalescent patients’ plasma, which contains neutralizing antibodies produced by the adaptive immune response, has led to a clear clinical improvement of both mild and severe COVID-19 patients when used as a therapeutic modality (Chen et al., 2020, Shen et al., 2020, Cao, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we report the rapid and efficient identification of SARS-CoV-2-neutralizing antibodies achieved by high-throughput single-cell RNA and VDJ sequencing of antigen-binding B cells from convalescent COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Overall, we showed that high-throughput single-cell sequencing could lead to the identification of highly potent neutralizing mAbs that have strong therapeutic and prophylactic efficacy, which could greatly assist in the intervention of prevailing and emerging infectious diseases, such as COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To exploit this hypothesis, we first collected peripheral blood mononuclear cells (PBMCs) and isolated the B cells from 12 COVID-19 convalescent patients from Beijing Youan Hospital (Table S1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To evaluate their neutralization potential against the authentic virus, we performed the plaque reduction neutralization test (PRNT) using authentic SARS-CoV-2 isolated from COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We compared every IgG1-presenting clonotype’s predicted structure based on CDR3H using FREAD to the available SARS-CoV-neutralizing mAbs’ crystal structure in the PDB database as well as the structure of BD-23."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, a total of 12 IgG1 clonotypes showed high structure similarity with ",
            "PDB",
            " ID ",
            "2dd8",
            " and ",
            "2ghw",
            " (Table S2; Figure 5C), which corresponds to previously isolated SARS-CoV-neutralizing mAbs m396 and 80R, respectively (Prabakaran et al., 2006, Hwang et al., 2006)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1775,
                "end": 1778,
                "name": "PDB"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 1782,
                "end": 1786,
                "name": "2dd8"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 1791,
                "end": 1795,
                "name": "2ghw"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T1",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "A total of 64 confirmed COVID-19 patients discharged from Beijing Youan Hospital, China, from February 01 to February 28, 2020, were enrolled in this study (Table S1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patients 13-64, as well as 8 patents from ID 1-12, enrolled in the study corresponding to sequence batch 1-6 (Table S1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Discharged COVID-19 patients were isolated and observed continually for 28 days."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All COVID-19 patients were confirmed infected according to positive respiratory RT-PCR tests."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The SARS-CoV-2 pseudovirus is a gift from the Division of HIV/AIDS and Sex-transmitted Virus Vaccines, National Institutes for Food and Drug Control (NIFDC)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The S trimer (",
            "PDB",
            " ID: ",
            "6VSB",
            ") was used as a reference for the 3D classifications."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 2597,
                "end": 2600,
                "name": "PDB"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 2605,
                "end": 2609,
                "name": "6VSB"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T4",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "This BD23-Fab model and the S trimer structure (PDB ID: 6VSB) were docked into the cryo-EM density using UCSF Chimera."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Various concentrations of mAbs (3-fold serial dilution using DMEM, 50 μL aliquots) were mixed with the same volume of SARS-CoV-2 pseudovirus with a TCID50 of 1.3 × 104 in a 96 well-plate."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Cell types were identified using SingleR (Aran et al., 2019) against a human immune reference dataset (Monaco et al., 2019)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 pandemic urgently needs therapeutic and prophylactic interventions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Graphical Abstract      Neutralizing antibodies, which could effectively block virus entry into host cells, are urgently needed for intervention against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronaviruses were detected in three individuals by mapping clean reads without ribosomes and host sequences to an in-house virus reference dataset separated from the ",
            "GenBank",
            " non-redundant nucleotide database using the Burrows-Wheeler Aligner (BWA) ver 0.7.17 [10, 23]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 167,
                "end": 174,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "After gap filling, the whole genome sequence of pangolin-CoV-2020 was submitted to ",
            "GenBank",
            " databases (accession no. ",
            "MT121216",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 353,
                "end": 360,
                "name": "GenBank"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 386,
                "end": 394,
                "name": "MT121216"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "We downloaded 44 full-length genome sequences of coronaviruses isolated from different hosts from the public database (S5 Table), with the data kindly shared by the submitters."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The outbreak of a novel corona Virus Disease 2019 (COVID-19) in the city of Wuhan, China has resulted in more than 1.7 million laboratory confirmed cases all over the world."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Age-wise and gender-wise distribution of COVID-19 in Faisalabad is shown in Table 1",
            "."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or COVID-2019 is a new global health challenge which causes severe respiratory complications."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This retrospective study is the first report of epidemiological trends of COVID-19 in Faisalabad, Pakistan."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "RNA was extracted using QIAsymphony DSP Virus/Pathogen Midi Kit and real-time PCR was performed to quantify COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our finding showed that overall prevalence of COVID-19 in Faisalabad on April 4th was 17.18% (22 of 128)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patients belonging to age group 37–47 years were found to be most (45.5%) infected with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Highlights     •  SARS-CoV-2 or COVID-2019 is global health challenge."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This retrospective study is the first report of epidemiological trends of COVID-19 in Faisalabad, Pakistan.    •",
            "Our finding showed that overall prevalence of COVID-19 in Faisalabad on April 4th was 17.18% (22 of 128)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Arizona’s first confirmed case of COVID-19, the disease caused by SARS-CoV-2, was detected in late January 2020 in a student attending Arizona State University who had traveled to China (5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In order to assist with both local and global efforts to track the spread and evolution of this virus, we began intensive sequencing of viral genomes from across Arizona and deposition of these sequences in the ",
            "GISAID",
            " database, which makes them accessible to the research community for downstream analyses, notably including real-time pathogen tracking through ",
            "Nextstrain",
            " (12)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 402,
                "end": 408,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 552,
                "end": 562,
                "name": "Nextstrain"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "First, did the initial case of COVID-19 in Arizona lead to cryptic community transmission that helped to fuel the ongoing epidemic?",
            "This data set includes at least one genome from 11 of the 15 Arizona counties (see Table S3 in the supplemental material)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first case of COVID-19 in Arizona (AZ1) was documented in late January 2020, and contact tracing suggested that this initial case did not result in additional symptomatic infections within the state (5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The genomes used in this analysis were selected using a novel bioinformatics pipeline (see Materials and Methods), which subsampled genomes uploaded to ",
            "GISAID",
            " to reduce the size of the data set while representing the temporal, spatial, and genetic diversity of the full data set."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 1184,
                "end": 1190,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A reduced version of this data set, including 376 genomes with complete date information, was used in the Bayesian analysis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Sequence database representation through time for each of the six major named lineages or sublineages observed in Arizona."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Lineages were assigned using Pangolin (37) for all sequences uploaded to ",
            "GISAID",
            " as of 16 April 2020."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 1636,
                "end": 1642,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For this analysis, we considered the full collection of SARS-CoV-2 genomes available on ",
            "GISAID",
            " (as of 16 April 2020)."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 1752,
                "end": 1758,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The second case of COVID-19 in Arizona was reported on 3 March from a traveler who returned from France on 27 February (40)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on our phylogenetic analysis, it is clear that the ongoing COVID-19 outbreak in Arizona has been fueled by multiple distinct introductions of SARS-CoV-2 to the state."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Sequences included in the analyses presented here were derived from ",
            "GISAID",
            " (accessed on 16 April 2020), ",
            "NCBI GenBank",
            ", and sequences generated by our teams at Northern Arizona University and TGen North (n = 75), Arizona State University (n = 3), and University of Arizona (n = 1) (collectively referred to as the “Arizona sequences”)."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 2148,
                "end": 2154,
                "name": "GISAID"
            },
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 2184,
                "end": 2196,
                "name": "NCBI GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To support efficient Bayesian phylogenetic analysis of this large number of sequences, we developed genome-sampler (36), a novel protocol and software for sampling sequences from ",
            "GISAID",
            " across time of sequence acquisition, geographic source of sequence, and SARS-CoV-2 diversity."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Dataset",
                "start": 2593,
                "end": 2599,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As the COVID-19 pandemic swept across the United States, there was great differential impact on local and regional communities."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The novel coronavirus SARS‐CoV‐2 leads to coronavirus disease 2019 (synonym: COVID‐19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Numerous researcher groups have been focusing on the COVID‐19 pandemic in recent days."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Cancer patients are at a risk for the development of several infections, including the prevalent COVID‐19 pandemic in recent days."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Lung tumors may block normal mucus drainage, which can lead to infection, and further, other types of entrance molecules that have been changed by cancer can be more prone to COVID‐19 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this way, we first designed our in silico analyses regarding COVID‐19‐related genes (ACE2, TMPRSS2, CD147/BSG, and FURIN/PCSK3) expression, as well as mutation analyses, for revealing the susceptibility of COVID‐19 in lung cancer subtypes (lung squamous carcinoma [LUSC] and lung adenocarcinoma [LUAD])."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The lung cancer data set was obtained from ",
            "The Cancer Genome Atlas (TCGA)",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 851,
                "end": 881,
                "name": "The Cancer Genome Atlas (TCGA)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "cBio Cancer Genomics Portal",
            " (",
            "http://cbioportal.org",
            ") is an open accessed platform containing ",
            "TCGA",
            " data set; it is a collaboration between the ",
            "National Cancer Institute (NCI)",
            " and the ",
            "National Human Genome Research Institute (NHGRI)",
            ", is the large‐scale cancer genomics projects that allow interactive research of multiple cancer genomic data sets, and provides access to the data of more than 5000 tumor samples from various cancer studies."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 896,
                "end": 923,
                "name": "cBio Cancer Genomics Portal"
            },
            false,
            {
                "id": "T3",
                "type": "URL",
                "start": 925,
                "end": 946,
                "name": "http://cbioportal.org"
            },
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 988,
                "end": 992,
                "name": "TCGA"
            },
            false,
            {
                "id": "T5",
                "type": "Creator",
                "start": 1037,
                "end": 1068,
                "name": "National Cancer Institute (NCI)"
            },
            false,
            {
                "id": "T6",
                "type": "Creator",
                "start": 1077,
                "end": 1125,
                "name": "National Human Genome Research Institute (NHGRI)"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T5",
                "end": "T3"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T6",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "The selected ",
            "TCGA",
            " data set comprised the genome sequencing data of 1097 LUAD and LUSC patients."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 1347,
                "end": 1351,
                "name": "TCGA"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, the score given by the ",
            "COSMIC",
            "",
            " (",
            "https://cancer.sanger.ac.uk/cosmic",
            ") database was used to predict and verify the pathogenic effect of detected mutations."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 1462,
                "end": 1468,
                "name": "COSMIC"
            },
            false,
            false,
            {
                "id": "T9",
                "type": "URL",
                "start": 1471,
                "end": 1505,
                "name": "https://cancer.sanger.ac.uk/cosmic"
            },
            false
        ],
        "rel": [
            {
                "id": "R4",
                "bool": true,
                "head": "T8",
                "end": "T9"
            }
        ]
    },
    {
        "sen": [
            "GEPIA offers customizable features such as differentially expressed tumor/normal analysis from the ",
            "TCGA",
            " and the Genotype‐Tissue Expression databases."
        ],
        "lab": [
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 1691,
                "end": 1695,
                "name": "TCGA"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since the first case detected in December 2019, a new coronavirus causing COVID‐19 disease has led to more than 3 500 000 infections worldwide and about 245 000 deaths."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Cancer patients may be at a higher risk of being more susceptible to COVID‐19 infectious diseases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "First of all, mutation profiles of target genes, including ACE2, TMPRSS2, CD147/BSG, and FURIN/PCSK3 from the genome sequencing results of the LUAD and LUSC patient, which are accessible in ",
            "TGCA",
            " data sets, were analyzed extensively."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Repository",
                "start": 2200,
                "end": 2204,
                "name": "TGCA"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Ulrich et al",
            " reported that inhibition of CD147/BSG may have beneficial effects in the prevention of diabetic complications, involving severe acute respiratory syndrome triggers by COVID‐19."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, assessment of the TMPRSS2 gene downregulated expression only may be useful for predicting prognosis and susceptibility to COVID‐19 in these patient groups."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The challenge for today is building the assessment of genomic susceptibility to COVID‐19 in lung cancer, requiring detailed experimental laboratory studies, in addition to in silico analyses, as a way of assessing the mechanism of novel virus invasion that can be used in the development of effective SARS‐CoV‐2 therapy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The increased expression of ACE2 and CD147/BSG and decreased expression of TMPRSS2 in tumor tissues results in more susceptible to SARS‐CoV‐2 infection in COVID‐19 patients with lung cancer subtypes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The downregulated expression of TMPRSS2 may useful for predicting prognosis and susceptibility to COVID‐19 in LUAD cancer patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The impact of genetic variations in lung cancer patients need to be assessed in order to effectively reveal potential invasion genes for SARS‐CoV‐2 in COVID‐19 susceptibility."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On 11 February 2020, the International Committee on Taxonomy of Viruses officially renamed the novel coronavirus (ie, previously 2019‐nCoV) responsible for the current outbreak of COVID‐19, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The virus, which emerged in December 2019 in the Chinese city of Wuhan, causes a respiratory illness called COVID‐19, which can spread from person to person."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "World Health Organization (WHO) officials outlined their top research priorities for controlling the outbreak of the coronavirus‐associated disease known as COVID‐19 and highlighted the importance of developing candidate therapeutics and easy‐to‐apply diagnostics for identifying active, asymptomatic, and resolved infections."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The discovery of a virus closely related to the newly emerged SARS‐CoV‐2 in a data set from pangolins sampled more than a year ago illustrates that the sampling of other mammals handled or consumed by humans could uncover even more closely related viruses."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of 9 February 2020, 73 genomes of SARS‐CoV‐2 strains obtained from humans have been released on ",
            "GISAID",
            " (",
            "http://gisaid.org/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 1095,
                "end": 1101,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 1103,
                "end": 1121,
                "name": "http://gisaid.org/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "The final data set (“dataset_70”) included 70 genomes of SARS‐CoV‐2 strains from Australia (n = 4), Belgium (n = 1), China (n = 40), Finland (n = 1), France (n = 4), Germany (n = 1), Japan (n = 1), Korea (n = 1), Singapore (n = 3), Thailand (n = 2), UK (n = 2), and USA (n = 10) with sampling dates between 24 December 2019 and 3 February 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To investigate the potential intermediate hosts of SARS‐CoV‐2 (between originating animal and human hosts), two samples (SRR10168377 and SRR10168378) obtained from previously reported Malayan pangolin (Manis javanica) viral metagenomic sequencing data (Bio Project ",
            "PRJNA573298",
            ") were downloaded from the ",
            "NCBI SRA",
            " public database."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 1734,
                "end": 1745,
                "name": "PRJNA573298"
            },
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 1772,
                "end": 1780,
                "name": "NCBI SRA"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T4",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "We defined another data set (“dataset_6”) composed of six genome sequences of coronavirus strains."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The two data sets (“dataset_70” and “dataset_6”) were aligned using MAFFT v7.222",
            " and then manually curated using BioEdit v7.2.5."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To assess the recombination of “dataset_70,” we employed the pairwise homoplasy index (PHI) to measure the similarity between closely linked sites using SplitsTree v4.15.1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The best‐fit nucleotide substitution models for the two data sets were identified according to the Bayesian information criterion (BIC) method with 3 (24 candidate models) or 11 (88 candidate models) substitution schemes in jModelTest v2.1.10."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To evaluate the phylogenetic signals of “dataset_70” and “dataset_6,” we performed likelihood‐mapping analysis",
            " using TREE‐PUZZLE v5.3,",
            " with 25 000 to 175 000 randomly chosen quartets for the two data sets."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For “dataset_70,” split network analysis was performed using Kishino‐Yano‐85 distance transformation with the NeighborNet method, which can be loosely thought of as a “hybrid” between the neighbor‐joining (NJ) and split decomposition methods, implemented in TREE‐PUZZLE v5.3."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For “dataset_70,” NJ",
            " phylogenetic trees were constructed using the Kimura 2‐parameter method",
            " implemented in MEGA v7.0.26."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For “dataset_6,” NJ",
            " phylogenetic trees were constructed using the Maximum Composite likelihood (MCL) method,",
            " and rate variation among sites was modeled with a gamma distribution (shape parameter = 4) in MEGA v7.0.26."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For “dataset_70,” maximum‐likelihood (ML) phylogenies were reconstructed using the Hasegawa‐Kishino‐Yano (HKY)",
            " nucleotide substitution model in PhyML v3.1."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For “dataset_6,” ML phylogenies were reconstructed using the general time reversible",
            " nucleotide substitution model with gamma‐distributed rate variation among sites (GTR + G) model in PhyML v3.1."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For all NJ and ML phylogenies of the two data sets, bootstrap support values were calculated with 1 000 replicates",
            " and trees were midpoint rooted."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For “dataset_70,” regression analyses were used to determine the correlations among sampling dates and root‐to‐tip genetic divergences of the respective ML phylogenies with TempEst v1.5."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also estimated the evolutionary rate and time to the most recent common ancestor (TMRCA) for “dataset_70” using ML dating in the TreeTime package."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We used two schemes to set the time‐scale prior for each data set: that is, constrained evolutionary rate method with a log‐normal prior (mean = 1.0 × 10−3 substitutions per site per year; 95% Bayesian credible interval [BCI]: 1.854 × 10−4 to 4 × 10−3 substitutions per site per year) placed on the evolutionary rate parameter, as per previous studies,",
            ", ",
            ", ",
            " and the tip‐dating method, for which the overall estimated evolutionary rate was given an uninformative continuous‐time Markov chain (CTMC) reference prior."
        ],
        "lab": [
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The HIV TRAnsmission Cluster Engine (HIV‐TRACE; www.hivtrace.org)",
            " was employed to infer transmission network clusters for SARS‐CoV‐2 “dataset_70.”",
            "We divided “dataset_6” into four clades (ie, Clade A, Clade B, Clade C, and Clade D), with Clade A designated as the query group."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For “dataset_70” and “dataset_6,” HKY and GTR +",
            "G were the models of best‐fit, respectively, across the two different substitution schemes (ie, 24 and 88 candidate models) according to the BIC method, and were thus used in subsequent likelihood‐mapping and phylogenetic analyses for the two data sets."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The PHI tests of “dataset_70” did not find statistically significant evidence of recombination (P = 1.0)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Likelihood‐mapping analysis of “dataset_70” revealed that 69.7% of the quartets were distributed in the center of the triangle, indicating a strong star‐like topology signal reflecting a novel virus, which may be due to exponential epidemic spread (Figure 1A)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Likewise, 25.9% of the quartets from “dataset_6” were distributed in the center of the triangle, indicating a strong phylogenetic signal (Figure 1B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The split network generated for “dataset_70” using the NeighborNet method was highly unresolved, and the phylogenetic relationship of “dataset_70” was probably best represented by a network rather than a tree (Figure 1C)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Both the NJ and ML phylogenetic analyses of SARS‐CoV‐2 “dataset_70” also showed star‐like topologies, in accordance with the likelihood‐mapping results (Figures 2 and S1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ML phylogenetic tree showed greater star‐like topology than the NJ phylogenetic tree, indicating that the ML method was more reasonable for “dataset_70.”",
            "Root‐to‐tip regression analyses between genetic divergence and sampling date using the best‐fitting root showed that “dataset_70” had a minor strong positive temporal signal (R",
            "ML dating analyses between genetic divergence and sampling date also showed that “dataset_70” had a minor strong positive temporal signal (R",
            "Based on Bayesian time‐scaled phylogenetic analysis using the constrained evolutionary rate method with a log‐normal prior (mean = 1.0 × 10−3 substitutions per site per year; 95% BCI: 1.854 × 10−4 to 4 × 10−3 substitutions per site per year) placed on the evolutionary rate parameter, the estimated TMRCA dates and evolutionary rates for SARS‐CoV‐2 from “dataset_70” ranged from 21 May 2019 to 13 October 2019 (95% BCI: 27 and 30 January 2020) and from 1.57 × 10−4 to 1.06 × 10−3 substitutions per site per year (95% BCI: 1.08 × 10−4 to 3.10 × 10−3), respectively (Table 1)."
        ],
        "lab": [
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, based on Bayesian time‐scaled phylogenetic analysis using the tip‐dating method, the estimated TMRCA dates and evolutionary rates from “dataset_70” ranged from 22 to 24 November 2019 (95% BCI: 23 October 2019 and 16 December 2019) and from 1.19 × 10−3 to 1.31 × 10−3 substitutions per site per year (95% BCI: 6.22 × 10−4 to 1.96 × 10−3), respectively (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, the estimated TMRCA dates and evolutionary rates for SARS‐CoV‐2 from “dataset_70” were consistent among the different clock models (strict and relaxed) but were distinct among the different dating methods (constrained‐dating and tip‐dating)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The estimated TMRCA dates and evolutionary rates for SARS‐CoV‐2 from “dataset_70” using the tip‐dating method exhibited much narrower 95% BCIs than the constrained‐dating method."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, the estimated TMRCA dates and evolutionary rates for SARS‐CoV‐2 from “dataset_70” were consistent between the different coalescent tree models (ie, constant and exponential) when using the tip‐dating method but were distinct when using the constrained‐dating method."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For each data set, we employed the HKY nucleotide substitution model, as well as a constant size coalescent tree prior and strict molecular clock model to estimate the TMRCA."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on this, we identified one large transmission cluster that included 66 of 70 (94.29%) genomes, thus suggesting low genetic divergence for “dataset_70” (Figure S3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on this, we identified 6 transmission clusters that included 37 of 70 (52.86%) genomes for “dataset_70” (Figure 5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On the basis of “dataset_70,” our likelihood‐mapping analysis confirmed additional tree‐like signals over time compared with our previous results."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            ", ",
            " Split network analysis for SARS‐CoV‐2 “dataset_70” using the NeighborNet method was highly unresolved, indicating an explosive, star‐like evolution of SARS‐CoV‐2, and recent and rapid human‐to‐human transmission (Figure 1C)."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These results are consistent with the ML phylogenetic analyses, which showed polytomy topology from “dataset_70” (Figure 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, we concluded that the human SARS‐CoV‐2 virus, which is responsible for the current outbreak of COVID‐19, did not come directly from pangolins."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To explore the potential intermediate animal host of the SARS‐CoV‐2 virus, we reanalyzed virome data sets from pangolins and representative SARS‐related coronaviruses isolates from bats, with particular attention paid to the spike glycoprotein gene."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, we concluded that the human SARS‐CoV‐2 virus, which is responsible for the recent outbreak of COVID‐19, did not come directly from pangolins."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "First case of COVID-19 was reported in December 2019 in Wuhan (China) and since then it has spread worldwide becoming a pandemic, with maximum death cases in Italy, although initially, the maximum mortality was reported from China [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to a World Health Organization (WHO) report, as of 2 April 2020, there were confirmed 823626 COVID-19 cases and 40598 deaths, that included cases which were both locally transmitted or imported [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "From India, there were only two full genome sequences submitted from the state of Kerala (",
            "GenBank",
            " accession numbers ",
            "MT012098",
            " {(isolate SARS-CoV-2/human/IND/29/2020 or isolate 29) and ",
            "MT050493",
            " (isolate SARS-CoV-2/human/IND/166/2020 or isolate 166)}."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 535,
                "end": 542,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 561,
                "end": 569,
                "name": "MT012098"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 628,
                "end": 636,
                "name": "MT050493"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T1",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "Structure of the spike glycoprotein was retrieved from the protein data bank (",
            "PDB",
            " ID: ",
            "6VXX",
            ") (Figure 5)."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 772,
                "end": 775,
                "name": "PDB"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 780,
                "end": 784,
                "name": "6VXX"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T4",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "Abstract  Since 2002, β coronaviruses (CoVs) have caused three zoonotic outbreaks, SARS-CoV in 2002, MERS-CoV in 2012, and the recent outbreak of SARS-CoV-2 late in 2019 (also named as COVID-19 or novel coronavirus 2019 or nCoV2019)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As the nCoV2019 takes its course throughout the world, more and more sequence analyses are being done and genome sequences are being deposited in various databases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We are seeing that even in epidemics from an infectious agent like COVID-19, there are differing clinical phenotypes that lead to MODS, requiring changes in therapeutic course (14, 15)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using only the first of the paired-end reads, we performed bacterial and viral read mapping with kraken2-2.0.7-beta (61) used against the full transcriptome database of the tool downloaded on June 24, 2019."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Samples were normalized to every million mapped reads to human and clustered based on patient ID."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using ",
            "GTEx",
            " (28) tissue annotated expression data sets, we filtered for genes that are unique to each tissue/organ."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 497,
                "end": 501,
                "name": "GTEx"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All sex-specific organs were removed from the database to begin."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While reads align to some of these transcriptomes, reads may belong to closely related species not within our transcriptome database."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This is further exemplified by viral outbreaks, such as COVID-19, that show selectivity in age- and sex-related vulnerability and inflammatory phenotypes leading to differences in presentation, severity, and management (14, 17)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The entire world is facing a devastating crisis in the growing pandemic associated with the coronavirus disease—COVID-19—and Italy is paying dearly for this pandemic both in terms of public health and economics."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since Feb 21, 2020, when the first Italian COVID-19 patient was confirmed, the National Healthcare Service, based on the Beveridge model offering universal and equal health care to all citizens, has faced increasing pressure, with 110,574 total cases of COVID-19 and 13,155 deaths as of April 1, 2020 [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Herein, we report changes regarding the execution of the germline BRCA (gBRCA) testing, during the COVID-19 outbreak in March 2020, in a referral center for the gBRCA testing [2–5]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With the implementation of the behavioural restrictions by the Italian Government (March 2020) during the COVID-19 pandemic, a substantial reduction in gBRCA testing (about 60%) compared to the first 2 months of the current year was registered, but the requests have not been reset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Even in the presence of a serious ongoing emergency, such as the COVID-19 pandemic, it is evident that cancer patients must continue to take advantage of gBRCA testing to target therapy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first person-to-person transmission of the 2019-novel coronavirus in Italy on 21 February 2020 led to an infection chain that represents one of the largest known COVID-19 outbreaks outside Asia."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "An outbreak of Coronavirus disease 2019 (COVID-19) occurred in Wuhan, China in December 2019 and has spread rapidly across the globe."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Several studies have provided evidence that coagulation dysfunction is a major cause of death in severe COVID-19 patients [1], [2], [3], [4]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Awareness regarding thrombotic complications in COVID-19 patients is extremely important for deciding the appropriate course of treatment."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A large number of COVID-19 infected patients have been reported to have other chronic diseases such as cardiovascular disease, malignancy, respiratory diseases and kidney and liver abnormalities."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Presence of such comorbidities results in increased severity of COVID-19 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Increasing viral load during COVID-19 infection progression leads to cascade of events like inflammation and sepsis releasing inflammatory cytokines which in turn leads to increase in circulating thrombin levels."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Various recent reports have shown increasing concerns of hypercoagulability in COVID-19 patients [14], [15]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Higher incidences of thrombotic complications have been observed in COVID-19 patients admitted in Intensive Care Unit (ICU)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Reports have also shown that coagulopathy in COVID-19 infection results in higher D-dimer levels and subsequently high mortality rates [14] and this mortality is reduced by the use of anticoagulation therapy with heparin [15]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, abnormal coagulation parameters, especially increased D-dimer and FDP levels are associated with deaths in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This study was conducted on 449 severe COVID-19 patients and 99 of them received low molecular weight heparin (LMWH) treatment for 7 days or longer."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "They further reported that among patients had higher mortality rates and raised D-dimer levels in absence of heparin treatment and LMWH treatment was associated with better prognosis in severe COVID-19 patients [15]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Researchers further stated that VTE incidence in severe NCP patients was the prime cause of their poor prognosis and significant increase in the D-dimer levels could be a good parameter for identifying high VTE risk amongst COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, the abnormality in coagulation in COVID-19 differs from what is typically found in other infectious diseases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the non-survivors of COVID-19 there was a marked decrease in fibrinogen levels and elevation in FDP."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Most recent reports demonstrate that D dimer levels are significantly increased in COVID-19 non-survivors and thus its prognosis can be predicted based on this parameter [1], [4], [18]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Asakura et al. suggested combination therapy of heparin and Nafamostat against COVID-19 infection [22]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Other recent reports also suggest thromboprophylaxis for all hospitalized COVID-19 patients [23]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "During these unforeseen conditions with worldwide pandemic of coronavirus, it is extremely important to consider risk of thrombotic complications while treating an infected COVID-19 patient."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Highlights     •  Coagulation parameters such should be checked at the time of admission of COVID-19 patient."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Background  Recent reports on outbreak of SARS-CoV-2 coronavirus (COVID-19) have shown its association with abnormal blood clots."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Spread of COVID-19 has been associated with disseminated intravascular coagulation (DIC) and subsequent coagulopathy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Initially coagulopathy in COVID-19 patients result in significant elevation of D-dimer, fibrin/fibrinogen degradation products (FDP), and abnormalities in coagulatory parameters, which resulting in formation of thrombus and eventually death."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Methodology  Present report intends to summarize the information of the research reports available so far on the complications of formation of unusal blood clots (thrombosis) during COVID-19 infection and its therapeutic strategies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Extensive web search was done for various reports associating COVID-19 infection with increased coagulopathy and abnormal coagulatory parameters such as PT, PTT, and platelet counts; along with increased D-dimer and fibrinogen levels."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Results and conclusion  Findings of these research reports were summarized to recommend cautions for clinicians while treating COVID-19 patient."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19, caused by a positive sense single strand RNA virus (a member of the coronavirus family) called SARS-CoV-2 [1], [2] does not, as of now, have any treatment and a majority of its aspects are yet unknown [3]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As is the case with many viral diseases there is no vaccine for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With the number of cases crossing six million (and more than three hundred and seventy thousand deaths) worldwide, there is a dire need of a vaccine (and repurposing of drugs) for SARS-CoV-2 disease (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As testing for SARS-CoV-2 was limited to hospitalised patients across much of Europe there is limited data on the self-reported clinical characteristics and outcomes of patients in the community with coronavirus disease 2019 (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Anonymised record linkage was conducted between routinely collected healthcare datasets in order to ascertain clinical characteristics and outcomes of those who tested positive."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hospitalisations were recorded using the new ICD code for COVID-19: U07.1 [5]",
            "As testing for SARS-CoV-2 was limited to hospitalised patients across much of Europe there is limited data on the self-reported clinical characteristics and outcomes of patients in the community with coronavirus disease 2019 (COVID-19)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Anonymised record linkage was conducted between routinely collected healthcare datasets in order to ascertain clinical characteristics and outcomes of those who tested positive."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This new strain was first described in January 2020 as a cause of a novel severe respiratory illness now known as COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "RNA was detected in 54 % of those who reported symptoms compatible with COVID-19, but in only 4% who were asymptomatic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among these, 115 SARS-CoV-2 isolates were obtained from humans, 4 SARS-CoV-2 isolates were collected from the environment, and 8 SARSr-CoVs from pangolin were downloaded from ",
            "GISAID",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 175,
                "end": 181,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The consensus sequence of HKU-SZ-002a (accession number ",
            "MN938384",
            ") and HKU-SZ-005b (accession number ",
            "MN975262",
            ") have been deposited into ",
            "GenBank",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "AccessionNumber",
                "start": 56,
                "end": 64,
                "name": "MN938384"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 100,
                "end": 108,
                "name": "MN975262"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 135,
                "end": 142,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T3",
                "end": "T1"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "Raw reads, after excluding human reads, have been deposited into ",
            "BioProject",
            " (accession number ",
            "PRJNA601630",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 209,
                "end": 219,
                "name": "BioProject"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 238,
                "end": 249,
                "name": "PRJNA601630"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T4",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "Two complete virus genomes (HKU-SZ-002a and HKU-SZ-005b) were sequenced using Nanopore technology and showed a novel coronavirus that is most closely related to those of the bat SARS-like coronavirus bat-SL-CoVZXC21 (",
            "NCBI",
            " accession number ",
            "MG772934",
            ") and bat-SL-CoVZC45 (",
            "NCBI",
            " accession number ",
            "MG772933",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 469,
                "end": 473,
                "name": "NCBI"
            },
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 491,
                "end": 499,
                "name": "MG772934"
            },
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 521,
                "end": 525,
                "name": "NCBI"
            },
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 543,
                "end": 551,
                "name": "MG772933"
            },
            false
        ],
        "rel": [
            {
                "id": "R4",
                "bool": true,
                "head": "T6",
                "end": "T7"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T8",
                "end": "T9"
            }
        ]
    },
    {
        "sen": [
            "Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first reported from China in December, 2019."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV) infections have a higher mortality rate than does COVID-19, SARS-CoV-2 spreads much more rapidly than MERS-CoV and SARS-CoV."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We have reported use of posterior oropharyngeal (deep throat) saliva for diagnosis and viral load monitoring in a cohort of 12 patients with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we report use of self-collected posterior oropharyngeal saliva samples from patients with COVID-19, which avoids close contact between health-care workers and patients, for viral load monitoring."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "If patients were intubated, we obtained endotracheal aspirate instead of posterior oropharynx saliva.6, 9, 10, 11 Our initial experience showed that such saliva samples are promising in viral load monitoring in patients with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Ten patients had severe COVID-19, of whom all required oxygen supplementation, and 13 patients had mild disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Chronic comorbidities were more common among patients with severe COVID-19 (seven [70%] patients with severe disease had chronic comorbidities vs four [31%] with mild disease), although this difference was not significant (table",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A high viral load on presentation of COVID-19 was recorded in our cohort, even for patients who were hospitalised shortly after symptom onset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Currently, no standard treatment is available for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Background  Coronavirus disease 2019 (COVID-19) causes severe community and nosocomial outbreaks."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We aimed to ascertain the serial respiratory viral load of SARS-CoV-2 in posterior oropharyngeal (deep throat) saliva samples from patients with COVID-19, and serum antibody responses."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We included patients with laboratory-confirmed COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Unlike severe acute respiratory syndrome, patients with COVID-19 had the highest viral load near presentation, which could account for the fast-spreading nature of this epidemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The fifth, isolated from a pangolin, Pan_SL-CoV_GD/P1L, had been deposited in the ",
            "GISAID",
            " database as Pangolin."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 82,
                "end": 88,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Outbreaks due to members of the coronavirus family have been especially prominent in terms of transmission and mortality, beginning with the emergence of SARS-CoV in 2002–2003 [1,2], followed by middle east respiratory syndrome coronavirus (MERS-CoV) in 2012 [3] and SARS-CoV-2 (COVID-19) in late 2019 [4]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The door of development for peptide-based therapeutics was widely opened by introducing peptides with varying sequence length, side-chain reactivity and degree of modification and incorporation of unnatural components."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the immediate future, repurposed drugs and vaccines will be the first line of defense against COVID-19 [53], however drug resistance and other issues with vaccines (use in immunocompromised or immune deficient individuals) should allow room for development of therapeutics targeting other pathways."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "During a disease outbreak/pandemic situation such as COVID-19, researchers are in a prime position to identify and develop peptide-based therapies, which could be more rapidly and cost-effectively advanced into a clinical setting."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, we discuss the advantages of peptidomimetics and other potential targets that have been studied using peptide-based therapeutics for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Abstract  Reverse transcription (RT)-PCR, the principal diagnostic method applied in the world-wide struggle against COVID-19, is capable of detecting a single molecule of a viral genome."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease 2019 (COVID‐19) clinical data has so far shown that the mortality rate for men is higher than for women."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "An initial report released by the Centers for Disease Control and Prevention (CDC) on population‐based surveillance sampled across 14 states, representing 10% of the US population, has indicated that age and comorbidities are associated with increased hospitalization rates of patients with COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on data from literature, we propose a novel mechanism of the observed sex differences in clinical outcomes in patients and identify a role for the transmembrane protease serine 2 (TMPRSS2) as a contributing factor to the more severe outcomes noted for COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While ACE2 is the main receptor for the spike protein for both viruses, its expression and gene polymorphisms did not influence sex‐specific effects or outcomes for SARS",
            " or COVID‐19 (based on 2 recent preprint studies published on medRxiv that have yet to be peer‐reviewed at the time of writing)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Indeed, the clinical manifestations of COVID‐19 include not only complications from acute myocardial injury, elevated liver enzymes, and acute kidney injury in patients presenting to hospitals, but also gastrointestinal symptoms in community patients experiencing milder forms of the disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The study proposed that TMPRSS2 could possibly be a candidate gene that contributes to the COVID‐19 epidemiologic data seen in the Italian population, with higher death rates and differences in severity among sexes compared to East Asians."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We may never know the true incidence rates for COVID‐19; however, looking at current data, Europe and the United States have overtaken China and eastern Asia as the epicenters of the pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Clinically, increases in IL‐6 have been linked to severe COVID‐19 cases",
            " and have been discussed as a potential biomarker."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Cytokine release syndrome (CRS) has been noted in some severe patients of COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, autopsy findings from COVID‐19 patients revealed that tissues that had been destroyed by SARS‐CoV‐2 exhibited characteristics of the so‐called primary cytokine storm (induced by viral infection and mainly produced by alveolar macrophages, epithelial cells, and endothelial cells), rather than those observed in secondary cytokine storm (induced by different subsets of activated T lymphocytes in late‐stage viral infections or a complication of T‐cell–engaging therapies)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since SARS‐CoV‐2 shares similar mechanisms of viral entry with SARS‐CoV, this transgenic model could potentially be used to study novel therapeutics for COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In summary, no in vivo preclinical data for SARS‐CoV‐2 are available to justify any of the treatment regimens for combination trials currently under investigation for COVID‐19, as an in vivo mouse model for SARS‐CoV‐2 is not yet available, and it would require too much time to test each proposed drug combination in primate models of human disease or use existing models for MERS‐CoV and SARS‐CoV pathogenesis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There is no doubt that antivirals and supportive treatments are key areas to focus on in treating patients with COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our proposed treatment combination is based on existing data from in vitro/in vivo studies that have been conducted for SARS‐CoV and MERS‐CoV for each individual agent as well as clinical features of COVID‐19 since current in vivo animal models are not available for SARS‐CoV‐2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Both are being investigated in Japan and other countries for their ability to block SARS‐CoV‐2 entry, with Japan initiating a clinical trial for nafamostat (which is also a short‐acting anticoagulant) for COVID‐19–positive patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Direct inhibition of TMPRSS2 using protease inhibitors (nafamostat) or indirectly by downregulating TMPRSS2 expression with androgen pathway inhibitors, as with all potential novel treatments for COVID‐19, are promising hypotheses, and it remains to be determined whether this approach can mediate the sex‐specific outcomes and severity of outcomes in patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Another drug under investigation for COVID‐19 is remdesivir, an RNA‐dependent RNA polymerase inhibitor with antiviral activity, which has been shown to act on viral replication after entry in SARS‐CoV‐2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While remdesivir is not US Food and Drug Administration approved for any indications, the WHO considered it as a promising drug candidate to treat COVID‐19 based on its broad‐spectrum activity, in vitro/in vivo data for coronaviruses (SARS‐CoV‐2, SARS‐CoV, and MERS‐CoV), and clinical safety data from Ebola virus disease trials."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Initial results of the compassionate use of remdesivir in patients with COVID‐19 have shown some encouraging results."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additionally, there are clinical trials using the antimalarial drugs hydroxychloroquine (HCQ) and chloroquine to treat COVID‐19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The clinical data for HCQ from early trials for COVID‐19 have been mixed, with some studies showing encouraging results and others demonstrating lack of efficacy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            ",",
            "Potential inhibitors of cytokine storm have shown some clinical benefit in COVID‐19 patients and include agents that target cytokine release such the anti–IL‐6 antibody tocilizumab, the anti‐human granulocyte macrophage colony‐stimulating factor monoclonal antibody lenzilumab, or the Janus kinase 1/2 inhibitor ruxolitinib (with phase III trials initiated or being planned for COVID‐19)."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Sanders et al",
            " provide a comprehensive review of the recent clinical experience for remdesivir, HCQ, and other therapeutics, including inhibitors of CRS that are currently under investigation as potential COVID‐19 treatments."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since high levels of inflammatory markers such as IL‐6 have been reported in patients experiencing COVID‐19 complications, we suggest using this potential clinical biomarker or any of the above laboratory markers as a guide to monitor patients on drug therapy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID‐19 treatment will involve a polypharmacy approach; we therefore expect a multitude of adverse effects from these drug combinations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There are also many factors that can explain the difference in outcomes in men and women afflicted with COVID‐19, and TMPRSS2 emerges as an interesting candidate."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, genotyping studies performed on clinical specimens collected from patients on COVID‐19 trials are warranted to further evaluate known SNPs and to find additional functional polymorphisms in the TMPRSS2 gene."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On a broader scope, multiple institutions have initiated genomic investigations in a project called the ",
            "COVID Host Genetics Initiative",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 6440,
                "end": 6470,
                "name": "COVID Host Genetics Initiative"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SNPs that are confirmed to be predictive biomarkers can be incorporated in the CDC's current list of clinical biomarkers for disease severity as discussed above."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ongoing pandemic of COVID-19 has infected over 20 million people globally, of which over 750,000 have died (as of 13 August 2020) [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, which emerged in December 2019 [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For COVID-19, the rapid development of diagnostic polymerase chain reaction (PCR) was facilitated by the availability of genome sequences of SARS-CoV-2 isolates [4,5]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The primary objective of this analysis is to compare genome sequencing results from direct amplification of the SARS-CoV-2 genome (i.e., the Liverpool or ARTIC PCR protocols) [7] with bait capture enrichment from COVID-19 patient swabs with markedly different viral RNA concentrations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To confirm the epidemiological origin of both isolates, the best genome sequence of each was included in a uniform manifold approximation and projection (UMAP) involving the aligned genomes of 8074 SARS-CoV-2 isolates (obtained from ",
            "Global Initiative on Sharing All Influenza Data, GISAID",
            ", ",
            "https://www.gisaid.org",
            ") labelled by country of origin [28]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 967,
                "end": 1022,
                "name": "Global Initiative on Sharing All Influenza Data, GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 1024,
                "end": 1046,
                "name": "https://www.gisaid.org"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "FASTQ sequences and assembly FASTA have been deposited in ",
            "NCBI",
            " Bioproject ",
            "PRJNA636446",
            ", with assembly FASTA sequences additionally submitted to ",
            "GISAID",
            " (Wuhan-derived: ",
            "EPI_ISL_413015",
            " as submitted previously, Iran-derived: ",
            "EPI_ISL_450747",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 1142,
                "end": 1146,
                "name": "NCBI"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 1158,
                "end": 1169,
                "name": "PRJNA636446"
            },
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 1227,
                "end": 1233,
                "name": "GISAID"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 1250,
                "end": 1264,
                "name": "EPI_ISL_413015"
            },
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 1304,
                "end": 1318,
                "name": "EPI_ISL_450747"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T5",
                "end": "T7"
            }
        ]
    },
    {
        "sen": [
            "There is very little variation among available SARS-CoV-2 genome sequences, as summarized at ",
            "GISAID",
            " (",
            "www.gisaid.org",
            ") and exemplified by our own detection of only 6 SNPs between the original Wuhan genome and our Iran-derived sample."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Dataset",
                "start": 1414,
                "end": 1420,
                "name": "GISAID"
            },
            false,
            {
                "id": "T9",
                "type": "URL",
                "start": 1422,
                "end": 1436,
                "name": "www.gisaid.org"
            },
            false
        ],
        "rel": [
            {
                "id": "R5",
                "bool": true,
                "head": "T8",
                "end": "T9"
            }
        ]
    },
    {
        "sen": [
            "Cross-referencing with ",
            "GISAID",
            " metadata revealed that within this small cluster, isolates from Australia (2 isolates), India (4 isolates), and Pakistan (1 isolate) also had travel history associated with the outbreak in Iran."
        ],
        "lab": [
            false,
            {
                "id": "T10",
                "type": "Dataset",
                "start": 1576,
                "end": 1582,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Unfortunately, ",
            "GISAID",
            " did not contain sequences from Iran, but phylogenetic analysis confirmed these UMAP results, placing our Iran-derived sample and the nearby UMAP samples in a well supported clade (Figure S1)."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Dataset",
                "start": 1793,
                "end": 1799,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, our work did detect mismatches for currently used diagnostics PCR primers, specifically in primers designed by the CDC and the Japanese NID."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The foundation of COVID-19 diagnostic testing has included direct detection of viral genomes through nucleic acid amplification methods."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Reports of false negative results from real time PCR testing indicate that even the high analytical sensitivity of RT-PCR may be challenged by the pathology of COVID-19 [6,7]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Eluted RNA (5 μl for the CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel (111 specimens), 10 μl for the Taqpath COVID-19 (EUA) Multiplex assay (Thermo Scientific, Waltham, MA) (5 specimens) was subjected to real time PCR either by the CDC EUA Real Time PCR for SARS-CoV-2, or the Taqpath COVID-19 Multiplex assay."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Comparison of the Taqpath COVID-19 Multiplex relative to the CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel showed 100 % sensitivity and specificity relative to one another, with 100 % concordance through 20 specimens."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As shown in Table 1, the Taqpath COVID-19 Multiplex assay demonstrated detection capability of 5/5 (100 %) samples at 5.5 × 10e5 copies per milliliter and at least one SARS-CoV-2 gene in 5/5 (100 %) of samples at a concentration of 5.5 × 10e4 copies per milliliter."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This ability to perform high-throughput testing, on a sensitive molecular detection platform has potential to make a significant contribution to the COVID-19 pandemic, where such high demands exist for testing."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "After two months of relative quiescence, a large COVID-19 outbreak occurred in Hong Kong in July 2020 after gradual relaxation of social distancing policy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, treatment of COVID-19 should be based on the staging of patients, and the window of opportunity may lie between the first and the second phases, when clinical deterioration is observed with evidence of abrupt inflammation and hypercoagulable status."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease-19 (COVID-19) outbreak is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) at present has jolted the entire human race."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 pandemic has affected natives in more than 200 countries and territories located in different geographical locations and climatic conditions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to World Health Organization (WHO), nearly 3.8 million individuals have already been infected globally and more than 260 thousands have died till date (WHO COVID-19 Situation Report-109, 08/5/2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recent trend indicates much lower overall case fatality rate (CFR) in COVID-19 pandemic (4.58%) compared to outbreak of SARS (11%) and Middle East respiratory syndrome (MERS) (35%) (Peeri et al. 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The incidence and CFR varies drastically in different populations, where the present global CFR (6.9%) is significantly lower than Europe (9.2%) and considerably higher than Africa (3.4%), East Mediterranean and Southeast Asia (3.6%), Western Pacific (4.1%) and America (5.5%) (WHO COVID-19 Situation Report-109, 08/5/2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Genotypes of these variants in 26 populations from five major global regions were obtained from ",
            "1000 Genomes",
            " database (",
            "https://www.internationalgenome.org",
            ") and used for comparative analysis."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1145,
                "end": 1157,
                "name": "1000 Genomes"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 1168,
                "end": 1203,
                "name": "https://www.internationalgenome.org"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "",
            "GTEx",
            " database was used to evaluate the eQTL (Aguet et al."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 1240,
                "end": 1244,
                "name": "GTEx"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "2019)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At present, more than 200 countries and territories are directly affected by the coronavirus disease-19 (COVID-19) pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In late December 2019, an outbreak of a novel coronavirus disease 2019 (COVID-19) originated in Wuhan, China."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Diamond Princess (DP) cruise ship was put under quarantine soon after its return to Yokohama, Japan on February 3, 2020, after visiting Kagoshima, Hong Kong, Vietnam, Taiwan, and Okinawa, because an 80-y-old passenger who disembarked in Hong Kong was confirmed as a COVID-19 case on February 1 after the ship had departed from Hong Kong on January 25."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Japanese government asked about 3,600 passengers and crew members to stay on board in Yokohama during the 14-d isolation period through February 19 to prevent the further spread of COVID-19 cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A field epidemiological study about the DP COVID-19 cases has been published (3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of March 8, 697 COVID-19 cases had been identified among the 3,711 persons on the DP and 7 people had died (4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The 73 genome sequences (including 3 sequences of DP isolates deposited in the ",
            "Global Initiative on Sharing All Influenza Data [GISAID]",
            ") were compared with the Wuhan-Hu-1 (isolated on December 26, 2019 in China) genome sequence as a reference."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 943,
                "end": 999,
                "name": "Global Initiative on Sharing All Influenza Data [GISAID]"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A number of nucleotide variations have been identified; specifically, 52 SNVs among DP isolates (n = 73) and 449 SNVs among all tested isolates, including entries from ",
            "GISAID",
            " (n = 412), (Dataset S3) (Fig. 1)."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 1276,
                "end": 1282,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Maximum-likelihood (ML) phylogenetic analysis including other SARS-CoV-2 genome sequences that are publicly available on ",
            "GISAID",
            " and haplotype networks from genomic SNVs (HN-GSNVs) were used to map the genotypes of the SARS-CoV-2 isolates that disseminated in the DP cruise ship after isolation of the passengers on February 5, 2020 (Fig. 2)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 1438,
                "end": 1444,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We did not find any area-specific events of COVID-19 spread in the DP because all COVID-19 patients were widely distributed in all 18 decks across the ship."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The highest incidence of COVID-19 onset was observed on February 7, 2020; the epidemic curve in the latter half of the epidemic was dominated by crew members whose work was not strictly controlled to maintain service on the ship (7)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Zhang et al. (9) also estimated that the reproduction number (R0) for COVID-19 cases was 2.28 (95% confidence interval: 2.06 to 2.52) during the early stage, and estimated that the outbreak size on the DP cruise ship might have been greater, if the strict infection management and quarantine had not been conducted."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The personal data related to the clinical information were anonymized, and our procedure is not to request written consent for all patients suffering from COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, the virus content in pharyngeal swabs is not abundant at the early onset of COVID-19, which might lead to difficulties in achieving WGS."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The obtained NGS reads were mapped to the SARS-CoV-2 Wuhan-Hu-1 reference genome sequence (29.9 kb single-strand RNA; ",
            "GenBank",
            " ID: ",
            "MN908947",
            "), resulting in a specimen-specific SARS-CoV-2 genome sequence fully mapped with a read depth of at least ≥100× from the 99- to 29,796-nt region of Wuhan-Hu-1 genome sequence (see details in Dataset S2)."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 2795,
                "end": 2802,
                "name": "GenBank"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 2807,
                "end": 2815,
                "name": "MN908947"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T4",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "The nearly full-length genome sequence (≥29 kb) of SARS-CoV-2 isolates until February 19, 2020 were retrieved from the ",
            "GISAID EpiCoV",
            " database on May 14, 2020, followed by multiple alignment using MAFFT v7.222 (17)."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 3138,
                "end": 3151,
                "name": "GISAID EpiCoV"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The poorly aligned regions in 5′ and 3′ ends were trimmed; we determined that the core regions were from the 99- to 29,794-nt position by comparison against the Wuhan-Hu-1 genome sequences (",
            "GISAID",
            " ID, ",
            "EPI_ISL_402125",
            "; ",
            "GenBank",
            " ID, ",
            "MN908947.3",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Dataset",
                "start": 3424,
                "end": 3430,
                "name": "GISAID"
            },
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 3435,
                "end": 3449,
                "name": "EPI_ISL_402125"
            },
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 3451,
                "end": 3458,
                "name": "GenBank"
            },
            false,
            {
                "id": "T10",
                "type": "AccessionNumber",
                "start": 3463,
                "end": 3473,
                "name": "MN908947.3"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T7",
                "end": "T8"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T9",
                "end": "T10"
            }
        ]
    },
    {
        "sen": [
            "Gap-containing sequences in the core region were excluded; sequences of 243 isolates from the ",
            "GISAID",
            " database were used in subsequent analyses."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Dataset",
                "start": 3570,
                "end": 3576,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The genome sequences of the DP isolates were aligned using MAFFT with sequences retrieved from the database, followed by extraction of SNV and deletion sites."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, started in November 2019 in Wuhan (China), and from there it was transmitted and rapidly dispersed all over the world (Jin et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In March 2020, the WHO declared COVID-19 to be a pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The spread of emerging infectious diseases such as COVID-19 has a link to unsustainable use of the environment."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A relationship between pollutants and viral diseases (such as COVID-19) was recently reported (Tsatsakis et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This is an important finding, because pollutants can depress the immune system of animals and thus might increase the impacts of pathogens, such as the current global coronary disease (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The main effects of COVID-19 on human health are related to respiratory problems (Xu et al., 2020b)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This fine particulate matter can obstruct the airways, exacerbating the effects of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Some research has correlated fine particulate matter (PM2.5, PM10) with confirmed cases of deaths due to COVID-19 (Table 1",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "They found a strong relationship between PM2.5 and death risk from COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The study conducted by Saha et al. (2020) also reported that areas with better air quality showed a larger number of COVID-19 recoveries."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Concerns have been raised regarding an association of indoor air pollution with susceptibility to COVID-19, mainly in geographical areas where wood or coal is still used for cooking and heating (Mbandi, 2020; Sharma and Hossain, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All available research so far show a positive correlation between air pollution (PM2.5) and COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The evidence indicates that particulate matter appears to play a key role in the incidence and severity of cases of COVID-19, because it acts as a carrier of viruses, influences lung obstruction, and produces immunological effects by chemicals associated with it."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The underlying question here is whether multiple pollutants carried simultaneously on particulate matter act in an additive, synergistic way to increase the severity of COVID-19-like diseases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The relationships between confirmed cases or deaths by COVID-19 and environmental factors has been studied in Europe, Middle East, and Asia (mainly China, Table 2",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Temperature appears to be the environmental factor most related to COVID-19 spreading."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A study performed in several locations of China found that environmental factors by themselves could not explain variations in those cases of confirmed COVID-19 (Poirier et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interestingly, environmental variables have been found to be crucial just in the initial phase of the COVID-19 infection, during which time the dynamics of transmission are more affected by airborne viral infectivity rather than human-to-human transmission (Coccia, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although SARS-CoV-2 RNA has been detected in the air (Liu et al., 2020c), the way environmental factors may affect COVID-19 transmission is not well established."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is necessary to assess whether environmental factors really have a cause-and-effect relationship for infection cases or deaths by COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There is evidence for an indirect effect (negative/positive) of COVID-19 on environmental outcomes, mainly related to preventive confinement measures on the population imposed worldwide by various authorities (Fig. 1",
            ", Braga et al., 2020, Corlett et al., 2020, Saadat et al., 2020, Zambrano-Monserrate et al., 2020)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The worldwide COVID-19 pandemic has caused various positive impacts on the environment and the climate (Sarkodie and Owusu, 2020a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In USA, NO2 declined around 25% during the COVID-19 pandemic as compared to 2017–2019 levels (Berman and Ebisu, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Prior to the COVID-19 pandemic, greenhouse gases raised average global temperatures, causing melting of glaciers and rising sea levels."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The use of wood for heating, along with other commonly used fossil fuel, probably increases outdoor and/or indoor air pollution, which is worrisome considering that air pollution is associated with COVID-19 (Setti et al., 2020; Wu et al., 2020b)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hospital wastewater usually contains high levels of drugs, and one would expect that their concentrations and diversity has increased during the COVID-19 pandemic due to a higher demand by patients (Escher et al., 2011; Jelic et al., 2011; Ort et al., 2010)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hydroxychloroquine and chloroquine are some of the drugs that have been used to treat COVID-19 (Liu et al., 2020a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of July 2020, there are more than 15 million confirmed COVID-19 cases around the world, and an unknown number of negative cases (Dong et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On the contrary, plastics and drugs in wastewater produced during this pandemic by COVID-19 will persist longer, particularly those are not biodegradable."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There are key lessons that can be learned from COVID-19, which relate to the need to be prepared and environmentally responsible."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is necessary to establish preventive epidemiological models (e.g., monitoring of domestic wastewater) to detect the occurrence of COVID-19 in advance."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease 2019 (COVID-19) has become a global pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This article aims to deal with a possible association between COVID-19 and environmental factors and provide some recommendations for adequately controlling future epidemic threats."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Pollutants and viruses (such as COVID-19) produce negative immunological responses and share similar mechanisms of action."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Significant associations between air pollution and COVID-19 have been reported."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Particulate matter (PM2.5, PM10) can obstruct the airway, exacerbating cases of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Too little is known about the current pandemic to evaluate whether there is an association between environment and positive COVID-19 cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "•  Climatic factors are not well established as factors influencing COVID-19 pandemic dissemination."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Alternatively, with prolonged waiting times until results are available, viral replication may be measured by determining the RNA or infectious titers of progeny virus released from infected cells by RT-qPCR (Chu et al., 2020; Liu et al., 2020a; Yao et al., 2020), or tissue culture infectious dose 50 (TCID50) endpoint titrations (Chin et al., 2020; Manenti et al., 2020) and plaque assays (Keil et al., 2020; Ma et al., 2020; Runfeng et al., 2020; Xia et al., 2020a), respectively."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It can be used to measure the TCID50, to screen for antivirals, and to determine antiviral potencies of drugs (as inhibitory concentration 50), neutralizing sera or antibodies in a timely and cost-effective manner, within only two days."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Two SARS-CoV-2 permissive cell lines, Vero E6 (African green monkey epithelial kidney cells) and Caco-2 (heterogeneous human epithelial colorectal adenocarcinoma cells), were seeded in 96 well plates and inoculated with increasing multiplicities of infection (MOIs) of a SARS-CoV-2 isolate from France (BetaCoV/France/IDF0372/2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The antibody-targeted S2 domain is generally conserved between SARS-CoV-2 strains (Ng et al., 2014; Walls et al., 2020) (",
            "www.nextstrain.org",
            " (",
            "Hadfield et al., 2018",
            ")) which allows detection of the S protein of the France/IDF0372/2020 as well as the Netherlands/01 isolate and two isolates from Ulm, Southern Germany (Fig. S1)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "URL",
                "start": 1175,
                "end": 1193,
                "name": "www.nextstrain.org"
            },
            false,
            {
                "id": "T2",
                "type": "Creator",
                "start": 1195,
                "end": 1216,
                "name": "Hadfield et al., 2018"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T1"
            }
        ]
    },
    {
        "sen": [
            "We were wondering whether this high sensitivity and ease of quantitation may also allow to determine the TCID50 of virus stocks, that is usually done on Vero E6 cells by manually counting infected wells using a microscope."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The subsequent calculation of TCID50/ml by Reed and Muench revealed exactly the same viral titer for the in-cell ELISA (Fig. 4b) as for microscopic evaluation (Fig. 4a) showing that the established ELISA is suitable for determination of viral titers."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As shown in Fig. 6",
            ", the two control sera, that were obtained before the COVID-19 outbreak or shown to contain no SARS-CoV-2 immunoglobulins, did not affect infection."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In contrast, both COVID-19 sera neutralized SARS-CoV-2 infection (Fig. 6)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These titers corresponded well to the presence of immunoglobulins which suggests that the here established method can be used to detect and quantify the neutralizing capacities of sera from COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additionally, the assay can be applied to detect and quantify titers of neutralizing sera of COVID-19 patients, all within only 2 days."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We found that the in-cell ELISA allows to i) discriminate infected from uninfected wells, and ii) even after infection with very low MOIs (as low as 0.000005, which corresponds to one virion per three wells) at 4 days post infection (Fig. 4), representing an alternative for non-biased determining the TCID50 without the need of counting infected wells or plaques."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The development of efficient drugs and vaccines against COVID-19 requires detailed knowledge about SARS-CoV-2 biology."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Utilization of the in-cell ELISA allows to e.g. determine TCID 50 of virus stocks, antiviral efficiencies (IC 50 values) of drugs or neutralizing activity of sera."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The SARS‐CoV‐2 ssRNA virus was initially detected in December 2019 within China's Hubei province and its associated COVID‐19 pandemic is currently ongoing, with a global toll of over 5 million infections and 333 thousand deaths so far (WHO coronavirus disease [COVID‐19] situation report‐124, published on 23 May 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Despite having such climate conditions, COVID‐19 cases are increasing at an alarming rate in relatively hot and humid subtropical South‐East Asian countries."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of 22 May, a total of 182,278 cases of SARS‐CoV‐2‐infected cases were identified in South‐East Asia, with a death toll of over 5,500 (WHO coronavirus disease [COVID‐19] situation report‐124, published on 23 May 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, ",
            "GISAID",
            " differentiated COVID‐19 into three major clades: Clade S (prevalent in North America), Clade V (prevalent in Asia and Europe) and Clade G (prevalent in Europe), having NS mutations with aa substitutions at NS8_L84S, NS3_G251V and S_D614G, respectively (Fuertes et al., 2020)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 712,
                "end": 718,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, based on genomic data available from the ",
            "GISAID",
            ", ",
            "Nextstrain",
            "'s SARS‐CoV‐2 global genomic epidemiology analysis shows 10 major clades for this virus."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 1045,
                "end": 1051,
                "name": "GISAID"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 1053,
                "end": 1063,
                "name": "Nextstrain"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The number and ratio of sequence by country were determined based on the available number of sequences and the total number of COVID‐19 cases up to 23 May 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Accession ID, collection dates and locations of this subset are provided in Supporting Information S1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Non‐synonymous mutations with their specific mutation sites in the 60 genomes were determined using ‘CoVsurver enabled by ",
            "GISAID",
            "’ in ",
            "GISAID’s EpiCoV",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 1538,
                "end": 1544,
                "name": "GISAID"
            },
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 1549,
                "end": 1564,
                "name": "GISAID’s EpiCoV"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "Group 1 consists of 11 sequences, including the reference sequence hCoV19/Wuhan/WIV04/2019 (Accession: ",
            "EPI_ISL_402124",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 1678,
                "end": 1692,
                "name": "EPI_ISL_402124"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A geographic heat map (Figure 5) revealed that most of the 78 NS mutations found from 60 sequences were also common in Europe and North America (according to global mutation statistics database; Supporting Information S3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This mutation was later reported as C type by another group (Forster, Forster, Renfrew, & Forster, 2020) and was clustered as S clade by ",
            "GISAID",
            " (",
            "Fuertes et al., 2020",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Dataset",
                "start": 2055,
                "end": 2061,
                "name": "GISAID"
            },
            false,
            {
                "id": "T8",
                "type": "Creator",
                "start": 2063,
                "end": 2083,
                "name": "Fuertes et al., 2020"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Most of the S protein mutations identified in this region (Supporting Information S2) were also observed in Europe and North America according to the ",
            "GISAID",
            " global mutation database."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Dataset",
                "start": 2236,
                "end": 2242,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This specific aa substitution was identified on 55 occasions according to the global database."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The SARS‐CoV‐2 coronavirus is responsible for the current COVID‐19 pandemic, with an ongoing toll of over 5 million infections and 333 thousand deaths worldwide within the first 5 months."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The incidence rate of COVID‐19 is increasing at an alarming pace within subtropical South‐East Asian nations with high temperatures and humidity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To understand this spread, we analysed 444 genome sequences of SARS‐CoV‐2 available on the ",
            "GISAID",
            " platform from six South‐East Asian countries."
        ],
        "lab": [
            false,
            {
                "id": "T10",
                "type": "Dataset",
                "start": 2789,
                "end": 2795,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus Diseases (COVID-19) comprises symptoms reported by patients infected by SARS-CoV-2, ranging from mild to severe, and some cases result in death."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We analyzed 17,928 genomic sequences obtained from the ",
            "GISAID",
            " database (updated on 07/24/2020) derived from patients infected by SARS-CoV-2 from different areas around the world."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 212,
                "end": 218,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 reference genome (",
            "RefSeq",
            ": ",
            "NC_045512.2",
            ") was obtained from the ",
            "GenBank",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 365,
                "end": 371,
                "name": "RefSeq"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 373,
                "end": 384,
                "name": "NC_045512.2"
            },
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 408,
                "end": 415,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T4",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "Furthermore, the dataset available did not allow us to determine whether this deletion happened as a series of independent events in different temporal moments and geographical areas, as if the virus has an intrisecally fragile site, or it emerged from a single transforming event originating from a unique cluster."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Understanding the different steps that characterize the pathogenicity of this virus, as well as the spreading and changes of these pathogenic determinants among the population, may help determining proper strategies of containment of SARS-CoV-2 spread and identify better drugs for treatment of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 17,928 genome sequences were obtained from the ",
            "GISAID",
            " database (December 2019 to July 2020) from patients infected by SARS-CoV-2 from different areas around the world."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 1105,
                "end": 1111,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The rapid advance of the coronavirus COVID-19 pandemic has significantly increased mortality but also has demonstrated considerable potential to negatively impact mental health, including in the young [1,2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Perhaps no group of individuals with mental illness is as directly affected by the worsening outbreak of COVID-19 as people living with obsessive-compulsive disorder (OCD)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For others, COVID-19 is likely to cast a long shadow, as people of all ages with OCD are known to be particularly inflexible at ‘unlearning’ danger responses when they become obsolete [6,7] and thereby conditioned to prolonged virus-induced distress and anxiety."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Confirm the diagnosis of OCD, paying particular attention to other obsessive-compulsive and related disorders (OCRDs) including hypochondriasis (recently endorsed as an OCRD in the World Health Organization (WHO) ICD-11) [8], as these disorders are likely to be most affected by COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is also important not to assume that every patient with contamination fears related to germs and illness will necessarily be excessively concerned about COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In particular, note WHO ICD-11 guidelines regarding mental health and psychosocial considerations during the COVID-19 outbreak [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additional COVID-related factors found anecdotally to potentially increase suicidal risk include a recent increase in OCD severity, experiencing a family member found positive for COVID-19 or finding the effects of quarantine or isolation distressing."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Review medication status as a priority: Based on the risks associated with exposure and response prevention (ERP) in the pandemic (see below), and uncertainty as to which of the two evidence-based treatments, pharmacotherapy or cognitive behaviour therapy (CBT), represents the most efficacious first line treatment modality [11], pharmacotherapy should be the first option for adults and children with OCD with contamination, washing or cleaning symptoms during the COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This case-control study examines the association between receipt of the bradykinin 2 (B2) receptor antagonist icatibant and improved oxygenation in patients with coronavirus disease 2019 (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This emerging virus was later identified as coronavirus called SARS-CoV-2 responsible on Coronavirus Disease 19 (COVID-19) [1,2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Despite the fact that COVID-19 has a death rate of 2.8% as of April, the 8,844,171 confirmed cases with 465,460 confirmed deaths in a few months (December 8, 2019 to June 22, 2020) are terrifying."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The complete genomes were downloaded from the ",
            "NCBI",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 373,
                "end": 377,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our genomic database contains in totally 22 species (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Fig. 1.b shows an example of the CGR-centroid plot of each sub-region and the center of CGR (X) for COVID 19 after being partitioned into sub-regions of size 2 × 2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nucleotide sequences are converted into a numerical sequence (1D signals) before processing from our database extracted from ",
            "NCBI",
            " platform."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 741,
                "end": 745,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The used methods are an alignment free method, requesting only a sequence database and a bioinformatics and signal processing knowledges [[16], [17], [18]]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Prior scientists searched the evolutionary history of the Wuhan COVID-19 virus [1], [2], [3], [4], [5], [6], [7], [8], [9], [10], [11], [12], [13], [14], [15],34,35]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nevertheless, it was not clear, till now, if the COVID-19 arose from a recombination event or no between those viruses [12]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Others scientists suggested possible genesis of COVID-19 virus through recombination between Bat [10,11] and Pangolin coronaviruses [14,15]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our results support this possibility of COVID-19 virus genesis though evolution of Bat and Pangolin coronaviruses by accumulation of point mutations and recombination."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The SARS-CoV-2 Orf9b biotin-streptavidin affinity purification mass spectrometry data are deposited on ",
            "ProteomeXchange",
            " (Project accession: ",
            "PXD019803",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 103,
                "end": 118,
                "name": "ProteomeXchange"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 139,
                "end": 148,
                "name": "PXD019803"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "In this study, I mined the ",
            "NCBI",
            " expressed sequence tag (est) database to discover sequences related to SARS‐CoV‐2."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 27,
                "end": 31,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "RNA extraction, library construction, and sequencing was performed previously by Zhong et al",
            " and Adams et al",
            " and uploaded to ",
            "GenBank",
            " on the expressed sequence tag (est) database."
        ],
        "lab": [
            false,
            false,
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 242,
                "end": 249,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To identify novel coronavirus sequences, translated nucleotide BLAST (tblastn) database searches were performed by searching for SARS‐CoV‐2 sequences in the ",
            "NCBI",
            " expressed sequence tag (est) database."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 453,
                "end": 457,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS‐CoV‐2 protein sequences (amino acids 266‐13 468 and 13 468‐21 555) used to search the database (Figure S1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We then identified the submitting laboratories through the NCBI database and found that both cDNA libraries were submitted by laboratories at the Institute of Hydrobiology, Chinese Academy of Sciences, in Wuhan, China."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On this basis of the structure of 3CL hydrolase (Mpro) of 2019‐nCoV, the joint team integrated the strategy of virtual screening and enzymology test, focused on the drug screening for the marketed drugs, as well as the self‐built “database of high‐yield compounds” and “database of compounds from medicinal plants”, and quickly found 30 kinds of possible treatments for 2019‐nCoV drugs, active natural products, and traditional Chinese medicine."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The research team built the protein structure of 2019‐nCoV PLP by using homology modeling method, defined its drug‐binding pocket, and screened the active molecules from the existing drug compound library of ZINC, the database of traditional Chinese medicine and natural products established by their own laboratory by using the computer‐aided structure‐based virtual screening method."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "After triphosphate in vivo, it is incorporated into the newly synthesized RNA chain of the virus as a substrate, and then the synthesis of the virus genome is interrupted."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            ", ",
            ", ",
            ",",
            "The program compares nucleotide or protein sequences to sequence databases and calculates the statistical significance of matches."
        ],
        "lab": [
            false,
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID‐2019 pneumonia continues to spread on a global scale."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            ", ",
            ", ",
            ",",
            "Protease inhibitor is a kind of drug targeting protease to treat AIDS."
        ],
        "lab": [
            false,
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At present, the National Health Commission has recommended that anti‐AIDS drugs can be included in the trial."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The world continues to wait expectantly for health researchers to develop effective prevention tools, tests, vaccines, and treatments for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Many forms of COVID-19 health research involve the processing of personal data, including human health or genetic data."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The aim of our analysis is to help research institutions navigate European data protection law within the COVID-19 crisis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At first glance, consent appears to be a straightforward solution for processing personal data in COVID-19 research, as it coincides with the research ethics principle of consent."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Where people are in a critical status of health, which will be the case for most hospitalized patients with COVID-19, obtaining consent may not be practically possible."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With this position in mind, it is particularly unfortunate that the EDPB guidelines on COVID-19 and research make no mention that broader consent is suitable for pandemic research [6]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For ongoing research studies, deleting individual data sets may not render the research impossible, although having to repeat analyses could be cumbersome."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For completed research studies, however, the situation is different, as altering the underlying database may undermine scientific reproducibility."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As scientific research on COVID-19 aims to benefit society as a whole, using the legal basis of a task performed in the public interest appears to be a natural choice."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is also the choice suggested by the EDPB as more appropriate than consent for research in clinical trials [13] and is one of the potential legal grounds mentioned in the EDPB’s guidelines on COVID-19 and research."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The EDPB remains silent on the subject in their guidelines on COVID-19 and research; however, dedicated guidance on the subject of further processing is expected [9]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This may pose challenges for research on COVID-19, where a broad consent model would be necessary to cover the full range from disease mechanisms to transmission pathways to psychological or socioeconomic consequences of the disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There are two likely options for processing health and genetic data for research in the COVID-19 context."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This is also demonstrated by the EDPB’s guidelines on COVID-19 and research [6]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, the continued validity of adequacy decisions may be imperiled if recipient third countries adopt aggressive data collection and processing practices in response to COVID-19 [28,29]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The EDPB furthermore notes that explicit consent is only suitable for certain situations, such as for private entities conducting COVID-19 research; however, it provides no further guidance other than its guidelines on COVID-19 and research (paragraph 67) [6]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the specific situation of the COVID-19 outbreak, the EDPB has conceded “that the fight against COVID-19 has been recognized by the EU and most of its Member States as an important public interest,” grounding this claim in provisions of EU law interpreted through the prism of national measures by Member States adopted in response to the crisis (paragraphs 62-67) [6]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Along these lines, a joint statement has been signed by more than 550 researchers worldwide calling for privacy preserving technologies, strict limitation to COVID-19 purposes, and a voluntary basis for the use of any contact tracing app [39]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This requirement is arguably disproportionate even in normal circumstances; however, even in the present state of the COVID-19 crisis, it is only applicable to clinical trials, observational medicinal product studies, and compassionate therapeutic use that is essential for combating the disease as well as for COVID-19 research projects of the Institutes of Scientific Hospitalization and Treatment funded by the Ministry of Health."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Before they process special categories of data in the COVID-19 context, research institutions will most likely need to perform data protection impact assessments (DPIAs), which act as both a safeguard and a mechanism for enhancing transparency and accountability."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our analysis demonstrates that variation across national implementations hampers a coordinated global research response in the fight against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The subsequently published guidelines on COVID-19 and research [6] contain only limited advice that takes into account specific challenges in the research contexts (eg, hospitalized people who are unable to give consent, challenges in information-giving obligations)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Researchers must collaborate globally to rapidly respond to the COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 experience provides lessons for national legislatures."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Early clinical descriptions of the first severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–caused coronavirus disease 2019 (COVID-19) cases at the end of 2019 rapidly highlighted distinct patterns of disease progression ()."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On the basis of data from patients with laboratory-confirmed COVID-19 from mainland China, admission to intensive care unit (ICU), invasive mechanical ventilation, or death occurred in 6.1% of cases (), and the death rate from recent current French data was 0.70% ()."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, little is known about the immunological features and the molecular mechanisms involved in COVID-19 severity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We next evaluated the response of whole blood cells to IFN-α stimulation () and observed a comparable increase in ISG score upon IFN-α stimulation between groups of any severity and controls (Fig. 3H), suggesting that the potential for response to type I IFN was not affected in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Overall, these data suggest that infected patients had no detectable circulating IFN-β and that an impaired IFN-α production characterized the most severe COVID-19 cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severe COVID-19 was reported to be associated with hypercytokinaemia (, )."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interleukin-6 (IL-6), a key player of the exacerbated inflammatory response in COVID-19 (), was not detected in peripheral blood at the transcriptional level (fig. S9B), contrasting with high amounts of IL-6 protein (Fig. 4B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These observations are in accordance with published studies in bronchoalveolar fluids from COVID-19 patients, describing the key role of monocytes ()."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, we identified an impaired type I IFN response in severe and critical COVID-19 patients, accompanied by high blood viral load and an excessive NF-κB–driven inflammatory response associated with increased TNF-α and IL-6."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We observed that SARS-CoV-2 infection was characterized by an absence of circulating IFN-β in COVID-19 patients with all disease-severity grades."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, most severe COVID-19 patients displayed impaired IFN-α production that was associated with lower viral clearance."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It will be important to assess in severe and critical COVID-19 patients whether this reduced type I IFN production is present at the onset of infection, whether the production is delayed, or whether IFN production is exhausted after an initial peak."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Comorbidities are risk factors for severe COVID-19 that could negatively affect IFN production and in contrast exacerbate inflammatory responses (, )."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this respect, data from ",
            "Bost et al.",
            " describe a reduced type I IFN signature in bronchoalveolar lavage macrophages from severe COVID-19 patients, supporting the validity of our analysis ()."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Creator",
                "start": 2478,
                "end": 2489,
                "name": "Bost et al."
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Accordingly, IFN-λ has been proposed as a therapeutic in coronavirus disease 2019 (COVID-19) and other such viral respiratory diseases (see the Perspective by Grajales-Reyes and Colonna)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Broggi et al. report that COVID-19 patient morbidity correlates with the high expression of type I and III IFNs in the lung."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Complicating this picture, Hadjadj et al. observed that peripheral blood immune cells from severe and critical COVID-19 patients have diminished type I IFN and enhanced proinflammatory interleukin-6– and tumor necrosis factor-α–fueled responses."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease 2019 (COVID-19) is characterized by distinct patterns of disease progression that suggest diverse host immune responses."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We performed an integrated immune analysis on a cohort of 50 COVID-19 patients with various disease severity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These data suggest that type I IFN deficiency in the blood could be a hallmark of severe COVID-19 and provide a rationale for combined therapeutic approaches."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 is a virus that causes the ongoing COVID-19 pandemic, an acute respiratory distress syndrome which represents the most serious problem for global health (Cascella et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, since March 2020, some manufacturers reported the shortage of supplies related to COVID-19 driven by the sudden increase in global demand for RNA extraction kits."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, heating oropharyngeal swabs is not as sensitive or accurate as RT-qPCR reactions performed on purified samples, detecting 97.4 % of the COVID-19-positive patients with no false positives results (Fomsgaard and Rosenstierne, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Also, Chelex-100 was incorporated as a protective agent during extraction at high temperatures because this reagent favors chelating groups to bind to cellular components (Lounsbury et al., 2012)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This protocol allowed detecting only 97.4 % of COVID-19-positive patients in comparison to PEG/NaCl precipitation that detected 100 % of the positive cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At the end of 2019, an outbreak of a new Coronavirus 2019 (COVID-19) emerged in Wuhan in China, being called the causative agent of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1], [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to the World Health Organization, more than 5 million people are infected in 216 countries and more than 331 thousand people died from COVID-19 [5]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The frequent and persistent clinical manifestations of anosmia / dysgeusia is present in patients with COVID-19, and neurological symptoms are also reported in severe cases, which may be secondary to severe respiratory failure [24]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "One study showed that a patient with SARS-CoV-2 infection and encephalitis had a severe increase in inflammatory cytokines in the CSF, such as Interleukin-8, TNF-α, a finding that demonstrates the inflammatory involvement in neurological repercussions related to COVID-19 [28]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At the end of 2019, there was an outbreak of a new Coronavirus 2019 (COVID-19 disease)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease 2019 (COVID-19) pandemic is causing huge impacts on health and social care systems globally."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Several health authorities have published their guidelines for COVID-19 diagnosis and treatment including the administration of antimicrobial agents."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Both guidelines for COVID-19 management by the UK National Institute for Health and Care Excellence and by World Health Organization discourage antibiotic therapy or prophylaxis for suspected COVID-19 patients and confirmed patients with mild symptoms, but suggest to prescribe antibiotics for suspicious bacterial infections."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            " The US National Institutes of Health guideline indicates that no sufficient data supports empirical antibiotic therapy, but acknowledges that some clinicians routinely administer broad-spectrum antibiotics to all patients with moderate or severe hypoxemia."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The latest version of Chinese clinical guideline for COVID-19 diagnosis and treatment published in March 2020 only suggests to avoid inappropriate use of antibacterial drugs, especially the broad-spectrum ones, but without clear explicitness for empirical antibiotic therapy or prophylaxis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This suggests that the administration of antibiotics on suspected COVID-19 patients is heavily dependent on the judgement and experience of frontline clinicians, especially at the early stage of pandemic outbreak."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, during the Severe Acute Respiratory Syndrome (SARS) outbreak in 2003 and the more recent Middle East Respiratory Syndrome (MERS) outbreak in 2012, most suspected patients were administrated with potent broad-spectrum antibiotics even before the confirmation of the aetiological agents."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            " This empirical procedure may be applied to treat COVID-19."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the early outbreaks of COVID-19 in Wuhan, China occurred in late 2019, Chen et al. reported that 77 (71%) of their patients (n = 99) received antibiotic treatment and only 1 (1%) patients developed bacterial co-infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For the COVID-19, only 8% of patients with co-infections were reported, although 72% of the patients received antimicrobial therapy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Lansbury L and colleagues have written to this Journal for their systematically search from literature between 1 January 2020 to 17 April 2020 for studying secondary infections in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "From their results, only 7% of hospitalised COVID-19 patients had bacterial co-infections."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this context, the article sheds light on the potential of plants and plant-based drugs for their use in treating COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This altogether accentuates the importance of plant-based drugs in treating COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease, or COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), may be more severe in patients with chronic lung disease, including patients with asthma (1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among patients with asthma, it is possible that demographic or biological factors influence susceptibility to SARS-CoV-2 infection or severity of COVID-19 disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We reasoned that differences in ACE2 or TMPRSS2 gene expression in sputum cells among patients with asthma may identify subgroups at risk for worse COVID-19 outcomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In particular, we hypothesized that comorbidities such as diabetes mellitus or hypertension may affect ACE2 or TMPRSS2 gene expression in sputum cells, because these diseases are reported to influence the severity of COVID-19 or its outcome (1, 4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Models incorporate the same demographic features in Figure 3 and the three asthma control factors."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "ACE2 and TMPRSS2 expression mediate SARS-CoV-2 infection of host lung cells (3), and it is reasonable to infer that increases in their expression in lung cells will increase susceptibility to SARS-CoV-2 infection or lead to more severe COVID-19 disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although gene expression for ACE2 and TMPRSS2 did not differ from health in asthma, we report that males, African Americans, and patients with diabetes mellitus have increased expression of ACE2 and TMPRSS2 in their sputum cells, and these patient subgroups should therefore be monitored for poor COVID-19 outcomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In contrast, we report lower expression of ACE2 and TMPRSS2 in sputum cells from patients with asthma taking ICS, and this finding warrants prospective research to determine if ICS use predicts decreased susceptibility to SARS-CoV-2 infection or decreased COVID-19 morbidity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The higher expression of ACE2 that we report in male patients is notable because of the high mortality of COVID-19 in males (1, 5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This finding is interesting, because diabetes is a risk factor for severe morbidity or death from COVID-19 (1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hypertension is also a risk factor for COVID-19 morbidity (1), but we did not find increases in ACE2 expression in sputum cells from patients with asthma with and without hypertension."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The higher expression of ACE2 in African Americans is also noteworthy, because COVID-19 outcomes in African Americans, Africans, or other persons of African descent have not yet been reported in any detail."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The similar increases in both genes in the same patient subgroups provide a mechanism for a “double hit” susceptibility for SARS-CoV-2 infection and COVID-19 morbidity in these patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Non–asthma-related factors, such as male sex, African American race, and metabolic disease (diabetes mellitus), may be more important and more generalizable risks for susceptibility to SARS-CoV-2 infection and more severe COVID-19 morbidity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Rationale: Coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We reasoned that differences in ACE2 or TMPRSS2 gene expression in sputum cells among patients with asthma may identify subgroups at risk for COVID-19 morbidity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Conclusions: Higher expression of ACE2 and TMPRSS2 in males, African Americans, and patients with diabetes mellitus provides rationale for monitoring these asthma subgroups for poor COVID-19 outcomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The lower expression of ACE2 and TMPRSS2 with ICS use warrants prospective study of ICS use as a predictor of decreased susceptibility to SARS-CoV-2 infection and decreased COVID-19 morbidity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "An outbreak of a viral respiratory illness (officially named by the World Health Organization coronavirus disease, COVID-19) caused by the newly discovered severe acute respiratory syndrome coronavirus (SARS-CoV-2), started around mid-December 2019, in the city of Wuhan, Hubei province, China [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The outbreak subsequently spread further and as at 31 March 2020, 750,890 cases of COVID-19 have been confirmed worldwide including 668,345 outside China [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since 20 February 2020, sustained local transmission has been documented in Italy [3], where to date, 98,716 COVID-19 cases testing positive for SARS-CoV-2 have been diagnosed, with 10,943 deaths [4]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The reads were trimmed for quality and length and assembled by mapping to the reference genome from Wuhan, China (",
            "GenBank",
            " accession number: ",
            "NC_045512.2",
            ") using Geneious Prime (www.geneious.com) [5]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 773,
                "end": 780,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 799,
                "end": 810,
                "name": "NC_045512.2"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "Viral sequences from the two patients were deposited in the ",
            "Global Initiative on Sharing All Influenza Data (GISAID",
            "; ",
            "https://www.gisaid.org/epiflu-applications/next-hcov-19-app/",
            "",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 917,
                "end": 972,
                "name": "Global Initiative on Sharing All Influenza Data (GISAID"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 974,
                "end": 1034,
                "name": "https://www.gisaid.org/epiflu-applications/next-hcov-19-app/"
            },
            false,
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "To analyse the obtained SARS-CoV-2 genomes respectively derived from the infected Chinese tourist (",
            "GISAID",
            " accession ID: ",
            "EPI_ISL_412974",
            ") and the Italian patient (",
            "GISAID",
            " accession ID: ",
            "EPI_ISL_412973",
            ") in a phylogenetic context, a dataset of 40 available SARS-Cov-2 complete genomes from different countries was retrieved from ",
            "GISAID",
            " (",
            "https://www.gisaid.org/",
            ", last access 2 March 2020; Supplementary material)."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 1137,
                "end": 1143,
                "name": "GISAID"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 1158,
                "end": 1172,
                "name": "EPI_ISL_412974"
            },
            false,
            {
                "id": "T7",
                "type": "Dataset",
                "start": 1199,
                "end": 1205,
                "name": "GISAID"
            },
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 1220,
                "end": 1234,
                "name": "EPI_ISL_412973"
            },
            false,
            {
                "id": "T9",
                "type": "Dataset",
                "start": 1361,
                "end": 1367,
                "name": "GISAID"
            },
            false,
            {
                "id": "T10",
                "type": "URL",
                "start": 1369,
                "end": 1392,
                "name": "https://www.gisaid.org/"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T7",
                "end": "T8"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T9",
                "end": "T10"
            }
        ]
    },
    {
        "sen": [
            "The viral genome sequence of the Chinese tourist (",
            "GISAID",
            " accession ID: ",
            "EPI_ISL_412974",
            ") was identical to that retrieved from one sample of another Chinese tourist, hospitalised at the same hospital in Rome (",
            "GISAID",
            " accession ID: ",
            "EPI_ISL_410546",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Dataset",
                "start": 1495,
                "end": 1501,
                "name": "GISAID"
            },
            false,
            {
                "id": "T12",
                "type": "AccessionNumber",
                "start": 1516,
                "end": 1530,
                "name": "EPI_ISL_412974"
            },
            false,
            {
                "id": "T13",
                "type": "Dataset",
                "start": 1651,
                "end": 1657,
                "name": "GISAID"
            },
            false,
            {
                "id": "T14",
                "type": "AccessionNumber",
                "start": 1672,
                "end": 1686,
                "name": "EPI_ISL_410546"
            },
            false
        ],
        "rel": [
            {
                "id": "R6",
                "bool": true,
                "head": "T11",
                "end": "T12"
            },
            {
                "id": "R7",
                "bool": true,
                "head": "T13",
                "end": "T14"
            }
        ]
    },
    {
        "sen": [
            "The latter was closely related to that of another sample taken from the same patient (",
            "GISAID",
            " accession ID: ",
            "EPI_ISL_410545",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T15",
                "type": "Dataset",
                "start": 1775,
                "end": 1781,
                "name": "GISAID"
            },
            false,
            {
                "id": "T16",
                "type": "AccessionNumber",
                "start": 1796,
                "end": 1810,
                "name": "EPI_ISL_410545"
            },
            false
        ],
        "rel": [
            {
                "id": "R8",
                "bool": true,
                "head": "T15",
                "end": "T16"
            }
        ]
    },
    {
        "sen": [
            "The genome-wide SNPs are reported in Table 1 (positions referred respect to the reference sequence; ",
            "GenBank",
            " accession number: ",
            "NC_045512",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T17",
                "type": "Repository",
                "start": 1913,
                "end": 1920,
                "name": "GenBank"
            },
            false,
            {
                "id": "T18",
                "type": "AccessionNumber",
                "start": 1939,
                "end": 1948,
                "name": "NC_045512"
            },
            false
        ],
        "rel": [
            {
                "id": "R9",
                "bool": true,
                "head": "T17",
                "end": "T18"
            }
        ]
    },
    {
        "sen": [
            "The genome sequence from the Chinese tourist hospitalised in Rome differed in two nt positions from that of the COVID-19 patient in Wuhan (",
            "NC_045512",
            "), while the genome sequence isolated from the Italian patient showed four nt variations (Table 1)."
        ],
        "lab": [
            false,
            {
                "id": "T19",
                "type": "AccessionNumber",
                "start": 2090,
                "end": 2099,
                "name": "NC_045512"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Second, airborne pathogens usually exhibit a relatively low 50% infectious dose (ID50) value."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Edouard Lansiaux has just shown that subjects from the regions of Puglia, Sardinia and Sicilia in Italy have a high prevalence of Beta-thalassemia and are, thus, more resistant to the coronavirus pneumonia called SARSCoV2, (formerly known as 2019-nCoV), that causes the COVID19 disease [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We should like to add that Ferrara, (132,000 inhabitants), a town in Northern Italy whose origins are from the Renaissance, situated in the region of Emilia Romagna, (4449 million inhabitants, 27,842 COVID+ patients, the third place most affected in Italy), is also very resistant to the COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On the 2nd June 2020, Italy counted 33,530 deaths and 233,197 cases COVID+."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A study has showed a heme attack on the 1-beta chain of haemoglobin by COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 is a pandemic as of Mar. 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "African Americans and Latinos are disproportionately affected by COVID-19 and show significantly higher mortality compared to the other race and ethnic groups in the US (Wadhera et al., 2020) and in the UK (Kirby, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of note, a 3p21.31 gene cluster—SLC6A20, LZTFL1, CCR9, FYCO1, CXCR6 and XCR1—is associated with genetic susceptibility for severe COVID-19 cases with respiratory failure (Ellinghaus et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To find allelic variation across populations in the genes that are known be involved in viral entry to the host cells and sensing of viral RNA in host immune cells, we surveyed publicly available databases of genomic variants."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recent studies demonstrated that an inhibitor of the protease activity of TMPRSS2—camostat mesylate—attenuated SARS-CoV-2 entry into lung epithelial cells suggesting a promising candidate for potential intervention against COVID-19 (Hoffmann et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The list of reported genetic variants in the genes and their allele frequencies (AFs) were compiled from three population-scale genomic variants databases— ",
            "gnomAD",
            " (",
            "Karczewski et al., 2020",
            "), ",
            "Korean Reference Genome Database",
            " (",
            "Jung et al., 2020",
            "), and ",
            "TogoVar",
            " (a Japanese genetic variation database available at ",
            "https://togovar.biosciencedbc.jp/",
            ") —and three whole-genome sequencing datasets (i.e., ",
            "1000 Genomes Project",
            " (",
            "Clarke et al., 2017",
            "), ",
            "Gene-Tissue Expression",
            " (",
            "Consortium et al., 2017",
            "), and ",
            "Simons Genome Diversity Project",
            " (",
            "Mallick et al., 2016",
            "))."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1146,
                "end": 1152,
                "name": "gnomAD"
            },
            false,
            {
                "id": "T2",
                "type": "Creator",
                "start": 1154,
                "end": 1177,
                "name": "Karczewski et al., 2020"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 1180,
                "end": 1212,
                "name": "Korean Reference Genome Database"
            },
            false,
            {
                "id": "T4",
                "type": "Creator",
                "start": 1214,
                "end": 1231,
                "name": "Jung et al., 2020"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 1238,
                "end": 1245,
                "name": "TogoVar"
            },
            false,
            {
                "id": "T6",
                "type": "URL",
                "start": 1298,
                "end": 1331,
                "name": "https://togovar.biosciencedbc.jp/"
            },
            false,
            {
                "id": "T7",
                "type": "Dataset",
                "start": 1384,
                "end": 1404,
                "name": "1000 Genomes Project"
            },
            false,
            {
                "id": "T8",
                "type": "Creator",
                "start": 1406,
                "end": 1425,
                "name": "Clarke et al., 2017"
            },
            false,
            {
                "id": "T9",
                "type": "Dataset",
                "start": 1428,
                "end": 1450,
                "name": "Gene-Tissue Expression"
            },
            false,
            {
                "id": "T10",
                "type": "Creator",
                "start": 1452,
                "end": 1475,
                "name": "Consortium et al., 2017"
            },
            false,
            {
                "id": "T11",
                "type": "Dataset",
                "start": 1482,
                "end": 1513,
                "name": "Simons Genome Diversity Project"
            },
            false,
            {
                "id": "T12",
                "type": "Creator",
                "start": 1515,
                "end": 1535,
                "name": "Mallick et al., 2016"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "However, it was found with higher AF of 0.23% at Japanese genetic variation database (N = 3552)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Especially, ACE2 and TLR7 seem to be under strong selection pressure as reflected in their relatively lower number of loss-of-function variants than expected in large variant databases such as ",
            "gnomAD",
            " (",
            "Karczewski et al., 2020",
            "): three observed variants out of 31 expected ones for ACE2 and two observed variants out of 20.7 expected ones for TLR7."
        ],
        "lab": [
            false,
            {
                "id": "T13",
                "type": "Repository",
                "start": 1829,
                "end": 1835,
                "name": "gnomAD"
            },
            false,
            {
                "id": "T14",
                "type": "Creator",
                "start": 1837,
                "end": 1860,
                "name": "Karczewski et al., 2020"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, nonsynonymous variants in these genes were mostly of very low frequencies which suggests the chance of gene function altered by these variants would be unlikely, compared to the incidence of COVID-19 around the globe."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, underlying medical conditions, age, environmental factors (e.g., air pollution, smoking, and humidity), and a healthcare disparity influence morbidity and mortality from COVID-19 considering the allelic spectrum for the key genes associated with viral entry."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The population-scale genotype databases and datasets used in this study have limitations from relatively small sample size and imbalanced and incomplete representation of various human populations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, there could be unreported variants in ACE2, TMPRSS2, and TLR3/7/8 that may be associated with change of susceptibility to COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With additional population-scale genomic databases for diverse populations, it will be possible to identify the individuals with rare genetic variants such as rs758278442 in the interacting domain of ACE2 and the genetic predisposition to cytokine storm that causes an acute progress of illness in young people."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 pandemic highlighted healthcare disparities in multiple countries."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Non-genetic factors are likely to contribute differential population characteristics affected by COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Most SARS-CoV-2 infections are asymptomatic or benign, but SARS-CoV-2 infectious disease 2019 (COVID-19) can cause life-threatening disease, which typically begins with pneumonia."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severe COVID-19 occurs much more frequently in patients over the age of 50 years and/or with comorbid conditions such as pulmonary, cardiovascular, and metabolic disorders (Figure 1",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Why are previously healthy children, adolescents, young, or middle-aged adults being admitted to intensive care for respiratory failure, encephalitis, or Kawasaki disease, due to COVID-19?",
            "Why would a 40-year-old man who completed a marathon in October 2019 find himself intubated and ventilated for COVID-19 respiratory failure in April 2020?",
            "The COVID Human Genetic Effort (https://www.covidhge.com/) proposes that previously healthy, young patients with severe COVID-19 carry causal genetic variants."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This hypothesis is not yet supported by specific genetic epidemiological studies of COVID-19, but it follows a long line of classical genetic studies since 1905, relating to diverse infections in plants and animals, including humans (Casanova and Abel, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The protein encoded by Mx, a gene cloned by cell complementation, protects mice from influenza virus (Staeheli et al., 1986) and is potentially relevant to COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Other examples more closely related to COVID-19 include influenza virus pneumonia, which can be caused by inborn errors impairing antiviral type I and III IFN immunity (IFN-α/β and -λ), including IRF7, IRF9, and TLR3 deficiencies, in circulating plasmacytoid dendritic cells and/or pulmonary epithelial cells (Ciancanelli et al., 2015, Hernandez et al., 2018, Lim et al., 2019), and rhinovirus pneumonia, which can be caused by a deficiency of IFN-inducing MDA5 (Asgari et al., 2017, Lamborn et al., 2017)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 is a completely new disease, and the current pandemic dwarfs previous SARS-CoV-1 and MERS-CoV outbreaks."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 provides us with a tragic but unparalleled opportunity to define precisely the genetic requirements for the control of an emerging, virulent, viral infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Amid the uncertainties concerning the genetic architecture of COVID-19 suceptibility, only one thing is almost certain: as for other infectious diseases, there will be considerable genetic heterogeneity, reflecting the multiple layers of host defense that a virus must overcome to lead to mortality."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The analysis and comparison of genetic variants from a large number of individuals from diverse backgrounds will be crucial, as we cannot solely rely on current databases of data for “healthy” individuals to identify rare variants, which include individuals never before exposed to SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Once candidate genotypes have been identified, their contribution to the pathogenicity of severe COVID-19 will be investigated with in-depth molecular, cellular, and immunological approaches."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In these genetic studies, we aim to discover the pathogenesis of unexplained, severe COVID-19 in young, previously healthy patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 pandemic should make us consider an alternative approach to studying infectious diseases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This paradigm shift would open up new avenues for studying host-pathogen interactions in the course of evolution, controlling the current COVID-19 threat in the general population, and developing the infrastructure required to thwart future emerging threats."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By August 2020, the COVID-19 (Coronavirus Disease-2019) pandemic caused more than 20 million confirmed infections and more than 700000 deaths ()."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Most of COVID-19 cases are mild, while about 15 % develop severe disease that results in acute respiratory distress syndrome associated with dysregulated immune response, systemic inflammation and cytokine storm."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The high fatality rate of COVID-19 may be partly due to excessive production of cytokines and inflammatory mediators(cytokine storm) leading to a hyperactive non-productive immune state causing lung and other organs injury (Zhou et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of August 12, 2020, there are more than 200 host genetics studies – with different study designs – trying to identify possible associations between human genetic variants and the prognosis of COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Most of these studies are Genome-Wide Association Studies (GWAS) and depend on the association of genetic variations with different phenotypes such as severe COVID-19 disease ()."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is essential for these investigators to have a list of candidate genes that are likely to be involved in COVID-19 pathogenesis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Genomics England used wide inclusion criteria to design a gene panel to investigate COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In our review, we refine this panel and create a gene list of the most likely genes that might be involved in severe COVID-19 disease based on a set of criteria discussed below in the methods section."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These criteria dictate that our curated gene list contains only studies on humans and that genetic mutations predisposed to severe viral infections in otherwise healthy individuals (in case report studies) or predisposed to SARS-CoV or SARS-CoV-2 in GWAS studies providing the highest evidence for possible involvement in severe COVID-19 disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This gene list can benefit investigators in two ways: the first one is to make sure that those genes are present in gene panels used for host genetic studies as they are likely candidates of association with severe COVID-19 disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, we provide new insights and different hypotheses for genes involved in severe COVID-19 disease based on our reviews of different viral susceptibility studies and briefly review the COVID-19 host genetics studies published up to this date."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Next, we checked the ",
            "OMIM",
            " database to find the related studies."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 2275,
                "end": 2279,
                "name": "OMIM"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We identified 40 genes that we expect to be highly involved in host genetic susceptibility to severe COVID-19, and hence deserve consideration during design and interpretation of case report and GWAS studies of COVID-19 and also during a meta-analysis of different GWAS studies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In some cases, a single gene (e.g., TLR3) was involved in predisposition to several viruses (Lim et al., 2019; Zhang et al., 2007) and a single mutation (P 554S) predisposed to different viral infections (HSE and ARDS due to IAV) which support our hypothesis of the possible involvement of our reviewed genes in COVID-19 susceptibility, and hence the need for a candidate gene list (Lim et al., 2019; Zhang et al., 2007)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Accordingly, polymorphisms in C-lectin genes might explain severe COVID-19 disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Consequently, we suggest dendritic cells might play the role of the safe house for SARS-CoV-2 explaining many cases of recurrent COVID-19 disease (Ravioli et al., 2020; Loconsole et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Inflammasome activation is one of the main theories for explanation of the cytokine storm during COVID-19 causing severe manifestations in around 15 % of the infected population (van den Berg and te Velde, 2020; Rodrigues et al., 2020; Freeman and Swartz, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "NLRP3 activation in COVID-19 patients was proven in vitro in PBMCs and tissues of COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additionally, higher levels of IL-18 and Casp1p20(Inflammasome products) -in the sera of COVID-19 patients- were associated with COVID-19 severity and poor prognosis (Rodrigues et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hence, we invite researchers to study the possible involvement of NLRP1 in severe COVID-19 disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We searched for IL-18 inhibition as a possible treatment option for severe COVID-19 using the keywords “COVID-19” and “IL-18” in clinicaltrials.gov and found no registered clinical trials."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Accordingly, we think that IL-18 inhibition can provide a therapeutic option in patients with severe COVID-19 disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We suggest that Inhibition of EndoU in SARS-CoV-2 might represent a potential therapeutic target in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additionally, higher expression of antiviral genes is not always a good prognostic factor as in the example of MxA which we should investigate and take into consideration during interpretation of differential gene expression studies of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Accordingly, studying close family members is essential to understand the penetrance of the suspected mutation and the inheritance pattern which can help us in prevention and prediction of severe COVID-19 disease in susceptible relatives of patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severe COVID-19 risk factors include old age, smoking and preexisting medical conditions such as diabetes mellitus, hypertension and cardiovascular disease (Ellinghaus et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Unexpected clinical manifestations or complications from infection -e.g. COVID-19- in otherwise healthy individuals are a suggestion of the genetic origin of susceptibility."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Statistical methods are essential to compare genetic variants in those patients with a matched control (e.g. general population or other family members who tested positive without severe manifestation or complication from COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Case report studies of COVID-19 represents an opportunity for researchers to identify the largest number of genes associated with severe viral infections in humans and to confirm previous case-report studies of viral susceptibility."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In our case, severe COVID-19 affects a significant number of the population and different factors have been associated with severe manifestation, and it is time for GWAS to discover the role of common and rare variants -with different effect sizes- in the pathogenesis of the disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Accordingly, we invite GWAS investigators to widen their inclusion criteria to include all patients of different age groups to find common and rare variants associated with severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We predict that GWAS studies are more able to discover gene regulation elements involved in COVID-19 susceptibility more than case report studies because of the tendency to suspect genetic mutation with deleterious effect on proteins and neglect gene regulatory elements in case report studies as we can see on the IUIS list and also because of the wide use of WGS instead of WES in GWAS (Tangye et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of August 21, 2020, we found 5 studies (one of them is a preprint) associating COVID-19 severity with different genes as in Table 2 (Ellinghaus et al., 2020; Kuo et al., 2020; Lu et al., 2020; Wu et al., 2020; Zhao et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Three studies reported that ABO genes are associated with severity of COVID-19 disease and that blood group A individuals are more susceptible to risk of infection and severe manifestation while blood group O has a protective effect (Wu et al., 2020; Zhao et al., 2020; Ellinghaus et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The largest COVID-19 GWAS published recently associates the locus 3p21.31 with severe manifestations of COVID-19(Mechanical ventilation)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We suggest CCR1 and CCR9 as a potential therapeutic target in COVID-19 patients which needs further investigations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Other associated genes with severe COVID-19 are described in Table 2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "During our review of genes potentially involved in the COVID-19 response, we excluded genes differentially expressed in patients such as ACE2 and TMPRSS2 genes whose polymorphisms were not proven to be associated with severe COVID-19 (Wen et al., 2020; Sungnak et al., 2020; Bilinska et al., 2020; Hoffmann et al., 2020) because we wanted our study to be restricted to genes with mutations involved directly in association with the severe disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 is an emergent viral disease that caused millions of COVID-19 cases all over the world."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There is increasing evidence that severe manifestations of COVID-19 might be attributed to human genetic variants in genes related to immune deficiency and or inflammasome activation (cytokine storm)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Objective  Identify the candidate genes that are likely to aid in explaining severe COVID-19 and provide insights to understand the pathogenesis of severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this article, we systematically reviewed genes related to viral susceptibility that were reported in human genetic studies (Case-reports and GWAS) to understand the role of host viral interactions and to provide insights into the pathogenesis of severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We found 40 genes associated with viral susceptibility and 21 of them were associated with severe SARS-CoV disease and severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This compilation represents a list of candidate genes that are likely to aid in explaining severe COVID-19 which are worthy of inclusion in gene panels and during meta-analysis of different variants in host genetics studies of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, we provide several hypotheses for severe COVID-19 and possible therapeutic targets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The recent spread of a novel coronavirus, SARS‐CoV‐2, causing coronavirus disease 2019 (COVID‐19), represents a global health emergency of inconceivable severity, characterized by a remarkable morbidity and mortality worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease-2019 (COVID-19), caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), is now one of the deadliest pandemics in modern history."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The mode of infection of COVID-19 is thought to be direct entry of the SARS-CoV-2 virus into cells via the human angiotensin-converting enzyme 2 (ACE2) receptor, which is expressed predominantly in the lungs but also throughout the cardiovascular system (1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, although the most virulent manifestation of COVID-19 is acute respiratory distress syndrome, reports from Europe and China have also demonstrated cardiac injury reflected through elevated troponin concentrations among infected patients (2, 3, 4, 5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In these limited case series, troponin elevation was more common in patients with pre-existing cardiovascular disease (CVD) and, when present, was associated with higher rates of adverse outcomes in patients hospitalized with COVID-19 (6)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "During the study period, 3,069 COVID-19 positive patients were hospitalized at 1 of 5 MSHS New York City hospitals."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of 2,736 COVID-19 patients included in our study, 506 (18.5%) died, 1,132 (41.4%) were discharged, and 1,098 (40.1%) remained hospitalized at the time of data freeze for this report."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although pulmonary manifestations are its most common consequence, COVID-19 causes systemic inflammation with varying presentations of cardiac involvement as well (10)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this multihospital retrospective cohort study of nearly 3,000 patients, we demonstrate the following observations: 1) myocardial injury is common among patients hospitalized with COVID-19 but is more often mild, associated with low-level elevation in troponin concentration; 2) more significant myocardial injury may be associated with more than a tripling in risk of mortality; and 3) COVID-19 patients with a history of CVD are more likely to experience myocardial injury than patients without CVD but without obvious corroborating evidence for primary acute myocardial infarction (Central Illustration",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Despite several reports of COVID-19 associated myocarditis, to date, no case has demonstrated COVID-19 genome in cardiac tissue on biopsy or autopsy accompanied by troponin elevation consistent with criteria used to diagnose myocarditis (3, 4, 5,14, 15, 16)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Other postulated mechanisms by which COVID-19 leads to cardiovascular morbidity include direct myocardial injury as a result of the inflammatory cascade or cytokine release, microvascular damage due to disseminated intravascular coagulation and thrombosis, direct entry of SARS-CoV-2 into myocardial cells via binding to ACE2 receptors, hypoxemia combined with increased metabolic demands of acute illness leading to myocardial injury akin to type 2 myocardial infarction, and finally, acute coronary syndrome from acute inflammation-triggered destabilization of atheromas (17, 18, 19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In a recent case series of 18 patients with COVID-19 infection and ST-segment elevation on electrocardiogram, 10 were deemed to have noncoronary myocardial injury by virtue of nonobstructive disease on coronary angiography and/or normal wall motion on echocardiography (20)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Despite lower troponin concentrations in this group, 9 died as opposed to 4 of 8 in the ST-segment elevation MI group, which may suggest higher mortality associated with nonischemic mediated myocardial injury in the setting of COVID-19; however, more data are needed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The benefit of statins in the setting of myocardial injury is well established (27, 28, 29), yet whether statins confer an anti-inflammatory effect or allow for amelioration of endothelial dysfunction in COVID-19 have not been elucidated."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interestingly, higher BMI was associated with increased mortality in the setting of COVID-19 among our cohort, consistent with a prior report (30)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The degree of myocardial injury, as reflected by troponin elevation, and associated outcomes among U.S. hospitalized patients with coronavirus disease-2019 (COVID-19) are unknown."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The purpose of this study was to describe the degree of myocardial injury and associated outcomes in a large hospitalized cohort with laboratory-confirmed COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Methods  Patients with COVID-19 admitted to 1 of 5 Mount Sinai Health System hospitals in New York City between February 27, 2020, and April 12, 2020, with troponin-I (normal value <0.03 ng/ml) measured within 24 h of admission were included (n = 2,736)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Conclusions  Myocardial injury is prevalent among patients hospitalized with COVID-19; however, troponin concentrations were generally present at low levels."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Troponin elevation among patients hospitalized with COVID-19 is associated with higher risk of mortality."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The fast-spreading of COVID-19 raised a notion that mutations may drive its evolution."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The genome of COVID-19 is evoluted from SARS- CoV and MERS CoV6."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Comparison of the genome sequences of the COVID-19, SARS-CoV, and MERS-CoV showed that 2019-CoV has better sequence identity with SARS-CoV than the MERS CoV6."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Kabir et al. [3] extensively reviewed factors that affect COVID-19 genetic diversity and its evolution."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 has a unique amino acid sequence from other coronaviruses entirely in the regions of 1ab polyprotein and surface glycoprotein or S-protein."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Studies indicate that the human receptor for COVID-19 could be angiotensin-converting enzyme 2 (ACE2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The coronavirus disease 2019 (COVID-19) virus is spreading rapidly worldwide, and the global interested scientists are endeavoring to discover drugs for its efficacious treatment."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Chloroquine phosphate, an old drug for the treatment of malaria, is shown to have apparent efficacy and acceptable safety against COVID-19 associated pneumonia in multicenter clinical trials conducted in China [5]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Excessive inflammation, oxidation, and an exaggerated immune response very likely contribute to COVID-19 pathology."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The authors in this report concluded that a synthesized mRNA of COVID 19 vaccine-induced anti–SARS-CoV-2 immune responses in all participants, and no trial-limiting safety concerns were identified."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recently, a complete genome sequence for a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strain isolated from an oropharyngeal swab specimen of a Nepalese patient with coronavirus disease 2019 (COVID-19) was published in ",
            "GenBank",
            " (accession number ",
            "NC_045512",
            "), excluding the poly(A) tail of the genome [14]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1616,
                "end": 1623,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 1642,
                "end": 1651,
                "name": "NC_045512"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "Taking this advantage, we hypothesized that designing a synthetic miRNA complemented to COVID-19 at 3′ UTR and another essential region, including ORF9, which encodes a nucleocapsid phosphoprotein (N)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This protein is a basic RNA-binding protein encoded in the most 3′ protein of the COVID genome, plays both structural and non-structural roles in infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The 3′ UTR region and ORF9 of COVID-19 were identified using the sequence (Acc.#: ",
            "NC_045512",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 2142,
                "end": 2151,
                "name": "NC_045512"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, Thei-score designer (www.med.nagoya-u.ac.jp/neurogenetics/i_Score/i_score.html) was used to deduce some candidates of miRNAs complemented of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As pandemic, COVID-19, and its consequences on the global economy, we hypothesized a new approach for the treatment of COVID-19 paints."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This approach includes designing a mix of miRNAs targeting several regions on COVID-19 open reading frame (ORF) and 3 UTR and suitable delivery system targeting respiratory system tissues."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The emergence and spread of 2019 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the possible development of coronavirus disease (COVID-19) it brings, has led us to a public health crisis, threatening the world and its population, since and all groups and ages are susceptible (Singhal, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Infected patients may never develop any symptoms; and the ones affected by COVID-19 may present variable clinical conditions, from loss of smell and taste, to mild respiratory issues, and with the possibility of severe symptoms such as respiratory insufficiency, that can result in death (Singhal, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The SARS-CoV-2 virus particles are transmitted by symptomatic or asymptomatic carrier people, and in the case of people developing COVID-19, the propagation begins days before the onset of symptoms, in form of large droplets during coughing and sneezing (Rothe et al., 2020), and possibly even during normal conversations, what results in a disseminated mass contagion (Stadnytskyi et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In face of this scenario, of a highly infective disease with potential to cause death, it has been previously shown that people with a pre-existing chronic medical condition such as obesity are more susceptible to develop severe COVID-19 outcomes (Chen et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Obesity has an impact on pulmonary function as it leads to decreased functional capacity and respiratory system compliance; a fact that may explain the impact of COVID-19 on these patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, increased inflammatory cytokines may contribute to the increased morbidity associated with obesity in COVID-19 infections (Dietz and Santos-Burgoa, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The more frequent development of severe form of COVID-19 in patients with chronic medical conditions is possibly related to the role of angiotensin-converting enzyme 2 (ACE2) in the viral infection (Wang et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Adipocytes and adipocyte-like cells, such as pulmonary lipofibroblasts, may play an important role in the pathogenic response to COVID-19, especially in obese and diabetic individuals; in these individuals, the ACE2 is increased which turns adipose tissue into a potential target and viral reservoir (Kruglikov and Scherer, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recently, a molecular study conducted with 700 lung transcriptome samples from patients with comorbidities, cardiovascular diseases, familial primary pulmonary hypertension, hypertension and pulmonary hypertension, associated with severe COVID-19 showed that ACE2 is more expressed in these patients than in control individuals (Pinto et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, there are other reports that contain other several genes with potential importance for SARS-CoV-2 cell cycle and invasion/attachment, that have been shown to be up-regulated in patients with severe COVID-19 comorbidities, such as: ADAM metallopeptidase domain 10 (ADAM10), toll like receptor 3 (TLR3), histone acetyltransferase 1 (HAT1), histone deacetylase 2 (HDAC2), lysine demethylase 5B (KDM5B), sirtuin 1 (SIRT1), member RAS oncogene family (RAB1A), transmembrane serine protease 2 (TMPRSS2), and furin paired basic amino acid cleaving enzyme (FURIN) (Pinto et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The RNA-Seq analysis was selected in order to perform a “free” investigation of the genes expressed in the cells, because RNA-Seq does not require predesigned probes, the data sets are unbiased, allowing for hypothesis-free experimental design."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "ACE2 is widely expressed in adipocytes and enriched in adipocytes of individuals with obesity and type II diabetes; there are ACE2 regulator genes in the human lung, and the protein is used by SARS-CoV-2 to infect alveolar epithelial cells, resulting in the development of COVID-19 (Kruglikov and Scherer, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In our transcriptome data from human subcutaneous adipocytes, there was no detection of ACE2 expression, what is probably due to the fact that the subcutaneous adipocytes used are from normal individuals, and the expression of ACE2 is low to the point that it might be undetected by the parameters determined in our study for the RNA-seq technique; however the cell line showed the expression of multiple genes related to severe COVID- 19, such as FURIN, ADAM10, TLR3, KDM5B, SIRT1 and TRIB3."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "FURIN cleaves SARS-CoV-2 spike (S) glycoprotein, the key protein used to infect mammal cells (Walls et al., 2020); ADAM10 is correlated with ACE2 cleavage regulation in human airway epithelia (Jia et al., 2009); TLR3 plays an important role in the innate response to SARS-CoV or MERS-CoV infection and regulates ACE2 cleavage (Totura et al., 2015); KDM5B regulates positively ACE2 (Wu et al., 2018); in more than 57% addressed studies, researchers found that SIRT1 was upregulated in the lung of patients with severe COVID-19 comorbidities; all these genes favor the viral infection and can be potential targets for preventing SARS-CoV-2 spread (Pinto et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On the other hand, TRIB3 gene has been linked to fatty acid synthesis control and insulin resistance, in addition to regulating plasma levels of triglycerides and HDL cholesterol in humans (Angyal and Kiss-Toth, 2012) and was previously reported to decrease virus infection and replication; so TRIB3 can be considered a therapeutic target for COVID-19 (Moraes et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The clinical characteristics of SARS-CoV-2 infection are varied and are similar to those described above by ARDS e ALI (Chen et al., 2020; Rubenfeld et al., 2005; Wheeler and Bernard, 2007; Matthay et al., 2012; Imai et al., 2008; Yu et al., 2016), a fact that reinforces testing irisin in cases of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The data presented by Pinto et al. (2020) and Moraes et al., 2020 (Moraes et al., 2020) offer gene targets for preventing severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In conclusion, irisin presented a very positive effect in the regulation of diverse genes related to the COVID-19 outcome in the adipose tissue, causing reduction of genes implicated in elevated viral infection, and increase in genes that block virus-cell cleavage; these results indicate that irisin treatment could end in a reduction of SARS-CoV-2 infection rate in human cells."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The obesity is associated with an increased recruitment of macrophages in the adipose tissue (Weisberg et al., 2003), and irisin modulates macrophage activity by reducing reactive oxygen species (ROS) overproduction and increasing the expression of anti-oxidative stress factors (Mazur-Bialy, 2017; Mazur-Bialy et al., 2018); thus, the beneficial effects of irisin not only depend on the positive effect on the regulation of diverse genes related to the COVID-19 outcome in the adipose tissue, but also to its anti-inflammatory properties related to the targeting of macrophages."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since the respiratory system is the most considerably affected in COVID-19, the effect of irisin in the lung tissue and the resulting gene expression must be tested."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This might evoke a COVID-19 therapeutic strategy to stimulate TRIB3 expression and decrease ACE2 regulatory genes, possibly aiding patients with both mild outcomes as well as the ones suffering from severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Obesity patients are more susceptible to develop COVID-19 severe outcome due to the role of angiotensin-converting enzyme 2 ( ACE2 ) in the viral infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our results, in human subcutaneous adipocytes cell culture, indicate a positive effect of irisin on the expression of multiple genes related to viral infection by SARS-CoV-2; furthermore, translatable for other tissues and organs targeted by the novel coronavirus and present, thus, promising approaches for the treatment of COVID-19 infection as therapeutic strategy to decrease ACE2 regulatory genes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This virus, SARS-CoV-2, which causes the COVID-19 disease, emerged in China from bats into a presumed intermediate species and then into humans."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In early March 2020, the ",
            "GISAID",
            " database (",
            "https://www.gisaid.org/",
            ") contained a compilation of 253 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) complete and partial genomes contributed by clinicians and researchers from across the world since December 2019."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 25,
                "end": 31,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 42,
                "end": 65,
                "name": "https://www.gisaid.org/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "The ",
            "Global Initiative on Sharing Avian Influenza Data (GISAID)",
            " was founded in 2006, and, since 2010, has been hosted by the German Federal Ministry of Food, Agriculture and Consumer Protection."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 277,
                "end": 335,
                "name": "Global Initiative on Sharing Avian Influenza Data (GISAID)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "",
            "GISAID",
            " has also become a coronavirus repository since December 2019."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 467,
                "end": 473,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of 4 March 2020, the cutoff point for our phylogenetic analysis, the ",
            "GISAID",
            " database (",
            "https://www.gisaid.org/",
            ") had compiled 254 coronavirus genomes, isolated from 244 humans, nine Chinese pangolins, and one bat Rhinolophus affinis (BatCoVRaTG13 from Yunnan Province, China)."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 608,
                "end": 614,
                "name": "GISAID"
            },
            false,
            {
                "id": "T6",
                "type": "URL",
                "start": 625,
                "end": 648,
                "name": "https://www.gisaid.org/"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "The network faithfully traces routes of infections for documented coronavirus disease 2019 (COVID-19) cases, indicating that phylogenetic networks can likewise be successfully used to help trace undocumented COVID-19 infection sources, which can then be quarantined to prevent recurrent spread of the disease worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Objective  Management of acute severe UC (ASUC) during the novel COVID-19 pandemic presents significant dilemmas."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We aimed to provide COVID-19-specific guidance using current British Society of Gastroenterology (BSG) guidelines as a reference point."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We convened a RAND appropriateness panel comprising 14 gastroenterologists and an IBD nurse consultant supplemented by surgical and COVID-19 experts."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patients with a positive swab should be discussed with COVID-19 specialists."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As per BSG guidance, intravenous hydrocortisone was considered appropriate as initial management; only in patients with COVID-19 pneumonia was its use deemed uncertain."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Delaying colectomy because of COVID-19 was deemed inappropriate."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Steroid tapering as per BSG guidance was deemed appropriate for all patients apart from those with COVID-19 pneumonia in whom a 4–6 week taper was preferred."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We have suggested COVID-19-specific adaptations to the BSG ASUC guideline using a RAND panel."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patients with cancer are at increased risk of contracting SARS-CoV-2 and have a high mortality rate from COVID-19 (Lee et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "https://www.asco.org/sites/new-www.asco.org/files/content-files/2020-ASCO-Guide-Cancer-COVID19.pdf)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is important that newly launched geographically diverse and national cancer efforts, such as the ",
            "UK Coronavirus Cancer Monitoring Project",
            " (",
            "UK Coronavirus Cancer Monitoring Project",
            ", 2020), collates evidence on whether such an approach has utility in reducing COVID-19 infection and mortality."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 335,
                "end": 375,
                "name": "UK Coronavirus Cancer Monitoring Project"
            },
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 377,
                "end": 417,
                "name": "UK Coronavirus Cancer Monitoring Project"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of 4 April 2020, the coronavirus disease 2019 (COVID-19) pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1], has infected more than 1.2 million people worldwide and the increase in cases has been exponential."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Viral genomes were aligned using MAFFT v7.427 [6] with 762 high-coverage viral genomes deposited in the ",
            "GISAID (Global Initiative for Sharing All Influenza Data,",
            " recently adapted to include SARS-CoV-2 genomes) database [7, 8] as of March 20, 2020, in addition to the most recent viral genomes sequenced in California as of May 3, 2020 [9], for a total of 983 sequences."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 360,
                "end": 417,
                "name": "GISAID (Global Initiative for Sharing All Influenza Data,"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Assembled SARS-CoV-2 genomes in this study were uploaded to the ",
            "GISAID",
            " database [7, 8] (accession numbers ",
            "EPI_ISL_417330",
            ", ",
            "EPI_ISL_417331",
            ", ",
            "EPI_ISL_429881",
            ", ",
            "EPI_ISL_EPI_ISL450232",
            " - ",
            "EPI_ISL450240",
            ") and were also submitted to the ",
            "National Center for Biotechnology Information (NCBI) GenBank",
            " database (accession numbers ",
            "MT419851",
            ", ",
            "MT419852",
            ", ",
            "MT419860",
            ", ",
            "MT510718-726",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 690,
                "end": 696,
                "name": "GISAID"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 732,
                "end": 746,
                "name": "EPI_ISL_417330"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 748,
                "end": 762,
                "name": "EPI_ISL_417331"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 764,
                "end": 778,
                "name": "EPI_ISL_429881"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 780,
                "end": 801,
                "name": "EPI_ISL_EPI_ISL450232"
            },
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 804,
                "end": 817,
                "name": "EPI_ISL450240"
            },
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 850,
                "end": 910,
                "name": "National Center for Biotechnology Information (NCBI) GenBank"
            },
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 939,
                "end": 947,
                "name": "MT419851"
            },
            false,
            {
                "id": "T10",
                "type": "AccessionNumber",
                "start": 949,
                "end": 957,
                "name": "MT419852"
            },
            false,
            {
                "id": "T11",
                "type": "AccessionNumber",
                "start": 959,
                "end": 967,
                "name": "MT419860"
            },
            false,
            {
                "id": "T12",
                "type": "AccessionNumber",
                "start": 969,
                "end": 981,
                "name": "MT510718-726"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T2",
                "end": "T4"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T2",
                "end": "T5"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T2",
                "end": "T6"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T2",
                "end": "T7"
            },
            {
                "id": "R6",
                "bool": true,
                "head": "T8",
                "end": "T9"
            },
            {
                "id": "R7",
                "bool": true,
                "head": "T8",
                "end": "T10"
            },
            {
                "id": "R8",
                "bool": true,
                "head": "T8",
                "end": "T11"
            },
            {
                "id": "R9",
                "bool": true,
                "head": "T8",
                "end": "T12"
            }
        ]
    },
    {
        "sen": [
            "Raw sequence data were submitted to the ",
            "NCBI Sequence Read Archive (SRA)",
            " database (BioProject accession number ",
            "PRJNA629889",
            " and umbrella BioProject accession number ",
            "PRJNA171119",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T13",
                "type": "Repository",
                "start": 1024,
                "end": 1056,
                "name": "NCBI Sequence Read Archive (SRA)"
            },
            false,
            {
                "id": "T14",
                "type": "AccessionNumber",
                "start": 1095,
                "end": 1106,
                "name": "PRJNA629889"
            },
            false,
            {
                "id": "T15",
                "type": "AccessionNumber",
                "start": 1148,
                "end": 1159,
                "name": "PRJNA171119"
            },
            false
        ],
        "rel": [
            {
                "id": "R10",
                "bool": true,
                "head": "T13",
                "end": "T14"
            },
            {
                "id": "R11",
                "bool": true,
                "head": "T13",
                "end": "T15"
            }
        ]
    },
    {
        "sen": [
            "Data from these patients with COVID-19 were matched with 102 randomly selected negative controls who were patients who tested negative for SARS-CoV-2 over the same time period."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among the 46 COVID-19–positive patients, the median age was 44 years, 46% were female, and 65% were outpatients (Supplementary Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We noted that a travel history within 2 weeks of symptom onset (median date, 11 March 2020) was significantly associated with COVID-19 infection (odds ratio [OR], 3.8; 95% confidence interval [CI] 1.8–8.4), comprising 43% (20/46) of newly diagnosed cases (Figure 1A)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Out of the 20 travelers with COVID-19 infection, there were significant associations for prior travel to Europe (5 travelers; OR, 6.1; 95% CI 1.1-32.7), travel outside of San Francisco to other cities within California or other states (United States) (14 travelers; OR: 4.0; 1.6–10.0), and specifically travel to New York (6 travelers; OR, 32.9; 95% CI 1.8-598) as compared with 17 travelers without infection (Figure 1B and Supplementary Tables 2 and 3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "One cluster of 3 positive cases associated with COVID-19 infection in an airport worker was categorized as a case of community- rather than travel-associated transmission."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "No significant associations were found with regard to close contacts with persons with known COVID-19 infection or frontline healthcare workers."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Those who did not have a recent travel history, a close contact who was COVID-19 positive, or were not a frontline healthcare worker were categorized as community transmission with an unknown source of infection and comprised 39% of cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We defined genomic clades through the ",
            "GISAID",
            " nomenclature found at that point in time on 20 March 2020 [7, 8]."
        ],
        "lab": [
            false,
            {
                "id": "T16",
                "type": "Dataset",
                "start": 2795,
                "end": 2801,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Real-time dissemination of epidemiological survey data from positive COVID-19 cases is critical to support efforts to contain or reduce spread of viral infection in the community."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our evaluation of diagnosed COVID-19 cases in San Francisco in early March 2020 associates with travelers from New York prior to the recognized spike in New York cases in late March (Figure 1C)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Travel from New York was underrecognized as a risk factor for COVID-19 infection in the United States in early March."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Guidelines for COVID-19 testing have not included screening for domestic travel."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Cryptogenic transmission of COVID-19 by individuals with mild illness or asymptomatic infection is a tremendous challenge to the containment of COVID-19 [15, 16]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In early-to-mid March 2020, 20 of 46 (43%) COVID-19 cases at a tertiary care hospital in San Francisco, California were travel related."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As an outbreak of COVID-19 emerged during the manuscript review process, we rapidly incorporated a new test for the novel coronavirus SARS-CoV-2 into a coronavirus panel taken from the HV panel, demonstrating the power of this modular master set to be adapted to real-world challenges (Fig. 2d)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For 4-channel datasets, analysis of 3-colour space was performed directly on normalized intensities."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For 5-channel datasets, droplets were divided into UV intensity bins for downstream analysis (Extended Data Fig. 4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For 5-channel datasets, UV intensity bins were recombined after assignments to create the full dataset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For 167 of the 169 HV10 species, it was possible to design primer sets using ADAPT/primer3 that cover >90% of the genomes in the database with fewer than 10 primer pairs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We improved our design approach throughout the process by incorporating new features into each round of design."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the work presented here, the radius of the sliding distance filter was set to achieve at least 99.5% correct classification in the test dataset, corresponding to the removal of 6% of droplets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using CARMEN–Cas13, we developed a multiplexed assay that simultaneously differentiates all 169 human-associated viruses with at least 10 published genome sequences and rapidly incorporated an additional crRNA to detect the causative agent of the 2020 COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of May 31, 2020, nearly 6 million cases of coronavirus disease 2019 (COVID-19) and over 350,000 deaths from the disease, have been reported worldwide [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A novel coronavirus is the cause of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This new finding provides a clue for understanding the previously unresolved physiological roles of the proteasome-dependent degradation of the SARS-CoV-2 N protein during pathogenesis of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These results suggest that PA28γ binding is important in regulating 20S proteasome activity, which in turn regulates levels of the critical nCoV N nucleocapsid protein of SARS-CoV-2, furthering our understanding of the pathogenesis of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, the role and timing of tracheostomy for patients requiring critical care for coronavirus disease 2019 (COVID-19) is unclear."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Early guidelines from both the UK and national bodies proposed a cautious approach to tracheostomy in patients with COVID-19—avoiding before 10 days of intubation and giving serious consideration before performing at all between 10 and 21 days after intubation, allowing for a sufficient decline in viral load."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With a dedicated 24 h on call tracheostomy service competent in percutaneous and surgical techniques, and access to dedicated COVID emergency theatres, the choice of performing a surgical or percutaneous tracheostomy depended only on patient body habitus, adequate neck extension, and grade of direct laryngoscopy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19-related laryngeal oedema, and upper airway oedema from prone-positioning also increased the risk of failure of extubation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These factors all guided a more interventionalist approach adopted by our COVID-19 airway team."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the absence of an evidence base, many guidelines based on expert opinion were published referencing the role of tracheostomy in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Later guidelines from an expert working group adopted a more moderate stance and the results of this study provide support for this approach."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            " Tracheostomy timing in COVID-19 patients should take into consideration the safety and ideal timing for patient outcomes, and the safety of healthcare personnel performing the tracheostomy."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "However, tracheostomy occurred in both trial arms much earlier after intubation than is recommended in the COVID-19 setting."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among the tracheostomy team, none of the clinicians developed COVID-19 symptoms during the study period and subsequent antibody testing at 2 weeks after the study period was negative in all but one surgeon, who developed COVID-19 before commencing on the team."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, none of the SLT or ODP team members involved developed COVID-19 symptoms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our experience in a much larger cohort supports the assertion that tracheostomy can be performed with low risk to COVID-19 patients and healthcare workers."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Prolonged continuous sedation requirements are a recognised feature of ventilated COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The role of tracheostomy in coronavirus disease 2019 (COVID-19) is unclear, with several consensus guidelines advising against this practice."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We developed both a dedicated airway team and coordinated education programme to facilitate ward management of tracheostomised COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we report outcomes in the first 100 COVID-19 patients who underwent tracheostomy at our institution."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This was a prospective observational cohort study of patients confirmed to have COVID-19 who required mechanical ventilation at Queen Elizabeth Hospital, Birmingham, UK."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Secondary outcomes included duration of ventilation, ICU stay, and healthcare workers directly involved in tracheostomy care acquiring COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Results  A total of 164 patients with COVID-19 were admitted to the ICU between March 9, 2020 and April 21, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "No healthcare workers developed COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Conclusion  Independent of the severity of critical illness from COVID-19, 30-day survival was higher and ICU stay shorter in patients receiving tracheostomy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Early tracheostomy appears to be safe in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of COVID-19, a major pandemic that threatens millions of lives and the global economy (1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is also crucial for protecting populations of wildlife species in native habitats and under human care, particularly nonhuman primates, which may be susceptible to COVID-19 (10)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We drew on the rapidly growing database of annotated vertebrate genomes, including new genomes produced by the ",
            "Genomes 10K",
            "-affiliated ",
            "Bat1K Consortium",
            ", ",
            "Zoonomia",
            ", and ",
            "Vertebrate Genomes Project",
            ", and other sources (30, 31)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 458,
                "end": 469,
                "name": "Genomes 10K"
            },
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 481,
                "end": 497,
                "name": "Bat1K Consortium"
            },
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 499,
                "end": 507,
                "name": "Zoonomia"
            },
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 513,
                "end": 539,
                "name": "Vertebrate Genomes Project"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nonetheless, our predictions provide a useful starting point for the selection of appropriate animal models for COVID-19 research and identification of species that may be at risk for human-to-animal or animal-to-animal transmissions of SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of the 19 catarrhine primates analyzed, 18/19 scored very high for binding of their ACE2 to SARS-CoV-2 S and one scored high (the Angola colobus); the 18 species scoring very high had 25/25 binding residues identical to human ACE2, including rhesus macaques, which are known to be infected by SARS-CoV-2 and develop COVID-19-like clinical symptoms (3, 43)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Chiroptera represents a clade of mammals that are of high interest in COVID-19 research because several bat species are known to harbor coronaviruses, including those most closely related to SARS-CoV-2 (1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Presently, there is a tremendous need for animal models to study SARS-CoV-2 infection and pathogenesis, as the only species currently known to be infected and show similar symptoms of COVID-19 is rhesus macaque."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The sources and accession numbers for the genomes or proteins retrieved from ",
            "NCBI",
            " are listed in Dataset S1."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 1671,
                "end": 1675,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of COVID-19, a major pandemic that threatens millions of human lives and the global economy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This can assist the identification of intermediate hosts for SARS-CoV-2 and hence reduce the opportunity for a future outbreak of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we utilized a unique dataset of ACE2 sequences from 410 vertebrate species, including 252 mammals, to study the conservation of ACE2 and its potential to be used as a receptor by SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our results, if confirmed by additional experimental data, may lead to the identification of intermediate host species for SARS-CoV-2, guide the selection of animal models of COVID-19, and assist the conservation of animals both in native habitats and in human care."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The novel coronavirus (2019-nCoV) has recently emerged, causing COVID-19 outbreaks and significant societal/global disruption."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Importantly, COVID-19 infection resembles SARS-like complications."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, the lack of knowledge about the underlying genetic mechanisms of COVID-19 warrants the development of prospective control measures."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To understand the pathogenetic behavior of 2019-nCoV, we compared gene expression datasets of viral infections closest to 2019-nCoV with four COVID-19 clinical presentations followed by functional enrichment of shared dysregulated genes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among the dysregulated genes, SARS-CoV shared ≤19 upregulated and ≤22 downregulated genes with each of different COVID-19 complications."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Besides, 14 genes were common to different SARS-CoV comorbidities that might influence COVID-19 disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also observed similarities in pathways that can lead to COVID-19 and SARS-CoV diseases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, protein–chemical interactions suggest cyclosporine, resveratrol and quercetin as promising drug candidates against COVID-19 as well as other SARS-like viral infections."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease 2019 (COVID-19) is caused by a novel coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]), which primarily affects the respiratory system."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patients with COVID-19 present with variable disease symptoms and severity, some can be severe, resulting in hospitalization, respiratory failure, or even death."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A recent meta-analysis of 35 COVID-19 studies reported that the pooled prevalence of digestive symptoms was 15% and pooled prevalence of digestive system comorbidities was 4%."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, SARS-CoV-2 virus was detected in the feces and anal swabs in patients with COVID-19 and can infect human intestinal epithelium.3, 4, 5 Altogether these data suggest that the GI tract is an important extrapulmonary site for SARS-CoV-2 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our recent study showed that the gut bacterial microbiome was significantly altered in patients with COVID-19 with a significant expansion of opportunistic pathogens in the gut, which was associated with disease severity and fecal SARS-CoV-2 shedding."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is unclear if the gut mycobiome is also altered and whether fungal pathogens cobloom in COVID-19 and underlie disease course."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this pilot study, we hypothesize that the intestinal fungal microbiome (mycobiome) is altered in SARS-CoV-2 infection and COVID-19 is associated with blooms of certain fungi in the gut."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We prospectively included 30 patients with COVID-19 (Table 1",
            ", Figure 1",
            ", Supplementary Figure 1), admitted between February 16, 2020, and April 1, 2020, in Hong Kong, China, followed from hospital admission until discharge."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We investigated intestinal fungal compositions in patients with COVID-19 as compared with healthy individuals and patients with community-acquired pneumonia, and their temporal changes over time of hospitalization, via broad-target deep shotgun metagenomics sequencing."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This prospective study involved 30 patients with COVID-19 hospitalized with laboratory-confirmed SARS-CoV-2 infection, 9 patients hospitalized with community-acquired pneumonia (pneumonia controls), and 30 healthy individuals (controls) (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thirty hospitalized patients with COVID-19 were admitted between February 16, 2020, and April 1, 2020, in Hong Kong, China, and were followed from hospital admission until discharge (Figure 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patients with COVID-19 and pneumonia controls were admitted to the Prince of Wales Hospital or the United Christian Hospital, Hong Kong."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severity of COVID-19 infection was categorized as (1) mild, if there was no radiographic evidence of pneumonia; (2) moderate, if pneumonia was present along with fever and respiratory tract symptoms; (3) severe, if respiratory rate ≥30/min, oxygen saturation ≤93% when breathing ambient air, or PaO2 / FiO2 ≤300 mm Hg (1 mm Hg = 0.133 kPa); or (4) critical, if there was respiratory failure requiring mechanical ventilation, shock, or organ failure requiring intensive care."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Fecal samples from patients with COVID-19 were collected serially 2 to 3 times per week until discharge."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Contaminating human reads were filtering using Kneaddata (Reference database: GRCh38 p12) with default parameters."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nonmetric multidimensional scaling analyses were performed on all baseline fecal mycobiomes between groups, and serial fecal mycobiomes in each COVID-19 case during the disease course, based on Bray-Curtis dissimilarities using vegan package (v2.5–3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Differential fungal taxa between patients with COVID-19 (at baseline or across all time points during hospitalization) and healthy controls were identified using LefSE."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 30 patients hospitalized with COVID-19, 30 healthy controls, and 9 patients hospitalized with community-acquired pneumonia were included (",
            "Table 1; Supplementary Table 1)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All patients with COVID-19 presented with respiratory symptoms and 4 also had diarrhea at presentation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To understand alterations of the gut mycobiome that underlies SARS-CoV-2 infection, we compared baseline fecal mycobiome composition (first time point of stool sampling after hospitalization) between patients with COVID-19, healthy controls, and pneumonia controls."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At the whole fungal community level, fecal mycobiome of healthy controls densely clustered together, whereas that of patients with COVID-19 formed a substantially broader cluster significantly different from that of controls (PERMANOVA test, P = .001, Figure 2",
            "A)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Fecal mycobiome was more heterogeneous across patients with COVID-19 than controls, as demonstrated by an approximately 6-fold increase in interindividual mycobiome dissimilarity in patients with COVID-19 relative to controls (P < 2.22e-16, Figure 2",
            "B)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patients with community-acquired pneumonia also showed heterogeneous fecal mycobiome configurations (Figure 2",
            "B), indicating that both community-acquired pneumonia and COVID-19–associated pneumonia were associated with fungal dysbiosis in the gut."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We next identified differential fungal species in fecal samples between patients with COVID-19 and healthy controls adjusting for antibiotics use and comorbidities."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We found that Candida albicans was significantly enriched in 6 (20%) of 30 patients with COVID-19 but was absent in healthy controls (false discovery rate P = .04, Figure 2",
            "C)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These data suggest that gut mycobiome was significantly altered in patients with COVID-19 with an increase in Candida species."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We investigated longitudinal dynamics of the gut mycobiome in COVID-19 over time of hospitalization and explored whether recovery from SAR-CoV-2 infection was associated with restoration of gut mycobiome to a community similar to that of healthy individuals."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The gut mycobiome in most (22 of 30) patients with COVID-19 was stable over the course of hospitalization and remained similar to that of healthy controls at the latest follow-up (Figure 3",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The diversity of the fecal mycobiome did not differ between healthy controls and patients with COVID-19 at baseline (Figure 4",
            "A)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In contrast, the diversity and richness of the gut mycobiome were both significantly higher in patients with community-acquired pneumonia than patients with COVID-19 at baseline (Figure 4",
            "A and B, P < .05 and < .01, respectively)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At the last follow-up after hospitalization, patients with COVID-19 showed a 2.5-fold higher diversity of the fecal mycobiome compared with healthy controls (P < .05, Figure 4",
            "A)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Overall, during disease course, the diversity of the fecal mycobiome showed constant changes in 53% (16 of 30) of patients with COVID-19 (Supplementary Figure 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Altogether these data suggest that the gut mycobiome was unstable in a subset of patients with COVID-19 during the time of hospitalization."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These data indicate persistent gut fungal dysbiosis despite disease resolution in a subset of patients with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Across all time points during hospitalization, C. albicans, Candida auris and Aspergillus flavus were overrepresented in fecal samples of patients with COVID-19; these species however were absent in healthy controls (Figure 4",
            "C, Supplementary Figures 2 and 3, and Figure 5",
            "A)."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Two fungal species from the genus Aspergillus, A. flavus and Aspergillus niger, known to cause pulmonary aspergillosis and respiratory illnesses (particularly cough),",
            ",",
            " were detected in serial fecal samples of 6 and 4 patients with COVID-19, respectively, during hospitalization (Figure 5)."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All 6 patients presented with cough and varying degree of COVID-19 severity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A. niger was absent at baseline but showed a low relative abundance of <1% in 4 of 30 patients with COVID-19 over time of hospitalization (Figure 5",
            "B)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These data indicate cobloom of opportunistic fungal pathogens, Candida species and Aspergillus species, in the gut of patients with COVID-19 over the disease course."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We showed for the first time that the gut mycobiome was disturbed in patients with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These data suggest that gut microbiota changes induced by SARS-CoV-2, might at least in part, be stochastic, therefore leading to transition from a stable to unstable microbial community state in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In line with our findings in patients with COVID-19, a highly heterogeneous assembly of microbial community in response to disease stressors have been reported in the gut of patients with inflammatory bowel disease and in the lungs of patients with human immunodeficiency virus/AIDs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            ",",
            " Human immunodeficiency virus/AIDs is associated with decreased CD4+",
            "In favor of this hypothesis, the overall gut mycobiome was unstable in a subset of patients with COVID-19 over time of hospitalization, and these individuals ended up with a different gut mycobiome composition compared with that of healthy individuals."
        ],
        "lab": [
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, gut mycobiome diversity of patients with COVID-19 at the last follow-up during hospitalization was significantly higher than that of healthy individuals."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These data indicate expansion of fungi in the gut of patients with COVID-19 and SARS-CoV-2 infection may be associated with a persistent gut mycobiome dysbiosis in some patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Secondary fungal infection or coinfection in patients with COVID-19 during the pandemic is garnering increased attention."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Specific enrichments of opportunistic fungal pathogens, Candida and Aspergillus lineages, were observed in patients with COVID-19 during the disease course."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among them, C. albicans was overrepresented in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Aspergillus infections were recently reported in respiratory tract secretions and tracheal aspirates in patients with COVID-19 from 2 studies (detection rate of 10% and 20%, respectively, in cohorts from China and France)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            " Population-based studies have reported 19% to 33% incidence of pulmonary aspergillosis in patients with COVID-19.31, 32, 33",
            "Aspergillus is a genus of ubiquitous fungi that cause a variety of pulmonary and respiratory symptoms."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To date, there are a lack of data on whether fungal pathogens exist in the gut of patients with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this case series, we provide the first evidence demonstrating the presence of opportunistic Aspergillus pathogens in the feces of patients with COVID-19; A. flavus were detected in the feces of 20% of patients with COVID-19 via metagenomics sequencing."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All 6 patients with COVID-19 who had fecal A. flavus presented with cough during hospitalization, suggestive of a systemic effect of Aspergillus infection and the intricate link between the GI and respiratory systems."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Two of the 3 patients (CoV1 and 3) who had both fungal species A. flavus and A. niger in their feces presented with critical COVID-19 and were admitted to intensive care unit, and the third case (CoV7) had high fever and moderate COVID-19 severity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patient CoV19 who had mild COVID-19 showed clearance of A. flavus and A. niger over time of hospitalization."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although the overall gut mycobiome structure in patients with COVID-19 gradually resembled that of healthy individuals over time of hospitalization (Figure 3), Aspergillus species continued to be present in a subset of patients with COVID-19 (CoV3 and CoV15) even after nasopharyngeal clearance of SARS-CoV-2 (Figure 5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The post-recovery existence of Aspergillus species underscores a potential prolonged detrimental effect of secondary fungal infection on host health after SARS-CoV-2 infection, cautioning on long-term monitoring of patients with COVID-19 after recovery."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similar to patients with COVID-19, blooms of opportunistic fungal pathogens, Candida species and Aspergillus species, were also seen in patients with community-acquired pneumonia."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In contrast, patients with community-acquired pneumonia showed more heterogeneous gut mycobiome configurations than patients with COVID-19, indicating that the gut mycobiome in community-acquired pneumonia may be more “dysbiotic” than that in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, the diversity and richness of the gut mycobiome were both significantly lower in patients with COVID-19 than patients with community-acquired pneumonia."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These data collectively suggest that patients with COVID-19 have a similar but less severe dysbiosis of gut mycobiome compared with patients with community-acquired pneumonia."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We performed deep shotgun metagenomic sequencing analysis of fecal samples from 30 patients with coronavirus disease 2019 (COVID-19) in Hong Kong, from February 5 through May 12, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We compared fecal mycobiome compositions of patients with COVID-19 with those from 9 subjects with community-acquired pneumonia and 30 healthy individuals (controls)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Results  Patients with COVID-19 had significant alterations in their fecal mycobiomes compared with controls, characterized by enrichment of Candia albicans and a highly heterogeneous mycobiome configuration, at time of hospitalization."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although fecal mycobiomes of 22 patients with COVID-19 did not differ significantly from those of controls during times of hospitalization, 8 of 30 patients with COVID-19 had continued significant differences in fecal mycobiome composition, through the last sample collected."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The diversity of the fecal mycobiome of the last sample collected from patients with COVID-19 was 2.5-fold higher than that of controls ( P < .05)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Samples collected at all timepoints from patients with COVID-19 had increased proportions of opportunistic fungal pathogens, Candida albicans , Candida auris , and Aspergillus flavus compared with controls."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Two respiratory-associated fungal pathogens, A. flavus and Aspergillus niger , were detected in fecal samples from a subset of patients with COVID-19, even after clearance of SARS-CoV-2 from nasopharyngeal samples and resolution of respiratory symptoms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In a pilot study, we found heterogeneous configurations of the fecal mycobiome, with enrichment of fungal pathogens from the genera Candida and Aspergillus, during hospitalization of 30 patients with COVID-19 compared with controls."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Unstable gut mycobiomes and prolonged dysbiosis persisted in a subset of patients with COVID-19 up to 12 days after nasopharyngeal clearance of SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The outbreak of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has gradually expanded to pandemic (Wang et al., 2020a; World Health Organization, 2020b), due to the strong infectivity of the virus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In order to extend the cell-based data to tissue-specific mode, we collected population-based proteomic datasets, from human lung (",
            "Mertins et al., 2018",
            "), colon (",
            "Vasaikar et al., 2019",
            "), kidney (",
            "Clark et al., 2019",
            "), liver (",
            "Gao et al., 2019",
            "), and heart (",
            "Doll et al., 2017",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Creator",
                "start": 362,
                "end": 382,
                "name": "Mertins et al., 2018"
            },
            false,
            {
                "id": "T2",
                "type": "Creator",
                "start": 392,
                "end": 413,
                "name": "Vasaikar et al., 2019"
            },
            false,
            {
                "id": "T3",
                "type": "Creator",
                "start": 424,
                "end": 442,
                "name": "Clark et al., 2019"
            },
            false,
            {
                "id": "T4",
                "type": "Creator",
                "start": 452,
                "end": 468,
                "name": "Gao et al., 2019"
            },
            false,
            {
                "id": "T5",
                "type": "Creator",
                "start": 482,
                "end": 499,
                "name": "Doll et al., 2017"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first four datasets are from the ",
            "National Cancer Institute Clinical Proteomic Tumor Analysis Consortium (CPTAC)",
            ", which include various normal tissues."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 539,
                "end": 617,
                "name": "National Cancer Institute Clinical Proteomic Tumor Analysis Consortium (CPTAC)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "First, we checked RNA and antibody-based protein data for three receptors and TMPRSS2, from a variety of tissues in the ",
            "Human Protein Atlas (HPA)",
            " database (",
            "https://www.proteinatlas.org/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 777,
                "end": 802,
                "name": "Human Protein Atlas (HPA)"
            },
            false,
            {
                "id": "T8",
                "type": "URL",
                "start": 813,
                "end": 842,
                "name": "https://www.proteinatlas.org/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T7",
                "end": "T8"
            }
        ]
    },
    {
        "sen": [
            "Then, we collected mass spectrometry-based proteomic data of normal tissues of four organs from ",
            "CPTAC",
            " database and a set of data of normal heart (",
            "Doll et al., 2017",
            "), including two parts, respectively, from cavities and vessels."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 941,
                "end": 946,
                "name": "CPTAC"
            },
            false,
            {
                "id": "T10",
                "type": "Creator",
                "start": 991,
                "end": 1008,
                "name": "Doll et al., 2017"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The correlation between each two proteins across individuals in each dataset was used as the weight of the edge."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to the threshold that we set, TMPRSS2 is not associated with the three receptors in the String database and TMPRSS2 is not found in two tissues of the heart."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Next, we extracted 45 upregulated proteins in host cells affected by 24-h SARS-CoV-2 infection from a recently reported dataset (",
            "Bojkova et al., 2020",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Creator",
                "start": 1483,
                "end": 1503,
                "name": "Bojkova et al., 2020"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There are also interactions between the nodes obtained from the two datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The data downloaded from ",
            "CPTAC",
            " database provide relative protein abundance by sample."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 1609,
                "end": 1614,
                "name": "CPTAC"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For patients with COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the damages to multiple organs have been clinically observed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on collected proteomic datasets from human lung, colon, kidney, liver, and heart, we constructed a virus-receptor network, a virus-interaction network, and a virus-perturbation network."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The present analysis implies that SARS-CoV-2 could affect multi-targets in diverse host tissues, and the treatment of COVID-19 would be a complex task."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The global outbreak of COVID-19 has emerged as a severe threat to human health (–)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 is caused by a novel coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is an enveloped, positive-strand RNA virus that causes symptoms such as cough, headache, dyspnea, myalgia, fever, and severe pneumonia in humans (, –)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The SARS-CoV-2 S protein–targeting monoclonal antibodies (mAbs) with potent neutralizing activity are a focus in the development of therapeutic interventions for COVID-19 (–)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We isolated and characterized monoclonal antibodies (mAbs) from 10 convalescent COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This points to the NTD as a promising target for therapeutic mAbs against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ongoing pandemic of COVID-19 which originated at Wuhan and its progressing rate of transmission into 188 countries and territories has created a havoc in the society declaring it as a global health emergency by WHO on 30 January 2020 (Rasmussen et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since then, the situation has been deteriorating in the European provinces and American regions, where the South Asian countries have also been carrying a worse COVID-19 burden."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Currently more than 400 genome sequences SARS-CoV2 are available at ",
            "NCBI",
            " databases and that gives a plethora of information to aid the development of the drug and vaccine."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 510,
                "end": 514,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The SARS-CoV-2 miRNA prediction was carried out using the complete genome sequence of SARS-CoV2 carrying accession number (",
            "NC_045512.2",
            ", ",
            "MT435086",
            ", ",
            "MT339041",
            ", ",
            "MT066156",
            " and ",
            "MT507794.1",
            ") for China, India, USA, Italy and Jamaica respectively; obtained from the ",
            "National Centre for Biotechnology Information (NCBI)",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 737,
                "end": 748,
                "name": "NC_045512.2"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 750,
                "end": 758,
                "name": "MT435086"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 760,
                "end": 768,
                "name": "MT339041"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 770,
                "end": 778,
                "name": "MT066156"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 783,
                "end": 793,
                "name": "MT507794.1"
            },
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 868,
                "end": 920,
                "name": "National Centre for Biotechnology Information (NCBI)"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T7",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T7",
                "end": "T3"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T7",
                "end": "T4"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T7",
                "end": "T5"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T7",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "Human miRNA sequences are available in the ",
            "miRBase",
            " database (",
            "http://www.mirbase.org",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 965,
                "end": 972,
                "name": "miRBase"
            },
            false,
            {
                "id": "T9",
                "type": "URL",
                "start": 983,
                "end": 1005,
                "name": "http://www.mirbase.org"
            },
            false
        ],
        "rel": [
            {
                "id": "R6",
                "bool": true,
                "head": "T8",
                "end": "T9"
            }
        ]
    },
    {
        "sen": [
            "Each of the Candidate precursor miRNAs was searched for the nucleotide similarity with all human miRNAs by using the SSEARCH (it is useful for finding a short sequence within the library of miRNA) menu of the ",
            "miRbase",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 1217,
                "end": 1224,
                "name": "miRbase"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Gene ID’s of target genes were used for this analysis to find GO terms related to gene products (Chen and Glover, 2016; Dalmer and Clugston, 2019; Hu et al., 2019)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The sequences of all the five viral SARS-CoV2 miRNA candidate precursors obtained was searched using SSEARCH menu the ",
            "miRbase",
            " database for finding the nucleotide similarity with all human microRNAs using the default parameters (E-cut off value: 10, Maximum no. of hits: 100, Specific organism: human)."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Repository",
                "start": 1518,
                "end": 1525,
                "name": "miRbase"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, in SARS-CoV2; only 2–11 % infected patients carry liver morbidities but remains indistinct whether the liver damage in COVID-19 patients was caused by a viral infection or drug toxicity (Liu et al., n.d.)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Another phenomenon associated is the basal transcription machinery of the SARS-CoV2 (TAF’s) of TFIID complex which could prevent the RNA polymerase II to assemble on the promoters of the host genes at the initiation step that can specifically block the transcription."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Predicted miRNAs from SARS-CoV2 viral genomes were used for effective hybridization sequence identification along the nucleotide similarities with human miRNAs from ",
            "miRbase",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 2350,
                "end": 2357,
                "name": "miRbase"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since its first occurrence in December 2019 in China, the SARS-CoV-2 outbreak, leading to COronaVIrus Disease 2019 (COVID-19), spread around the world."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although other studies have already evaluated mismatches in primers and probes used for SARS-CoV-2 detection, they have often only incorporated a limited number of genome sequences or RT-qPCR assays, or only evaluated the situation at a single time point [28,35,36,37,38]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Seven RT-qPCR tests originated from the WHO technical guidance published for laboratory testing of SARS-CoV-2 in humans [27] and were developed by (in no specific order) the Chinese Center for Disease Control and prevention (CDC) (Assays_1 (ORF1b and N)), the German Charité Hospital (Assays_2 (RdRp-P1, RdRp-P2, E, and N)), the French Institut Pasteur (Assays_3 (RdRp-IP2, RdRp-IP4, and E)), the US CDC (Assays_4 (N-1, N-2, and N-3)), the Japanese National Institute for Infectious Diseases (NIID) (Assay_5_N), the Hong-Kongese Faculty of Medicine HKU Med (Assays_6 (RdRp/nsp14 and N)), and the Thai National Institute of Health (NIH) (Assay_7_N)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Other assays (5) were retrieved from the literature or from a working document of the European Commission inventorying the diagnostic tests developed for COVID-19 [34]—i.e., Assays_8 (RdRp/Hel, S, and N)), Assays_9_ORF1a, Assays_10 (RdRp, S, E, and N), Assays_11 (N-1, N-2, ORF1a-3, ORF1a-4, S-5, and S-6), and Assay_12_E."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 3590 SARS-CoV-2 genomes, sequenced from samples collected before the 7th of April 2020, were downloaded from the ",
            "GISAID EpiCoV",
            " database, the ",
            "NCBI Virus",
            " database, and the ",
            "CNGB hCoV-19",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 1521,
                "end": 1534,
                "name": "GISAID EpiCoV"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 1549,
                "end": 1559,
                "name": "NCBI Virus"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 1578,
                "end": 1590,
                "name": "CNGB hCoV-19"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For exclusivity testing, 2624 non-SARS-CoV-2 genomes belonging to other members of the Coronaviridae family and other common respiratory viruses were downloaded from the ",
            "NCBI Virus",
            " database and ",
            "ViralZone",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 1771,
                "end": 1781,
                "name": "NCBI Virus"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 1795,
                "end": 1804,
                "name": "ViralZone"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With the aim of evaluating the stability of the assay’s specificity over time, a second batch of SARS-CoV-2 genomes (1165), sequenced from samples collected between the 7th of April and the 7th of May 2020, was downloaded from the ",
            "GISAID EpiCoV",
            " and ",
            "NCBI Virus",
            " databases."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 2037,
                "end": 2050,
                "name": "GISAID EpiCoV"
            },
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 2055,
                "end": 2065,
                "name": "NCBI Virus"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "After clearing this dataset from low-quality sequences and the clustering of identical genomes, 968 representative unique SARS-CoV-2 genomes were obtained."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The other primers and probe sets evaluated with this more recent dataset all demonstrated a 100% inclusivity, except Assay_2_RdRp-P1, Assay_2_RdRp-P2, and Assay_8_N, which showed an inclusivity of between 99% and 100%."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interestingly, when the inclusivity of Assays 1 (ORF1b and N), Assays_2 (RdRp-P1, RdRp-P2, E, and N), Assays_4 (N-1, N-2, and N-3), and Assays_8 (RdRp/Hel, S, and N) was evaluated again with a new dataset of SARS-CoV-2 genomes downloaded one month after the first one; some of these SNPs were not detected any more, while few new ones were observed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To better appreciate any bias, it would be beneficial to add to the public databases enough relevant metadata with the exact information on how the SARS-CoV-2 positive samples were determined (including which RT-qPCR assay was used, if determined as such), and how the libraries for the WGS of the viral genome were made, as this information is not always available."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This positive signal is not surprising, as a close genomic similarity was observed between the first SARS-CoV and the bat-coronavirus suspected to be the origin of the COVID-19 zoonosis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The diversity in the amplicon sequences was very limited and remained unchanged when using a new dataset of SARS-CoV-2 genomes collected one month after the first one, indicating that this locus is a good RT-qPCR target, although this should be re-evaluated on regular basis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, to determine if new stable mutations will appear in SARS-CoV-2, potentially impacting the specificity of RT-qPCR tests, an evaluation similar to what was presented in this study should be conducted regularly and definitely as soon as a vaccine or treatment is in place, as new data are uploaded to the genomic databases daily."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Firstly, the genome sequence for the same sample can potentially be deposited in multiple databases that, however, all use different identifiers that cannot be reconciled."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SCREENED is available as an open-source tool that can be executed through a user-friendly interface using the Galaxy Workflow Management system [57] incorporated in the public Galaxy @Sciensano instance (https://galaxy.sciensano.be, Sciensano, Brussels, Belgium), or alternatively that can be downloaded (https://github.com/BioinformaticsPlatformWIV-ISP/SCREENED, GitHub, San-Francisco, CA, USA) to be run locally on the Linux command line."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The current COronaVIrus Disease 2019 (COVID-19) pandemic started in December 2019."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 cases are confirmed by the detection of SARS-CoV-2 RNA in biological samples by RT-qPCR."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Till date, the Integrated Disease Surveillance Programme (IDSP), a national health programme, Government of India, has collected samples from symptomatic travellers in liaison with the State-level Viral Research and Diagnostic Laboratories (VRDLs), Department of Health Research."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These sequences were also compared with the available ",
            "GenBank",
            " sequences to monitor the mutations and understand their relation with other known SARS-CoV-2 available in the public database."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 334,
                "end": 341,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Full-length genome sequences of SARS-CoV-2 were downloaded from the ",
            "GISAID",
            " database17 (Supplementary Table I (available from ))."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 537,
                "end": 543,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Multiple sequence alignment was performed using the MEGA software version 7.018 with retrieved sequences from two of the three positive cases and the available ",
            "GISAID",
            " sequences."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 758,
                "end": 764,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The FastQ files were reference mapped with the available Wuhan seafood pneumonia virus (Wuhan Hu-1) complete SARS-CoV-2 genome (accession number: ",
            "NC 045512.2",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 922,
                "end": 933,
                "name": "NC 045512.2"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Prediction of conformational B-cell epitopes revealed that one of these (residue positions 341-505) in the spike protein incorporates two of the predicted linear epitopes (327-342 and 404-419) having good antigenicity along with a favourable IFN-γ response that enables differentiation and proliferation of the B-cells25."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The sequences of Indian SARS-CoV-2 though not identical showed high (~99.98%) identity with Wuhan seafood market pneumonia virus (accession number: ",
            "NC 045512",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 1406,
                "end": 1415,
                "name": "NC 045512"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As government restrictions put in place to slow the acceleration of the coronavirus disease-2019 (COVID-19) pandemic start to ease, many people, including elite athletes, will begin to return back to their normal daily activities."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although the majority of risk factors for severe COVID-19—hypertension, respiratory system disease, obesity, older age, and cardiovascular disease—are exceptionally rare in elite athletes, when athletes train in groups or common training areas, they are not immune from contracting the illness; and, although the subsequent risk of death is low, it is not zero."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It has been estimated that 22% of the global population are at increased risk of severe COVID-19 if infected."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "One area with potential early promise is that of genetic testing, with a number of genetic variants tentatively associated with an increased susceptibility to, and an increased chance of complications from, contracting COVID-19.,",
            "So far, 4 studies4, 5, 6, 7 have shown that at least 6 DNA polymorphisms might be implicated in COVID-19 severity, with the ABO blood group (ABO) rs657152 A, angiotensin I converting enzyme (ACE) D, apolipoprotein E (APOE) rs429358 C, leucine zipper transcription factor like 1 (LZTFL1) rs11385942 GA, transmembrane protein 189-ubiquitin-conjugating enzyme E2 variant 1 (TMEM189-UBE2V1) rs6020298 A, and transmembrane serine protease 2 (TMPRSS2) rs12329760",
            "We thus hypothesized that polygenic risk scores for COVID-19 severity based on 6 DNA polymorphisms may vary across different sporting groups (endurance and power oriented)."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using the ",
            "1000 Genomes",
            " database and our own data of 802 Russian elite athletes and 224 controls (Supplementary Table 3 and Supplementary Methods), we first identified the proportion of subjects with increased risk in each population."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1573,
                "end": 1585,
                "name": "1000 Genomes"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In conclusion, we identified that team sport, power, and combat athletes possess a higher genetic risk for COVID-19 severity than untrained subjects or endurance athletes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Highlights     •  Predictive genetic testing of an asymptomatic person has considerable potential to predict future risk of coronavirus disease-2019 (COVID-19) severity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Risk alleles for COVID-19 severity due to the pleiotropic effects are associated with performance-related traits."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Team sport, power, and combat athletes possess a higher genetic risk for COVID-19 severity than untrained subjects or endurance athletes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Acute kidney injury (AKI) is a life-threatening disorder, although the rate of AKI in COVID-19 is relatively rare."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to reports from Wuhan, China, among 138 hospitalized patients with COVID-19, only 5 (3.6%) patients developed AKI and 2 (1.5%) patients required continuous renal replacement therapy (CRRT) [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There are no data about managing CRRT, including prevention of secondary infection and control (IPC) in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we report a case of a patient with severe COVID-19 who required CRRT."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A septuagenarian male suffering from COVID-19 was referred to our hospital."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to a recent report from Wuhan, China, among 52 critically ill adult patients with COVID-19 pneumonia who were admitted to the ICU, 12 (23%) patients developed AKI and 9 (17%) required renal replacement therapy (RRT) [6]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With the increasing number of COVID-19 patients, the need for RRT is likely to increase."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although the recommendation by the WHO for the use of personal protective equipment for COVID-19 did not include CRRT [8], we considered the risk of aerosol generation during CRRT."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To the best of our knowledge, this is the first report describing the management of CRRT including IPC among COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "From our experience, we suggest clinical practice and IPC for delivering RRT in the acute phase in COVID-19 patients who develop AKI (Table 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The outbreak of coronavirus disease 2019 (COVID-19) is a global health threat."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recently, we had a critically ill COVID-19 patient who developed severe AKI and needed continuous RRT (CRRT)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Due to unstable hemodynamic status in critically ill patients, CRRT should be the first choice for severe AKI in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We suggest prevention of clinical infection and control during administration of RRT in the acute phase of COVID-19 patients with AKI or multiple organ failure."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and its associated disease known as COVID-19, was originated in Wuhan, China (Zhu et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among others, symptoms of COVID-19 include fever, cough and shortness of breath (Chen et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Generally, the mutation occurs when an error is incorporated in a viral genome (Fleischmann, 1996)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The genomic sequences of Indian SARS-CoV-2 virus was collected from ",
            "Global Initiative on Sharing All Influenza Data (GISAID)",
            "2",
            "in fasta format on 11th June 2020."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 427,
                "end": 483,
                "name": "Global Initiative on Sharing All Influenza Data (GISAID)"
            },
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The dataset contains 566 genomes with sequence ID and sequence in fasta format."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We have extracted the date from the sequence ID to show the number of sequences uploaded per month."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, the original and shorter sequence IDs (for better visualization) and the length of each genome are mentioned in the supplementary Table S1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The wave of COVID-19 is a big threat to the human population."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Forster et al. (1) performed a phylogenetic network analysis with 160 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomes from a public database and proposed a network of ancestral nodes and derived types, suggesting virus adaptability to specific geographical regions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 has caused coronavirus disease 2019 (COVID-19) across the country and abroad."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 83 157 COVID-19 cases with 4.02% mortality has been reported in China up to 7 April 2020 [4]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A COVID-19 patient usually presents with fever, a nonproductive cough, myalgia and malaise."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The transmission dynamics of COVID-19 in hospitals in the initial period, especially among HCWs, are important for deeper understanding of the epidemiology of the disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nasopharyngeal and/or oropharyngeal swabs were obtained from all COVID-19 cases for SARS-CoV-2 nucleic acid assay, and 22 were processed using whole-genome sequencing."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "After the 25 HCWs' onset of illness, 10 out of 43 family members were confirmed as COVID-19 cases via nucleotide tests."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In summary, from 5 to 29 January 2020, 25 HCWs and 10 family members out of seven families were diagnosed with COVID-19 in a single hospital."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We obtained 12 whole-genome sequences (",
            "GenBank",
            " accession numbers ",
            "MT079843",
            "–",
            "MT079854",
            ") after implementing de novo sequencing from 22 swab specimens from 22 COVID-19 patients."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 927,
                "end": 934,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 953,
                "end": 961,
                "name": "MT079843"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 962,
                "end": 970,
                "name": "MT079854"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T1",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "Sequencing analysis of the sequences of 12 COVID-19 cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "WHUHnCoV001–WHUHnCoV008, WHUHnCoV011, WHUHnCoV012, WHUHnCoV0020 and WHUHnCoV021 are the sample IDs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The letters following them represent the corresponding patient IDs from figure 1b. a)",
            "Full-genome structure and mutation information compared with Wuhan-Hu-1 (",
            "GenBank",
            " accession number ",
            "NC_0455122",
            ")."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 1378,
                "end": 1385,
                "name": "GenBank"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 1403,
                "end": 1413,
                "name": "NC_0455122"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T4",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "At the very early stage of the outbreak of COVID-19 in Wuhan City and Hubei Province in China, we lacked efficient viral identification capacity to diagnose probable COVID-19 cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There were no effective prevention measures in general hospital settings to isolate and manage the suspected COVID-19 cases, or valid containment measures to block the transmission pathways [12]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "HCWs are the highest risk occupational population in outbreaks of such acute respiratory infectious diseases, such as SARS and COVID-19, which are transmitted by contact or respiratory droplets, aerosols or fomites [24]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we have described several clusters of COVID-19 cases in a hospital, showing person-to-person transmission of SARS-CoV-2, and have assessed the epidemiological features of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Some patients had no fever but only mild symptoms such as nasal congestion, which may have led to patients being overlooked, causing a wider spread of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We collected and analysed data on exposure history, illness timelines and epidemiological characteristics from 25 healthcare workers with laboratory-confirmed coronavirus disease 2019 (COVID-19) and two healthcare workers in whom COVID-19 was highly suspected, as well as 10 of their family members with COVID-19, between 5 January and 12 February 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of March 24, 2020, the worldwide tracking for COVID‐19 infections reported 1,603,433 cases including 95,716 deaths (",
            "Worldometers",
            ", 2020)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 119,
                "end": 131,
                "name": "Worldometers"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among the 18 countries that have reported more than 20,000 COVID‐19 cases, the total number of cases per population ranged from 3,277 per million people in Spain to 57 per million cases in China and the total death rate among these countries ranged from 330 per million in Spain to 2 per million in China (",
            "Worldometers",
            ", 2020)."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 446,
                "end": 458,
                "name": "Worldometers"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Differences among the host, particularly the sex of the patient and presence of selected comorbid diseases and immunosuppressive state have been identified as risk factors from severe COVID‐19 (China‐CCDC, 2020; World Health Organization, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "An increased association with the use of angiotensin‐converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) has been reported for severe COVID‐19 cases (Zhou, Yang, et al., 2020), however, the clinical relevance of this finding is uncertain and possibly influenced by the presence of confounders (Gracia‐Ramos, 2020",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Further attention has been drawn to the ACE2 receptor as antimalarials, which can interfere with ACE2 expression, have resulted in increased clearing of the SARS‐CoV‐2 clearance among COVID‐19 patients (Gautret et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The initial wild‐type structure of the human ACE2 (hACE2) was selected from the X‐ray crystal complex structure between hACE2 with SARS‐CoV‐2 spike (S) protein from Protein Data Bank (Berman, Henrick, Nakamura, & Markley, 2007) (PDB ID: 6LZG)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also found that there was some variability of genetic expression of hACE2 among various populations, but the magnitude of the differences was small and so it is unclear if this has any impact based on this subtle differences in susceptibility or severity of COVID‐19 among various ethnicities."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also did not notice a differential expression of hACE2 between the sexes, even though it is widely reported that males have a worse prognosis than females for complications of COVID‐19 (Zhou, Yu, et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There appears to be large regional variation for susceptibility, severity, and mortality for COVID‐19 infections."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Angiotensin Enzyme and Receptor are now active targets for potential treatment of COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We searched the 29.9 kb genome of SARS-CoV-2 stored in the ",
            "China National Microbiological Data Center",
            " (accession number ",
            "CNP0000881",
            ") for PQSs using QGRS-Mapper [13]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 59,
                "end": 101,
                "name": "China National Microbiological Data Center"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 120,
                "end": 130,
                "name": "CNP0000881"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "The ",
            "National Center for Biotechnology Information database (NCBI)",
            " harbors more than 50 sequenced genomes of CoVs, including bat CoVs, Middle East respiratory syndrome-related CoV (MERS-CoV) and SARS-CoV."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 169,
                "end": 230,
                "name": "National Center for Biotechnology Information database (NCBI)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "HDOCK incorporates the binding interface information into the docking concept, which accepts both sequences and structures as input for the protein docking prediction [47]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "RNA sequence of SARS-CoV-2 was obtained from the ",
            "China National Microbiological Data Center",
            " (accession number ",
            "CNP0000881",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 591,
                "end": 633,
                "name": "China National Microbiological Data Center"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 652,
                "end": 662,
                "name": "CNP0000881"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T4",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was discovered as the viral pathogen that causes COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "When COVID-19 quickly spread outside China, sequencing of the viral genome was conducted from infected patients in other countries to compare the sequence with the reference sequence."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Intriguingly, genomic sequence of SARS-CoV-2 of the first two COVID-19 patients diagnosed in Italy during January and February 2020 already showed mutations compared to the reference sequence established in China [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, this recent study [2] did not explore the association between genetic variation in SARS-CoV-2 and the severity of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Another analysis of 86 genomic sequences obtained from ",
            "GISAID",
            " database (",
            "https://www.gisaid.org/",
            ") identified 3 deletions in the genomes of SARS-CoV-2 from Japan, USA and Australia, and 93 mutations over the entire SARS-CoV-2 genomes [3]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 714,
                "end": 720,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 731,
                "end": 754,
                "name": "https://www.gisaid.org/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "Pachetti et al. [4] analyzed 220 SARS-CoV-2 genomic sequences from the ",
            "GISAID",
            " database and found 8 novel mutation hot spots: 5 of them were predominantly observed in Europe and 3 were exclusively present in North America but none of them was detected in Asia."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 967,
                "end": 973,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, it is an urgent need to explore the association of the mutation pattern of SARS-CoV-2 genome with the severity and fatality of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on the above discussion, we hypothesize that the genetic variation in SARS-CoV-2 may explain variable severity of COVID-19 in the population."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Analysis of sequencing data of SARS-CoV-2 genome showed evidence of mutation at the beginning of the worldwide spread of COVID-19 [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On 26 February, the Director‐General of the WHO announced that the number of new cases of the disease, now officially known as COVID‐19, reported outside China since the day before had for the first time exceeded the number of new cases in China (https://www.who.int/dg/speeches/detail/who‐director‐general‐s‐opening‐remarks‐at‐the‐mission‐briefing‐on‐covid‐19‐‐‐26‐february‐2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The results were mapped and aligned to the reference genome obtained from ",
            "GISAID",
            " (",
            "https://www.gisaid.org/",
            ", accession ID: ",
            "EPI_ISL_412973",
            ") using Geneious software, v. 9.1.5 (http://www.geneious.com)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 456,
                "end": 462,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 464,
                "end": 487,
                "name": "https://www.gisaid.org/"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 503,
                "end": 517,
                "name": "EPI_ISL_412973"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T1",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "A root‐to‐tip regression analysis was made using TempEst in order to investigate the temporal signal of the dataset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Root‐to‐tip regression analysis of the temporal signal from the dataset revealed a relatively weak association between genetic distances and sampling days (a correlation coefficient of 0.46 and a coefficient of determination [R",
            "2] of 0.21) (Figure 1)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The present phylogenetic analysis confirms that the common origin of the SARS‐CoV‐2 strains characterized so far was several weeks before the first cases of COVID‐19 pneumonia were described in China."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The German sequence at the outgroup of the clade came from a COVID‐19 outbreak reported between 20 and 24 January and occurring after business meetings with a Shanghai business woman who tested positive after returning to China."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This report describes the isolation, molecular characterization, and phylogenetic analysis of the first three complete genomes of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) isolated from three patients involved in the first outbreak of COVID‐19 in Lombardy, Italy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On 11 February 2020, the International Committee on Taxonomy of Viruses officially renamed 2019-nCoV, which is responsible for the current outbreak of coronavirus disease 2019 (COVID-19), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Notably, the current COVID-19 outbreak is characterized by its significant dispersal into many major urban centers in China and beyond, further facilitating its continued spread from person to person (Chan et al., 2020; Li et al., 2020a), and has caused considerable morbidity and mortality in China and elsewhere."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although the number of confirmed cases of COVID-19 worldwide has excessed 12 million, it showed that countries had only discovered on average about 6 % of coronavirus infections and the true number of infected people worldwide may already have reached several tens of millions(https://medicalxpress.com/news/2020-04-covid-average-actual-infections-worldwide.html)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These factors will contribute the subsequent COVID-19 outbreaks, and many scientists believe that COVID-19 outbreaks will be recurrence."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, identifying the animal source of SARS-CoV-2 is still a top research priority for controlling the COVID-19 outbreak."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since the first whole-genome sequence (Wuhan-Hu-1; ",
            "GenBank",
            " accession number ",
            "MN908947",
            ", also named hCoV-19/Wuhan/Hu-1/2019 with accession ID ",
            "EPI_ISL_402125",
            " in ",
            "GISAID",
            ") of the novel coronavirus, SARS-CoV-2, which was isolated from a 41-year old man who worked at Wuhan Huanan Seafood Wholesale Market, was shared online on 11 January, 2020, that first genome became the baseline for researchers to track the SARS-CoV-2 virus as it spreads around the world (Wu et al., 2020b)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1245,
                "end": 1252,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 1270,
                "end": 1278,
                "name": "MN908947"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 1333,
                "end": 1347,
                "name": "EPI_ISL_402125"
            },
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 1351,
                "end": 1357,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T4",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "Since the start of the COVID-19 outbreak and the identification of the pandemic virus, laboratories around the world are generating viral genome sequence data with unprecedented speed, researchers have sequenced and shared some 66 000 viral genomes from around the world on 14 July, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Such a vast amount of available genetic data presents a unique opportunity for researchers to trace the origin and spread of COVID-19 outbreaks in different countries and gain real-time insights into the pandemic, enabling real-time progress in the understanding of the new disease and in the research and development of candidate medical countermeasures."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of 19 February 2020, more than 100 genomes of human-obtained SARS-CoV-2 strains have been released on ",
            "GISAID",
            " (",
            "http://gisaid.org/",
            ") (",
            "Elbe and Buckland-Merrett, 2017",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 2416,
                "end": 2422,
                "name": "GISAID"
            },
            false,
            {
                "id": "T6",
                "type": "URL",
                "start": 2424,
                "end": 2442,
                "name": "http://gisaid.org/"
            },
            false,
            {
                "id": "T7",
                "type": "Creator",
                "start": 2445,
                "end": 2476,
                "name": "Elbe and Buckland-Merrett, 2017"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T7",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "The dataset used in present study was also not randomized."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The final dataset (“dataset_112”) included 112 genomes of SARS-CoV-2 from Australia (n = 8), Belgium (n = 1), China (n = 53), Finland (n = 1), France (n = 10), Germany (n = 1), Japan (n = 7), Korea (n = 1), Nepal (n = 1), Singapore (n = 11), Thailand (n = 2), UK (n = 2), and USA (n = 14) with sampling dates between 24 December 2019 and 9 February 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We first aligned the collected dataset (“dataset_112”) using MAFFT v7.222 (Katoh and Standley, 2013) and subsequently edited the alignment manually using BioEdit v7.2.5 (Hall, 1999)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To assess recombination of our dataset (“dataset_112”), we employed the pairwise homoplasy index (PHI) to measure similarity between closely linked sites using SplitsTree v4.15.1 (Huson and Bryant, 2006) and the default recombination detection methods using the Recombination Detection Program (RDP) v4.100 (Martin et al., 2015)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The best-fit nucleotide substitution model for “dataset_112” was identified according to the Bayesian information criterion (BIC) method with three (24 candidate models) or 11 (88 candidate models) substitution schemes in jModelTest v2.1.10 (Darriba et al., 2012)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To evaluate the phylogenetic signals of “dataset_112”, we performed likelihood-mapping analysis (Schmidt and von Haeseler, 2007) using TREE-PUZZLE v5.3 (Schmidt et al., 2002), with 280 000 randomly chosen quartets for the dataset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Split network analysis was performed for “dataset_112” using Kishino-Yano-85 (Kimura, 1980) distance transformation with the NeighborNet method, which can be loosely thought of as a “hybrid” between the neighbor-joining (NJ) and split decomposition methods, implemented in TREE-PUZZLE v5.3 (Schmidt et al., 2002)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Maximum-likelihood (ML) phylogenetic trees for the dataset were estimated using PhyML v3.1 (Guindon et al., 2010) under a Hasegawa-Kishino-Yano (HKY) (Kimura, 1980) nucleotide substitution model with a proportion of invariable sites, which was identified as the best fitting model for ML inference by jModelTest v2.1.10 (Darriba et al., 2012)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Analysis of temporal molecular evolutionary signals for the dataset was conducted using TempEst v1.5 (Rambaut et al., 2016)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also estimated the evolutionary rate and time to the most recent common ancestor (TMRCA) for “dataset_112” using ML dating in the TreeTime package (Sagulenko et al., 2018)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To estimate the Bayesian molecular clock phylogenies of SARS-CoV-2, Bayesian inference analyses were performed for “dataset_112” through a Markov chain Monte Carlo (MCMC) (Yang and Rannala, 1997) framework implemented in BEAST v1.8.4 (Drummond et al., 2012), with the BEAGLE v2.1.2 library program (Suchard and Rambaut, 2009) used for computational enhancement."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For model selection, we tested five coalescent tree priors for our dataset: a constant-size population (Kingman, 1982), an exponential growth population with growth rate parameterization (Griffiths and Tavare, 1994), another exponential growth population with doubling time parameterization (Griffiths and Tavare, 1994), a Bayesian skyline tree prior (five groups, piecewise-constant model) (Drummond et al., 2005), and a Bayesian Skygrid tree prior (five population sizes across our 0.2 year interval, allowing a different population size to be estimated for 14.6 days (d)) (Gill et al., 2013)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For “dataset_112”, a HKY (Kimura, 1980) nucleotide substitution model with a proportion of invariable sites was the model of best fit across the two different substitution schemes (i.e., 24 and 88 candidate models) according to the BIC method, and was thus used in subsequent likelihood-mapping and phylogenetic analyses."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The PHI test of “dataset_112” did not find statistically significant evidence of recombination (p = 1.0)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our likelihood-mapping analysis revealed that the quartets from “dataset_112” were primarily distributed in the center (63.2 %) rather than the corners (36.8 %) or sides (0%) of the triangle, indicating a strong star-like topology signal, which may be due to exponential epidemic spread (Fig. 1",
            "A), in accordance with previous studies (Li et al., 2020b; Li et al., 2020c; Li et al., 2020d)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The split network generated for “dataset_112” using the NeighborNet method revealed the existence of polytomies, and thus was highly unresolved."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This indicated that the phylogenetic relationship of our dataset was probably best represented by a star-like phylogenetic tree rather than a strictly bifurcating tree (Fig. 1B), suggesting possible rapid early spread of SARS-CoV-2, in accordance with the likelihood-mapping results."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "ML phylogenetic analysis of “dataset_112” also showed star-like topology (Fig. 2",
            "), indicating the introduction of a new virus to an immunologically naive population, in accordance with the likelihood-mapping and split network results."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Root-to-tip linear regression analyses between genetic divergence and sampling date using the best-fitting root, which minimizes the mean of the squares of the residuals, showed that “dataset_112” had a minor positive temporal signal (R = 0.087; correlation coefficient = 0.2945), thus suggesting a minor clocklike pattern of molecular evolution (Fig. 3",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ML dating analyses between root-to-tip genetic divergence and sampling date also showed that our dataset had a minor strong positive temporal signal (R = 0.09) (Supplementary Fig. 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The evolutionary rate and TMRCA date estimates of SARS-CoV-2 for “dataset_112” were 5.35 × 10−3 substitutions per site per year and 19 October 2019, respectively, in accordance with the root-to-tip regression results using TempEst v1.5 (Rambaut et al., 2016)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on Bayesian time-scaled phylogenetic analysis using the tip-dating method, the estimated TMRCA dates and evolutionary rates of SARS-CoV-2 for “dataset_112” ranged from 12 November 2019 to 7 December 2019 (95 % BCI: 11 October 2019 and 21 December 2019) and from 8.37 × 10−4 to 1.12 × 10−3 substitutions per site per year (95 % BCI: 5.06 × 10−4–1.53 × 10−3), respectively (Table 1",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The best-fitting combination was an UCLN relaxed molecular clock along with an exponential growth tree prior model with growth rate parameterization, as shown by the marginal likelihood estimates for “dataset_112” when comparing the two clock models and five tree prior models."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, the TMRCA date and evolutionary rate estimates of SARS-CoV-2 for “dataset_112” with the best-fitting combination were 12 November 2019 (95 % BCI: 11 October 2019 and 09 December 2019) and 9.90 × 10−4 substitutions per site per year (95 % BCI: 6.29 × 10−4–1.35 × 10−3), respectively (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The estimates of the MCC phylogenetic relationships among the SARS-CoV-2 genomes for our dataset from the Bayesian coalescent framework using the tip-dating method, as well as the exponential coalescent tree prior with doubling time parameterization and UCLN relaxed molecular clock, are displayed in Fig. 4",
            "."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As shown, “dataset_112” exhibited more genetic diversity than our previous datasets (",
            "Li et al., 2020b",
            "; ",
            "Li et al.",
            "",
            "Analysis showed that the R estimates of SARS-CoV-2 for “dataset_112” experienced complex phylodynamics characterized by at least two growing and two declining phases (Fig. 5",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Creator",
                "start": 9469,
                "end": 9485,
                "name": "Li et al., 2020b"
            },
            false,
            {
                "id": "T9",
                "type": "Creator",
                "start": 9487,
                "end": 9496,
                "name": "Li et al."
            },
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The mean R estimates of SARS-CoV-2 for our dataset ranged from 0.336 to 4.137, and the first growth phase had more uncertainty compared to the remaining phases due to the wider 95 % highest posterior density (HPD) interval of R estimates."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Notably, we found very low R estimates of SARS-CoV-2 for “dataset_112″ during the recent sampling time period."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To investigate the global epidemic spread of SARS-CoV-2, we performed comprehensive evolutionary analyses of 112 genomes from “dataset_112”."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Split network analysis of SARS-CoV-2 based on “dataset_112” using the NeighborNet method was more resolved over time as more genome sequences were added to our study compared with our previous results (Li et al., 2020d)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These results are also consistent with our ML phylogenetic analyses, which showed a more bifurcating tree topology from “dataset_112” compared to our previous results (Li et al., 2020c; Li et al., 2020d; Li et al., 2020e), (Fig. 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our dataset still had a minor positive temporal signal based on regression analysis using TempEst v1.5 (Rambaut et al., 2016) and ML dating analysis using TreeTime package (Sagulenko et al., 2018) compared to our previous results (Li et al., 2020d)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, the estimated TMRCA dates and evolutionary rates of SARS-CoV-2 for “dataset_112” were found to be nearly identical using both analyses (Fig. 3 and Supplementary Fig. 1), consistent with earlier results (Li et al., 2020d)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The estimated TMRCA dates of SARS-CoV-2 based on “dataset_112” using TempEst v1.5 (Rambaut et al., 2016) (19 October 2019) and ML dating analysis using TreeTime (Sagulenko et al., 2018) (19 October 2019) were also identical to our previous results (Li et al., 2020d)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, the estimated evolutionary rates of SARS-CoV-2 for “dataset_112” using TempEst v1.5 (Rambaut et al., 2016) (5.3504 × 10−3 substitutions per site per year) and ML dating analysis using TreeTime (Sagulenko et al., 2018) (5.35 × 10−3 substitutions per site per year) were very distinct to our prior results (Li et al., 2020d) using TempEst v1.5 (Rambaut et al., 2016) (3.3452 × 10−4 substitutions per site per year) and ML dating analysis using TreeTime (Sagulenko et al., 2018) (3.34 × 10−4 substitutions per site per year)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The estimated TMRCA dates and evolutionary rates of SARS-CoV-2 for “dataset_112” were very similar across different clocks using the tip-dating method, but very distinct across different coalescent tree priors (e.g., parametric coalescent and nonparametric coalescent models) (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In summary, the TMRCA date and evolutionary rate estimates of SARS-CoV-2 for “dataset_112” are still sensitive to the tree prior, and additional genomes should make these estimates more robust towards the tree prior choice."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We employed the BDSKY model (Stadler et al., 2013) and found that the R estimates of SARS-CoV-2 for “dataset_112” experienced a complex phylodynamic history (Fig. 5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For the epidemiological analysis of SARS-CoV-2 from “dataset_112”, the non-random and non-well-mixing of the sampled population, and the non-constant sampling effort may be potential strong sources of bias in the estimates of SARS-CoV-2 epidemic parameters, which is an issue for all molecular evolutionary studies using real world data."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is important to note that there is currently not enough genomic data from the early COVID-19 outbreak period to interpret the early history of global transmissions of COVID-19 from few genomes in detail."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The 95 % BCI estimates for the evolutionary rates and TMRCA dates are averaged over many plausible phylogenetic reconstructions of the genome data; thus, as more patients with COVID-19 are sampled and more SARS-CoV-2 genomes become available, we expect these estimates will become narrower."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To investigate the evolutionary and epidemiological dynamics of the current COVID-19 outbreak, a total of 112 genomes of SARS-CoV-2 strains sampled from China and 12 other countries with sampling dates between 24 December 2019 and 9 February 2020 were analyzed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The novel betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), was first reported in Wuhan, China in December 2019 [1, 2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to the World Health Organization, the current outbreak of COVID-19 has nearly 11.5 million confirmed cases worldwide with more than 530,000 deaths, as of July 6, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although the estimated fatality rate in the confirmed cases is 6.6% in SARS-CoV-2, which is lower than those of SARS-CoV and MERS-CoV, 9.6% and 34.3%, respectively [4], there is an urgent need for its effective treatment based on antivirals and vaccines that reduce the mortality and morbidity rates of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, up to now, the causes of the large country-by-country difference of the mortality rates related to COVID-19 have not been clearly understood."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Full-length viral nucleotide sequence of the reference SARS-CoV-2 (accession number ",
            "MN908947",
            ") [1] was downloaded from the ",
            "NCBI GenBank",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "AccessionNumber",
                "start": 925,
                "end": 933,
                "name": "MN908947"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 963,
                "end": 975,
                "name": "NCBI GenBank"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T1"
            }
        ]
    },
    {
        "sen": [
            "Briefly, we first aligned each of the SARS-CoV-2 sequences to the reference sequence SARS-CoV-2_Wuhan-Hu-1 (accession number ",
            "MN908947",
            ") using BLAT software [7]."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 1102,
                "end": 1110,
                "name": "MN908947"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "After the alignment, we extracted nucleotide sequences corresponding to individual proteins of SARS-CoV-2, translated them into amino acid sequences, and then compared them to reference amino acid sequences of SARS-CoV-2_Wuhan-Hu-1 (accession numbers ",
            "QHD43415",
            "-",
            "QHD43423",
            ", ",
            "QHI42199",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 1388,
                "end": 1396,
                "name": "QHD43415"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 1397,
                "end": 1405,
                "name": "QHD43423"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 1407,
                "end": 1415,
                "name": "QHI42199"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Data on numbers of confirmed cases and deaths related to COVID-19 were obtained from the ",
            "Worldometer",
            " (",
            "https://www.worldometers.info/coronavirus/",
            ") on 7 May 2020 (Supplementary Table 1)."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Dataset",
                "start": 1507,
                "end": 1518,
                "name": "Worldometer"
            },
            false,
            {
                "id": "T8",
                "type": "URL",
                "start": 1520,
                "end": 1562,
                "name": "https://www.worldometers.info/coronavirus/"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T7",
                "end": "T8"
            }
        ]
    },
    {
        "sen": [
            "Multiple regression analysis was used to test for an independent contribution of identified factors to fatality rates of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Correlation analysis of variant frequencies of SARS-CoV-2 ORF1ab 4715L (a) or S 614G (b) with fatality rates of COVID-19 among 28 countries."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Several other factors are investigated in association with mortality related to COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Ecological studies have suggested that countries that mandate BCG vaccination for the population have a lower number of infections and a reduced mortality from COVID-19, although the association is still controversial and the underlying mechanism has not been clarified [9, 14, 15]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Concordant to our results, a few reports demonstrated that S 614G variant was associated with the mortality related to COVID-19 [13, 22]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since immune responses through HLA and T cells are important to protect from virus infections and also known to be involved in the progression of COVID-19, we screened epitopes around the mutations associated with fatality rates (Supplementary Table 3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The coronavirus disease 2019 (COVID-19) outbreak, caused by SARS-CoV-2, has rapidly expanded to a global pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, numbers of infected cases, deaths, and mortality rates related to COVID-19 vary from country to country."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Through a hierarchical clustering based on the mutant frequencies, we classified the 28 countries into three clusters showing different fatality rates of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our findings suggest that SARS-CoV-2 mutations as well as BCG-vaccination status and a host genetic factor, HLA genotypes might affect the susceptibility to SARS-CoV-2 infection or severity of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This novel strain of coronavirus has been identified as the causative agent for the epidemic of acute respiratory distress syndrome (also referred to as coronavirus disease 2019 [COVID-19]) in Wuhan, China.1, 2, 3 Since then, the COVID-19 outbreak has rapidly swept all of the provinces of China and has disseminated globally to 216 countries and territories through travel."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 is a potential zoonotic disease with a low to moderate mortality rate (2%–5%) and is primarily transmitted through droplet and direct contact with infected individuals or incubation carriers."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 patients develop dynamic innate and adaptive immune responses to SARS-CoV-2.7, 8, 9 SARS-CoV-2 has a preferential tropism for airway epithelial cells mediated through the accessibility of the angiotensin-converting enzyme 2 (ACE2) receptor.10, 11, 12, 13 The common clinical manifestations of fever and cough in conjunction with laboratory results of progressively increasing neutrophil counts and leukocytopenia in serum samples taken from COVID-19 patients at various stages of the illness indicate uncontrolled neutrophil extravasation and activation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A large number of macrophages and neutrophils were found in alveolar cavities in COVID-19 fatalities, suggesting their roles in cytokine storms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While uncontrolled neutrophil activity and aberrant cytokine response contribute to SARS-CoV-2 pathogenesis in COVID-19, how SARS-CoV-2 causes these immunological changes, especially the enhancement of neutrophil chemotaxis and activation, remains largely undetermined."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The disruption of these intraviral PPIs by repurposing small molecule or peptide drugs that target specific epitopes can be a treatment strategy against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 infection can lead to imbalanced host immune responses such as diminished type I and type III interferon (IFN) signaling, as well as strong chemotactic and inflammatory response in infected cell lines, animal models, and COVID-19 patients,",
            ",",
            ",",
            " Nsp10 may regulate IL-8 levels by targeting NKRF and shapes the unique immune signature in COVID-19."
        ],
        "lab": [
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To elucidate the mechanism and effect of SARS-CoV-2 infection in patients, we determined the global proteome profile changes in PBMCs samples taken from healthy donors compared with PBMCs collected from COVID-19 patients with mild or severe symptoms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The PBMC samples were obtained from the ",
            "Shanghai Public Health Clinical Center",
            " and include 6 healthy donors, 22 COVID-19 patients with mild symptoms (COVID-19-MS), and 13 COVID-19 patients with severe symptoms (COVID-19-SS) (Table S2)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 2366,
                "end": 2404,
                "name": "Shanghai Public Health Clinical Center"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 5,521 proteins were quantified according to criteria and included in global proteomic profiling to reveal a list of 726 proteins found to be differentially expressed (|log2 [fold change]| ≥ 0.58, adjusted p ≤ 0.01, n ≥ 3) in the PBMCs of COVID-19-MS compared with those of healthy donors; 333 proteins showed a statistically significant increase, while 393 proteins showed a reduction in expression when comparing COVID-19-MS with control (Figures 3",
            "A, S4A, and S4B; Table S3)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Analysis of the global proteomic changes reveals significantly reduced levels of PF4, GP1BA, SERPINA5, HBB, HBD, C1QBP, HRG, and RAC1 in the COVID-19-MS PBMC cohort (Figure 3B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "RAC1 also directly interacts with SigmaR1, a potential therapeutic target for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Overall, our functional analysis reveals the complexity of host responses to SARS-CoV-2 infection in mildly symptomatic COVID-19 patients, highlighting the abnormal regulations in blood coagulation and hemostasis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Next, we compared the proteome change between PBMCs isolated from COVID-19-SS and COVID-19-MS patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among 6,235 quantified proteins (n ≥ 3), 366 proteins were found to be significantly differentially expressed (|log2 [fold change]| ≥ 0.58, adjusted p ≤ 0.01) between the PMBCs of COVID-19-SS and COVID-19-MS."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 209 of these proteins were upregulated and 157 of these proteins were downregulated in COVID-19-SS as compared to COVID-19-MS (Figures 3D, 3E, S4D, and S4E; Table S3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The expression levels of neutrophil surface receptors (CXCR1, Siglec5, and CD177) and neutrophil granule contents (DEFA1) were dramatically upregulated in COVID-19-SS (Figures 3D and 3E), which is consistent with the elevated neutrophil population in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            " Consistent with RNA sequencing results from COVID-19 patients,",
            ",",
            "Laboratory results reveal increased neutrophils counts to ∼90% of the white blood cell count as COVID-19 progresses to critical stages."
        ],
        "lab": [
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "14, 15, 16 The elevation of IL-8 and IL-6 but not IL-17 in PMBCs collected from severe symptomatic COVID-19 patients indicates critical roles for IL-8 and IL-6 in the severe inflammatory response induced by SARS-CoV-2 infection (Figures 3G, 3H, and S4H)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, a cluster of genes related to blood coagulation was dramatically upregulated in COVID-19-SS as compared to COVID-19-MS (Figure S4G), supporting the hypothesis that the abnormal blood clotting contributes to de ath in some severe COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As compared to COVID-19-MS, the downregulated proteins of COVID-19-SS are highly enriched in T cell activation, T cell receptor (TCR) signaling, viral transcription, viral gene expression, translation initiation, and lymphocyte co-stimulation (Figures 3F and S4F)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The expression of TCR subunits (CD3e, CD3g, and CD247), T cell surface molecules (CD4, CD8a, CD8b, CD2, CD5, and CD7), major histocompatibility complex (MHC) class II molecules (HLA-DRA), TCR signaling kinases and adaptors (LCK, FYN, SKAP1, CARD11, CAMK4, and BTN3A1), and T cell differentiation and survival (BCL11B) were dramatically diminished in COVID-19-SS compared to COVID-19-MS (Figures 3D and 3E), suggesting a failure of T cell activation and function."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These results demonstrate that severe COVID-19 patients undergo a functional decline in adaptive immunity, which correlates with their lower T cell population."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "14, 15, 16",
            "From the quantitative proteome analysis of PBMCs, it is clear that SARS-CoV-2 triggers IL-8 expression and increases neutrophil count, which may mediate the manifestation of acute respiratory distress syndrome in COVID-19 patients."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Establishing viral-viral and virus-host PPI networks is of high priority to understand the host response to SARS-CoV-2 infection and guide the design of potential drug candidates for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While nsp10-NKRF interaction was not captured by the Krogan group, we have confirmed that nsp10 is associated with endogenous NKRF in HEK293T cells, suggesting that our dataset could serve as a valuable additional resource for host targets that are potentially involved in SARS-CoV-2 immune evasion and pathogenesis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our quantitative proteomic analysis using PBMC samples derived from both mild and severe COVID-19 patients begins to address this gap in knowledge."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since our viral-host interactome analysis indicates that SARS-CoV-2 viral proteins may modulate and evade host innate immune response by interacting with key kinases and adaptors of the immune signaling pathway, it is not surprising that COVID-19 patients fail to mount robust antiviral IFN responses."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "From our quantitative proteomic analysis, neutrophilia, leukocytopenia, and hypercoagulation were observed in PBMCs of COVID-19-SS patients as compared to COVID-19-MS patients, supporting the hypothesis that imbalanced inflammatory cytokine production, such as IL-8 and IL-6 dysregulation, contributes to the overactivation of neutrophils and regulation of the bloodclotting cascade."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "To our knowledge, this is the first study to characterize the PBMC proteome profile in both mild and severe cases of COVID-19 infection, and it contextualizes the overall clinical features of COVID-19 patients at the protein level."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Follow-up work is required to tease out the detailed mechanisms involved and translate the therapeutic relevance of these findings in targeting the cytokine storm in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The datasets generated during this study were deposited to the ",
            "ProteomeXchange Consortium",
            " (",
            "http://proteomecentral.proteomexchange.org",
            ") via the iProX partner repository with the dataset identifier ",
            "IPX0002285000",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 7961,
                "end": 7987,
                "name": "ProteomeXchange Consortium"
            },
            false,
            {
                "id": "T3",
                "type": "URL",
                "start": 7989,
                "end": 8031,
                "name": "http://proteomecentral.proteomexchange.org"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 8094,
                "end": 8107,
                "name": "IPX0002285000"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T2",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "The trypsin-digested peptides were desalted by monospin C18 and loaded on a home-made 40 cm-long pulled-tip analytical column (75 μm ID x 360 μm OD, ReproSil-Pur C18-AQ 1.9 μm resin, Dr. Maisch GmbH), connected to a Thermo Easy-nLC1000 HPLC system."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The acquired MS/MS data were analyzed against a ",
            "UniProtKB Human",
            " database (database released on Sept. 30, 2018) containing SARS-CoV-2 viral proteins using Maxquant V1.6.10.43."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 8406,
                "end": 8421,
                "name": "UniProtKB Human"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To accurately estimate peptide probabilities and false discovery rates (FDR), we used a decoy database containing the reversed sequences of all the proteins appended to the target database."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "MiST algorithm was used to calculate the statistical significance of the dataset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The information of 35 patients with confirmed SARS-CoV-2 infection (13 COVID-19 patients with severe symptoms and 22 COVID-19 patients with mild symptoms) and 6 health donors as control are listed in Table S2, including age (47-73), sex, and symptoms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Basically, protein samples were combined to generate 3 control sample pools from 6 healthy donors (one sample pool was excluded from the list for the sample quality issue), 13 mild-case sample pools from 22 COVID-19-MS patients, and 10 severe-case sample pools from 13 COVID-19-SS patients according to the protein concentrations of all the samples due to the limited protein amounts extracted from the variable PBMCs of each case (Table S2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Briefly, the datasets were merged by matching the protein accession numbers of each dataset using in-house developed Python scripts (comparepg.py)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Protein features with less than 3 quantitative values in each condition (H&MS or MS&SS) were removed from the dataset to make sure each quantitative protein in the list have at least 3 values for H cases, MS cases, and SS cases during the proteomics analysis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "MiST algorithm was used to calculate the statistical significance of the dataset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The acquired MS/MS data were analyzed against a ",
            "UniProtKB human",
            " (database released on Sept. 30, 2018) by Maxquant V1.6.10.43 using the default setting."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 10038,
                "end": 10053,
                "name": "UniProtKB human"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ongoing coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a global public health concern due to relatively easy person-to-person transmission and the current lack of effective antiviral therapy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Quantitative proteomics was used to investigate the peripheral blood mononuclear cell (PBMC) proteome signature in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We elucidated 286 host proteins targeted by SARS-CoV-2 and >350 host proteins that are significantly perturbed in COVID-19-derived PBMCs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This signature in severe COVID-19 PBMCs reveals a significant upregulation of cellular proteins related to neutrophil activation and blood coagulation, as well as a downregulation of proteins mediating T cell receptor signaling."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "From the interactome, we further identified that non-structural protein 10 interacts with NF-κB-repressing factor (NKRF) to facilitate interleukin-8 (IL-8) induction, which potentially contributes to IL-8-mediated chemotaxis of neutrophils and the overexuberant host inflammatory response observed in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Funding  National Key Research and Development Project of China, National Natural Science Foundation of China, National Science and Technology Major Project, Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, Shanghai Science and Technology Commission, Shanghai Municipal Health Commission, Shanghai Municipal Key Clinical Specialty, Innovative Research Team of High-level Local Universities in Shanghai, Interdisciplinary Program of Shanghai Jiao Tong University, SII Challenge Fund for COVID-19 Research, Chinese Academy of Sciences (CAS) Large Research Infrastructure of Maintenance and Remolding Project, and Chinese Academy of Sciences Key Technology Talent Program."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 pandemic is caused by SARS-CoV-2, but little is known about the functions of its viral proteins."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Quantitative proteomic analysis revealed elevated levels of IL-6 and IL-8 in PBMCs collected from severe COVID-19 patients compared with mild ones, and the functional annotation of differentially expressed proteins implicate pathways involved in neutrophil activation, T cell receptor signaling, and the coagulation cascade."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Combining virus-host interactome with COVID-19 proteomic analysis, the authors found that nsp10 interacts with NKRF to mediate IL-8 expression, providing a potential molecular mechanism for SARS-CoV-2-induced cytokine storm and marking it as a possible emerging therapeutic target."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Li et al. establish the SARS-CoV-2 intraviral and virus-host protein-protein interaction networks and reveal the overall proteome signature in PBMCS from COVID-19 patients by quantitative proteomic analysis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Levels of specific immune mediators in the first plasma samples collected from patients with COVID-19 during hospitalisation were quantified by multiplex microbead-based immunoassays."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Protein–protein interaction networks of these immune mediators and previously reported host proteins targeted by SARS-CoV-2 ORF8 were predicted and illustrated with the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database version 11.0)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All these interactions were derived from high-throughput lab experiments and previous knowledge in curated databases at a confidence threshold of 0·5."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We observed that patients infected with the ∆382 variant had lower concentrations of proinflammatory cytokines, chemokines, and growth factors that are strongly associated with severe COVID-19.15, 16 Notably, patients with pneumonia from the ∆382 variant had higher concentrations of SDF-1α, which is usually downregulated during hypoxia."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Lymphopenia and functional exhaustion of T cells correlate with disease severity in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Significant CD4-positive and CD8-positive T-cell responses to ORF8 have also been described in patients who recover from COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Exact logistic regression was used to examine the association between the infection groups and the development of hypoxia requiring supplemental oxygen (an indicator of severe COVID-19, the primary endpoint)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The novel coronavirus disease 2019 (COVID-19) outbreak occurred in December 2019 and in the following months this epidemic was declared as a global health emergency by the World Health Organization (WHO) with more than 600 thousand deaths reported till date [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similar to SARS-CoV and the Middle East respiratory syndrome (MERS), severe symptoms such as acute respiratory distress syndrome (ARDS) and multiple organ failure were observed in nearly 20% patients suffering from COVID-19 infection [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recently, it has also been reported as a receptor for the spike protein of SARS-CoV-2 and plays pivotal roles during the COVID-19 infection [4]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Notably, COVID-19 patients with severe symptoms also seem to suffer from various other health conditions including cardiovascular disease (CVD), hypertension and diabetes [5]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, it is likely that the extent of COVID-19 infection gets more pronounced by ACE2 in patients with comorbidities, which in turn may cause additional myocardial damage."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In our pervious review, we summarized the state of art of investigation and potential therapeutic strategies for COVID-19 patients with cardiac disease [8]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, we investigate several in-silico identified miRNAs which could regulate ACE2 in vitro and therefore provide a potential strategy to develop novel therapeutic candidates for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As one of the main receptors of SARS-CoV-2 [4], ACE2 is considered as a potential target for COVID-19 prevention."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Another multi-organ autopsy study of COVID-19 patients revealed the presence of SARS-CoV-2 viral RNA in the heart tissue [11]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To fight the COVID-19 pandemic in the absence of vaccines, it is necessary to identify promising drugs which act against SARS-CoV-2 infection in cardiomyocytes and such in vitro translational platforms can immensely aid in this process."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Vaccine is one of the most efficient tools to prevent COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By April 2020, 115 vaccine candidates for COVID-19 were reported, out of which 73 targets were selected for pre-clinical investigation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of note, patients with pre-existing CVDs are more likely to suffer from severe symptoms of COVID-19 [5]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, the contradicting effects of ACE2 in CVDs and COVID-19 infection should be considered carefully."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, it is a big challenge to ascertain the therapeutic time window for targeting ACE2 in COVID-19 patients with CVDs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nevertheless, a miR-200c based therapy may help to bridge the time till an effective COVID-19 vaccine is available to the world."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The World Health Organization (WHO) declared coronavirus disease 2019 (COVID-19) as a public health emergency of international concern as more than 15 million cases were reported by 24th July 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Angiotensin-converting enzyme 2 (ACE2) is a COVID-19 entry receptor regulating host cell infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We report the first miRNA candidate that can target ACE2 in cardiomyocytes and thus may be exploited as a preventive strategy to treat cardiovascular complications of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A novel human coronavirus, now provisionally called ‘SARS-CoV-2’, was identified as the cause of this disease, now named ‘COVID-19’."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There have been reports of COVID-19 associated neurological manifestations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To the best of our knowledge CNS demyelinating disease has not been associated with COVID-19 so far; however, other coronaviruses were previously associated with CNS demyelinating autoimmune diseases, including MS exacerbations [5] and autoreactive T cells able to recognize myelin antigens [6, 7]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 is caused by SARS-CoV-2, a novel beta coronavirus and now affecting more than 210 countries, areas or territories (WHO 2020; Zhou et al."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "2020; Zhu et al."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The World Health Organization (WHO) has declared the COVID-19 outbreak as a global pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 is highly contagious with an estimated R0 of 2–3 and causes COVID-19 with a wide range of clinical manifestations including asymptomatic infection to severe pneumonia with deadly outcome (Hellewell et al."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to different reports published so far, COVID-19 has a mortality rate of 2%–10% (Li et al."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "2020b; Yang et al."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "2020a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 has an incubation period of 2–14 days (Jiang et al."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, a highly sensitive and specific laboratory method is essential for early diagnosis of SARS-CoV-2 infection, which is critical for appropriate management of suspected COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In fact, a sequential change of positive-to-negative-to-positive results could not be properly explained but could cause great concern about potential viral reactivation and re-infection in cured COVID-19 patients (Chen et al."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "2020a; Ye et al."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 RT-PCR may fail to provide a positive result with specimens from COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A retrospective analysis showed that only 39.1% of 573 sputum specimens and 19.2% of 579 throat specimens from COVID-19 patients collected at different time points were consistently tested positive for SARS-CoV-2 RNAs by RT-PCR (Fig. 1A, 1B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To validate the performance of these cutoff values, these cutoff values were applied to data for 253 specimens from patients with conflicting positive and negative test results and for that from patients with multiple samples and data for 254 pairs of sputum and throat swab specimens from confirmed COVID-19 patients, respectively."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In recent reports, recovered COVID-19 patients, defined by negative test results for SARS-CoV-2 RNA in at least two independent tests, were found repeatedly positive for SARS-CoV-2 RNA testing during post-discharge monitoring (Chen et al."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "2020a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, contradicting test results from the same patients are not rare in the diagnosis and clinical care for COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Multiple sputum and throat swab specimens from 161 confirmed COVID-19 patients were tested with a commercial fluorescent RT-PCR kit targeting the ORF1ab and N regions of SARS-CoV-2 genome."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The clinical presentation of COVID-19 varies from asymptomatic or mild respiratory symptoms, to severe pneumonia with respiratory failure and death, mainly in elderly with other chronic underlying diseases [5]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As the global scientific community is in the race for finding novel therapies for the disease, in late April 2020 over 500 interventional clinical studies on the current COVID-19 have been registered at ClinicalTrials.gov [6]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While waiting for a preventative vaccine, most of the therapeutic strategies against COVID-19 are currently based on slowing down the virus replication (i.e. by using antivirals adopted for other viruses), and on reducing severe forms of disease (i.e. by counteracting the cytokine storm syndrome)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Conceptually, the protein sequence and structure similarity of SARS-CoV-2 with other types of coronavirus might help to develop effective anti-COVID-19 approaches."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on this evidence, we speculate that the use of G4-mediated antiviral drugs may represent a significant turning point in the therapeutic management of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we used the Quadruplex forming G-Rich Sequences (QGRS) Mapper, a web-based server database [19], that generates detailed information on composition and distribution of PG4FS."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This finding suggests that G4s ligands could represent a potential therapeutic strategy for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interestingly, after a search in the ",
            "DrugBank",
            " database (",
            "https://www.drugbank.ca",
            "/, version 5.1.5, released 2020-01-03), we retrieved 18 entries for FDA-approved compounds that have the term “helicase” as a target (Table 2)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1387,
                "end": 1395,
                "name": "DrugBank"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 1406,
                "end": 1429,
                "name": "https://www.drugbank.ca"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "It is plausible that most of these molecules have already been tested during this emergency period caused by COVID-19, with unknown large-scale effect."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of today, no FDA-approved therapies to treat COVID-19 or other coronaviruses exist."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, as recently emerged from the work by Zhou et al. [8], the search and use of FDA-approved or investigational drugs that are outside the scope of the original clinical indication, currently known as drug repositioning, could be a promising approach to find a rapid strategy to limit the effects of the COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we outline the existing evidence indicating that G4 ligands and inhibitors of SARS-CoV-2 helicase may exert some antiviral activity reducing viral replication and can represent a potential therapeutic approach to tackle the COVID-19 pandemic due to SARS-CoV-2 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also discuss how repositioning of FDA-approved drugs against helicase activity of other viruses, could represent a rapid strategy to limit deaths associated with COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), can spread rapidly in high-risk congregate settings such as skilled nursing facilities (SNFs) ()."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In Minnesota, SNF-associated cases accounted for 3,950 (8%) of 48,711 COVID-19 cases reported through July 21, 2020; 35% of SNF-associated cases involved health care personnel (HCP*), including six deaths."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "During April–June 2020, the Minnesota Department of Health (MDH), with CDC assistance, conducted weekly serial testing at two SNFs experiencing COVID-19 outbreaks."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As part of comprehensive COVID-19 preparation and response, including early identification of cases, SNFs should conduct serial testing of residents and HCP, maximize HCP testing participation, ensure availability of personal protective equipment (PPE), and enhance IPC practices (–)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interim guidance for HCP mask use and SNF visitor restriction was implemented statewide by March 31, 2020; however, during April, an increase in COVID-19 diagnoses and deaths among SNF residents in Minnesota occurred."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Paul metropolitan area contacted MDH after identifying multiple confirmed resident and HCP COVID-19 cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Starting in mid-March, HCP were screened daily for COVID-19–compatible symptoms, and symptomatic HCP were sent home per MDH and CDC guidance."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Data on symptoms, demographic characteristics, and HCP work assignment were collected from resident charts, MDH COVID-19 case interviews, and SNF administrator interviews."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Residents with positive SARS-CoV-2 test results were moved to a COVID-19 care unit within each facility, and HCP with positive test results were excluded from work for at least 10 days ()."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Before serial testing (April 17–29), COVID-19 was laboratory-confirmed in 14 (18%) symptomatic residents."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Date of serial testing round and daily specimen test results*,†,§ for SARS-CoV-2 detection by reverse transcription–polymerase chain reaction (RT-PCR) testing — two skilled nursing facilities, Minnesota, April–June 2020",
            "During April 15–29, 15 (10%) symptomatic HCP at facility A received diagnoses of confirmed COVID-19 by their health care providers (Figure 1)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Overall, among 182 residents tested, 114 (63%) COVID-19 cases were identified; 19 (17%) were hospitalized, and 40 (35%) died."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among the 31 HCP COVID-19 cases, 18 (58%) HCP worked on the first floor, where 21 (88%) of 24 infected residents were initially identified."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among 114 total HCP COVID-19 cases diagnosed at facilities A and B, 73 (64%) were in nurses or nursing assistants who provided direct resident care."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Phylogenetic trees showing genetic distance between available* SARS-CoV-2 virus specimens collected from health care personnel (HCP) and residents at facility A† and facility B§— Minnesota, April–June 2020",
            "Serial testing of residents and all HCP, until no new cases are detected after 14 days (), together with IPC strengthening, are critical strategies necessary to control COVID-19 outbreaks in SNFs."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Because residents and HCP can sustain SARS-CoV-2 transmission and HCP present an ongoing risk for introducing SARS-CoV-2-from the community, barriers to HCP testing must be addressed and overcome for test-based approaches to successfully reduce COVID-19–related morbidity and mortality."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Eleven per cent of the participants reported having comorbidities and 36.3% reported having had COVID-19-compatible symptoms in the previous months."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thirty-nine participants (6.7%) had been previously diagnosed with COVID-19 confirmed by rRT-PCR, of which only one had required hospital admission (Table 1 and Supplementary Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Around 15% (6/39) of HCW who had been previously diagnosed with COVID-19 by rRT-PCR did not show a detectable response of any of the antibody isotypes (Supplementary Table 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Twenty per cent (11/54) of seropositive participants did not report COVID-19 compatible symptoms in the previous months."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Around 39% (21/54) of seropositive HCW had never been diagnosed of COVID-19, although 10 of these (47.6%) reported past COVID-19-compatible symptoms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The odds of being seropositive were higher in participants who reported having had any COVID-19-compatible symptom in the previous months (adjusted OR: 8.8, 95% CI 4.41–17.73, p < 0.0001) (Table 3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The professional category, working in COVID-19 units, daily contact with patients, close contact with a COVID-19 case, comorbidities or sex, did not show any statistically significant association with presence of antibodies to SARS-CoV-2 (Table 3, Supplementary Fig. 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "IgA levels were higher in participants reporting COVID-19-compatible symptoms in the previous months than in those reporting being asymptomatic (p = 0.041) (Fig. 3c), and among symptomatic individuals, duration of symptoms >10 days was associated with higher IgM levels (p = 0.022) (Fig. 3d)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among them, 23.1% (15/65) did not report any COVID-19 compatible symptom in the previous months."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Forty per cent (26/65) had not been previously diagnosed with COVID-19, although 12 of them reported COVID-19 compatible symptoms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Five microliters of RNA solution were added to 15 μl of rRT-PCR master mix (Luna Universal Probe One-Step RT-qPCR Kit; New England Biolabs) and used for amplification of SARS-CoV-2 N1 and N2 regions, as well as the human RNase P gene as control, using probes, primers and cycling conditions described in the CDC-006-00019 CDC/DDID/NCIRD/ Division of Viral Diseases protocol (3/30/2020 release, Supplementary Note 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Each batch of RNA extractions and rRT-PCR reactions included three positive controls (EURM-019 single stranded RNA fragments of SARS-CoV-2 provided by the European Commission Joint Research Centre), 2019-nCoV_N_Positive Control (IDT integrated technologies, ref. 10006625) and Hs_RPP30 Positive Control (IDT integrated technologies, ref. 10006626), as well as negative controls."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Next, 10 μl of test plasma samples (final dilution 1/500), 10 μl of a positive control (pool of 20 plasmas from subjects with a positive SARS-CoV-2 rRT-PCR, at four dilutions, 1/500, 1/2000, 1/8000 and 1/32000, for QA/QC), and 10 μl of two negative controls (plasmas from European subjects collected before the COVID-19 pandemic, at 1/500), were added per plate."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Sensitivity of the assay using samples from participants previously diagnosed with COVID-19 and with more than 10 days since the onset of symptoms was 97% for IgA and IgG and 75% for IgM, with specificities of 100% for IgG and IgM and 98% for IgA (Supplementary table 4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The area under the receiver operating characteristic curve (AUC) was >0.97 for each of the isotypes using these same samples (Supplementary Fig. 1a) and >0.87 using samples from any participant previously diagnosed with COVID-19 regardless of the time since onset of symptoms (Supplementary Fig. 1b)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among those with evidence of past or current infection, 40.0% (26/65) had not been previously diagnosed with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here we report a relatively low seroprevalence of antibodies among HCW at the peak of the COVID-19 epidemic in Spain."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A large proportion of HCW with past or present infection had not been previously diagnosed with COVID-19, which calls for active periodic rRT-PCR testing in hospital settings."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Symptoms associated with coronavirus disease 2019 (COVID-19) are quite diverse, ranging from fever, muscle aches, cough and shortness of breath."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Searching against ",
            "UniProt",
            " database (",
            "UniProt Consortium",
            ") [65] resulted in matches for the polyprotein (wORF1ab), all four structural proteins (wS, wE, wM, and wN), and six ORFs (wORF3a, wORF6, wORF7a, wORF7b, wORF8, and wORF10), also referred to as the accessory proteins."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 18,
                "end": 25,
                "name": "UniProt"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 36,
                "end": 54,
                "name": "UniProt Consortium"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our search resulted in three new homologs of ORF8 not reported in ",
            "UniProt",
            " that were originated from three different isolates of bat SARS-like coronavirus: bat-SL-CoVZC45 (",
            "GenBank",
            " ID: ",
            "MG772933",
            ", collected in 2017), bat-SL-CoVZXC21 (",
            "GenBank",
            " ID: ",
            "MG772934",
            ", collected in 2015), and RaTG13 (",
            "GenBank",
            " ID: ",
            "MN996532",
            ", collected in 2013)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 338,
                "end": 345,
                "name": "UniProt"
            },
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 443,
                "end": 450,
                "name": "GenBank"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 455,
                "end": 463,
                "name": "MG772933"
            },
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 502,
                "end": 509,
                "name": "GenBank"
            },
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 514,
                "end": 522,
                "name": "MG772934"
            },
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 556,
                "end": 563,
                "name": "GenBank"
            },
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 568,
                "end": 576,
                "name": "MN996532"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T4",
                "end": "T5"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T6",
                "end": "T7"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T8",
                "end": "T9"
            }
        ]
    },
    {
        "sen": [
            "To expedite the advancement of our knowledge, we leveraged data about the related coronaviruses that is readily available in public databases and integrated these data into a single computational pipeline."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The emergence of novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes the respiratory disease coronavirus disease 2019 (COVID-19), triggered a global pandemic that has led to an unprecedented worldwide public health emergency (1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Incorporation of substitution mutations would require a more complex representation of the data, which is outside of the scope of this study."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Crystal structures of the RBDs of the spike glycoproteins of SARS-CoV (",
            "Protein Data Bank [PDB]",
            " ID code ",
            "2ajf",
            ") (27), SARS-CoV-2 (",
            "PDB",
            " ID code ",
            "6m0j",
            ") (28) and MERS-CoV (",
            "PDB",
            " ID code ",
            "4l72",
            ") (23) complexed with their respective receptors, and the full cryoelectron microscopy structure of the SARS-CoV-2 spike glycoprotein (",
            "PDB",
            " ID code ",
            "6vxx",
            ") (29) were downloaded from the ",
            "PDB",
            " (30)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 472,
                "end": 495,
                "name": "Protein Data Bank [PDB]"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 504,
                "end": 508,
                "name": "2ajf"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 528,
                "end": 531,
                "name": "PDB"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 540,
                "end": 544,
                "name": "6m0j"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 565,
                "end": 568,
                "name": "PDB"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 577,
                "end": 581,
                "name": "4l72"
            },
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 716,
                "end": 719,
                "name": "PDB"
            },
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 728,
                "end": 732,
                "name": "6vxx"
            },
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 764,
                "end": 767,
                "name": "PDB"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T7",
                "end": "T8"
            }
        ]
    },
    {
        "sen": [
            "The ongoing COVID-19 pandemic is an urgent, global threat."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here we analyze the genome of the virus that causes COVID-19, SARS-CoV-2, along with other members of the coronavirus family."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronaviruses (CoVs) induced three major outbreaks of respiratory distress syndrome in the last decades including severe acute respiratory syndrome (SARS) in 2003 with an epicenter in Guangdong, China [1], Middle East respiratory syndrome (MERS) in 2012 in Saudi Arabia [2], and novel coronavirus disease (COVID-19) firstly observed in Wuhan province, China, in late 2019 [3]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 symptoms vary from mild to severe that can eventually lead to death."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The human-to-human transmission of COVID-19 is reported to occur by respiratory droplets or direct contact with the patients [4, 5]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "World Health Organization (WHO) announced COVID-19 as a pandemic on 11th March 2020 [6]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The number of infected cases and deaths by COVID-19 is sharply rising daily."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to the WHO report, as of 18th April 2020, COVID-19 has spread to more than 200 countries and territories with over 2,160,207 confirmed cases and over 146,088 confirmed deaths worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Novel coronavirus (2019-nCoV) also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of COVID-19 [9]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This functional prominence of Mpro in the viral life cycle, along with the lack of closely associated homologues in humans, makes the Mpro a promising target for COVID-19 antiviral drug design [13–17]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Many research groups have carried out the repurposing process, and to date many approved drugs are being tried in more than 100 clinical trial studies, but as of now, none of them turned out to be completely effective for COVID-19 treatment."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Unfortunately, no vaccine has been developed/approved yet to combat COVID-19 [18]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To meet this urgent medical need for an effective drug for COVID-19, we planned to identify potential SARS-CoV-2 Mpro inhibitors as possible anti-COVID-19 agents, by carrying out screening of a drug library containing drugs and diagnostic agents (approved by FDA or other world authorities) [19, 20] and the ",
            "Asinex BioDesign",
            " library [21]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 1934,
                "end": 1950,
                "name": "Asinex BioDesign"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The resulted scaffolds, mainly from ",
            "Asinex BioDesign",
            " library, are discussed in detail that could be utilized as potential hits for further drug development to find out an acceptable drug treatment of COVID-19."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 2001,
                "end": 2017,
                "name": "Asinex BioDesign"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "",
            "Asinex BioDesign",
            " library [21], which consists of pharmacologically important structural features from natural products in the chemical scaffolds having synthetic feasibility, was obtained from ",
            "Asinex",
            " database and 175,815 molecules (database updated in early 2020) were prepared using LigPrep module [25]."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 2175,
                "end": 2191,
                "name": "Asinex BioDesign"
            },
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 2368,
                "end": 2374,
                "name": "Asinex"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On the basis of protein amino acids present, excluded volume was calculated to avoid false selection of ligands during screening of the database."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Abstract  The Co rona vi rus D isease (COVID-19) is caused because of novel coronavirus (SARS-CoV-2) pathogen detected in China for the first time, and from there it spread across the globe creating a worldwide pandemic of severe respiratory complications."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These could be used as potential molecules or hits for further drug development to obtain clinically useful therapeutic agents for the treatment of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At the date of 23 April, there were about 2,700,000 confirmed cases of COVID-19 (probably an under-estimated count, due to the high proportion of asymptomatic patients that are not tested) and almost 190,000 deaths recorded worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These epidemiological figures are mainly due to the rapid spreading of COVID-19 in Lombardy and Northern Italian regions of the Po Valley (Padana Plain), an area characterized by constant high concentrations of particulate matter (PM10 and PM2.5), already recognized as one of the most polluted zones in Europe [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Lombardy accounts for 56% of the overall COVID-19 confirmed cases, 45% of hospital admissions and 55% of total deaths, followed by Emilia Romagna (15% of cases and 13% of deaths), Piedmont (12% of cases and 8% of deaths), and Veneto (11% of cases and 5% of deaths) [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Italian Society of Environmental Medicine (SIMA) has been the first to hypothesize—by releasing a specific Position Paper on 16 March—a possible link between the high mortality rates observed in Northern Italy due to COVID-19 and the PM concentrations [3,4]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A significant correlation was found between the geographical distribution of the daily PM10 exceedances in 110 Italian Provinces (number of days exceeding the PM10 law limit of 50 µg/m3) and the spreading of the COVID-19 infection before the shutdown decided by the Government [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These first observations suggest that particulate matter could be regarded—if not as a “carrier” or a “boosting factor”—at least as an indicator of the severity of COVID-19 infection in terms of diffusion and health outcomes observed in Northern Italy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Meanwhile, a survey carried out in the U.S. by the Harvard School of Public Health has suggested a strong association between increases in particulate matter concentration and mortality rates due to COVID-19, with The Lancet scientific community highlighting the need for adopting a planetary health perspective on COVID-19 outbreak [6,7]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At the present, no assumptions can be made concerning the correlation between the possible presence of the virus on PM and COVID-19 outbreak progression."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, based on the available literature, there is already enough evidence to consider the airborne route, with a potential role of particulate matter, as a possible additional factor for interpreting the anomalous COVID-19 outbreaks observed in Northern Italy and in the U.S., as well as in other areas characterized by high PM concentrations [8,9,10,11,12,13,14,15,16,17,18]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On these bases, in the frame of the One Health approach that can be applied to the international emergency generated by the SARS-COV-2 as it involves the interactions between humans and environment, the Italian Society of Environmental Medicine and the UNESCO Chair on Health Education and Sustainable Development support the vision of Sir Andy Haines, who has called for the adoption of urgent actions to counteract climate changes and the alteration of ecosystems that might trigger new and unexpected threats to human health such as that of COVID-19, which we are so dramatically experiencing worldwide [19]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The presence of SARS-COV-2 RNA on PM10 of outdoor air samples in any city of the world could represent a potential early indicator of COVID-19 diffusion."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Actually, it could be proposed that air pollution could influence the COVID-19 outbreak progression in a direct way or also indirectly, by enhancing the host susceptibility to viral infection and independently increasing the baseline risk of cardiovascular events or complications, chronic obstructive pulmonary diseases (COPD), and other conditions that are known to increase the severity of viral infections."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On the other hand, COVID-19 has clearly shown its potential to become a hospital infection, at least in Europe and U.S. (whose healthcare systems are usually centralized at hospital level), with 10% of infected people being healthcare workers, and a huge proportion of cases and deaths possibly related to infections acquired in hospital setting or nursing homes [23,24]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At the present, many research groups are working on COVID-19 clinical features and on the diffusion of SARS-COV-2 in outdoor or indoor air (especially in hospital settings) as well as in water/wastewater."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A number of nations were forced to declare a total shutdown due to COVID-19 infection, as extreme measure to cope with dramatic impact of the pandemic, with remarkable consequences both in terms of negative health outcomes and economic loses."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On 16 March, a Position Paper launched by the Italian Society of Environmental Medicine (SIMA) hypothesized for the first time a possible link between the dramatic impact of COVID-19 outbreak in Northern Italy and the high concentrations of particulate matter (PM 10 and PM 2.5 ) that characterize this area, along with its well-known specific climatic conditions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thereafter, a survey carried out in the U.S. by the Harvard School of Public Health suggested a strong association between increases in particulate matter concentration and mortality rates due to COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although no assumptions can be made concerning the link between this first experimental finding and COVID-19 outbreak progression or severity, the presence of SARS-COV-2 RNA on PM 10 of outdoor air samples in any city of the world could represent a potential early indicator of COVID-19 diffusion."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similarly to SARS, epidemiological links between the majority of COVID-19 cases and Huanan South China Seafood Market, a live-animal market, have been reported."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 76,775 confirmed cases of “Coronavirus Disease 2019” (COVID-19) were reported up to February 21st 2020, from which 2247 died and 18,855 recovered."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Indeed, it is suggested that SARS-CoV-2 genomic variants that emerge from inter- and intra-host evolution might be associated with susceptibility to SARS-CoV-2 infection and the severity of COVID-19 [24]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All datasets available in ",
            "SRA",
            " up to February 20th, 2020 were analysed."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 550,
                "end": 553,
                "name": "SRA"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The third 41-year-old male patient (",
            "SRR1097138",
            "/",
            "PRJNA603194",
            "), presented acute onset of common COVID19 symptoms."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 631,
                "end": 641,
                "name": "SRR1097138"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 642,
                "end": 653,
                "name": "PRJNA603194"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The raw read data were aligned on the complete (29,891 bp) SARS-CoV-2 reference sequence (",
            "GenBank",
            " accession no."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 796,
                "end": 803,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For the datasets analyzed in this study (average read depth 133.5x – 598.2x) and based on the assessed read quality > Q30 = 88.2–92.7%, LoFreq has calling sensitivity = ∼1% and PPV = 100 [39]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The colocalization of the intra-host SNVs and population level SNPs retrieved from ",
            "www.GISAID.org",
            " on February 18th 2020, with primers and probes coordinates was also examined, to identify potential interferences with all currently available molecular diagnostic assays [42]."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "URL",
                "start": 1094,
                "end": 1108,
                "name": "www.GISAID.org"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "More studies based on genomic datasets accompanied by clinical metadata are needed, in order to accurately define associations between intra-host SARS-CoV-2 genomic variants, the progression and the clinical outcome of COVID19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In December 2019, an outbreak of atypical pneumonia (Coronavirus disease 2019 -COVID-19) associated with a novel coronavirus (SARS-CoV-2) was reported in Wuhan city, Hubei province, China."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The pandemic Corona Virus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an urgent public health emergency and made a serious impact in global health and economy (https://www.cdc.gov/coronavirus/2019-ncov)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, there are about 106 complete and validated sequence data sets available in the ",
            "NCBI",
            " database (",
            "https://www.ncbi.nlm.nih.gov/labs/virus/vssi/#/",
            ") and (",
            "https://bigd.big.ac.cn/ncov/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 351,
                "end": 355,
                "name": "NCBI"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 366,
                "end": 413,
                "name": "https://www.ncbi.nlm.nih.gov/labs/virus/vssi/#/"
            },
            false,
            {
                "id": "T3",
                "type": "URL",
                "start": 420,
                "end": 448,
                "name": "https://bigd.big.ac.cn/ncov/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "Surprisingly, we noticed several hundreds of point mutations or SNPs among the different isolates from all over the world with different sequence data sets (Fig. 1A and B) and (Fig. S1A and S2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The morbidity of SARS-CoV-2 (COVID-19) is reaching 3 Million landmark causing and a serious public health concern globally and it is enigmatic how several antiviral and antibody treatments were not effective in the different period across the globe."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, as for SARS and MERS, SARS-CoV-2 RNA has been detected in stool samples from patients exhibiting symptoms of COVID-19 and from asymptomatic carriers (He et al., 2020; Pan et al., 2020; Wölfel et al., 2020; Young et al., 2020; Zhang et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Wu et al., 2020a; Wurtzer et al., 2020), and wastewater testing has been suggested as a non-invasive early-warning tool for monitoring the status and trend of COVID-19 infection and as an instrument for tuning public health response (Daughton, 2020; Mallapaty, 2020; Naddeo and Liu, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The sets of primers and probe (2019-nCoV RUO Kit) as well as the positive control (2019-nCoV_N_Positive Control, 2 × 105 genome copies (gc)/μL) were provided by IDT (Integrated DNA Technologies, Leuven, Belgium)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As expected, biobanked samples collected in October 2019, before the first COVID-19 case was documented, tested negative for all the three RT-qPCR assays thus excluding false positive reactions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Epidemiological data on COVID-19 in the Murcia Region have been retrieved from the publically available repository of the ",
            "“Servicio de epidemiologia”",
            " of the “Consejería de Salud de la Región de Murcia” (available at ",
            "http://www.murciasalud.es/principal.php",
            ")",
            "Epidemiological dataa summary of COVID-19 cases in the area of study."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1076,
                "end": 1103,
                "name": "“Servicio de epidemiologia”"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 1170,
                "end": 1209,
                "name": "http://www.murciasalud.es/principal.php"
            },
            false,
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "Therefore, our outcomes support that WBE could be used as an early warning tool to monitor the status of COVID-19 infection within a community."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our wastewater data do not quantitatively resemble the prevalence of COVID-19 confirmed cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For instance, not all COVID-19 positive patients excrete SARS-CoV-2 RNA in faeces, and when it occurs, the titers and the duration of shedding vary among individuals and across time (He et al., 2020; Pan et al., 2020; Wölfel et al., 2020; Xu et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused more than 200,000 reported COVID-19 cases in Spain resulting in more than 20,800 deaths as of April 21, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Faecal shedding of SARS-CoV-2 RNA from COVID-19 patients has extensively been reported."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, we investigated the occurrence of SARS-CoV-2 RNA in six wastewater treatments plants (WWTPs) serving the major municipalities within the Region of Murcia (Spain), the area with the lowest COVID-19 prevalence within Iberian Peninsula."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This environmental surveillance data were compared to declared COVID-19 cases at municipality level, revealing that members of the community were shedding SARS-CoV-2 RNA in their stool even before the first cases were reported by local or national authorities in many of the cities where wastewaters have been sampled."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The detection of SARS-CoV-2 in wastewater in early stages of the spread of COVID-19 highlights the relevance of this strategy as an early indicator of the infection within a specific population."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "None of the tertiary effluent samples (n = 12) tested positive for SARS-CoV-2.    •  SARS-CoV-2 RNA was detected in wastewater before the first COVID-19 cases were declared by local authorities."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By phylogenetic analysis of the four structural genes, our sequences clustered with all the SARS-CoV-2 reference sequences issued from the ",
            "NCBI",
            " database, and were distinct from the other human coronaviruses (Supplementary Material Fig. S1)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 139,
                "end": 143,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is an enveloped, non-segmented, positive-sense RNA virus (1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Developing a vaccine during or after the pandemic outbreaks is too slow to provide timely responses against COVID-19, and risks many lives."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These changes could be incorporated into the four essential viral genes (S, N, M, and E). (2) These genes would then be subcloned individually into integrating gene delivery vehicles, such as lentiviral vectors (9) or transposons (10, 11)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Lentiviral vectors could generate a stable cell line that is transgenic for the highly immunogenic antigenic determinants of COVID-19 (15), and would be able to continuously secrete VLPs into the culture media (16)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "",
            "NCBI",
            " database was used for the retrieval of Corona viruses (RdRp region) sequences."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 0,
                "end": 4,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The accession no ",
            "MT042778",
            " was used as query sequence in the ",
            "NCBI",
            " Blast for obtaining highly similar sequence."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 101,
                "end": 109,
                "name": "MT042778"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 144,
                "end": 148,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T3",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "A cryo-EM structure of RdRp from SARs-CoV-2 was downloaded from ",
            "RCSB",
            " using ",
            "PDB",
            " ID: ",
            "6M71",
            " [19]."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 258,
                "end": 262,
                "name": "RCSB"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 269,
                "end": 272,
                "name": "PDB"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 277,
                "end": 281,
                "name": "6M71"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T4",
                "end": "T6"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "The database of compounds from medicinal plants from Northern south Africa was retrieved from ",
            "NANPDB",
            " (",
            "https://african-compounds.org/nanpdb/",
            ") [24]."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 382,
                "end": 388,
                "name": "NANPDB"
            },
            false,
            {
                "id": "T8",
                "type": "URL",
                "start": 390,
                "end": 427,
                "name": "https://african-compounds.org/nanpdb/"
            },
            false
        ],
        "rel": [
            {
                "id": "R4",
                "bool": true,
                "head": "T7",
                "end": "T8"
            }
        ]
    },
    {
        "sen": [
            "This database is a diverse source of natural drugs from 617 source species, which comes from 146 families of plants, animals, bacteria, and fungi."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The database was then converted to.mdb format to be used as input for Molecular Operating Environment (MOE v2016) [25]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A cryo-EM structure of RdRp from SARs-CoV-2 was used to identify novel drugs from ",
            "Northern South African medicinal compounds database (NANPDB)",
            " by using computational virtual screening and molecular docking approaches."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 784,
                "end": 844,
                "name": "Northern South African medicinal compounds database (NANPDB)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Italy is one of the countries with the highest number of coronavirus disease (COVID-19) cases (,)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The analysis of sequence data shown in ",
            "GISAID",
            " (",
            "https://www.gisaid.org",
            ") indicates that the initial introduction of SARS-CoV-2 in Italy through 2 infected tourists in January was effectively contained (), and no further circulation of similar clade V strains has been so far detected."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 138,
                "end": 144,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 146,
                "end": 168,
                "name": "https://www.gisaid.org"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "We analyzed nasopharyngeal swab (n = 6) and bronchoalveolar lavage (n = 3) samples from 9 patients with COVID-19 to perform SARS-CoV-2 whole-genome reconstruction and mutational analysis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We named the sequences INMI3–INMI10 for their detection at National Institute for Infectious Diseases and analyzed them together with the previously published INMI1 and INMI2 (), along with all the sequences from Italy posted to ",
            "GISAID",
            " database by April 11, 2020."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 799,
                "end": 805,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We submitted consensus sequences to ",
            "GISAID",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 870,
                "end": 876,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "data, https://doi.org/10.1101/2020.04.17.046086) in phylogenetic analysis; for comparison to previously published reports, we maintained references to clades reported in ",
            "GISAID",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 1048,
                "end": 1054,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "INMI1 and INMI2 are included in clade V according to ",
            "GISAID",
            " phylogenetics, as reported (), and clade B2; the clade includes other sequences from EU countries, but no additional sequences from Italy."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 1109,
                "end": 1115,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All other INMI sequences cluster with the ",
            "GISAID",
            " G clade, and with the B1 clade; we focused subsequent analysis on clade B1 (Figure)."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Dataset",
                "start": 1297,
                "end": 1303,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of note, in both clusters the sequences from Italy are intermixed with sequences from other EU countries, which can also be seen in the broader phylogenetic analysis on ",
            "GISAID",
            ", in which more EU sequences are analyzed."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Dataset",
                "start": 1558,
                "end": 1564,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although viral RNA can be detected in multiple organs in COVID-19 patients, infectious SARS-CoV-2 has only been isolated from respiratory specimens [3,4]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since the viral receptor, angiotensin-convertase-2 (ACE2) protein, is expressed in the kidney, the testis and the bladder [5,6] and viral RNA has been detected in the sink and toilet of COVID-19 patients, the virus may be secreted through the urinary system [7]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Full-length viral genome sequence was acquired by next-generation sequencing (Accession number ",
            "MT446312",
            ") with 5 nucleotide mutations as compared to the original Wuhan viral stain (Accession number ",
            "NC045512.2",
            ") (Table S1)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "AccessionNumber",
                "start": 513,
                "end": 521,
                "name": "MT446312"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 615,
                "end": 625,
                "name": "NC045512.2"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "ABSTRACT  SARS-CoV-2 caused a major outbreak of severe pneumonia (COVID-19) in humans."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Viral RNA was detected in multiple organs in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, infectious SARS-CoV-2 was successfully isolated from urine of a COVID-19 patient."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Currently, multiple databases/platforms, such as ",
            "DrugBank",
            " Database, ",
            "Comparative Toxicogenomics Database (CTD)",
            ", ",
            "Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP)",
            " and Integrative Pharmacology-based Research Platform of Traditional Chinese Medicine (TCMIP), were commonly applied to acquire potential targets of small molecular compounds [31,32,33]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 49,
                "end": 57,
                "name": "DrugBank"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 68,
                "end": 109,
                "name": "Comparative Toxicogenomics Database (CTD)"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 111,
                "end": 199,
                "name": "Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Basically, the target information in these three databases is complementary, a combination of which could provide relatively comprehensive compound-target interactions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "DAVID Bioinformatics Resources 6.8 [42] was applied to perform GO analysis for the hub targets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, the analysis of specific GO annotation involved in immune system processes was carried out with ClueGo (Version 2.5.6) [43], a Cytoscape plug-in integrating EBI-Uniport GO annotation database (updated in Mar 2019)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Three public databases were used to mine the potential targets for the three (phyto-) nutrients in VCG Plus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Comparing the results with “virus diseases” and “immune system disease” gene data in ",
            "CTD",
            ", it was found that 179 targets existed in both the “virus diseases” and “immune system disease” gene database."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 1073,
                "end": 1076,
                "name": "CTD"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to the KEGG database, the obtained pathways are mainly concentrated on categories of signal transduction involved in environmental information processes, immune systems involved in organismal systems, infectious diseases involved in human diseases and other pathways."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The severe respiratory disease COVID-19 was first noticed in late December 2019 ()."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At the beginning of May, COVID-19 had spread to ~150 countries and infected more than 3.3 million people ()."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The etiological agent of COVID-19 (), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (), was identified as a new member of the genus Betacoronavirus, which includes a diverse reservoir of coronaviruses (CoVs) isolated from bats (–)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While hundreds of new SARS-CoV-2 sequences are added to the ",
            "GISAID (Global Initiative on Sharing All Influenza Data)",
            " repertoire every day (), we note that the RBM region currently remains highly conserved."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 500,
                "end": 556,
                "name": "GISAID (Global Initiative on Sharing All Influenza Data)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "No amino acid within 6 Å of the ACE2 binding site has repeated variations, with the exception of G476S, a very rare mutation found in eight sequences from a local cluster in the Washington state, out of 6400 total sequences from GISAID (13 April 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "An analysis of 6400 SARS-CoV-2 sequences from ",
            "GISAID",
            " (, ) identifies only one very rare mutation, G476S that is a direct ACE2 contact residue."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 945,
                "end": 951,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All 43 CoV complete genome sequences were obtained from ",
            "GenBank",
            " and ",
            "GISAID",
            " (, ) and were selected to be representative of the diversity (tables S2 and S3)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 1098,
                "end": 1105,
                "name": "GenBank"
            },
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 1110,
                "end": 1116,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Pan_SL-CoV_GD/P1La sequence was generated by combining Pan_SL-CoV_GD/P1L () with some additional sequences from the ",
            "National Center for Biotechnology Information (NCBI) BioProject",
            " database ",
            "PRJNA5732983",
            " (, ) to have a maximal coverage of the complete genome sequence for analysis."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 1314,
                "end": 1377,
                "name": "National Center for Biotechnology Information (NCBI) BioProject"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 1387,
                "end": 1399,
                "name": "PRJNA5732983"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "Recombination regions and breakpoints were also analyzed using the LANL (Los Alamos National Laboratory) database () tool RIP () with a 400-bp window."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Cumulative plots of the average behavior of each codon for all pairwise comparisons in the input data, for insertions and deletions (indels), synonymous (syn), and nonsynonymous (nonsyn) mutations and values of the ratios of the rate of synonymous nucleotide substitutions per synonymous site and nonsynonymous substitutions per nonsynonymous site (dN/dS or ω), were obtained using the LANL database tool SNAP ()."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 has become a global pandemic caused by the novel coronavirus SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral pandemic that causes coronavirus disease 2019 (COVID-19) is the worst respiratory disease outbreak of the generation, if not a century, and currently crippling the entire global fabric of the human socioeconomic life."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With no known efficacious therapy for COVID-19, repurposing other known antiviral drugs and pathologies related to the lethal episode of COVID-19 are our best approach for rigorous experimental (in vitro and in vivo) tests and clinical trials."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Good examples of antiviral drugs with protease and polymerase mechanism of action are indinavir, saquinavir, lopinavir/ritonavir and remdesivir, which gained attention in recent weeks for clinical trial of COVID-19 infection (1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On these bases, studies on the potential of viral helicase inhibitors in SARS-CoV-2 infection or COVID-19 is well justified."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Highlighting the experience gained from targeting Nsp13 in similar coronaviruses (SARS-CoV and MERS) and known inhibitors, the article calls for research on helicase inhibitors as potential COVID-19 therapy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The outbreak of the novel coronavirus disease COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) started in Wuhan, Hubei, China from December 2019, and has been spread out to the world [1, 2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This case report describes the symptoms, diagnosis and treatments of one unconventional COVID-19 pneumonia case in our hospital during early period of the outbreak when having very little understanding on the virus and the infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, COVID-19 ribonucleic acid test was negative using nasopharyngeal swabs done by Shenzhen Center for Disease Control (Shenzhen CDC)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to the seventh edition of Novel Coronavirus Pneumonia (NCP) treatment plan issued by National Health Commission of the People’s Republic of China, this patient in the case report is considered as a severely ill case of the COVID-19 pneumonia."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As reported by Dr. Yang Yang and his group, the nucleic acid of SARS-COV-2 could be detected from BALF samples of critically ill patients with COVID-19 pneumonia while not from the upper respiratory tract specimens of some patients [10]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our report highlights the importance to carry out bronchoscopy and detection of SARS-COV-2 RNA from BALF samples as complementary interventions in addition to monitoring epidemiological changes, clinical symptoms and chest CT findings of the unconventional COVID-19 pneumonia cases like the one described in this report, which will be informative and clinically significant in guiding the prognosis of the disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The novel coronavirus disease 2019 (COVID-19) outbreak started in Wuhan, Hubei, China since Dec 2019 and cases of infection have been continuously reported in various countries."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nucleic acid detection is considered as the gold standard for the diagnosis of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Strategies to limit the severe pandemic and to manage coronavirus disease (COVID-19) patients strongly depend on readily available, accurate and reliable RT-PCR assays to detect the genome of the causative agent acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in biosamples."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This stool sample was from a 5-year-old child with COVID-19 [7] and was chosen because of high initial PCR signals and sufficient sample availability to generate large quantities of eluate for further distribution."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "When compared with all genomes available on ",
            "GISAID",
            " (9,184 SARS-CoV-2 genomes on 15 April 2020, Supplement), the regions used for amplification in the CDC and Charité protocol are highly conserved: Only 1.55%, 0.45% and 2.4% of genome sequences contain any kind of mismatch within the primer/probe regions of the CDC N1, N2 and N3 protocols, respectively, and 0.25%, 0.29% and 0.67% in the primer/probe regions of the Charité E, RdRp and N protocols, respectively."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 540,
                "end": 546,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of note, in a routine clinical setting, the CDC N1 reaction also detected SARS-CoV-2 RNA in nucleic acid extracts from 37 of 83 sera (45%) from COVID-19 patients in intensive care units, with a positive correlation of their Cp values with those of the corresponding respiratory material (Spearman Rank correlation co-efficient r=0.4285, p (two-tailed) < 0.0001 (data not shown))."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Containment strategies and clinical management of coronavirus disease (COVID-19) patients during the current pandemic depend on reliable diagnostic PCR assays for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (13), has become an unprecedented public health crisis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus Resource Center at Johns Hopkins University of Medicine has reported a total of 23,638 deaths as worldwide COVID-19 infections surpass 500,000 (as of 5 PM EST on March 26, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On March 16, 2020, the White House, collaborating with research institutes and tech companies, issued a call to action for global artificial intelligence (AI) researchers for developing novel text and data-mining techniques to assist COVID-19-related research."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Allen Institute for AI in partnership with leading research groups issued an open-source, weekly updated ",
            "COVID-19 Open Research Dataset",
            " (2), which continuously documents COVID-19-related scholarly articles to accelerate novel research projects urgently requiring real-time data."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 725,
                "end": 755,
                "name": "COVID-19 Open Research Dataset"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The large-scale data of COVID-19 patients can be integrated and analyzed by advanced machine learning algorithms to better understand the pattern of viral spread, further improve diagnostic speed and accuracy, develop novel effective therapeutic approaches, and potentially identify the most susceptible people based on personalized genetic and physiological characteristics."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Inspirationally, within a short period of time since COVID-19 outbreak, advanced machine learning techniques have been used in taxonomic classification of COVID-19 genomes (8), CRISPR-based COVID-19 detection assay (6), survival prediction of severe COVID-19 patients (11), and discovering potential drug candidates against COVID-19 (4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Personalized protective strategies can greatly benefit from precise classifications of the population based on categorized COVID-19 susceptibility."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The earlier observation that elderly people have a higher risk to COVID-19 is challenged by a recent finding that more and more young adults suffer from severe COVID-19 symptoms, indicating an urgent need of a comprehensive risk evaluation based on personalized genetic and physiological characteristics."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Fang et al. (3) hypothesized that increased expression of ACE2, from using ACE2-stimulating drugs to treat hypertension and diabetes, could actually worsen clinical outcomes of COVID-19 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, biochemistry (e.g., ACE2 expression level) and clinical data (e.g., age, respiratory pattern, viral load, and survival) of COVID-19 patients with underlying medical conditions can be analyzed by machine learning approaches to not only identify any reliable features (e.g., ACE2) for risk prediction, but also further perform risk classification and prediction for a balanced preparation of ongoing disease treatment and COVID-19 defense (Fig. 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "ACE2 genetic polymorphism, represented by diverse genetic variants in human genome, has been shown to affect virus-binding activity (1), suggesting a possible genetic predisposition to COVID-19 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, machine learning analysis of genetic variants from asymptomatic, mild or severe COVID-19 patients can be performed to classify and predict people based on their vulnerability or resistance to potential COVID-19 infection, by which the machine learning model can also return those prioritized genetic variants, such as ACE2 polymorphism, in their decision-making process as important features for functional and mechanistic studies (Fig. 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Neural network classifiers were developed for large-scale screening of COVID-19 patients based on their distinct respiratory pattern (10)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similarly, a deep learning-based analysis system of thoracic CT images was constructed for automated detection and monitoring of COVID-19 patients over time (5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Rapid development of automated diagnostic systems based on artificial intelligence and machine learning not only can contribute to increased diagnostic accuracy and speed but will also protect healthcare workers by decreasing their contacts with COVID-19 patients (Fig. 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "An effective therapeutic strategy is urgently needed to treat rapidly growing COVID-19 patients worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As there is no effective drug proven to treat COVID-19 patients, it is critical to develop efficient approaches to repurpose clinically approved drugs or design new drugs against SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "AlphaFold (9), which is a deep learning system developed by Google DeepMind, has released predicted protein structures associated with COVID-19, which can take months by traditional experimental approaches, serving as valuable information for COVID-19 vaccine formulation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, COVID-19 vaccine candidates were proposed by a newly developed Vaxign reverse vaccinology tool integrated with machine learning (7)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The tremendous amount of COVID-19 treatment data in worldwide hospitals also require advanced machine learning methods for analyzing personalized therapeutic effects for evaluating new patients, such as hospitalization prediction, which can not only provide better care for each patient but also contribute to local hospital arrangement and operation (Fig. 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As artificial intelligence and machine learning scientists have been eagerly searching and waiting for real-time data generated by this pandemic around the world, timely delivery of COVID-19 patient data, such as physiological characteristics and therapeutic outcome of COVID-19 patients, followed by subsequent data transformation for easy access, is extremely important, but challenging."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Figure 1 is a schematic representation of the workflow, but there are several steps in the process that currently limit the application of machine learning and artificial intelligence to combat COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Availability of COVID-19-related clinical data, which can be managed and processed into easily accessible databases, is a key current barrier."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition to these initiatives, integrating COVID-19-related clinical data with existing biobanks, such as the ",
            "UK Biobank",
            ", with pre-existing data of those patients (if already in biobanks), such as their genotype and physiological characteristics, could maximize our efforts toward a faster and feasible approach for meaningful data-mining by bioinformaticians and computational scientists."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 5878,
                "end": 5888,
                "name": "UK Biobank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A centralized collection of worldwide COVID-19 patient data will be beneficial for future artificial intelligence and machine learning research to develop predictive, diagnostic, and therapeutic strategies against COVID-19 and similar pandemics in future."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Targeted screening of suspected coronavirus disease 2019 (COVID-19) cases, as well as a series of successive nationwide travel restrictions, were put in place to curtail SARS-CoV-2 introductions into the continental United States from outbreak hotspots in China (2 February 2020), Iran (2 March 2020), mainland European countries (13 March 2020), and the United Kingdom and Ireland (16 March 2020) (–)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Despite these measures, the first COVID-19 case in New York State was identified in New York City (NYC) on 29 February 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of 2 May 2020, there were 312,977 confirmed COVID-19 cases in New York state, including 172,354 (55%) in NYC [New York State Department of Health (NYS DOH); https://coronavirus.health.ny.gov]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We performed phylogenetic analysis of the 84 distinct patient isolates, together with 2363 sequences deposited in ",
            "GISAID",
            " up to 1 April 2020 (Fig. 2A)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 838,
                "end": 844,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This clade is largely composed of isolates obtained from patients with COVID-19 in Europe (72%) (Fig. 2B), suggesting that introductions from Europe account for the majority of cases found in NYC in the first weeks of March 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "(A) ML phylodynamic inference of 84 SARS-CoV-2 sequences from New York from this study in a global background of 2363 sequences available in the ",
            "GISAID",
            " EpiCoV database as of 1 April 2020."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 1250,
                "end": 1256,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Science this issue p. 297   New York City became an epicenter for COVID-19 cases that originated in Europe and elsewhere in the United States."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To identify the early transmission events underlying the rapid spread of the virus in the NYC metropolitan area, we sequenced the virus that causes coronavirus disease 2019 (COVID-19) in patients seeking care at the Mount Sinai Health System."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Abstract   Background  COVID-19 has highlighted deficiencies in the testing capacity of many developed countries during the early stages of pandemics."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Driven by a desire to reduce potential infections during the COVID-19 pandemic, health authorities and professional bodies in the United Kingdom (UK) [1], Canada [2] and Australia [3] have issued urgent statements designed to limit the need for pregnant women to attend prolonged appointments at pathology testing centers for OGTTs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Clearly, they differ in many ways, both pre and post COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For comparison of GDM frequency using the pre and post COVID-19 diagnostic processes and criteria, we have considered national diagnostic criteria."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Table 1 shows the current recommendations for GDM testing in each of the three countries, their revised recommendations for use during the COVID-19 pandemic (indicated by the column entitled “Modified GDM diagnostic approach during COVID-19 pandemic”) and the specific diagnostic process and threshold(s) evaluated in the current study (indicated by the column entitled “Post-COVID approach tested in current paper”)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Each participant was classified into the following groups for each of the UK, Canadian and Australian diagnostic criteria (as specified in Table 1): 1) “Missed GDM” - GDM by local pre COVID-19 criteria but not identified as GDM using local post COVID-19 criteria; 2) GDM by local post COVID-19 criteria; and 3) not GDM by both pre and post COVID-19 local criteria."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using the newly recommended national COVID-19 processes and criteria would result in markedly reduced GDM frequency in the UK (81% reduction to 2.5%) and Canada (82% reduction to 1.7%), with a less marked 25% reduction to 12.7% in Australia (Fig. 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Considering the UK situation (Table 3), the 684 women currently classified as GDM but who would not be detected (“missed”) under the post COVID-19 guidelines demonstrate statistically significantly higher rates of preterm birth, LGA, primary CS, neonatal hyperinsulinemia and neonatal adiposity than non GDM women."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Considering the Canadian criteria (Table 4",
            "), the 524 women currently classified as GDM but considered non GDM under post COVID-19 guidelines demonstrate increased risks (compared to non-GDM women) for all the outcomes listed for the UK, including pregnancy related hypertension."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The 253 women with IADPSG GDM, who would be “missed” under the proposed Australian post COVID-19 process (fasting glucose followed by selective OGTT, no change in diagnostic thresholds) have outcome frequencies similar to those of non GDM women, whilst those who would remain in the GDM group with post COVID-19 testing show significantly higher risks for all listed outcomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Table 3, Table 4, Table 5 also document the proportion of pregnancy complications which occurred amongst GDM women using pre COVID-19 diagnostic processes, but which would be “missed” post COVID-19 as these women would no longer be classified as GDM and therefore would no longer receive any additional care."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Perhaps unsurprisingly, the three different suggested modifications in diagnostic strategies proposed for GDM testing in response to the COVID-19 pandemic also appear to have different potential advantages and disadvantages [14]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The UK (1) and Canadian (2) strategies both prioritize avoidance of OGTTs with the intention of reducing potential COVID-19 exposure."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the case of the Canadian criteria (Table 4), the “Missed GDM” women carry risks which are comparable to those who would still be detected under post COVID-19 guidelines and the percentage of GDM outcomes missed generally exceeds the overall reduction in GDM prevalence."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, we acknowledge that, for the UK and Canada, our processes do not precisely match current or proposed (post COVID-19) testing recommendations for GDM."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 pandemic poses a variety of serious challenges to pregnancy care [22] and GDM detection and management are only one part of a complex and rapidly evolving set of adaptations to care (e.g. use of telehealth or telephone visits) designed to both optimize pregnancy outcomes and protect pregnant women and health care staff."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A woman who contracts COVID-19 infection during pregnancy clearly may acquire this through household or community transmission, rather than specifically at a pathology collection centre, so our primary clinical aim should be to reduce avoidable exposure and to encourage general protective measures in other settings."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Australia has experienced far fewer COVID-19 cases than the UK or Canada, and testing recommendations have already been modified, with routine OGTTs again recommended where COVID-19 transmission risk is considered low [23], the strategy described in this paper recommended for moderate risk situations and fasting glucose testing alone preferred if COVID-19 risk is considered high."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Highlights     •  Guidelines for GDM diagnosis during COVID have changed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We assessed how altered diagnostic processes and criteria for gestational diabetes mellitus (GDM) recommended by the United Kingdom (UK), Canada and Australia for use during the COVID-19 pandemic would affect both GDM frequency and related adverse outcomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All post COVID-19 modified pathways reduced GDM frequency – UK (81%), Canada (82%) and Australia (25%)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Canadian women whose GDM would remain undetected post COVID-19 (missed GDMs) displayed similar rates of pregnancy complications to those with post COVID-19 GDM."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Each has both potential benefits in terms of reduction in potential exposure to COVID-19 and costs in terms of missed opportunities to influence pregnancy and postpartum outcomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Caused by SARS-CoV-2, this disease was named as COVID-19 by the World Health Organization (WHO) and quickly spreads all over the world [8]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 outbreak was declared an epidemic by the World Health Organization after causing the death of tens of thousands of people [9]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 epidemic is continuing to be a major problem for the whole world [8], [11]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As COVID-19, the largest epidemic of modern times turned into a pandemic, an urgent search was started throughout the world for a therapeutic drug against COVID-19 to control the epidemic and decrease the high mortality rates."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In COVID-19, the reason why the disease was very mild in some people and very severe in others is thought to be related to the amount of retinol previously stored in the patient's liver."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In COVID-19, the falling levels of retinoic acids, which are rapidly depleted in the body, and the resulting excessive cytokine release syndrome, are responsible for most of the disease, severe clinical and symptoms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Two separate clinical studies from Egypt reported to the US NIH clinical trials are underway to determine the effectiveness of Isotretinoin, a retinoic acid derivative, in COVID-19 [22]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The clinical picture, which is common in severe COVID-19 patients and is referred to as “pink eye” [23], [24], is nothing more than conjunctivitis seen in severe vitamin A deficiency."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although attempts are made to explain the taste and olfactory disorders in COVID-19 patients with ACE2 receptors it is clear that it takes place through retinoic acid receptors [25]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This also suggest that vitamin A deficiency also develops in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The findings and symptoms that arise in the nervous system and eyes of COVID-19 patients are nothing but the results of retinoic acid deficiency manifested through retinoid acid receptors."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Dizziness, headache, impaired consciousness, acute cerebrovascular disorder, ataxia and epilepsy are observed in COVID-19 patients as central nervous system involvement and hypogeusia, hyposmia, hypopsia and neuralgia are observed as peripheral nervous system involvement."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Acute hemorrhagic necrotizing encephalopathy cases related to COVID-19 were also reported."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first Guillain-Barré syndrome that could be related to COVID-19 was reported by Zhao et al [28]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It could be considered that the reason for observing autoimmune diseases such as Kawasaki in COVID-19 is related to this mechanism."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first Guillain-Barré syndrome that could be related to COVID-19 was reported by Zhao et al [28]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This may increase the tendency to thrombosis in addition to hypoxia and endothelial damage in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In some COVID-19 patients, the cause of inadequate antibody response may be due to retinol depletion."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Vitamin A deficiency increases mortality in AIDS."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Vitamin A replacement also provides benefit for other infections in AIDS."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A deficiency increases mortality in AIDS [56]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The frequency of Measles, Chicken Pox, RSV, AIDS and pneumonia increase in vitamin A deficiency [57]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All the drugs bound to a certain protocol by the COVID-19 Science and Advisory Board in our country, as in many countries throughout the world, and used in COVID-19 treatment, inhibit the cytochrome P450 system (Table 1",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The table below shows the drugs included in the COVID-19 treatment protocol and their stimulation / inhibition status on the CYP P450 system."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The study conducted in China found this drug to be unsuccessful against COVID-19 [36]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this respect, the use of alcohol has a negative impact on COVID-19 prognosis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "French people were consuming high amounts of red wine on the first days of the COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It was stated that red wine (not white wine) consumption protected people from COVID-19 and that it was even good for the patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The reason why COVID-19 progresses more in males than females (ignoring smoking) is that the cytochrome oxidase system is less inhibited in males than females."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this case, all drugs and compounds that inhibit the liver cytochrome P450 oxidase system may be effective against COVID-19 by preventing retinoic acid metabolism."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In fact, it is not difficult to predict that even Ketoconazole, which is used as an antifungal, can have significant efficacy in COVID-19 treatment as a strong cytochrome oxidase P450 inhibitor (if sufficient retinoic acid is available in the body) [30]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Retinoic acids, zinc and RAMBAs may work against COVID-19, which continues with full intensity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 and previously defined sepsis, SIRS and ARDS are each retinoic acid depletion syndrome."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We claim that retinoic acid metabolism is defective in most inflammatory diseases, particularly COVID-19 (cytokine storm) sepsis, SIRS and ARDS."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We used the open COVID-19 sequencing available and the bioinformatics protocols developed by the ARTIC network."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Raw files were base-called with Guppy, demultiplexed and trimmed with Porechop (https://github.com/rrwick/Porechop) and mapped against reference sequence Wuhan-Hu-1 (",
            "GenBank",
            " Accession Number ",
            "MN908947",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 278,
                "end": 285,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 303,
                "end": 311,
                "name": "MN908947"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "We conducted the genome sequencing and analysis of the first confirmed COVID-19 infections in Brazil."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Rapid sequencing coupled with phylogenetic analyses in the context of travel history corroborate multiple independent importations from Italy and local spread during the initial stage of COVID-19 transmission in Brazil."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The outbreak of coronavirus disease 2019 (COVID-19) has been spreading rapidly throughout the globe, resulting in ~0.8 million confirmed infections as of March 31, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On March 11, 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a positive-sense single-stranded RNA virus that belongs to the genus Betacoronavirus within the family Coronaviridae [1,2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The pandemic of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has posed a severe threat to global public health."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Subgroups of patients with COVID-19 have been identified who appear to be at increased risk of morbidity and mortality, including patients of older age, male sex (vs female), and those with comorbidities, such as hypertension, chronic lung disease, diabetes, and cancer."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since COVID-19 began to spread across the globe in early 2020, patients with cancer were identified as a particularly susceptible subgroup of the population."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, labelling all patients with cancer as susceptible to COVID-19 is probably neither reasonable nor informative."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As a consequence of generic advice given to people who are clinically susceptible to COVID-19, patients with cancer (of any age, sex, tumour subtype, and stage) have been labelled as at high risk from COVID-19, which has led to sweeping changes in management for all cancer types during the past few months, including shortening of radiotherapy, switching from intravenous to oral chemotherapy regimens, and modifications in immunotherapy use.5, 6, 7, 8 These changes were instigated with little evidence to support them, perhaps reasonably in an acute pandemic situation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "From the ",
            "UK Coronavirus Cancer Monitoring Project (UKCCMP)",
            ", we report the first analysis, to our knowledge, of the complex interaction between patient demographics and tumour subtype, to more accurately estimate the risk of SARS-CoV-2 infection and COVID-19 in patients with cancer."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1132,
                "end": 1181,
                "name": "UK Coronavirus Cancer Monitoring Project (UKCCMP)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We aimed to describe the clinical outcomes of COVID-19 in patients with cancer entered into the ",
            "UKCCMP",
            " registry and compare primary cancer subtype prevalence and case fatality with ",
            "UK Office for National Statistics",
            " cancer incidence data."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 1502,
                "end": 1508,
                "name": "UKCCMP"
            },
            false,
            {
                "id": "T3",
                "type": "Creator",
                "start": 1587,
                "end": 1620,
                "name": "UK Office for National Statistics"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "UKCCMP",
            " database of UK patients with COVID-19 who have cancer was designed as a public health surveillance registry for the COVID-19 pandemic and a prospective, observational cohort study."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 1648,
                "end": 1654,
                "name": "UKCCMP"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The database was set up to support rapid clinical decision making, in accordance with the UK Policy Framework for Health and Social Care Research, the UK National Research Ethics Service, and the UK Governance Arrangement for Research Ethics Committees."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Management of patients with cancer with COVID-19 was directed by the patient's clinician team without input from the ",
            "UKCCMP",
            " and was based on local policies and standard UK clinical practice at the time of this study."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 2207,
                "end": 2213,
                "name": "UKCCMP"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Decisions about intensive care unit admission and ventilation were guided by the UK National Health Service National Institute of Health and Care Excellence COVID-19 rapid guidelines."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Case reporting of patient tumour stage and demographics was lead by a COVID-19 emergency response reporting individual (ERRI), using data from clinical records or from direct assessment."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Tumour subtype and demographic analyses used the latest release of the ",
            "Cancer Registration Statistics",
            ", England, 2017, which is the most recent cancer registration database in England and involves registrations of patients from Jan 1 to Dec 31, 2017."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 2749,
                "end": 2779,
                "name": "Cancer Registration Statistics"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "1044 patients with active cancer and documented SARS-CoV-2 infection or COVID-19 disease were registered in the ",
            "UKCCMP",
            " database from March 18, 2020, with outcomes censored on May 8, 2020."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 3040,
                "end": 3046,
                "name": "UKCCMP"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patients were followed up from the point of COVID-19 diagnosis to either discharge from hospital or death."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We compared the demographics and cancer subtype of patients with cancer with COVID-19 from the ",
            "UKCCMP",
            " registry with those from the population of patients represented in the ONS cancer census, which was used as a control group."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 3318,
                "end": 3324,
                "name": "UKCCMP"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We found that patients with cancer with COVID-19 were significantly more likely to be men (595 [56·9%] of 1044 ",
            "UKCCMP",
            " patients vs 145 034 [51·3%] of 282 878 ONS patients; OR 1·26, 95% CI 1·12–1·43; p=0·0002) compared with the ONS control population, but the age distribution of patients with cancer who contracted COVID-19 did not differ between the two groups (appendix p 2)."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 3561,
                "end": 3567,
                "name": "UKCCMP"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patients with haematological malignancies appeared to be at significantly increased risk of COVID-19 infection, including those with leukaemia (OR 2·82, 95% CI 2·21–3·55; p<0·0001), myeloma (2·03, 1·42–2·83; p=0·0001), and lymphoma (1·63, 1·28–2·06; p<0·0001; table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By contrast, patients with lung cancer and prostate cancer were relatively under-represented in the ",
            "UKCCMP",
            " population compared with the control ONS population (table 1)."
        ],
        "lab": [
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 4197,
                "end": 4203,
                "name": "UKCCMP"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "319 (30·6%) of 1044 patients in the ",
            "UKCCMP",
            " cohort died, 295 (92·5%) of whom had a cause of death recorded as due to COVID-19."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Repository",
                "start": 4303,
                "end": 4309,
                "name": "UKCCMP"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The all-cause case–fatality rate in patients with cancer after COVID-19 infection was significantly associated with increasing age (figure 1",
            "; appendix pp 2–3)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additionally, the all-cause case–fatality rate in patients with cancer once they had contracted COVID-19 was significantly associated with sex (212 [35·6%] of 595 male patients vs 105 [23·6%] of 445 female patients; OR 1·92, 95% CI 1·51–2·45; p<0·0001)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On univariable analysis, we observed a significantly higher risk of death from COVID-19 in patients with prostate cancer (OR 2·14, 95% CI 1·17–3·96; p=0·014) and leukaemia (2·03, 1·04–3·97; p=0·038), and a significantly lower risk of death from COVID-19 for patients with breast cancer (0·53, 0·28–1·00; p=0·049) and female genital cancers (0·36, 0·13–0·87; p=0·031; table 2",
            "; figure 2",
            "; appendix p 3)."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In multivariable analyses, we found no increased case–fatality rate due to COVID-19 in patients with lung cancer compared with the rest of the ",
            "UKCCMP",
            " population (table 2)."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 5354,
                "end": 5360,
                "name": "UKCCMP"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We undertook a specific detailed analysis of 227 patients with haematological malignancies who were diagnosed with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "108 (47·6%) of 227 patients with haematological malignancies had received recent chemotherapy within 4 weeks of COVID-19 presentation, compared with 241 (29·5%) of 817 patients with non-haematological malignancies (appendix p 5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, after correction for age and sex, patients with haematological malignancies who had recent chemotherapy had an increased risk of death during COVID-19-associated hospital admission (OR 2·09, 95% CI 1·09–4·08; p=0·028)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patients with haematological malignancies were at a greater risk of having a more severe COVID-19 clinical phenotype, to require more intensive supportive interventions, and to suffer an increased risk of death compared with patients with non-haematological malignancies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In multivariable analyses, patients with leukaemia had a significantly higher risk of COVID-19-related death, after taking into account age and sex."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "15, 16 However, this finding contrasts with the results of an American cohort study, which did not suggest increased mortality from COVID-19 in patients with haematological malignancies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Large COVID-19 cancer cohorts of predominantly solid organ tumours have shown no significant excess mortality risk from recent chemotherapy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additionally, once COVID-19 was established in patients with lung cancer, we did not observe an increased case–fatality rate compared with the remaining population with cancer and COVID-19 in the ",
            "UKCCMP",
            " cohort, suggesting that patients with lung cancer are not a specifically susceptible group."
        ],
        "lab": [
            false,
            {
                "id": "T13",
                "type": "Repository",
                "start": 6911,
                "end": 6917,
                "name": "UKCCMP"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "First, there are methodological differences in our study; we compared patients with lung cancer and COVID-19 to patients with cancer without COVID-19, rather than to people who did not have cancer."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Third, lung cancer is the most common cancer in China, and hence would be over-represented in Chinese patients with COVID-19 and cancer."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additionally, we observed a low admission rate of patients with cancer to the intensive care unit, which could affect COVID-19 outcomes in patients with cancer in the UK."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Background  Patients with cancer are purported to have poor COVID-19 outcomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The aim of this study was to investigate COVID-19 risk according to tumour subtype and patient demographics in patients with cancer in the UK."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We compared adult patients with cancer enrolled in the ",
            "UK Coronavirus Cancer Monitoring Project (UKCCMP)",
            " cohort between March 18 and May 8, 2020, with a parallel non-COVID-19 UK cancer control population from the ",
            "UK Office for National Statistics",
            " (2017 data)."
        ],
        "lab": [
            false,
            {
                "id": "T14",
                "type": "Repository",
                "start": 7793,
                "end": 7842,
                "name": "UK Coronavirus Cancer Monitoring Project (UKCCMP)"
            },
            false,
            {
                "id": "T15",
                "type": "Creator",
                "start": 7951,
                "end": 7984,
                "name": "UK Office for National Statistics"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We analysed the effect of tumour subtype and patient demographics (age and sex) on prevalence and mortality from COVID-19 using univariable and multivariable models."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Findings  319 (30·6%) of 1044 patients in the ",
            "UKCCMP",
            " cohort died, 295 (92·5%) of whom had a cause of death recorded as due to COVID-19."
        ],
        "lab": [
            false,
            {
                "id": "T16",
                "type": "Repository",
                "start": 8210,
                "end": 8216,
                "name": "UKCCMP"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patients with haematological malignancies (leukaemia, lymphoma, and myeloma) had a more severe COVID-19 trajectory compared with patients with solid organ tumours (odds ratio [OR] 1·57, 95% CI 1·15–2·15; p<0·0043)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "After correction for age and sex, patients with haematological malignancies who had recent chemotherapy had an increased risk of death during COVID-19-associated hospital admission (OR 2·09, 95% CI 1·09–4·08; p=0·028)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interpretation  Patients with cancer with different tumour types have differing susceptibility to SARS-CoV-2 infection and COVID-19 phenotypes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our results could be useful to assist physicians in informed risk–benefit discussions to explain COVID-19 risk and enable an evidenced-based approach to national social isolation policies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It was therefore termed SARS-CoV-2 and the disease it causes was named COVID-19 (Corona Virus Disease 2019) [3]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Several real time RT-PCR assays protocols for detection of SARS-CoV-2 RNA have been developed and approved from Centers for Disease Control and Prevention Nucleic acid in US and are now widely employed to diagnose COVID-19 disease [7, 8]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, recent meta-analysis on 4243 COVID-19 patients reported that stool samples from 48.1% of patients tested positive for virus RNA, among these patients 70.3% tested positive for RNA virus even after respiratory specimens tested negative [11]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Between March 4 and April 20, 2020, we collected every 5 days respiratory and fecal specimens from fifteen COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We selected 15 positive novel coronavirus disease 19 (COVID-19) patients with mild or no symptom."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Diagnostic microbiology: Boosting confidence in COVID-19 detection  A design strategy for virus detection tests could lead to improved detection of SARS-CoV-2 coronavirus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Source: *Ref. 6, ‡Ref. 7",
            "Multiple sequence alignment of 21 full genomes obtained and 1563 full-genome sequences (Supplementary Table (available from )) available at the ",
            "Global Initiative on Sharing All Influenza Data (GISAID)",
            " database (as of March 26, 2020) was carried out in MAFFT v.7.4509."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 169,
                "end": 225,
                "name": "Global Initiative on Sharing All Influenza Data (GISAID)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This tree was used to reduce the dataset to 121 sequences, on the basis of country and the genetic variant identified based on the ",
            "GISAID",
            " classification."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 424,
                "end": 430,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Phylogenetic trees based on full-genome sequences deposited and available at ",
            "GISAID",
            " revealed the diversification and the clustering of sequences into groups, based on the genetic variants."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 524,
                "end": 530,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To date, there are no other sequences from Iran in the ",
            "GISAID",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 691,
                "end": 697,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since December 2019, the coronavirus disease (COVID-19) due to the severe acute respiratory syndrome (SARS) originating from Wuhan, China, has been causing a pandemic across the world [1,2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "",
            "MT451874",
            ", ",
            "MT451876",
            ", ",
            "MT451877",
            ", ",
            "MT451878",
            ", ",
            "MT451880",
            ", ",
            "MT451881",
            ", ",
            "MT451882",
            ", ",
            "MT451883",
            ", ",
            "MT451884",
            ", ",
            "MT451885",
            ", ",
            "MT451886",
            ", ",
            "MT451887",
            ", ",
            "MT451888",
            ", ",
            "MT451889",
            ", ",
            "MT451890",
            ", ",
            "MT435079",
            ", ",
            "MT435080",
            ", ",
            "MT435081",
            ", ",
            "MT435082",
            ", ",
            "MT435083",
            ", ",
            "MT435084",
            ", ",
            "MT435085",
            ", ",
            "MT435086",
            ", ",
            "MT415320",
            ", ",
            "MT415321",
            ", ",
            "MT415322",
            ", ",
            "MT415323",
            ", ",
            "MT358637",
            ", ",
            "MT012098",
            " and ",
            "MT050493",
            " of SARS-CoV2 from Indian patients are available in the ",
            "NCBI",
            " database and that are considered for this present study [25]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "AccessionNumber",
                "start": 191,
                "end": 199,
                "name": "MT451874"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 201,
                "end": 209,
                "name": "MT451876"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 211,
                "end": 219,
                "name": "MT451877"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 221,
                "end": 229,
                "name": "MT451878"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 231,
                "end": 239,
                "name": "MT451880"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 241,
                "end": 249,
                "name": "MT451881"
            },
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 251,
                "end": 259,
                "name": "MT451882"
            },
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 261,
                "end": 269,
                "name": "MT451883"
            },
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 271,
                "end": 279,
                "name": "MT451884"
            },
            false,
            {
                "id": "T10",
                "type": "AccessionNumber",
                "start": 281,
                "end": 289,
                "name": "MT451885"
            },
            false,
            {
                "id": "T11",
                "type": "AccessionNumber",
                "start": 291,
                "end": 299,
                "name": "MT451886"
            },
            false,
            {
                "id": "T12",
                "type": "AccessionNumber",
                "start": 301,
                "end": 309,
                "name": "MT451887"
            },
            false,
            {
                "id": "T13",
                "type": "AccessionNumber",
                "start": 311,
                "end": 319,
                "name": "MT451888"
            },
            false,
            {
                "id": "T14",
                "type": "AccessionNumber",
                "start": 321,
                "end": 329,
                "name": "MT451889"
            },
            false,
            {
                "id": "T15",
                "type": "AccessionNumber",
                "start": 331,
                "end": 339,
                "name": "MT451890"
            },
            false,
            {
                "id": "T16",
                "type": "AccessionNumber",
                "start": 341,
                "end": 349,
                "name": "MT435079"
            },
            false,
            {
                "id": "T17",
                "type": "AccessionNumber",
                "start": 351,
                "end": 359,
                "name": "MT435080"
            },
            false,
            {
                "id": "T18",
                "type": "AccessionNumber",
                "start": 361,
                "end": 369,
                "name": "MT435081"
            },
            false,
            {
                "id": "T19",
                "type": "AccessionNumber",
                "start": 371,
                "end": 379,
                "name": "MT435082"
            },
            false,
            {
                "id": "T20",
                "type": "AccessionNumber",
                "start": 381,
                "end": 389,
                "name": "MT435083"
            },
            false,
            {
                "id": "T21",
                "type": "AccessionNumber",
                "start": 391,
                "end": 399,
                "name": "MT435084"
            },
            false,
            {
                "id": "T22",
                "type": "AccessionNumber",
                "start": 401,
                "end": 409,
                "name": "MT435085"
            },
            false,
            {
                "id": "T23",
                "type": "AccessionNumber",
                "start": 411,
                "end": 419,
                "name": "MT435086"
            },
            false,
            {
                "id": "T24",
                "type": "AccessionNumber",
                "start": 421,
                "end": 429,
                "name": "MT415320"
            },
            false,
            {
                "id": "T25",
                "type": "AccessionNumber",
                "start": 431,
                "end": 439,
                "name": "MT415321"
            },
            false,
            {
                "id": "T26",
                "type": "AccessionNumber",
                "start": 441,
                "end": 449,
                "name": "MT415322"
            },
            false,
            {
                "id": "T27",
                "type": "AccessionNumber",
                "start": 451,
                "end": 459,
                "name": "MT415323"
            },
            false,
            {
                "id": "T28",
                "type": "AccessionNumber",
                "start": 461,
                "end": 469,
                "name": "MT358637"
            },
            false,
            {
                "id": "T29",
                "type": "AccessionNumber",
                "start": 471,
                "end": 479,
                "name": "MT012098"
            },
            false,
            {
                "id": "T30",
                "type": "AccessionNumber",
                "start": 484,
                "end": 492,
                "name": "MT050493"
            },
            false,
            {
                "id": "T31",
                "type": "Repository",
                "start": 548,
                "end": 552,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T31",
                "end": "T1"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T31",
                "end": "T2"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T31",
                "end": "T3"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T31",
                "end": "T4"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T31",
                "end": "T5"
            },
            {
                "id": "R6",
                "bool": true,
                "head": "T31",
                "end": "T6"
            },
            {
                "id": "R7",
                "bool": true,
                "head": "T31",
                "end": "T7"
            },
            {
                "id": "R8",
                "bool": true,
                "head": "T31",
                "end": "T8"
            },
            {
                "id": "R9",
                "bool": true,
                "head": "T31",
                "end": "T9"
            },
            {
                "id": "R10",
                "bool": true,
                "head": "T31",
                "end": "T10"
            },
            {
                "id": "R11",
                "bool": true,
                "head": "T31",
                "end": "T11"
            },
            {
                "id": "R12",
                "bool": true,
                "head": "T31",
                "end": "T12"
            },
            {
                "id": "R13",
                "bool": true,
                "head": "T31",
                "end": "T13"
            },
            {
                "id": "R14",
                "bool": true,
                "head": "T31",
                "end": "T14"
            },
            {
                "id": "R15",
                "bool": true,
                "head": "T31",
                "end": "T15"
            },
            {
                "id": "R16",
                "bool": true,
                "head": "T31",
                "end": "T16"
            },
            {
                "id": "R17",
                "bool": true,
                "head": "T31",
                "end": "T17"
            },
            {
                "id": "R18",
                "bool": true,
                "head": "T31",
                "end": "T18"
            },
            {
                "id": "R19",
                "bool": true,
                "head": "T31",
                "end": "T19"
            },
            {
                "id": "R20",
                "bool": true,
                "head": "T31",
                "end": "T20"
            },
            {
                "id": "R21",
                "bool": true,
                "head": "T31",
                "end": "T21"
            },
            {
                "id": "R22",
                "bool": true,
                "head": "T31",
                "end": "T22"
            },
            {
                "id": "R23",
                "bool": true,
                "head": "T31",
                "end": "T23"
            },
            {
                "id": "R24",
                "bool": true,
                "head": "T31",
                "end": "T24"
            },
            {
                "id": "R25",
                "bool": true,
                "head": "T31",
                "end": "T25"
            },
            {
                "id": "R26",
                "bool": true,
                "head": "T31",
                "end": "T26"
            },
            {
                "id": "R27",
                "bool": true,
                "head": "T31",
                "end": "T27"
            },
            {
                "id": "R28",
                "bool": true,
                "head": "T31",
                "end": "T28"
            },
            {
                "id": "R29",
                "bool": true,
                "head": "T31",
                "end": "T29"
            },
            {
                "id": "R30",
                "bool": true,
                "head": "T31",
                "end": "T30"
            }
        ]
    },
    {
        "sen": [
            "It is worth mentioning that the OF3a-Type-3 and ORF3a-Type-4 genes were blasted in the ",
            "NCBI",
            " database and do not find any 100% similar sequence with 100% query coverage."
        ],
        "lab": [
            false,
            {
                "id": "T32",
                "type": "Repository",
                "start": 702,
                "end": 706,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The numbers 1, 2, 3, denote the ORF3a gene/Genome ID from the top to bottom of the first column of Table 6, respectively."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A global emergency due to the COVID-19 pandemic demands various studies related to genes and genomes of the SARS-CoV2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We read with interest a recent article in this journal regarding co-infections in people with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Rapid and simultaneous detection of SARS-CoV-2, the cause of COVID-19, and co-infections is essential for clinical management of COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Detection of SARS-CoV-2 and co-infections in the obtained sequence data was carried out using a combination of publically availably pipelines namely IDseq (idseq.net) and DISCVR (https://bioinformatics.cvr.ac.uk/software/discvr/)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 was detected in sequence data obtained from all eight RT-PCR positive NTS samples by both IDseq and DISCVR, but not in the NTS sample."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Notably, the vast majority of SARS-CoV-2 infections are asymptomatic or mild, while COVID-19 patients present with signs/symptoms undistinguished with respiratory diseases caused by other viruses."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The rapid spread of the COVID-19 pandemic is a sparking challenge for the entire world, and climate change may also affect the emergence of this novel coronavirus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The recent emerging evidences suggested that the transmission of COVID-19 is associated with weather conditions, with dry and cold conditions appeared to boost the spreading of the infections."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, the per day mortality rate of COVID-19 is positively associated with diurnal temperature range (DTR) but negatively with relative humidity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, this study has targeted the genome-wide mutational spectra covering nucleotide, aa and deletion mutations in 2,492 complete (and/or near complete) genomes of SARS-CoV-2 retrieved from the ",
            "global initiative on sharing all influenza data (GISAID)",
            " (",
            "https://www.gisaid.org/",
            ") up to 30 March 2020 (Supplementary Fig. 1, Supplementary Table 1a)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 706,
                "end": 762,
                "name": "global initiative on sharing all influenza data (GISAID)"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 764,
                "end": 787,
                "name": "https://www.gisaid.org/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "Nucleotide (nt) sequence alignment revealed a total of 1,516 mutations (synonymous vs nonsynonymous ratio = 2.5:1) across the entire set of genomes of the SARS-CoV-2 strains compared to the ",
            "NCBI",
            " reference strain, Wuhan-Hu-1 (Accession ",
            "NC_045512",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 1047,
                "end": 1051,
                "name": "NCBI"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 1092,
                "end": 1101,
                "name": "NC_045512"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "To our knowledge and based on this dataset, the 24-nt deletion (G32:L39) is only found in Japanese strain."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Also, the high morbidity and mortality of immune-compromised patients infected by COVID-19 might be correlated with the disastrous consequences of these mutations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Further phylogenic study targeting those unique mutations may guide to proper global phylodynamics of the virus and modulate the regional control strategy against the COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Temperate European countries such as Italy, Spain, France, Netherlands and England are major COVID-19 infected countries with higher mortality rates at this initial stage."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Regardless of the importance of geography on the COVID-19 epidemiology, the effects of global mobility upon the genetic diversity and molecular evolution of SARS-CoV-2 are underappreciated and only beginning to be comprehended."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, the recent monograph on the spatial epidemiology of COVID-19 makes no reference to the genetic variation of SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To decipher the genetic variations, we retrieved two thousand four hundred and ninety-two (n = 2,492) complete or near-complete genomes of SARS-CoV-2 available at the ",
            "global initiative on sharing all influenza data (GISAID)",
            " (",
            "https://www.gisaid.org/",
            ") up to 30 March 2020."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 2258,
                "end": 2314,
                "name": "global initiative on sharing all influenza data (GISAID)"
            },
            false,
            {
                "id": "T6",
                "type": "URL",
                "start": 2316,
                "end": 2339,
                "name": "https://www.gisaid.org/"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "To estimate the case fatality (mortality) rates of SARS-CoV-2 infections, we collected information on total infected cases, and total reported deaths in these countries from the World Health Organization (WHO) COVID-19 Reports up to March 30, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We aligned the SARS-CoV-2 genome sequences using MAFFT online server using default parameters, and the complete genome sequence SARS-CoV-2 Wuhan-Hu-1 strain (Accession ",
            "NC_045512",
            ", Version ",
            "NC_045512.2",
            ") was used as a reference genome."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 2779,
                "end": 2788,
                "name": "NC_045512"
            },
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 2798,
                "end": 2809,
                "name": "NC_045512.2"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a novel evolutionary divergent RNA virus, is responsible for the present devastating COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To explore the genomic signatures, we comprehensively analyzed 2,492 complete and/or near-complete genome sequences of SARS-CoV-2 strains reported from across the globe to the ",
            "GISAID",
            " database up to 30 March 2020."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Dataset",
                "start": 3185,
                "end": 3191,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We used the complete genome sequence SARS-CoV-2 Wuhan-Hu-1 strain (Accession ",
            "NC_045512",
            ", Version ",
            "NC_045512.2",
            ") as a reference genome."
        ],
        "lab": [
            false,
            {
                "id": "T10",
                "type": "AccessionNumber",
                "start": 3299,
                "end": 3308,
                "name": "NC_045512"
            },
            false,
            {
                "id": "T11",
                "type": "AccessionNumber",
                "start": 3318,
                "end": 3329,
                "name": "NC_045512.2"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The annotated genomes (n = 2,492) have been retrieved from publicly open database, the ",
            "global initiative on sharing all influenza data (GISAID)",
            " (",
            "https://www.gisaid.org/",
            ") up to March 30, 2020."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "Dataset",
                "start": 3441,
                "end": 3497,
                "name": "global initiative on sharing all influenza data (GISAID)"
            },
            false,
            {
                "id": "T13",
                "type": "URL",
                "start": 3499,
                "end": 3522,
                "name": "https://www.gisaid.org/"
            },
            false
        ],
        "rel": [
            {
                "id": "R4",
                "bool": true,
                "head": "T12",
                "end": "T13"
            }
        ]
    },
    {
        "sen": [
            "Further information regarding the accession numbers of the studied genomes could be found in the Supplementary Data 1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In December 2019, a coronavirus disease (named as COVID-19 later) was reported in Wuhan city, which rapidly spread throughout China and then to many other countries in the world (Li et al., 2020a, Zhu et al., 2020b)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The World Health Organization (WHO) declared COVID-19 as a pandemic on March 11, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The HFH4-hACE2 mice were intranasally infected with 3 × 104 TCID50 virus each and sacrificed to collect tissue and blood samples at 1, 3, 5, and 7 days post-infection (DPI) (Figure 1",
            "A)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All the dying mice (dead or lost >20% body weigh) showed significantly decreased lymphocyte numbers, which is one of the key clinical hallmarks of COVID-19 patients (Wang et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The lung isolates indicated two mutations, C14554T (nsp13, L372F) and C23525T (spike, H644Y), compared with the genome of SARS-CoV-2-WIV04 (",
            "GISAID",
            ": ",
            "EPI_ISL_402124",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 817,
                "end": 823,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 825,
                "end": 839,
                "name": "EPI_ISL_402124"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "The viral titers in the infected lung ranged from 9.4 × 103 to 9.1 × 105TCID50 per gram of tissue, as determined by serial dilution of VeroE6 cell lines (Figure S5",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These mice generated antibodies against SARS-CoV-2 that could neutralize 100 TCID50 viruses at dilutions of 1:10 to 1:40 (Table S4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We then intranasally infected the three SARS-CoV-2 survivors and another three healthy mice with 7 × 105 TCID50 virus/each."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 patients commonly exhibit pneumonia with typical signs including fever, cough, dyspnea, and bilateral lung infiltration (Guan et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Some alveolar cells were dissolved and necrotic, and some terminal bronchioles were blocked, which simulated the pathological findings in COVID-19 patients (Xu et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "During routine blood examination, lymphopenia is a common feature in COVID-19 patients, and some patients had high-level aspartate amino transferase (AST) and creatine kinase (CK) (Chen et al., 2020, Guan et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There are few reports about organ tropism of virus infection in the patients of COVID-19, but multiple organ infections have been reported in SARS patients (Gu et al., 2005)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In summary, a human ACE2 mouse model that partially simulated the pathology of COVID-19, will be a valuable platform for testing vaccines and other potential therapeutics."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The successful establishment of an animal model for COVID-19 pathogenesis will be valuable for evaluating vaccines and therapeutics to combat SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Three days after inoculation, CPE was scored, and the Reed-Muench formula was used to calculate the TCID50."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Mice were anaesthetised with tribromoethanol (Avertin) (250 mg/kg) and intranasally infected with 3∗104 TCID50 (for naive infection) or 7∗105 TCID50 (for the viral challenge) SARS-CoV-2 in 50 μL DMEM per mouse."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 has spread worldwide since 2019 and is now a severe threat to public health."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The infected mice generated typical interstitial pneumonia and pathology that were similar to those of COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Graphical Abstract      A SARS-CoV-2 hACE2 transgenic mouse infection model recapitulates a number of infection symptoms and pathology in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Some studies listed platelet counting as economic, ubiquitous and ephemeral in discriminating the coronavirus disease (COVID) into severe/moderate as thrombocytopenia is linked to COVID-19 [6]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We have postulated virion propagation and causes of pneumonia in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This, in turn, led to inflammation and loss of platelets via deposition in peripheral microvascular beds, thereby heralding symptom-thrombocytopenia and intravascular coagulopathy in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severe acute respiratory coronavirus 2 (SARS-CoV-2), a single-stranded RNA virus that binds to the angiotensin-converting enzyme 2 receptor and causes the illness called coronavirus disease 2019 (COVID-19), has precipitated devastating personal, economic, and societal repercussions worldwide.1, 2, 3, 4 SARS-CoV-2 usually causes a mild, self-limited illness, but approximately 15% of affected individuals have a more severe, sometimes life-threatening course, with the risk of poor outcomes increasing with age and comorbidities."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "5, 6, 7 Diffuse alveolar damage and acute respiratory distress syndrome are the most common presentations in severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Profound dysregulation of innate and acquired immunity can occur with more severe COVID-19, including significant lymphopenia as a direct result of viral-induced apoptosis and necrosis of lymphocytes in the spleen and lymph nodes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The persistent interferon response can result in systemic hyperinflammation, also known as cytokine storm."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            " Several of the cytokines elevated in severe COVID-19 patients (tumor necrosis factor [TNF], interleukin 6, and interleukin 17) are also elevated in patients with psoriatic disease."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "15, 16, 17",
            "The current model of COVID-19 is that immune suppression in early infection may be harmful by allowing uncontrolled SARS-CoV-2 replication and dissemination but may be helpful in severe illness by limiting organ damage from a dysregulated hyperimmune response."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Many treatments used for psoriatic disease directly or indirectly impact immune pathways involved in COVID-19.19, 20, 21, 22 Patients and providers are concerned about the safety of immunomodulating agents in the setting of the COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These concerns are particularly relevant given that many of the comorbidities associated with psoriasis and psoriatic arthritis, including obesity, diabetes, and cardiovascular disease, are risk factors for the development of severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "To address the questions posed by patients and providers, the National Psoriasis Foundation (NPF) commissioned a COVID-19 task force (TF) to develop scientifically based guidance that promotes optimal management of psoriatic disease during the pandemic."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patients with psoriatic disease appear to have similar rates of infection with SARS-CoV-2 and COVID-19 outcomes33, 34, 35, 36, 37 as the general population (Guidance 1.1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "First, a few reports suggest that patients with psoriasis may be more prone to infection with COVID-19 or have worse outcomes.38, 39, 40 For example, a United Kingdom study with more than 17 million patients found a small but statistically increased risk of death from COVID-19 (fully adjusted hazards ratio, 1.19; 95% confidence interval, 1.11-1.27) in individuals with psoriasis, rheumatoid arthritis, or lupus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additionally, patients with psoriatic disease may be prone to thrombotic complications that can also occur in COVID-19.41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55 There was unanimous agreement that severity of COVID-19 is driven by risk factors such as older age and comorbidities (Guidance 1.2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            ",",
            "56, 57, 58, 59 Psoriatic disease—particularly severe psoriasis—is associated with many of the comorbidities that drive COVID-19 mortality."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            ",",
            "The existing literature suggests that treatments for psoriasis or psoriatic arthritis, or both, do not meaningfully alter the risk of acquiring SARS-CoV-2 infection or having worse COVID-19 outcomes (Guidance 2.1)."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            ",",
            "61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85 Cyclosporine, the most broadly immunosuppressive of psoriasis treatments, was not found to alter the risk of COVID-19 in 130 patients in Italy with psoriasis or atopic dermatitis (2 became infected with SARS-CoV-2 and recovered without hospitalization)."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "One study suggested that patients with psoriasis on biologics were more likely to be hospitalized for COVID-19 but did not adjust for risk factors known to drive poor COVID-19 outcomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The rheumatology literature also suggests that treatments used for psoriatic disease, such as TNF inhibitors and methotrexate, do not negatively impact COVID-19,87, 88, 89, 90 with 1 large registry (600 case reports from 40 countries) finding that TNF inhibitors are associated with a reduced adjusted odds of COVID-19 hospitalization compared with patients with rheumatic conditions not treated with TNF inhibitors."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similarly, adverse effects of TNF inhibitors on COVID-19 were not observed in large registries of patients with inflammatory bowel disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            " Small case series have reported poor COVID-19 outcomes in patients on Janus kinase inhibitors for psoriatic arthritis and secukinumab for ankylosing spondylitis; however, these isolated reports could be due to selection bias, chance, or underlying comorbidity."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By contrast, an analysis of approximately 1400 patients from the rheumatology, gastroenterology, and dermatology literature concluded that biologic or targeted synthetic disease-modifying antirheumatic drug therapy has not been associated with more severe COVID-19 outcomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By contrast, studies in the rheumatology and gastroenterology literature have observed that long-term use of oral corticosteroids is associated with worse COVID-19 outcomes (ie, hospitalization or a composite outcome of any or all of intensive care unit admission, ventilator use, or death)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "Psoriasis, even when involving the face or hands, is not a contraindication to face coverings and hand washing, respectively, and a variety of approaches can be applied to mitigate skin irritation (E-Table VII, available via ",
            "Mendeley Data",
            ", V2, at https://doi.org/10.17632/w5m8jf94m8).106, 107, 108 Patients with psoriatic disease should receive the seasonal inactivated (eg, killed) influenza vaccine, which is of special importance to individual and public health during the COVID-19 pandemic (Guidance 4.4)."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 5615,
                "end": 5628,
                "name": "Mendeley Data"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patients with psoriatic disease who become infected with SARS-CoV-2 should monitor their symptoms (Supplemental E-Table VIII), discuss management of their psoriatic disease treatments with their health care providers, and should be prescribed and adhere to evidence-based COVID-19 treatments, if available (Guidance 5.1 and 5.2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "110, 111, 112",
            "The mortality benefit of initiation of corticosteroids in patients with severe COVID-19 outweighs the risks of potentially precipitating a psoriasis flare, and therefore, acute systemic corticosteroids are not contraindicated for the management of COVID-19 in patients with psoriatic disease (Guidance 5.3)."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Consistent with guidance from the Food and Drug Administration and the American College of Physicians, the use of hydroxychloroquine or chloroquine is not recommended to prevent or treat COVID-19 in patients with psoriatic disease outside of a clinical trial (guidance 5.4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126 Patients with psoriatic disease should be aware that infection with SARS-CoV-2 may result in a flare of psoriasis, which may occur due to discontinuation of psoriasis treatments, treatment of COVID-19 with antimalarial drugs, or due to triggering of inflammation as part of COVID-19 illness (Guidance 5.6)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "127, 128, 129",
            "Patients with psoriatic disease who become infected with SARS-CoV-2 should follow CDC guidance130, 131, 132, 133 on home isolation and discuss with their health care providers when they can end home quarantine (Guidance 5.7; Supplemental E-Table IX)."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "The persistence of 1 or more symptoms of COVID-19, such as fatigue or joint pain, beyond the acute phase of the illness can occur and may complicate the decision to restart psoriasis or psoriatic arthritis medications."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For example, studies evaluating the safety of treatments for psoriasis and psoriatic arthritis in the setting of COVID-19 involve small case series or large collections of case reports and thus should be considered preliminary."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Large-scale, longer-term, population-based studies with appropriate comparator groups, adjustment for relevant confounding variables, and complete ascertainment of clinically important COVID-19 outcomes are urgently needed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To provide guidance about management of psoriatic disease during the coronavirus disease 2019 (COVID-19) pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These statements provide guidance for the management of patients with psoriatic disease on topics ranging from how the disease and its treatments impact COVID-19 risk and outcome, how medical care can be optimized during the pandemic, what patients should do to lower their risk of getting infected with severe acute respiratory syndrome coronavirus 2 and what they should do if they develop COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nevertheless, 17 years later, SARS‐CoV‐2 brought a much more severe and widespread pandemic of coronavirus disease 2019 (COVID‐19) to the world (Wu et al., 2020; Zhu et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Up to 17 June 2020, about 6 months after the first reported case of COVID‐19, SARS‐CoV‐2 has caused 8,179,520 confirmed infections and 441,491 deaths worldwide, far surpassing the SARS pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The high transmissibility of SARS‐CoV‐2 is probably a major reason for the rapid development of COVID‐19 epidemic and more studies on the transmission of pathogenic HCoV is urgently required."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Full‐length SARS‐CoV‐2 spike (",
            "GenBank",
            " accession number ",
            "MN908947.3",
            "), SARS‐CoV BJ01 spike (",
            "GenBank",
            " accession number ",
            "AY278488.2",
            ") and pangolin‐CoV GD1 spike (",
            "GISAID",
            " accession number: ",
            "EPI_ISL_410721",
            ") were all synthesized by Sangon and subcloned into the pcDNA3.1 vectors with a C‐terminal HA tag."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 598,
                "end": 605,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 623,
                "end": 633,
                "name": "MN908947.3"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 657,
                "end": 664,
                "name": "GenBank"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 682,
                "end": 692,
                "name": "AY278488.2"
            },
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 722,
                "end": 728,
                "name": "GISAID"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 747,
                "end": 761,
                "name": "EPI_ISL_410721"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "Typically, severe acute respiratory syndrome CoV (SARS‐CoV) caused SARS pandemic in 2003 and SARS‐CoV‐2 caused the ongoing COVID‐19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of Apr. 22, 2020, the World Health Organization (2020) has reported over 2.4 million confirmed coronavirus disease 2019 (COVID-19) patients and 169 151 deaths."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recent articles have uncovered genomic characteristics and clinical features of COVID-19 (Chan et al., 2020; Chang et al., 2020; Guan et al., 2020; Zhu et al., 2020), while our understanding of COVID-19 is still limited."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As suggested by guidelines promoted by the General Office of National Health Commission of the People’s Republic of China (2020) (from Versions 1 to 6), discharged standards for COVID-19 were still dependent on viral real-time polymerase chain reaction (RT-PCR) tests of respiratory specimens, showing that recovered COVID-19 patients with twice negative RT-PCR could meet discharge criteria."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patient 1, a 40-year-old female, presented with fever and a mild dry cough on Jan. 17, 2020 (Day −4) after contact with a colleague from Wuhan, China, 4 d previously, who was confirmed to have COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "She was diagnosed with COVID-19 in our center on Jan. 21 (Day 1) with a positive RT-PCR test in sputum and bilateral infiltration lesions on chest CT images (Fig. 1a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patient 2, a 50-year-old male, had fever for 8 d and was confirmed to have COVID-19 on Jan. 23, 2020 (Day 1) in our center."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our study describes two cases with subsequently positive nucleic acid results in patients of COVID-19 who met discharge criteria and this raises concern about the transmission risk associated with discharged COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of Apr. 22, 2020, the World Health Organization ( 2020 ) has reported over 2.4 million confirmed coronavirus disease 2019 (COVID-19) patients and 169 151 deaths."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recent articles have uncovered genomic characteristics and clinical features of COVID-19 (Chan et al., 2020 ; Chang et al., 2020 ; Guan et al., 2020 ; Zhu et al., 2020 ), while our understanding of COVID-19 is still limited."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As suggested by guidelines promoted by the General Office of National Health Commission of the People’s Republic of China ( 2020 ) (from Versions 1 to 6), discharged standards for COVID-19 were still dependent on viral real-time polymerase chain reaction (RT-PCR) tests of respiratory specimens, showing that recovered COVID-19 patients with twice negative RT-PCR could meet discharge criteria."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The novel coronavirus disease 2019 (COVID-19), a viral outbreak caused by the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), first arose in Wuhan, China, in December 2019, and it was declared a Public Health Emergency of International Concern on January 30, 2020 (WHO, 2020b)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Seven months into the COVID-19 pandemic, the number of cumulative cases continues to steadily increase."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 has placed an unparalleled burden on the health systems and economies of all affected countries, with a projected serious impact on African countries that are already saddled with weak health care provision and economic systems."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Mass testing is being advocated, and this requires molecular techniques, the current gold standard for COVID-19 detection, as recommended by the World Health Organisation (WHO) (WHO/Africa, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The use of high-throughput next-generation sequencing tools can provide additional data to refine strategies to fight against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While SARS-CoV-2 sequence data are an integral part of the information used for making decisions on other continents (Lu et al., 2020, Zhu et al., 2020), Africa has yet to integrate this information into our decision making for managing COVID-19 outbreaks within the continent."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To the present, only 900 SARS-CoV-2 genome sequences from 14 African countries have been uploaded out of a total of 62,267 whole-genome sequences in ",
            "GISAID",
            " (",
            "GISAID",
            ", 2020), an online database for the rapid sharing of viral genomes and clinical and epidemiological data."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 1394,
                "end": 1400,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 1402,
                "end": 1408,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Africa has recorded approximately 642,387 cases and close to 10,789 deaths from COVID-19 (WHO, 2020a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The above narrative could be different if each country appreciated the need for genetic data and deliberately empowered at least one molecular laboratory involved in COVID-19 detection and diagnostics with sequencing technologies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recently, the African Union Commission/ACDC formally launched the Partnership to Accelerate COVID-19 Testing (PACT) on June 4, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The goals of PACT are to improve testing for COVID-19, enhance the training of health workers across the continent, establish a central procurement system at ACDC and deploy one million community health workers to perform contact tracing of confirmed cases at the community level (ACDC, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To respond to epidemics such as COVID-19, genomic data generation for real-time decision making could be enhanced by the adoption and decentralised application of small, portable and easily operated experimental tools such as the Oxford Nanopore technology-MinION sequencer, Illumina MiniSeq or the BGI-DNBSeq across all countries."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The health impacts of COVID-19 are much more devastating in resource-poor settings such as Africa."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "•  SARS-CoV-2 genome samples from Africa are underrepresented in the ",
            "GISAID",
            " data repository."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 2775,
                "end": 2781,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Genomic technologies are vital for enhancing the understanding and development of intervention approaches against these pathogens, including Ebola and the novel coronavirus disease 2019 (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Soon after the COVID-19 outbreak, China initiated several in vitro studies and clinical trials to discover effective antiviral drugs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our results are promising and may be considered for both in vitro and in vivo clinical trials for inhibition of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on similarity in amino acid residues of both RdRps, a reference template of SARS-CoV RdRp (",
            "PDB",
            " ID: ",
            "6NUR",
            "; kindly provided by the Ward lab) was used for further analysis [52]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 353,
                "end": 356,
                "name": "PDB"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 361,
                "end": 365,
                "name": "6NUR"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "The binding pocket of the RdRp—GLY616, TRP617, ASP618, TYR619, LEU758, SER759, ASP760, ASP761, ALA762, LYS798, TYS799, TRP800, GLU811, PHE812, CIS813, and/or SER814—was found using the MOE SiteFinder algorithm, and most optimal docked compounds were selected based on higher S-score and lower RMSD with a reference inhibitor (",
            "PubChem",
            " CID: ",
            "10445549",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 762,
                "end": 769,
                "name": "PubChem"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 775,
                "end": 783,
                "name": "10445549"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "",
            "CID123624208",
            " and ",
            "CID11687749",
            "—were selected from the docking analysis."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 786,
                "end": 798,
                "name": "CID123624208"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 803,
                "end": 814,
                "name": "CID11687749"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, we identified interspecies divergence among all the 94 validated viral genomic sequences belonging to the family Coronavirinae retrieved from the ",
            "NCBI",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 1017,
                "end": 1021,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The accessions, origin and taxonomic classification of all sequences are given in Additional file 1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Most of the accessions in clade I belong to the Betacoronaviruses, indicating they all are closely related to each other, while only one and two accessions belong to alpha-CoV and gamma-CoV, respectively, thereby representing some distance with respect to the Betacoronavirus members."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For accessions, origin and other relevant data, see Additional file 1",
            "The SARS-CoV-2 RdRp protein sequence was queried using pBLAST and 94 validated sequences were downloaded from the ",
            "NCBI",
            " database for evaluating its phylogenetic relationship with other viral RdRp proteins."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 1602,
                "end": 1606,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Most of the viral RdRps in clade I belong to beta-CoV; the same is true for clades II and III with most accessions belonging to beta-CoV, while a few remain unclassified and require more research for proper designation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Accession ",
            "QHR63299.1",
            " was also unclassified but shows close association with other SARS RdRp relatives (Fig. 5)."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 1923,
                "end": 1933,
                "name": "QHR63299.1"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 accession (red circle) is closely associated with other SARS RdRp proteins (blue circle)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For accessions, origin and other relevant data, see Additional file 1: Data 2",
            "Compounds with > 95% structural similarity to Galidesivir were selected for ligand-based virtual screening from the ",
            "PubChem",
            " database."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 2320,
                "end": 2327,
                "name": "PubChem"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 1061 compounds were retrieved and Pfizer’s rule of five was applied to all the compounds, out of which 677 were aligned after minimizing energy in a new database for docking with the protein of interest RdRp."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "",
            "CID123624208",
            " and ",
            "CID11687749",
            " interactions with RdRP are presented in Figs. 6 and 7."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "AccessionNumber",
                "start": 2558,
                "end": 2570,
                "name": "CID123624208"
            },
            false,
            {
                "id": "T12",
                "type": "AccessionNumber",
                "start": 2575,
                "end": 2586,
                "name": "CID11687749"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "ADMET profiling for drug-like compounds demonstrated positive results for blood–brain barrier (BBB), human intestinal absorption (HIA), renal organic cation transporter (ROCT) for ",
            "CID11687749",
            " and ",
            "CID123624208",
            " (Table 3), whereas CaCO2 permeability results were found to be negative for both the compounds."
        ],
        "lab": [
            false,
            {
                "id": "T13",
                "type": "AccessionNumber",
                "start": 2822,
                "end": 2833,
                "name": "CID11687749"
            },
            false,
            {
                "id": "T14",
                "type": "AccessionNumber",
                "start": 2838,
                "end": 2850,
                "name": "CID123624208"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "",
            "CID123624208",
            " and ",
            "CID11687749",
            " were the best suggested drug-like compounds analyzed through in silico analysis and may act as strong inhibitors against SARS-CoV-2."
        ],
        "lab": [
            false,
            {
                "id": "T15",
                "type": "AccessionNumber",
                "start": 2947,
                "end": 2959,
                "name": "CID123624208"
            },
            false,
            {
                "id": "T16",
                "type": "AccessionNumber",
                "start": 2964,
                "end": 2975,
                "name": "CID11687749"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our study indicates that the novel predicted drug-like compounds ",
            "CID123624208",
            " and ",
            "CID11687749",
            " have a strong affinity with the residues of the RdRp catalytic domain (Figs. 6, 7)."
        ],
        "lab": [
            false,
            {
                "id": "T17",
                "type": "AccessionNumber",
                "start": 3174,
                "end": 3186,
                "name": "CID123624208"
            },
            false,
            {
                "id": "T18",
                "type": "AccessionNumber",
                "start": 3191,
                "end": 3202,
                "name": "CID11687749"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, in summary, Galidesivir and the two drugs-like compounds ",
            "CID123624208",
            " and ",
            "CID11687749",
            " screened in the present study could more likely have potential as therapeutic drugs targeting SARS-CoV-2."
        ],
        "lab": [
            false,
            {
                "id": "T19",
                "type": "AccessionNumber",
                "start": 3350,
                "end": 3362,
                "name": "CID123624208"
            },
            false,
            {
                "id": "T20",
                "type": "AccessionNumber",
                "start": 3367,
                "end": 3378,
                "name": "CID11687749"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The anti-polymerase drugs predicted here—",
            "CID123624208",
            " and ",
            "CID11687749",
            "—may be considered for in vitro and in vivo clinical trials."
        ],
        "lab": [
            false,
            {
                "id": "T21",
                "type": "AccessionNumber",
                "start": 3526,
                "end": 3538,
                "name": "CID123624208"
            },
            false,
            {
                "id": "T22",
                "type": "AccessionNumber",
                "start": 3543,
                "end": 3554,
                "name": "CID11687749"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronaviruses have gained much attention as the causative agents for the outbreaks of human respiratory syndromes such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS) and most recently coronavirus disease-2019 (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, COVID-19 has shown rapid global spread resulting in many infected individuals as cases increase above 1,200,000 and counting (7 April 2020) [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Analysis of the SARS-CoV2 (COVID-19) sequence indicated that it shows 77.2% amino acid identity with SARS-CoV (SARS) with the non-structural proteins (nsp's) 7–10 showing between 97.1% to 98.8% identity [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus are the causative agents in many globally concerning respiratory disease outbreaks such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS) and coronavirus disease-2019 (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The rapid international spread of novel coronavirus disease 2019 (COVID-19) (1) has resulted in 5,103,006 confirmed cases and 333,401deaths worldwide as of May 23, 2020 (2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 is caused by SARS-coronavirus 2 (SARS-CoV-2) infection in the lower respiratory tract (3), but the mechanisms underlying infection remain poorly understood (4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As information is still emerging about the health consequences of COVID-19, assisted reproductive treatments (ARTs) have been delayed due to fear of the unknown impact of SARS-Cov-2 on fertility (10, 11)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The clinical presentation of COVID-19 ranges from mild respiratory symptoms to severe progressive pneumonia, gastrointestinal symptoms, fecal shedding, multiorgan failure, and even death (32, 33), but few studies have focused on the virus’s effect on fertility and damage to reproductive tissues, or on concerns regarding the use of reproductive treatments."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Numerous transcriptomic studies have sought to understand gene expression changes throughout the menstrual cycle (40), and most of these data sets are available in public repositories, such as the ",
            "Gene Expression Omnibus (GEO)",
            " database (41)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1104,
                "end": 1133,
                "name": "Gene Expression Omnibus (GEO)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The keywords searched in PubMed (44) included all possible combinations between “SARS-CoV-2,” “COVID-19,” “coronavirus,” “cell entry mechanisms,” “long-term implications,” and “fertility.”",
            "Public transcriptomic data sets were used to analyze expression of SARS-CoV-2 infectivity-related genes throughout the menstrual cycle."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Endometrial transcriptomic experiments for control patients (without any known endometrial pathology) were systematically searched in the ",
            "GEO",
            " database (41) with no restrictions on publication date or language and according to preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines (45)."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 1612,
                "end": 1615,
                "name": "GEO"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Experiments were selected if",
            "Transcriptomic raw data were downloaded from the ",
            "GEO",
            " database and processed according to the standards of the technology used (microarrays or RNA-seq) using limma R-package (version 3.34.9) (46)."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 1871,
                "end": 1874,
                "name": "GEO"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To integrate the included endometrial transcriptomic experiments, several steps were followed as recommended by Tajti et al. (49): after being independently normalized, selected studies were joined in a unique data set, and batch effects were corrected using linear models (limma R package) (43)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The thresholds respectively correspond to 1% to 10%, 11% to 50%, and 51% to 100% categories of gene expression values of the entire integrated data set."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A unique combined data set with a population of 109 patients was obtained, comprising 29 samples in the proliferative phase, 29 in the early secretory phase, 43 in the medium secretory phase, and eight in the late secretory phase (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Last row indicates the total number of samples accounted and genes in common between all data sets for all menstrual cycle phases (53, 54, 55)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To make data sets comparable after the integration of all samples, this batch effect was removed (Fig. 1A, right)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Low, medium, and high expression thresholds correspond to 1% to 10%, 11% to 50%, and 51% to 100% categories of gene expression values of the entire integrated data set, respectively."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Viral genes are positioned in their schematized cell locations as stablished by GeneCards database > Localization section (release 4.14) (56)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Because our study integrates data sets from ",
            "GEO",
            ", this approach is limited by the study design."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 3338,
                "end": 3341,
                "name": "GEO"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To determine the susceptibility of the endometrium to infection by—and thereby potential damage from—SARS-CoV-2.    Design  Analysis of SARS-Cov-2 infection-related gene expression from endometrial transcriptomic data sets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Viral genome sequences from pangolins were retrieved from the ",
            "GISAID",
            " (",
            "https://www.gisaid.org",
            ") database, whereas all other genome sequences were downloaded from the ",
            "NCBI (National Center for Biotechnology Information)",
            " database (",
            "http://www.ncbi.nlm.nih.gov/",
            ")",
            "Thus, the final genome dataset included SARS-CoV-2 (reference genome, Wuhan-Hu-1), three bat viruses (BatCoV RaTG13, bat-SL-CoVZC45 and bat-SL-CoVZXC21), and the two pangolin viruses (Fig. 1a)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 62,
                "end": 68,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 70,
                "end": 92,
                "name": "https://www.gisaid.org"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 164,
                "end": 216,
                "name": "NCBI (National Center for Biotechnology Information)"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 227,
                "end": 255,
                "name": "http://www.ncbi.nlm.nih.gov/"
            },
            false,
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "The 9b protein encoded by SARS-CoV is incorporated into mature virions (Xu et al., 2009) but is dispensable for viral replication in vitro and in vivo (",
            "von Brunn et al., 2007",
            ";",
            "DeDiego et al., 2008",
            ")."
        ],
        "lab": [
            false,
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Presently, more than 350 sequences of virus isolated from several countries are shared in ",
            "GISAID",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 90,
                "end": 96,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All the 351 sequences available of COVID-19 isolated from humans have been downloaded from ",
            "GISAID",
            " (",
            "https://www.gisaid.org/",
            ") databank."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 198,
                "end": 204,
                "name": "GISAID"
            },
            false,
            {
                "id": "T3",
                "type": "URL",
                "start": 206,
                "end": 229,
                "name": "https://www.gisaid.org/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "A dataset has been built including sequences from human and excluding sequences from animals (like bat or pangolin)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The complete dataset was assessed for presence of phylogenetic signal by applying the likelihood mapping analysis implemented in the IQ-TREE 1.6.8 software (http://www.iqtree.org)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A comparison of data from evolutionary and phylogenetic analysis leads us to hypothesize that the mutations are probably unrelated to a strain or a sub-family of the COVID-19 but are due to independent converging evolution of the virus that promote these changes in the viral genome."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of 12 July 2020, coronavirus disease 2019 (COVID-19) has caused over 12.5 million cases and 561 thousand deaths globally ()."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, despite the thousands of virus genomes deposited on public access databases, there is a lack of consistent sampling structure, and limited data from Brazil (–), which hampers accurate reconstructions of virus movement and transmission using phylogenetic analyses."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We then focused our sequencing efforts on generating a large and spatially representative genomic dataset with curated metadata in order to maximise the association between the number of sequences and the number of SARS-CoV-2 confirmed cases per state."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "When we include 63 additional available sequences from Brazil deposited in ",
            "GISAID",
            " (29) (see data S1 and S2), we find the data set is representative of the spatial heterogeneity of the Brazilian epidemic."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 729,
                "end": 735,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We estimated maximum likelihood and molecular clock phylogenies for a global dataset with a total of 1,182 genomes sampled from 24 Dec 2019 to 30 Apr 2020 (root-to-tip genetic distance correlation with sampling dates, r2 = 0.53; Fig. 3A and fig. S7)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We provide a comprehensive analysis of SARS-CoV-2 spread in Brazil that shows the importance of community and nation-wide measures to control the COVID-19 epidemic Brazil."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Sequencing of 427 new genomes and analysis of a geographically representative genomic dataset identified >100 international virus introductions in Brazil."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our analysis provides clues for pathogenesis and targeted therapy of coronavirus disease 2019 (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The outbreak of corona virus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is spreading globally and quickly, leading to emerging health issues."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our discovery provides clues for pathogenesis and targeted drug therapy towards ACE2 expression for prevention and adjuvant therapy of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, as the antiretroviral activities of these and other A3 proteins require viral particle incorporation in virus-producing cells (37), A3-related effects could be excluded in the postentry restriction as all of our viral stocks were produced in 293T cells."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, a putative P. alecto TRIM5 orthologue with 78% coverage and 57% identity to human TRIM5α (",
            "GenBank",
            " accession no. ",
            "ELK09387.1",
            ") was previously annotated during a high-throughput analysis of multiple bat genomes (17)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 362,
                "end": 369,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 384,
                "end": 394,
                "name": "ELK09387.1"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "The 5′RACE-derived TRIM5 transcript (",
            "Genbank",
            " accession no. ",
            "MT649092",
            ") was aligned with the putative TRIM5 orthologue ",
            "ELK09387.1",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 522,
                "end": 529,
                "name": "Genbank"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 544,
                "end": 552,
                "name": "MT649092"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 601,
                "end": 611,
                "name": "ELK09387.1"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "Having identified and cloned the full-length P. alecto TRIM5 cDNA, we used a lentiviral vector to stably express the predicted protein with an N-terminally incorporated hemagglutinin (HA) epitope tag in CrFK cells (Fig. 4A)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A cDNA with 99.6% amino acid identity to the longest predicted P. alecto MX2 isoform (",
            "NCBI",
            " accession no."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 924,
                "end": 928,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There were a total of 401 positions in the final data set."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 pandemic suggests that bat innate immune systems are insufficiently characterized relative to the medical importance of these animals."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 pandemic has resulted in nearly 7 million confirmed infections and >400 000 deaths as of June 7, 2020, with 3 billion people under lockdown worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Early in the history of ",
            "GenBank",
            ", Michael Waterman presciently wrote that “Entering new sequences into the databases requires the database staff to analyze and interpret the sequences and the associated scientific literature [4].”",
            "Even earlier, Margaret Dayhoff had justified her enormous efforts at sequence database curation reasoning that “a carefully verified collection [of sequences] was more economical in the long run than a quick and dirty collection” [5]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 24,
                "end": 31,
                "name": "GenBank"
            },
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "VAPiD [7] is designed to simplify the submission of complete viral genome sequences to ",
            "GenBank",
            " by adding metadata, and annotating each input sequence based on comparison with its best-matching reference sequence in a large reference dataset derived from ",
            "GenBank",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 552,
                "end": 559,
                "name": "GenBank"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 719,
                "end": 726,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "VIGOR [8, 9] annotates input sequences by first identifying the most relevant reference database in its collection and then comparing all reference protein and mature peptide sequences in that database to the input sequence to determine its annotation and to identify certain types of errors."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additional programs for viral annotation include VGAS [10], which incorporates ab initio ORF prediction as well as similarity-based annotation, and VIGA [11] which can be optimized for speed for huge metagenomics datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "VADR compares each input sequence to a library of homology models of viral species built from reference sequences from the ",
            "RefSeq",
            " database [12], identifies the most similar model, and uses that model to compute an alignment to the ",
            "RefSeq",
            " from which feature annotation boundaries (e.g. coding sequences (denoted CDS), mature peptides, ncRNAs) are derived."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 1367,
                "end": 1373,
                "name": "RefSeq"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 1475,
                "end": 1481,
                "name": "RefSeq"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additionally, v-build.pl uses the makeblastdb program from BLAST v2.9.0+ [15] to create a BLAST database from amino acid translations of the ",
            "RefSeq",
            " CDS features."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 1740,
                "end": 1746,
                "name": "RefSeq"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "v-annotate.pl uses this database with blastx to validate its nucleotide-based predictions of CDS features."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We ran the VADR v1.0 v-annotate.pl script with default parameters on the four sequence datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Table 5 lists each type of fatal VADR alert observed in one of the four datasets with counts of instances reported and sequences for which one or more instances was reported."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The next most common alert, noannotn, occurs for 2753 sequences, 2236 of which are in the DP dataset, indicating that no similar ",
            "RefSeq",
            " was found for these sequences during the classification stage."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 2269,
                "end": 2275,
                "name": "RefSeq"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The 34 fatal alert codes reported at least once for any test dataset are listed sorted by total number of reports."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "4 fatal alert types (unexdivg, lowsimis, incsbgrp and indfstrp) were not reported for any of the four test sets and are not shown."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, here, we report VAPiD tests only on the NC and DC (complete) datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The version of VIGOR we tested (VIGOR3) lacks a Dengue virus database, so we tested VIGOR only on the Norovirus NC and NP."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Table 6 shows the number of sequences that pass and fail with each of the three methods for the datasets on which they were tested."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Table 7 further compares the results of VADR and VAPiD on the NC and DC datasets, and Table 8 further compares the results of VADR and VIGOR on the NC and NP datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To determine whether this is the case or not in our test sets, we examine the set of sequences that fail each method in turn below."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In our tests of the NC and DC datasets, VAPiD failed 43 total sequences; 12 of these were also failed by VADR and 31 were passed by VADR and VIGOR (Table 7)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In our tests of the NC and NP datasets, VIGOR failed seven total sequences, all seven of which also fail VADR (Table 8)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In our tests of the NC, NP, and DC datasets, VADR failed 53 sequences; 18 of these were also failed by VAPiD and/or VIGOR as mentioned above (exactly one sequence, ",
            "FV536857.1",
            ", in the NC dataset failed all three methods), and 35 passed VAPiD and/or VIGOR (Table 8)."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 3665,
                "end": 3675,
                "name": "FV536857.1"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the set of 4171 sequences that passed VADR in the full DC dataset of 4580 sequences, VADR annotated between 4 and 9 stem_loop features and exactly 1 ncRNA feature in each sequence for a total of 35,676 stem_loop features and 4171 ncRNA features."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the set of 17,276 sequences that passed VADR in the full 20,973 sequence DP dataset, VADR annotated between 1 and 6 stem_loop features in 2335 sequences, and exactly one ncRNA feature in 623 of those 2327 sequences for a total of 5157 stem_loop features and 623 ncRNA features."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The failures of some sequences from the test datasets that pass VAPiD and/or VIGOR can be attributed to this, as discussed in the Results section."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All data generated or analyzed during this study are included in this published article, its supplementary material, or ",
            "NCBI’s",
            " ",
            "GenBank",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 4563,
                "end": 4569,
                "name": "NCBI’s"
            },
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 4570,
                "end": 4577,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The sequence dataset was aligned using MAFTT v.7.450 software",
            " and manually edited by Bioedit program v. 7.0.5."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As was suspected, most of the identified mutations were located in the S (spike) gene, which encompasses positions between 21 563 and 25 384 base pair (",
            "GenBank",
            " accession number: ",
            "MN908947",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 264,
                "end": 271,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 290,
                "end": 298,
                "name": "MN908947"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "The enrichment probe set contains 502 single‐stranded DNA biotin‐labeled probes at 2× tiling designed based on all available SARS‐CoV‐2 viral sequences, downloaded from the ",
            "Global Initiative on Sharing All Influenza Data (GISAID",
            "; ",
            "https://www.gisaid.org/",
            ") on 1 February 2020, and it can be used to enrich for SARS‐CoV‐2 sequences without prior knowledge of type or subtype."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 173,
                "end": 228,
                "name": "Global Initiative on Sharing All Influenza Data (GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 230,
                "end": 253,
                "name": "https://www.gisaid.org/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "Five clades could be identified and labeled, corresponding to the full genome tree delivered by ",
            "GISAID",
            " (see Figure S1)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 469,
                "end": 475,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Following the CDC health and safety guidelines, marked enrichment was demonstrated in a virus strain sample from cell culture, three nasopharyngeal swab samples (cycle threshold [ C  t ] values: 32.36, 36.72, and 38.44) from patients diagnosed with COVID‐19 (positive control) and four throat swab samples from patients without COVID‐19 (negative controls), respectively."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To the Editor—The 2019 novel coronavirus disease (2019-nCoV or COVID-19) recently reported from Wuhan (China), which has cases in Thailand, Japan, South Korea, and the United States, has been confirmed as a new coronavirus [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 is caused by an RNA virus that produces Severe Acute Respiratory Syndrome (SARS)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "After this stage the 1st step of protection may take place by the use of shRNAs that may be incorporated within the host cell far before the infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "After the uptake of this nanoconjugate the shRNA-plasmid is incorporated within the genome of the cell and start transcribing the pre-shRNA."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Currently, there is no such vaccine for COVID-19 although some are in clinical trials."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 is the pandemic outbreak that is caused by SARS-CoV-2 virus from December, 2019."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this article we are intended to propose a hypothesis on the development of a vaccine that is molecular in nature to work against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The World Health Organization declare this outbreak as a public health emergency of international concern on 30th January 2020",
            " and the disease caused by this specific virus species have recently been designated as coronavirus disease 2019 (COVID‐19)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Available complete genome sequences of 64 SARS‐CoV‐2 strains recently isolated from 30th December 2019 to 9th March 2020 in Europe (including Netherland, Luxembourg, Switzerland, Ireland, France, Italy, Germany, Portugal, and England), North America (including USA, Canada and Mexico), South America (including Chile and Brazil), and South East Asia (including Hong Kong, Singapore, Japan, South Korea, Taiwan and China) were obtained from the ",
            "Global Initiative on Sharing Avian Influenza Data (GISAID)",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 696,
                "end": 754,
                "name": "Global Initiative on Sharing Avian Influenza Data (GISAID)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For accession number, country of origin and date of isolation, see the Supplementary Material Table 1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Then, the evolutionary model that best fit the sequence dataset was determined using MEGA‐X program."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "DensiTree draws all the trees in the dataset simultaneously, but instead of using opaque lines, transparency is used when drawing the trees."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As many early cases of COVID‐19 were linked to the Huanan market in Wuhan,",
            " it is possible that an animal source was present at this location."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Currently, there is only one complete 2019-nCoV genome (29870-bp, excluding the poly(A) tail) in ",
            "GenBank",
            " (accession number ",
            "MN908947",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 97,
                "end": 104,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 123,
                "end": 131,
                "name": "MN908947"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "Our pair-wise sequence analysis demonstrated that bat SARS-like coronavirus (",
            "Genbank",
            " accession number ",
            "MG772933",
            ") was the closest relative to 2019-nCoV, sharing 88% nucleotide similarity (Fig. 1",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 211,
                "end": 218,
                "name": "Genbank"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 236,
                "end": 244,
                "name": "MG772933"
            },
            false,
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "After multiple sample collections and laboratory analyses, the pathogen was identified as a novel coronavirus named severe acute respiratory syndrome coronavirus 2 by the International Committee of Taxonomy of Viruses [1], and the disease was named coronavirus disease (COVID-19) by the World Health Organization on February 11, 2020 [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Other countries such as Japan, South Korea, Thailand, Singapore, and the United States also reported COVID-19 cases in their countries [4]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The rapid spread of COVID-19 has already caused great public attention and many heated discussions, and the Chinese mass media have been reporting relevant information about the virus and the outbreak."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Data from Chinese news and related articles were collected from the ",
            "WiseSearch",
            " database [6]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 749,
                "end": 759,
                "name": "WiseSearch"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "WiseSearch",
            " database is one of the most reputable, ever-growing Chinese media content databases, containing the news and article data from more than 1500 print media sources and over 10,000 internet media sources."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 778,
                "end": 788,
                "name": "WiseSearch"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is famous for its reproducibility, timeliness, great coverage, and high data integrity compared with the other database [7]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The news and article data in the ",
            "WiseSearch",
            " database are updated in a timely manner [6]."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 1152,
                "end": 1162,
                "name": "WiseSearch"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also built a document-term matrix and used term frequency–inverse document frequency (TF–IDF) to process the data."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "TF–IDF is a numerical statistic that is used to reflect the importance of a word to an article in a corpus [19]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To seek a suitable LDA topic number and the explanations to investigate the relationship between the COVID-19 crisis and news reports, we conducted multiple studies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We selected topic 1 and the system visualized the word frequency distribution relative to the full corpus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The increase in the number of cases on February 12 and 13, 2020, was due to the updated diagnosis criteria in the COVID-19 protocol (fifth version) [28]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "University affinitive hospitals and university alumni associations participated actively in the fight against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 crisis has aroused great public concern in China and around the world."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Topic modeling provides an alternative perspective to investigate the relationship between media reports and the COVID-19 outbreak."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although several COVID-19 cases were found in December 2019, we observed few news reports about them, showing that the press media did not focus on this disease at that time."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These two themes indicate that the mass media adopts a people-oriented principle when reporting on the COVID-19 crisis, contributing to the warm society phenomenon."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This study is the first step to understanding the Chinese mass media’s role during the COVID-19 crisis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "First, we included a large number of Chinese news articles about COVID-19 from the ",
            "WiseSearch",
            " mass media database, which only covers text news articles."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 2729,
                "end": 2739,
                "name": "WiseSearch"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Some relative studies introduced sentiment analysis to investigate the emotional differences in the message content [35]; it would be valuable if we could also apply sentiment analysis to supervise the news and investigate the public’s reaction to news related to COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In December 2019, a few coronavirus disease (COVID-19) cases were first reported in Wuhan, Hubei, China."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As this dreadful disease spreads rapidly, the mass media has been active in community education on COVID-19 by delivering health information about this novel coronavirus, such as its pathogenesis, spread, prevention, and containment."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The aim of this study was to collect media reports on COVID-19 and investigate the patterns of media-directed health communications as well as the role of the media in this ongoing COVID-19 crisis in China."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We adopted the ",
            "WiseSearch",
            " database to extract related news articles about the coronavirus from major press media between January 1, 2020, and February 20, 2020."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 3634,
                "end": 3644,
                "name": "WiseSearch"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Comparing the number of articles for each day and the outbreak development, we noted that mass media news reports in China lagged behind the development of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 crisis has become a worldwide issue, and society has become concerned about donations and support as well as mental health among others."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We recommend that future work addresses the mass media’s actual impact on readers during the COVID-19 crisis through sentiment analysis of news data."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The World Health Organization (WHO) declared the current COVID-19 a public health emergency of international concern on January 30, 2020 [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The causative agent of the current outbreak, which has originated in Wuhan City in China, was identified as a novel coronavirus on January 7, 2020 [5], and the disease has been named COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Many countries worldwide are making every effort to prevent the spread of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The probable transmission from individuals before the onset of symptoms or very early minimal symptoms makes COVID-19 much more difficult to control."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Beside the protracted conflicts in many countries in the region, lack of infrastructure, limited resources, inadequate prevention control practices, poor preparedness capacity, and inadequate laboratory infrastructures and resources in many countries in the EMR are among the main barriers to adequately detect and respond to COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Not only has it created a page titled “COVID-19 Updates” to post hourly updates on the virus and its spread, but it has also created a private group titled “FETP Professionals,” which serves as a space for FETP directors, advisors, and coordinators to discuss key issues of concern in this regard."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The World Health Organization (WHO) declared the current COVID-19 a public health emergency of international concern on January 30, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This viewpoint article aims to highlight the contribution of the Global Health Development (GHD)/Eastern Mediterranean Public Health Network (EMPHNET) and the EMR’s Field Epidemiology Training Program (FETPs) to prepare for and respond to the current COVID-19 threat."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is essential that GHD/EMPHNET and FETPs continue building the capacity to respond to COVID-19 and intensify support for preparedness and response to public health emergencies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Abstract  Nationwide shortages of tests that detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and diagnose coronavirus disease 2019 (COVID-19) have led the US Food and Drug Administration (FDA) to significantly relax regulations regarding COVID-19 diagnostic testing."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To date the FDA has given emergency use authorization (EUA) to 48 COVID-19 in vitro diagnostic tests and 21 high complexity molecular-based laboratory developed tests, as well as implemented policies that give broad authority to clinical laboratories and commercial manufacturers in the development, distribution, and use of COVID-19 diagnostic tests."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The world is currently experiencing the devastating effects of the coronavirus disease 2019 (COVID-19) pandemic caused by the newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 has severely challenged the health care systems in most countries around the world, with increased demand for rapid diagnosis and treatment of seriously ill patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "28,274-29,533), spike (S, nt 21,563-25,384) and open reading frame 1ab (ORF1ab, nt 266-13,467) of SARS-CoV-2 WA1 strain (",
            "GenBank",
            " accession number ",
            "MN985325.1",
            ") were designed and manufactured by a commercial company (Advanced Cell Diagnostics [ACD], Newark, CA; Table 1)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 499,
                "end": 506,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 524,
                "end": 534,
                "name": "MN985325.1"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "The coronavirus disease (COVID-19) outbreak has spread globally and caused a pandemic that has led to almost 10,000,000 diagnosed cases and 500,000 deaths as of June 28, 2020 [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The impact of COVID-19 can be greater in vulnerable populations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the midst of the COVID-19 pandemic, it is advisable that pregnant women should stay at home and receive necessary antenatal care via online antenatal care programs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Network operators need to be improved to guarantee the widespread use of internet services during the COVID-19 outbreak."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "People across the world have been greatly affected by the ongoing coronavirus disease (COVID-19) pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we report how the COVID-19 pandemic brings not only opportunities for the development and popularization of online antenatal care programs but also challenges."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As many early cases of COVID-19 were linked to the Huanan market in Wuhan, it is possible that an animal source was present at this location."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Most patients with SARS-CoV-2 infection, or coronavirus disease 2019 (COVID-19), present with acute onset of fever, myalgia, cough, dyspnea, and radiological evidence of ground-glass lung opacities compatible with atypical pneumonia (5–7)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, clinical features and epidemiological links to Wuhan alone are not reliable for establishing the diagnosis of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As evidenced by previous epidemics caused by SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), highly sensitive and specific laboratory diagnostics for COVID-19 are essential for case identification, contact tracing, animal source finding, and rationalization of infection control measures (14–16)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Because of these limitations, reverse transcription-PCR (RT-PCR) remains the most useful laboratory diagnostic test for COVID-19 worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The availability of the complete genome of SARS-CoV-2 early in the epidemic facilitated the development of specific primers and standardized laboratory protocols for COVID-19 (18, 19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, we developed novel, highly sensitive and specific real-time RT-PCR assays for COVID-19 and compared their performances with that of the established RdRp-P2 assay using both in vitro and patient specimens."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Clinical evaluation using different types of clinical specimens from patients with laboratory-confirmed COVID-19 showed that our novel assay targeting a different region of the RdRp/Hel was significantly more sensitive and specific than the RdRp-P2 assay."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 was isolated from a patient with laboratory-confirmed COVID-19 in Hong Kong (22)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The viral isolate was amplified by one additional passage in VeroE6 cells to make working stocks of the virus (1.8 × 107 50% tissue culture infective doses [TCID50]/ml)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For the clinical evaluation study, a total of 273 (120 respiratory tract and 153 non-respiratory tract) clinical specimens were collected from 15 patients with laboratory-confirmed COVID-19 in Hong Kong whose nasopharyngeal aspirate/swabs, throat swabs, and/or sputum specimens tested positive for SARS-CoV-2 RNA by the RdRp2 assay (22)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Three novel real-time COVID-19 RT-PCR assays targeting the RdRp/Hel, S, and N genes of SARS-CoV-2 were developed (see Table S1 in the supplemental material)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To determine the analytical sensitivity of the COVID-19 assays, we first evaluated their LODs using viral genomic RNA extracted from culture lysates and clinical specimens."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The LOD of COVID-19-RdRp/Hel, COVID-19-S, and COVID-19-N was 1.8 × 10° TCID50/ml, while the LOD of RdRp-P2 was 1 log unit higher (1.8 × 101 TCID50/ml) (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The LOD of COVID-19-RdRp/Hel and COVID-19-N (10−5 fold dilution) was 1 log unit lower than that of COVID-19-S and RdRp-P2 (10−4 fold dilution) (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On the basis of these results, we then selected the COVID-19-RdRp/Hel and COVID-19-N assays for further evaluation and determined their LODs using in vitro viral RNA transcripts (Table 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The LODs of the COVID-19-RdRp/Hel and COVID-19-N assays using serial dilutions of in vitro viral RNA transcripts as calculated with probit analysis were 11.2 RNA copies/reaction (95% confidence interval, 7.2 to 52.6 RNA copies/reaction) and 21.3 RNA copies/reaction (95% confidence interval, 11.6 to 177.0 copies/reaction), respectively."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Test results used for the calculation of limits of detection of the COVID-19 real-time RT-PCR assays with genomic RNA for SARS-CoV-2 in culture lysates and clinical specimens",
            "Among the 273 specimens collected from these 15 patients, 77 (28.2%) were positive by the RdRp-P2 assay (Table 3)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The novel COVID-2019-RdRp/Hel assay was positive for all of these 77 specimens."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additionally, the COVID-2019-RdRp/Hel assay was positive for another 42 specimens (119 positive specimens of 273 total specimens [43.6%] by COVID-2019-RdRp/Hel versus 77 positive specimens of 273 total specimens [28.2%] by RdRp-P2; P < 0.001), including 29/120 (24.2%) respiratory tract specimens and 13/153 (8.5%) non-respiratory tract specimens that were negative by the RdRp-P2 assay."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19-RdRp/Hel assay was significantly more sensitive than the RdRp-P2 assay for the detection of SARS-CoV-2 RNA in nasopharyngeal aspirates/swabs or throat swabs (P = 0.043), saliva (P < 0.001), and plasma (P = 0.001) specimens."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As shown in Fig. 1, the COVID-19-RdRp/Hel assay consistently detected SARS-CoV-2 RNA in these samples with a higher sensitivity than the RdRp-2 assay throughout the patients’ course of illness up to day 12 (nasopharyngeal aspirates/swabs and/or throat swabs) to day 18 (saliva)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To investigate whether the novel COVID-19-RdRp/Hel and COVID-19-N assays cross-react with SARS-CoV, other human-pathogenic coronaviruses, and respiratory viruses, we used the assays to test 17 culture isolates of coronaviruses (SARS-CoV, MERS-CoV, human coronavirus HCoV-OC43, HCoV-229E, and HCoV-NL63), adenovirus, human metapneumovirus, influenza A (H1N1 and H3N2) viruses, influenza B virus, influenza C virus, parainfluenza viruses types 1 to 4, rhinovirus, and respiratory syncytial virus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To investigate whether the COVID-19-RdRp/Hel assay was specific for SARS-CoV-2 in clinical specimens, we used the assay to test 22 archived nasopharyngeal aspirates/swabs and throat swabs that were positive for other respiratory pathogens by FilmArray RP2 from 22 patients with upper and/or lower respiratory tract symptoms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As shown in Table 5, none of these specimens was positive by the COVID-19-RdRp/Hel assay, suggesting that the assay was specific for the detection of SARS-CoV-2 RNA in nasopharyngeal aspirates/swabs and throat swabs containing DNA/RNA of other human-pathogenic coronaviruses and respiratory pathogens."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Lack of cross-reactivity between the COVID-19-RdRp/Hel assay and other respiratory pathogens in clinical specimens",
            "For COVID-19, the protocols of a number of RT-PCR assays used by different institutes have recently been made available online (https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Importantly, the in-use evaluation data of these assays using a large number of clinical specimens from patients with confirmed COVID-19 are lacking."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We showed that the novel COVID-19-RdRp/Hel assay was highly sensitive and specific for the detection of SARS-CoV-2 RNA in vitro and in COVID-19 patient specimens."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among the three assays developed in this study, the COVID-19-RdRp/Hel assay has the lowest LOD with in vitro viral RNA transcripts (11.2 RNA copies/reaction; 95% confidence interval; 7.2 to 52.6 RNA copies/reaction)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The LOD with genomic RNA was also very low (1.80 TCID50/ml)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Importantly, the COVID-19-RdRp/Hel assay was significantly more sensitive (P ≤ 0.001) than the established RdRp-P2 assay for the detection of SARS-CoV-2 RNA in both respiratory tract and non-respiratory tract clinical specimens."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19-RdRp/Hel assay detected SARS-CoV-2 RNA in 42/273 (15.4%) additional specimens that tested negative by the RdRp-P2 assay."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These findings are clinically and epidemiologically relevant, because asymptomatic and mildly symptomatic cases of COVID-19 have been increasingly recognized, and these patients with cryptic pneumonia may serve as a potential source for propagating the epidemic (2, 8)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Given the large number of patients (>60,000 cases in China at the time of writing) involved in this expanding epidemic, the additional positive specimens detected by the COVID-19-RdRp/Hel assay might translate into thousands of specimens that would otherwise be considered SARS-CoV-2 negative by the less-sensitive RdRp-P2 assay."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Regarding the different types of clinical specimens, the COVID-19-RdRp/Hel assay was significantly more sensitive than the RdRp-P2 assay for the detection of SARS-CoV-2 RNA in nasopharyngeal aspirates/swabs or throat swabs, saliva specimens, and plasma specimens."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "False-negative results might arise from testing nasopharyngeal aspirate/swabs or throat swabs with low viral loads in COVID-19, SARS, and MERS patients (2, 30–33)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "RT-PCR assays with higher sensitivity, such as the COVID-19-RdRp/Hel assay, might help to reduce the false-negative rate among these specimens which are frequently the only specimens available for establishing the diagnosis of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We have previously shown that saliva has a high concordance rate with nasopharyngeal aspirates for the detection of influenza viral RNA and might also be a suitable specimen for diagnosing COVID-19 (22, 34)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The use of the highly sensitive COVID-19-RdRp/Hel assay to test saliva specimens from suspected cases of COVID-19 might be a simple and rapid way to avoid the need of aerosol-generating procedures during collection of nasopharyngeal aspirates and suction of sputum, especially in regions most heavily affected by the ongoing COVID-19 outbreak where there are insufficient supplies of full personal protective equipment (13)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 RNAemia has been reported in a small proportion of COVID-19 patients (2, 5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, as shown in our clinical evaluation in which the RdRp-P2 assay gave negative test results for all 10 plasma specimens that gave positive test results by the COVID-19-RdRp/Hel assay, the genuine incidence of SARS-CoV-2 RNAemia might be underestimated by less sensitive RT-PCR assays."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, serial monitoring of the plasma viral load in COVID-19 patients with the highly sensitive COVID-19-RdRp/Hel assay should be considered to provide prognostic insights and facilitate treatment decisions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19-RdRp/Hel assay was highly specific and exhibited no cross-reactivity with other common respiratory pathogens in vitro and in nasopharyngeal aspirates."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This cross-reactivity would be especially important for laboratories in areas where SARS-CoV might reemerge and cocirculate with SARS-CoV-2, as the differences in clinical progression between SARS and COVID-19 remain incompletely understood at this stage."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Highly sensitive and specific laboratory diagnostics are important for controlling the rapidly evolving SARS-CoV-2-associated coronavirus disease 2019 (COVID-19) epidemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Highly sensitive and specific laboratory diagnostics are important for controlling the rapidly evolving SARS-CoV-2-associated coronavirus disease 2019 (COVID-19) epidemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among the three novel assays, the COVID-19-RdRp/Hel assay had the lowest limit of detection in vitro (1.8 50% tissue culture infective doses [TCID 50 ]/ml with genomic RNA and 11.2 RNA copies/reaction with in vitro RNA transcripts)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among 273 specimens from 15 patients with laboratory-confirmed COVID-19 in Hong Kong, 77 (28.2%) were positive by both the COVID-19-RdRp/Hel and RdRp-P2 assays."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19-RdRp/Hel assay was positive for an additional 42 RdRp-P2-negative specimens (119/273 [43.6%] versus 77/273 [28.2%]; P < 0.001), including 29/120 (24.2%) respiratory tract specimens and 13/153 (8.5%) non-respiratory tract specimens."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19-RdRp/Hel assay did not cross-react with other human-pathogenic coronaviruses and respiratory pathogens in cell culture and clinical specimens, whereas the RdRp-P2 assay cross-reacted with SARS-CoV in cell culture."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The highly sensitive and specific COVID-19-RdRp/Hel assay may help to improve the laboratory diagnosis of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Significance Statement  Kidney involvement may occur in coronavirus disease 2019 (COVID-19), and can be severe among Black individuals."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study of collapsing glomerulopathy in six Black patients with COVID-19, the authors found that all six had variants in the gene encoding apo L1 (APOL1) that are more common among those of African descent and linked by past research to susceptibility to collapsing glomerulopathy in non–COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Visual Abstract         Background  Kidney involvement is a feature of COVID-19 and it can be severe in Black patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To investigate genetic, histopathologic, and molecular features in six Black patients with COVID-19 presenting with AKI and de novo nephrotic-range proteinuria, we obtained biopsied kidney tissue, which was examined by in situ hybridization for viral detection and by NanoString for COVID-19 and acute tubular injury–associated genes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This case series included six Black patients with COVID-19 (four men, two women), mean age 55 years."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Conclusions  Collapsing glomerulopathy in Black patients with COVID-19 was associated with high-risk APOL1 variants."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Given this entity’s resemblance with HIV-associated nephropathy, we propose the term COVID-19–associated nephropathy to describe it."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recently, novel coronavirus (virus, SARS-COV2; disease, COVID-19) infection and its related mortality are so severe internationally that the WHO declared it as a pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "They concluded that this triple drug treatment has a superior effect in curing COVID-19 patients than lopinavir-ritonavir or ribavirin alone (Hung et al. 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, clinical trials of IFN-beta supplement could be considered an effective treatment for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Taken together, an IFN-beta supplement might aid in preventing COVID-19 infection and help in development of herd immunity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID‐19 is global pandemic caused by severe acute respiratory syndrome coronavirus‐2 (SARS‐COV‐2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To provide further insight, root‐mean‐square deviation (rmsd) tool and population distribution plot were used to investigate the conformations sampled by the two biosystems in comparison with the open (",
            "PDB",
            " ID: ",
            "6vyb",
            ")",
            " and closed (",
            "PDB",
            " ID: ",
            "6vxx",
            ") states."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 302,
                "end": 305,
                "name": "PDB"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 310,
                "end": 314,
                "name": "6vyb"
            },
            false,
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 329,
                "end": 332,
                "name": "PDB"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 337,
                "end": 341,
                "name": "6vxx"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "To further establish these findings, the conformations sampled were also compared with that of S2‐post‐fusion core (",
            "PDB",
            " ID: ",
            "6lxt",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 467,
                "end": 470,
                "name": "PDB"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 475,
                "end": 479,
                "name": "6lxt"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "The conformations sampled by S2 unit in the G614 biosystem were predominantly those of the post‐fusion core (Figure 1d), while the wild type sampled the pre‐fusion core conformation (data not shown); and clearly, the conformations of the RBD of G614 biosystem were those previously characterized to bind ACE2 (",
            "PDB",
            " ID: ",
            "6lzg",
            ", Figure 1e) but not the wild type."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 792,
                "end": 795,
                "name": "PDB"
            },
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 800,
                "end": 804,
                "name": "6lzg"
            },
            false
        ],
        "rel": [
            {
                "id": "R4",
                "bool": true,
                "head": "T7",
                "end": "T8"
            }
        ]
    },
    {
        "sen": [
            "The results obtained from comparison with antibody (B38, ",
            "PDB",
            " ID: ",
            "7bz5",
            ")",
            "‐bound conformation revealed a rather unusual pattern."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 897,
                "end": 900,
                "name": "PDB"
            },
            false,
            {
                "id": "T10",
                "type": "AccessionNumber",
                "start": 905,
                "end": 909,
                "name": "7bz5"
            },
            false,
            false
        ],
        "rel": [
            {
                "id": "R5",
                "bool": true,
                "head": "T9",
                "end": "T10"
            }
        ]
    },
    {
        "sen": [
            "Abstract  D614G spike glycoprotein (sgp) mutation in rapidly spreading severe acute respiratory syndrome coronavirus‐2 (SARS‐COV‐2) is associated with enhanced fitness and higher transmissibility in new cases of COVID‐19 but the underlying mechanism is unknown."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The causative agent of COVID‐19; SARS‐COV‐2 has acquired a rare mutation (G23403A) in the region encoding spike glycoprotein (D614G) resulting in enhanced fitness and higher transmissibility."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had a dramatic impact on the health of millions of people and became a challenge for the worldwide health systems [1, 2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this work we explored the landscape of ACE2 and TMPRSS2 regulation mediated by miRNAs and isomiRs in different human organs using bioinformatic analysis of publicly available paired miRNA/mRNA-sequencing datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The latter included hsa-miR-125a-5p (targeting ACE2 in esophagus, kidney and lung), as well as hsa-miR-199a-5p (regulating expression of TMPRSS2 in liver, stomach and uterine corpus, see Fig 3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In order to determine the other players involved in the interplay between hsa-let-7e-5p / hsa-miR-125a-5p and ACE2 / TMPRSS2 genes we searched for proteins regulating the transcription of those miRNAs using literature-curated interaction databases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, lysine-specific demethylase 5B (JARID1B, encoded by the KDM5B gene) had been previously shown to repress the transcription of hsa-let-7e / hsa-mir-125a miRNAs and miR-200 family (including miR-141, miR-200a, miR-200b, miR-200c and miR-429) by promoting H3K4me3 histone mark demethylation within the regulatory regions of miRNAs, thereby facilitating epigenetic repression of their transcription."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As a result, JARID1B epigenetic activity can indirectly regulate expression of ACE2 and TMPRSS2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To explore putative interactions between JARID1B and ACE2 / TMPRSS2 genes more deeply we analyzed publicly available single-cell RNA sequencing (scRNA-seq) data obtained from certain human organs (annotated and deposited by ",
            "Sungnak et al.",
            " [26])."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Creator",
                "start": 1603,
                "end": 1617,
                "name": "Sungnak et al."
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Specifically, the mean dropout rate (i.e. the ratio of the number of cells with no JARID1B, ACE2 or TMPRSS2 aligned reads to the total number of cells) across all cell types was 87.9% for KDM5B, 99.1% for ACE2 and 93.2% for TMPRSS2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To overcome the issue caused by high dropout rates we calculated the mean expression of each gene for all cell types from the explored datasets (see S3 Table)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using the literature-curated interaction database we have found strong indications that the JARID1B gene can repress let-7e / miR-125a as well as miR-200 families presumably via epigenetic mechanisms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, Mitra et al. [31] have previously provided experimental evidence that the JARID1B gene represses transcription of the let-7e and miR-125a by promoting H3K4me3 demethylation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Specifically, shRNA-mediated knockdown of JARID1B in MCF-7 and T47D cells led to a several-fold increase in expression of both miRNAs, while simultaneous ChIP analysis confirmed the H3K4 demethylation of the corresponding regulatory DNA sequences."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In another report, Enkhbaatar et al. [32] showed that JARID1B represses transcription of miR-200 family by a similar mechanism."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Specifically, the overexpression of JARID1B in lung cancer cell line A549 resulted in 3-fold decrease of miR-200a and miR-200c expression while JARID1B knockdown led to 1.5-fold increase of their steady-state levels."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, our results go in accordance with the experimental data showing the existence of regulatory network involving let-7e / miR-125a / miR-200 families, histone demethylase JARID1B as well as ACE2 / TMPRSS2, and further suggest a new way for regulating ACE2 expression."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, our single-cell RNA sequencing data analysis strongly supports the existence of such interactions in other cells, and indicates that in the majority of human cells ACE2 and TMPRSS2 are not expressed without JARID1B."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In particular, high expression levels of JARID1B, ACE2 and TMPRSS2 in human respiratory epithelium cells intimate that further investigation of the identified regulatory network could expand our understanding of the viral infection pathogenesis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The potential interactions between ACE2 and histone modifiers such as HAT1, HDAC2, and JARID1B in the lung has been previously shown by Pinto and co-authors [33]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, Gordon D. et al. suggested the inhibition of histone deacetylase 2 (HDAC2) to be used as a promising strategy for COVID-19 therapy [34]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interestingly, Valproic acid was also shown to directly inhibit JARID1B in human embryonic kidney cells (HEK 293) [35] and H9 human embryonic stem cells (H9 hESC) [36]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The data included samples from several tissues: 19 for bladder (",
            "TCGA-BLCA",
            "), 104 for breast (",
            "TCGA-BRCA",
            "), 8 for colon (",
            "TCGA-COAD",
            "), 11 for esophagus (",
            "TCGA-ESCA",
            "), 127 for kidney (",
            "TCGA-KICH",
            ", ",
            "TCGA-KIRC",
            ", ",
            "TCGA-KIRP",
            "), 50 for liver (",
            "TCGA-LIHC",
            "), 58 for lung (",
            "TCGA-LUAD",
            ", ",
            "TCGA-LUSC",
            "), 52 for prostate (",
            "TCGA-PRAD",
            "), 32 for stomach (",
            "TCGA-STAD",
            "), 58 for thyroid (",
            "TCGA-THCA",
            ") and 22 for uterine corpus (",
            "TCGA-UCEC",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 4289,
                "end": 4298,
                "name": "TCGA-BLCA"
            },
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 4317,
                "end": 4326,
                "name": "TCGA-BRCA"
            },
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 4342,
                "end": 4351,
                "name": "TCGA-COAD"
            },
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 4372,
                "end": 4381,
                "name": "TCGA-ESCA"
            },
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 4400,
                "end": 4409,
                "name": "TCGA-KICH"
            },
            false,
            {
                "id": "T7",
                "type": "Dataset",
                "start": 4411,
                "end": 4420,
                "name": "TCGA-KIRC"
            },
            false,
            {
                "id": "T8",
                "type": "Dataset",
                "start": 4422,
                "end": 4431,
                "name": "TCGA-KIRP"
            },
            false,
            {
                "id": "T9",
                "type": "Dataset",
                "start": 4448,
                "end": 4457,
                "name": "TCGA-LIHC"
            },
            false,
            {
                "id": "T10",
                "type": "Dataset",
                "start": 4473,
                "end": 4482,
                "name": "TCGA-LUAD"
            },
            false,
            {
                "id": "T11",
                "type": "Dataset",
                "start": 4484,
                "end": 4493,
                "name": "TCGA-LUSC"
            },
            false,
            {
                "id": "T12",
                "type": "Dataset",
                "start": 4513,
                "end": 4522,
                "name": "TCGA-PRAD"
            },
            false,
            {
                "id": "T13",
                "type": "Dataset",
                "start": 4541,
                "end": 4550,
                "name": "TCGA-STAD"
            },
            false,
            {
                "id": "T14",
                "type": "Dataset",
                "start": 4569,
                "end": 4578,
                "name": "TCGA-THCA"
            },
            false,
            {
                "id": "T15",
                "type": "Dataset",
                "start": 4607,
                "end": 4616,
                "name": "TCGA-UCEC"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "TransmiR v2.0 [47] literature-curated database was used to extract information on protein-miRNA regulatory interactions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Development of novel approaches for regulating the expression of angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) is becoming increasingly important within the context of the ongoing COVID-19 pandemic since these enzymes play a crucial role in cell infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In particular, we found that lysine-specific demethylase 5B (JARID1B), encoded by the KDM5B gene, can indirectly affect ACE2 / TMPRSS2 expression by repressing transcription of hsa-let-7e / hsa-mir-125a and hsa-mir-141 / hsa-miR-200 miRNA families which are targeting these genes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The entire world is currently under the big threat of coronavirus disease (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV2) virus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Epidemiological surveys show that diabetic patients are at high risk to contract COVID-19 infection [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "More importantly, they are also the major victims of COVID-19 associated mortalities."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In a study done by the COVID-19 surveillance group of Italy on 3200 patients, 34% of 481 nonsurvivors had diabetes [3]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similarly, reports from the Centers for Diabetes Control and Prevention, United States show that 11% of COVID-19 patients have diabetes [5]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The most populated country like India, more than 70% of COVID-19-associated mortalities are due to comorbidities including diabetes, hypertension, CVD, and pulmonary problems."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The diabetic population has crossed 120 million worldwide in 2019 and this in turn poses an increased threat for further COVID-19 infection and related mortalities in these patients in upcoming days."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hence, understanding the pathobiology behind the increased mortality in COVID-19-affected diabetic patients is highly essential to develop prominent prognostic biomarkers and accurate therapies that save their lives."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furin cleaves this S1/S2 site and allows viral entry into host cells which in turn leads to the onset of COVID-19 infection in humans (Fig. 1) [9]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This in turn broadens the cell tropism of the SARS CoV2 virus and may probably be the reason behind the multiple organ damages observed in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This is proven by the fact that organs severely affected by SARS CoV2 infection in COVID-19 patients including lungs, liver, kidney express high levels of furin."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hence, furin overexpression in diabetes patients may be the key reason behind their increased risk to contract COVID-19 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Blood clots are other major fatal complications that cause increased mortalities in COVID-19 patients [13]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hence, furin might also be associated with COVID-19-related mortalities that occur due to blood clots."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This in turn might increase the susceptibility of diabetes patients to contract COVID-19 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hence, it is highly plausible that furin might be the major risk factor for the increased mortality of COVID-19 infected diabetes patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Detailed investigations on the correlation between plasma furin levels, viral load, and severity of fatal complications in COVID-19-infected diabetes patients are very much needed to decipher the link between furin and prognosis status in these patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These findings will aid in determining if plasma furin could act as a prominent prognostic biomarker in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Also, it will provide clues for the utilization of furin inhibitors to save the lives of COVID-19-infected diabetes patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On January 23, 2020, a case of coronavirus disease (COVID-19) was detected in Toronto, Canada (); since then, multiple cases have been identified across Canada."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The next day, we collected 200 μL of mid-turbinate swab samples from 2 COVID-19 patients, mixed it with 200 μL of DMEM containing 16 μg/mL TPCK-treated trypsin and inoculated the cells."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Supernatant from the cells was used to determine virus titers (50% tissue culture infectious dose [TCID50]/mL) according to the Spearman and Karber method (,) as outlined previously ()."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For primary antibody staining, we used a combination of 6.6 μg/mL rabbit anti-SARS-CoV-2 N (BioVision, https://www.biovision.com) plus 10 μg/mL recombinant human anti-SARS-CoV-2 spike S1 (GenScript, https://www.genscript.com) and 1:100 diluted serum from a recovered COVID-19 patient (OM8073) (Figure 1, panels A, B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, maximum-likelihood phylogenetic analysis including >1,900 SARS-CoV-2 isolates from ",
            "GISAID",
            " (",
            "https://www.gisaid.org",
            ") placed both SARS-CoV-2/SB2 and SARS-CoV-2/SB3-TYAGNC within a clade of isolates from patients around the globe but with evidence of travel history associated with the COVID-19 outbreak in Iran (Appendix Figure 2)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 947,
                "end": 953,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 955,
                "end": 977,
                "name": "https://www.gisaid.org"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "To enhance our ability to detect SARS-CoV-2 proteins in these cells, we immunostained the cells by using a cocktail of antibodies that included SARS-CoV-2 S1 antibody, SARS-CoV-2 N antibody, and diluted serum from a recovered COVID-19 patient (Figure 1, panels A and B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We report the isolation of 2 replication competent SARS-CoV-2 virus samples from COVID-19 patients in Canada."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "After only 2 months, the epidemic of COVID‐19 is already larger than the severe acute respiratory syndrome (SARS) coronavirus (SARS‐CoV) outbreak, which during 2002/2003 lasted 8 months and infected 8096 people, with a mortality rate of 9·5%."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This lack of homologous DNA sequences was a bit surprising, as Lu et al. (12) recently published a phylogenetic tree based on 50 genome sequences (including 10 2019_nCoV isolates) with high bootstrap values, which can only be obtained with sufficient degrees of conservation between members of the data set."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, the database is highly biased towards particular bat species that were specifically sampled in search of the source of SARS."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread rapidly around the world since the first cases were reported in late 2019 (,)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Prior to April 9, 2020, Heilongjiang Province, China, had not reported a new COVID-19 diagnosis since March 11, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We defined confirmed COVID-19 cases as persons who tested positive for SARS-CoV-2 and had clinical symptoms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On April 9, investigators also learned that A0, B1.1’s neighbor, had returned on March 19 from the United States, where COVID-19 cases had been detected."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Emerging infectious diseases (EIDs) represent a significant challenge to global health."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The frequency of EID outbreaks has dramatically increased over the last decades."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Most EIDs have a zoonotic origin; more than 70% of them are caused by pathogens originating from wildlife [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ongoing outbreak with the new severe acute respiratory syndrome coronavirus (SARS-CoV-2), responsible for the COVID-19 pandemic, is a perfect illustration of the potential impact and the global consequences resulting from a single cross-species transmission from an animal virus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is thus important to be prepared for new EID outbreaks."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The current COVID-19 outbreak with the SARS-CoV-2 virus, is the seventh coronavirus (CoV) identified in humans since the 1960s [6,7]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here we conducted a pilot study on the presence of CoVs in bats in Guinea, West Africa, a country with a high likelihood for EID outbreaks and where humans are frequently directly or indirectly exposed to bats (A.K. Keita, personal observation)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The new sequences were deposited in the ",
            "GenBank",
            " under accession numbers ",
            "MT586773",
            "-",
            "MT586805",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1043,
                "end": 1050,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 1075,
                "end": 1083,
                "name": "MT586773"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 1084,
                "end": 1092,
                "name": "MT586805"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T1",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "The new sequences were deposited in ",
            "GenBank",
            " under accession numbers ",
            "MT586830",
            "-",
            "MT586867",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 1130,
                "end": 1137,
                "name": "GenBank"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 1162,
                "end": 1170,
                "name": "MT586830"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 1171,
                "end": 1179,
                "name": "MT586867"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T4",
                "end": "T5"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T4",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "Zoonoses can constitute a threat for public health that can have a global importance, as seen with the current COVID-19 pandemic of severe acute respiratory syndrome coronavirus (SARS-CoV2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The outbreak of coronavirus COVID-19 has become a most challenging health emergency in over the world [4,5]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The number of deaths associated COVID-19 is greatly higher than the other two coronaviruses (SARS-CoV and MERS-CoV), and the outbreak is still ongoing, which global concern to the public health and economics [14]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The most common symptoms of coronavirus disease (COVID-19) are fever, tiredness, and dry cough."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There are no specific vaccines or treatments for COVID-19 [17]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "That could be used as peptide vaccines against SARS-CoV-2/COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The S protein sequence was retrieved from ",
            "NCBI",
            " at ",
            "http://www.ncbi.nlm.nih.gov/protein",
            " and saved in FASTA format for further analyses; then Protein BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi) against reference sequence on the database was performed using Blosum80 matrix to collect homologous sequences between different Coronaviruses."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 593,
                "end": 597,
                "name": "NCBI"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 601,
                "end": 636,
                "name": "http://www.ncbi.nlm.nih.gov/protein"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "S protein sequence with accession No. ",
            "QII57161.1",
            " is available as a query for protein BLAST against Coronavirus producing a set of sequences containing various species of Coronaviruses."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 928,
                "end": 938,
                "name": "QII57161.1"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The best epitopes recommended by this server are ‘‘LNEVAKNLNESLIDLQELGK’‘, “TLVKQLSSNFGAISSVLNDI”, “QQLIRAAEIRASANLAATKM” and “KEELDKYFKNHTSPDVDLGD” at regions 1186–1205, 961–980, 1010–1029 and 1149–1168 respectively."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus that it disease spreads in over the world."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At this time, there are no specific vaccines or treatments for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The pandemic of COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has posed a serious threat to global public health, calling for the development of reliable diagnostic tests, able to identify (and possibly quantify) SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The persistently negative rtPCR results in patients with clinical suspects of COVID-19, and no alternative diagnosis, could be related to the lower viral titers that characterize the most widely used nasopharyngeal samples [7] in comparison to other respiratory specimens, such as sputum [8], as well as to the replication kinetics of the virus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Standing the necessity of a limitation (as much as possible) of false negative results in COVID-19 diagnosis, the use of ddPCR could provide a critical support [8]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All patients were symptomatic with exception of one (COVID-19 contact) and thus immediately hospitalized and tested for SARS-CoV-2 rtPCR, whose result was negative."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of note, a severe COVID-19 manifestation characterized 14 of the 19 patients with a ddPCR confirmed SARS-CoV-2 infection (73.7%, S1 Table)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The SARS-CoV-2 RNA positivity in the 5 samples with a serological assay not available (ID 1, 4, 8, 12, 13) was further confirmed by using a second assay adapted for ddPCR and targeting two different portions of RdRp [17]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 was detected at later time points also by standard qualitative rtPCR for three of these five patients (ID 1, 4, 8, S1 Table)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By using this reliable, reproducible and highly sensitive assay, we could improve the efficiency of COVID-19 diagnosis on nasopharyngeal swabs even at a very early stage of viral replication, or in anatomical districts where the virus is present at lower levels, such as the oropharyngeal or the nasopharyngeal samples [8, 9]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the context of COVID-19 diagnosis, two recent studies highlight the best performances of ddPCR in detecting low viral load samples [19,20]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In particular, without this assay, no molecular laboratory confirmation of SARS-CoV-2 would have been available at hospitalization for 12 patients, all characterized by a severe COVID-19 manifestation and with evidence of bilateral interstitial pneumonia, and for two patients affected by pneumonia with pleuritis (n = 1), and lung cancer (n = 1), for whom the mere clinical evaluation excluded the COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since SARS-CoV-2-based disease (COVID-19) spreads as a pandemic, the necessity of a highly sensitive molecular diagnosis that can drastically reduce false negatives reverse transcription PCR (rtPCR) results, raises as a major clinical need."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here we evaluated the performance of a ddPCR-based assay to quantify SARS-CoV-2 titer in 55 suspected COVID-19 cases with negative rtPCR results thanks to in-house ddPCR assay (targeting RdRp and host RNaseP)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In 15 of them (78.9%), chest CT showed a classical COVID-19 bilateral interstitial pneumonia; 14 patients (73.7%) showed severe COVID-19 manifestations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thanks to a ddPCR-based assay, we achieved a rapid and accurate SARS-CoV-2 diagnosis in rtPCR-negative respiratory samples of individuals with COVID-19 suspect, allowing the rapid taking care and correct management of these patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Subsequently, the virus spread globally causing a pathological condition which was termed as coronavirus disease 2019 (COVID-19), and the pathogen was named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The synonymous codon usage data of human, dog, cat, pig, horse and cattle were retrieved from the codon usage database (",
            "http://www.kazusa.or.jp/codon/",
            "), whereas for bat, the sequence of Pteropus vampyrus (",
            "NW_011888782",
            ") was retrieved from ",
            "NCBI",
            " (",
            "https://www.ncbi.nlm.nih.gov",
            ") and by using online program ‘Countcodon’ (available at: http://www.kazusa.or.jp/codon/countcodon.html) the reference codon usage table for bat was prepared."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "URL",
                "start": 342,
                "end": 372,
                "name": "http://www.kazusa.or.jp/codon/"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 427,
                "end": 439,
                "name": "NW_011888782"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 460,
                "end": 464,
                "name": "NCBI"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 466,
                "end": 494,
                "name": "https://www.ncbi.nlm.nih.gov"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T3",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "Another web-based tool was used to obtain the tRNA database (",
            "GtRNAdb",
            ": Genomic tRNA database)."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 714,
                "end": 721,
                "name": "GtRNAdb"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Higher average CAI values of human compared to dog observed in the present study indicated that dog is less susceptible to COVID 19 than human."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the UK, the death toll from severe COVID-19 is among the highest worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severe COVID-19 is characterised by respiratory failure, with so-called cytokine storm occurring in some patient subsets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Pathological correlates are required to understand the pathophysiology of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In anticipation of the COVID-19 pandemic, our group produced national guidelines for autopsy performance in suspected COVID-19 cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 is caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).4, 5 Although SARS-CoV-2 and its predecessor SARS-CoV (causing severe acute respiratory syndrome [SARS]) are similar on a molecular and clinical level, COVID-19 has a lower death rate (4% for COVID-19 vs 15% for SARS) and a substantially higher death toll (700 539 deaths worldwide from COVID-19 as of Aug 5, 2020 vs 774 from SARS) than SARS due to a higher basic reproduction number."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Various autopsy series on COVID-19 have begun to emerge in the literature.7, 8, 9, 10, 11, 12, 13, 14, 15 Here, we document the major pathological findings of ten post-mortem examinations done on patients with clinically confirmed COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The conclusion by Copin and colleagues that COVID-19-related lung injury “is not diffuse alveolar damage” might relate to their sampling strategy and chronicity (five patients had spent approximately 3 weeks on a ventilator)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Reports of lung histology in early COVID-19 also suggest a degree of lymphocytic pneumonia, although DAD is probably superimposed on this over time in the majority of fatal cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Pulmonary macrophage infiltration and multinucleated giant cell reactions are prominent, similar to other series.8, 9, 10, 11, 12 Definite evidence of tissue-related lymphocyte depletion in COVID-19 will require quantitative analysis comparing tissues from COVID-19 patients with DAD associated with other conditions and unaffected tissues."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Several cases of invasive pulmonary aspergillosis have been reported in patients with severe COVID-19 pneumonia."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To our knowledge, this is the first description of histologically proven mucormycosis in patients with COVID-19 and suggests that other human fungal pathogens, including members of Mucoromycotina, can complicate COVID-19-associated infections."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Numerous clinical features, including raised serum D-dimer concentrations, raised pro-calcitonin concentrations, and imaging findings, suggest thrombosis is prominent in patients with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thrombotic features were universal among patients who underwent full autopsies (all nine patients had thrombi in at least one major organ) and have been noted to be prominent in other COVID-19 autopsy series."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Whether thrombosis in COVID-19 is more common than in other causes of DAD remains uncertain; however, our data support thrombosis as being a striking feature in these patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A study suggested endotheliitis as a prominent feature in patients with severe COVID-19, but this was not a prominent feature in our patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A raised cytokine profile has been documented in a subset of patients with severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A substantial feature in COVID-19 is lymphocyte depletion, and this is supported in our series by the spleen and lymph node findings."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "When compared with those with mild disease, patients with severe COVID-19 tend to have a higher neutrophil to lymphocyte ratio and higher CD4-positive to CD8-positive T-cell ratio."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We have corroborated this evidence by documenting a low number of T cells (especially CD8-positive T cells and FOXP3-positive regulatory T cells) in the spleen and lymph nodes in severe fatal COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A report identified low viral load in the brain of three of 18 patients with COVID-19, but could not detect the virus in subsequent immunohistochemistry and concluded that the viral genomes might have been present in the blood."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Pancreatic pathology was a major unexpected pathology in this series, which had not been previously reported in COVID-19 autopsies or large clinical COVID-19 series."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Serum amylase is not part of the routine care bundle for COVID-19 in our Trust."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Most cases had evidence of hepatic steatosis, which is consistent with clinical findings that obesity is a risk factor for poor outcome in COVID-19, and liver cirrhosis or bridging fibrosis was prominent in this cohort."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Background  Severe COVID-19 has a high mortality rate."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Comprehensive pathological descriptions of COVID-19 are scarce and limited in scope."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We aimed to describe the histopathological findings and viral tropism in patients who died of severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this case series, patients were considered eligible if they were older than 18 years, with premortem diagnosis of severe acute respiratory syndrome coronavirus 2 infection and COVID-19 listed clinically as the direct cause of death."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Between March 1 and April 30, 2020, full post-mortem examinations were done on nine patients with confirmed COVID-19, including sampling of all major organs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our series supports clinical data showing that the four dominant interrelated pathological processes in severe COVID-19 are diffuse alveolar damage, thrombosis, haemophagocytosis, and immune cell depletion."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additionally, we report here several novel autopsy findings including pancreatitis, pericarditis, adrenal micro-infarction, secondary disseminated mucormycosis, and brain microglial activation, which require additional investigation to understand their role in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Briefly, reads containing adaptor sequences and low-complex regions were removed from the dataset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All non-human and non-repeat sequence reads were then compared to a reference virus database (downloaded from ",
            "https://ftp.ncbi.nih.gov/blast/db/ref_viruses_rep_genomes.tar.gz",
            ") and the non-redundant protein database (nr) using blastn and diamond blastx programs [4], respectively."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "URL",
                "start": 209,
                "end": 273,
                "name": "https://ftp.ncbi.nih.gov/blast/db/ref_viruses_rep_genomes.tar.gz"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Taxonomy lineage information was obtained for each blast hits by matching the accession number with the taxonomy database, which was subsequently used to identify reads of virus origin."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The entire viral genome is 29,881 nt in length (",
            "GenBank",
            " ",
            "MN988668",
            " and ",
            "MN988669",
            ", ",
            "Sequence Read Archive",
            " database Bioproject accession ",
            "PRJNA601736",
            ") and is classified into β-coronavirus genus."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 613,
                "end": 620,
                "name": "GenBank"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 621,
                "end": 629,
                "name": "MN988668"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 634,
                "end": 642,
                "name": "MN988669"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 644,
                "end": 665,
                "name": "Sequence Read Archive"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 696,
                "end": 707,
                "name": "PRJNA601736"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T2",
                "end": "T4"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "In this paper we discuss ethical implications of the use of mobile phone apps in the control of the COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, the high proportion of pre-symptomatic transmission in COVID-19 means that standard contact tracing methods are too slow to stop the progression of infection through the population."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The recent pandemic of the coronavirus disease 2019 (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become one of the major health concerns of the 21st century [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, drug-repurposing attempts aimed at identification of efficient therapeutic agents for the treatment of COVID-19 has emerged as a promising approach to compensate for this urgent need."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Studies were selected as they provide the latest curated data regarding the dataset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The effect of USP13 (",
            "Affymetrix",
            " ID: ",
            "226902_at",
            ") mRNA expression levels on overall survival was assessed via Kaplan-Meier Plotter (https://kmplot.com/analysis/) [21]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 519,
                "end": 529,
                "name": "Affymetrix"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 534,
                "end": 543,
                "name": "226902_at"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "In order to analyze the effect of USP13 somatic copy number alterations on immune cell infiltration, TIMER analysis was performed on all ",
            "TCGA",
            " datasets, which showed significant correlation in Head-Neck Squamous Cell Carcinoma (HNSC), LUAD, LUSC, STAD and OV tumors (Fig. 4",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 800,
                "end": 804,
                "name": "TCGA"
            },
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 is currently one of the most urgent health issues that need immediate attention worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "One explanation for this unexpected result could be that different analyses might have been run on different datasets for the same cancer type."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Aims  Coronavirus disease 2019 (COVID-19), which is caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), is a major health concern worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although the latest data are not yet available, it is likely that the vaccination rate would not change significantly in 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Identification and rapid global spread of the novel SARS-CoV-2 coronavirus with first cases of the disease COVID-19 being detected in Europe in January 2020 [1] necessitated the development and deployment of diagnostic tests for the specific detection of SARS-CoV-2 genome sequences in human samples."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Examination of a publicly available gene expression data set (",
            "Gene Expression Omnibus [GEO]",
            " accession number ",
            "GSE147507",
            ") from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection of A549 human lung cells also showed a significant upregulation of CD47 compared to mock-infected controls (Fig. 1D)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 62,
                "end": 91,
                "name": "Gene Expression Omnibus [GEO]"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 109,
                "end": 118,
                "name": "GSE147507"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "To examine CD47 expression in human viral infection, we first compared transcriptional levels of CD47 from publicly available microarray data (",
            "GEO",
            " accession number ",
            "GSE38597",
            ") from healthy and hepatitis C virus (HCV) patient liver biopsy specimens."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 457,
                "end": 460,
                "name": "GEO"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 478,
                "end": 486,
                "name": "GSE38597"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "La Crosse virus (LACV) infections were performed with a 1978 human isolate provided as a gift from Stephen Whitehead (NIAID, NIH)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All antibodies were from BD Biosciences, BioLegend, or eBioscience/Thermo Fisher Scientific, including Brilliant Violet 605-anti-CD11b (clone M1/70), phycoerythrin (PE)-CF594-anti-CD19 (clone ID3), PE-Cy7-anti-CD11c (clone HL3), PE-Cy7-anti-Ter119 (clone TER-119), Alexa Fluor 647-anti-CD47 (clone MIAP301), and fluorescein isothiocyanate (FITC)-anti-major histocompatibility complex class II (MHCII) (I-A/I-E) (catalog number FAB6118F); lymphocyte populations were initially gated on single live cells on the basis of forward scatter (FSC) versus side scatter (SSC)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A publicly available gene expression data set from SARS-CoV-2 infection of A549 cells (accession number ",
            "GSE147507",
            ") (n = 10) was downloaded from the ",
            "Gene Expression Omnibus (GEO)",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 1364,
                "end": 1373,
                "name": "GSE147507"
            },
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 1408,
                "end": 1437,
                "name": "Gene Expression Omnibus (GEO)"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T6",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "Considering the epidemic nature SARS-CoV-2 in the COVID-19 outbreak, identifying the intermediate and original host of SARS-CoV-2 is crucial for preventing new large-scale infection and transmission of viruses."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The host identification was also based on these 95 complete SARS-CoV-2 records from ",
            "GISAID",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 295,
                "end": 301,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 outbreak in Wuhan this time was firstly located at a so-called seafood market, but actually it was a live animal market because a variety of animals were for sale in this seafood market for a long time."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We collected 823 coronaviruses with other animal hosts on ",
            "NCBI",
            " and 3 pangolin-CoVs from ",
            "GISAID",
            " and compared these 826 records with the 95 SARS-CoV-2 strains."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 577,
                "end": 581,
                "name": "NCBI"
            },
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 607,
                "end": 613,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All the accession numbers of the datasets are shown in Supplementary files S1, S2 and S3."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The biological distance between two sequences can be expressed as the Euclidean distance between the two corresponding natural vectors in 12-dim space, as applied on many datasets [25]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, for a dataset of n sequences, the relationship is here described as a  pairwise distance matrix."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For a dataset of n units, we first find the neighbor of each unit by searching for the smallest distance from each unit to any other units."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patients possibly became infected during their stay in Wuhan, but showed no obvious symptoms during the incubation, and after returning to home city/province, had fever or dry cough that further confirmed to be COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Though we have filtered out these sequences, it also decreases the size of dataset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In [50], the author collected 86 complete or near-complete genomes of SARS-CoV-2 strains on GISAID, and performed pair-wise nucleotide sequence alignment by ClustalX2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The severe respiratory disease COVID-19 was initially reported in Wuhan, China, in December 2019, and spread into many provinces from Wuhan."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of 2 May, 2020, over 3 million COVID-19 cases had been confirmed, and 235,290 deaths had been reported globally, and the numbers are still increasing."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is plausible that different strategies will contribute to eventually defeat the Covid-19: small anti-viral molecules are being tested to block the infection, and the nucleotide analogue Remdesivir has recently been approved by FDA as “standard of care” for patients with COVID-19 [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We quantified virus infectivity with the 50% tissue culture infectious dose TCID50 assay, and estimated the corresponding plaque forming units (PFU)/ml using the conversion PFU/ml = 0.7 TCID50",
            "."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The results are reported as the estimate plaque forming units (PFU)/ml using the conversion PFU/ml = 0.7 TCID50",
            " by applying the Poisson distribution."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is also important to note that the previous results with H1N1 virus utilized a fluorescent focus assay to assess virus survival in contrast to this work which used the TCID50 assay."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While both assays are widely used to accurately determine viral infectivity, the former employs immunofluorescence to detect a specific viral antigen, instead of depending on cytopathic effects as in the TCID50 assay."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The dataset file generated during and/or analysed during the current study is available in the ",
            "Open Science Framework (OSF)",
            " repository, identifier: ",
            "DOI 10.17605/OSF.IO/KGZAF",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 844,
                "end": 872,
                "name": "Open Science Framework (OSF)"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 897,
                "end": 922,
                "name": "DOI 10.17605/OSF.IO/KGZAF"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "After exposure to SARS-COV-2, susceptible individuals can develop coronavirus disease 2019 (COVID-19) consisting of symptoms that may range from fever and cough to severe respiratory illness; in some cases, COVID-19 is life-threatening (Centers for Disease Control and Prevention, 2020a; Wadman, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since the onset of the outbreak, more than 10 million COVID-19 cases have been confirmed, accounting for more than 500,000 deaths (COVID-19, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By April 2019, the states of New York and Michigan were the most severely affected (COVID-19, 2020), given that the metropolitan areas of New York City and Detroit possess large populations subject to health disparities that include limited access to health care, chronic exposure to pollution, and pre-existing cardiovascular conditions (Centers for Disease Control and Prevention, 2020b)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Pregnant women and their fetuses represent a potential high-risk population in light of the COVID-19 outbreak (Dashraath et al., 2020; Liu et al., 2020; Rasmussen et al., 2020; Ashokka et al., 2020; Della Gatta et al., 2020; Weber LeBrun et al., 2020; Tekbali, 2020; Vintzileos, 2020; Lokken, 2020) given that viral infections such as influenza (Neuzil et al., 1998; Lindsay et al., 2006; Jamieson et al., 2006; Cervantes-Gonzalez and Launay, 2010; Pandemic H1N1 Influenza in Pregnancy Working Group et al., 2010; Mosby et al., 2011; Pazos et al., 2012; Raj et al., 2014), varicella (Triebwasser et al., 1967; Paryani and Arvin, 1986; Esmonde et al., 1989; Haake et al., 1990; Swamy and Dotters-Katz, 2019), Ebola (Olgun, 2018; Muehlenbachs et al., 2017), and measles (Christensen et al., 1954; Atmar et al., 1992) show increased severity in this physiological state."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Consequently, the clinical characteristics of pregnant women with COVID-19 appear similar to those of non-pregnant adults (Yu et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Yet, recent reports have shown that severe COVID-19 can lead to maternal death (Hantoushzadeh et al., 2020; Blitz, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Consistently, infants born to mothers with COVID-19 test negative for SARS-CoV-2, do not develop serious clinical symptoms (e.g., fever, cough, diarrhea, or abnormal radiologic or hematologic evidence), and are promptly discharged from the hospital (Chen et al., 2020c)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Case reports have shown that a small fraction of neonates born to women with COVID-19 tested positive for the virus at 1–4 days of life (Zeng et al., 2020a; Alzamora et al., 2020), yet these neonates subsequently tested negative on day 6-7 (Zeng et al., 2020a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, serological studies revealed that a few neonates born to mothers with COVID-19 had increased concentrations of SARS-CoV-2 immunoglobulin (Ig)M as well as IgG (Zeng et al., 2020b; Dong et al., 2020b)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the first case report, the viral RNA was detected in amniotic fluid from a woman who was severely affected and died of COVID-19 (Zamaniyan, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our first-trimester data are in agreement with a prior report showing minimal expression of ACE2 at the human maternal-fetal interface (Zheng et al., 2020); however, the same dataset was recently used to report the opposite (Li et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, we explored the expression of ACE2 and TMPRSS2 in third-trimester placental tissues by mining two microarray datasets that we have previously reported (Kim et al., 2009; Toft et al., 2008)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This reduced expression contrasts with the high expression of ACE2 and TMPRSS2 in nasal goblet and ciliated cells within the human airways, lungs, and gastrointestinal tract, which are targeted during COVID-19 (Muus, 2020; Wang, 2020b; HCA Lung Biological Network et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The expression of additional SARS-CoV-2-related receptors or proteins in the human placenta is shown in Figure 2, CoV-Alt; however, further research is required to test their participation in the pathogenesis of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, it is unlikely that this protein alone is a sufficient requirement for SARS-CoV-2 viral entry, and other proteins may be required to explain the cell type primarily affected by COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The cellular receptors and mechanisms that could be exploited by SARS-CoV-2 are still under investigation (Gordon et al., 2020), yet single-cell atlases can help to identify cell types with a similar transcriptional profile to those that are known to participate in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Data for third-trimester samples previously collected by our group are available through ",
            "NIH dbGAP",
            " (accession number ",
            "phs001886.v2.p1",
            "), and newly generated second-trimester scRNA-seq and third-trimester snRNA-seq data are being deposited into the same repository (Supplementary file 1)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 4375,
                "end": 4384,
                "name": "NIH dbGAP"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 4403,
                "end": 4418,
                "name": "phs001886.v2.p1"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "Gene expression data for the study by ",
            "Kim et al., 2009",
            " was available from the ",
            "www.ebi.ac.uk/microarray-as/ae/",
            " database (entry ID: ",
            "E-TABM-577",
            "), while data for the study by ",
            "Toft et al., 2008",
            " is available in our data repertoire."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Creator",
                "start": 4610,
                "end": 4626,
                "name": "Kim et al., 2009"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 4650,
                "end": 4681,
                "name": "www.ebi.ac.uk/microarray-as/ae/"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 4702,
                "end": 4712,
                "name": "E-TABM-577"
            },
            false,
            {
                "id": "T6",
                "type": "Creator",
                "start": 4743,
                "end": 4760,
                "name": "Toft et al., 2008"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T3",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "The pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected more than 10 million people, including pregnant women."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "GenBank",
            " accession numbers (",
            "LC494126",
            "-",
            "LC494192",
            ") for each BCoV isolate are summarized in Table S1."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 4,
                "end": 11,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 31,
                "end": 39,
                "name": "LC494126"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 40,
                "end": 48,
                "name": "LC494192"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T1",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "By February 14, 2020, a total of 66,576 confirmed cases of COVID-19, people infected with SARS-CoV-2, were reported in China, leading to 1524 deaths, per the ",
            "Chinese CDC",
            " (",
            "http://2019ncov.chinacdc.cn/2019-nCoV/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Creator",
                "start": 158,
                "end": 169,
                "name": "Chinese CDC"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 171,
                "end": 209,
                "name": "http://2019ncov.chinacdc.cn/2019-nCoV/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "The sequences of BetaCoV were downloaded on February 3, 2020 from the ",
            "GISAID",
            " platform."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 282,
                "end": 288,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 58 accessions were available, among which BetaCoV/bat/Yunnan/RaTG13/2013 is a known close relative of SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Four accessions, namely, BetaCov/Italy/INM1/2020, BetaCov/Italy/INM2/2020, BetaCoV/Kanagawa/1/2020, and BetaCoV/USA/IL1/2020, were excluded because of the short-truncated sequences or multiple ambiguous nucleotides."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 54 accessions (Supplementary Table 1) isolated from humans were utilized in the following analysis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, two accessions (BetaCoV/Shenzhen/SZTH-001/2020 and BetaCoV/Shenzhen/SZTH-004/2020) from Shenzhen, which had 5 and 16 mutations, respectively, were excluded, considering the possible experimental issues."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, a history of cigarette smoke exposure, the major risk factor for the development of COPD, has been associated with more severe disease in patients infected with a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent in the ongoing coronavirus disease 2019 (COVID-19) pandemic ()."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Mice with homozygous loss of Miz1 showed up-regulation in the expression of angiotensin-converting enzyme 2 (Ace2), the receptor for SARS-CoV-2, which is the causative organism in the current COVID-19 pandemic ()."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Reads were aligned using TopHat2 to the mm10 reference genome, differential expression was assessed using edgeR, and enrichment analysis was performed using curated databases including GO or KEGG PATHWAY mapping."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The tandem mass spectra were searched against the ",
            "UniProt",
            " mouse protein database, and sequences of known contaminants such as keratin and porcine trypsin concatenated to a decoy database in which the sequence for each entry in the original database was reversed."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 818,
                "end": 825,
                "name": "UniProt"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our data suggest that Miz1 down-regulation–induced sustained activation of NF-κB–dependent inflammation in the lung epithelium is sufficient to induce progressive lung and airway destruction that recapitulates features of COPD, with implications for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The novel coronavirus disease (COVID‐19) has spread worldwide, resulting in numerous cases of morbidity and death."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Generally, COVID‐19 has an incubation period of 2–7 days,[",
            "Therefore, early accurate diagnosis and isolation of patients is key to controlling the COVID‐19 pandemic."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, nucleic acid detection continues to be the gold standard for COVID‐19 diagnosis, with several such methods having been employed for detection of the COVID‐19 causative virus, SARS‐CoV‐2.[",
            "] which can facilitate infection transmission through delayed patient isolation and treatment, resulting in continued COVID‐19 spread."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "] Additional new methods based on isothermal PCR amplification are also available, such as Abbott's ID Now instrument, which can interpret results in minutes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "] Cross‐infection during the diagnosis process both propagates the spread of SARS‐CoV‐2 and subjects COVID‐19 patients to other respiratory viruses."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, detection of virulence mutations, virus typing, and epidemiological analysis are critical for the prevention and control of COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To test the SARS‐CoV‐2 detection efficiency by NTS, we used standard plasmids harboring COVID‐19 virus S and N genes to simulate SARS‐CoV‐2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Evaluation of the target distribution of the datasets revealed that in higher‐copy samples (1000 and 3000 copies per reaction), all targeted regions were detected (Figure 2c,d)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The samples were divided into two groups: i) 45 nasopharyngeal swabs from outpatients with suspected COVID‐19 early in the epidemic (January 2020), for whom detailed records and suitable clinical data were unavailable, preventing us from confirming SARD‐CoV‐2 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "ii) 16 nasopharyngeal swabs from hospitalized patients who had been diagnosed with COVID‐19 by clinicians through comprehensive results of nucleic acid tests, chest computed tomography scans, blood tests, and clinical symptoms and, hence, for whom nucleic acid samples tested positive for SARS‐CoV‐2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, we next evaluated samples retained from hospitalized patients with confirmed COVID‐19 subjected to RT‐qPCR testing (kit 1, Figure 1) on February 11 and 12, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These results suggest that NTS could identify positive COVID‐19 infected cases, seems has higher identification ability than RT‐qPCR."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, genome wide allele frequency analysis (Experimental Section) of 50 NTS positive samples, as well as 1145 recently published (before March 24, 2020) SARS‐CoV‐2 genomes from the ",
            "GISAID",
            " database[",
            "] also indicated a common SNP at position 28144 (Figure 7a), with a similar allele frequency (26.7% of NTS and 28.3% of ",
            "GISAID",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 2453,
                "end": 2459,
                "name": "GISAID"
            },
            false,
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 2590,
                "end": 2596,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To verify the ability of NTS to detect SARS‐CoV‐2 and other respiratory viruses within a single assay, 13 of the 45 suspected COVID‐19 outpatient samples were subjected to simultaneous detection analysis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "] was used to map the reads of each sample against the virus genome reference database."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All virus genomic sequences were downloaded on January 20, 2020, from ",
            "NCBI",
            " ",
            "Refseq",
            " FTP (",
            "http://ftp.ncbi.nlm.nih.gov/refseq/release/viral/",
            "); the SARS‐CoV‐2 genome was added to the ",
            "BLAST",
            " database because the genome was not collected in the virus ",
            "Refseq",
            " database prior to January 20, 2020."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 2962,
                "end": 2966,
                "name": "NCBI"
            },
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 2967,
                "end": 2973,
                "name": "Refseq"
            },
            false,
            {
                "id": "T5",
                "type": "URL",
                "start": 2979,
                "end": 3028,
                "name": "http://ftp.ncbi.nlm.nih.gov/refseq/release/viral/"
            },
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 3070,
                "end": 3075,
                "name": "BLAST"
            },
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 3135,
                "end": 3141,
                "name": "Refseq"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T4",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "The ongoing global novel coronavirus pneumonia COVID‐19 outbreak has engendered numerous cases of infection and death."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID‐19 diagnosis relies upon nucleic acid detection; however, currently recommended methods exhibit high false‐negative rates and are unable to identify other respiratory virus infections, thereby resulting in patient misdiagnosis and impeding epidemic containment."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Parallel testing with approved real‐time reverse transcription‐polymerase chain reaction kits for SARS‐CoV‐2 and NTS using 61 nucleic acid samples from suspected COVID‐19 cases show that NTS identifies more infected patients (22/61) as positive, while also effectively monitoring for mutated nucleic acid sequences, categorizing types of SARS‐CoV‐2, and detecting other respiratory viruses in the test sample."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "NTS is thus suitable for COVID‐19 diagnosis; moreover, this platform can be further extended for diagnosing other viruses and pathogens."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The availability of the virus genome sequence (",
            "GenBank",
            " ID: ",
            "MN908947.3",
            ") makes it possible to identify treatments."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 47,
                "end": 54,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 59,
                "end": 69,
                "name": "MN908947.3"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "However, 2019‐nCoV shares 82 % sequence identity with severe acute respiratory syndrome‐related coronavirus (SARS‐CoV, ",
            "GenBank",
            " ID: ",
            "NC_004718.3",
            ") and more than 90 % sequence identity in several essential enzymes (see figures below)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 232,
                "end": 239,
                "name": "GenBank"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 244,
                "end": 255,
                "name": "NC_004718.3"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "Both crystal and cryo‐EM structures of the SARS‐CoV spike‐ACE2 complex (",
            "PDB",
            " IDs: ",
            "2AJF",
            " and ",
            "6ACD",
            ") have showed that only regions 1 and 2 engage in hydrogen bonding and hydrophobic interactions with ACE2."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 416,
                "end": 419,
                "name": "PDB"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 425,
                "end": 429,
                "name": "2AJF"
            },
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 434,
                "end": 438,
                "name": "6ACD"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T5",
                "end": "T7"
            }
        ]
    },
    {
        "sen": [
            "33 Exonuclease activity by the enzyme nsp14 has been shown to be able to remove mismatches as well as incorporated nucleoside analogues, and inactivation of nsp14′s exonuclease activity has been shown to increase the efficacy of nucleosides like RBV.32, 34 In order to develop nucleoside analogues to effectively inhibit viral RNA replication, the nucleoside must either evade detection by the exonuclease or must outcompete exonuclease activity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Abstract   Background  Waning immunity occurs in patients who have recovered from COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Whole genome sequencing was performed directly on respiratory specimens collected during two episodes of COVID-19 in a patient."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Compared to viral genomes in ",
            "GISAID",
            ", the first virus genome has a stop codon at position 64 of orf8 leading to a truncation of 58 amino acids, and was phylogenetically closely related to strains collected in March/April 2020, while the second virus genome was closely related to strains collected in July/August 2020."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 249,
                "end": 255,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Exclusion criteria included current symptoms consistent with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Some groups seem particularly vulnerable to severe COVID-19, notably the elderly and those with existing health conditions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Apparent familial or heritable variations in susceptibility to disease have long been recognized, for example in relation to tuberculosis, malaria, leprosy, and HIV, and preliminary reports are emerging in relation to COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "The scientific community has acted rapidly to establish the ",
            "COVID-19 Host Genetics initiative",
            ", which includes 127 studies in a global collaboration to investigate the genomes of those infected by coronavirus."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 414,
                "end": 447,
                "name": "COVID-19 Host Genetics initiative"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Leading commercial genetic companies have also launched studies of COVID-19 susceptibility, drawing on their substantial privately held data sets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This commentary highlights the need for COVID-19 host genetics to engage with questions related to the role of genetic susceptibility factors in creating potential inequalities in the ability to work or access public space, stigma, and inequalities in the quality and scope of data."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It may also enable employers to extend steps to protect staff, minimize the likelihood of workplace illness, and help them maintain a healthy workforce, for example in line with recommendations from the US Equal Employment Opportunity Commission on COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, here COVID-19 research encounters well-described challenges associated with the population distribution of genetic data, and the consequent privileging of specific groups in genetic analyses."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The data sets used for genome-wide association studies (GWAS) are skewed toward Northern European ancestry populations, who account for nearly 80% of individuals in GWAS catalogs—with 70% of participants recruited from the UK, United States, and Iceland alone."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "Inequalities in existing genetic data sets have implications for efforts to understand genetic influences on susceptibility to COVID-19, to predict which groups are most likely to be affected, and to estimate the wider prevalence of identified variants."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This is not a problem unique to COVID research."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Such problems may compound existing concerns related to the quality of data underpinning existing COVID-19 diagnostic and predictive models, and the absence of relevant features, including ethnicity, from clinical data sets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "Given emerging evidence of ethnic and gender differences related to COVID consequences, it is essential that host genetic analyses build on this progress to ensure the collection of data of sufficient scale, scope, and quality to provide equitable access to benefits that accrue from research."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All SARS-CoV-2 genomes sequences in the final dataset from May 2020 were copied into a separate FASTA file (n = 778 sequences), then 100 bases were trimmed from the 5′ and 3’ ends of each sequence to remove low-quality degenerate nucleotides."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To assess the inclusivity of oligonucleotides from these assays, we curated a dataset of 15,001 SARS-CoV-2 genome sequences from specimens collected between Dec 31, 2019 and May 31, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The composition of the dataset by region and collection month is shown in Fig. 1",
            "."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using PCR_strainer, we identified genomes in our dataset with nucleotide mismatches in locations targeted by the early SARS-CoV-2 LDTs described above."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Two sets of oligonucleotides had mismatches against all 15,001 SARS-CoV-2 reference genomes in our dataset: the Charité group’s RdRP gene assay and the Japan NIID’s N gene assay."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "One of these variants, which we will call the ‘AAC’ variant, was present in 18.8 % of genomes in our dataset (Table 3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Next, we constructed a phylogeny of all SARS-CoV-2 genomes in our dataset from May 2020, the most recent completed month at the time of writing (Fig. 4",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, this clade closely overlapped with the ",
            "GISAID",
            " ‘GR’ clade: 99.5 % of genomes with the ‘AAC’ variant were identified as members of Clade ‘GR’, and 100 % of genomes identified as members of clade ‘GR’ contained the ‘AAC’ variant."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 1172,
                "end": 1178,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Single mismatches in the Charité group and Japan NIID assays were uniform and pervasive, suggesting they were artefacts of the oligonucleotide design process."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The mismatch in the Japan NIID’s assay was due to an error in the first reported SARS-CoV-2 genome assembly, and investigations by the assay’s designers did not find any impact on clinical performance [11]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Mismatches in the Charité group and Japan NIID assays were both 14 positions from the more-crucial 3’ end of the primers."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Indeed, as stated above, the Japan NIID group failed to observe a difference in detection between primers with and without the mismatch [11]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of the 384,096 contigs assembled by Megahit, the longest (30,474 nucleotides (nt)) had a high abundance and was closely related to a bat SARS-like coronavirus (CoV) isolate—bat SL-CoVZC45 (",
            "GenBank",
            " accession number ",
            "MG772933",
            ")—that had previously been sampled in China, with a nucleotide identity of 89.1% (Supplementary Tables 1, 2)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 189,
                "end": 196,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 214,
                "end": 222,
                "name": "MG772933"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "This virus strain was designated as WH-Human 1 coronavirus (WHCV) (and has also been referred to as ‘2019-nCoV’) and its whole genome sequence (29,903 nt) has been assigned ",
            "GenBank",
            " accession number ",
            "MN908947",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 505,
                "end": 512,
                "name": "GenBank"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 530,
                "end": 538,
                "name": "MN908947"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "The viral genome organization of WHCV was determined by sequence alignment to two representative members of the genus Betacoronavirus: a coronavirus associated with humans (SARS-CoV Tor2, ",
            "GenBank",
            " accession number ",
            "AY274119",
            ") and a coronavirus associated with bats (bat SL-CoVZC45, ",
            "GenBank",
            " accession number ",
            "MG772933",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 728,
                "end": 735,
                "name": "GenBank"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 753,
                "end": 761,
                "name": "AY274119"
            },
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 819,
                "end": 826,
                "name": "GenBank"
            },
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 844,
                "end": 852,
                "name": "MG772933"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T7",
                "end": "T8"
            }
        ]
    },
    {
        "sen": [
            "Sequence reads generated in this study are available from the ",
            "NCBI",
            " ",
            "Sequence Read Archive (SRA)",
            " database under BioProject accession number ",
            "PRJNA603194",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Creator",
                "start": 917,
                "end": 921,
                "name": "NCBI"
            },
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 922,
                "end": 949,
                "name": "Sequence Read Archive (SRA)"
            },
            false,
            {
                "id": "T11",
                "type": "AccessionNumber",
                "start": 993,
                "end": 1004,
                "name": "PRJNA603194"
            },
            false
        ],
        "rel": [
            {
                "id": "R5",
                "bool": true,
                "head": "T10",
                "end": "T11"
            }
        ]
    },
    {
        "sen": [
            "The complete genome sequence of WHCV has been deposited in ",
            "GenBank",
            " under accession number ",
            "MN908947",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 1065,
                "end": 1072,
                "name": "GenBank"
            },
            false,
            {
                "id": "T13",
                "type": "AccessionNumber",
                "start": 1096,
                "end": 1104,
                "name": "MN908947"
            },
            false
        ],
        "rel": [
            {
                "id": "R6",
                "bool": true,
                "head": "T12",
                "end": "T13"
            }
        ]
    },
    {
        "sen": [
            "A total of 447 patients were enrolled in mainland China, and 617 were from other Asian sites; the corresponding numbers of patients with COVID-19 were 78,497 and ranged from 0 to 1,766, respectively (Fig 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Overall, 37,846 genes targeted by 48,804 probes were analyzed for all samples (",
            "Gene Expression Omnibus",
            " accession number ",
            "GSE36961",
            "), and 8443 genes (22% of the transcriptome) were expressed differentially between HCM and controls based on a false discovery rate q-value less than 0.05."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 79,
                "end": 102,
                "name": "Gene Expression Omnibus"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 120,
                "end": 128,
                "name": "GSE36961"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "Given the current and devastating coronavirus disease 2019 (COVID-19) pandemic (>2.5 million confirmed cases) that has claimed more than 172,000 lives worldwide in less than 4 months (April 21, 2020), it was noteworthy that the most up-regulated gene in HCM samples was ACE2 (3.53-fold; q-value=1.30×10−23)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This viral internalization may result in loss of membrane ACE2 and a subsequent increase in the angiotensin II to angiotensin-(1-7) ratio, which in turn allows excessive angiotensin II and unopposed angiotensin type 1 receptor–mediated lung injury in patients with COVID-19 infection and the development of severe acute respiratory distress syndrome."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nevertheless, widespread ACE2 expression may contribute to the multiorgan dysfunction seen in patients with COVID-19 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "The marked 5-fold increase in ACE2 protein in HCM may provide a mechanism to explain higher rates of severe outcomes in COVID-19–infected patients who also have cardiovascular comorbid conditions, as well as the direct cardiac damage caused by SARS-CoV-2 infections."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although the incidence of COVID-19 infection seems highest in the elderly or immunocompromised, a large number of affected patients and those requiring hospitalization have significant comorbid conditions, including highly prevalent cardiovascular diseases such as HTN or CHF."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In early studies, 7.2% of all COVID-19–infected patients and 22% of patients admitted to ICUs showed evidence of myocardial injury with elevated high-sensitivity troponin I levels or new ECG abnormalities with clinical manifestations of myocardial ischemia or myocarditis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although initial reports suggested potentially worse outcomes in patients with COVID-19 infection who were using ACEis,",
            ",",
            " a subsequent review article concluded that there was insufficient evidence for this claim, prompting all major cardiac societies to advise that patients with heart disease treated with these medications should continue to use them as prescribed."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, a large study among 1128 patients with HTN and diagnosed with COVID-19 infection showed that the unadjusted mortality rate was significantly lower in those for whom HTN was treated with ACEi/ARBs (3.7% vs 9.8%; P=.001)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In light of these findings, a clinical trial has been launched testing the effect of losartan in study-eligible patients with COVID-19 infection (",
            "NCT04312009",
            "; Figure 4",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 2638,
                "end": 2649,
                "name": "NCT04312009"
            },
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Notably, in the context of coronavirus disease 2019 (COVID-19), the transcript for angiotensin I converting enzyme 2 ( ACE2 ), a negative regulator of the angiotensin system, was the single most up-regulated gene in HCM (fold-change, 3.53; q-value =1.30×10 −23 ), which was confirmed by qRT-PCR in triplicate (fold change, 3.78; P =5.22×10 −4 ), and Western blot confirmed greater than 5-fold overexpression of ACE2 protein (fold change, 5.34; P =1.66×10 −6 )."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, given that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses ACE2 for viral entry, this 5-fold increase in ACE2 protein may confer increased risk for COVID-19 manifestations and outcomes in patients with increased ACE2 transcript expression and protein levels in the heart."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To analyse the phylogenetic relationship between different coronaviruses, 591 genomes were downloaded from ",
            "Global Initiative on Sharing All Influenza Database (GISAID)",
            " (",
            "https://www.gisaid.org/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 107,
                "end": 167,
                "name": "Global Initiative on Sharing All Influenza Database (GISAID)"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 169,
                "end": 192,
                "name": "https://www.gisaid.org/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "To prevent anomaly in the data represented, complete genomes and only high coverage datasets were utilized."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We investigated the phylogenetic analysis of 591 genomic sequences of hCoV obtained from ",
            "GISAID",
            " database using RAxML methods."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 392,
                "end": 398,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since December 2019, a pneumonia associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), named as coronavirus disease 2019 (COVID-19) by World Health Organization (WHO), emerged in Wuhan, China (1–3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although remdesivir was reported to possess potential antiviral effect in one COVID-19 patient from the United States, randomized controlled trials of this drug are ongoing to determine its safety and efficacy (6)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, the corticosteroid treatment for COVID-19 lung injury remains controversial, due to delayed clearance of viral infection and complications (7, 8)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since the effective vaccine and specific antiviral medicines are unavailable, it is an urgent need to look for an alternative strategy for COVID-19 treatment, especially among severe patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since the virological and clinical characteristics share similarity among SARS, Middle East Respiratory Syndrome (MERS), and COVID-19 (15), CP therapy might be a promising treatment option for COVID-19 rescue (16)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patients who have recovered from COVID-19 with a high neutralizing antibody titer may be a valuable donor source of CP."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nevertheless, the potential clinical benefit and risk of convalescent blood products in COVID-19 remains uncertain."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hence, we performed this pilot study in three participating hospitals to explore the feasibility of CP treatment in 10 severe COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among the first batch of CP samples from 40 recovered COVID-19 patients, 39 showed high antibody titers of at least 1:160, whereas only one had an antibody titer of 1:32."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "From January 23, 2020, to February 19, 2020, 10 severe COVID-19 patients (six males and four females) were enrolled and received CP transfusion."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Lymphocytopenia, an important index for prognosis in COVID-19 (2), tended to be improved after CP transfusion (median: 0.65 × 109 per L vs. 0.76 × 109 per L), 7 out of 10 patients showing an increase of lymphocyte counts (Fig. 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recent studies on COVID-19 demonstrated that the lymphocyte counts in the peripheral blood were remarkably decreased and the levels of cytokines in the plasma from patients requiring intensive care unit (ICU) support, including IL-6, IL-10, TNF-ɑ, and granulocyte-macrophage colony-stimulating factor, were significantly higher than in those who did not require ICU conditions (2, 18)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "CP, obtained from recovered COVID-19 patients who had established humoral immunity against the virus, contains a large quantity of neutralizing antibodies capable of neutralizing SARS-CoV-2 and eradicating the pathogen from blood circulation and pulmonary tissues (19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on our preliminary results, CP therapy can be an easily accessible, promising, and safe rescue option for severe COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the present study, recently recovered COVID-19 patients, who were infected by SARS-CoV-2 with neutralizing antibody titer above 1:640 and recruited from local hospitals, should be considered as suitable donors."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The antibody titers in CP in COVID-19 seem thus higher than those used in the treatment of MERS patient (1:80) (12)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All patients were diagnosed as having severe COVID-19 according to the WHO Interim Guidance (30) and the Guideline of Diagnosis and Treatment of COVID-19 of National Health Commission of China (version 5.0) (31), with confirmation by real-time RT-PCR assay."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Significance  COVID-19 is currently a big threat to global health."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These results indicate that CP can serve as a promising rescue option for severe COVID-19, while the randomized trial is warranted."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Currently, there are no approved specific antiviral agents for novel coronavirus disease 2019 (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This study showed CP therapy was well tolerated and could potentially improve the clinical outcomes through neutralizing viremia in severe COVID-19 cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), is a pandemic that has infected more than 3.2 million people around the world and caused more than 250,000 deaths as of May 4, 2020 (), including >1.2 million cases in the United States (US) and >52,000 in California."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In particular, Washington State has reported a series of COVID-19 cases from Jan 21 to Mar 18, following the identification of the earliest case reported in the US, WA1, on Jan 19, suggesting the presence of a persistent transmission chain in the community (, )."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, real-time genomic epidemiology data of COVID-19 to inform public health interventions in California have been lacking to date."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here we used this method and/or tiling multiplex PCR to recover viral genomes from COVID-19 patients in Northern California and perform phylogenetic analyses to better understand the genetic diversity of SARS-CoV-2 in the US and the nature of transmission of virus lineages in the community."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We screened a total of 62 respiratory swab samples from 54 COVID-19 patients available from hospitals and clinics at University of California, San Francisco (UCSF), the California Department of Public Health (CDPH), and 8 county public health departments in Northern California (table S1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Phylogenetic analysis revealed that the 36 SARS-CoV-2 genomes from California generated in this study were dispersed across the evolutionary tree of SARS-CoV-2 that was built from 789 worldwide genomes deposited into ",
            "GISAID",
            " as of March 20, 2020 (Fig. 2A)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 1538,
                "end": 1544,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This suggested that the virus from UC19 could be basally positioned relative to the cruise ship strains from voyage B, and that COVID-19 infections associated with voyage A may have been passed onto passengers and crew on voyage B."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Three patients examined in this study (CA3, CA4, and UC12) had COVID-19 infections associated with international travel or exposure to international travelers."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In Santa Clara County, we sequenced 7 genomes from individuals who were part of a local outbreak of COVID-19 at a large workplace facility with multiple employers, large areas of shared space, and heavy pedestrian traffic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The genomic epidemiology of the COVID-19 cases associated with community spread studied here do not show any predominant SARS-CoV-2 lineage circulating in Northern California."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, WA1 lineage viruses have been identified in COVID-19 cases from many states including Minnesota, Connecticut, Utah, Virginia, and New York (, )."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Undersampling of virus genomes is due in part to the high proportion of cases (80%) with asymptomatic or mild disease (–) and limited diagnostic testing for COVID-19 infection to date in California and throughout the US."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Despite this, our study shows that robust insights into COVID-19 transmission are achievable if virus genomic diversity is combined and jointly interpreted with detailed epidemiological case data."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our data suggest concerning trends in this direction, such as the association between the WA1 lineage and community-acquired COVID-19 cases in several counties of Northern California, and a virus from the SCC1 lineage detected in residents of neighboring San Mateo and Solano County."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2 has spread globally, with >52,000 cases in California as of May 4, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The sudden epidemic outbreak of the new coronavirus disease 2019 (COVID-19) in Wu Han City, China, has rapidly spread all over the world, leading to one of the worst pandemic outbreaks since the Spanish Flu that occurred 100 years ago (1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on that, the World Health Organization (WHO) declared the COVID-19 outbreak a pandemic on March 11th 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Herein, we will discuss the pathological progression of this disease along with the activated inflammatory response that underlies the lethal complications of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We will also evaluate the current status of Thalidomide usage as an anti-inflammatory therapy for COVID-19 induced pneumonia and acute lung injury (ALI)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since the human respiratory system is the primary target for coronavirus pathogens, abnormal respiratory findings are highly detected in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This cytokine storm initiates lung injures and is considered the primary clinical cause of death among COVID-19 patients (11)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, if kept untreated, COVID-19 can cause damage to the heart, the liver, and the kidneys, as well as to organ systems such as the blood and the immune system (13)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among the tested anti-inflammatory drugs are the non-steroidal anti-inflammatory (NSAID) drugs, glucocorticoids, intravenous immunoglobulin therapy, NK cell-based immunotherapy, immunosuppressants, and inflammatory cytokines antagonists (17, 19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although some of these drugs have shown to be efficient in COVID-19 treatment, yet the accompanying adverse side effects or the reported non-significant outcomes did not support their further usage (4, 20, 21)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "So far, chloroquine and hydroxychloroquine usage have been highly applauded and was given an emergency approval by the FDA to slow the progression of COVID-19 among critical cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The above cases are characterized by similar disease manifestations, pathogenicity, and progression as the ones encountered in COVID-19 cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similar to COVID-19, Paraquat (PQ) poisoning is known to be associated with respiratory distress due to the alveolar epithelial cell disruption, hemorrhage, and the infiltration of inflammatory cells into the interstitial and alveolar spaces which ends up with fibroblastic proliferation, collagen deposition, and progressive fibrosis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In both (PQ) and (BLM)-induced pulmonary fibrosis models, the core pro-inflammatory cytokines underlying the pathogenicity of these conditions such as TNF-α, IL-6, IL-1β, and TGF-β are common with that of COVID-19 cases (38, 39)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on the above, Thalidomide could be hypothetically listed among the potential drugs to be tested in treating respiratory complications associated with COVID-19 based on its potent anti-inflammatory properties and its activity in attenuating exaggerated inflammation and cytokine storms (Figure 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On February 26th 2020, a case-report preprint manuscript was published online with a single Chinese patient with severe COVID-19 pneumonia being treated with Thalidomide in combination with low-dose glucocorticoids and anti-viral therapy (43)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The results presented Thalidomide as a promising therapeutic drug to treat severe cases of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first clinical trial (",
            "NCT04273581",
            ") would address the efficacy and safety of this drug in combination with low-dose hormones for treating severe COVID-19 cases."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "AccessionNumber",
                "start": 3148,
                "end": 3159,
                "name": "NCT04273581"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The second trial (",
            "NCT04273529",
            ") would investigate the efficacy and safety of this drug as an adjuvant treatment for moderate new COVID-19 cases with pneumonia."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 3304,
                "end": 3315,
                "name": "NCT04273529"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this trial, Thalidomide (100 mg) will be used for 14 days to treat lung inflammation in 100 participants with COVID-19 (44, 45)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, using this drug for treating respiratory conditions such as those encountered by COVID-19 should be further investigated before proceeding."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Currently, the only available case-report on the efficacy of Thalidomide in treating severe COVID-19 cases is not sufficient to promote the usage of the drug due to several reasons."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Aside from being a non-peer reviewed article that describes the outcomes in only one COVID-19 patient, the combination of Thalidomide with corticosteroids might be a drawback since the latter were reported to cause lung injury, and thus, their usage is not clinically supported (20)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Second, the two clinical trials that aim at studying the efficacy and safety of this drug in COVID-19 patients were initiated by the same author who published the discussed single case-report."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, further studies on the usage of Thalidomide in COVID-19 cases should take into account the resultant induced birth defects and the severe toxicities that are encountered during its intake, such as sensorimotor peripheral neuropathy, somnolence, acute pulmonary toxicities, and thromboembolic events (22, 51–53)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The coronavirus disease 2019 (COVID-19) pandemic is a worldwide threatening health issue."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the absence of an effective anti-viral molecule and until the formulation of a successful vaccine, anti-inflammatory drugs might offer a complementary tool for controlling the associated complications of COVID-19 and thus decreasing the subsequent fatalities."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Drug repurposing for several molecules has emerged as a rapid temporary solution for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on just one-case report that presented positive outcomes in a patient treated amongst others with Thalidomide, two clinical trials on the efficacy and safety of Thalidomide in treating severe respiratory complications in COVID-19 patients were registered."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Herein, we will discuss the theoretical effectiveness of Thalidomide in attenuating inflammatory complications that are encountered in COVID-19 patients while pinpointing the lack of the needed evidences to move forward with this drug."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Removal of unincorporated ddNTP’s, salts, and dye blobs were performed by BigDye XTerminator Purification Kit (Applied Biosystems, San Diego, CA, USA)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The genomic data was analyzed and submitted to a public database (",
            "GenBank",
            ") under accession numbers ",
            "MK858156",
            "-",
            "MK858164",
            " and ",
            "MN735679",
            "-",
            "MN735682",
            " (Supplementary Table S1)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 218,
                "end": 225,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 251,
                "end": 259,
                "name": "MK858156"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 260,
                "end": 268,
                "name": "MK858164"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 273,
                "end": 281,
                "name": "MN735679"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 282,
                "end": 290,
                "name": "MN735682"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T1",
                "end": "T3"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T1",
                "end": "T4"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T1",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "Potential recombination events among MERS-CoV S gene complete reference sequences retrieved from ",
            "GenBank",
            " sequence database (n = 147) and the study strains (n = 13) (Supplementary Table S1) were identified using automated RDP, GENECONV, BOOTSCAN, MaxChi, CHIMAERA, and SISCAN methods provided in RDP4 software [34]."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 414,
                "end": 421,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The resulting N protein-gRNA ribonucleoprotein complexes are finally incorporated into the forming viral particles through interactions with the C terminus of the M proteins (25)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Virus titers of the culture supernatants were determined on LR7 cells with a dilution factor of 3, and the 50% tissue culture infectious dose (TCID50) units per milliliter of supernatant were calculated according to the Reed-Muench method (53)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "TCID50 per milliliter values were then converted into PFU per microliter as follows: TCID50 per milliliter × 0.00069 (54)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "ABSTRACT  Coronavirus (CoV) nucleocapsid (N) proteins are key for incorporating genomic RNA into progeny viral particles."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Available datasets are more sparse for incidence, and the patterns are inconsistent between studies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Analysis of datasets, specifically of serosurveys, needs to account for the kinetics of waning immunity and effects of imperfect assays to draw meaningful inferences."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We conducted searches of the PubMed database on March 20, 2020 using the search term “coronavirus” and each of the following terms or phrases: “serolog*”, “serop*”, “cross reactivity”, “antibod* human coronavirus”, and “complement fixation”."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Articles included electronic, ahead-of-print publications available in the ",
            "PubMed",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 585,
                "end": 591,
                "name": "PubMed"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Many public health responses and modeled scenarios for COVID-19 outbreaks caused by SARS-CoV-2 assume that infection results in an immune response that protects individuals from future infections or illness for some amount of time."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease 2019 (COVID-19) is a pandemic infection caused by a positive-sense RNA betacoronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Acute respiratory distress syndrome (ARDS) and multiorgan dysfunction are among the leading causes of death in critically ill patients with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Elevated concentrations of proinflammatory cytokines and chemokines including interleukin (IL)-2, IL-6, interferon gamma–induced protein 10, macrophage inflammatory protein alpha, monocyte chemotactic protein 1 and tumour necrosis factor-alpha (TNF-α) [1,2] suggest that a cytokine release syndrome may play a major role in the pathology of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Given the limited number of cases analysed, these findings could simply be due to chance; however, it also adds to other evidence suggesting that ICIs are protective rather than harmful in patients with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There is increasing recognition that a state of impaired host immunity accompanied by a significant cell degeneration in secondary lymphoid tissues follows the initial hyperinflammatory phase of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "First, critically ill high-risk patients with COVID-19 often present with lymphocytopenia:",
            "Second, patients with COVID-19 have high levels of serum IL-6, IL-10 and TNF-α and express increased levels of exhaustion markers PD-1 and T-cell immunoglobulin mucin-3 on the surface of their peripheral T cells, which in turn impair T-cell effector functions and prevent functional memory [9]."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, compared with cases of pneumonia not caused by SARS-CoV-2, patients with COVID-19 have decreased B cell and Th counts but a comparable number of the main cytokine storm (CS) players including monocytes, neutrophils and natural killer cells [10]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These latest data suggest that viral damage is direct rather than inflammatory driven and strongly supports the use of immune-activating drugs that have been little considered to date for fear of exacerbating the inflammatory reaction and causing a CS."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Currently, there are no finally verified data and no antiviral drugs licensed by the US Food and Drug Administration and European Medicines Agency for treating patients with COVID-19 or for managing their complications."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since its first outbreak in China, COVID-19 was empirically treated with antiviral and respiratory supportive therapies mainly agents already used in prior SARS epidemics."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, this provides an opportunity for the research community to better outline the value of immune-modulating agents in the treatment of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on the promising results from an open-label study in 21 patients with severe and critical COVID-19 [16], tocilizumab—a human monoclonal antibody that binds to both soluble and membrane-bound IL-6 receptors (IL-6Rs)—is currently being investigated to address cytokine release syndrome in patients with severe ARDS, which includes randomised, controlled trials (",
            "ChiCTR2000029765",
            "; ",
            "NCT04320615",
            ") and single-arm trials (",
            "ChiCTR2000030796",
            "; ",
            "NCT04317092",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "AccessionNumber",
                "start": 2894,
                "end": 2910,
                "name": "ChiCTR2000029765"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 2912,
                "end": 2923,
                "name": "NCT04320615"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 2948,
                "end": 2964,
                "name": "ChiCTR2000030796"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 2966,
                "end": 2977,
                "name": "NCT04317092"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Genetic differences in HLA alleles have been recently recognised to confer differential viral susceptibility and severity of COVID-19 [19]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These findings highlight that genetic variability in the immune system may affect susceptibility to (and severity of) SARS-CoV-2; therefore, strategies to boost immune responses at this stage are certainly important for individuals particularly vulnerable to COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While confirmed cases of the deadly coronavirus disease 2019 (COVID-19) have exceeded 4.7 million globally, scientists are pushing forward with efforts to develop vaccines and treatments in an attempt to slow the pandemic and lessen the disease's damage."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although no proven effective therapies for treating patients with COVID-19 or for managing their complications currently exist, the rapidly expanding knowledge regarding severe acute respiratory syndrome coronavirus 2 and its interplay with hosts provides a significant number of potential drug targets and the potential to repurpose drugs already tested in other diseases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 is the etiologic agent of COVID-19 which is now considered a pandemic [[1], [2], [3], [4]]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 is the etiologic agent of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The National Institute of Allergy and Infectious Diseases Systems Biology for Infectious Disease Research Program was established to support research focusing on multi-omics approaches and dataset integration to develop and validate predictive models of infectious disease initiation, progression, and outcomes [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Lipidomics software 1: LIQUID: an open-source software for identifying lipids [33]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The subsequent datasets are analyzed using MSCovert for spectrum to peak list conversion, mzRefinery for mass recalibration, and MS-GF+ for peptide/protein identification [28–30]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The lipid phase is dried in vacuo, reconstituted in methanol, and analyzed via a Waters Acquity UPLC H-class system and Velos Pro Orbitrap mass spectrometer, and lipid identifications are made via the LIQUID software [33]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Launch LIQUID program [33] and upload a .raw or .mzXL data file using the drop down menu."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Individuals infected with SARS‐CoV‐19 have a variety of clinical manifestations of the disease described as COVID‐19 (Huang et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While almost all patients develop COVID pneumonia, approximately 29% cases progress to acute respiratory distress syndrome which occurs 10–12 days after the onset of symptoms (Huang et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The upregulation of HLA‐DR expression in lung tissue of patients affected with COVID pneumonia (Wang et al., 2020) suggests that this process is instrumental in the immunological control of the disease process and therefore must be considered to be biologically relevant."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It could be argued that the use of the UK deceased donors as a control population in this study has simply highlighted more frequent occurrence of antigens common to BAME communities in our COVID‐19 population requiring hospital support for their disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "HLA‐DRB1*10 and A*26 are common within all European subregions (Sanchez‐Mazas et al., 2017) and offer an independent mechanistic explanation for severity of clinical disease in COVID‐19 patients which is independent of skin colour or other immunogenetic variation due to heritage."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In December 2019, SARS-CoV-2 emerged, causing the coronavirus disease 2019 (COVID-19) pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The biological mechanisms that may govern differences in the number of SARS and COVID-19 cases remain undefined."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, a clinical study with an anti-CD147 intervention reduced symptoms and duration of hospital admission for COVID-19 patients [27]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our computational analysis used publicly available microarray gene expression datasets from airway epithelial cells of 515 unique subjects, single cell sequencing data from 10 subjects, and the ",
            "FANTOM5",
            " dataset for promoter activities of 74 lung-related cell and tissue types."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 545,
                "end": 552,
                "name": "FANTOM5"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our proteomic analysis used data from the ",
            "Human Proteome Map",
            " [31] and a dataset from primary human airway epithelial cells grown under air–liquid interface culture conditions [32]."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 669,
                "end": 687,
                "name": "Human Proteome Map"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our protein expression data are consistent with low ACE2promoter activity in a variety of lung epithelial cell samples and low ACE2 gene expression in both microarray and single cell RNA sequencing (scRNAseq) datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Public microarray experiments using Affymetrix chips (HuGene-1.0-st-v1 and HG-U133 Plus 2) on airway epithelial cell samples collected from nasal (",
            "GSE19190",
            ") or bronchial (",
            "GSE11906",
            ") brushings of healthy nonsmokers were obtained from the ",
            "NCBI Gene Expression Omnibus (GEO)",
            " database [33, 34]."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 1174,
                "end": 1182,
                "name": "GSE19190"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 1198,
                "end": 1206,
                "name": "GSE11906"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 1263,
                "end": 1297,
                "name": "NCBI Gene Expression Omnibus (GEO)"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T5",
                "end": "T3"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T5",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "For all dataset samples, raw intensity values and annotation data were downloaded using the GEOquery R package (version 2.52.0) [35] from the Bioconductor project [36]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All gene expression data were unified into a single dataset that was then normalised by robust multiarray average (RMA) normalisation, and only genes present in both of the Affymetrix platforms (n=16 013) were kept for subsequent analyses."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "FANTOM5",
            " promoterome dataset [39] for the hg38 assembly [40] was used to examine promoter activity of SARS-CoV-2-related human genes, namely ACE2, TMPRSS2, ADAM17, CTSL, CD147 and GRP78."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 1730,
                "end": 1737,
                "name": "FANTOM5"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The dataset consists of CAGE promoter activity data for 1866 primary cells, cell lines and tissues from humans, and is quantified as normalised transcripts per million (TPM)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Publicly available human proteomic data from the datasets of ",
            "Kim et al.",
            " [31] and ",
            "Foster et al.",
            " [32] were used to evaluate SARS-CoV-2 receptor-related protein expression in different human tissues and experimental conditions."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Creator",
                "start": 2152,
                "end": 2162,
                "name": "Kim et al."
            },
            false,
            {
                "id": "T8",
                "type": "Creator",
                "start": 2172,
                "end": 2185,
                "name": "Foster et al."
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Expression values were extracted from the dataset of ",
            "Kim et al.",
            " [31] for ACE2, TMPRSS2, ADAM17, CTSL, CD147 and GRP78, using CDH1 as a control for airway cells."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Creator",
                "start": 2369,
                "end": 2379,
                "name": "Kim et al."
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Proteomic data from the dataset of ",
            "Foster et al.",
            " [32] consist of bronchial epithelial cells collected from healthy nonsmokers (n=4; males) and exposed to PBS control vehicle."
        ],
        "lab": [
            false,
            {
                "id": "T10",
                "type": "Creator",
                "start": 2512,
                "end": 2525,
                "name": "Foster et al."
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The immunogen for the GRP78 Atlas Antibodies primary antibody is the recombinant protein epitope signature tag antigen sequence, EKFAEEDKKLKERIDTRNELESYAYSLKNQIGDKEKLGGKLSSEDKETMEKAVEEKIEWLESHQDADIEDFKAKKKELEEIVQPIISKL."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We first examined these genes in a curated dataset of upper and lower airway epithelial cell gene expression from the nasal sinus to the 12th generation of airway in the lung (figure 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Following our observation of consistent expression along the upper and lower airways of candidate genes important in SARS-CoV-2 infection, we determined whether sex or age affected gene expression levels in healthy individuals using a curated dataset of bronchial brushings from 504 healthy subjects (supplementary table S1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For quantitative analyses related to age and gene expression, our curated database was divided into datasets that used either the HG-U133 Plus 2 or HuGene-1.0-st-v1 microarray due to differences in age distributions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the HuGene-1.0-st-v1 dataset (n=181), which included a greater proportion of older individuals (>50 years), we observed reduced ACE2 gene expression with age (figure 2e; p<0.05)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Promoter activity data of each of the candidate genes important in SARS-CoV-2 binding and infection were extracted and analysed from the ",
            "FANTOM5",
            " dataset, which includes 1866 primary cells, cell lines, and tissue sample types (figure 3)."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Dataset",
                "start": 3921,
                "end": 3928,
                "name": "FANTOM5"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Both microarray gene expression analysis and promoter activity were consistent with results of candidate gene expression in a scRNAseq dataset of 10 healthy subjects (supplementary figure S1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We therefore interrogated a publicly available proteomic dataset derived from primary human airway epithelial cells grown under air–liquid interface culture conditions [32], examining the same candidates."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Collectively, two proteomic datasets from distinct lung sample formats provide complementary and consistent expression profiles of candidate molecules important in SARS-CoV-2 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The global COVID-19 pandemic that emerged in late 2019 is caused by SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using a curated microarray gene expression dataset generated from bronchial brushings of 504 healthy subjects that considers the limitations of merging multiple datasets from distinct sources, we observed that sex did not correlate with gene expression of any candidate host molecule involved in SARS-CoV-2 infection and that ACE2 and TMPRSS2 were the lowest expressed genes of interest examined."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In one dataset, ACE2 gene expression modestly decreased with age, although protein level confirmation was not possible."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Importantly, these elegant transcriptomic analyses confirm our observations in bulk tissue microarray datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Consortium-based publicly available datasets represent another parallel approach to confirm our data."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We have used the ",
            "FANTOM5",
            " dataset containing CAGE promoter activation data for 1866 primary cells, cell lines and tissue samples from humans [39] to examine the level of promoter activity for each candidate SARS-CoV-2 receptor gene."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "Dataset",
                "start": 5433,
                "end": 5440,
                "name": "FANTOM5"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged, causing the coronavirus disease 2019 (COVID-19) pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To determine the expression and in situ localisation of candidate SARS-CoV-2 receptors in the respiratory mucosa, we analysed gene expression datasets from airway epithelial cells of 515 healthy subjects, gene promoter activity analysis using the ",
            "FANTOM5",
            " dataset containing 120 distinct sample types, single cell RNA sequencing (scRNAseq) of 10 healthy subjects, proteomic datasets, immunoblots on multiple airway epithelial cell types, and immunohistochemistry on 98 human lung samples."
        ],
        "lab": [
            false,
            {
                "id": "T13",
                "type": "Dataset",
                "start": 6041,
                "end": 6048,
                "name": "FANTOM5"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We demonstrate absent to low ACE2 promoter activity in a variety of lung epithelial cell samples and low ACE2 gene expression in both microarray and scRNAseq datasets of epithelial cell populations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This set of identified DEGs was firstly evaluated in databases comprising hotspot genes known to be involved in aging and various lung diseases (COPD, pneumonia, pulmonary fibrosis, and asthma, etc.)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "An overlap of the DEGs with genes in the database indicated that aging is a major contributing factor for chronic respiratory diseases and infection (Fig. 2b; Supplementary information, Fig. S3a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These data identified AT1 and AT2 as susceptible cell types for COVID-19 in the lung."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Alarming findings report that COVID-19 causes pervasive endotheliitis and blood clots, and viral particles have been detected in endothelial cells of COVID-19 victims."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We focused our attention on IL7, as our bulk RNA-seq analysis had revealed that IL7 was not only commonly upregulated in the aged lung (P value = 0.024), heart (P value = 0.058), and aorta (P value = 0.006) (Fig. 6a–c; Supplementary information, Fig. S8), but was also among the cytokines that drive the immune overreaction known as cytokine storm in patients with COVID-19 (Fig. 6a–c; Supplementary information, Table S6)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Altogether, these findings add new insights into ACE2 regulation in aged VECs and suggest that geroprotective strategies may reduce COVID-19 severity in the elderly."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, we analyzed the single-nucleus transcriptomic maps of aged primate respiratory and cardiovascular tissues to understand the cellular and molecular basis for their vulnerabilities to age-related diseases and COVID-19 (Fig. 6k)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Altogether, we here depict the first transcriptomic atlas of the aged primate cardiopulmonary system, which provides mechanistic insights into how aging-related inflammation and susceptibility to microorganismal infection are interconnected to increase the vulnerability of older human to COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "HAECs were cultured in 6-well plates (Corning Incorporated, 3516) with EGM-2 medium to reach ~80% confluence."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Aging is a major risk factor for many diseases, especially in highly prevalent cardiopulmonary comorbidities and infectious diseases including Coronavirus Disease 2019 (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Altogether, our findings depict the first transcriptomic atlas of the aged primate cardiopulmonary system and provide vital insights into age-linked susceptibility to SARS-CoV-2, suggesting that geroprotective strategies may reduce COVID-19 severity in the elderly."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The accession numbers for the raw snRNA-seq data reported in this paper in ",
            "Genome Sequence Archive (GSA)",
            ": ",
            "CRA002577",
            " (lung), ",
            "CRA002689",
            " (heart)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 2414,
                "end": 2443,
                "name": "Genome Sequence Archive (GSA)"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 2445,
                "end": 2454,
                "name": "CRA002577"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 2463,
                "end": 2472,
                "name": "CRA002689"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T1",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "The accession numbers for the raw bulk RNA-seq data in ",
            "GSA",
            ": ",
            "CRA002810",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 2537,
                "end": 2540,
                "name": "GSA"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 2542,
                "end": 2551,
                "name": "CRA002810"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T4",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "It is believed that this is the same virus as that also called SARS-CoV-2 or COVID-19 virus after the disease now designated COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At the time of final writing of this text, the WHO named the disease COVID-19, so one can reasonably speak of the “COVID-10” or “Covid-19 virus”."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Renaming the believed causative agent of COVID-19 to indicate it as a type of SARS does not alleviate the concern that different strains use different mechanisms: very few point mutations might change the modes of cell entry."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The very recent close match with a SARS virus entry in the databases makes the assumptions used in the present paper much more plausible, however."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It shows that after circa 150 arbitrarily selected proteins are brought into the training set., the predictions begin to change and improve dramatically as more and more homologous proteins of similar folded structure are encountered and the coverage of sampled proteins spans the commoner protein families Obvious pre-known homologues were discarded in that study [34], but the above concern still applies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "ID:",
            "ALB35880.1",
            " the internal match with the FIEDLL motif is not significant and the NVL and following sequence usually carry no cleavage arginine R at the corresponding point."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "AccessionNumber",
                "start": 1065,
                "end": 1075,
                "name": "ALB35880.1"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "TLADAGFIKQYGDCTo compare, an alternative to the part in brackets is RRSFIDELAFGRG: it is an example of a tentative specific design “hunch” based on a section of a human semaphorin (",
            "GenBank",
            " ",
            "NP_001243276.1",
            ") produced in response to lung diseases, a suggestive biologically-related match with conservative replacements but not one suggested by the general rules and probably coincidental."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 1417,
                "end": 1424,
                "name": "GenBank"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 1425,
                "end": 1439,
                "name": "NP_001243276.1"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "Early alternative choices of binding protein as model included growth hormone secretagogue receptor type 1 ",
            "GenPept",
            " accession ",
            "NP_796304",
            " because of some evidence in the literature of the action of anthraquinone, emoghrelin derivatives, and indanthrone, amongst others, which have some of the features of emodin, and because of an initial suspicion that a sequence segment in growth hormone receptor might contribute to binding and had some features relating to the current peptide of interest, but none of the alternatives were ultimately seen as persuasive as the steroid dehydrogenase choice."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 1728,
                "end": 1735,
                "name": "GenPept"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 1746,
                "end": 1755,
                "name": "NP_796304"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T4",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "This paper concerns study of the genome of the Wuhan Seafood Market isolate believed to represent the causative agent of the disease COVID-19.",
            "Highlights     •  Bioinformatics studies are carried out on the COVID-19 virus.    •"
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "PCR tests for theaccurate and fastSARS-CoV-2 testing are crucial for the identification of carriers and control the spreading of COVID19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "During the first months of the COVID19 pandemic we faced a demand for SARS-Cov-2 testing that exceeded our qtPCR capacity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nowadays, the COVID 19 pandemic scenario is being increasing over the world."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, the severity of the atypical pneumonia caused by SARS‐CoV‐2 (COVID‐2019), often requiring multiweek hospital stays and the use of invasive ventilators,",
            ", ",
            ", ",
            " highlights the need for therapeutics to lessen the severity of individual infections."
        ],
        "lab": [
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Initial trials using antibody‐containing plasma of convalescent COVID‐19 patients has also shown promise in lessening the severity of the disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "(c) Structural overlay of the SARS‐CoV‐2 N2b dimer (blue) and the equivalent domain of SARS‐CoV‐N (",
            "PDB",
            " ID ",
            "2CJR",
            ")",
            "Our structures also overlay closely with four other recently deposited structures of the SARS‐CoV‐2 N2b domain (",
            "PDB",
            " IDs ",
            "6WJI",
            ", ",
            "6YUN",
            ", ",
            "6ZCO",
            ", and ",
            "7C22",
            "; all unpublished)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 501,
                "end": 504,
                "name": "PDB"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 508,
                "end": 512,
                "name": "2CJR"
            },
            false,
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 626,
                "end": 629,
                "name": "PDB"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 634,
                "end": 638,
                "name": "6WJI"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 640,
                "end": 644,
                "name": "6YUN"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 646,
                "end": 650,
                "name": "6ZCO"
            },
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 656,
                "end": 660,
                "name": "7C22"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T3",
                "end": "T5"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T3",
                "end": "T6"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T3",
                "end": "T7"
            }
        ]
    },
    {
        "sen": [
            "One of these structures (",
            "PDB",
            " ID ",
            "7C22",
            ") adopts the same space group and unit cell parameters as our structure of untagged N2b."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 705,
                "end": 708,
                "name": "PDB"
            },
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 712,
                "end": 716,
                "name": "7C22"
            },
            false
        ],
        "rel": [
            {
                "id": "R6",
                "bool": true,
                "head": "T8",
                "end": "T9"
            }
        ]
    },
    {
        "sen": [
            "Since the first genome sequence of SARS‐CoV‐2 was reported in January 2020,",
            ", ",
            " over 38,000 full genomic sequences have been deposited in public databases (as of June 3, 2020)."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While many of these substitutions arise only once in our dataset and may therefore reflect errors in sequencing or sequence assembly, most likely reflect true variation among circulating strains of SARS‐CoV‐2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The most common substitutions are R203K and G204R, which occur together as the result of a common trinucleotide substitution in genomic positions 28,881–28,883, from GGG to AAC (~4,100 of the 38,318 sequences in our dataset; Figure S2a,b)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While positions 203 and 204 accounted for over two‐thirds of the total individual amino acid substitutions in this dataset, the N2a domain shows a strong enrichment of mutations even when these positions are not considered (Figure 2a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "(b) Surface views of the N protein N1b domain (",
            "PDB",
            " ID ",
            "6VYO",
            "; Center for Structural Genomics of Infectious Diseases [CSGID], unpublished)."
        ],
        "lab": [
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 1715,
                "end": 1718,
                "name": "PDB"
            },
            false,
            {
                "id": "T11",
                "type": "AccessionNumber",
                "start": 1722,
                "end": 1726,
                "name": "6VYO"
            },
            false
        ],
        "rel": [
            {
                "id": "R7",
                "bool": true,
                "head": "T10",
                "end": "T11"
            }
        ]
    },
    {
        "sen": [
            "Two high‐resolution crystal structures of the SARS‐CoV‐2 N1b domain have been determined (",
            "PDB",
            " ID ",
            "6M3M",
            " and ",
            "6VYO",
            "),",
            " and a recent NMR study determined a solution structure of the domain and defined its likely RNA binding surface (Figure 2b)."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 1895,
                "end": 1898,
                "name": "PDB"
            },
            false,
            {
                "id": "T13",
                "type": "AccessionNumber",
                "start": 1902,
                "end": 1906,
                "name": "6M3M"
            },
            false,
            {
                "id": "T14",
                "type": "AccessionNumber",
                "start": 1911,
                "end": 1915,
                "name": "6VYO"
            },
            false,
            false
        ],
        "rel": [
            {
                "id": "R8",
                "bool": true,
                "head": "T12",
                "end": "T13"
            },
            {
                "id": "R9",
                "bool": true,
                "head": "T12",
                "end": "T14"
            }
        ]
    },
    {
        "sen": [
            "In keeping with its functional importance, the identified RNA binding surface shows only a single mutation in this dataset (Figure 2b; middle panel)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Prior work with the Murine Hepatitis Virus N protein showed that this region can, on its own, incorporate into nucleocapsid structures that lack the associated Membrane (M) protein, suggesting that the region mediates a homotypic interaction between N proteins."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Given the severity of the ongoing COVID‐19 pandemic, a deep understanding of the SARS‐CoV‐2 life cycle is urgently needed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "N protein constructs (NFL [residues 2–419], N1ab [2–175], N1ab2a [2–246], N1b [49–175], N1b2a [49–246], N2b [247–364], N2b3 [247–419]) were amplified by PCR from the IDT 2019‐nCoV N positive control plasmid (IDT cat."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Diffraction data were collected at beamline 24ID‐E at the Advanced Photon Source."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Diffraction datasets were processed with the RAPD pipeline (https://github.com/RAPD/RAPD/), which uses XDS",
            " for indexing and data reduction, and the CCP4 programs AIMLESS",
            " and TRUNCATE",
            " for scaling and conversion to structure factors."
        ],
        "lab": [
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The structure of untagged N2b was determined by molecular replacement in PHASER",
            " using a dimer of the SARS‐CoV N2b domain (",
            "PDB",
            " ID ",
            "2GIB",
            ")",
            " as a template."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T15",
                "type": "Repository",
                "start": 3236,
                "end": 3239,
                "name": "PDB"
            },
            false,
            {
                "id": "T16",
                "type": "AccessionNumber",
                "start": 3243,
                "end": 3247,
                "name": "2GIB"
            },
            false,
            false
        ],
        "rel": [
            {
                "id": "R10",
                "bool": true,
                "head": "T15",
                "end": "T16"
            }
        ]
    },
    {
        "sen": [
            "Data collection statistics, refinement statistics, and database accession numbers for diffraction data and final structures can be found in Table S1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We used the ",
            "NextStrain",
            " database",
            " to visualize the prevalence of the N protein G204R mutation, which is diagnostic of the GGG ➔ AAC trinucleotide substitution in positions 28,881–28,883."
        ],
        "lab": [
            false,
            {
                "id": "T17",
                "type": "Repository",
                "start": 3427,
                "end": 3437,
                "name": "NextStrain"
            },
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID‐2019 pandemic is the most severe acute public health threat of the twenty‐first century."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This virus belongs to the genera Betacoronavirus and has been designated as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), and the disease is named as Coronavirus Disease 2019 (COVID-19) [7]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of April 14, 2020, the outbreak of COVID-19 has resulted in 1,844,863 confirmed cases and 117,021 deaths worldwide [8], among which 393 confirmed cases and 6 deaths were reported in Taiwan [9]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With rapidly increasing number of infections, the ",
            "Global Initiative on Sharing All Influenza Data (GISAID)",
            " [10] provides a platform for sharing SARS-CoV-2 sequences and their metadata."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 454,
                "end": 510,
                "name": "Global Initiative on Sharing All Influenza Data (GISAID)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Three major clades, including clade G (with G variant at position 614 within the spike protein, as S-D614G), clade S (ORF8-L84S), and clade V (ORF3a-G251V), were designated by the ",
            "GISAID",
            " (",
            "https://www.gisaid.org/hcov-19-analysis-update/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 769,
                "end": 775,
                "name": "GISAID"
            },
            false,
            {
                "id": "T3",
                "type": "URL",
                "start": 777,
                "end": 824,
                "name": "https://www.gisaid.org/hcov-19-analysis-update/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "SPAdes (version 3.14.0) [14] was then used to perform de novo assembly for constructing contig sequences, and BLASTN was used to query the assembled contigs by searching the nucleotide sequence (NT) database of the ",
            "National Center for Biotechnology Information (NCBI)",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 1042,
                "end": 1094,
                "name": "National Center for Biotechnology Information (NCBI)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To specifically determine the SARS-CoV-2 genome of interest, on the other hand, we used a reference strain Wuhan-1 (accession number ",
            "MN908947.3",
            ") as the mapping template and used an iterative mapping approach [15] to increase the read depth and coverage."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 1229,
                "end": 1239,
                "name": "MN908947.3"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In total, genomic data of 26 strains were deposited in the ",
            "GISAID",
            " with accession numbers also given in Table 1."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 1409,
                "end": 1415,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also downloaded all complete and high-coverage genomes of SARS-CoV-2 from ",
            "GISAID",
            " as of March 14, 2020 and obtained 332 sequences after removing those with sequence gaps or ambiguous nucleotides."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Dataset",
                "start": 1539,
                "end": 1545,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Complete genomic data of 20 SARS-CoV-2 strains obtained in this study were derived from 3 specimens (CGMH-CGU-01, -07, and -08) and 17 isolates (-02 to -06 and -09 to -20), and have been uploaded in ",
            "GISAID",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Dataset",
                "start": 1859,
                "end": 1865,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Figure 1A shows the NGS coverage and depth distribution of CGMH-CGU-01, which has an identical genome as the Wuhan-1 strain (accession number ",
            "MN908947.3",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 2009,
                "end": 2019,
                "name": "MN908947.3"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To better illustrate phylogenetic clades, we designated and numbered yellow clade as IV harbouring ORF1ab-V378I mutation in this study and three others (blue clade I of ORF8-L84S, gray clade II of ORF3a-G251V, and pink clade III of S-D614G) identified based on previous ",
            "GISAID",
            " annotations of clades S, V, and G, respectively."
        ],
        "lab": [
            false,
            {
                "id": "T10",
                "type": "Dataset",
                "start": 2292,
                "end": 2298,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Five Australian strains (NSW05, NSW06, NSW11, NSW12, and NSW13) [19] and one German strain (BavPat2, according to the metadata from the ",
            "GISAID",
            ") from patients having a travel history to Iran were also grouped in this clade."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Dataset",
                "start": 2484,
                "end": 2490,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 can be transmitted via close contact with infected patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition to the signature mutation S-D614G annotated by ",
            "GISAID",
            " in clade III, all the Taiwanese genomes shared two ORF1ab mutations C2772T and C14144T (P4715L) (Figure 3E)."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "Dataset",
                "start": 2700,
                "end": 2706,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Ou et al. recently detected Haemophilus parainfluenzae and Moraxella catarrhalis from sputum samples collected from a severe COVID-19 case [37]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "ABSTRACT  Taiwan experienced two waves of imported infections with Coronavirus Disease 2019 (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This study describes results of PCR and viral RNA testing for SARS-CoV-2 in bronchoalveolar fluid, sputum, feces, blood, and urine specimens from patients with COVID-19 infection in China to identify possible means of non-respiratory transmission."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Following the first case reports in Hubei province, China, in late 2019, a pandemic of coronavirus disease 2019 (COVID-19) was declared by the World Health Organization in March 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although COVID-19 causes minimal or mild illness in most, a small but appreciable proportion of individuals require oxygen therapy and often admission to an intensive care unit (ICU)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ensuing unprecedented pressure on hospital wards and ICUs has necessitated rapid re-deployment of staff and capacity towards the management of COVID-19 cases with deprioritisation of non-emergency clinical services, including diagnostics and elective specialist surgery."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "ICU COVID-19 mortality, distribution by age and duration of stay and proportion referred into ICU were obtained from ",
            "ICNARC (Intensive Care National Audit and Research Centre)",
            " and data from hospitalised UK cases."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 760,
                "end": 818,
                "name": "ICNARC (Intensive Care National Audit and Research Centre)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            " Because of lack of UK data, data from Wuhan were used as the basis for the age distribution of community infection, age-specific likelihoods of admission from community to hospital and case fatality rates for non-ICU COVID-19 patients",
            ",",
            " (see supplementary Table S1, available at Annals of Oncology online)."
        ],
        "lab": [
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To compare life-years associated with timely cancer surgery with those afforded by hospitalisation of COVID-19 patients, we modelled a volume of community-ascertained COVID-19 infection, resulting in an equivalent volume of hospital admissions to cancer surgeries (see supplementary Table S1, available at Annals of Oncology online)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Accounting for nosocomial COVID-19 infection, for cancers with a relatively good overall prognosis, delay of surgery by 3 months had a minimal impact on survival: <1% for all stage 1 ER+ and HER2+ breast cancers, for example."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In older patients (aged >70), for early stage colorectal, kidney and ER+ breast cancers, the current impact on survival of COVID-related mortality exceeded the impact of 3 or even 6 months' delay (Table 2; see also supplementary Table S3, available at Annals of Oncology online)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Prior to the COVID-19 crisis, each year cancer surgery was directly responsible for 1 717 051 LYGs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For contextualisation, we compare the impact of cancer surgery delay with hospital care for patients with community-acquired COVID-19 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 ICU admission for those aged 40–49 yielded on average 27.5 LYGs and 0.8 RALYGs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These estimates are inherently conservative as they do not take into account the impact on life expectancy of the excess comorbidities associated with many hospitalised COVID-19 cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 community-acquired infection of 683 083 individuals would result in 94 912 hospital admissions (i.e. the equivalent number to number of annual admissions for cancer surgery; Table 4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This represents on average 5.08 LYGs and 0.46 RALYGs per hospitalised COVID-19 patient."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This will serve to minimise nosocomial acquisition and mortality from COVID-19, to protect staff and also to provide reassurance to the public regarding uptake of diagnostics and surgery for cancer."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Background  Cancer diagnostics and surgery have been disrupted by the response of health care services to the coronavirus disease 2019 (COVID-19) pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using health care resource costing, we contextualise attributable lives saved and life-years gained (LYGs) from cancer surgery to equivalent volumes of COVID-19 hospitalisations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For 94 912 hospital COVID-19 admissions, there are 482 022 LYGs requiring 1 052 949 HCRUs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hospitalisation of community-acquired COVID-19 patients yields on average per patient 5.08 LYG and 0.46 RALYGs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Delay of 3/6 months in surgery for incident cancers would mitigate 19%/43% of LYGs, respectively, by hospitalisation of an equivalent volume of admissions for community-acquired COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Highlights     •  Lockdown and re-deployment due to the COVID-19 pandemic have caused significant disruption to cancer diagnosis and management."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The resource-adjusted benefit in avoiding delay in cancer management compares favourably with admission for COVID-19 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recent release of the high-resolution crystal structure for the main proteinase 3CLpro (",
            "Protein Data Bank",
            ", ",
            "PDB",
            " ID: ",
            "6Y2G",
            "), describing an additional amide bond with the α-ketoamide inhibitor pyridone ring to enhance the half-life of the compound in plasma [16] is suggested to accelerate the targeted drug discovery efforts."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 88,
                "end": 105,
                "name": "Protein Data Bank"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 107,
                "end": 110,
                "name": "PDB"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 115,
                "end": 119,
                "name": "6Y2G"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T3"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T2",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "The complete genomes of SARS-Cov-2 from all over the world have been deposited at The ",
            "Global Initiative on Sharing Avian Influenza Data (GISAID)",
            " [19] database and more sequences continue to be deposited with the passage of time."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 409,
                "end": 467,
                "name": "Global Initiative on Sharing Avian Influenza Data (GISAID)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This may be attained by freely accessing the ",
            "GISAID",
            " database and processing the data to enhance our understanding of the fine biochemical and genetic differences that differentiate this virus from the previously known strains [20]."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 597,
                "end": 603,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "",
            "PDB",
            " ID: ",
            "3TNT",
            ", SARS main protease was selected as reference to analyse the variants in SARS-CoV-2 3CLpro (",
            "PDB",
            " ID: ",
            "6Y2G",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 784,
                "end": 787,
                "name": "PDB"
            },
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 792,
                "end": 796,
                "name": "3TNT"
            },
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 889,
                "end": 892,
                "name": "PDB"
            },
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 897,
                "end": 901,
                "name": "6Y2G"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T6",
                "end": "T7"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T8",
                "end": "T9"
            }
        ]
    },
    {
        "sen": [
            "The dataset comprises of flavones and biflavanoids, anti-viral, anti-malarial and vitamins as SARS-CoV-2 3CLpro inhibitors [16]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In total 17 repurposed drugs were collected from the ",
            "Pubchem",
            " database [33]."
        ],
        "lab": [
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 1086,
                "end": 1093,
                "name": "Pubchem"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Two-dimensional (2D) structures were downloaded from the ",
            "Pubchem",
            " database in.sdf format."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Repository",
                "start": 1166,
                "end": 1173,
                "name": "Pubchem"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Crystal structure of the SARS-CoV-2 3CLpro was retrieved from ",
            "PDB",
            " (",
            "PDB",
            " ID: ",
            "6Y2G",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 1260,
                "end": 1263,
                "name": "PDB"
            },
            false,
            {
                "id": "T13",
                "type": "Repository",
                "start": 1265,
                "end": 1268,
                "name": "PDB"
            },
            false,
            {
                "id": "T14",
                "type": "AccessionNumber",
                "start": 1273,
                "end": 1277,
                "name": "6Y2G"
            },
            false
        ],
        "rel": [
            {
                "id": "R5",
                "bool": true,
                "head": "T12",
                "end": "T14"
            },
            {
                "id": "R6",
                "bool": true,
                "head": "T13",
                "end": "T14"
            }
        ]
    },
    {
        "sen": [
            "Chain A of PDB ID: 6Y2G containing alpha-ketoamide (O6K) inhibitor was used for identification of substrate binding site."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 9761 SARS-CoV-2 genomes were retrieved from The ",
            "GISAID",
            " database (",
            "https://www.gisaid.org",
            ") that contain 3 sequences from bat (Betacoronavirus) and 9 sequences from Malayan Pangolin (Manis javanica) (Additional file 1: Table S1)."
        ],
        "lab": [
            false,
            {
                "id": "T15",
                "type": "Dataset",
                "start": 1461,
                "end": 1467,
                "name": "GISAID"
            },
            false,
            {
                "id": "T16",
                "type": "URL",
                "start": 1478,
                "end": 1500,
                "name": "https://www.gisaid.org"
            },
            false
        ],
        "rel": [
            {
                "id": "R7",
                "bool": true,
                "head": "T15",
                "end": "T16"
            }
        ]
    },
    {
        "sen": [
            "We have divided our dataset into 6 different geographic areas: Europe (20.31%), North America (21.13%), Asia (35.37%), Oceania (20.86%), South America (16.63%) and Africa (10.35%)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 patient genome sequences deposited in ",
            "GISAID",
            " database from more than 60 different countries (a) radial and (b) unrooted phylogeny created by ",
            "Nextstrain",
            " program [66] (c) Pie chart representation of number of SARS-CoV-2 patient genomes deposited in ",
            "GISAID",
            " till 15th April 2020 from six different regions; Asia (orange, 35.37%), Oceania (purple, 20.86%), North America (brown, 21.13%), Europe (blue, 20.31%), Africa (red, 10.35%) and South America (black, 16.63%)."
        ],
        "lab": [
            false,
            {
                "id": "T17",
                "type": "Dataset",
                "start": 1870,
                "end": 1876,
                "name": "GISAID"
            },
            false,
            {
                "id": "T18",
                "type": "Repository",
                "start": 1973,
                "end": 1983,
                "name": "Nextstrain"
            },
            false,
            {
                "id": "T19",
                "type": "Dataset",
                "start": 2079,
                "end": 2085,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our study highlights the presence of additional “conserved mutations” in the South American and African communities, considering only those occurring ≥ 5 times in our database."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS and SARS-CoV-2 complete genomes were collected from ",
            "NCBI",
            ", ",
            "GenBank",
            " database (",
            "NC_004718",
            " and ",
            "NC_045512",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T20",
                "type": "Repository",
                "start": 2528,
                "end": 2532,
                "name": "NCBI"
            },
            false,
            {
                "id": "T21",
                "type": "Repository",
                "start": 2534,
                "end": 2541,
                "name": "GenBank"
            },
            false,
            {
                "id": "T22",
                "type": "AccessionNumber",
                "start": 2552,
                "end": 2561,
                "name": "NC_004718"
            },
            false,
            {
                "id": "T23",
                "type": "AccessionNumber",
                "start": 2566,
                "end": 2575,
                "name": "NC_045512"
            },
            false
        ],
        "rel": [
            {
                "id": "R8",
                "bool": true,
                "head": "T21",
                "end": "T22"
            },
            {
                "id": "R9",
                "bool": true,
                "head": "T21",
                "end": "T23"
            }
        ]
    },
    {
        "sen": [
            "Re-docking of O6K inhibitor occupied the similar docking pose in the SARS-CoV-2 3CLpro catalytic dyad active site as previously reported in the crystal structure (",
            "PDB",
            " ID: ",
            "6Y2G",
            ") (Fig. 5c, d)."
        ],
        "lab": [
            false,
            {
                "id": "T24",
                "type": "Repository",
                "start": 2741,
                "end": 2744,
                "name": "PDB"
            },
            false,
            {
                "id": "T25",
                "type": "AccessionNumber",
                "start": 2749,
                "end": 2753,
                "name": "6Y2G"
            },
            false
        ],
        "rel": [
            {
                "id": "R10",
                "bool": true,
                "head": "T24",
                "end": "T25"
            }
        ]
    },
    {
        "sen": [
            "Furthermore, we report that in isolates of human Wuhan SARS-CoV-2 there is an 85.98% similarity in identity to Pangolin-SARS-CoV, which suggests that Pangolin may be associated with the evolution of subsequent outbreaks of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 host genomes were collected from The ",
            "Global Initiative on Sharing All Influenza Data (GISAID)",
            " database containing 9 genomes from pangolin-CoV origin and 3 genomes from bat-CoV origin, Wuhan SARS-CoV2 reference genome was collected from ",
            "GeneBank",
            " database.",
            "",
            "GISAID",
            " database (",
            "https://www.gisaid.org/",
            "), SARS-CoV-2 isolate Wuhan-Hu-1, complete genome (",
            "https://www.ncbi.nlm.nih.gov/nuccore/1798174254",
            ")"
        ],
        "lab": [
            false,
            {
                "id": "T26",
                "type": "Dataset",
                "start": 3050,
                "end": 3106,
                "name": "Global Initiative on Sharing All Influenza Data (GISAID)"
            },
            false,
            {
                "id": "T27",
                "type": "Repository",
                "start": 3249,
                "end": 3257,
                "name": "GeneBank"
            },
            false,
            false,
            {
                "id": "T28",
                "type": "Dataset",
                "start": 3268,
                "end": 3274,
                "name": "GISAID"
            },
            false,
            {
                "id": "T29",
                "type": "URL",
                "start": 3285,
                "end": 3308,
                "name": "https://www.gisaid.org/"
            },
            false,
            {
                "id": "T30",
                "type": "URL",
                "start": 3359,
                "end": 3406,
                "name": "https://www.ncbi.nlm.nih.gov/nuccore/1798174254"
            },
            false
        ],
        "rel": [
            {
                "id": "R11",
                "bool": true,
                "head": "T28",
                "end": "T29"
            }
        ]
    },
    {
        "sen": [
            "It has the potential to yield complex and predictive biomarker signatures that support clinical decision making, as well as to enable the prediction of patient trajectories via machine learning methods with datasets of sufficient depth and size (Ahadi et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We first benchmarked the platform on a cohort-based epidemiological study, Generation Scotland (GS) (Smith et al., 2013), and at considerably higher throughput, demonstrated a level of precision and consistency that, to our knowledge, is yet unachieved in comparable large-scale proteomic studies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We then employed this workflow in an immediate response to the SARS-CoV-2 pandemic outbreak in Germany, by applying it to a cohort that includes the first COVID-19 patients hospitalized at the Charité Universitätsmedizin Berlin."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We measured samples from a primary exploratory cohort comprising thirty-one COVID-19 patients to identify clinical classifiers, candidate biomarkers as well as potential targets that picture the host immune response specific to a SARS-CoV-2 infection (Figure 4A)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We identified protein expression signatures that can classify COVID-19 patients according to WHO grading, introduced as of April 2020 (World Health Organization, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "First, a spectral library is automatically “refined” using the dataset in question: only detectable peptide precursors are retained, and their reference spectra and retention times are replaced with empirically observed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We applied the developed workflow for the analysis of serum and citrate plasma samples for two independent COVID-19 cohorts that included patients who were among the first that were hospitalized at Charité Universitätsmedizin Berlin, between March 1st and March 26th 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severity of COVID-19 was graded using the WHO ordinal outcome scale of clinical improvement (score 3 = hospitalized, no oxygen therapy; score 4 = oxygen by mask or nasal prongs; score 5 = non-invasive ventilation or high-flow oxygen; score 6 = intubation and mechanical ventilation; score 7 = ventilation and additional organ support) (World Health Organization, 2020) (Table S2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Four patients (13%) died from COVID-19, and 4 patients remain hospitalized at the time of writing."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Successively, a control group, consisting of 15 healthy volunteers and 17 further patients suffering from COVID-19, was recruited at the same hospital and used for validation of the biomarkers discovered (Table S1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Protein responses based on COVID-19 severity were obtained from a cohort of 31 hospitalized SARS-CoV-2 infected patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severity of COVID-19 was graded using the WHO ordinal outcome scale of clinical improvement (World Health Organization, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "(C) Heatmap shows protein signatures that report on COVID-19 severity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the exploratory cohort, which included 104 serum samples obtained from the 31 of the earliest COVID-19 patients, we quantified 297 protein groups among which 229 unique proteins were detected with 75% data completeness."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To account for this biological limitation, we applied very strict filtering to the dataset, namely, we only tested for differential abundance of proteins which had at least five different peptide precursors identified at least in one of the acquisitions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Next, to validate the biomarkers, we processed the validation cohort (Table S1) and recorded 96 proteomes in triplicates for 15 healthy volunteers and 17 COVID-19 patients (Table S1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We illustrate the quantitative variability of the validated biomarkers for COVID-19 severity on a heatmap (Figure 4C) and as boxplots (Figures 4D) as well as summarize their potential connection to COVID-19 in Table S3."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To exclude the possibility that concentration changes in these markers are due to frequent confounders, like age, we have plotted the variability of the same proteins in the GS cohort, with age spanning from 37 to 79, on samples that have been collected before the COVID-19 outbreak."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We note that for identified proteins the change between mild and severe COVID-19 substantially exceeds the variation seen in the general population (Figure 4D)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A PCA categorizes the individuals according to the severity of COVID-19 (Figure 4B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, we illustrate the concentration changes of the biomarkers validated in the control cohort, upon grouping of the patients according the WHO severity criteria, ranging from scale 3 (hospitalized, no oxygen therapy) to the most critical (scale 7) in a heatmap (Table S1 for the grading of each patient), which graphically illustrates how level changes in these proteins reflect a progression from mild to severe COVID-19 (Figure 4C)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "First, two patients (#13 and #32) in the group of critical patients, which later died from COVID-19, clearly clustered in the heatmap and indeed had one of the most pronounced proteomic signatures (Figure 4C), implying that proteomics bears the potential to support predictions of clinical trajectories."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "When we first obtained the dataset, two individuals (patients 4 and 6) initially clinically assessed as severe (Kurth et al., 2020) clustered with patients that suffered from the mild form of COVID-19 (Figure S3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These results triggered a retrospective assessment, which revealed that patient 4 turned out to be suffering from type B influenza rather than a SARS-CoV-2 infection, whereas patient 6 was classified as severe due to recent chemo-immunotherapy due to a hematological malignancy, applied just ten days before his COVID-19-related hospitalization."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We have, as a consequence, excluded patient 4 from the COVID-19 dataset (all results shown in Figure 4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also observe upregulation of fibrinogen, a coagulation factor, and SERPINA10, an inhibitor of the F10a coagulation factor, further highlighting the importance of coagulation in SARS-CoV-2 infection, established by previous observations of elevated coagulation in severe COVID-19 cases (Zhou et al., 2020a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A parallel study by (Shen et al., 2020) used a more conventional and time consuming (120× pre-fractionation consolidated in 40 fractions with TMT-16 plex) proteomics method to characterize plasma samples from 99 study participants, including 46 samples from patients with COVID-19 diagnosed in China."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For instance, we cannot confirm the downregulation of pro-platelet basic protein (PPBP) and platelet factor 4 (PF4) in severe COVID-19 as highlighted by Shen et al."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Extensive worldwide efforts have been directed recently into finding drug targets for COVID-19 treatment."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For example, pro-inflammatory signaling via IL-6 has been determined to be a marker of severe COVID-19 (Chen et al., 2020; Ruan et al., 2020) and preliminary results on the inhibition of IL-6 receptor (IL-6R) with tocilizumab seem to indicate clinical improvement (Coomes and Haghbayan, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we discovered several proteins that are differentially expressed with the severity of COVID-19 that are linked to IL-6-mediated proinflammatory cytokine signaling: (1) the CD14-LBP LPS recognition system, (2) upregulation of LRG1, an angiogenesis and anti-apoptotic factor associated with inflammation, and (3) upregulation of the LGALS3BP, an inducer of IL-6."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we observed upregulation of both monocyte differentiation antigen CD14 (~2.7×) and LBP (~3.9×) in severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of note, the glycosylphosphatidylinositol (GPI)-anchored form of CD14 is primarily displayed by monocytes and macrophages (Marcos et al., 2010), while the proportion of CD14+CD16+ inflammatory monocytes in the peripheral blood increases along with COVID-19 severity (Zhou et al., 2020b)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Given that CD14 is a potent activator of pro-inflammatory cytokine signaling (Zanoni and Granucci, 2013), it might present a potential therapeutic target for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Given the previously reported association of the Middle East respiratory syndrome (MERS) infection with lung fibrosis (Zhao et al., 2008) and emerging reports (British Thoracic Society, 2020) of lung fibrosis in a substantial proportion of COVID-19 survivors, we hypothesize that the ~2.1× elevation of serum LRG1 levels we observe in critical COVID-19 cases in comparison with the mild cases might indicate the increased risk of fibrosis, highlighting LRG1 as yet another potential therapeutic candidate for COVID-19 treatment."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Inhibition of galectin-3-mediated signaling pathways hence represents another potential therapeutic target against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Going forward, it will be important to assess GSN levels in at-risk populations for severe COVID-19, e.g., patients with diabetes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The development of therapies to stabilize the GSN levels could hence be of direct therapeutic value for treating COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although decreased APOA1 levels have been observed in systemic inflammatory response (Kumaraswamy et al., 2012; Sirniö et al., 2017), including in COVID-19 (Nie et al., 2020), a potential explanation of the downregulation we observe here would also be provided, if naturally lower APOA1 and hence a different metabolic condition of the individual were associated with a higher risk of severe SARS-CoV-2 disease progression."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The raw data of the acquired commercial plasma and serum control samples within the GS study have been deposited to the ",
            "ProteomeXchange Consortium",
            " via PRIDE (Perez-Riverol et al., 2019) partner repository with the dataset identifier Pride:",
            "PXD018874",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 9131,
                "end": 9157,
                "name": "ProteomeXchange Consortium"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 9250,
                "end": 9259,
                "name": "PXD018874"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "Sampling was performed as part of the Pa-COVID-19 study, a prospective observational cohort study assessing pathophysiology and clinical characteristics of patients with COVID-19 at Charité Universitätsmedizin Berlin (Kurth et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The study assesses epidemiological and demographic parameters, medical history, clinical course, morbidity and quality of life during hospital stay of COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Treatment and medical interventions follow standard of care as recommended by current international and German guidelines for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Pa-COVID-19 study is carried out according to the Declaration of Helsinki and the principles of Good Clinical Practice (ICH 1996) where applicable and was approved by the ethics committee of Charité- Universitätsmedizin Berlin (EA2/066/20)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Human ",
            "UniProt",
            " (",
            "UniProt",
            " Consortium, 2019) isoform sequence database (",
            "3AUP000005640",
            ") was used to annotate the library."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 10057,
                "end": 10064,
                "name": "UniProt"
            },
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 10066,
                "end": 10073,
                "name": "UniProt"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 10119,
                "end": 10132,
                "name": "3AUP000005640"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "The library was first automatically refined based on the dataset in question at 0.01 global q-value (using the “Generate spectral library” option in DIA-NN)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As we were specifically interested in proteins which could serve as biomarkers of COVID-19 severity, the test was performed using the Kendall’s Tau test for the Theil-Sen trend estimator (as implemented in the EnvStats R package (Millard, 2014)) against the disease severity as classified according to the WHO ordinal scale (Table S1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the case of this dataset, however, we observed very significant differences in the variance, e.g. many proteins seem a lot more variable between patients with severe and critical COVID-19 than mild COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 pandemic is an unprecedented global challenge, and point-of-care diagnostic classifiers are urgently required."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We use our platform on samples collected from a cohort of early hospitalized cases of the SARS-CoV-2 pandemic and identify 27 potential biomarkers that are differentially expressed depending on the WHO severity grade of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In total, this work supports the development of routine proteomic assays to aid clinical decision making and generate hypotheses about potential COVID-19 therapeutic targets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A standardized, ultra-high-throughput clinical platform for serum and plasma proteomics    •  Platform enables high precision quantification of 180 human proteomes per day at low cost    •  27 biomarkers are differentially expressed between WHO severity grades for COVID-19    •  Biomarkers include proteins not previously associated with COVID-19 infection      Messner et al. present a standardized, low-cost, ultra-high-throughput platform for serum and plasma proteomics designed for clinical use and apply it to a cohort of hospitalized COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "They identify 27 potential biomarkers that are differentially expressed depending on the WHO severity grade of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At different time points postinfection (hpi), cells were harvested for determining host and viral RNA levels by quantitative PCR analysis, and the supernatants were collected and subjected to TCID50 assays for measuring viral titers."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The pandemic of COVID-19 has posed an unprecedented threat to global public health."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, the interplay between the viral pathogen of COVID-19, SARS-CoV-2, and host innate immunity is poorly understood."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Care homes have been disproportionately affected by coronavirus disease 2019 (COVID-19) with high rates of severe illness and deaths among the vulnerable residents with multiple comorbidities."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Detailed investigations of care homes experiencing a COVID-19 outbreak identified high rates of SARS-CoV-2 positivity among residents and staff, most of whom were asymptomatic at the time of testing.1, 2, 3 In England, the first imported cases of COVID-19 were reported at the end of January 2020 and autochthonous transmission was confirmed a month later."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "London was one of the earliest and worst affected cities in England and large outbreaks of COVID-19 were reported in care homes during the peak of the pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By May 01, 2020, there had been excess of 22,000 deaths among care home residents during the COVID-19 pandemic, accounting for 54% of all the excess mortality in England and Wales."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Six London care homes reporting a suspected outbreak (≥2 suspected cases) of COVID-19 to Public Health England during April 10–13, 2020 were investigated."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Across the six care homes experiencing a COVID-outbreak, 254 of 474 (54%) staff members were working during April 10–13, 2020, and provided a nasal swab and 53 (21%) tested positive for SARS-CoV-2, including 12 (23%) who were symptomatic at the time of swabbing."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Within the small cohort of SARS-CoV-2 positive staff, genomic analysis identified two pairs of samples that were not separated when placed in the context of the background of SARS-CoV-2 genomic samples from across greater London (",
            "COVID-19 Genomics UK Consortium",
            ": ",
            "https://www.cogconsortium.uk/",
            ") dataset (n = 27,768), indicating a higher likelihood of transmission between the individuals."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 1540,
                "end": 1571,
                "name": "COVID-19 Genomics UK Consortium"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 1573,
                "end": 1602,
                "name": "https://www.cogconsortium.uk/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "A putative cluster involving staff from care home A (highlighted in red) was not present when these sequences were compared with the ",
            "COG",
            " dataset, suggesting that transmission between care home staff was unlikely in this case."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 1831,
                "end": 1834,
                "name": "COG"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In six London care homes experiencing a COVID-19 outbreak during the peak of the pandemic, 21% of staff tested positive for SARS-CoV-2 and, of those positive, only 23% were symptomatic at the time of testing."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additionally, in many countries including the UK and the US, care homes are heavily reliant on temporary “bank” or agency staff to provide cover for their staff in case of shortages or sick leave."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            " Staff are also recognised sources of infection, especially respiratory and gastrointestinal viruses, in care homes, and COVID-19 is no exception."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "The staff members put themselves at increased risk of COVID-19 and their risk of severe disease may be increased by pre-existing health condition; care workers have among the highest mortality rates among all occupations."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            " Infected care home workers also put their household members at risk of COVID-19 and, depending on the careers of the household members potentially contribute to ongoing transmission in the community."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "10, 11, 12",
            "Highlights     •  21% of 255 staff working in 6 care homes with a COVID-19 outbreak were SARS-CoV-2 positive."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Background  Care homes have been disproportionately affected by the COVID-19 pandemic and continue to suffer large outbreaks even when community infection rates are declining, thus representing important pockets of transmission."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We assessed occupational risk factors for SARS-CoV-2 infection among staff in six care homes experiencing a COVID-19 outbreak during the peak of the pandemic in London, England."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "During the initial period of the epidemic, many patients were diagnosed with coronavirus disease 2019 (COVID‐19) only after developing critical illness or even at the time of death, whereas asymptomatic or paucisymptomatic patients were untested, leading to an underestimation of the denominator."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, several mutated strains of SARS‐CoV‐2 are constantly emerging,",
            ", ",
            " while the infectivity rates and COVID‐19‐associated number of deaths are decreasing."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Besides SARS-CoV, there are five well known human coronaviruses (HCoVs), such as HCoV-OC43, HCoV-NL63, HCoV-HKU1, Middle East respiratory syndrome CoV (MERS-CoV), and coronavirus COVID-19 (formerly known as Wuhan coronavirus and 2019-nCoV) [5]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among them, SARS-CoV, MERS-CoV, and COVID-19 are highly pathogenic HCoVs, and their spread initiated global outbreaks with high fatality rates in 2003, 2012, and 2020, respectively [6,7]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nowadays, COVID-19 has caused a big outbreak in China and is spreading globally by a limited people-to-people transmission, resulting in 2,319,066 confirmed cases including 157,920 deaths in 213 countries, areas or territories, with cases during the period from 31st December 2019 to 21st April 2020 (https://www.who.int/emergencies/diseases/novel-coronavirus-2019)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The mortality rate of these pathogenic coronaviruses ranges from 6.8% for COVID-19 patients to 35% for MERS patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, an increase in the plasma level of CXCL10 is found in the severe pneumonia patients infected with MERS-CoV and COVID-19, which is linked with the infiltration of immune cells into alveolar space, peribranchial, and perivascular of the lung [12,13]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV unique domain (SUD) appears in SARS-CoV, as also found in other coronaviruses like MERS CoV and COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, amino acid alignment of SARS-SUD with MERS-CoV and COVID-19 shows 15% and 75% identity, respectively."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The nucleotide sequences of SARS-CoV full-length SUD, SUD-NM, and SUD-MC within the SARS-CoV genome nucleotides 3887–4941, 3887–4673, and 4311–4880 (",
            "GenBank",
            " accession no. ",
            "AY291451",
            "), respectively, were amplified using PCR with specific primer pairs."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1553,
                "end": 1560,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 1575,
                "end": 1583,
                "name": "AY291451"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "Coronavirus disease 2019 (COVID-19), the infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a global pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Emerging evidence has described several risk factors (e.g., older age, cardiovascular disease, chronic lung disease) for COVID-19 severity and mortality [[1], [2], [3]]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Centers for Disease Control and Prevention (CDC) list severe obesity (body mass index [BMI] of ≥40 kg/m2) as a risk factor for severe illness from COVID-19 [5]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Despite the clinical and research significance, no study has examined the relationship of obesity—let alone of its related traits (e.g., central obesity) and their genetic factors—with severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using standardized protocols, the study has collected comprehensive phenotypic information (such as demographics, anthropometric measures [e.g., height, weight, waist and hip circumference] and medical history), tested for biochemical assays, performed genome-wide genotyping, and longitudinally measured health outcomes (e.g., hospitalizations) through linkages to national datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the current study, we analyzed the first set of the ",
            "UK Biobank",
            " data with laboratory-confirmed COVID-19 status, which were released on April 16, 2020."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1139,
                "end": 1149,
                "name": "UK Biobank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These hospitalized patients with SARS-CoV-2 infection had “severe COVID-19” [22,23]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The detailed information on released COVID-19 data can be found elsewhere [22]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Second, to visualize the relationship of BMI and two markers of central obesity (i.e., waist circumference and waist-to-hip ratio) with the risk of developing severe COVID-19, we used generalized additive models with penalized cubic regression splines."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Next, to examine the relationship between the genetic predisposition for obesity traits and the risk of developing severe COVID-19, we computed a polygenic risk score (PRS) for each of three obesity measures—i.e., BMI, BMI-adjusted waist circumference, and BMI-adjusted waist-to-hip ratio, according to prior research [26], using genome-wide genotyping data from the ",
            "Genetic Investigation of Anthropometric Traits (GIANT)",
            " consortium and ",
            "UK Biobank",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 2022,
                "end": 2076,
                "name": "Genetic Investigation of Anthropometric Traits (GIANT)"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 2092,
                "end": 2102,
                "name": "UK Biobank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In brief, we retrieved the genome-wide association study (GWAS) summary statistics of BMI (nmax = 322,154) [27], BMI-adjusted waist circumference (nmax = 231,355) [28], and BMI-adjusted waist-to-hip ratio (nmax = 210,086) [28] from the ",
            "GIANT",
            " consortium data as an independent base dataset."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 2340,
                "end": 2345,
                "name": "GIANT"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We then applied the LDpred method [29] to compute model coefficients using approximately 1,480,000 single nucleotide polymorphisms (SNPs), and computed a PRS for each trait in an independent target dataset (n = 459,331) from the ",
            "UK Biobank",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 2623,
                "end": 2633,
                "name": "UK Biobank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Lastly, we investigated the association of derived PRSs with the risk of severe COVID-19 in the ",
            "UK Biobank",
            " by fitting logistic regression models adjusting for age, sex, 30 ancestry principal components (which account for population stratification), and genotyping array."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 2731,
                "end": 2741,
                "name": "UK Biobank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "UK Biobank",
            " also identified a total of 641 patients with severe COVID-19."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 2910,
                "end": 2920,
                "name": "UK Biobank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Fig. 1",
            "shows the relationship of BMI and markers of central obesity with the risk of developing severe COVID-19."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For example, BMI was positively associated with the risk of severe COVID-19 (unadjusted OR 1.35 per 5 kg/m2 increase; 95% CI 1.26–1.45; P < 0.001; Fig. 1A)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Compared to adults with normal weight, those with a higher BMI had a dose-response increase in the risk of developing severe COVID-19, with the following ORs: for overweight, 1.55 (95% CI 1.26–1.91; P < 0.001); for class I obesity, 1.92 (95% CI 1.51–2.44; P < 0.001); for class II obesity, OR 3.06 (95% CI 2.26–4.14; P < 0.001); and for class III obesity, 3.45 (95% CI 2.28–5.21; P < 0.001) (Fig. 2",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Likewise, adults with central obesity were at higher risk of severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To examine the relationship of the individual's overall genetic risks for obesity and central obesity with the risk of developing severe COVID-19, we examined the associations of the derived PRSs with the outcome risk (Table 3",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Consistent with these observations, a recent sentinel surveillance of 1482 adults hospitalized with COVID-19 in 14 U.S. states reported that obesity was the second most prevalent underlying condition (48% prevalence), following hypertension [30]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additionally, retrospective studies—either from single centers [[9], [10], [11], [12], [13], [14], [15], [16]] or health systems [3,18]—have reported associations between obesity and higher morbidity of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For example, in a single-center analysis of 389 patients hospitalized for COVID-19 in China, Cai et al. reported patients with obesity (defined by BMI of ≥28 kg/m2) had higher severity of illness [9]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similarly, in another single-center case-control study of 150 patients hospitalized for COVID-19 in China, Gao et al. found that patients with obesity (defined by BMI of ≥25 kg/m2) had a longer hospital length-of-stay and higher disease severity [11]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These earlier studies—albeit from different patient populations and settings with varying definitions of obesity and outcomes—collectively indicate that obesity is a risk factor for severe illness from COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The current study builds on these prior reports, and extends them by demonstrating, in a large cohort, the relations of obesity-related traits (including central obesity) and their genetic predisposition with the risk of developing severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The exact mechanisms linking the observed obesity (and its genetic predisposition) to severe COVID-19 are likely multifactorial—which stem from obesity-related changes in pulmonary physiology and the genetics to alterations in immune response and inflammatory profiles, endothelial dysfunction, and metabolic dysfunction [31]—and warrant clarification."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The observed relation between the genetic preposition to obesity and severe COVID-19 also suggest the role of genetics in the pathogenesis of severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Fourth, a recent non-COVID-19 study also demonstrated that patients with a higher BMI had higher expression of ACE2 (the SARS-CoV-2 receptor [38]) in their bronchial epithelium [39], suggesting an increased susceptibility to SARS-CoV-2 infection in patients with obesity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Notwithstanding the complexity, the identification of obesity and its genetic predisposition as a culprit of COVID-19 morbidity is an important finding."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our observations should encourage future research disentangling the complex web of the pathogen, obesity, airway and systemic inflammation, and COVID-19 pathobiology."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The observed relationship between PRS for BMI and risks of severe COVID-19 has several clinical and research implications."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The use of PRS strengthens the causal inference, such as the causal effects of obesity on severity of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This complexity has hindered efforts to robustly examine the effect of these obesity-related factors on various disease conditions, including COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By contrast, the use of PRS—which captures and summarizes the cumulative effects of many common DNA variants [42]—effectively captures the obesity-related genetic factors (i.e., well-defined exposure), and hence potentially enables us to examine its effects on severe COVID-19 that are independent from the aforementioned confounders."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In contrast, the use of PRS for obesity-related traits and careful investigations of individuals at the extremes of its distribution (even without a clinically-evident obesity trait) potentially enables us to uncover new causal risk factors for the development of severe COVID-19 as well as to identify individuals at risk."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, biological profiling of these individuals at the extremes of obesity-related PRS distribution may identify molecular pathways that link obesity to severe COVID-19, thereby potentially leading to the development of novel prevention, prediction, and treatment strategies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Anthropometric measurements performed at assessment visits may have not accurately reflected the exposure data at the COVID-19 inception."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Yet, the PRS for BMI—time-invariant genetic data—was also significantly associated with the risk of developing severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, the study focused on severe COVID-19 requiring inpatient management, thereby mitigating, at least partially, this problem."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, the study sample consisted mainly of white individuals and we focused on severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We must cautiously generalize the inferences to other populations or patients with mild-to-moderate COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nevertheless, our inferences are directly relevant to hundreds of thousands of patients hospitalized for COVID-19 [44]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We aimed to examine the associations of obesity-related traits (body mass index [BMI], central obesity) and their genetic predisposition with the risk of developing severe COVID-19 in a population-based data."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The outcome was severe COVID-19, defined by hospitalization for laboratory-confirmed COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "UK Biobank",
            " identified 641 patients with severe COVID-19."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 8805,
                "end": 8815,
                "name": "UK Biobank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Compared to adults with normal weight, those with a higher BMI had a dose-response increases in the risk of severe COVID-19, with the following adjusted ORs: for 25.0–29.9 kg/m 2 , 1.40 (95%CI 1.14–1.73; P = 0.002); for 30.0–34.9 kg/m 2 , 1.73 (95%CI 1.36–2.20; P < 0.001); for 35.0–39.9 kg/m 2 , 2.82 (95%CI 2.08–3.83; P < 0.001); and for ≥40.0 kg/m 2 , 3.30 (95%CI 2.17–5.03; P < 0.001)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Likewise, central obesity was associated with significantly higher risk of severe COVID-19 (P < 0.001)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this large population-based cohort, individuals with more-severe obesity, central obesity, or genetic predisposition for obesity are at higher risk of developing severe-COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Individuals with more-severe obesity, central obesity are at higher risk of developing severe-COVID-19.    •",
            "The genetic predisposition for obesity as measured by polygenic risk score is at higher risk of developing severe-COVID-19."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The BMI-severe COVID-19 associations were consistent across the sex strata, except women with class I obesity had a non-significant increase in the risk of severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "•  Adults with both class III obesity and diabetes or adults with both a larger waist circumference and diabetes appeared to have a larger magnitude of BMI-severe COVID-19 association compared to those without diabetes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to data from the ",
            "World Health Organization (WHO)",
            ", Coronavirus Disease 2019 or COVID-19 (Gorbalenya et al., 2020) has been diagnosed in over 6,057,853 people from more than 200 countries or territories and caused over 371,166 deaths worldwide as of 1 June 2020 (World Health Organization, 2020a)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Creator",
                "start": 27,
                "end": 58,
                "name": "World Health Organization (WHO)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, the QIAstat-Dx SARS-CoV-2 assay remains highly specific and sensitive against SARS-CoV-2 even in light of genomic variations from the first five months of the COVID-19 outbreak (Visseaux et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of week 21, 2020, the complete set of available SARS-CoV-2 genomes from ",
            "GISAID",
            " and ",
            "GenBank",
            " databases were used in this study."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 594,
                "end": 600,
                "name": "GISAID"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 605,
                "end": 612,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Considering that the sequence of SARS-CoV-2 is similar to the SARS-CoV and that SARS-CoV-2 appears to use the same ACE2 receptor to enter cells, analyses of ACE2 expression and distribution in lung and related biological processes may help us understand the pathogenesis and design therapeutic strategies for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 patients often have underlying diseases, including chronic respiratory disease and cardiovascular disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To investigate the virus-related potential biological processes associated with ACE2, we extracted the expression profiles of 15 healthy non-smokers from dataset ",
            "GSE89809",
            " and divided them into two groups: high and low-expression level of ACE2."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "AccessionNumber",
                "start": 597,
                "end": 605,
                "name": "GSE89809"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This may be related to pyroptosis, which has been suggested as another pathogenic mechanism involved in COVID-19 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The fact that tissue injury and death may be related to a pro-inflammatory process resulting from the viral infection suggests that the use of IL-1β blockers or IL-18 blockers may have some benefit in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In view of the role of the ACE2 receptor in the ability of SARS-CoV-2 to enter host cells [20], the question arises as to the effect of ACE inhibitors and angiotensin-receptor blockers (ARBs) in the pathogenesis of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At present there is no strong evidence to discontinue ACE inhibitors or ARBs in patients with COVID-19, nor conversely, to use these drugs as treatment for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is postulated that this may be related to the higher mortality in Chinese patients with COVID-19 who have hypertension as a comorbidity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "If ACE2 is downregulated by SARS-CoV-2 S protein binding to ACE2, this may explain why cardiac impairment is observed to be a significant characteristic of patients who die from COVID-19 [32]",
            "This illustrates a proposed mechanism of the effects of ACE2 in COVID-19 infection."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In conclusion, COVID-19 is a global pandemic that has already caused over 110,000 deaths worldwide so far."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These findings may help clinicians and researchers gain more insight into the pathogenesis and use this to design therapeutic strategies for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, we utilized previously uploaded information on ACE2 expression in various conditions including SARS-CoA to evaluate the role of ACE2 in SARS-CoV and extrapolate that to COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, based on the elevated expression of ACE2 in cigarette smokers, we speculate that long-term smoking may be a risk factor for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our findings may help clinicians and researchers gain more insight into the pathogenesis of SARS-CoV-2 and design therapeutic strategies for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Strains, ",
            "GenBank",
            " accessions and other details are listed in Table S1."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 9,
                "end": 16,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, human genomes with unrealistically large (>30) numbers of single-nucleotide variations (SNVs) were removed from the datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Briefly, a whole SARS-CoV-2 sequence (Wuhan-Hu-1, ",
            "GenBank",
            " accession number ",
            "MN908947",
            "; previously called ",
            "NC_045512",
            ") was mapped to the RaTG13 (",
            "GenBank",
            " accession ",
            "MN996532",
            ") accession as the reference."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 259,
                "end": 266,
                "name": "GenBank"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 284,
                "end": 292,
                "name": "MN908947"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 312,
                "end": 321,
                "name": "NC_045512"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 349,
                "end": 356,
                "name": "GenBank"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 367,
                "end": 375,
                "name": "MN996532"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T2",
                "end": "T4"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "Synonymous and nonsynonymous mutations in SARS-CoV-2 reading frames were determined according to annotated accession ",
            "MN908947",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 522,
                "end": 530,
                "name": "MN908947"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The datasets contained 152 SNVs, of which 84 (55%) were shared between at least two accessions; 68 (45%) were singletons (Table S4, sheet 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We determined the frequency of CpG dinucleotide in 17 human (including eight randomly selected SARS-CoV-2 accessions), nine bat, and eight other animal Betacoronaviruses (Figure 5a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In December 2019, the Chinese government reported several human pneumonia cases in Wuhan city and designated the disease as coronavirus disease 2019 (COVID 19) (Wang et al., 2020a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Major symptoms of COVID-19 include fever, cough, dyspnoea, and muscular soreness."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There were some patients with COVID 19, where atypical symptoms like diarrhea and vomiting were also found (Ding, 2020; Wang, 2020; Zhu et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Later on, the International Committee on Taxonomy of Viruses (ICTV) officially designated the virus as SARS-CoV-2. WHO on March 11, 2020, has declared the COVID-19 outbreak as a global pandemic (Cucinotta and Vanelli, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The SARS-CoV-2 isolate with ",
            "GenBank",
            " accession ID ‘",
            "NC_045512",
            "’, as downloaded from ",
            "NCBI",
            " (",
            "https://www.ncbi.nlm.nih.gov/nuccore/NC_045512",
            ") was used as the reference strain in this study."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 668,
                "end": 675,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 690,
                "end": 699,
                "name": "NC_045512"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 721,
                "end": 725,
                "name": "NCBI"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 727,
                "end": 773,
                "name": "https://www.ncbi.nlm.nih.gov/nuccore/NC_045512"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "The protein sequences of Bat coronavirus RaTG13 (",
            "GenBank",
            " Accession ID ",
            "MN996532.1",
            "), Pangolin coronavirus (",
            "MT072864.1",
            "), and two SARS-CoV strains TW11 (",
            "AY502924.1",
            ") and GD01 (",
            "AY278489.2",
            ") were downloaded from ",
            "NCBI",
            " (",
            "https://www.ncbi.nlm.nih.gov/protein",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 872,
                "end": 879,
                "name": "GenBank"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 893,
                "end": 903,
                "name": "MN996532.1"
            },
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 928,
                "end": 938,
                "name": "MT072864.1"
            },
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 972,
                "end": 982,
                "name": "AY502924.1"
            },
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 994,
                "end": 1004,
                "name": "AY278489.2"
            },
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 1027,
                "end": 1031,
                "name": "NCBI"
            },
            false,
            {
                "id": "T11",
                "type": "URL",
                "start": 1033,
                "end": 1069,
                "name": "https://www.ncbi.nlm.nih.gov/protein"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T5",
                "end": "T7"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T5",
                "end": "T8"
            },
            {
                "id": "R6",
                "bool": true,
                "head": "T5",
                "end": "T9"
            },
            {
                "id": "R7",
                "bool": true,
                "head": "T10",
                "end": "T11"
            }
        ]
    },
    {
        "sen": [
            "For this purpose, we have used SWISS-MODEL (https://swissmodel.expasy.org/) homology modelling online server with Spike glycoprotein sequence (uniprt_ID: ",
            "P0DTC2",
            ") and three individual ",
            "PDBs",
            " were used as a template to generate three conformations."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "AccessionNumber",
                "start": 1226,
                "end": 1232,
                "name": "P0DTC2"
            },
            false,
            {
                "id": "T13",
                "type": "Repository",
                "start": 1255,
                "end": 1259,
                "name": "PDBs"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Minor (less frequently) mutated residues that showed variations in ",
            "Nextstrain",
            " data compared to ",
            "NCBI",
            " virus database were excluded from the analysis."
        ],
        "lab": [
            false,
            {
                "id": "T14",
                "type": "Repository",
                "start": 1384,
                "end": 1394,
                "name": "Nextstrain"
            },
            false,
            {
                "id": "T15",
                "type": "Repository",
                "start": 1412,
                "end": 1416,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To further validate these findings, we visualized these major substitutions by observing the phylogeny of SARS-CoV-2 in Nextstrain, which contains a curated database of more than 10,000 SARS-CoV-2 sequences, depicted in the form of phylogenetic trees (Fig. 2",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As observed previously, substitutions at 5828th and 5865th position co-occurred even in this large sample set of ",
            "Nextstrain",
            " data."
        ],
        "lab": [
            false,
            {
                "id": "T16",
                "type": "Repository",
                "start": 1840,
                "end": 1850,
                "name": "Nextstrain"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Overall, the mutation profile that we identified with 664 samples showed excellent concordance with the ",
            "Nextstrain",
            " data comprising ~10,000 samples."
        ],
        "lab": [
            false,
            {
                "id": "T17",
                "type": "Repository",
                "start": 1961,
                "end": 1971,
                "name": "Nextstrain"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The analysis of the larger ",
            "Nextstrain",
            " dataset indicated that D614G mutation is significantly more prevalent, indeed."
        ],
        "lab": [
            false,
            {
                "id": "T18",
                "type": "Repository",
                "start": 2032,
                "end": 2042,
                "name": "Nextstrain"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Comparing the inert ‘DOWN' and active ‘UP’ conformations (",
            "PDB",
            "_ID s: ",
            "6VXX",
            " and ",
            "6VYB",
            " respectively), it is found that RBD moves as a rigid-body in a hinge bending motion around its linker region with NTD and CTD2 with all-atom rmsd for 198 residues is around 2.8 Å (Fig. 3B)."
        ],
        "lab": [
            false,
            {
                "id": "T19",
                "type": "Repository",
                "start": 2180,
                "end": 2183,
                "name": "PDB"
            },
            false,
            {
                "id": "T20",
                "type": "AccessionNumber",
                "start": 2190,
                "end": 2194,
                "name": "6VXX"
            },
            false,
            {
                "id": "T21",
                "type": "AccessionNumber",
                "start": 2199,
                "end": 2203,
                "name": "6VYB"
            },
            false
        ],
        "rel": [
            {
                "id": "R8",
                "bool": true,
                "head": "T19",
                "end": "T20"
            },
            {
                "id": "R9",
                "bool": true,
                "head": "T19",
                "end": "T21"
            }
        ]
    },
    {
        "sen": [
            "Those strains that corresponded to structures with low stabilities were consequently found to have low transmission capabilities as verified in the ",
            "Nextstrain",
            " data."
        ],
        "lab": [
            false,
            {
                "id": "T22",
                "type": "Repository",
                "start": 2542,
                "end": 2552,
                "name": "Nextstrain"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, considering only the disparity in the effectiveness of transmission among the different spike protein variants, we have two important suggestions to the different nations in tackling and curbing the spread of COVID-19 with greater efficacy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "First and foremost, the mutational profile of a patient found to be COVID-19 positive needs to be analysed, specifically at these key sites of five proteins, either by Sanger sequencing or designing probes corresponding to these regions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, our hypothesis and interpretation of the mutations show good concordance as evidenced by the ",
            "Nextstrain",
            " data."
        ],
        "lab": [
            false,
            {
                "id": "T23",
                "type": "Repository",
                "start": 3149,
                "end": 3159,
                "name": "Nextstrain"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We have identified frequently mutated residues by aligning ~660 SARS-CoV-2 genomes and validated in 10,000 datasets available in ",
            "GISAID",
            " ",
            "Nextstrain",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T24",
                "type": "Dataset",
                "start": 3295,
                "end": 3301,
                "name": "GISAID"
            },
            false,
            {
                "id": "T25",
                "type": "Repository",
                "start": 3302,
                "end": 3312,
                "name": "Nextstrain"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Identification of frequently mutated variants among COVID-19 patients might be useful for better clinical management, contact tracing, and containment of the disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Most people who develop COVID-19 after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection present with paucisymptomatic and non-severe disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, approximately 20% of patients develop severe COVID-19 requiring hospitalisation, including 5% who are admitted to the intensive care unit (ICU)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ongoing COVID-19 outbreak has led to an unprecedented health crisis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hence, it is crucial to identify individuals who are susceptible to developing severe COVID-19 and could require hospitalisation, especially in the ICU."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Studies from Chinese cohorts of patients with COVID-19 have identified several risk factors of severe COVID-19 including age, cardiomyopathy, and obesity-related complications such as type 2 diabetes and hypertension."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, to our knowledge, only few studies so far have included information regarding the BMI of patients with COVID-19, which suggest a high prevalence of obesity in patients with severe COVID-19.4, 5, 6, 7 Data from New York City suggest that obesity, as defined by BMI of at least 30 kg/m2, might be a risk factor for ICU admission among patients with COVID-19, especially among those younger than 60 years."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additionally, preliminary analyses from Lille University Hospital have reported differences in BMI distribution in ICU patients with COVID-19 compared with ICU patients without COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On March 27, 2020, 357 patients were hospitalised in Lyon University Hospital with COVID-19, of whom 17 patients had no data on BMI (appendix p 5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "340 patients with confirmed, severe COVID-19 were included in our population, including 230 (68%) patients with non-critical COVID-19 and 110 (32%) patients with critical COVID-19 (appendix p 5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our retrospective non-COVID-19 ICU comparison group included 1210 patients with BMI values admitted to ICU units in Lyon University Hospital on March 27 each year between 2007 and 2019 (appendix p 5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "85 (25%) of 340 patients with severe COVID-19 had obesity, compared with 15·3% in the French adult population in 2014 (appendix p 8)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "After standardisation on age and sex, the prevalence of obesity was 1·35 times (95% CI 1·08–1·66) higher in patients with severe COVID-19 than in the general French population (p=0·0034; figure 1",
            "; appendix pp 6–8)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In multivariable logistic regression adjusted for age and sex, the prevalence of obesity remained higher in patients with critical COVID-19 than in those with non-critical COVID-19 (OR 1·96 [95% CI 1·13–3·42]; p=0·018; appendix pp 7–8)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among the 1210 patients in our retrospective ICU non-COVID-19 comparison group, 314 (26%) patients had obesity (appendix p 9)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The prevalence of obesity was numerically higher in patients with critical COVID-19 than in ICU patients without COVID-19 (p=0·066; appendix p 9)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "After adjustment for age and sex, odds of obesity were significantly higher in patients with critical COVID-19 (OR 1·69 [95% CI 1·10–2·56]; p=0·017; figure 2A",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our findings are in agreement with preliminary findings from a population comprising 124 patients with critical COVID-19 and 306 ICU patients without COVID-19 from Lille University Hospital (appendix p 5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As observed in the Lyon population, the prevalence of obesity in patients with critical COVID-19 in the Lille population was 2·88 times (95% CI 2·19–3·66) higher than in the French general population after standardisation on age and sex (p<0·0001; figure 1; appendix p 6)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among the 306 ICU patients in the Lille population without COVID-19, 79 (26%) had obesity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The prevalence of obesity was higher in patients with critical COVID-19 than in ICU patients without COVID-19 (p<0·0001; appendix p 9)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The prevalence of obesity in patients with critical COVID-19 was higher than in ICU patients without COVID-19 in the Lille population (OR 2·86 [95% CI 1·78–4·61]; p=0·017; figure 2B) after standardisation on age and sex."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, in exploratory analyses, we looked at whether specific risk factors other than obesity were associated with critical COVID-19 versus non-critical COVID-19 in univariable analyses (appendix pp 9–10)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In multivariable analyses, odds of critical COVID-19 versus non-critical COVID-19 were higher in patients with obesity than in patients without obesity when adjusted for age and sex (appendix p 9)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This study reports a significant association between the prevalence of obesity and severe COVID-19, including critical COVID-19, and suggests that obesity might be a risk factor of pejorative evolution of COVID-19, increasing the risk of ICU admission."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Preliminary analyses from Lille University Hospital, using the same cohort of patients, have also reported a higher prevalence of invasive mechanical intubation in male patients and those with higher BMI, especially at least 35 kg/m2 in ICU patients with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our study helps to fill this gap in knowledge by providing evidence of a higher prevalence of obesity among patients with severe COVID-19, especially those admitted to the ICU."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We acknowledge that the findings in our study might not be generalised to other centres depending on the clinical algorithm implemented for ICU admission and ICU capacity and recommendations for the intensive care management of COVID-19 should be considered in future research."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, the comparison of the prevalence of obesity with the general population is based only on our sample of patients with COVID-19, and a population-based study would be needed to precisely assess the demographics of patients with COVID-19 with respect to the general population."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Emerging in late 2019, the novel Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2 has disseminated rapidly around the globe and has been declared a pandemic [5,6]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "After initially optimizing the hydrolysis probe-based version of the assay to show that it reached the sensitivity of our previously published COVID-19-RdRp/Hel assay (data not shown), we used only the primers (nsp2f: 5′-ATGCATTTGCATCAGAGGCT-3′, nsp2r: 5′-TTGTTATAGCGGCCTTCTGT-3′), to develop the subsequent probe-free, COVID-19-nsp2 real-time RT-PCR assay."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To determine the analytical sensitivity of the COVID-19-nsp2 assay, the limit of detection (LOD) was evaluated by using viral genomic RNA extracted from a culture isolate of SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The LOD of the COVID-19-nsp2 assay was 1.8 TCID50/mL (Table 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using TNA extracted from SARS-CoV-2 isolate at different concentrations, the new COVID-19-nsp2 assay was performed in triplicate for each concentration to evaluate the intra- and inter-assay variations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To evaluate the diagnostic performance of the assay, 59 clinical specimens (23 positive and 36 negative) from 14 confirmed cases (defined as at least one respiratory specimen positive for SARS-CoV-2 by our previously established COVID-19-RdRp/Hel assay) [24] were used."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Twenty-three were positive (including 22 respiratory specimens and 1 stool specimen, with Cp values ranged from 18.69 to 36.21) and 36 were negative (including four respiratory and 32 non-respiratory specimens) by the COVID-19-nsp2 assay."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The melting curve from COVID-19-nsp2-positive specimens showed a unique peak with the melting temperature of around 80 °C."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The results from the two assays were 100% concordant, and no additional positive result was detected from the specimens previously tested negative by the COVID-19-RdRp/Hel assay."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Early in the COVID-19 outbreak, when the virus was reported to be related to the SARS-CoV and the exact genomic variation of the virus was not adequately known [25], multiple groups developed and published assays based on conserved regions that could potentially detect additional coronaviruses [26,27] (see also https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the present study, we demonstrated that the diagnostic performance of the hydrolysis probe-free COVID-19-nsp2 assay was comparable to that of our previously developed COVID-19-RdRp/Hel assay [24]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The current nsp2 assay was highly specific (without cross-reaction with other common respiratory viruses) and comparable to the COVID-19-RdRp/Hel assay in terms of analytical sensitivity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The diagnostic sensitivity and specificity of the nsp2 assay was 100% in comparison with the COVID-19-RdRp/Hel assay in this study."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, the PCR reaction time of the nsp2 assay was within an hour, which is shorter than that of the previously developed COVID-19-RdRp/Hel assay [24]; this is a distinct advantage in clinical laboratories, as rapid results can facilitate the timely triage of suspected COVID-19 cases and guide infection control and patient management."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As COVID-19 unfolded into a pandemic, rapid, robust and sensitive diagnostic testing became a priority in containment-based control strategies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As nucleic acid amplification-based testing allows exquisite sensitivity (1.8 TCID50/mL in our case) and can be readily adopted in laboratories with basic molecular facilities, it is an essential tool in the clinical management and triage of patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The robust design of the optimized assay, requiring only one pair of SARS-CoV-2-specific primers to diagnose COVID-19 infection in humans, avoids the potential logistics, reagent and manpower constraints in performing multiple or cascade testing or the use of relatively costly reporter probes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using the software tool, degenerate bases may be strategically incorporated into the COVID-19-nsp2 assay primers to broaden the specificity, or additional targets may be iteratively identified from further coronavirus pan-genome analyses."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The GolayMetaMiner software first downloads the genomes of the target and non-target species from the ",
            "NCBI",
            " nucleotide database and generates a pool of nucleotide k-mers (k = 12 by default) for both forward and reverse directions of the non-target genomes."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 4107,
                "end": 4111,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The longer of the two SARS-CoV-2 genomes sequenced by our group [23], HKU-SZ-005b, was used as the reference genome (--primary_target ",
            "MN975262",
            "), and a list of accession numbers of publicly available SARS-CoV-2 genomes were used as secondary targets (--secondary_target_list SARS-CoV-2_genomes.txt); the accession number of the reference genome was manually commented out with a “#” to avoid double-counting the reference genome in estimating conservedness."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 4395,
                "end": 4403,
                "name": "MN975262"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The lists of accession numbers of the 96 SARS-CoV-2 and 104 non-SARS-CoV-2 coronavirus genomes are available in Supplementary Materials."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 was isolated from the nasopharyngeal aspirate specimen of a laboratory-confirmed COVID-19 patient in Hong Kong as previously described [42]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The viral isolate stock (1.8 × 107 50% tissue culture infective doses [TCID50]/mL) was prepared using VeroE6 cells as previously described [20,24,43]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For assay performance evaluation, 59 archived clinical specimens (26 respiratory specimens including nasopharyngeal aspirate/swab, throat swab, endotracheal aspirate, sputum and saliva, and 33 non-respiratory specimens including plasma, urine, rectal swab/stool) from 14 patients with laboratory-confirmed COVID-19 were used [24]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These specimens were evaluated previously using the established COVID-19-RdRp/Hel assay [24]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The pandemic novel coronavirus infection, Coronavirus Disease 2019 (COVID-19), has affected at least 190 countries or territories, with 465,915 confirmed cases and 21,031 deaths."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The new COVID-19-nsp2 assay had a limit of detection (LOD) of 1.8 TCID 50 /mL and did not amplify other human-pathogenic coronaviruses and respiratory viruses."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Evaluation of the new assay using 59 clinical specimens from 14 confirmed cases showed 100% concordance with our previously developed COVID-19-RdRp/Hel reference assay."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A rapid, sensitive, SARS-CoV-2-specific real-time RT-PCR assay, COVID-19-nsp2, was developed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "ALV has experienced substantial clinical testing and safety database development with more than 2000 patients treated for up to 48 weeks."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This was supported by a spectrometric profiling study showing the incorporation of CypA into SARS-CoV virions (Neuman et al., 2008)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With the current outbreak of coronavirus disease-2019 (COVID-19) [1]",
            ", debates are taking place around the consequences this pandemic would have on different aspects of the human health including obesity."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "During this critical period of COVID-19 pandemic, the mental health is among what health professionals are most concerned about."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Within the context of diet choice, the socioeconomic crisis expected to develop during and after the current COVID-19 crisis [18], [19] would lead to inflation of different products prices."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, patients who get the respiratory illness of COVID-19 might have reduced lung function [21], [22] (possibly even after they recover), which would limit their ability to perform physical activity due to the respiratory failure."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Herein, we have illustrated how selected COVID-19 pandemic-related concepts do increase obesity risk and therefore multiple obesity-related morbidities including cardiovascular diseases, diabetes, etc [23]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Obesity and those morbidities resulting from measures implemented to prevent COVID-19 spread and limit its mortality would, ironically, make the individuals more vulnerable to COVID-19 [24]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Importantly, it is of an extreme importance to make sure we do not replace COVID-19 pandemic with another pandemic(s) such as obesity which is already epidemic [25]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A novel coronavirus (CoV), designated severe acute respiratory syndrome (SARS)-CoV-2, underlies a pandemic infection, coronavirus disease 2019 (COVID-19), which rapidly spread globally and has been proclaimed a severe public health emergency of international concern (PHEIC) by the World Health Organization (WHO) (Wang et al., 2020a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By June 30, 2020, more than 200 countries and territories reported COVID-19 infections, together comprising 10,185,374 confirmed cases and 503,862 deaths (data from ",
            "WHO",
            ", the ",
            "Centers for Disease Control and Prevention [CDC]",
            ", and the ",
            "European Centre for Disease Prevention and Control [ECDC]",
            " are at ",
            "https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Creator",
                "start": 501,
                "end": 504,
                "name": "WHO"
            },
            false,
            {
                "id": "T2",
                "type": "Creator",
                "start": 510,
                "end": 558,
                "name": "Centers for Disease Control and Prevention [CDC]"
            },
            false,
            {
                "id": "T3",
                "type": "Creator",
                "start": 568,
                "end": 625,
                "name": "European Centre for Disease Prevention and Control [ECDC]"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 633,
                "end": 714,
                "name": "https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T4"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T2",
                "end": "T4"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "After COVID-19 diagnosis, other symptoms can be detected by routine blood examination."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The neutrophils in 38% of COVID-19 patients were above the normal range, while the hemoglobin in 51% COVID-19 patients lies below the normal range, according to research at the Jinyintan Hospital in Wuhan, China."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, lymphocyte levels decreased in 35% of patients (Chen et al., 2020), suggesting possible dysfunctional cell-mediated immunity in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It has been reported that interleukin-6 (IL-6) concentrations and ferritin increase with illness deterioration in non-survivors compared with survivors within a subgroup of patients with COVID-19 (Zhou et al., 2020a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To investigate the pathogenesis and mechanism of SARS-CoV-2 infections in COVID-19 patients, blood samples were collected from three healthy controls, two IAV-infected patients, and five COVID-19 patients, including four patients (COV-1 to COV-4) with uncomplicated disease courses and one patient (COV-5) that subsequently progressed to severe disease (Figure 1",
            "A; Table S1)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, COVID-19 has distinct clinical signatures compared to IAV infections, including high morbidity and mortality."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 patients were enrolled within 5–10 days of symptom onset based on positive nucleic acid testing results, and the day when PBMCs were first collected was named day 1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "After filtering out cells with low quality, we obtained transcriptome datasets from 46,022 cells with an average of 2,000 cells for each participant at each time point (Figure 1B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To uncover immune cell populations in COVID-19, we performed unsupervised clustering and obtained 15 cell populations (Figure 1C)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The proportion of plasma cells and cycling plasma cells were increased significantly in both COVID-19- and IAV-infected patients (Figures 2B and S2), and there was no difference between these two types of virus infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As expected, when examining the functions of upregulated genes in B cells of COVID-19 patients compared with healthy donors, protein complex assembly and protein-transport-related pathways were especially enriched, which may be because a large number of proteins are synthesized during this process (Figure 2C)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "T cells of COVID-19 (Figure 2E)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Taken together, these results demonstrated that elevated plasma cells and increased activation of T cells and NK cells in COVID-19 patients may contribute to defense against the virus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Gene Ontology (GO) analyses were performed to gain insight into functions of different cell subsets between COVID-19 patients and healthy controls."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Consistently, “defense response to virus signaling” genes were also enriched in T, B, and NK cells of all five COVID-19 patients on D1 and D4, but not D16 (Figures 3A and S3A), implying an ongoing immune response against SARS-CoV-2 virus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Differentially expressed genes (DEGs) in these transcriptomic profiles were then compared between COVID-19 patients and healthy controls."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The expression of these four genes was also much higher in COVID-19 patients compared to healthy controls at the bulk level (Figure 3C)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To achieve this, we divided the disease processes of COVID-19 patients from symptom onset to discharge into four stages (Table S3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Expression of IRF1, TP53, and CASP3 was increased in T, B, and NK cell subsets in COVID-19 patients compared to controls, while BCL2L11 exhibited different patterns in different cell subsets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition to the XAF1 related apoptosis pathway, expression of genes in other apoptosis-linked pathways, including TNF and Fas pathways (Elmore, 2007), was examined in both COVID-19 patients and healthy controls (Figures 3F and S3E)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The expression of TNFSF10 (TRAIL) and its receptor TNFRSF10A were increased in T cells from COVID-19 patients relative to healthy controls."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Other TNF path members, including TNFRSF1B, were also relatively upregulated in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As for the FAS path, the expression of FAS, FASLG, and FADD were upregulated in T cells of COVID-19 patients, though not significantly (Figure 3F)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In B and NK cell subsets, TNFSF10 and FADD were notably increased in COVID-19 patients with other genes increased mildly, except that Fas in B cells and TRADD in NK cells were subtly decreased (Figure S3E)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Taken together, we find that upregulated genes relevant to the XAF1, TNF, and Fas pathways may lead to increased T cell apoptosis in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Next, we sought to identify the immune molecular signatures associated with COVID-19 and IAV infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, we compared the expression of cytokines, cytokine receptors, and transcription factors in T cell subsets, NK cells, and DCs among COVID-19 patients, IAV patients, and healthy controls (Figures 4",
            "A and S4A)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As the gene clustering pattern suggested, upregulated genes in COVID-19 patients mostly encode proinflammatory cytokines, cytokine receptors, and IFN-responsive transcription factors, while in IAV patients, proinflammatory transcription factors and virus-interacting host factors seem to be highly expressed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Expression of STAT3 was elevated in IAV patients compared to COVID-19 patients and healthy controls and seemed to correlate with time post admission."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For COVID-19 patients, STAT1, a major transcription factor activated in response to interferon, was upregulated in activated CD4+",
            "We measured plasma concentrations of IL-6 during hospitalization of these COVID-19 patients and after leaving the hospital (Figure S4D)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There was a rising phase of IL-6 in most COVID-19 patients, indicating an active inflammatory response, which is also observed in IAV patients (Yu et al., 2011)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "T cells, naive T cells, and DCs of COVID-19 patients compared to IAV patients and healthy controls (Figures 4C and S4A)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Meanwhile, expression of IL6ST was upregulated in various cell types from COVID-19 patients and IAV patients compared to healthy controls."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on clinical observations that plasma concentrations of inflammatory cytokines, such as IFN-α2, IL-7, IL-17, and IL-10 were higher in COVID-19 patients than in healthy adults (Huang et al., 2020), we compared expression levels of their corresponding receptors in activated CD4+",
            "T cells, MAIT cells, and NK cells across COVID-19 patients, IAV patients, and healthy controls."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Upregulation of IFNAR1, the α chain of the interferon α/β receptor, was significant in these cell types in COVID-19 patients compared to healthy controls."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "T cells of COVID-19 patients compared to other groups, indicating that CD4+",
            "Here, we performed scRNA-seq on PBMCs from COVID-19 patients."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among all the immune cell clusters, the percentage of plasma cells was increased significantly among all five COVID-19 patients compared with healthy controls."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "IFNα2 and IFNγ have also been strongly associated with lung injury in COVID-19 (Liu et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Consistently, “IFN-I response” was enriched in different PBMC subsets of COVID-19 patients in our study."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, severe COVID-19 patients showed a stronger response to IFNs and virus infection compared to mild patients and healthy ones."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This indicates that the intensity of the interferon response may both indicate the severity of COVID-19 disease and distinguish COVID-19 patients from healthy individuals."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to our results, upregulated XAF1 expression may be involved in increased T cell apoptosis in COVID-19 patients, cooperating with other genes, including IRF1, TP53, BCL2L11, and CASP3 (Jeong et al., 2018; Zou et al., 2012)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Consistently, TP53 expression was increased in COVID-19 patients in another COVID-19 study (Xiong et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition to XAF1-induced apoptosis, the extrinsic pathway of apoptosis, including TNF-α/TNFR1 and Fas/FasL path (Elmore, 2007), were also found to be involved in different cell subtypes in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, plasma TNF-α was reported to be increased in severe cases of COVID-19 (Chen et al., 2020; Huang et al., 2020), and TNF expression was upregulated in PBMCs of COVID-19 patients in our study, demonstrating a correlation between increased TNF-α secretion and TNF-α-induced apoptosis in COVID-19 patients (Rath and Aggarwal, 1999)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Taken together, we found that the upregulated genes relevant to XAF1, TNF, and Fas pathways may lead to increased T cell apoptosis in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We analyzed the expression of cytokines, cytokines receptors, and transcription factors that are essential in the immune responses to viral infection and pinpointed gene expression patterns in COVID-19 patients that differ from IAV patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The fact that expression of most cytokines was not detected in PBMCs might indicate that serum cytokines largely arise from the infection site, i.e., the lower respiratory tract for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We found that plasma concentrations of IL-6 are above normal levels in the majority of COVID-19 patients, consistent with other studies (Chen et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our data show that expression of IL6R and IL6ST was upregulated in patients with COVID-19, and we suggest that increased expression of IL6R and IL6ST might synergize with elevated IL-6 to induce a strong inflammatory response, indicating that patients might benefit from IL-6 or IL-6R antagonist treatment."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Five patients with COVID-19 were recruited in the Fifth Medical Center of PLA General Hospital from January to February 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Influenza virus infection, respiratory syncytial virus infection and adenovirus infection were excluded in all patients with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The genome of SARS-CoV-2 was downloaded from ",
            "NCBI",
            " (",
            "https://www.ncbi.nlm.nih.gov/",
            ") with the accession number ",
            "GenBank",
            ":",
            "NC_045512.2",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 10157,
                "end": 10161,
                "name": "NCBI"
            },
            false,
            {
                "id": "T6",
                "type": "URL",
                "start": 10163,
                "end": 10192,
                "name": "https://www.ncbi.nlm.nih.gov/"
            },
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 10220,
                "end": 10227,
                "name": "GenBank"
            },
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 10228,
                "end": 10239,
                "name": "NC_045512.2"
            },
            false
        ],
        "rel": [
            {
                "id": "R4",
                "bool": true,
                "head": "T5",
                "end": "T6"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T5",
                "end": "T8"
            },
            {
                "id": "R6",
                "bool": true,
                "head": "T7",
                "end": "T6"
            },
            {
                "id": "R7",
                "bool": true,
                "head": "T7",
                "end": "T8"
            }
        ]
    },
    {
        "sen": [
            "Then, the integrated dataset was scaled and PCA was calculated."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We used Mfuzz (Kumar and Futschik, 2007) to identify time dependent transcriptional program in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The samples from COVID-19 patients were grouped according to the disease progression stage (Table S3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The coronavirus disease 2019 (COVID-19) pandemic poses a current world-wide public health threat."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we report the single-cell transcriptional landscape of longitudinally collected peripheral blood mononuclear cells (PBMCs) in both COVID-19- and influenza A virus (IAV)-infected patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We observed increase of plasma cells in both COVID-19 and IAV patients and XIAP associated factor 1 (XAF1)-, tumor necrosis factor (TNF)-, and FAS-induced T cell apoptosis in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Further analyses revealed distinct signaling pathways activated in COVID-19 (STAT1 and IRF3) versus IAV (STAT3 and NFκB) patients and substantial differences in the expression of key factors."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These factors include relatively increase of interleukin ( IL ) 6R and IL6ST expression in COVID-19 patients but similarly increased IL-6 concentrations compared to IAV patients, supporting the clinical observations of increased proinflammatory cytokines in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, we provide the landscape of PBMCs and unveil distinct immune response pathways in COVID-19 and IAV patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We generated a single-cell atlas of PBMCs in both COVID-19 and influenza patients    •  Plasma cells increase significantly in both COVID-19 and influenza patients    •  COVID-19 is featured with XAF1-, TNF-, and FAS-induced T cell apoptosis    •  COVID-19 activates distinct pathway (STAT1/IRF3) versus influenza (STAT3/NFκB)      COVID-19 and influenza are both respiratory infections with cytokine release syndrome."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, some recent coronavirus infections have resulted in serious morbidity and mortality, including the severe acute respiratory syndrome coronavirus (SARS-CoV) [2–4], Middle East respiratory syndrome coronavirus (MERS-CoV) [5, 6], and SARS-CoV-2, which are responsible for the current worldwide pandemic, COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In Abelin et al. [34], we demonstrated that improved HLA-II binding prediction led to improved immunogenicity prediction by validating this approach on a data set of immune responses to a diverse collection of pathogens and allergens [35, 36]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we specifically validated the binding predictors utilizing Coronaviridae family peptides that had been assayed for T cell reactivity or MHC binding from the ",
            "Virus Pathogen Resource (ViPR)",
            " database [34]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 727,
                "end": 757,
                "name": "Virus Pathogen Resource (ViPR)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "ViPR",
            " database integrates viral pathogen data from internally curated data, researcher submissions, and data from various external sources."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 777,
                "end": 781,
                "name": "ViPR"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Experimentally determined epitopes for the Coronaviridae family for human hosts were retrieved from the ",
            "ViPR",
            " database (",
            "https://www.viprbrc.org/",
            "; accessed March 5, 2020) [39]."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 1020,
                "end": 1024,
                "name": "ViPR"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 1035,
                "end": 1059,
                "name": "https://www.viprbrc.org/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "To build a validation dataset, both positives and negatives for T cell assays and MHC binding assays were obtained."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Peptide-HLA-I allele pairs in the ",
            "ViPR",
            " validation dataset were scored using our HLA-I binding predictor, a neural network trained on mono-allelic MS data [33]."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 1241,
                "end": 1245,
                "name": "ViPR"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similarly, peptide-HLA-II allele pairs in the ",
            "ViPR",
            " validation dataset were scored using our HLA-II binding predictor, a recently published convolutional neural network-based model also trained on mono-allelic MS data [34]."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 1413,
                "end": 1417,
                "name": "ViPR"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In vitro MHC binding assays, which represent the vast majority of the ",
            "ViPR",
            " dataset, do not require endogenous processing and presentation for a positive binding result."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 1660,
                "end": 1664,
                "name": "ViPR"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "GenBank",
            " reference sequence for SARS-CoV-2 (accession: ",
            "NC_045512.2",
            ", ",
            "https://www.ncbi.nlm.nih.gov/nuccore/NC_045512",
            ") was used for this study."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 1763,
                "end": 1770,
                "name": "GenBank"
            },
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 1817,
                "end": 1828,
                "name": "NC_045512.2"
            },
            false,
            {
                "id": "T10",
                "type": "URL",
                "start": 1830,
                "end": 1876,
                "name": "https://www.ncbi.nlm.nih.gov/nuccore/NC_045512"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T8",
                "end": "T9"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T8",
                "end": "T10"
            }
        ]
    },
    {
        "sen": [
            "In addition, due to its high expression level in recently published proteomic datasets [40–42], ORF9b, as annotated by ",
            "UniProt",
            " (",
            "P0DTD2",
            ", ",
            "https://www.uniprot.org/proteomes/UP000464024",
            "), was also used for epitope predictions."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Repository",
                "start": 2022,
                "end": 2029,
                "name": "UniProt"
            },
            false,
            {
                "id": "T12",
                "type": "AccessionNumber",
                "start": 2031,
                "end": 2037,
                "name": "P0DTD2"
            },
            false,
            {
                "id": "T13",
                "type": "URL",
                "start": 2039,
                "end": 2084,
                "name": "https://www.uniprot.org/proteomes/UP000464024"
            },
            false
        ],
        "rel": [
            {
                "id": "R4",
                "bool": true,
                "head": "T11",
                "end": "T12"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T11",
                "end": "T13"
            }
        ]
    },
    {
        "sen": [
            "When comparing our 20 SARS-CoV-2-predicted epitopes with the ",
            "ViPR",
            " dataset, 8 epitopes were previously assayed and confirmed as HLA-A02:01 binders."
        ],
        "lab": [
            false,
            {
                "id": "T14",
                "type": "Repository",
                "start": 2187,
                "end": 2191,
                "name": "ViPR"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 proteomic datasets were downloaded from the ",
            "PRIDE",
            " repository (",
            "Bojkova et al.",
            " [40]: ",
            "PXD017710",
            ", ",
            "https://www.ebi.ac.uk/pride/archive/projects/PXD017710",
            "; ",
            "Bezstarosti et al.",
            " [41]: ",
            "PXD018760",
            ", ",
            "https://www.ebi.ac.uk/pride/archive/projects/PXD018760",
            "; ",
            "Davidson et al.",
            " [42]: ",
            "PXD018241",
            ", ",
            "https://www.ebi.ac.uk/pride/archive/projects/PXD018241",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T15",
                "type": "Repository",
                "start": 2328,
                "end": 2333,
                "name": "PRIDE"
            },
            false,
            {
                "id": "T16",
                "type": "Creator",
                "start": 2346,
                "end": 2360,
                "name": "Bojkova et al."
            },
            false,
            {
                "id": "T17",
                "type": "AccessionNumber",
                "start": 2367,
                "end": 2376,
                "name": "PXD017710"
            },
            false,
            {
                "id": "T18",
                "type": "URL",
                "start": 2378,
                "end": 2432,
                "name": "https://www.ebi.ac.uk/pride/archive/projects/PXD017710"
            },
            false,
            {
                "id": "T19",
                "type": "Creator",
                "start": 2434,
                "end": 2452,
                "name": "Bezstarosti et al."
            },
            false,
            {
                "id": "T20",
                "type": "AccessionNumber",
                "start": 2459,
                "end": 2468,
                "name": "PXD018760"
            },
            false,
            {
                "id": "T21",
                "type": "URL",
                "start": 2470,
                "end": 2524,
                "name": "https://www.ebi.ac.uk/pride/archive/projects/PXD018760"
            },
            false,
            {
                "id": "T22",
                "type": "Creator",
                "start": 2526,
                "end": 2541,
                "name": "Davidson et al."
            },
            false,
            {
                "id": "T23",
                "type": "AccessionNumber",
                "start": 2548,
                "end": 2557,
                "name": "PXD018241"
            },
            false,
            {
                "id": "T24",
                "type": "URL",
                "start": 2559,
                "end": 2613,
                "name": "https://www.ebi.ac.uk/pride/archive/projects/PXD018241"
            },
            false
        ],
        "rel": [
            {
                "id": "R6",
                "bool": true,
                "head": "T15",
                "end": "T17"
            },
            {
                "id": "R7",
                "bool": true,
                "head": "T15",
                "end": "T18"
            },
            {
                "id": "R8",
                "bool": true,
                "head": "T15",
                "end": "T20"
            },
            {
                "id": "R9",
                "bool": true,
                "head": "T15",
                "end": "T21"
            },
            {
                "id": "R10",
                "bool": true,
                "head": "T15",
                "end": "T23"
            },
            {
                "id": "R11",
                "bool": true,
                "head": "T15",
                "end": "T24"
            },
            {
                "id": "R12",
                "bool": true,
                "head": "T16",
                "end": "T17"
            },
            {
                "id": "R13",
                "bool": true,
                "head": "T16",
                "end": "T18"
            },
            {
                "id": "R14",
                "bool": true,
                "head": "T19",
                "end": "T20"
            },
            {
                "id": "R15",
                "bool": true,
                "head": "T19",
                "end": "T21"
            },
            {
                "id": "R16",
                "bool": true,
                "head": "T22",
                "end": "T23"
            },
            {
                "id": "R17",
                "bool": true,
                "head": "T22",
                "end": "T24"
            }
        ]
    },
    {
        "sen": [
            "For the dataset from ",
            "Bojkova et al.",
            " [40] which employed isobaric mass tags, TMT11 was added as a fixed modification to peptide N-termini and lysines, and 13C6-15N2-TMT11-lysine and 13C6-15N4-arginine were added as variable modifications."
        ],
        "lab": [
            false,
            {
                "id": "T25",
                "type": "Creator",
                "start": 2637,
                "end": 2651,
                "name": "Bojkova et al."
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All datasets were searched against the SARS-CoV-2 proteome (",
            "UniProtKB",
            ", 28 April 2020, 14 entries) concatenated to databases containing either the Homo sapiens proteome ([40], UCSC Genome Browser hg19 annotation, 63,691 entries) or the Chlorocebus sabaeus proteome ([41, 42] ",
            "UniProtKB",
            ", 9229 entries)."
        ],
        "lab": [
            false,
            {
                "id": "T26",
                "type": "Repository",
                "start": 2914,
                "end": 2923,
                "name": "UniProtKB"
            },
            false,
            {
                "id": "T27",
                "type": "Repository",
                "start": 3128,
                "end": 3137,
                "name": "UniProtKB"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Spectral counts were normalized to the length of each protein, and the maximum value within each dataset was set to 100%."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To that end, we used the ",
            "ViPR",
            " database [39], which lists the results of T cell immunogenicity and MHC-peptide binding assays for both HLA-I and HLA-II alleles for viral pathogen epitopes."
        ],
        "lab": [
            false,
            {
                "id": "T28",
                "type": "Repository",
                "start": 3301,
                "end": 3305,
                "name": "ViPR"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We used all assays of Coronaviridae family viruses with human hosts from ",
            "ViPR",
            " as our validation dataset."
        ],
        "lab": [
            false,
            {
                "id": "T29",
                "type": "Repository",
                "start": 3537,
                "end": 3541,
                "name": "ViPR"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For HLA-I, within the validation dataset, there were a total of 4445 unique peptide-HLA allele pairs that were assayed for MHC binding, using variations of (1) cellular MHC or purified MHC, (2) a direct or competitive assay, and (3) measurement by fluorescence or radioactivity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We then applied our HLA-I binding predictor to the peptide-MHC allele pairs in the validation dataset and compared the computed HLA-I percent ranks of these pairs with the reported MHC binding assay results (Additional file 8: Table S8)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In total, there were 4445 peptide-HLA-I allele pairs in the ",
            "ViPR",
            " dataset we obtained (see the “Methods” section)."
        ],
        "lab": [
            false,
            {
                "id": "T30",
                "type": "Repository",
                "start": 4146,
                "end": 4150,
                "name": "ViPR"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There were 259 unique peptide-MHC allele pairs assayed by MHC binding assays in the ",
            "ViPR",
            " validation dataset for HLA-II."
        ],
        "lab": [
            false,
            {
                "id": "T31",
                "type": "Repository",
                "start": 4284,
                "end": 4288,
                "name": "ViPR"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This comparison could not be performed with the “Negative” pairs as an independent group since there was only one negative result in the validation dataset for HLA-II."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similar to the HLA-I T cell assays, there were too few recorded HLA-II T cell assays in our validation dataset to determine percent rank differences between peptide-HLA II allele pairs testing positive and negative."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We first performed the analysis for HLA-I peptide binding and computed the likelihood of each peptide of lengths 8–12 amino acids from the 13 SARS-CoV-2 ORFs to bind to any HLA-I allele in our database."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To test the validity of the SARS-CoV-2-predicted peptide-HLA pairs, we looked for peptide sequences in the Coronaviridae portion of the ",
            "ViPR",
            " database which exactly matched SARS-CoV-2 peptide sequences (Fig. 2d)."
        ],
        "lab": [
            false,
            {
                "id": "T32",
                "type": "Repository",
                "start": 5043,
                "end": 5047,
                "name": "ViPR"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 374 HLA-I peptide-MHC allele pairs from SARS-CoV-2 had both a percent rank lower than 1% by our predictor and were found in the HLA-I MHC binding validation dataset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As a comparison, we also tested for overlap between epitopes predicted to have low likelihood of MHC binding (percent rank 50% or higher) and the validation dataset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Despite the significantly smaller number of peptide-MHC allele pairs that were tested for T cell reactivity in the validation dataset, 10 assayed pairs were also highly predicted by our HLA-I binding predictor."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "No low-scoring pairs (percent rank of 50% or above) were reported in the validation dataset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In order to determine the relative abundance of SARS-CoV-2 proteins, we analyzed three publicly available proteomic datasets that acquired unbiased LC-MS/MS on tryptic digestions of SARS-CoV-2-infected host cells [40–42]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Specifically, it confirmed that the N protein is the most abundant viral protein across all three datasets following SARS-CoV-2 infection (Fig. 5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This finding is corroborated by reports of N-derived peptides being detected in gargle solution samples from COVID-19 patients [57]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our database of supported HLA-I and HLA-II alleles provides us with the ability to not only identify many peptide-MHC allele pairs, but to generate a narrow list of peptides with many potential HLA pairings that could be presented by the entire US, European, and Asian-Pacific Islander populations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "T cell responses to a small set of epitopes from the S protein in COVID-19 patient or healthy donor PBMCs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "T cell responses in COVID-19 patients from healthy donor samples collected before or during the pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Their data also show that 10 additional peptides sporadically induce responses in 2–3 individuals from either the healthy donor or the COVID-19 patient cohorts (total of 31 individuals)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While focusing on a small set of two COVID-19 patients and one healthy donor, Chour et al. [61] demonstrate that five HLA-A02:01-restricted epitopes from the S protein elicited a CD8+",
            "The differences in training data lead to algorithms that prioritize substantially different epitope sets, even for well-studied alleles."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additional file 10: Table S10. spectral counts from published SARS-CoV-2 proteomic datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "MS/MS spectra assigned to peptides from SARS-CoV-2 proteins were tallied across datasets, divided by protein length, and normalized within each dataset to generate Fig. 5."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additional file 13."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ongoing COVID-19 pandemic has created an urgency to identify novel vaccine targets for protective immunity against SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We first validated HLA-I and HLA-II predictions on Coronaviridae family epitopes deposited in the ",
            "Virus Pathogen Database and Analysis Resource (ViPR)",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T33",
                "type": "Repository",
                "start": 7803,
                "end": 7855,
                "name": "Virus Pathogen Database and Analysis Resource (ViPR)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "From our SARS-CoV-2-predicted peptide-HLA-I allele pairs, 374 pairs identically matched what was previously reported in the ",
            "ViPR",
            " database, originating from other coronaviruses with identical sequences."
        ],
        "lab": [
            false,
            {
                "id": "T34",
                "type": "Repository",
                "start": 7990,
                "end": 7994,
                "name": "ViPR"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All data generated or analyzed during this study are included in this published article, its supplementary information files, or the following external sources: SARS-CoV-2 reference sequences used in this study were obtained from ",
            "GenBank",
            " (accession: ",
            "NC_045512.2",
            ", ",
            "https://www.ncbi.nlm.nih.gov/nuccore/NC_045512",
            ") and ORF9b, as annotated by ",
            "UniProt",
            " (",
            "P0DTD2",
            ", ",
            "https://www.uniprot.org/proteomes/UP000464024",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T35",
                "type": "Repository",
                "start": 8298,
                "end": 8305,
                "name": "GenBank"
            },
            false,
            {
                "id": "T36",
                "type": "AccessionNumber",
                "start": 8318,
                "end": 8329,
                "name": "NC_045512.2"
            },
            false,
            {
                "id": "T37",
                "type": "URL",
                "start": 8331,
                "end": 8377,
                "name": "https://www.ncbi.nlm.nih.gov/nuccore/NC_045512"
            },
            false,
            {
                "id": "T38",
                "type": "Repository",
                "start": 8406,
                "end": 8413,
                "name": "UniProt"
            },
            false,
            {
                "id": "T39",
                "type": "AccessionNumber",
                "start": 8415,
                "end": 8421,
                "name": "P0DTD2"
            },
            false,
            {
                "id": "T40",
                "type": "URL",
                "start": 8423,
                "end": 8468,
                "name": "https://www.uniprot.org/proteomes/UP000464024"
            },
            false
        ],
        "rel": [
            {
                "id": "R18",
                "bool": true,
                "head": "T35",
                "end": "T36"
            },
            {
                "id": "R19",
                "bool": true,
                "head": "T35",
                "end": "T37"
            },
            {
                "id": "R20",
                "bool": true,
                "head": "T38",
                "end": "T39"
            },
            {
                "id": "R21",
                "bool": true,
                "head": "T38",
                "end": "T40"
            }
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 proteomic datasets were downloaded from the ",
            "PRIDE",
            " repository (",
            "Bojkova et al.",
            " [40]: ",
            "PXD017710",
            ", ",
            "https://www.ebi.ac.uk/pride/archive/projects/PXD017710",
            "; ",
            "Bezstarosti et al.",
            " [41]: ",
            "PXD018760",
            ", ",
            "https://www.ebi.ac.uk/pride/archive/projects/PXD018760",
            "; ",
            "Davidson et al.",
            " [42]: ",
            "PXD018241",
            ", ",
            "https://www.ebi.ac.uk/pride/archive/projects/PXD018241",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T41",
                "type": "Repository",
                "start": 8526,
                "end": 8531,
                "name": "PRIDE"
            },
            false,
            {
                "id": "T42",
                "type": "Creator",
                "start": 8544,
                "end": 8558,
                "name": "Bojkova et al."
            },
            false,
            {
                "id": "T43",
                "type": "AccessionNumber",
                "start": 8565,
                "end": 8574,
                "name": "PXD017710"
            },
            false,
            {
                "id": "T44",
                "type": "URL",
                "start": 8576,
                "end": 8630,
                "name": "https://www.ebi.ac.uk/pride/archive/projects/PXD017710"
            },
            false,
            {
                "id": "T45",
                "type": "Creator",
                "start": 8632,
                "end": 8650,
                "name": "Bezstarosti et al."
            },
            false,
            {
                "id": "T46",
                "type": "AccessionNumber",
                "start": 8657,
                "end": 8666,
                "name": "PXD018760"
            },
            false,
            {
                "id": "T47",
                "type": "URL",
                "start": 8668,
                "end": 8722,
                "name": "https://www.ebi.ac.uk/pride/archive/projects/PXD018760"
            },
            false,
            {
                "id": "T48",
                "type": "Creator",
                "start": 8724,
                "end": 8739,
                "name": "Davidson et al."
            },
            false,
            {
                "id": "T49",
                "type": "AccessionNumber",
                "start": 8746,
                "end": 8755,
                "name": "PXD018241"
            },
            false,
            {
                "id": "T50",
                "type": "URL",
                "start": 8757,
                "end": 8811,
                "name": "https://www.ebi.ac.uk/pride/archive/projects/PXD018241"
            },
            false
        ],
        "rel": [
            {
                "id": "R22",
                "bool": true,
                "head": "T41",
                "end": "T43"
            },
            {
                "id": "R23",
                "bool": true,
                "head": "T41",
                "end": "T44"
            },
            {
                "id": "R24",
                "bool": true,
                "head": "T41",
                "end": "T46"
            },
            {
                "id": "R25",
                "bool": true,
                "head": "T41",
                "end": "T47"
            },
            {
                "id": "R26",
                "bool": true,
                "head": "T41",
                "end": "T49"
            },
            {
                "id": "R27",
                "bool": true,
                "head": "T41",
                "end": "T50"
            },
            {
                "id": "R28",
                "bool": true,
                "head": "T42",
                "end": "T43"
            },
            {
                "id": "R29",
                "bool": true,
                "head": "T42",
                "end": "T44"
            },
            {
                "id": "R30",
                "bool": true,
                "head": "T45",
                "end": "T46"
            },
            {
                "id": "R31",
                "bool": true,
                "head": "T45",
                "end": "T47"
            },
            {
                "id": "R32",
                "bool": true,
                "head": "T48",
                "end": "T49"
            },
            {
                "id": "R33",
                "bool": true,
                "head": "T48",
                "end": "T50"
            }
        ]
    },
    {
        "sen": [
            "Global public health concern with pandemic notion of COVID-19 was declared on January 30th, 2020 by the World Health Organization (WHO), 2020a, World Health Organization (WHO), 2020b."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Again, an adverse situation has also been announced on 13 March 2020 for increasing the infections of COVID-19 (Kunz and Minder, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Some common clinical manifestations of COVID-19 are fever, sputum production and shortness in breath, cough, fatigue, sore throat and headache which leads to severe cases of pneumonia."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Though several early studies showed that the mortality rate for SARS-CoV-2 is not as high (2–3%), the latest global death rate for COVID-19 is 3.4% which indicates the increasing trends (Wu et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The investigation of Chinese Center for Diseases Control and Prevention (2020) revealed that the prevalence of COVID-19 is more apparent in the people ages 50 years rather than the lower age groups (Jeong-ho et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Though the species of SARS-CoV-1 and bat coronavirus shares sufficient sequence similarities with the COVID-19, the known way mechanism of infection to the host, and the death rate is quite different in case of the novel coronavirus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, there is an evolutionary distance between SARS-CoV-1 and bat coronavirus as well as the COVID-19 (Hu et al., 2018; Wu et al., 2020; Wu 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While some natural metabolites and traditional medication may come up with comfort and take the edge off few symptoms of COVID-19, there is no proof that existing treatment procedures can effectively combat against the diseased condition (World Health Organization (WHO), 2020a, World Health Organization (WHO), 2020b)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Reverse vaccinology approach, on the other hand, is an effective way to develop vaccine against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At present, a suitable peptide vaccine to combat COVID-19 is urgently necessary that could efficiently generate enough immune response to destroy the virus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Complete Genomes of the COVID-19 and other coronaviruses were retrieved from the ",
            "NCBI",
            " (",
            "https://www.ncbi.nlm.nih.gov/",
            "), using the keyword ‘coronavirus’ and the search option ‘nucleotide’."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1986,
                "end": 1990,
                "name": "NCBI"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 1992,
                "end": 2021,
                "name": "https://www.ncbi.nlm.nih.gov/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "For the retrieval of the domain sequences of the stated protein sequences, ",
            "InterPro",
            " database (",
            "https://www.ebi.ac.uk/interpro/",
            ") was utilized."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 2167,
                "end": 2175,
                "name": "InterPro"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 2186,
                "end": 2217,
                "name": "https://www.ebi.ac.uk/interpro/"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "Among 496 proteins (available in the ",
            "NCBI",
            " database) from different strains of novel corona virus, four structural proteins, i.e. spike glycoprotein, membrane glycoprotein, envelope protein and nucleocapsid protein, were prioritized for further investigation (File S2)."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 2270,
                "end": 2274,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Homologous sequence sets of the chosen antigenic proteins were retrieved from the ",
            "NCBI",
            " database by utilizing BLASTp tool."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 2584,
                "end": 2588,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For construction of novel corona vaccine, the chosen adjuvants i.e. L7/L12 ribosomal protein, beta defensin (a 45 mer peptide) and HABA protein (M. tuberculosis, accession number: ",
            "AGV15514.1",
            ") were used (Rana and Akhter, 2016)."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 2804,
                "end": 2814,
                "name": "AGV15514.1"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Several linkers such as EAAAK, GGGS, GPGPG and KK in association with PADRE sequence were incorporated to construct fruitful vaccine sequences against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These 61 species of corona viruses included 7 pathogenic species (Fig. 2), which are: COVID-19 or SARS-CoV-2, SARS-CoV-1 virus, MERS virus, HCoV-HKU1, HCoV-OC43, HCoV-NL63, HCoV-229E",
            "COVID-19 or SARS-COV-2 formed clade with SARS-COV-1 and bat beta-coronaviruses (Fig. 2), which is consistent with the previous finding (Ceraolo and Giorgi 2020)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Though SARS-CoV-1 belongs to the same sub-genus as the COVID-19, the bat coronaviruses belong to two different sub-genera including Hibecovirus and Nobecovirus (File S1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-1 contains an extra domain, namely spike glycoprotein N-terminal domain (",
            "IPR032500",
            "), which is also present in some the sub-genera (Embecovirus) of beta-coronavirus, but not in COVID-19."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 3610,
                "end": 3619,
                "name": "IPR032500"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "One important finding in our study is that the COVID-19 candidates do not contain the domain spike glycoprotein (",
            "IPR042578",
            "), which is present in the SARS-CoV-1 (Fig. 3)."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 3836,
                "end": 3845,
                "name": "IPR042578"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Most of them fall within the S1 spike protein, which is 654 amino acid long in SARS-CoV-1, while 672 amino acids long in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The RGD motif which is conserved within the COVID-19 is present in the vicinity of the S1 protein."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Again, the receptor binding domain and receptor binding motif analyses disclose variations within several region between the COVID19 and SARS-CoV-1 (File S2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The domain-based phylogenetic analysis reflects two main divisions, where the all the novel beta-coronavirus i.e., COVID19 form clade with the SARS-CoV-1; while other beta-coronavirus fall in another clade which further divide to give rise different sub-genera."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This clearly shows that the COVID-19 exerts specific ancestral connection to the SARS-CoV-1 in terms of spike glycoproteins."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interestingly, our study also revealed close relatedness of both the SARS-CoV-1 and COVID-19 to the bat beta-coronavirus that belongs to the Hibecovirus sub-genus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The phylogenetic study and MSA also revealed that, the functional portion of the spike glycoprotein domain and spike glycoprotein N-terminal domain might be lost from the COVID-19 during the course of evolution."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The length of the domains for the COVID-19, SARS-CoV and MARS virus are 75, 76 and 82 amino acids, respectively."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The average length of the COVID-19 envelope proteins is 75 amino acids long."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Though the computational analysis of CoVID-19 envelope protein secondary structure shows 2 transmembrane domains, our domain analysis shows only one such domain in their structures."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Unlike to earlier finding, we got that gamma-coronavirus candidate in our study shows close connection with both SARS-CoV-1 and COVID-19 in terms of envelope proteins."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Computational analysis of secondary structures shows some variations of COVID-19 with SARS-CoV-1 and MERS virus (File S3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to our domain-based phylogeny study of nucleocapsid proteins, we found the close approximation of the COVID-19 with the SARS-CoV-1, which is consistent with the findings of phylogeny of whole genome."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Strikingly, unlike spike and membrane proteins, the closest homologs of COVID-19 are not only the SARS-COV-1 and bat coronaviruses (Sub-genus: Hibecovirus and Nobecovirus), but it also includes the MERS viruses and other proteins which is from the Merbecovirus sub-genus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total 31, 24, 29 and 29 sequences of spike glycoprotein, membrane protein, envelope protein and nucleocapsid protein were retrieved from the ",
            "NCBI",
            " database belonging to different strains of SARS-CoV-2."
        ],
        "lab": [
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 6333,
                "end": 6337,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among the potential SARS-CoV-2 vaccines in the pipeline, four have nucleic acid based designs, four involve non-replicating viruses or protein constructs, two contain live attenuated virus and one involves a viral vector (Pang et al. 2020), while only one, called mRNA-1273 (developed by NIAID collaboration with Moderna, Inc.), has confirmed to start phase-1 trial (NIH News Event, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, in this study we emphasized on a different approaches by prioritizing the advantages of different genome and proteome database using the immunoinformatic approach."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Researchers have already considered Envelope (E) protein for vaccine candidacy against COVID-19 due to high antigenicity (Abdelmageed et al. 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our results infer a significant level of similarities within the COVID-19 and SARS-CoV-1 which was also aligned with the previous findings (Jaimes et al., 2020; Sun et al., 2020a, Sun et al., 2020b; Wu 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The sequence similarities between the SARS-CoV, bat coronaviruses and the COVID-19 from the reported studies (Hu et al."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interestingly, the COVID-19 envelope proteins form clade with the Turkey coronavirus which belongs to gamma-coronavirus genus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Overall, the COVID-19 might go through complex adaptation strategies in order to be transmitted into the human via different animals."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The potential B cell epitopes were generated by three different algorithms (Bepipred linear epitope prediction 2.0, Kolaskar and Tongaonkar antigenicity prediction and Emini surface accessibility prediction) from ",
            "IEDB",
            " database (Table 3)."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Repository",
                "start": 7907,
                "end": 7911,
                "name": "IEDB"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Top putative epitopes were combined with appropriate adjuvants and linkers to construct a novel multiepitope subunit vaccine against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The structure of ACE2-PD in complex with SARS-CoV-2-RBD",
            "was retrieved from ",
            "Protein Data Bank (PDB)",
            " file ",
            "PDB",
            " ID ",
            "6VW1",
            ", while the structure",
            "of ACE2-PD complexed with SARS-CoV-RBD has ",
            "PDB",
            " ID ",
            "2AJF",
            "(19) (Figure )."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 75,
                "end": 98,
                "name": "Protein Data Bank (PDB)"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 104,
                "end": 107,
                "name": "PDB"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 111,
                "end": 115,
                "name": "6VW1"
            },
            false,
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 180,
                "end": 183,
                "name": "PDB"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 187,
                "end": 191,
                "name": "2AJF"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T4",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "The virus causes the coronavirus disease 2019 (COVID-19), with common symptoms such as fever, cough, shortness of breath and fatigue., Early data indicated that about 20% of patients develop severe COVID-19 requiring hospitalization, including 5% who are admitted to the intensive care unit."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The mortality from COVID-19 is higher in people older than 65 years and in people with underlying comorbidities, such as chronic lung disease, serious heart conditions, high blood pressure, obesity and diabetes.–",
            "Therefore, systematic tracking of demographic and clinical patient information, as well as strain information is indispensable to effectively combat COVID-19."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In total, we downloaded 15 755 genome sequences from the following databases: the ",
            "Chinese National Microbiology Data Center",
            " on 1 February 2020; the ",
            "Chinese National Genomics Data Center",
            " Genome Warehouse on 4 February 2020; ",
            "GISAID",
            " on 1 May 2020 and ",
            "GenBank",
            " on 1 May 2020."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 746,
                "end": 787,
                "name": "Chinese National Microbiology Data Center"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 812,
                "end": 849,
                "name": "Chinese National Genomics Data Center"
            },
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 887,
                "end": 893,
                "name": "GISAID"
            },
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 912,
                "end": 919,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Methods  Between 1 February and 1 May 2020, we downloaded 10 022 SARS CoV-2 genomes from four databases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The coronavirus disease 2019 (COVID‐19) pandemic, an infectious disease caused by a novel strain of human coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2),",
            " has become the focus of attention worldwide."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since its first report in late December 2019 in Wuhan, China,",
            " COVID‐19 has aggressively spread across the world and dramatically impacted people's health and daily life."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of July 1, 2020, according to the Situation Report issued by the World Health Organization (WHO), the number of confirmed COVID‐19 cases reported in over two hundred regions exceeded 10.3 million with around 508 000 deaths."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The clinical patterns of COVID‐19 ranged from asymptomatic cases to critically ill patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Fever, dry cough, and radiological changes in lungs tend to be common clinical manifestations in COVID‐19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to data provided by the China National Health Commission, the mortality rate of COVID‐19 patients was 7.7% in Wuhan,",
            " which was higher than the world average (4.9%)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As the number of infected and fatal cases is rising across the globe, there is a pressing need to investigate the clinical, radiological, and laboratory characteristics, and more importantly, the mortality risk factors in severe COVID‐19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, the mortality risk factors of COVID‐19 patients have not yet been previously reported in detail."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "289 patients with positive real‐time reverse transcription‐polymerase chain reaction (rRT‐PCR) results of SARS‐CoV‐2 nucleic acid test were diagnosed as COVID‐19 and included in the analysis set."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In accordance with the criteria stated in the clinical guidelines for hospital discharge of a COVID‐19 patient,",
            " all the following four conditions should be met: (a) normal temperature lasting longer than 3 days, (b) significantly improved respiratory symptoms, (c) substantially improved acute exudative lesions on chest CT images, and (d) two consecutive negative nucleic acid test results of respiratory tract samples (at least 24 hours apart)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 289 patients with COVID‐19 were included in this study."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Multivariate analysis indicated that the age of patients (OR, 1.04; 95% CI, 1.00‐1.08), smoking history (OR, 5.21; 95% CI, 1.39‐19.52), chest tightness/dyspnea (OR, 3.03; 95% CI, 1.18‐7.79), number of affected lobes on admission (OR, 1.71; 95% CI, 1.06‐2.78), and CRP levels on admission (OR, 1.01; 95% CI, 1.00‐1.02) were risk factors associated with death in cases with severe COVID‐19 (Table 4, Figure 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Risk factors associated with death in critically ill",
            " COVID‐19 patients",
            "Of the 289 laboratory‐confirmed COVID‐19 cases in this study, most of the patients were more than 50 years old, with an almost 1:1 female‐male ratio."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The present study supports the association of elderly age and increased mortality rate in COVID‐19 patients, in accordance with a previous study."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Several studies have reported that hypertension, hypoxia, leukocytosis, lymphopenia, and high serum LDH levels were independent predictors for in‐hospital death."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            ", ",
            ", ",
            " However, in the present study, only dyspnea and leukocytosis were found to be independent risk factors of death in critically ill COVID‐19 patients."
        ],
        "lab": [
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Previous reports identified that lower baseline levels and/or progressively decreasing platelet counts were associated with higher mortality of COVID‐19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Elevated IL‐6, which is the trigger of CRP synthesis in the liver, was also observed in COVID‐19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A cytokine storm has been suggested as a culprit for poor prognosis of critically ill COVID‐19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Wang et al identified higher levels of CRP in nonsurvivors compared with survivors within 15 days of COVID‐19 hospitalization."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Wu et al found that elevated high‐sensitivity CRP was significantly associated with higher risks of acute respiratory distress syndrome (ARDS) in COVID‐19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The data suggested that CRP was a marker of a developing cytokine storm in COVID‐19 patients and was associated with disease mortality."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In a recent study,",
            " higher NLR was suggested to be independent risk factors of mortality in hospitalized COVID‐19 patients."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similarly, Mehra et al",
            " demonstrated that current smokers had higher in‐hospital death rate in COVID‐19 patients."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In view of these results, smoking should not be considered a preventive measure for COVID‐19 and as a public health issue should be discouraged at all times."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although smoking is a major cause of chronic obstructive pulmonary disease (COPD), a recent study reported that COPD did not increase the risk of COVID‐19 patients requiring admission to the intensive care unit (ICU)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The higher levels of ACE2 expression in the lower respiratory tract of current smokers may contribute to the increased risk of developing severe COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "The strong positive correlations identified between the affected lobe numbers, patients’ age, neutrophil, and lymphocyte counts indicate that more severe pneumonia was associated with elderly age and higher degree of lymphopenia, indicating that the numbers of affected lobes could be a possible risk factor for severe cases and in‐hospital mortality of severe COVID‐19 patients."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As previously reported, eosinopenia may be an indicator for SARS‐CoV‐2 infection,",
            " and the degree of eosinopenia was associated with the severity of COVID‐19."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            " Persistent eosinopenia may be a predictor of disease severity and adverse clinical outcome during hospitalization, which is consistent with the results reported by Xie et al."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The anti‐viral effect exhausts eosinophils and may be the cause of eosinopenia in COVID‐19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Lymphopenia is prominent in adult COVID‐19 patients, but not in pediatric patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, multivariate regression analysis did not identify D‐dimer as an independent risk factor of the mortality in severe COVID‐19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This was consistent with a previous study conducted by Chen et al,",
            " but different from the result from Zhou et al, which showed that elevated D‐dimer was associated with poor prognosis of hospitalized COVID‐19 patients."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A recent study on COVID‐19 patients in Wuhan revealed an extremely high incidence of thrombosis (41/48, 85.4%) in severe patients with a death rate of 31.7% (13/41)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, elevated D‐dimer levels could occur in deep venous thrombosis (DVT) and in capillary microthrombi, secondary to pulmonary capillary endothelial injury, contributing to the death of severe COVID‐19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Venous thromboembolism (VTE) had a higher incidence in ICU COVID‐19 patients than those on the wards, and the incidence increased along with the duration of hospitalization."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A study of 184 ICU COVID‐19 patients reported that computed tomography pulmonary angiography (CTPA) and/or ultrasonography confirmed VTE was 27% and arterial thrombotic events was 3.7%."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The coronavirus disease 2019 (COVID‐19) has become a global pandemic, with 10%‐20% of severe cases and over 508 000 deaths worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This study aims to address the risk factors associated with the severity of COVID‐19 patients and the mortality of severe patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Methods  289 hospitalized laboratory‐confirmed COVID‐19 patients were included in this study."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Conclusions  Survived severe and nonsurvived COVID‐19 patients had distinct clinical and laboratory characteristics, which were separated by principle component analysis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Elder age, increased number of affected lobes, higher levels of serum CRP, chest tightness/dyspnea, and smoking history were risk factors for mortality of severe COVID‐19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This study compares the clinical, radiological, and laboratory characteristicsand longitudinal variations in laboratory parameters of the 289 hospitalized patients with COVID‐19 with different severity and clinical outcomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We propose that elder age, a greater number of affected lobe(s), elevated C‐CRP level and increased prevalence of chest tightness/dyspnea and smoking history may be associated with the fatal outcome of patients with severe COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Abbreviations: BUN, blood urea nitrogen; COVID‐19, coronavirus infectious disease 2019; CRP, C‐reactive protein; NLR, neutrophil‐to‐leucocyte ratio; PC1/2, principal component 1/2; PCT, procalcitonin."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To determine the suitability of NHP species for modeling COVID-19, we experimentally inoculated three species of monkeys belonging to two families (Old World and New World monkeys) with SARS-CoV-2 (Fig. 1a and Supplementary Table 1) according to the methods described for a reported SARS model, followed by comprehensive comparisons of the clinical signs of COVID-19, viral shedding and replication, and host responses to viral infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Detection of viral genomic RNA is the most important evidence for the diagnosis of COVID-19 due to SARS-CoV-2 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the present study, the dynamics of viral shedding in the NHP models were similar to those reported in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The lung is widely considered to be the target organ of SARS-CoV-2 replication since a large viral copy number was detected in bronchoalveolar lavage fluid from COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Importantly, we also detected viral RNA in the spleen and blood of our model, which is consistent with the clinical findings that SARS-CoV-2 is present in patients’ spleens and blood and correlated with the severity of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In terms of host responses to SARS-CoV-2 infection, our NHP model partially recapitulates COVID-19 through at least three features."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Typical histopathology of pneumonia is observed in COVID-19 patients in additional to mild inflammation in liver."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19-associated cytokine storm is reported to be an important pathogenic factor and a potential promising therapeutic target in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although not consistent with those in COVID-19 patients, the cytokines induced in our model could be used as markers for the evaluation of anti-inflammatory drugs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Elevated serum IL-6 is clinically correlated with the severity of COVID-19 and regarded as an important biomarker."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In a reported NHP model of COVID-19, the level of IL-6 peaked at 1 dpi and decreased to 0 at 3 dpi."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Identification of a suitable nonhuman primate (NHP) model of COVID-19 remains challenging."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Collectively, these data revealed the different susceptibilities of Old World and New World monkeys to SARS-CoV-2 and identified M. mulatta as the most suitable for modeling COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The data sets used for the current study are available from the corresponding author upon reasonable request."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease−19 (COVID-19) is a pandemic disease caused by severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) which originated in the Wuhan city of China, spreading across 215 countries and affecting more than 7.2 million people worldwide, and cases are still increasing further (",
            "https://www.worldometers.info/coronavirus/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "URL",
                "start": 297,
                "end": 339,
                "name": "https://www.worldometers.info/coronavirus/"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The diagnosis of coronavirus disease−19 (COVID-19) relies on the detection of severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) RNA by real-time reverse-transcription polymerase chain reaction in respiratory samples."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Rapid increase in the COVID-19 cases across the world requires fast and efficient testing as testing capacity is a bottleneck in diagnosis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Highlights     •  Utility of pooling samples in COVID-19 testing to save time, cost, and manpower."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Abstract  Coronavirus Disease 2019 (COVID-19) is a sudden viral contagion that appeared at the end of last year in Wuhan city, the Chinese province of Hubei, China."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The fast spread of COVID-19 has led to a dangerous threat to worldwide health."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this research, an automated system is created to differentiate between the COVID-19, SARS-CoV and MERS-CoV epidemics by using their genomic sequences recorded in the ",
            "NCBI GenBank",
            " in order to facilitate the diagnosis process and increase the accuracy of disease detection in less time."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 413,
                "end": 425,
                "name": "NCBI GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The selected database contains 76 genes for each epidemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hence, while we await for the results of the efficacy of camostat in a very recently initiated human clinical trial with COVID19 patients (https://clinicaltrials.gov/ct2/show/NCT04321096), this report wishes to incentivize once again private and public efforts to consider developing new pan-serine protease inhibitors, perhaps taking advantage of several agents already being reported in pre-clinical studies [36,37,38,39,40], into emergency therapeutics to combat the new coronavirus SARS-CoV2 and to ward off future similar pandemics that are likely to occur when pathogens acquire the further optimized furin cleavage sites within their priming entry mechanisms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Accession numbers for sequences used in this study can be found in",
            "Table 1 and the test."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "",
            "GSAID",
            " is a free-to-use resource, but requires",
            "registration prior to accessing."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 89,
                "end": 94,
                "name": "GSAID"
            },
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On April 27, 2020, the first five sequences from the state of West Bengal (Eastern India) were deposited on ",
            "GISAID",
            ", a global initiative for sharing avian flu data."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 276,
                "end": 282,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To test the hypothesis and to estimate the extent to which exposition to air pollution can increase the risk of viral infections, we performed a statistical analysis correlating the number of infected people and COVID-19 mortality indexes in the period 20 February–31 March 2020 to the particulate matter (PM)2.5 concentration levels in 110 Italian provinces in the period 16–26 February 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The CAMS near-real-time reanalysis is the most recent global reanalysis data set of atmospheric composition and air quality [14], with a demonstrated unprecedented level of accuracy and space–time resolution."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Data on the population for all Italian provinces has been extracted from the ",
            "ISTAT",
            " Dataset [15], while the number of infected patients has been extracted from the ",
            "Italian Civil Protection Department",
            " database [16]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 680,
                "end": 685,
                "name": "ISTAT"
            },
            false,
            {
                "id": "T2",
                "type": "Creator",
                "start": 766,
                "end": 801,
                "name": "Italian Civil Protection Department"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The number of deaths due to COVID-19 over the time period 20 February–31 March 2020 for the 110 Italian provinces are from the ",
            "Italian Statistics Institute (ISTAT)",
            " report [1]."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 944,
                "end": 980,
                "name": "Italian Statistics Institute (ISTAT)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The “mortality rate” for COVID-19 was defined as the number of deaths normalized to the province population [18], which quantifies the frequency of death occurrence in a defined population."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Surface PM2.5 concentration measurements from ground stations and COVID-19 epidemiology are shown in Figure 3 for the 110 Italian provinces with color-coded maps."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Visual inspection reveals good overlap in the intensity scale between PM2.5 concentration values, averaged over the period 15–26 February 2020 (panel A), and COVID-19 epidemiology over the period 20 February–31 March 2020, e.g., the incidence of COVID-19 cases (panel B), the mortality rate (panel C) and the case fatality rate (panel D)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The correlations between PM2.5 and COVID-19 cases and outcome were statistically significant."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In detail, we found a positive correlation (r = 0.67, p < 0.0001) between the average PM2.5 level in the period 15–26 February 2020 and the incidence of COVID-19 (infected/population ratio) in the period 20 February–31 March 2020 (Figure 4, panel A)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Different reports from China, which was first affected by the pandemic and has relevant pollution problems, found significant links between different pollutants, including PM2.5, and COVID-19 confirmed cases [29,30] and similar associations were evidenced in the United States [31]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In Italy, the association of pollution with increased rates of COVID-19 cases was first proposed by Conticini et al. [32]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Soon after, Fattorini and Regoli [33] demonstrated a statistically significant correlation with various pollutants (NO2, O3, PM2.5 and PM10) with the number of COVID-19 cases in 71 Italian provinces."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Being confirmatory of previous general results, data from our study give an in-deep look at the strength of correlation between PM2.5 and the extent of the COVID-19 outbreak."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In particular, we performed correlation analysis: (i) considering data from all Italian provinces and (ii) considering the COVID-19 cases and outcomes normalized by the population (incidence and mortality rate) or by the infected population (case fatality risk)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Enhanced persistence of the virus in the air, promotion of a pro-inflammatory state, immune dysregulation, disturbance of pulmonary surfactant homeostasis and increased expression of the viral receptor ACE-2 [36] have been proposed as possible links between air pollution and COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The differential expression level of ACE-2 in various human tissues explains the COVID-19 symptomatology: it is extensively expressed in the upper part of the esophagus, in the lung, in enterocytes [37]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Accordingly, the different prevalence and severity of COVID-19 in male and females gave rise to the hypothesis of differential, gender-related expression of ACE-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similarly, ACE-2 up-regulation following treatment with anti-hypertensive drugs such a angiotensin AT1 receptor blockers, has been proposed as contributing to the increased susceptibility of aged peoples to COVID-19 [39]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Notably, following the binding of the viral spike protein, the level of ACE-2 on the cell surface decreases [47], shifting the ACE/ACE-2 balance towards activation of the inflammatory cascade, which represent a hallmark of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19/SARS-CoV-2 pandemic struck health, social and economic systems worldwide, and represents an open challenge for scientists —coping with the high inter-individual variability of COVID-19, and for policy makers —coping with the responsibility to understand environmental factors affecting its severity across different geographical areas."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Air quality and COVID-19 epidemiological data from 110 Italian provinces were studied by correlation analysis, to evaluate the association between particulate matter (PM) 2.5 concentrations and incidence, mortality rate and case fatality risk of COVID-19 in the period 20 February–31 March 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Positive correlations between PM 2.5 levels and the incidence (r = 0.67, p < 0.0001), the mortality rate (r = 0.65, p < 0.0001) and the case fatality rate (r = 0.7, p < 0.0001) of COVID-19 were found."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Infectious virus titers ranged from 100.75 to 102.75 TCID50/ml (median tissue culture infectious dose per ml) in the donor ferrets, from 100.75 to 103.5 TCID50/ml in the direct contact ferrets and from 100.75 to 104.25 TCID50/ml in the indirect recipient ferrets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Four donor ferrets were inoculated intranasally with 6 × 105 TCID50 of SARS-CoV-2 virus diluted in 500 μl of phosphate-buffered saline (PBS) (250 μl instilled dropwise in each nostril) and were housed individually in a cage."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 has become a planetary emergency which is seriously threatening human health [1, 2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "E sequences differ from the homologous proteins also at positions 55-56, where the dyad Ser-Phe replaces Thr-Val (except in Bat coronavirus isolate BtKY72, accession code ",
            "KY352407",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "AccessionNumber",
                "start": 265,
                "end": 273,
                "name": "KY352407"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The size of each Envelope variant cluster is reported in Table 1 along with accession codes and definitions of the isolates."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The size of each Membrane variant cluster is reported in Table 1 along with accession codes and definitions of the isolates."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Noteworthy, the protein from the Sars-CoV-2 NIHE isolate (accession code ",
            "MT127115",
            ") possesses an Arg instead of a conserved Gly at position 89 (Figure 3)."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 599,
                "end": 607,
                "name": "MT127115"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to the accepted theories, the current COVID-19 pandemic has been caused by the cross-species transmission of a β-coronavirus normally hosted by Bats and, perhaps, Pangolin to humans [3, 26]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this paper, E and M proteins from 797 Sars-CoV-2 genomes have been compared to the counterparts taken from the most closely related virus also to evaluate the potential role of amino acid mutations in the epizootic origin of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Coronavirus Disease 2019 (COVID-19) is a new viral infection caused by the severe acute respiratory coronavirus 2 (SARS-CoV-2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We firstly collected the representative SARS-COV-2 genome (",
            "MN908947",
            ", ",
            "https://www.ncbi.nlm.nih.gov/nuccore/MN908947",
            ") and the mutation information of the SARS-COV-2 genomes from the ",
            "2019nCoVR",
            " database (Zhao et al.2020), which is available at ",
            "https://bigd.big.ac.cn/ncov/",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "AccessionNumber",
                "start": 59,
                "end": 67,
                "name": "MN908947"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 69,
                "end": 114,
                "name": "https://www.ncbi.nlm.nih.gov/nuccore/MN908947"
            },
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 180,
                "end": 189,
                "name": "2019nCoVR"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 240,
                "end": 268,
                "name": "https://bigd.big.ac.cn/ncov/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "The ",
            "2019nCoVR",
            " database not only integrates genomic and proteomic sequences of SARS-COV-2 from different resources, but also provides a series of scientific services, such as variation visualization, variation annotations, AI diagnosis, etc."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 274,
                "end": 283,
                "name": "2019nCoVR"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, we also analyzed the mutations of the target sequences by comparing all the 143 high quality strains in the ",
            "2019nCoVR",
            " database (as of March 15, 2020)."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 632,
                "end": 641,
                "name": "2019nCoVR"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The spike protein, the major envelope protein of HCoV-NL63, specifically binds to the zinc peptidase angiotensin-converting enzyme 2 (ACE2) identified as the receptor for pathogenic coronaviruses SARS-CoV and COVID-19 (formerly known as Wuhan coronavirus, 2019-nCoV, and SARS-CoV-2) [16,17,18,19]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The World Health Organization (WHO) named the disease COVID-19, short for “coronavirus disease 2019”."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of 27 May 2020, the WHO reported a total of 5 488 825 COVID-19 cases and 349 095 deaths globally [3], which brought a great challenge to public health worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Its genome sequence has been released and reported by Chinese scientists and submitted to the ",
            "GenBank",
            " database on 12 January 2020 [5]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 361,
                "end": 368,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Protein sequences of SARS-CoV-2 were retrieved from the ",
            "NCBI",
            " database (",
            "YP_009724390",
            ", ",
            "YP_009724397",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 458,
                "end": 462,
                "name": "NCBI"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 473,
                "end": 485,
                "name": "YP_009724390"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 487,
                "end": 499,
                "name": "YP_009724397"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T2",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "Prediction of discontinuous epitopes on spike protein (",
            "PDB",
            " ID: ",
            "6VSB",
            " chain B) was conducted via DiscoTope 2.0 server [19]."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 557,
                "end": 560,
                "name": "PDB"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 565,
                "end": 569,
                "name": "6VSB"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "This method is based on surface accessibility, residue statistics, and spatial information in a compiled data set of discontinuous epitopes discovered by X-ray crystallography of antigen/antibody complex structure."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All protein sequences were downloaded from ",
            "NCBI",
            " database with accession IDs shown in Fig. 2a."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 882,
                "end": 886,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These peptides were scanned on the ",
            "IEDB",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 968,
                "end": 972,
                "name": "IEDB"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The genome sequence and protein sequences of SARS-CoV-2 were retrieved from the ",
            "National Center for Biotechnology Information (NCBI)",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 1063,
                "end": 1115,
                "name": "National Center for Biotechnology Information (NCBI)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "After the announcement by the UK Government on March 23, 2020, of implementation of a nationwide lockdown to combat the COVID-19 pandemic, hospital referrals for non-COVID-19-related illnesses have decreased substantially."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As the lockdown is lifted, a surge in presentations for non-COVID-19-related medical issues is anticipated."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For the calculation of the case-fatality rate associated with unselected COVID-19 infection, we used published data from China because UK COVID-19 case-fatality rate estimates were only available for patients who had been admitted to hospital."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To calculate COVID-19-related mortality in patients with cancer, we first estimated peri-surgical mortality from nosocomial infection as the product of operation-specific duration of surgical admission, age-specific case-fatality rates, and the rate of nosocomial infection per day (1%, 2%, 5%, or 10%)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Then we estimated COVID-19-related mortality in the community ascribing the patient a year of active cancer management status; this estimate was the product of the likelihood of community-acquired COVID-19 during the year (1%, 10%, 20%, or 50%), age-specific case-fatality rates, and the increase in COVID-19 case-fatality rate as a consequence of cancer as a comorbidity (two times or five times)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To estimate 10-year survival for individuals diagnosed with stage I–III cancer who have no delay in treatment, we used ",
            "NCRAS",
            " 10-year survival data and adjusted for COVID-19-related peri-surgical and community mortality."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1397,
                "end": 1402,
                "name": "NCRAS"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To estimate 10-year survival associated with delay, we applied the delay HR relating to the specified number of days of delay, along with the COVID-19-related peri-surgical and community mortality, to the ",
            "NCRAS",
            " 10-year survival (formulas are in appendix 1 [pp 1–3])."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 1703,
                "end": 1708,
                "name": "NCRAS"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We combined per-day rates of nosocomial infection with the age-specific COVID-19 case-fatality rates to quantify the COVID-19-related fatality associated with investigatory referral."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Unless otherwise specified, we applied the default values for likelihood of community-acquired COVID-19, which was 20%, and per-day rate of nosocomial infection, which was 2%, which were selected to be conservatively high."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For cancer-related increase in mortality due to community-acquired COVID-19, we used a default value of two times, which is at the low-to-intermediate end of the published estimates (reflecting a non-metastatic cancer population; appendix 1 p 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Issues of capacity and delays in diagnosis are of global interest as part of moving towards benchmarked metrics (eg, International Cancer Benchmarking Partnership).3, 23",
            "Our analyses at the level of referral are subject to the limitations of data collection for diagnostic-conversion rates, which were only available at the level of tumour-referral group, precluding analyses specific to age stratum or tumour type-specific symptomatology."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The severity of local COVID-19 patterns, method-specific diagnostic capacity, and organisation of cancer services will all have an effect, as will local variation in pathway innovations in both diagnostics (FIT triage, colonography) and treatment (a priori use of radiotherapy and hormonal treatments)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Background  During the COVID-19 lockdown, referrals via the 2-week-wait urgent pathway for suspected cancer in England, UK, are reported to have decreased by up to 84%."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using referral-to-diagnosis conversion rates and COVID-19 case-fatality rates, we also estimated the survival increment per patient referred."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The SARS coronavirus 2 (SARS-CoV-2) pandemic is a global challenge, which the scientific community has tackled by mounting extensive global collaborations, combining expertise in diverse areas and applying cutting-edge techniques, to dissect mechanisms underlying coronavirus disease-19 (COVID-19) pathology.",
            "The ",
            "Human Cell Atlas",
            " consortium in collaborative work on COVID-19"
        ],
        "lab": [
            false,
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 313,
                "end": 329,
                "name": "Human Cell Atlas"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ongoing worldwide outbreak of the novel coronavirus SARS-CoV-2 (COVID-19) started as an epidemic event in the city of Wuhan, China in late December 2019 and evolved as a pandemic declared by March 2020 (World Health Organization, 2020, L. Wang et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to the report of the World Health Organization as of 29 April 2020, the current outbreak of COVID-19, has affected over 3,160,540 people and killed >219,253 people in >200 countries throughout the world, and only few countries appear to have passed the peak."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In Italy have been recorded 201,505 confirmed COVID-19 cases and 27,359 fatalities."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In Italy outbreak of COVID-19 started in Lombardy county, first 3 COVID-19 cases have been reported on 15 February 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Early studies estimated the risk of COVID-19 cases importation to Europe by air travel from infected areas in China (Pullano et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Also, air pollution is exacerbating the susceptibility and severity of respiratory viral infections like as coronaviruses (SARS, MARS and COVID-19), with a high impact on host morbidity and mortality and public health all over the world (Manisalidis et al., 2020; Pothirat et al., 2019)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Besides environmental pollution, climate change and increased frequency of extreme events as a recorded feedback of anthropogenic pollution can also affect the geographical distribution of several infectious diseases including COVID-19 (Kawasaki et al., 2019; Linares et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As an infectious viral disease SARS-CoV-2 (COVID-2019) arised from viruses, like previous outbreaks: 2002–2003 Severe Acute Respiratory Syndrome (SARS-CoV) viruses and 2012–2015 Middle East Respiratory Syndrome (MERS-CoV), belongs to human Beta coronaviruses category."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 is a spherical or pleomorphic enveloped particle with an average diameter size of 0.1 μm in the range of 0.06–0.14 μm, and contains single-stranded (positive-sense) RNA associated with a nucleoprotein within a capsid comprised of matrix protein (Mousavizadeh and Ghasemi, 2020; Y."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Advanced new studies attribute the fatalities of COVID-19 to cytokine storm syndrome (Guo et al., 2020; Mehta et al., 2020), also known as hypercytokinemia, which is characterized by an uncontrolled release of pro-inflammatory cytokines (Tisoncik et al., 2012), being a severe reaction of the immunity system, leading to death."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Table 1",
            "summarizes the Pearson coefficients and p-values descriptive statistics of COVID-19 Milan cases (Total confirmed, Daily New positive and Total Deaths) and daily average ground level gaseous pollutants O3 and NO2 concentrations together daily average climate variables (Planetary Boundary Layer height, air temperature, relative humidity, wind speed intensity and precipitation rate)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Due to COVID-19 pandemic event, starting with the end of February 2020 lockdown (as can be seen on Fig. 2), where drastic measures for reduction of air pollution were adopted to limit the spread of the coronavirus, our study revealed different concentrations levels for O3 and NO2 corresponding to pre-pandemic period (January–February) and beyond lockdown (March–April) 2020, namely: NO2 in Milan city has decreased by approximately 64.7%, while O3 has increased by a factor of 2.25."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our results have shown that the severe reductions in NO2 and other air pollution emissions during Milan's COVID-19 lockdown led to substantial increases in ground level O3, which in turn increased atmospheric oxidizing capacity and enhanced formation of secondary aerosols, with subsequent negative impact on human respiratory health and increasing of COVID-19 confirmed and fatalities numbers."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For this reason we considered O3 as a COVID incubator."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Also this study found that daily average ground level ozone concentrations values were positive correlated with all COVID-19 cases (confirmed Total, confirmed Daily New positive and Total Deaths) as can be seen in Table 1 and Fig."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "2. A similar result was recently reported for COVID-19 infections and ozone in Italy (Pansini and Fornacca, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Also, was found a negative correlation between average ground levels of NO2 and COVID-19 cases (Total, confirmed Daily New positive cases and Total Deaths) as can be seen in Table 1 and Fig."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on our analysis was found that daily average PBL values were positive correlated with all COVID-19 cases (confirmed Total, confirmed Daily New positive and Total Deaths) as can be seen in Fig. 3",
            "."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, air temperature also contributes towards the transmission of the virus (Chen et al., 2020; Ma et al., 2020; Shi et al., 2020) suggesting that humidity and temperature will play an important role in COVID-19 mortality rate."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Climate indicators and air temperature are well correlated with the spread of COVID-19 (Poole, 2020; Ahmadi et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This can explain the high rate of total COVID-19 positive cases registered in the metropolitan area of Milan, possibly attributed to bronchial hyperreactivity and immune disorders through several pathways."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among the climate variables, wind speed has a weakly inverse relationship with the recorded COVID-19 cases (Total confirmed, Daily New positive), as can be seen in Table 2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Statistical Pearson correlation shows that precipitation rate recorded in Milan metropolitan region had important effects on the transmission and severity of respiratory viral infection COVID-19, being negatively correlated with Daily New positive cases (R2 = 0.21 with significant p-value of 0.09 > 0.05 and also low negatively correlations with Total COVID-19 and Total Deaths cases with significant p-values > 0.05, as can be seen in Table 1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Omega meteorological chart 950 mb (0.762 km above sea level) is a better choice for our analysis because daily average PBL value recorded for Milan area was (797.53 ± 568.35) m. NOAA satellite Omega image for Italy in Europe (Fig. 6",
            ") shows existing atmospheric thermal inversion conditions over Milan and Lombardy region, associated with accumulation near the ground of high air pollutants concentrations (non-viable aerosols and viable-bioaerosols including viruses like as coronaviruses, bacteria, fungi, etc.) leading to a higher risk of COVID-19 infections development (Ogen, 2020)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Local favorable stagnant atmospheric conditions due to local topography of Milan area, the preexisting high levels of air pollutants during January–February 2020 can explain the high incidence of people's respiratory diseases and increased susceptibility to new viral infections COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Long-term conditions of population exposure (several years before 2020) when the number of days in which the regulatory limits of O3, NO2, PM2.5 and PM10 have been exceeded (EEA, European Environmental Agency, 2019, EEA, European Environmental Agency, 2020; Remuzzi and Remuzzi, 2020) in Milan metropolitan region as well as short-term exposure to high ground levels of O3, NO2, PM2.5 and PM10 can be correlated with the decreased people's immunity and immunopathology to viruses, and high fatality COVID-19 rates observed in Milan and Lombardy region."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As an important result, our analysis show the direct correlation of daily averaged ground levels O3 and NO2, with meteorological factors on COVID-19 infections outbreak in Milan."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In spite of cold season investigated period (winter-early spring) collected data, when usually recorded urban ozone levels have lower values than its summer peak concentrations, the findings of this study demonstrate that ground level ozone possible acts as a COVID-19 virus incubator, being positively correlated with COVID-19 infections and fatalities (Fig. 7",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It seems that under specific climate conditions (Bashir et al., 2020), air pollution acts as a carrier of the COVID-19 virus, facilitating its transmission and spreading, allowing its survival in active form with different residence times."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Association between Milan, with several days of smog and haze, which favor air pollutants accumulation near the ground level in cold and dry winter to spring seasons and the highest number of COVID-19 infection cases (Total confirmed, Daily New positive and Total Deaths), thereby is supports the possibility as the degree of air pollution and local topography together climate conditions may contribute to accelerated diffusion of COVID-19 cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Exhibited positive correlations of ambient ozone levels and negative correlations of NO 2 with the increased rates of COVID-19 infections (Total number, Daily New positive and Total Deaths cases), can be attributed to airborne bioaerosols distribution."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At this moment it is not clear if through airborne diffusion, in the presence of outdoor and indoor aerosols, this protein “spike” of the new COVID-19 is involved in the infectious agent transmission from a reservoir to a susceptible host during the highest nosocomial outbreak in some agglomerated industrialized urban areas like Milan is."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Also, in spite of collected data for cold season (winter-early spring) period, when usually ozone levels have lower values than in summer, the findings of this study support possibility as O 3 can acts as a COVID-19 virus incubator."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "",
            "Institute for Scientific Information (ISI) Web Science",
            ", ",
            "Scopus",
            ", ",
            "MEDLINE",
            " and ",
            "Google Scholar",
            " databases were used to search using MeSH (Medical Subject Headings), free text words and all possible combination."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 0,
                "end": 54,
                "name": "Institute for Scientific Information (ISI) Web Science"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 56,
                "end": 62,
                "name": "Scopus"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 64,
                "end": 71,
                "name": "MEDLINE"
            },
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 76,
                "end": 90,
                "name": "Google Scholar"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, it seems that the immunoinformatics-based approachs are required to investigate the immunogenic epitopes and vaccine design using data from proteins sequencing of the COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In these studies, the proteins of COVID-19 virus that have an essential role in virulence of the virus was selected and then its antigenic properties was examined."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "More for the most part, our deliberate assistance highlights the potential importance of past clinical and exploratory considerations for SARS-CoV, and is used in conjunction with growing information for SARS-CoV-2, in the search for compelling immunizations to combat the COVID-19 outbreak."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The beginning of 2020 was marked as the emergence of a COVID-19 outbreak caused by a new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To date, more than 10.7 million cases of the disease caused by SARS-CoV-2, termed COVID-19, have been reported globally [8,9]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On 26 February 2020, the first confirmed case of COVID-19 was reported in São Paulo (SP) state, Brazil [11]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Two months later (28 April 2020), 61,888 cases and 4,205 deaths attributed to COVID-19 had been reported in Brazil [12]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Initial phylogenetic analysis using the first two SARS-CoV-2 complete genomes isolated in São Paulo from travellers returning from Italy revealed two independent introductions into the country relative to the data set available at that time [13]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Due to its large population size and strong connections to active neighbouring states such as São Paulo and Rio de Janeiro, the state of MG is likely to be highly affected by the COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Public SARS-CoV-2 complete genome sequences available up to 15 April 2020 were retrieved from the ",
            "GISAID",
            " database (",
            "https://www.gisaid.org/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 900,
                "end": 906,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 917,
                "end": 940,
                "name": "https://www.gisaid.org/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "Four data sets of complete or near-complete SARS-CoV-2 genome sequences were generated."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Data set 1 (n = 3,102) comprised the data reported in this study (n = 40) plus publicly available SARS-CoV-2 sequences (n = 3,062) from ",
            "GISAID",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 1167,
                "end": 1173,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Subsequently, to investigate the evolutionary behaviour of SARS-CoV-2 within the three different SARS-CoV-2 lineages (A, B and B.1), Bayesian molecular clock analysis was conducted on three smaller subsets of data for each of the three lineages identified in the ML phylogeny and containing isolates from MG (data set 2 for subset A n = 100; data set 3 for subset B n = 84; data set 4 for subset B.1 n = 169)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We computed MCMC (Markov chain Monte Carlo) triplicate runs of 100 million states each, sampling every 10.000 steps for each data set."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By the 28th April 2020, more than 61,888 COVID-19 cases were confirmed in Brazil, 1,578 of which were from MG (Figure 2A) [30]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Over this period, MG registered 71 COVID-19-related deaths and the capital city, Belo Horizonte, with an estimated population of 2.5 million people, reported 555 cases [30,31]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Temporal trends reveal a growth in the number of cases in MG, although with SP accounting for the largest number of cases and deaths (24,041 cases; 2,049 deaths) by COVID-19 up to 28th April 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We used Nanopore sequencing to generate complete genomes from 40 COVID-19 patients in 15 different municipalities in MG (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All sequences generated in this study have been submitted to the ",
            "GISAID",
            " following WHO guidelines [38]."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 2418,
                "end": 2424,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To explore the epidemiological history of the virus in MG, we performed a maximum likelihood (ML) phylogenetic analysis on the 40 new sequences combined with another 3,062 sequences deposited in ",
            "GISAID",
            " up to 15 April 2020."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 2651,
                "end": 2657,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Aside from sublineage B.1, two sequences were assigned to lineage B in our ML phylogeny (isolates CV22 and CV36, with the former reporting travel to Germany), while one sequence could be assigned to lineage A (isolate CV7) who reported travel to European countries (full results from the Pangolin COVID-19 lineage assigner are presented in Supplementary Table S2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "One of these clusters (Figure 4d), with a posterior probability of 100%, was formed by isolates CV34 and CV36 that arose from local contacts with a confirmed and a suspected COVID-19 case, respectively."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The mean time of the most recent common ancestor of all Brazilian strains analysed in this study was estimated to be from 27 January to 22 February 2020, and range that includes the first COVID-19 confirmed case reported in 21 February 2020 [49]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These findings highlight the nature of the COVID-19 epidemic in MG and reinforce the need for real-time and continued genomic surveillance strategies to better understand and prepare for the epidemic spread of emerging viral pathogens.."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The central page of the coronavirus server (see Fig. 1a,) provides an interactive view of the SARS-CoV-2 genome (",
            "GenBank",
            " ID: ",
            "MN908947.3",
            "), with information on boundaries of the predicted proteins, currently available SARS-CoV-2 structures and a histogram of the amino-acid mutation frequency."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 113,
                "end": 120,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 125,
                "end": 135,
                "name": "MN908947.3"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "In the future we plan to incorporate ab initio models."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The example in Figure 1b shows the SARS-CoV-2 structure of the complex between nsp10 and nsp16 [",
            "PDB",
            " ID: ",
            "6w4h",
            " (Rosas-Lemus )]."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 443,
                "end": 446,
                "name": "PDB"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 451,
                "end": 455,
                "name": "6w4h"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "This mutation, P323>L (genomic position 14 408), is located at the interface between nsp12 and nsp8 proteins in the RdRp complex, as shown on the experimental structure of the nsp7/nsp8/nsp12 complex [",
            "PDB",
            " ID : ",
            "6yyt",
            " (Hillen )] (Fig. 1c, top)."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 674,
                "end": 677,
                "name": "PDB"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 683,
                "end": 687,
                "name": "6yyt"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "The second example shows the most widespread mutation in Spike glycoprotein - D614>G (genomic position 23 403), visualized here on the experimental structure of the spike protein and the human ACE2 receptor [",
            "PDB",
            " ID : ",
            "6vxx",
            " (Laha )] (Fig. 1c, bottom)."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 923,
                "end": 926,
                "name": "PDB"
            },
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 932,
                "end": 936,
                "name": "6vxx"
            },
            false
        ],
        "rel": [
            {
                "id": "R4",
                "bool": true,
                "head": "T7",
                "end": "T8"
            }
        ]
    },
    {
        "sen": [
            "As the COVID-19 pandemic is spreading around the world, the SARS-CoV-2 virus is evolving with mutations that potentially change and fine-tune functions of the proteins coded in its genome."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 pandemic began following a cross-species transmission event of the causative virus, SARS-CoV-2, sometime in late 2019 (Gorbalenya et al."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We re-analyze viral CpG deficiency data to incorporate key pangolin viral genomes that were available but omitted from Xia’s study."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Abstract  Due to the scope and impact of the COVID-19 pandemic there exists a strong desire to understand where the SARS-CoV-2 virus came from and how it jumped species boundaries to humans."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As the 2019 (COVID-19) pandemic caused by the novel coronavirus, SARS-CoV-2 spreads globally, differences in adverse clinical management outcomes have been associated with age >65 years, male gender, and comorbidities such as smoking, diabetes, hypertension, cardiovascular comorbidity, and immunosuppression."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition to ethnicity, socioeconomic factors, prior vaccinations, exposure to other coronaviruses, and other factors need to be considered to explain the geographical and regional variations in susceptibility and severity of the clinical expression of COVID-19 disease and outcomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the United States, there have been disproportionate COVID-19 death rates among African Americans at around 2.6 times higher than that of other groups."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Some individuals with COVID-19 experienced neurological symptoms, e.g., Guillain Barre Syndrome (Zhao et al., 2020), suggesting an autoimmune background, which has been associated with MHC alleles (Hasan et al., 2014)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Such aspects should be considered while examining neurological symptoms in patients after COVID-19 recovery, and also in SARS-CoV-2 vaccination efforts."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In order to test this possibility, we analyzed the most frequent MHC class I and II alleles in Europe, Asia, and Africa for binding to the mutations in ORF8 (L84S) and ORF3a (G251V) (see supplementary data sets)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For MHC class I, starting with a peptide with the mutation site in the middle (flanked by seven amino acid residues to the left and right, resulting in a 15mer peptide) for ORF8 (L84S) (GNYTVSCLPFTINCQ and GNYTVSCSPFTINCQ) and for ORF3a (G251V) (VQIHTIDGSSGVVNP and VQIHTIDVSSGVVNP), we tested all possible combinations of length from 8 to 14 residues for MHC class I binding, For MHC class II, starting with a peptide with 33 residues with the mutation site in the middle for ORF8 (L84S) (KSPIQYIDIGNYTVSCL/SPFTINCQEPKLGSLVV) and for ORF3a (G251V) (KIVDEPEEHVQIHTIDG/VSSGVVNPVMEPIYDEP), we tested all possible combinations to bind to MHC class II alleles listed in the supplementary data set since MHC class II molecules can accommodate longer peptides, and nominal epitopes may ‘glide’ within the MHC class II peptide binding cleft (Rammensee, 1995)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We could not identify differences in MHC class I or class II binding characteristics (see Appendix- supplementary data sets Tables S1, S2 and S3) except for three MHC class II alleles, i.e., DRB3*02:02, DRB1*09:01, and DRB1*04:01, that do not allow binding of the wildtype, but accommodate the SARS-CoV-2 ORF8 (L84S) variant (Table 1",
            ") and also two MHC class II alleles HLA-DPA1*01:03/DPB1*02:01 that do the opposite: they accommodate the wildtype but not the SARS-CoV-2 ORF8 (L84S) variant (Table 1)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of the 11,970 SARS-CoV-2 sequences deposited in the ",
            "GISAID",
            " database by April 27th, 2020, 85% exhibit the amino acid Leucine at the position 84 and 15% exhibit Serine."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 2742,
                "end": 2748,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Genetic factors such as the HLA type of patients may play a role in regard to disease severity and clinical outcome of patients with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Taking the data deposited in the ",
            "GISAID",
            " database, we made predictions using the IEDB analysis resource (TepiTool) to gauge how variants in the SARS-CoV-2 genome may change peptide binding to the most frequent MHC-class I and -II alleles in Africa, Asia and Europe."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 3033,
                "end": 3039,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "MHC 4-digit typing along with viral sequence analysis should be considered in studies examining clinical outcomes in patients with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By de novo assembly and targeted PCR, we obtained a 29,891-base-pair CoV genome that shared 79.6% sequence identity to SARS-CoV BJ01 (",
            "GenBank",
            " accession number ",
            "AY278488.2",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 134,
                "end": 141,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 159,
                "end": 169,
                "name": "AY278488.2"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "This sequence has been submitted to ",
            "GISAID",
            " (",
            "https://www.gisaid.org/",
            ") (accession number ",
            "EPI_ISL_402124",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 208,
                "end": 214,
                "name": "GISAID"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 216,
                "end": 239,
                "name": "https://www.gisaid.org/"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 259,
                "end": 273,
                "name": "EPI_ISL_402124"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T3",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "Four more full-length genome sequences of 2019-nCoV (WIV02, WIV05, WIV06 and WIV07) (",
            "GISAID",
            " accession numbers ",
            "EPI_ISL_402127–402130",
            ") that were more than 99.9% identical to each other were subsequently obtained from four additional patients using next-generation sequencing and PCR (Extended Data Table 2)."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 361,
                "end": 367,
                "name": "GISAID"
            },
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 386,
                "end": 407,
                "name": "EPI_ISL_402127–402130"
            },
            false
        ],
        "rel": [
            {
                "id": "R4",
                "bool": true,
                "head": "T6",
                "end": "T7"
            }
        ]
    },
    {
        "sen": [
            "We carried out full-length sequencing on this RNA sample (",
            "GISAID",
            " accession number ",
            "EPI_ISL_402131",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Dataset",
                "start": 640,
                "end": 646,
                "name": "GISAID"
            },
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 664,
                "end": 678,
                "name": "EPI_ISL_402131"
            },
            false
        ],
        "rel": [
            {
                "id": "R5",
                "bool": true,
                "head": "T8",
                "end": "T9"
            }
        ]
    },
    {
        "sen": [
            "We demonstrate that all samples were able to neutralize 100 TCID50 (50% tissue-culture-infective dose) of 2019-nCoV at a dilution of 1:40–1:80."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Sequence data that support the findings of this study have been deposited in ",
            "GISAID",
            " (",
            "https://www.gisaid.org/",
            ") with accession numbers ",
            "EPI_ISL_402124",
            ", ",
            "EPI_ISL_402127–EPI_ISL_402130",
            " and ",
            "EPI_ISL_402131",
            "; ",
            "GenBank",
            " with accession numbers ",
            "MN996527",
            "–",
            "MN996532",
            "; ",
            "National Genomics Data Center",
            ", ",
            "Beijing Institute of Genomics",
            ", ",
            "Chinese Academy of Sciences",
            " (",
            "https://bigd.big.ac.cn/databases?lang=en",
            ") with accession numbers ",
            "SAMC133236",
            "–",
            "SAMC133240",
            " and ",
            "SAMC133252",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T10",
                "type": "Dataset",
                "start": 902,
                "end": 908,
                "name": "GISAID"
            },
            false,
            {
                "id": "T11",
                "type": "URL",
                "start": 910,
                "end": 933,
                "name": "https://www.gisaid.org/"
            },
            false,
            {
                "id": "T12",
                "type": "AccessionNumber",
                "start": 958,
                "end": 972,
                "name": "EPI_ISL_402124"
            },
            false,
            {
                "id": "T13",
                "type": "AccessionNumber",
                "start": 974,
                "end": 1003,
                "name": "EPI_ISL_402127–EPI_ISL_402130"
            },
            false,
            {
                "id": "T14",
                "type": "AccessionNumber",
                "start": 1008,
                "end": 1022,
                "name": "EPI_ISL_402131"
            },
            false,
            {
                "id": "T15",
                "type": "Repository",
                "start": 1024,
                "end": 1031,
                "name": "GenBank"
            },
            false,
            {
                "id": "T16",
                "type": "AccessionNumber",
                "start": 1055,
                "end": 1063,
                "name": "MN996527"
            },
            false,
            {
                "id": "T17",
                "type": "AccessionNumber",
                "start": 1064,
                "end": 1072,
                "name": "MN996532"
            },
            false,
            {
                "id": "T18",
                "type": "Repository",
                "start": 1074,
                "end": 1103,
                "name": "National Genomics Data Center"
            },
            false,
            {
                "id": "T19",
                "type": "Repository",
                "start": 1105,
                "end": 1134,
                "name": "Beijing Institute of Genomics"
            },
            false,
            {
                "id": "T20",
                "type": "Repository",
                "start": 1136,
                "end": 1163,
                "name": "Chinese Academy of Sciences"
            },
            false,
            {
                "id": "T21",
                "type": "URL",
                "start": 1165,
                "end": 1205,
                "name": "https://bigd.big.ac.cn/databases?lang=en"
            },
            false,
            {
                "id": "T22",
                "type": "AccessionNumber",
                "start": 1230,
                "end": 1240,
                "name": "SAMC133236"
            },
            false,
            {
                "id": "T23",
                "type": "AccessionNumber",
                "start": 1241,
                "end": 1251,
                "name": "SAMC133240"
            },
            false,
            {
                "id": "T24",
                "type": "AccessionNumber",
                "start": 1256,
                "end": 1266,
                "name": "SAMC133252"
            },
            false
        ],
        "rel": [
            {
                "id": "R6",
                "bool": true,
                "head": "T10",
                "end": "T11"
            },
            {
                "id": "R7",
                "bool": true,
                "head": "T10",
                "end": "T12"
            },
            {
                "id": "R8",
                "bool": true,
                "head": "T10",
                "end": "T13"
            },
            {
                "id": "R9",
                "bool": true,
                "head": "T10",
                "end": "T14"
            },
            {
                "id": "R10",
                "bool": true,
                "head": "T15",
                "end": "T16"
            },
            {
                "id": "R11",
                "bool": true,
                "head": "T15",
                "end": "T17"
            },
            {
                "id": "R12",
                "bool": true,
                "head": "T20",
                "end": "T21"
            },
            {
                "id": "R13",
                "bool": true,
                "head": "T20",
                "end": "T22"
            },
            {
                "id": "R14",
                "bool": true,
                "head": "T20",
                "end": "T23"
            },
            {
                "id": "R15",
                "bool": true,
                "head": "T20",
                "end": "T24"
            }
        ]
    },
    {
        "sen": [
            "Since the beginning of the COVID-19 pandemic, viral genomes have been generated at an unprecedented rate, with over 60,000 sequences on ",
            "GISAID",
            " by early July 2020 (",
            "gisaid.org",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 136,
                "end": 142,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 163,
                "end": 173,
                "name": "gisaid.org"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "These analyses can now occur in near real-time [1,2] and have yielded important insights into the early COVID-19 pandemic in the United States, Brazil, and South Africa [3–7]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These dashboards often communicate data at global, national, and in the US, state and county levels, but do not (yet) incorporate any genomic data or analysis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With these initiatives in mind, we propose three guiding principles for genomic epidemiologists looking to communicate their locally focused results in the context of the current COVID-19 pandemic (Box 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We believe that presenting results rapidly, and tailored to a non-expert audience, can serve as a template for effective public health response to COVID-19 and other emerging viral diseases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The authors believe that presenting results rapidly, and tailored to a non-expert audience, can serve as a template for effective public health communication for COVID-19 and other emerging viral diseases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It has been reported that in severe cases of COVID-19, hypoxaemia is induced by the pneumonic process and might have several adverse effects in patients (Rello et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, in prolonged hypoxia induction via COVID-19, the UPR is triggered to help the cells to survive."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, prolonged hypoxia would possibly drive UPR role from survival to death and apoptotic mode, which possibly is one of the causes of cellular and organ damage in COVID-19 cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Usage of Zinc and Zinc ionophores may enhance the therapeutic effects of targeting autophagy and replication in COVID-19 by several compounds which along pyrithione include dithiocarbamates, disulfiram and quinoline derivatives such as clioquinol."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The pathologic source of this disease was a new RNA virus from Coronaviridae family, which was named COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The present pandemic situation of the Severe Acute Respiratory Syndrome (COVID-19) is caused by the RNA virus SARS-CoV2 which is characterized by its rapid mutations up to a million times higher than that of their hosts [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "From the ",
            "NCBI",
            " virus database, all the protein sequences of 3617 SARS-CoV2 genomes were fetched."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 234,
                "end": 238,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the ",
            "NCBI",
            " database, as on June 6, 2020, total number of available complete genome sequences of SARS-CoV2 across the world is 3617.",
            "In the ",
            "NCBI",
            " database, as on June 6, 2020, total number of available complete genome sequences of SARS-CoV2 across the world is 3617 on which the present study of mutation over the envelope protein is performed. .    •"
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 328,
                "end": 332,
                "name": "NCBI"
            },
            false,
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 461,
                "end": 465,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In December 31, 2019, the epidemic of novel human coronavirus (COVID-19) was first detected in Wuhan city, Hubei province, China, which has caused pneumonia by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The World Health Organization (WHO) has reported that the main route to spread of the COVID-19 virus is human-to-human transmission."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 has a very contagious nature and rapidly spreads to all developed and developing countries (WHO, 2020a; WHO, 2020b; Ma et al., 2020; Wang et al., 2020; Sohrabi et al., 2020; Noorimotlagh et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In Islamic Republic (IR) of Iran, on February 19, 2020, the Ministry of Health and Medical Education official announcement reported the first death caused by COVID-19 (Takian et al., 2020; Faridi et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to WHO situation report-108 on coronavirus disease (COVID-19) outbreak, on May 7, 2020, Iran was reported to have 103,330 and 6496 total confirmed cases and total deaths, respectively, which was the highest ranking among Eastern Mediterranean countries (WHO, 2020a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The very high prevalence of COVID-19 in the world has triggered rigorous investigations to determine the clinical characteristics and severity of the novel coronavirus disease and its potential transmission route including airborne transmission."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The present study was carried out on May 7, 2020, in Shahid Mustafa Khomeini Hospital wards in Ilam province, East of Iran, assigned for patients' treatment with confirmed COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Ilam, with 580,000 population, was then reported to have 576 and 54 confirmed COVID-19 cases and deaths, respectively."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All of the suspected and confirmed cases of COVID-19 in the other cities were transferred to Shahid Mustafa Khomeini Hospital."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the present study, the liquid impinger biosampler (liquid-phase sampler, SKC biosampler) was consumed as a highly efficient technique to capture airborne viruses in bio-aerosol sampling of the COVID-19 virus in the different wards of the hospital."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The novel human coronavirus (COVID-19) has recently emerged and rapidly spread through all developed and developing countries and caused a pandemic with great health burden worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As depicted in Table 3, there were 183 patients confirmed with COVID-19 with different conditions from severe and critical to mild circumstances."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Ong et al. (2020) suggest that environment, due to the significant contamination caused by respiratory droplets and fecal shedding of patients with confirmed COVID-19, is the potential medium of transmission (Ong et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, the main routes of preventing and limiting the exposure to COVID-19 recommended by WHO are hand washing and observing social distance (WHO, 2020a; Morawska and Cao, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These measures could not prevent people infection through inhalation of small droplets and aerosols emission by a COVID-19 patients (in many cases they are asymptomatic) that can travel distance of meters or 10 of meters in the air and transmit the viable virus of SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In another similar study, about aerodynamic characteristics and RNA concentration of SARS-CoV-2 aerosol in Wuhan hospitals during COVID-19 outbreak, Liu et al. (2020) confirmed that the resuspension process of the virus aerosol, which deposit on protective apparel or floor surface, could be a potential transmission route."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On December 31, 2019, the novel human coronavirus (COVID-19) was identified in Wuhan, China and swiftly spread in all nations and territories around the globe."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, we examined the potential aerosol transmission of the virus through hospital wards indoor air by confirmed COVID-19 patients on May 7, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Accordingly, we found two positive air samples (in the ICU) out of 14 ones taken from different wards with confirmed COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease-2019 (COVID-19) has led to >22 million affected (1) and >784,000 deaths worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Accordingly, it has been hypothesized that inflammation associated with SARS-CoV-2 infection leads to a “COVID-19–related coagulopathy” (5), resulting in increased thrombosis (6)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Observational analyses have suggested potential benefit for in-hospital use of anticoagulation (AC) in COVID-19 treatment (9,10)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Survival in days was calculated as time from hospital admission to in-hospital death, discharge, or the date of dataset lock (May 7, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Overall, 1,073 (24.4%) patients died during the study period, 2,892 (65.9%) were discharged alive, and 424 (9.7%) were still hospitalized by dataset freeze date."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Autopsies were performed on COVID-19 positive patients at Mount Sinai Health System starting on March 20, 2020, with 72 completed by May 7, 2020 (8)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thromboembolic disease has emerged as an important complication among hospitalized patients with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The mechanisms by which thrombotic disease may occur in the setting of COVID-19 infection include inflammation, hypoxia, and potentially pharmacotherapeutic interactions (2,4,12,13)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As such, the potential benefit of AC in the treatment of COVID-19 is based on the prevention and treatment of microvascular and macrovascular thrombosis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In our cohort of patients hospitalized with COVID-19, a strong association of AC with approximately 50% reduced hazard of in-hospital mortality was observed (Figure 1A)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As mortality rates for patients with COVID-19 who undergo intubation for respiratory failure range from 30% to 80% (16, 17, 18), we analyzed the association between AC and intubation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Background  Thromboembolic disease is common in coronavirus disease-2019 (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Conclusions  AC was associated with lower mortality and intubation among hospitalized COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The connection between the reality of the COVID‐19 in the US and around the world and the magical realism in a story set in a Caribbean Sea harbor town in Colombia is tenuous at best."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There are some parallels, though: anxiety, fear, and suffering throughout the population, and the frantic search for a cure for those seriously affected by COVID‐19, similar to Dr. Urbino’s passion for finding a cholera cure in the book."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Other similarities between the current COVID‐19 pandemic and the fictional cholera outbreak described by García Márquez include personal resilience and indomitable spirit under trying circumstances…and that life after the pandemic is not the same."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Other lessons learned during the COVID‐19 pandemic for medical genetics practice include the utility of telemedicine, which until now was largely used only for patients in remote locations, but which may well become the new norm after being employed successfully while patients, their families and healthcare providers are isolated at home."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Lessons learned from these new models of teaching the next generation of healthcare professionals in medical genetics and genomics may well be incorporated in (re)designing future didactics in our field."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 was declared a pandemic by the World Health Organization, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Respiratory failure is the most common mortality outcome in COVID-19 patients, yet serious and even fatal manifestations are seen across multiple organ systems, including the brain (Helms et al., 2020; Pleasure et al., 2020) and gastrointestinal tract (Goyal et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In one retrospective study of more than 400 COVID-19 patients, nearly 20% had suffered in-hospital cardiac injury, which was a significant independent risk factor for mortality (Shi et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nearly 25% of patients have gastrointestinal manifestations including anorexia, diarrhea, vomiting, and abdominal pain, and these symptoms are associated with worse COVID-19 outcomes (Pan et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A recent clinical study among 7,300 COVID-19 patients also showed a strong correlation between poor COVID-19 outcomes and type 2 diabetes (Zhu et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recent clinical studies suggest that diabetes is not only a risk factor for severe COVID-19 disease, but also that SARS-CoV-2 infection can induce new-onset diabetes (Bornstein et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Currently, there are no vaccines or effective treatment options for COVID-19 due to limited knowledge of SARS-CoV-2 viral biology."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A human cell-based platform to study viral tropism would be a first step toward defining cell types permissive to SARS-CoV-2 infection and for modeling COVID-19 disease across multiple organ systems."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To determine the relative permissiveness of hPSC-derived cells and organoids to SARS-CoV-2 viral entry, we used a vesicular stomatitis virus (VSV)-based SARS-CoV-2 pseudo-entry virus, for which the backbone was provided by a VSV pseudo-typed ΔG-luciferase virus with the SARS-CoV-2 Spike protein incorporated in the surface of the viral particle instead (Nie et al., 2020; Whitt, 2010)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Humanized mice carrying human pancreatic endocrine cells in vivo provide a unique platform for modeling COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In brief, hPSC-derived pancreatic endocrine cells were transplanted under the kidney capsule of SCID-beige mice (Figure 2G)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As it is technically challenging to obtain pancreatic samples from COVID-19 patients, we compared transcript profiles from lung autopsy samples from healthy donors or COVID-19 patients and identified a robust upregulation of chemokines, including CCL2, CXCL5, and CXCL6, in the COVID-19 patient samples as has been described previously (Figure 3G; Blanco-Melo et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Together, the data suggest that SARS-CoV-2-infected pancreatic endocrine cells show robust chemokine induction, which is similar to what is found in autopsy samples from COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Consistent with results using hepatocyte organoids, KEGG GSEA comparing mock infected with SARS-CoV-2-infected cholangiocyte organoids revealed the upregulation of inflammatory pathways, including cytokine-cytokine receptor interaction and IL-17 signaling (Figure 4N, Table S1), which is consistent with previous findings in COVID-19 lung autopsy samples (Han et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although respiratory failure is the most common adverse outcome for COVID-19 patients, they often present with additional clinical complications involving the metabolic, cardiac, neurological, and gastrointestinal systems."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although human coronaviruses previously had not been considered to infect liver cells, our results are consistent with current COVID-19 clinical observations that more than 50% of patients have evidence of viral hepatitis (Ong et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A recent clinical study showed a strong correlation between COVID-19 and type 2 diabetes (Zhu et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Closer monitoring of individuals with high risk for diabetes is needed to evaluate the contribution of SARS-CoV-2 in previously infected COVID-19 patients to progression toward type 1 or type 2 diabetes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2, isolate USA-WA1/2020 (NR-52281) was deposited by the Center for Disease Control and Prevention and obtained through BEI Resources, NIAID, NIH."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 has caused the COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 pathophysiology includes respiratory failure but involves other organ systems including gut, liver, heart, and pancreas."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recent clinical studies show a strong association with COVID-19 and diabetes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 infection caused striking expression of chemokines, as also seen in primary human COVID-19 pulmonary autopsy samples."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "hPSC-derived cells/organoids provide valuable models for understanding the cellular responses of human tissues to SARS-CoV-2 infection and for disease modeling of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Graphical Abstract      Yang et al. show that hPSC-derived cells and organoids provide valuable models to study SARS-CoV-2 tropism and to model COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in late 2019 and has been declared a pandemic [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Clinical presentation of COVID-19 varies widely, ranging from asymptomatic to mild or severe forms [2,3]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although epitopes mapping within all SARS-CoV-2 structural proteins have been shown to elicit NtAb, the receptor-binding domain (RBD) of the viral spike protein (S) is immunodominant and a highly specific target of most potent NtAbs in COVID-19 patients [[6], [7], [8], [9]]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The involvement of functional antibodies in SARS-CoV-2 clearance and modulation of COVID-19 severity remains to be precisely defined [10]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, passive immunization of critically ill COVID-19 patients with plasma from individuals who had recovered from SARS-CoV-2 infection and seroconverted was associated with improved clinical outcomes in uncontrolled case series [13,14]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this context, higher antibody titers, either neutralizing or not, have been reported to be present in patients developing severe forms of COVID-19 when compared to mildly symptomatic individuals who did not require hospitalization [[17], [18], [19], [20], [21], [22], [23]]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All patients presented with pneumonia and imaging/laboratory findings compatible with COVID-19 [2,3]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We considered high NtAb50 titers those ≥1/160, as this is the minimum NtAb titer of plasma from COVID-19 convalescent individuals recommended by the FDA for therapeutic use [30]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As expected, ICU patients were hospitalized for longer periods and the median serum levels of several pro-inflammatory biomarkers, (LDH, dimer-D and IL-6) were significantly higher in ICU patients, further confirming their association with COVID-19 severity [[2], [3], [4], [5]]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Avidity of SARS-CoV-2 IgGs in sera from COVID-19 patients was assessed by a conventional urea dissociation assay [26]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Very weak (Rho=>0.0–<0.2) or weak (Rho=>0.2–<0.4) correlations (either positive or negative) were found between SARS-CoV-2 RBD IgG levels or NtAb50 titers and all selected biomarkers when considering the entire data set (Fig. 6",
            ") or when analyses were done separately for specimens collected at different time frames after the onset of symptoms (days 1–15 or days 15–30; not shown)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, in addition to further characterizing the antibody response to SARS-CoV-2 in hospitalized COVID-19 patients, we mainly aimed to determine whether a relationship could be established between the magnitude of SARS-CoV-2 RBD IgG and NtAb levels and the “inflammatory state” of patients, which has been shown to directly correlate with COVID-19 severity and prognosis [[2], [3], [4], [5]]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Previous studies have reported a correlation between RBD IgG levels and NtAb titers in patients with comparable or less severe clinical presentations of COVID-19, using either live native SARS-CoV-2 virus, engineered SARS-CoV-2 pseudotype virus systems or replication-competent SARS-CoV-2 chimeric viruses [18,22,[30], [31], [32], [33], [34], [35], [36]]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The alleged association between high SARS-CoV-2 antibody levels and COVID-19 severity [[17], [18], [19], [20], [21], [22]] is a matter of concern."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Wang et al. [18] also reported higher NtAb50 titers quantitated by a pseudotyped-virus based neutralization assay in severely ill patients as compared to mild COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Other studies including relatively small cohorts also pointed to an association of COVID-19 severity with SARS-CoV-2 NtAb [20,22,38]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Disregulated synthesis and release of pro-inflammatory cytokines is thought to be a pathogenetic hallmark of most severe forms of COVID-19 [4,5]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although the mechanisms of COVID-19–induced lung injury remain unclear, the so-called “cytokine storm” may likely play a critical role in the process of disease worsening and thus in COVID-19 prognosis [40]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Taken together, these data argue against a robust relationship between the magnitude of the antibody responses subjected to analysis herein and the state of inflammation in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "•  NtAb and RBD IgGs levels do not associate with COVID-19 severity in hospitalized patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The involvement of SARS-CoV-2 antibodies in mediating immunopathogenetic events in COVID-19 patients has been suggested."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By using several experimental approaches, we investigated the potential association between SARS-CoV-2 IgGs recognizing the spike (S) protein receptor-binding domain (RBD), neutralizing antibodies (NtAb) targeting S, and COVID-19 severity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The data presented herein do not support an association between SARS-CoV-2 RBD IgG or NtAb50 levels and COVID-19 severity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Selected sites are mapped onto the 3D structure of models obtained using SARS-CoV proteins as a templates (",
            "PDB",
            " ID: ",
            "6ACG",
            " for panel A, ",
            "2CJR",
            " for panel B, ",
            "2HSX",
            " for panel C)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 107,
                "end": 110,
                "name": "PDB"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 115,
                "end": 119,
                "name": "6ACG"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 133,
                "end": 137,
                "name": "2CJR"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 151,
                "end": 155,
                "name": "2HSX"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T1",
                "end": "T3"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T1",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "These will need to be interpreted in the future, by incorporating epidemiological, biochemical, and additional genetic data."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Genome sequences were retrieved from the ",
            "National Center for Biotechnology Information",
            " database (",
            "NCBI",
            "; ",
            "https://www.ncbi.nlm.nih.gov/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 336,
                "end": 381,
                "name": "National Center for Biotechnology Information"
            },
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 392,
                "end": 396,
                "name": "NCBI"
            },
            false,
            {
                "id": "T7",
                "type": "URL",
                "start": 398,
                "end": 427,
                "name": "https://www.ncbi.nlm.nih.gov/"
            },
            false
        ],
        "rel": [
            {
                "id": "R4",
                "bool": true,
                "head": "T5",
                "end": "T7"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T6",
                "end": "T7"
            }
        ]
    },
    {
        "sen": [
            "The three-dimensional (3D) structures of SARS-CoV N (",
            "PDB",
            " identifier [ID]: ",
            "2CJR",
            ") (65) and S (",
            "PDB",
            " ID: ",
            "6ACG",
            ") (48) proteins were obtained from the ",
            "Protein Data Bank (PDB)",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 483,
                "end": 486,
                "name": "PDB"
            },
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 504,
                "end": 508,
                "name": "2CJR"
            },
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 522,
                "end": 525,
                "name": "PDB"
            },
            false,
            {
                "id": "T11",
                "type": "AccessionNumber",
                "start": 530,
                "end": 534,
                "name": "6ACG"
            },
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 573,
                "end": 596,
                "name": "Protein Data Bank (PDB)"
            },
            false
        ],
        "rel": [
            {
                "id": "R6",
                "bool": true,
                "head": "T8",
                "end": "T9"
            },
            {
                "id": "R7",
                "bool": true,
                "head": "T10",
                "end": "T11"
            }
        ]
    },
    {
        "sen": [
            "Biochemists, microbiologists, and ecologists with general molecular training may have the technical skills to run COVID-19 assays, but they don’t have the appropriate certifications."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Even so, the urgency of the pandemic has spurred some states to relax legal restrictions on who can perform COVID-19 testing."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On March 12, for example, California Governor Gavin Newsom issued an executive order suspending certification and licensure requirements for any researcher with relevant skills who meets CLIA requirements to run the COVID-19 test; such a person may now temporarily run the assays under the supervision of a medical laboratory scientist in a CLIA-certified lab (4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On March 19, Louisiana Governor John Bel Edwards issued a proclamation to temporarily suspend some certification and licensure requirements for running COVID-19 assays."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Now, laboratory personnel “who demonstrate molecular biology polymerase chain reaction (PCR) experience” can legally run COVID-19 tests if they are supervised by a licensed physician or PhD with related lab experience, according to the proclamation (5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hence, an ecologist trained in PCR might now be a candidate to run COVID-19 assays, if properly supervised, says Vincent Culotta, executive director of the Louisiana State Board of Medical Examiners in New Orleans."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The several medical laboratory scientists already working there will oversee at least 15 Berkeley postdoctoral molecular biologist volunteers, who will run the COVID-19 assays."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Some testing centers made their own COVID-19 assays, choosing their preferred brand of RNA extraction kits, primers, PCR machines, and swabs, Schaletzky explains."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "After the FDA granted emergency-use authorization for the test in late March, Abbott estimated that it could deliver 50,000 COVID-19 tests per day (10)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This leads to a respiratory disease called COVID-19 that was declared a global pandemic in early 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Discovery of pharmacological interventions that can interrupt this lung tissue to sensory neuronal innervation of the lung signaling could play an important role in treating severe COVID-19 cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There is strong evidence that neurogenic factors play an important role in sepsis (Bryant et al., 2003, Devesa et al., 2011), which also occurs in many severe COVID-19 patients (Zhou et al., 2020a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The unprecedented scientific response to the SARS-CoV-2 driven pandemic has produced datasets that enable computational determination of probable intercellular signaling between nociceptors and immune signaling or response in the lung."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Because these interactions might be a crucial driver of disease severity, we set out to comprehensively catalog these interactions using previously published datasets from COVID-19 patients (",
            "Gordon, et al., 2020",
            ", ",
            "Huang et al., 2020b",
            ", ",
            "Huang et al., 2020",
            ", ",
            "Liao et al., 2020",
            ", ",
            "Xiong et al., 2020b",
            ") and our own RNA sequencing (RNA-seq) datasets from human thoracic DRG (hDRG) (",
            "Ray et al., 2018",
            ", ",
            "North et al., 2019",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Creator",
                "start": 926,
                "end": 946,
                "name": "Gordon, et al., 2020"
            },
            false,
            {
                "id": "T2",
                "type": "Creator",
                "start": 948,
                "end": 967,
                "name": "Huang et al., 2020b"
            },
            false,
            {
                "id": "T3",
                "type": "Creator",
                "start": 969,
                "end": 987,
                "name": "Huang et al., 2020"
            },
            false,
            {
                "id": "T4",
                "type": "Creator",
                "start": 989,
                "end": 1006,
                "name": "Liao et al., 2020"
            },
            false,
            {
                "id": "T5",
                "type": "Creator",
                "start": 1008,
                "end": 1027,
                "name": "Xiong et al., 2020b"
            },
            false,
            {
                "id": "T6",
                "type": "Creator",
                "start": 1107,
                "end": 1123,
                "name": "Ray et al., 2018"
            },
            false,
            {
                "id": "T7",
                "type": "Creator",
                "start": 1125,
                "end": 1143,
                "name": "North et al., 2019"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A key finding emerging from the data is that certain interventions used or under development for rheumatic or neuropathic pain might be useful against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We first re-analyzed bulk RNA-seq data from published studies by mapping and quantifying relative gene abundance (in counts per million) from BALF (",
            "National Genomics Data Center",
            " accession number: ",
            "PRJCA002326",
            ", ) of severe COVID-19 patients (",
            "Xiong et al., 2020b",
            "), compared to BALF (",
            "NCBI SRAdb",
            " project ",
            "SRP230751",
            ", ) of healthy controls."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 1455,
                "end": 1484,
                "name": "National Genomics Data Center"
            },
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 1503,
                "end": 1514,
                "name": "PRJCA002326"
            },
            false,
            {
                "id": "T10",
                "type": "Creator",
                "start": 1547,
                "end": 1566,
                "name": "Xiong et al., 2020b"
            },
            false,
            {
                "id": "T11",
                "type": "Repository",
                "start": 1587,
                "end": 1597,
                "name": "NCBI SRAdb"
            },
            false,
            {
                "id": "T12",
                "type": "AccessionNumber",
                "start": 1606,
                "end": 1615,
                "name": "SRP230751"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T8",
                "end": "T9"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T11",
                "end": "T12"
            }
        ]
    },
    {
        "sen": [
            "Differences between the two COVID-19 BALF samples can likely be attributed to variability of the immune response from patient to patient, as well as the lower sequencing depth of the samples, as even after pooling technical replicates for the COVID-19 patient samples we had ~ 12 M and 7 M sequenced reads."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The two COVID-19 BALF samples were also found to contain SARS-CoV2 viral RNA reads confirming the presence of disease (",
            "Xiong et al., 2020b",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T13",
                "type": "Creator",
                "start": 2066,
                "end": 2085,
                "name": "Xiong et al., 2020b"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Out of 31,069 genes in the reference genome, we detected 18,507 and 18,855 genes in the control samples, and 13,973 and 13,545 genes in the COVID-19 patient samples; differences being primarily attributable to a decrease in sequencing depth for COVID-19 samples."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Due to this and the fact that our goal was to identify potentially targetable protein interaction pathways in COVID-19 patients, we performed downstream analysis only on 1372 genes that were upregulated in the COVID-19 BALF samples (Supplementary Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Genes upregulated in the COVID-19 patient samples include a multitude of genes that recapitulate clinical characteristics, such as increased cytokine signaling causing a “cytokine storm” (including CCL2/3/4/7/8, CXCL1/2/6/8/28, CCL3L3, CCL4L2), hypoxia (HIF1A, HLF), and inflammasome and sepsis-related genes (IL1R1/2, IL5RA, IL33, IL31RA)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additionally, we found that upregulation of transcription factor genes in COVID-19 samples identifies transcription factors associated with alveolar cell types (EHF, PAX9, ELF3, GHRL2) and immune cells (RFX3, SOX5, TP63, HOPX) with functions including regulation of antiviral pathways (NR3C2), based on ",
            "ARCHS4",
            " database (",
            "Lachmann et al., 2018",
            ") and the Enrichr gene set enrichment analysis tool (Kuleshov et al., 2016) (Supplementary Table 2)."
        ],
        "lab": [
            false,
            {
                "id": "T14",
                "type": "Dataset",
                "start": 3252,
                "end": 3258,
                "name": "ARCHS4"
            },
            false,
            {
                "id": "T15",
                "type": "Creator",
                "start": 3269,
                "end": 3290,
                "name": "Lachmann et al., 2018"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This suggests that cellular distress and virus-driven cell lysis causes lung cell mRNA content to be detected in COVID-19 BALF samples."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Immune cell markers like CD4, CD8, and CD68 were detected in COVID-19 samples, but were not consistently upregulated."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, lymphocyte markers CD24 and CD38 were upregulated in the COVID-19 BALF samples, which is also consistent with reports of lymphocyte induced apoptosis in COVID-19 (Huang et al., 2020a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These findings are congruent with reports of increased lactate dehydrogenase as a biomarker of COVID-19 severity wherein lactate dehydrogenase is a sign of pyroptosis – inflammasome driven programmed cell death (Rayamajhi et al., 2013, Chen et al., 2020, Han et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For this purpose, we used our interactome framework (Ramilowski et al., 2015) to elucidate possible pharmacological interactions that may be associated with disease in COVID-19 samples."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We focused first on ligands upregulated in the COVID-19 samples and receptors expressed in human thoracic DRG samples, which contain neurons that innervate the lungs (Springall et al., 1987, Kummer et al., 1992)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We found that many receptors for cytokines identified as upregulated in COVID-19 patients including CCR2, CXCR2, CCR5, and CXCR10, and IL15RA were also expressed in hDRG suggesting a potential direct connection between these cytokines and sensory neuron activation in the lung (Table 1",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also noted increased EREG expression in COVID-19 samples, which is known to signal via the epidermal growth factor receptor (EGFR) to sensitize nociceptors (Martin et al., 2017)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A complete list of the interactome featuring differentially increased ligands in BALF from COVID-19 samples can be seen in Supplementary Table 3, and expression profiles of the mouse orthologs in sensory neurons can be found in Supplementary Table 4."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The average of gene abundances in the 2 COVID-19 samples, weighted by sequencing depth are shown here."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The full dataset is shown in Supplementary Table 3."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, we also explored possible interaction points between sensory neurons that are likely to innervate the lung and receptors expressed in BALF samples from patients with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we identified a striking number of interactions between Eph ligands found in hDRG and receptors upregulated in COVID-19 BALF samples (Table 2",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our data suggests potential bidirectional interactions between these receptors and ligands on sensory nerve endings and immune cells in the lung of COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Another prominent interaction was with EGFR ligands and EGFR itself, again suggesting bidirectional interactions between neurons and immune cells in the lung in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, we also noted potential interactions between neurexins and neuroligins, which are also involved in junctions between neurons (Levinson and El-Husseini, 2005), suggesting that multiple types of mediators may be involved in remodeling nerve ending morphology within the lung driven by immune cell activation in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Collectively, these neuron-derived ligands could potentially exacerbate lung inflammation in COVID-19 contributing to a positive feedback loop."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A complete list of the interactome featuring differentially increased receptors in BALF from COVID-19 samples can be seen in Supplementary Table 5 and expression profiles of the mouse orthologs in sensory neurons can be found in Supplementary Table 6."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The average of gene abundances in the 2 COVID-19 samples, weighted by sequencing depth are shown here."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The full dataset is shown in Supplementary Table 5."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While our interactome identification from the BALF bulk RNA-seq is a starting point for identifying neuro-immune interactions in COVID-19 patient lungs, bulk RNA sequencing has limitations and other approaches are also being used to characterize the immune response in this disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We therefore studied the emerging COVID-19 literature for studies where raw datasets were not publicly available, but the studies provided gene or protein sets that were associated with clinical outcomes or pathologies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition to the Xiong et al study (Xiong et al., 2020b), we integrated gene and protein lists from sources that included BALF single-cell RNA-seq (scRNA-seq), blood protein levels and immune cell profiles from COVID-19 patients (Liao et al., 2020, Xiong et al., 2020b, Zhou et al., 2020, Zhou et al., 2020b)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These findings were consistent with the interactome generated from BALF samples from COVID19 patients with prominent interactions for cytokines, chemokines and other inflammatory molecules (Supplementary Table 7)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These finding implicate the potential off-label utility of anti-rheumatoid arthritis drugs that target TNF (infliximab or etanercept) or IL1 (anakinra) as well as EGFR inhibitors such as cetuximab for interfering with neuro-immune interactions in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Bulk hDRG sequencing libraries incorporate mRNA from not just sensory neurons, but also from glial, immune and vascular cells, leading to the possibility of false positives."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additionally, many lung innervating nociceptors are from the nodose or jugular ganglia so our dataset from thoracic hDRG may not represent the full possibility of receptors or ligands that could contribute to lung physiology from sensory afferents."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To predict which of the hDRG-expressed ligands or receptors are likely present in human nociceptors, we integrated several mouse datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We additionally included two datasets for gene expression in the mouse jugular-nodose complex (JNC), including the ",
            "Kupari et al",
            " scRNA-seq dataset (",
            "Kupari et al., 2019",
            ") and a study using bulk RNA-seq to study gene expression changes in the JNC following lung inflammation with Lipopolysaccharide (LPS) (",
            "Kaelberer et al., 2020",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T16",
                "type": "Creator",
                "start": 8907,
                "end": 8919,
                "name": "Kupari et al"
            },
            false,
            {
                "id": "T17",
                "type": "Creator",
                "start": 8939,
                "end": 8958,
                "name": "Kupari et al., 2019"
            },
            false,
            {
                "id": "T18",
                "type": "Creator",
                "start": 9094,
                "end": 9116,
                "name": "Kaelberer et al., 2020"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As mentioned above, EGFR ligands were strongly induced in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A major focus of current research into SARS-CoV-2 and COVID-19 is identification of potential therapeutics."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on this, we intersected differentially expressed BALF ligand and receptor genes in COVID-19 samples with mRNAs known to be regulated by eIF4E phosphorylation from previous studies (Furic et al., 2010, Aguilar-Valles et al., 2018, Amorim et al., 2018)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To do this we compiled a list of genes shown to be significantly changed in COVID-19 patients from the studies we cited and described above (Supplementary Tables 3, 5 and 7)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We found that 8 inflammatory mediators upregulated in the BALF of COVID-19 patients were reduced in vitro and/or in the brain of animals lacking eIF4E phosphorylation (Table 3",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "CCL2, which is among the most highly upregulated chemokines in COVID-19 patients, is one example."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hence, eFT508 (also known as Tomivosertib), a MNK1/2 inhibitor currently undergoing clinical trials (Reich et al., 2018), may prove beneficial against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also identified potential therapeutics for COVID-19 by intersecting the interactomes generated here with the ",
            "DGIdb",
            " database (",
            "Cotto et al., 2018",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T19",
                "type": "Dataset",
                "start": 10287,
                "end": 10292,
                "name": "DGIdb"
            },
            false,
            {
                "id": "T20",
                "type": "Creator",
                "start": 10303,
                "end": 10321,
                "name": "Cotto et al., 2018"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We identified 144 gene products with characterized antagonists, inhibitors, blockers or modulators in this curated database (a selection of these are shown in Table 4",
            ", full dataset in Supplementary Table 8)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This database highlights the potential for targeting cytokines and chemokines, such as CCL2, the CCR2 receptor and/or the EGFR receptor in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It also reveals several drugs that interact with ephrin – EphB signaling that may have promise if structural remodeling of lung afferent endings contributes to COVID-19 pathology."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The corresponding gene GRIN2B was strongly induced in BALF samples of COVID-19 samples."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "NMDA receptor activity and localization is strongly influenced by EphB receptors (Hanamura et al., 2017, Henderson and Dalva, 2018), which were also dramatically increased in COVID-19 BALF samples."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We used a computational framework to test the hypothesis that immune cells in the lungs of severe COVID-19 patients produce factors that are likely to interact with the sensory neuronal innervation of the lung."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our work finds support for this hypothesis and identifies potential interactions that may be critical drivers of disease severity in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To that end, MNK inhibitors, which were also identified by Gordon et al. (Gordon et al., 2020) may be particularly useful because they have an effect on coronavirus replication in murine models (Banerjee et al., 2002), interfere with the translation of chemokine and cytokines implicated in COVID-19 and reduce excitability of nociceptors (Moy et al., 2017, Megat et al., 2019) that may be driving neurogenic inflammation in the disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similar results have been found across studies (Huang et al., 2020b, Huang et al., 2020, Liao et al., 2020, Xiong et al., 2020b, Zhou et al., 2020, Zhou et al., 2020b), but there is an obvious need for additional sequencing on lung immune cells from patients with mild and severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Another important caveat is that the directionality of the influence of nociceptor-released factors on lung immunity and COVID-19 disease state is not currently clear."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Some studies on sepsis, which occurs in severe COVID-19 patients, have shown that nociceptors promote mortality in sepsis (Bryant et al., 2003) but others show that TRPV1-positive nociceptors are protective against mortality in sepsis (Guptill et al., 2011)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We have interpreted our interactome findings under the assumption that neurogenic responses may worsen the disease state in COVID-19, potentially leading to ARDS and fatality, but without perturbational animal model studies or additional human clinical data we cannot rule out the possibility that a subset of the interactome mitigates the disease state."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is formally possible that sensory neurons could express ACE2 allowing viral infection of these cells, but available datasets are unable to clarify this question."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Other datasets used here were based on analysis from datasets described in published studies from other groups."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Data for the curated COVID-19 interactome were obtained from (",
            "Huang et al., 2020b",
            ", ",
            "Huang et al., 2020",
            ", ",
            "Liao et al., 2020",
            ", ",
            "Xiong et al., 2020b",
            ", ",
            "Zhou et al., 2020",
            "), with BALF RNA-seq data from COVID-19 patients (",
            "National Genomics Data Center",
            " sample ids ",
            "CRR119894-7",
            ", ",
            "https://bigd.big.ac.cn/bioproject/browse/PRJCA002326",
            ") obtained from (",
            "Xiong et al., 2020b",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T21",
                "type": "Creator",
                "start": 13351,
                "end": 13370,
                "name": "Huang et al., 2020b"
            },
            false,
            {
                "id": "T22",
                "type": "Creator",
                "start": 13372,
                "end": 13390,
                "name": "Huang et al., 2020"
            },
            false,
            {
                "id": "T23",
                "type": "Creator",
                "start": 13392,
                "end": 13409,
                "name": "Liao et al., 2020"
            },
            false,
            {
                "id": "T24",
                "type": "Creator",
                "start": 13411,
                "end": 13430,
                "name": "Xiong et al., 2020b"
            },
            false,
            {
                "id": "T25",
                "type": "Creator",
                "start": 13432,
                "end": 13449,
                "name": "Zhou et al., 2020"
            },
            false,
            {
                "id": "T26",
                "type": "Repository",
                "start": 13499,
                "end": 13528,
                "name": "National Genomics Data Center"
            },
            false,
            {
                "id": "T27",
                "type": "AccessionNumber",
                "start": 13540,
                "end": 13551,
                "name": "CRR119894-7"
            },
            false,
            {
                "id": "T28",
                "type": "URL",
                "start": 13553,
                "end": 13605,
                "name": "https://bigd.big.ac.cn/bioproject/browse/PRJCA002326"
            },
            false,
            {
                "id": "T29",
                "type": "Creator",
                "start": 13622,
                "end": 13641,
                "name": "Xiong et al., 2020b"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T26",
                "end": "T27"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T26",
                "end": "T28"
            }
        ]
    },
    {
        "sen": [
            "Mouse bulk RNA-sequencing datasets were obtained from sorted neuronal cell pools from the DRG (",
            "Liang et al., 2019",
            ") and whole tissue RNA-seq from the JNC complex before and after LPS injury (",
            "Kaelberer et al., 2020",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T30",
                "type": "Creator",
                "start": 13739,
                "end": 13757,
                "name": "Liang et al., 2019"
            },
            false,
            {
                "id": "T31",
                "type": "Creator",
                "start": 13834,
                "end": 13856,
                "name": "Kaelberer et al., 2020"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "DGIdb",
            " database was used to identify known drugs (",
            "Cotto et al., 2018",
            ") that target proteins in our identified interactomes."
        ],
        "lab": [
            false,
            {
                "id": "T32",
                "type": "Dataset",
                "start": 13863,
                "end": 13868,
                "name": "DGIdb"
            },
            false,
            {
                "id": "T33",
                "type": "Creator",
                "start": 13912,
                "end": 13930,
                "name": "Cotto et al., 2018"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The interactome database is described in detail in our previous work (Wangzhou et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Replicates from each COVID-19 patient were pooled to increase sequencing depth."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Due to the higher sequencing depth of the control samples (over 40 million reads), compared to the COVID-19 samples (~7 and 12 million reads after pooling (Xiong et al., 2020b)), and due to specific interest in finding therapeutic targets, only genes identified as differentially expressed and increased in relative abundance in COVID-19 samples were further analyzed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Differentially expressed gene sets from both tools were intersected to identify genes that are differentially expressed in both models, and only genes with read frequency >1 in 200,000 genic reads for COVID-19 samples were retained to reduce potential effects of sampling variance."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Ramilowski et al. (Ramilowski et al., 2015) described 2557 pairs of ligand-receptor interactions that were used to populate the initial interactome database."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In order to curate a more complete ligand-receptor list, we collected gene lists from gene family and ontology databases ",
            "HUGO",
            " (",
            "Yates et al., 2017",
            ") and ",
            "GO",
            " (",
            "Carbon et al., 2009",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T34",
                "type": "Repository",
                "start": 15089,
                "end": 15093,
                "name": "HUGO"
            },
            false,
            {
                "id": "T35",
                "type": "Creator",
                "start": 15095,
                "end": 15113,
                "name": "Yates et al., 2017"
            },
            false,
            {
                "id": "T36",
                "type": "Repository",
                "start": 15119,
                "end": 15121,
                "name": "GO"
            },
            false,
            {
                "id": "T37",
                "type": "Creator",
                "start": 15123,
                "end": 15142,
                "name": "Carbon et al., 2009"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on a database (Szklarczyk et al., 2019) and the literature, corresponding receptors or ligands for these additional genes were identified and added to the list of ligand-receptor pairs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Not all ligands and receptors are encoded as genes, so we included some additional records in our database, such as enzymes known to synthesize ligands and paired with the corresponding receptor."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The entire interactome database is described in detail in (Wangzhou et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While many of these signaling interactions are likely involved in the immune response of COVID-19, we chose to focus on pairs where the ligand or receptor was shown to be differentially increased or discriminative marker for cell types with differentially increased proportions in the immune response since these are more likely to be successful points of therapeutic intervention."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, we filtered the candidate interactome based on the list of differentially expressed genes we obtained from the literature and re-analysis of COVID-19 BALF data (Supplementary Tables 3, 5 and 7)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Potentially relevant gene product – drug interactions (inhibitor, antagonist or blocker) based on these interactomes were mined from the ",
            "dgiDB",
            " database (Supplementary Table 8)."
        ],
        "lab": [
            false,
            {
                "id": "T38",
                "type": "Dataset",
                "start": 16336,
                "end": 16341,
                "name": "dgiDB"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Two of these help rank immune genes: mean expression level in COVID-19 samples, and degree of differential expression (fold change) in COVID-19 versus control BALF (Supplementary Tables 3 and 5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Two other metrics help rank neuronal genes: gene expression levels in sorted mouse DRG neuron datasets (",
            "Liang et al., 2019",
            ") and in mouse DRG neuron scRNA-seq datasets (",
            "Usoskin et al., 2015",
            "), and degree of differential expression (log fold change) in LPS based injury models of mouse airway-innervating neurons (Kaelberer et al., 2020) (Supplementary Tables 4 and 6)."
        ],
        "lab": [
            false,
            {
                "id": "T39",
                "type": "Creator",
                "start": 16676,
                "end": 16694,
                "name": "Liang et al., 2019"
            },
            false,
            {
                "id": "T40",
                "type": "Creator",
                "start": 16740,
                "end": 16760,
                "name": "Usoskin et al., 2015"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The directionality of changes in the LPS mouse injury model may not necessarily be consistent with changes in COVID-19 molecular changes, but are likely to be indicative of genes involved in neuroinflammation in mammalian lungs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To quantify relative gene abundances in (Liang et al., 2019), reported coding gene expressions were renormalized to TPMs across all samples, and samples having a clear bimodal distribution of TPMs were retained for further analysis and quantile normalized, of which the FACS-sorted neuronal datasets are used in our study for integrative analysis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the (",
            "Usoskin et al., 2015",
            ") dataset, the reported fraction of cells for each neuronal subpopulation (where a gene is detected) was used."
        ],
        "lab": [
            false,
            {
                "id": "T41",
                "type": "Creator",
                "start": 17524,
                "end": 17544,
                "name": "Usoskin et al., 2015"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To calculate a similar metric in the (",
            "Kupari et al., 2019",
            ") dataset, two steps were performed."
        ],
        "lab": [
            false,
            {
                "id": "T42",
                "type": "Creator",
                "start": 17693,
                "end": 17712,
                "name": "Kupari et al., 2019"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "•  Predicts interactome to find signaling between nociceptors and COVID-19 patient BALF."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "•  Findings reveal potential interventions to reduce neurogenic inflammation in COVID-19.    •",
            "Shows potential for COVID-19 clinical trial with existing CCL2, CCR5, EGFR inhibitors."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The SARS-CoV-2 virus infects cells of the airway and lungs in humans causing the disease COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Bronchial alveolar lavage fluid (BALF) and plasma from mild and severe cases of COVID-19 have been profiled using protein measurements and bulk and single cell RNA sequencing."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Onset of pneumonia and ARDS can be rapid in COVID-19, suggesting a potential neuronal involvement in pathology and mortality."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We sought to quantify how immune cells might interact with sensory innervation of the lung in COVID-19 using published data from patients, existing RNA sequencing datasets from human dorsal root ganglion neurons and other sources, and a genome-wide ligand-receptor pair database curated for pharmacological interactions relevant for neuro-immune interactions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our findings reveal a landscape of ligand-receptor interactions in the lung caused by SARS-CoV-2 viral infection and point to potential interventions to reduce the burden of neurogenic inflammation in COVID-19 pulmonary disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In particular, our work highlights opportunities for clinical trials with existing or under development rheumatoid arthritis and other (e.g. CCL2, CCR5 or EGFR inhibitors) drugs to treat high risk or severe COVID-19 cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) was identified in Wuhan, China (Li et al., 2020) and named COVID-19 by WHO."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 (coronavirus disease of 2019) has surprisingly caught the global community as of August 10, 2020, the number of COVID-19 cases going to reach twenty million (20,055,196) with over seven hundred thousands (734,536) deaths worldwide (",
            "https://www.worldometers.info/coronavirus/",
            "). ."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "URL",
                "start": 391,
                "end": 433,
                "name": "https://www.worldometers.info/coronavirus/"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Currently, there are no effective medications against COVID-19/SARS-CoV2 although several research groups throughout the world are working to develop the vaccine."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Drug repositioning or reprofiling is a promising strategy to conquer the battle against COVID-19 in a time-critical manner."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Zhou et al (2020) confirmed that SARS-CoV2 uses the same receptor (ACE2) as SARS-CoV, after isolating the BALF (bronchoalveolar lavage fluid) of a COVID-19 patients.et alIn the war against corona, scientists are working on following possible therapeutics measures: one is against the human cell to prevent virus entry or block the signaling pathways required for viral infection and other therapeutics against the virus itself by preventing the virus replication (non-structural proteins) and self-assembly (structural proteins)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Chloroquine, an anti-malarial drug has been shown to have antiviral activity at entry and post-entry stages of the COVID-19 infection (Gao et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In February 2020 Thailand health ministry announced marked progress in COVID-19 treatment with successful use of a cocktail (combined anti-flu drug oseltamivir with anti-HIV lopinavir and ritonavir) against coronavirus (https://www.dawn.com/news/1532081)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The 3-dimensional structure of the ACE2 (",
            "PDB",
            " ID:",
            "1R4L",
            "), SARS-CoV2 spike ectodomain structure (",
            "PDB",
            " ID:",
            "6vyB",
            ") and RdRp (",
            "PDB",
            " ID:",
            "6M71",
            ") were retrieved from ",
            "Protein Data Bank (PDB)",
            " (",
            "Berman et al., 2000",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 1706,
                "end": 1709,
                "name": "PDB"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 1713,
                "end": 1717,
                "name": "1R4L"
            },
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 1758,
                "end": 1761,
                "name": "PDB"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 1765,
                "end": 1769,
                "name": "6vyB"
            },
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 1781,
                "end": 1784,
                "name": "PDB"
            },
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 1788,
                "end": 1792,
                "name": "6M71"
            },
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 1814,
                "end": 1837,
                "name": "Protein Data Bank (PDB)"
            },
            false,
            {
                "id": "T9",
                "type": "Creator",
                "start": 1839,
                "end": 1858,
                "name": "Berman et al., 2000"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T4",
                "end": "T5"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T6",
                "end": "T7"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T9",
                "end": "T3"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T9",
                "end": "T5"
            },
            {
                "id": "R6",
                "bool": true,
                "head": "T9",
                "end": "T7"
            }
        ]
    },
    {
        "sen": [
            "The structure of the ligand; remdesivir (CID: ",
            "121304016",
            "), favipiravir (CID: ",
            "492405",
            "), chloroquine (CID: ",
            "83818",
            ") and SSAA09E2 (CID: ",
            "2738575",
            ") were retrieved from the ",
            "PubChem",
            " database (",
            "https://pusbchem.ncbi.nlm.nih.gov/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T10",
                "type": "AccessionNumber",
                "start": 1907,
                "end": 1916,
                "name": "121304016"
            },
            false,
            {
                "id": "T11",
                "type": "AccessionNumber",
                "start": 1937,
                "end": 1943,
                "name": "492405"
            },
            false,
            {
                "id": "T12",
                "type": "AccessionNumber",
                "start": 1964,
                "end": 1969,
                "name": "83818"
            },
            false,
            {
                "id": "T13",
                "type": "AccessionNumber",
                "start": 1990,
                "end": 1997,
                "name": "2738575"
            },
            false,
            {
                "id": "T14",
                "type": "Repository",
                "start": 2023,
                "end": 2030,
                "name": "PubChem"
            },
            false,
            {
                "id": "T15",
                "type": "URL",
                "start": 2041,
                "end": 2075,
                "name": "https://pusbchem.ncbi.nlm.nih.gov/"
            },
            false
        ],
        "rel": [
            {
                "id": "R7",
                "bool": true,
                "head": "T14",
                "end": "T10"
            },
            {
                "id": "R8",
                "bool": true,
                "head": "T14",
                "end": "T11"
            },
            {
                "id": "R9",
                "bool": true,
                "head": "T14",
                "end": "T12"
            },
            {
                "id": "R10",
                "bool": true,
                "head": "T14",
                "end": "T13"
            },
            {
                "id": "R11",
                "bool": true,
                "head": "T14",
                "end": "T15"
            }
        ]
    },
    {
        "sen": [
            "To find the appropriate binding orientations of the ligand dataset with the respective target automated dockings were performed using AutoDock 4.2 (Norgan et al., 2011) tool following standard protocol."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Molecular dynamic (MD) simulation studies of attractive drug targets of COVID-19 illness, spike protein, RdRp enzyme (Nsp12) and human receptor ACE2 enzyme in the apo and bound state were performed to assess the folding, stability, conformational changes and dynamic behaviors of all the systems."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The strong interaction of both remdesivir and favipiravir with RdRp of SARS-CoV2 suggests a worthy option to treat COVID-19 disease with these existing antiviral medicines."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, RdRp could be an attractive target to stop the COVID-19 illness caused by SARS-CoV2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The outbreak of this COVID-19 epidemic, triggered the researchers all over the world to explore drugs for potential therapeutics of this SARS-CoV2-induced respiratory disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Several drugs such as chloroquine, arbidol, remdesivir, and favipiravir are currently undergoing clinical studies to test their efficacy and safety in the treatment of COVID-19 in China and all across the world; some promising results was achieved in March 2020 and anti-malarial drug chloroquine was confirmed as an active drug in treating coronavirus and  has approved it on March 28, 2020 (Wang et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "an the On June 5, 2020 the investigators from United kingdom recovery trial announced that chloroquine and hydroxychloroquine do not prove promising to reduce the mortality rate of hospitalized COVID-19 patients and results were supported by another solidarity trial, the french discovery trial (https://www.sciencemag.org/news/2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "remdesivir and ravipiravir, are just approved for a clinical trial as a drug to treat COVID-19 (Maxmen, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although promising results were observed with remdesivir and favipiravir and many pharmaceutical companies are launching generic names for these drugs as COVID-19 treatment but to date, we are lacking sufficient pieces of evidence to call any drug as “game-changer”."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similarly, binding of these inhibitors with the ACE2 receptor protein is of significant interest and it is speculated based on these results that virus entry could be stopped by blocking the viral host interaction to cure this COVID-19 illness (Fig. 6",
            "A and B)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Likewise, our results support the computational (Wuet al, 2020) and muticlinical studies (Maxmen, 2020) conducted to find potential therapeutics measures in the war against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The rapid breakout of the coronavirus disease of 2019 (COVID-19) has been declared pandemic with serious global concern due to high morbidity and mortality."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As we enter the phase beyond limitations there is an urgent need for explicit treatment against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A number of multi clinical studies have repurposed combined cocktail (remdesivir + chloroquine and favipiravir + chloroquine) to be effective against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, drug repurposition is an attractive approach with reduced time and cost to treat COVID-19, we don't have enough time as the whole world is lockdown and we are in urgent need of an obvious therapeutics' measures."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Annotation of the 8 newly sequenced genomes MDS2, MDS4, MDS6, MDS11, MDS12, MDS14, MDS15 and MDS16, was performed by comparison with the HCoV−OC43 isolate from Mexico (",
            "Genbank",
            " accession ",
            "KX344031",
            ") [16] using BlastN [17]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 168,
                "end": 175,
                "name": "Genbank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 186,
                "end": 194,
                "name": "KX344031"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "For each of the two datasets, three distantly related bovine coronaviruses served as outgroup and multiple-sequence alignment was built using MUSCLE from SeaView 4.6.4 followed by a manual correction step taking into account protein coding sequences for coding regions [18,19]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These estimates obtained from two different databases were consistent and show that the strains of the clusters 2013 emerged from a common ancestor in 2010.9 and those of 2014 emerged from another in 2011 +/-0.5."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Due to limited HCoV−OC43 full-length genome published in databases, phylogenetic analyses were conducted on S gene sequences."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With the gradual reopening of economies and resumption of social life, robust surveillance mechanisms should be implemented to control the ongoing COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We performed shotgun transcriptome sequencing using RNA extracted from nasopharyngeal swabs of patients with COVID-19, and compared it to targeted SARS-CoV-2 genome amplification and sequencing with respect to virus detection, scalability, and cost-effectiveness."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Conclusions  SARS-CoV-2 whole genome sequencing is a practical, cost-effective, and powerful approach for population-based surveillance and control of viral transmission in the next phase of the COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In December 2019, a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified in Wuhan, China, as the etiologic agent of coronavirus disease (COVID-19); as of May 2020, this virus had spread to more than 187 countries [1,2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The implications of misunderstanding the real dynamics of the COVID-19 pandemic are extremely dangerous."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "GISAID (Global Initiative on Sharing All Influenza Data)",
            " database [20] was accessed on March 18, March 25, March 30, and April 24, 2020 (Table S1 in Multimedia Appendix 1 and Table S2 in Multimedia Appendix 2)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 372,
                "end": 428,
                "name": "GISAID (Global Initiative on Sharing All Influenza Data)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our main analyses compared the March 30 data set with the April 24 data set."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 full genome alignments generated from sequences in ",
            "GISAID",
            " [23] at different time points were analyzed as follows."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 722,
                "end": 728,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, in a new tree inferred just one week later, when more than 135 new full genome sequences were made available on ",
            "GISAID",
            " [23], the direct link between Germany and Italy in Subclade A disappeared due to additional clustering of previously unsampled sequences from Portugal, Brazil, Wales, and the Netherlands (Figure 2b)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 906,
                "end": 912,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As the number of available genome sequences is rapidly growing, SARS-CoV-2 full genome data sets are steadily showing less than 40% unresolved quartets in the center: 38.6% on March 18 (Figure S1c in Multimedia Appendix 3), 32.3% on March 25 (Figure S1d in Multimedia Appendix 3), 28.9% on March 30th (Figure S1e in Multimedia Appendix 3), and 27.6% on April 24 (Figure S1f in Multimedia Appendix 3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The phylogenetic signal is increasing in the global alignment; however, likelihood mapping per country using data from countries reporting the highest numbers of cases (United States, Italy, Spain, Germany, and France) indicates that some local data sets lacked sufficient signals up to March 30, 2020 (Figure S6 in Multimedia Appendix 3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The United States data set comprised mostly sequences collected in Washington State (423/612 genomes, 69.1%)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, while France and Germany also displayed sufficient temporal signals to allow in-depth molecular epidemiology studies, at least in principle, data sets from the United States (3.9-fold increase on April 24 with respect to March 30), the United Kingdom (5.5-fold increase), and Spain (3.9-fold increase), still showed weak or no temporal signals (Figure S10 in Multimedia Appendix 3) despite the substantial increases in the number of available sequences."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "More genome sequences, sampled at different time points and from diverse geographic areas, are becoming available daily; therefore, in-depth Bayesian phylodynamic and phylogeographic analyses of the COVID-19 pandemic will soon be a viable option."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first step that researchers must take before they complete their phylogenetic studies is determining whether the data set is biased in terms of the number of genomes per given location, host, source, etc."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, we did not test for recombination for the SARS-CoV-2 data set, as absence of recombination in the human lineage has previously been shown [41]; however, because coronaviruses are prone to recombination events, this step should be performed as more sequences become available."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We used maximum likelihood–based methods to assess the presence of sufficient information for robust phylogenetic and phylogeographic studies in several SARS-CoV-2 sequence alignments assembled from ",
            "GISAID (Global Initiative on Sharing All Influenza Data)",
            " data released between March and April 2020."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 3373,
                "end": 3429,
                "name": "GISAID (Global Initiative on Sharing All Influenza Data)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although the number of high-quality full genomes is growing daily, and sequence data released in April 2020 contain sufficient phylogenetic information to allow reliable inference of phylogenetic relationships, country-specific SARS-CoV-2 data sets still present severe limitations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At present, a total of 14 full-length genome sequences of 2019-nCoV have been submitted to ",
            "GISAID",
            " and among them only one has been released on ",
            "GenBank",
            " (Accession No: ",
            "MN908947",
            ") (Ji et al., 2020)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 91,
                "end": 97,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 143,
                "end": 150,
                "name": "GenBank"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 166,
                "end": 174,
                "name": "MN908947"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "They selected a series of potential drugs which exist in the market or the self-built database’s high-cost medicinal compounds and medicinal plant sources database compounds."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To date, the SARS-CoV-2 virus causing the coronavirus disease (COVID-19) pandemic is spreading throughout the world."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first COVID-19 case in Finland was a female Chinese tourist in her 30s, who had left Wuhan on 22 January and arrived in Finland on 23 January."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Suspicion of COVID-19 led to her direct transfer to the Lapland Central Hospital in Rovaniemi, where she was isolated and sampled on 28 and 29 January for laboratory confirmation of SARS-CoV-2 infection (Figure 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nearly the complete coding region of SARS-CoV-2 (",
            "GenBank",
            " accession number: ",
            "MT020781",
            ") was sequenced from the NPS collected on Day 4 (Table) and the complete coding region was sequenced from the virus isolate obtained after three passages in Vero E6 cells."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 528,
                "end": 535,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 554,
                "end": 562,
                "name": "MT020781"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "In the early phase of the COVID-19 outbreak, confirmed cases outside China were mostly imported among travellers from Wuhan [7]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As at 17 March 2020, 358 additional laboratory-confirmed cases of COVID-19 have been detected in Finland."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The risk of widespread national community transmission of COVID-19 infection in the European Union, European Economic Area and the United Kingdom in the coming weeks is considered high by the European Centre for Disease Prevention and Control [8]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Current guidelines from the World Health Organization for testing COVID-19 recommend collection of both acute and convalescent serum samples from patients for serological testing, which can support the identification of the immune response to a specific viral pathogen [10]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first case of coronavirus disease (COVID-19) in Finland was confirmed on 29 January 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "From its origin in Wuhan, China, in December 2019, the novel coronavirus disease, COVID‐19, caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) virus, has spread rapidly throughout the world [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In Israel, the first case of the COVID‐19 infection was reported on February 21st, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On March 11th, 2020, the World Health Organization (WHO) declared COVID‐19 disease a global pandemic [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Immediate targeted actions were needed to identify risk factors of COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In particular, the pronounced impact of vitamin D metabolites on the immune system response, and on the development of COVID‐19 infection by the novel SARS‐CoV‐2 virus, has been described [5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, we aimed to determine associations between low plasma 25(OH)D and the risk of COVID‐19 infection and hospitalization, using real‐world Israeli population‐based data."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We hypothesized that the mean plasma level of 25(OH)D would be significantly lower and, accordingly, the rate of suboptimal plasma 25(OH)D levels would be found frequently among persons testing positive for COVID‐19 infection, and among persons subsequently hospitalized, in a large population‐based epidemiological study."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of 14 022 subjects, aged 2 months to 103 years, who were tested for COVID‐19 infection, 1416 (10.1%) had at least one positive result; 12 606 (89.9%) had only negative results (Fig. 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Also for this sample, the proportion of infected individuals was 10.02% (782/7807) for COVID‐19‐positive (COVID‐19‐P), and 7025 (89.98%) for COVID‐19‐negative (COVID‐19‐N; Fig. 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We run an univariate logistic regression analysis, assessing the odds ratio (OR) for COVID‐19 infections and different categories of plasma 25 (OH) D levels (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In a primary univariate analysis, COVID‐19‐P subjects were younger, and more likely to be males and to reside in a lower socioeconomic status (SES) area than were COVID‐19‐N subjects (Table 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The mean plasma 25(OH)D level was significantly lower for COVID‐19‐P subjects (Table 2), and the proportion of individuals with low vitamin D levels was higher (89.90% vs. 84.91%, P < 0.001; Table 3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interestinly, the prevalence of dementia, hypertension, cardiovascular disease and chronic lung disorders was greater among persons who were COVID‐19‐N than those who were COVID‐19‐P (P < 0.05, P < 0.001, P < 0.001, P < 0.001; Table 3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Multivariate analysis, after controlling for the demographic variables, and psychiatric and somatic disorders, demonstrated an independent and significant association between the low 25(OH)D levels and the increased likelihood of COVID‐19 infection [adjusted OR of 1.50 (95% confidence interval (CI): 1.13–1.98, P < 0.001); Fig. 2A]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The risk of COVID‐19 infection was independently positively associated with being male [adjusted OR of 1.49 (95% CI: 1.24–1.79, P < 0.05)], aged older than 50 years [adjusted OR of 1.56 (95% CI: 1.26–1.92, P < 0.05)] and residing in a low–medium SES city or town [adjusted OR of 2.06 (95% CI: 1.65–2.59, P < 0.001)] (Fig. 2B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Independent negative associations were observed between the risk of COVID‐19 infection and having a diagnosis of dementia [adjusted OR of 0.56 (95% CI: 0.32–0.98, P < 0.05], of cardiovascular disease [adjusted OR of 0.59 (95% CI: 0.44–0.79 P < 0.001] and of a chronic lung disorder [adjusted OR of 0.58 (95% CI: 0.42–0.79 P < 0.001] (Table 4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interestingly, the hospitalized COVID‐19‐P individuals were older [58.69 years (95% CI: 54.78‐62.61) vs. 46.88 (95% CI: 46.42–47.35)], and more likely to be male (47.8% vs. 41.3%, P < 0.001) and to reside in a city or town of low–medium SES (73.64% vs. 69.45%, P < 0.001)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In a univariate analysis, a low plasma 25(OH)D level was associated with an increased likelihood of hospitalization for COVID‐19 infection [crude OR of 2.09 (95% CI: 1.01–4.31, P < 0.05)]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, in this analysis, only age over 50 years was statistically significant associated with the likelihood for hospitalization due to COVID‐19 [adjusted OR of 2.71(95% CI: 01.55‐ 4.78, P < 0.001); Table 5 and Fig. 3]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The main finding of this study was the low plasma 25(OH)D level association with COVID‐19 hospitalization as a risk factor, particularly, for patients tested positively for COVID‐19, after adjusting for age, gender, SES and chronic, mental and physical disorders."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hence, low 25(OH)D level was identified as independently associated with the likelihood of COVID‐19 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Notably, a recent study from the UK [31, 32, 33] that included 449 subjects (from the ",
            "UK Biobank",
            ") with confirmed COVID‐19 infection did not find an association between vitamin D metabolite concentration and the risk of viral infections [45] as well as COVID‐19 infection [5, 7, 9, 10, 11, 12, 13, 14, 15, 19, 30, 31, 32, 33, 34, 35, 36, 37, 39, 40, 41, 42, 46]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 4535,
                "end": 4545,
                "name": "UK Biobank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to our analysis, persons with COVID‐19‐P were younger than noninfected ones."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Two‐peak distributions for age groups were demonstrated to confer increased risk for COVID‐19: ages 25 years old and 50 years old (Fig. 4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Other clinical characteristics that were significantly linked to the likelihood of COVID‐19 infection included male gender and low residential SES."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Despite its being discussed as a risk factor in prior publications [47, 48, 49], obesity had not been significantly associated with either an increased risk for COVID‐19 infection or with hospitalization due to COVID‐19 in this study."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Two‐peak age groups as a high risk for COVID‐19: ages 25 and 50 years old (red bars)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This might indeed minimize the risk of COVID‐19 infection in that particular group of patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, in a subset analysis of only COVID‐19‐P subjects, hospitalized patients were significantly older (58.69 vs. 46.88 years)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To conclude, the plasma 25(OH)D level under 20 ng/mL almost doubled the risk for hospitalization due to the COVID‐19 infection in the Israeli studied cohort."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "An additional strength was the analysis of a multitude of variables that may affect the risk of COVID‐19 infection, independent of plasma 25(OH)D levels."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, the major weakness of the study was the retrospective database design."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Data regarding COVID‐19 symptoms and the hospitalization due to COVID‐19 infection, and also adverse clinical outcomes (for example, mechanical ventilation) should be further assessed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, our study found that suboptimal plasma vitamin D levels may be a potential risk factor for COVID‐19 infection, particularly, for the high hospitalization risks, independent of demographic characteristics and medical conditions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The finding is important, since it could guide healthcare systems in identifying populations at risk, and contribute to interventions aimed to reduce the risk of the COVID‐19 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "More studies are required to assess the effects of vitamin D3 supplements on the risk of hospitalizations due to COVID‐19 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We conducted a population‐based study utilizing data from the Leumit Health Services (LHS) database, a large health maintenance organization in Israel that provides services to around 730 000 members nationwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The comprehensive computerized database of LHS is continuously updated with regard to demographics, medical visits, laboratory tests and hospitalizations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The study population included all members of LHS who were tested for COVID‐19 infection during the study period and who had at least one previous test for plasma 25(OH)D level (7807 subjects)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID‐19 testing was done only by physician referral (based on clinical criteria of exposure to confirmed COVID‐19 patients or symptoms suggesting COVID‐19) using the AllplexTM 2019‐nCoV Assay (Seegene Inc., Seoul, Korea) [23]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Data of each subject were collected from the LHS computerized database and included age, gender, SES, weight, height, BMI, current smoking status, psychiatric and somatic comorbidities, and hospitalizations as a result of the COVID‐19 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The aim of this study was to evaluate associations of plasma 25(OH)D levels with the likelihood of coronavirus disease 2019 (COVID‐19) infection and hospitalization."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The study population included the 14 000 members of Leumit Health Services, who were tested for COVID‐19 infection from February 1 st to April 30 th , 2020, and who had at least one previous blood test for the plasma 25(OH)D level."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of 7807 individuals, 782 (10.02%) were COVID‐19‐positive, and 7025 (89.98%) COVID‐19‐negative."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The mean plasma vitamin D level was significantly lower among those who tested positive than negative for COVID‐19 [19.00 ng/mL (95% confidence interval (CI) 18.41–19.59) vs. 20.55 (95% CI: 20.32–20.78)]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Univariate analysis demonstrated an association between the low plasma 25(OH)D level and increased likelihood of COVID‐19 infection [crude odds ratio (OR) of 1.58 (95% CI: 1.24–2.01, P < 0.001)], and of hospitalization due to the SARS‐CoV‐2 virus [crude OR of 2.09 (95% CI: 1.01–4.30, P < 0.05)]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In multivariate analyses that controlled for demographic variables, and psychiatric and somatic disorders, the adjusted OR of COVID‐19 infection [1.45 (95% CI: 1.08–1.95, P < 0.001)] and of hospitalization due to the SARS‐CoV‐2 virus [1.95 (95% CI: 0.98–4.845, P = 0.061)] were preserved."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the multivariate analyses, age over 50 years, male gender and low–medium socioeconomic status were also positively associated with the risk of COVID‐19 infection; age over 50 years was positively associated with the likelihood of hospitalization due to COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We concluded that low plasma 25(OH)D levels appear to be an independent risk factor for COVID‐19 infection and hospitalization."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Vitamin D deficiency is recognized as a significant health concern in which there is heightened interest because of the potential impact on COVID‐19 risk."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In a landmark study involving a large Israeli population, Milana Morgenstern and colleagues found that the plasma level of vitamin D is lower among individuals who have tested positive for COVID‐19 and have been hospitalized."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This indicates that low vitamin D status is an independent risk factor for severe COVID‐19; male gender and low‐medium socioeconomic status were also shown to be positively associated with the risk of infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, age (being > 50 years old) was associated with COVID‐19 hospitalization."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In December 2019, Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was described in Wuhan, China (Guan et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, particulate matter 2.5 μm or less in diameter (PM2.5), particulate matter 10 μm or less in diameter (PM10), sulfur dioxide (SO2), nitrogen dioxide (NO2), carbon monoxide (CO) or ozone (O3) have been also associated with COVID-19 incidence (Bashir et al., 2020b; Fronza et al., 2020; Jiang et al., 2020; Ogen, 2020; Zhu et al., 2020), but it remains unclear if these correlations are actually related to causation (Riccò et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Regarding weather conditions, there are several studies that have been published during recent months reporting negative correlation between temperature and COVID-19 cases (see for example Luo et al., 2020; Pequeno et al., 2020; Wang et al., 2020), humidity and death counts (Ma et al., 2020) or rainfall and new daily cases (Menebo, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "More data is needed to derive more conclusive results and to elucidate the actual impact of ambient factors on COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Daily COVID-19 total cases and cases diagnosed with polymerase chain reaction (PCR) from the autonomous communities and provinces have been obtained from the ",
            "Ministry of Health of Spain (MISAN",
            ", 2020)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Creator",
                "start": 1253,
                "end": 1287,
                "name": "Ministry of Health of Spain (MISAN"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, this approach has been criticized due to the possible bias produced by the rapid expansion of the number of infected by COVID-19 (Baud et al., 2020; Spychalski et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In order to take into account the lockdown effect on the COVID-19 incidence, partial correlation was applied (Ahmadi et al., 2020) correcting by the number of lockdown days."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Taking the different phases of the COVID-19 pandemic in Spain (see Introduction section) into account, we analyzed the pollutants levels in 3 periods: prior to lockdown (January 23rd to March 13th, 50 days), strict lockdown (March 14th to May 3rd, 50 days) and relaxed lockdown (May 4th to June 20th, 47 days)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There are previous studies that associate temperature, solar radiation, wind speed or rainfall with COVID-19 cases or deaths in different regions (Bashir et al., 2020a; Guasp et al., 2020; Kifer et al., 2020; Liu et al., 2020; Luo et al., 2020; Pequeno et al., 2020; Rosario et al., 2020; Tosepu et al., 2020; Wang et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As can be observed, correlations among wind speed and rainfall with cases are very heterogeneous and non-significant for most of the Spanish communities, indicating that these variables were not correlated with the COVID-19 incidence in Spain."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, when we calculated partial correlations between temperature, solar radiation and daily detected COVID-19 cases controlling the influence of the lockdown (Table 3",
            "), correlation coefficients were low and non-significant for most of the communities."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These results indicate that although temperature and solar radiation may have a role in COVID-19 incidence, they are not the main factors and long-term data is required in order to have conclusive results."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this context, large efforts have been made to develop software tools to collect COVID-19 global pandemic data, like the dashboard developed by the John Hopkins University (Dong et al., 2020) or HealthMap (Xu et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also used DatAC to explore the relationship between meteorological variables and the amount of daily COVID-19 cases, finding heterogeneous and non-significant correlation for wind speed and rainfall, but large and significant negative correlation for temperature and solar radiation in almost all Spanish communities."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These results indicate that lockdown, and not temperature nor solar radiation, was the driving factor of the COVID-19 pandemic evolution in Spain."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The coronavirus disease 2019 (COVID-19) pandemic has caused an unprecedented global health crisis, with several countries imposing lockdowns to control the coronavirus spread."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Data with spatial and temporal information is a key factor to get reliable results and, although there are some data repositories for monitoring the disease both globally and locally, an application that integrates and aggregates data from meteorological and air quality variables with COVID-19 information has not been described so far to the best of our knowledge."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we present ",
            "DatAC (Data Against COVID-19)",
            ", a data fusion project with an interactive web frontend that integrates COVID-19 and environmental data in Spain."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 4258,
                "end": 4287,
                "name": "DatAC (Data Against COVID-19)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, the application allowed us to analyze correlations among climate factors, such as ambient temperature, and the incidence of COVID-19 in Spain."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease (COVID-19) is a pandemic manifesting respiratory illness and first reported in Wuhan, Hubei province of China in December 2019."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The virus causing COVID-19 is named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All available sequences (320 whole genome and surface glycoprotein amino acid sequences of SARS-CoV-2) related to the COVID-19 pandemic were retrieved from ",
            "NCBI Virus Variation Resource",
            " repository (",
            "https://www.ncbi.nlm.nih.gov/labs/virus/",
            ")",
            "The ",
            "NCBI",
            " reference sequence of SARS-CoV-2 S glycoprotein, accession number ",
            "YP_009724390",
            " was used as the canonical sequence for the analyses of spike protein variants."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 405,
                "end": 434,
                "name": "NCBI Virus Variation Resource"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 447,
                "end": 487,
                "name": "https://www.ncbi.nlm.nih.gov/labs/virus/"
            },
            false,
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 493,
                "end": 497,
                "name": "NCBI"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 564,
                "end": 576,
                "name": "YP_009724390"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "For multiple sequence alignment (MSA), Genome Detective Coronavirus Typing Tool uses a reference dataset of 431 whole genome sequences (WGS) where 386 WGS were from known nine coronavirus species."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The dataset was then aligned with MUSCLE (Edgar, 2004)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Tree structure was validated by running the analysis on 1000 bootstraps (Efron et al., 1996) replications dataset and the evolutionary distances were calculated using the Poisson correction method (Zuckerkandl and Pauling, 1965)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Variant sequences of SARS-CoV-2 were modeled in Swiss-Model (Andrew et al., 2018) using the Cryo-EM spike protein structure of SARS-CoV-2 (",
            "PDB",
            " ID ",
            "6VSB",
            "; (Wrapp et al., 2020)) as a template."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 1278,
                "end": 1281,
                "name": "PDB"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 1285,
                "end": 1289,
                "name": "6VSB"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "The superposition showed that most of the residual change was causing incorporation of bulky amino acid residues (T29I, H49Y, L54F, S221W, A348T, H519Q, A520S, A930V, D936Y, and A1078V) in place of smaller sized residues except for Y28N, D111N, R408I, D614G, and F797C (Fig. 4 B—P)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 is one of the most contagious pandemics the world has ever had with 1,250,000 confirmed cases to date (April 4, 2020) and the cases have increased as high as 5 times in less than a month (WHO (World Health Organization), 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of 19 May 2020, the coronavirus SARS-CoV-2 that causes the severe acute respiratory syndrome COVID-19 was reported to have infected over 5 million people and killed over 320 000 people around the world [1, 2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Large cohort studies such as the ",
            "UK Biobank (UKB)",
            ", which have gathered detailed epidemiological, medical and genetic records of hundreds of thousands of people, offer the opportunity to uncover risk factors for COVID-19, including the molecular genetic pathways underlying severe disease."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 246,
                "end": 262,
                "name": "UK Biobank (UKB)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The cohort is a particularly appropriate focus for the study of COVID-19, because incidence of this severe disease increases with age [1, 4–10]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Emergency ICD-10 codes for COVID-19 have been assigned (U07.1 COVID-19, virus identified; U07.2 COVID-19, virus not identified; https://www.who.int/classifications/icd/COVID-19-coding-icd10.pdf)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, there are limitations to these data for studying infection, as coding occurs in local National Health Service (NHS) Hospital Trusts, with subsequent central collation by the NHS and periodic (currently monthly) incorporation of summaries into ",
            "UKB",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 1095,
                "end": 1098,
                "name": "UKB"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Public Health England (PHE) microbiology database ",
            "SGSS (Second Generation Surveillance System)",
            " offers advantages over HES data for the ascertainment of infection in ",
            "UKB",
            " participants, because it provides more granular and highly specific diagnosis of microbiological confirmed infection, including both COVID-19 and infections caused by micro-organisms with antimicrobial resistance (AMR)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 1154,
                "end": 1198,
                "name": "SGSS (Second Generation Surveillance System)"
            },
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 1269,
                "end": 1272,
                "name": "UKB"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of note, it only allows identification of microbiologically confirmed disease; in the case of COVID-19, other databases with a more clinical focus also exist, such as the ",
            "PHE COVID-19 Hospitalization in England Surveillance System (CHESS)",
            " and ",
            "Intensive Care National Audit and Research Centre (ICNARC)",
            " databases containing individual patient data on critically ill patients in intensive care units."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 1664,
                "end": 1731,
                "name": "PHE COVID-19 Hospitalization in England Surveillance System (CHESS)"
            },
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 1736,
                "end": 1794,
                "name": "Intensive Care National Audit and Research Centre (ICNARC)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "SGSS",
            " database provides coverage of English ",
            "UKB",
            " participants, who make up 89 % of the cohort based on residence at the time of recruitment."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Dataset",
                "start": 1896,
                "end": 1900,
                "name": "SGSS"
            },
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 1939,
                "end": 1942,
                "name": "UKB"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There are specific challenges that arise when frequently linking data between the large ",
            "SGSS",
            " and ",
            "UKB",
            " participant databases."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Dataset",
                "start": 2123,
                "end": 2127,
                "name": "SGSS"
            },
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 2132,
                "end": 2135,
                "name": "UKB"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "(2) Periodically, the agent updates a database held at PHE Colindale with any new records from ",
            "SGSS",
            " that it matches with ",
            "UKB",
            " participants."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Dataset",
                "start": 2254,
                "end": 2258,
                "name": "SGSS"
            },
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 2280,
                "end": 2283,
                "name": "UKB"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We have tested this system by collecting bacteriology samples in the John Radcliffe Hospital, Oxford, prior to proposed England-wide deployment, although it could also be applied to COVID-19 samples."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The number of new cases of COVID-19 inpatients recorded in ",
            "SGSS",
            " has increased rapidly since early 2020, with close correspondence between the growth in cases among ",
            "UKB",
            " participants and England as a whole (Fig. 4)."
        ],
        "lab": [
            false,
            {
                "id": "T13",
                "type": "Dataset",
                "start": 2557,
                "end": 2561,
                "name": "SGSS"
            },
            false,
            {
                "id": "T14",
                "type": "Repository",
                "start": 2662,
                "end": 2665,
                "name": "UKB"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, ",
            "UKB",
            " participants made up 0.9 % of all COVID-19 inpatients in ",
            "SGSS",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T15",
                "type": "Repository",
                "start": 2718,
                "end": 2721,
                "name": "UKB"
            },
            false,
            {
                "id": "T16",
                "type": "Dataset",
                "start": 2779,
                "end": 2783,
                "name": "SGSS"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We estimated per capita incidence of our operational definition of severe COVID-19 for the period 16 March – 14 May 2020 using ",
            "SGSS",
            " data, not restricted to ",
            "UKB",
            " participants (Fig. 5a)."
        ],
        "lab": [
            false,
            {
                "id": "T17",
                "type": "Dataset",
                "start": 2912,
                "end": 2916,
                "name": "SGSS"
            },
            false,
            {
                "id": "T18",
                "type": "Repository",
                "start": 2941,
                "end": 2944,
                "name": "UKB"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In keeping with other reports (see Introduction), males over 50 were generally at elevated risk of developing severe COVID-19 across England (odds ratio 1.41, 95 % CI 1.39–1.43; Cochran–Mantel–Haenszel test stratified by age group), relative to females over 50."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Taking these differences into account using the age and sex distribution of the English ",
            "UKB",
            " cohort in early 2020 and the Office for National Statistics estimates of the English population from mid-2018 (https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/datasets/populationestimatesforukenglandandwalesscotlandandnorthernireland), we compared disease incidence in ",
            "UKB",
            " versus the general population."
        ],
        "lab": [
            false,
            {
                "id": "T19",
                "type": "Repository",
                "start": 3319,
                "end": 3322,
                "name": "UKB"
            },
            false,
            {
                "id": "T20",
                "type": "Repository",
                "start": 3639,
                "end": 3642,
                "name": "UKB"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Even taking into account this difference, the relative incidence of severe COVID-19 by age and sex was not identical between non-",
            "UKB",
            " inpatients and ",
            "UKB",
            " inpatients (P=0.005 females, P=0.0005 males, chi-square goodness-of-fit tests; Fig. 5b, c)."
        ],
        "lab": [
            false,
            {
                "id": "T21",
                "type": "Repository",
                "start": 3803,
                "end": 3806,
                "name": "UKB"
            },
            false,
            {
                "id": "T22",
                "type": "Repository",
                "start": 3822,
                "end": 3825,
                "name": "UKB"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In conclusion, incidence of severe COVID-19 by age and sex is similar but not identical between the English ",
            "UKB",
            " cohort and the rest of the population, with 27.4 % fewer positive inpatients than expected."
        ],
        "lab": [
            false,
            {
                "id": "T23",
                "type": "Repository",
                "start": 4026,
                "end": 4029,
                "name": "UKB"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We investigated the robustness of our method of identifying hospital inpatients, on which we base the definition of severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Fig. 6 indicates that the alternative definition (grey bars) may be more specific, because the odds ratios of severe COVID-19 were larger (further from 1) than under the proposed definition."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We conclude that greater sensitivity of the proposed definition (green bars) trades off some specificity compared to a more stringent alternative and, therefore, modestly dilutes the magnitude of age- and sex-specific differences in severe COVID-19 incidence."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our calculations do not take into consideration boosts in power that can be achieved by various means, including pooling the effects of multiple variants within or between genes using analyses of various kinds [17] or meta-analysis of the sort planned by the ",
            "COVID-19 Host Genetics Initiative",
            " (",
            "www.covid19hg.org",
            "), which aims to combine signals across multiple cohorts."
        ],
        "lab": [
            false,
            {
                "id": "T24",
                "type": "Repository",
                "start": 4965,
                "end": 4998,
                "name": "COVID-19 Host Genetics Initiative"
            },
            false,
            {
                "id": "T25",
                "type": "URL",
                "start": 5000,
                "end": 5017,
                "name": "www.covid19hg.org"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T24",
                "end": "T25"
            }
        ]
    },
    {
        "sen": [
            "Public Health England’s ",
            "Second Generation Surveillance System",
            " is a centralized microbiology database covering English clinical diagnostics laboratories that provides national surveillance of legally notifiable infections, bacterial isolations and antimicrobial resistance."
        ],
        "lab": [
            false,
            {
                "id": "T26",
                "type": "Dataset",
                "start": 5099,
                "end": 5136,
                "name": "Second Generation Surveillance System"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, we implemented rapid dynamic linkage, which allows us to provide a regular feed of new COVID-19 (SARS-CoV-2) test results to ",
            "UKB",
            " to facilitate rapid and urgent research into the epidemiological and human genetic risk factors for severe infection in the cohort."
        ],
        "lab": [
            false,
            {
                "id": "T27",
                "type": "Repository",
                "start": 5488,
                "end": 5491,
                "name": "UKB"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we have characterized the first 1352 cases of COVID-19 in ",
            "UKB",
            " participants, of whom 895 met our working definition of severe COVID-19 as inpatients hospitalized on or after 16 March 2020."
        ],
        "lab": [
            false,
            {
                "id": "T28",
                "type": "Repository",
                "start": 5688,
                "end": 5691,
                "name": "UKB"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We found that the incidence of severe COVID-19 among ",
            "UKB",
            " cases was 27.4 % lower than the general population in England, although this difference varied significantly by age and sex."
        ],
        "lab": [
            false,
            {
                "id": "T29",
                "type": "Repository",
                "start": 5871,
                "end": 5874,
                "name": "UKB"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The remaining data were then aligned to the local nucleotide database (using Burrows-Wheeler Alignment) and non-redundant protein database (using RapSearch), downloaded from the ",
            "US National Center for Biotechnology Information",
            " website, which contain only coronaviruses that have been published."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 178,
                "end": 226,
                "name": "US National Center for Biotechnology Information"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Mapped assemblies were also done using the bat-derived SARS-like coronavirus isolate bat-SL-CoVZC45 (accession number ",
            "MG772933.1",
            ") as a reference."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 413,
                "end": 423,
                "name": "MG772933.1"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "After removing host (human) reads, de novo assembly was done and the contigs obtained used as queries to search the non-redundant protein database."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A Blastn search of the complete genomes of 2019-nCoV revealed that the most closely related viruses available on ",
            "GenBank",
            " were bat-SL-CoVZC45 (sequence identity 87·99%; query coverage 99%) and another SARS-like betacoronavirus of bat origin, bat-SL-CoVZXC21 (accession number ",
            "MG772934",
            "; 87·23%; query coverage 98%)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 702,
                "end": 709,
                "name": "GenBank"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 864,
                "end": 872,
                "name": "MG772934"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "The subgenus Sarbecovirus could be classified into three well supported clades: two SARS-CoV-related strains from Rhinolophus sp from Bulgaria (accession number ",
            "GU190215",
            ") and Kenya (",
            "KY352407",
            ") formed clade 1; the ten 2019-nCoV from Wuhan and the two bat-derived SARS-like strains from Zhoushan in eastern China (bat-SL-CoVZC45 and bat-SL-CoVZXC21) formed clade 2, which was notable for the long branch separating the human and bat viruses; and SARS-CoV strains from humans and many genetically similar SARS-like coronaviruses from bats collected from southwestern China formed clade 3, with bat-derived coronaviruses also falling in the basal positions (figure 3)."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 1064,
                "end": 1072,
                "name": "GU190215"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 1085,
                "end": 1093,
                "name": "KY352407"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The three-dimensional structure of 2019-nCoV receptor-binding domain was modelled using the Swiss-Model program with the SARS-CoV receptor-binding domain structure (",
            "Protein Data Bank",
            " ID ",
            "2DD8",
            ") as a template."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 1732,
                "end": 1749,
                "name": "Protein Data Bank"
            },
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 1753,
                "end": 1757,
                "name": "2DD8"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T7",
                "end": "T8"
            }
        ]
    },
    {
        "sen": [
            "Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), causative agent of Coronavirus Disease 19 (COVID-19), has spread throughout the world since its first emergence in Dec. 2019 in Wuhan, China."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, a report from ",
            "COVID-19 Genomics UK Consortium",
            "(Report #9 - 25th June 2020) showed G614 virus has grown 1.22 times faster than the D614, but the statistical significance was low, indicating the role of other factors such as mutations in other genes."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 227,
                "end": 258,
                "name": "COVID-19 Genomics UK Consortium"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By the end of June 2020, 91.5% of patients from the U.S. had the D614G mutation (compared to Wuhan-Hu-1 isolate, ",
            "GenBank",
            " ID ",
            "NC_045512.2",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 574,
                "end": 581,
                "name": "GenBank"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 585,
                "end": 596,
                "name": "NC_045512.2"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "Editor —The coronavirus disease 2019 (COVID-19), associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread rapidly since the early cases identified in Wuhan, China."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There were more than 16 341 920 laboratory-confirmed COVID-19 cases worldwide and 87 245 cases in China as of July 28, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            " Among the latter, 19% were severe or critically ill patients who required some form of respiratory support as a result of hypoxaemia or respiratory failure."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Considering the potential of the COVID-19 pandemic to overwhelm healthcare systems, even in developed countries, there is a need to identify subgroups requiring different respiratory support techniques, and those requiring prolonged hospital admission, to inform service provision, allocate scarce medical resources appropriately, and maximise treatment benefits."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Previous studies have reported that older age and male sex were risk factors for poor prognosis in COVID-19 patients, with limited information about the need for respiratory support."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            " A recent study found high levels of respiratory complications in COVID-19 patients requiring surgery, with an associated high mortality."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We retrospectively reviewed demographic and clinical data available from electronic medical records at a branch of ",
            "Tongji Hospital",
            " (Wuhan, China), a 1050 bed hospital designated for severe and critically ill COVID-19 patients."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Creator",
                "start": 1283,
                "end": 1298,
                "name": "Tongji Hospital"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Diagnosis and treatment of COVID-19 were performed according to the protocol released by China's National Health Commission."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since the outbreak of COVID-19, the Chinese National Health Commission has published and updated ‘Chinese Clinical Guidance for COVID-19 Pneumonia Diagnosis and Treatment’."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 1792 patients hospitalised with COVID-19 between January 27, 2020 and April 20, 2020 were consecutively included."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A strength of the current study is the size of the cohort of COVID-19 patients requiring respiratory support."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our findings could be a useful supplement to previous studies of morbidity and mortality from COVID-19,",
            ",",
            ",",
            " to help inform allocation of scarce healthcare resources (especially respiratory support) and mitigation of adverse effects of the COVID-19 pandemic in other countries."
        ],
        "lab": [
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A third of patients with COVID-19 had abnormal pulmonary function at the time of hospital discharge with a higher percentage in older patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our results are consistent with the findings of a previous study in which 84.2% of severe cases with COVID-19 were discharged with impairment of diffusion capacity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Future studies to address persistent impairment of pulmonary function after COVID-19 and the impact of age are warranted."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is clear that health and social care provision, for both acute care and post-COVID-19 management, may need to be realigned."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Understanding the factors that impact on research in global challenges such as COVID-19 is important when good quality clinical guidance is urgently needed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since then, the coronavirus disease 19 (COVID-19) has rapidly spread across all continents, becoming a public health emergency (pandemic) as announced by World Health Organization (WHO) in early 2020 [21]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The main COVID-19 symptoms are fever and cough, but other conditions such as anosmia, cardiovascular and GI disorders have been increasingly reported, thus suggesting the presence of multiple targets of infection outside the respiratory tract [9,11,23]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, COVID-19 has been reported to be particularly more severe in patients with comorbidities unrelated to the respiratory tract, such as hypertension, diabetes and cardiovascular disease [24–27]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "(2) The digestive system, heart, kidneys, respiratory system and peripheral neurons are tissues/cells where SARS-CoV-2 might infect, generating different symptoms observable in COVID-19 patients [31,32,90,142,196,250–252]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Taking into consideration the high similarity between SARS-CoV and SARS-CoV-2, in regard to sequence conservation and structure of glycoproteins (Walls et al. 2020; Hoffmann et al. 2020,) and that SARS-CoV leads to the down-regulation of ACE2 [33], a recent study has suggested that this particular interaction may also occur in COVID-19 [34], thus promoting membrane fusion and SARS-CoV-2 entry into host cells."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, the identification of the transmembrane glycoprotein CD147 [41] as well as the presence of furin-like cleavage sites in the spike (S) protein (absent for other SARS-CoVs) [42] might be associated to viral–host mechanisms of invasion and pathogenicity of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As they lose ACE2-mediated protection, Ang-II signaling contributes to the pathological findings observed in COVID-19 patients, such as disseminated coagulopathy and acute tissue damage [91]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A number of cytokines, including IL-6, IL-1β, tumor necrosis factor α (TNF-α) and IFN-γ, have been frequently reported to be elevated in COVID-19 [9,51]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "CRS is believed to be a major cause of tissue damage in the pathophysiology of COVID-19 [52]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "IL-6, the most important CRS causative cytokine [55], was found to be increased in the serum of COVID-19 patients presenting acute respiratory distress syndrome (ARDS) [56]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Certain cytokines whose levels are elevated in COVID-19 patients (i.e. IL-6, IL-1β and IFN-γ), are important activators of the Janus kinase (JAK)/signal transducer of activators of transcription (STAT) JAK/STAT pathway and also able to induce NF-kB signaling [57]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "IL-6, an important player in COVID-19, binds IL-6R and gp130 receptors to activate JAK/STAT-3 pathway and then contribute to the CRS observed in COVID-19 patients [88]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among them, the p38s have already been described to be involved in SARS-CoV infection and, therefore, suggested as putative targets for COVID-19 treatment [68,69]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Taken together, we strongly believe that understanding the multitude of signaling routes affected by viral infections, in a cell/tissue-specific manner, can be crucial for the comprehension of the pathobiology as well as the therapeutics for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Accordingly, symptoms related to all these systems have been reported in COVID-19 patients [9]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The main clinical complication due to COVID-19, which also leads to a high fatality rate and affects ∼42% of the patients, refers to the ARDS [11]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 patients affected by ARDS develop a severe form of this condition (i.e. PaO2/FiO2 ratio < 100 mmHg) in 18.9% of the cases [90]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In COVID-19-associated ARDS, the cytokine storm consisting of high serum levels of IL-1β, TNF and IL-6 is possibly responsible by severe plasma leakage, vascular permeability and disseminated coagulation and thrombosis [9,57]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Even though TLRs are crucial for correct viral defense, the constitutive TLR signaling, particularly due to TLR4 [108], might contribute to an excessive inflammation in COVID-19-associated ARDS (Figure 4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "TLR4 polymorphism and dysregulation of associated pathway, could be potentially correlated with COVID-19-mediated suppression of IFN antiviral response in severe patients [110] and then contribute to excessive lung inflammation at later stages."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "TLR4 polymorphism might explain the differential susceptibility to ARDS in COVID-19 patients [106]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Cytokines that are commonly elevated in COVID-19 (such as TNF and IL-1β) can activate NF-κB-mediated gene expression in immune, bronchial epithelial and other lung cells [114]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The use of non-steroidal anti-inflammatory drugs or synthetic corticoids in COVID-19 treatment is still under debate, since NF-kB inhibition must be taken with caution, due to its vital role to elicit antiviral related gene expression [115]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Upon further data validation, IL-6 and STAT3 could serve as promising therapeutic options for preventing the progressive severity of COVID-19-associated ARDS."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Altogether, a controlled approach to modulate NLPR3 levels and activity could be used as a potential target against ARDS in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nevertheless, GI manifestations seem to be less prevalent in COVID-19 than SARS and MERS [140]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, it has been assumed that the consumption of animal food from a public market at Wuhan, was responsible by the appearance of the first case of COVID-19 in China [24]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This relationship, recognized as the gut–lung axis, may help explain the progression and outcome of the digestive and respiratory symptoms in some COVID-19 patients [153,154]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The reduced expression of ACE2 and B0AT1 in the intestine due to virus invasion, leading to low tryptophan availability, represents a possible mechanism of how SARS-CoV-2 could lead to digestive symptoms in COVID-19 patients [151]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nevertheless, the mechanisms involved in most of these SARS-CoV2-mediated events are still speculative, so more detailed research is required to help better understanding the temporal and prognostic profiles of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patients tested positive for COVID-19 present clinical respiratory symptoms related to viral infection, which include fever, cough and myalgia [9]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Symptoms affecting both peripheral (PNS) and CNS, nervous systems have been reported in ∼36% of COVID-19 patients, such as headache, acute cerebral diseases, impaired consciousness, seizure, smell/taste impairment, muscle injury and neuralgia [27,163,164]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Some authors have suggested that the lack of SARS-CoV-2 in the CSF of COVID-19 patients could be mainly related to (i) the low sensitivity of the techniques available, (ii) the reduced viral levels or (iii) clearance of SARS-CoV-2 in the CSF compartment [170]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on these current findings, further studies are still necessary to better elucidate this detection of SARS-CoV-2 in the CSF, especially in large cohorts of positive COVID-19 individuals."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The consequent damage on the olfactory endothelium is part of the clinical symptoms presented by COVID-19 patients, particularly related to the PNS, such as anosmia or hyposmia [27,166]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interestingly, some positive COVID-19 patients have been reported to present paranasal sinusitis with the presence of lymph endothelial cells infected by SARS-CoV-2 [181,182]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among the theories suggested for viral neuroinvasion (neuronal retrograde/hematogenous/glymplatic routes), the one regarding synapse-connected route is also related to the trans-synaptic exchange of coronavirus particles from peripheral nerves (innervating infected target-tissues), by which the interneuronal transfer of SARS-CoV-2 may occur, that in turn could reach and cause dysfunction of relevant homeostatic brainstem centers, as observed in COVID-19 [183,184]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Considering the presence of neurological manifestations (as described in previous studies), the indicative of brain injury in postmortem analysis [185] and the controversial aspects of SARS-CoV-2 detection in CSF, a recent study has presented neurochemical evidence of brain injury in severe positive COVID-19 patients [186]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By using two classical blood-based biomarkers for CNS injury, the glial fibrillary acidic protein (GFAp) and neurofilament light chain (NfL), it has been shown that moderate/severe COVID-19 patients present significantly higher plasma levels of both biomarkers [186]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Despite the limitations (including further data validation), these data suggest the existence of astrocytic activation/damage at the beginning of the disease (initial response/higher levels of GFAp), as well as neuronal damage at later stages of a severe condition (illness progression/higher levels of NfL) in COVID-19 patients [186]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nevertheless, despite the current advances in elucidating the mechanisms of SARS-CoV-2 invasion, the clinical symptoms regarding nervous system and their similarity to the other members of the β-coronaviruses, little is known about the nervous system signaling pathways affected in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since RAS has a relevant role in the regulation of brain homeostasis functions, such as modulation of water balance and blood pressure [187], the possible increase in Ang-II levels may be related to the development of severe cases presenting neurological manifestations (i.e. encephalitis and meningitis), as well as in cardiac and lung injuries in some severe COVID-19 patients [27,69,171]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, since some COVID-19 patients also present apoptosis of endothelial cells, these biological effects might be related to the elevated activity of MAPK signaling [69,180]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With regard to acute cerebral diseases, such as ischemic stroke and cerebral hemorrhage, which are detected in positive COVID-19 patients [27], ACE2 may also play an important role, since has been associated with damage along the brain endothelium (vascular injury) [171]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, COVID-19 patients with neurological manifestations may develop immunosuppression and elevated levels of D-dimer (a marker for venous thromboembolism) which are associated with a poor prognosis [27,188]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interesting, patients with severe COVID-19 may also present a prominent increase in cytokine release (hypercytokinemia) [9,189] that, in the context of the nervous system, can potentially compromise its homeostasis [61]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition to the neurological manifestations described for the CNS, the PNS also appears to be affected by COVID-19, since patients have presented smell and/or taste impairments, as well as complications due to the large amount of cytokines released systemically in the face of infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Koralnik and Tyler [190] described that COVID-19 positive patients developed Guillain–Barre syndrome (GBS) after the onset of viral infection, as an immune mediated complication of SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, electrophysiological studies performed in these GSB/COVID-19 patients have indicated a pattern compatible with demyelination process and axonal neuropathy, even without any positive detection of SARS-CoV-2 by RT-PCR in the CSF [191]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Despite the low cohort patients analyzed in this study, the authors highlight the necessity of better epidemiological data and further associations between immune diseases and COVID-19, which can promote a better understanding regarding possible pathogenic mechanisms and therapies [190]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In fact, patients with CV conditions have presented a case fatality rate of 10.5%, which is higher than the the overall COVID-19 cases (i.e. fatality rate of 2.3%) [195]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to a report from the National Health Commission of China, ∼12% of patients hospitalized due to COVID-19, without history of CV diseases, have presented elevated troponin levels and a high incidence of cardiac arrest during hospitalization, indicating that not only CV diseases could be a risk factor for COVID-19 but the presence of SARS-CoV-2 could also promote myocardial injury [196]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The impact of the CV diseases in severe COVID-19 patients has been clearly demonstrated by a recent study that compared non-surviving and surviving COVID-19 patients [180], in which 52% of the deceased patients presented heart failure, whereas only 12% of the survivors presented the same symptoms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Another study has shown that out of 68 patients who died from COVID-19, 13 had previous CV diseases while none of the 82 patients who survived presented a history of CV condition [197]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Despite the evidence, it is still unclear why cardiovascular diseases are so prevalent among the fatalities from COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to the evaluation of 150 COVID-19 cases identified in Wuhan, the troponin levels in the serum of non-surviving patients were higher than in patients who recovered from the disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, plaque rupture, ischemia or vasospasm have also been considered as potential causes of CV disease induced by a COVID-19 inflammatory response."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Despite the fact that further research in vivo still needs to be assessed, this mechanism could be useful as a target toward the treatment of COVID-19 and CV disease patients, since it would potentially alleviate an inflammatory response [199]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In fact, a number of arguments have been raised in regard to the use and cessation of these drugs during COVID-19 treatment in these patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, given the lack of evidence of their benefit (or harm) for therapeutic use in COVID-19, physicians should properly access patients’ concerns and evaluate their medical history in other to keep or suspend the prescription for COVID-19 patients with CV conditions [198]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although an early study has not identified any cases of acute kidney injury (AKI) in a cohort of 116 COVID-19 patients from Wuhan area [209], clinical reports have largely supported the association of SARS-CoV-2 infection with kidney conditions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to a large study including 701 COVID-19 patients, the most frequent finding related to kidney dysfunction was mild to moderate proteinuria (43.9%), possibly due to the disruption of glomerular filtration, while 26.7% of patients exhibited hematuria [210]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Another report focusing on 113 non-surviving COVID-19 patients pointed out that AKI was highly associated with increased mortality [212]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Another study that reviewed records from 13 academic and community hospitals in metropolitan New York, found that AKI was reported in 36.6% of the admitted COVID-19 patients, particularly in patients with respiratory failure who required mechanical ventilation (89% of the cases) [213]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Autopsy findings have demonstrated prominent acute proximal tubular injury, peritubular erythrocyte aggregation and glomerular fibrin thrombi in the kidneys of Chinese COVID-19 patients [214]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Several pathophysiological mechanisms have been proposed for the renal injuries observed in COVID-19, including organ-crosstalk and systemic-wide effects."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similarly, a heart–kidney cross-talk may also be considered as a contributor of AKI in COVID-19 patients, since cardiomyopathy and acute viral myocarditis can equally contribute to renal hypoperfusion, thus leading to a reduction in the glomerular filtration rate [218]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is worth considering that in a study with 1099 COVID-19 patients, septic shock was present in 6.4% of severe cases [223], raising the possibility that, for a subset of patients, intrarenal inflammation may be partially responsible for the association of AKI to more severe cases of COVID-19 [224]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These reports support a direct pathophysiological mechanism for the kidney damage due to COVID-19, following SARS-CoV-2 entry via ACE2 receptor [9]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "No effective treatment for COVID-19 has been discovered so far."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "(1) Commercially available angiotensin-II receptor antagonists, such as losartan and derivates, could act by mitigating the deleterious effects of AT1R activation in COVID-19 [229]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "(2) Blockage of RAS can prevent tissue damage in COVID-19 patients [229]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interleukin-6 (IL-6) is one of the major cytokines involved in COVID-19 progression, which leads to CRS and tissue damage due to severe inflammation [51]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Currently, most of the proposed drugs for COVID-19 treatment are (i) ACE inhibitors, (ii) blockers of Angiotensin II production, and (iii) blockers/antagonists of AT1R (Angiotensin II target) such as Losartan and derivatives [229]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These molecules counteract the effects of the classical renin-angiotensin system, thus acting as putative therapeutic targets to regulate the increased activation of RAS in COVID-19 [229]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to one double-blind, randomized, placebo-controlled trial, which encompassed a total of 1063 mild COVID-19 patients, Remdesivir provided very positive effects by shortening the time to recovery [238]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Favipiravir is another example of potential drug that can also inhibit viral replication in COVID-19 [239,240]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The humanized anti-IL-6 monoclonal antibody Tocilizumab has been empirically used in patients with severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, Tocilizumab has also been shown to induce liver injury in, at least, one COVID-19 patient [243]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "JAK inhibition has also been considered as a potential therapeutic approach for COVID-19, since a variety of molecules (known to be elevated in COVID-19 patients) signal JAK/STAT pathways."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Likewise, this drug is under clinical trial in COVID-19 since it may potentially reduce the cytokine storm in infected tissues, particularly the lungs [59,246,247]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The highly infective coronavirus disease 19 (COVID-19) is caused by a novel strain of coronaviruses – the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – discovered in December 2019 in the city of Wuhan (Hubei Province, China)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Remarkably, COVID-19 has rapidly spread across all continents and turned into a public health emergency, which was ultimately declared as a pandemic by the World Health Organization (WHO) in early 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although the mechanistic features underlying the COVID-19 progression have not been fully clarified, current evidence have suggested that SARS-CoV-2 may primarily behave as other β-coronavirus members."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To better understand the development and transmission of COVID-19, unveiling the signaling pathways that may be impacted by SARS-CoV-2 infection, at the molecular and cellular levels, is of crucial importance."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, the potential involvement of these signaling pathways in evoking the onset and progression of COVID-19 symptoms in these organ systems are presently discussed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A brief description of future perspectives related to potential COVID-19 treatments is also highlighted."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 is responsible for the coronavirus disease 2019 (COVID-19) pandemic which includes asymptomatic upper and lower respiratory tract infections."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among the first European cases of COVID-19, six were associated with a cluster of transmissions in the French Alps in late January 2020 [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The whole-genome sequence (WGS) generated from sample #2 was deposited on ",
            "GISAID (Global Initiative on Sharing All Influenza Data)",
            " (",
            "EPI_ISL_410486",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 368,
                "end": 424,
                "name": "GISAID (Global Initiative on Sharing All Influenza Data)"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 426,
                "end": 440,
                "name": "EPI_ISL_410486"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "The genome sequences of seven SARS-CoV and 475 MERS-CoV were also downloaded from the ",
            "National Center for Biotechnological Information (NCBI)",
            " (",
            "https://www.ncbi.nlm.nih.gov/",
            "), and the MERS-CoV dataset, which includes samples collected from both humans and camels."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 86,
                "end": 141,
                "name": "National Center for Biotechnological Information (NCBI)"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 143,
                "end": 172,
                "name": "https://www.ncbi.nlm.nih.gov/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "In addition, for further exploring evolution and molecular characteristics of SARS-CoV-2 based on the larger amount of genomic data, validation datasets of the genome sequences were redownloaded from ",
            "GISAID",
            " by 06 April 2020 and 10 June 2020, resulting in 3624 and 16373 sequences, respectively."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 463,
                "end": 469,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "After alignment of 624 high-quality SARS-CoV-2 genomes and manually deleting two highly divergent genomes (",
            "EPI_ISL_415710",
            " and ",
            "EPI_ISL_414690",
            ") according to the first constructed phylogenetic tree, the aligned dataset of 622 sequences was phylogenetically analyzed."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 665,
                "end": 679,
                "name": "EPI_ISL_415710"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 684,
                "end": 698,
                "name": "EPI_ISL_414690"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Information (ID, countries/regions and collection times) and variants (",
            "NC_045512.2",
            " as reference genome) of each genome from each Cluster were extracted."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 893,
                "end": 904,
                "name": "NC_045512.2"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Principal Component Analysis (PCA) was analyzed by the GCTA v1.93.1beta (Yang et al., 2011) with the specific sites and all SNV datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All three datasets exhibited a positive correlation between root-to-tip divergence and sample collecting time (Figure S1), so that they were suitable for molecular clock analysis in BEAST (Bouckaert et al., 2019, Rambaut et al., 2016)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The PCA results showed that these nine specific sites could clearly separate the three Clusters, while all SNV dataset could not clearly separate Cluster 1 and Cluster 2 (Figure S4), which further suggests that these nine specific sites were the key sites for separating the three Clusters."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Four major haplotypes – H1, H2, H3, and H4 – three minor haplotypes – H5, H7 and H8 – close to H1 and one minor haplotype – H6 – close to H3 were found in both datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Phylogenetic networks were inferred with 697 mutations from 3624 genome datasets, and the network structures of TCS and MSN were similar."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, a pathophysiological function has also be assigned to ACE2, which is as the entry receptor for SARS-Cov-1 and the novel SARS-Cov-2 viruses, which have been responsible for the sever acute respiratory syndrome (SARS) epidemic in 2003 and the current coronavirus infectious disease (COVID-19) pandemic, respectively [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The SARS-Cov-2 infection resulting in COVID-19 symptomatology is characterized by a range of symptoms, including dry cough, fever, myalgia or fatigue, dyspnoea, and pneumonia [1,9]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition to systemic and respiratory symptoms, 14–36% of severe patients with COVID-19 show neurological signs, including dizziness, headache, taste and smell impairment, impaired consciousness, encephalitis, seizures, ataxia, and stroke [11,12]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This finding, together with the evidence of SARS-Cov-2 in the cerebrospinal fluid of patients with COVID-19, suggested that the neurotropic effects of SARS-Cov-2 may contribute to the morbidity and mortality caused by COVID-19 [3]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Given the multiple roles of ACE2 and its expression pattern in different tissues, the alteration of its expression levels may have an impact on the susceptibility, symptomatology, and outcome of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The study was performed by utilizing 268 DNA samples representative of the Italian general population, which were partially available at the ",
            "Genomic Medicine Laboratory of Santa Lucia Foundation Hospital",
            " and partially derived from international databases."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Creator",
                "start": 1338,
                "end": 1400,
                "name": "Genomic Medicine Laboratory of Santa Lucia Foundation Hospital"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The genetic data referred to these samples were partially derived by whole exome sequencing (WES), available at the ",
            "Genomic Medicine Laboratory of IRCCS Santa Lucia Foundation Hospital",
            " and partially extracted by the ",
            "Ensembl",
            " database [13,14,15]."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Creator",
                "start": 1569,
                "end": 1637,
                "name": "Genomic Medicine Laboratory of IRCCS Santa Lucia Foundation Hospital"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 1669,
                "end": 1676,
                "name": "Ensembl"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We therefore selected the SNVs of interest by extracting the variants localized in the exonic and splice site regions of ACE2, whose frequency data were available from the ",
            "1000 Genomes",
            " and ",
            "GnomAD",
            " databases [15,16,17,18]."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 1870,
                "end": 1882,
                "name": "1000 Genomes"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 1887,
                "end": 1893,
                "name": "GnomAD"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "Ensembl",
            " database [15] was also utilized to download the allele frequency data of the 34 SNVs of interest in the worldwide populations, in order to compare the frequencies between the Italian cohort and the frequencies observed in African, American, Asian, and European populations."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 1923,
                "end": 1930,
                "name": "Ensembl"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The presence of the 34 SNVs in the Italian samples was evaluated by analyzing the output file derived by the WES and ",
            "Ensembl",
            " databases."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 2322,
                "end": 2329,
                "name": "Ensembl"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To this purpose, VarSite [23], Human Splicing Finder (HSF) [24], and ",
            "Uniprot",
            " database [25] were interrogated."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 2410,
                "end": 2417,
                "name": "Uniprot"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, ",
            "Uniprot",
            " annotation database was utilized to retrieve the topological and functional domains organization of proteins."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 2461,
                "end": 2468,
                "name": "Uniprot"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Concerning eQTL analysis, the ",
            "Genotype-Tissue Expression (GTex)",
            " database [26] was utilized to retrieve the eQTLs variants with a significant effect on ACE2 expression in different tissues, and Biomart tool [27] was used to extract the significant eQTLs distributed on the basis of the affected tissue."
        ],
        "lab": [
            false,
            {
                "id": "T10",
                "type": "Dataset",
                "start": 2609,
                "end": 2642,
                "name": "Genotype-Tissue Expression (GTex)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "",
            "GTex",
            " database is a public resource that enables us to study tissue-specific gene expression and regulation, as well as their relationship to genetic variation [26]."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Dataset",
                "start": 2881,
                "end": 2885,
                "name": "GTex"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The final goal of the study has been the research of variants potentially affecting ACE2 expression and function, which may contribute to SARS-Cov-2 spreading among worldwide populations, and may have a clinical significance regarding the clinical variability and outcome displayed by patients with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Successively, all previously discussed variants were evaluated as potential eQTLs in the ",
            "GTEx",
            " database, and only rs2285666 was classified as a significant eQTL in several brain tissues, namely the amygdala, anterior cingulate cortex, basal ganglia, cortex, cerebellum, hippocampus, and hypothalamus (Figure 3)."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "Dataset",
                "start": 3444,
                "end": 3448,
                "name": "GTEx"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This finding suggests that the genetic variability of ACE2 may have a greater impact on COVID-19-related symptoms and SARS-Cov-2 tissue tropism, rather than on the susceptibility to SARS-Cov-2 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Considering the broader effect of rs2285666 in multiple brain tissues, we decided to look at the distribution of the eQTL variants located in and targeting ACE2 in the different brain tissues, which may thereby affect ACE2 expression, and in turn, contribute to the neurological symptoms and complications observed in patients with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These findings suggest that the alteration of ACE2 expression may be involved in different neurological symptoms (seizures, stroke, encephalitis, dizziness, headache, confusion, alteration of body temperature, anosmia, and ataxia) observed in COVID-19 patients, in relation to the brain-affected area."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These findings raise the need for further investigation on the role of ACE2 genetic variability in the susceptibility and clinical outcome of patients with COVID-19, especially concerning neurological symptoms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Structural and sequence variants in ACE2 gene may affect its expression in different tissues and determine a differential response to SARS-Cov-2 infection and the COVID-19-related phenotype."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The eQTLs analysis located in and targeting ACE2 revealed a high distribution of eQTL variants in different brain tissues, suggesting a possible link between ACE2 genetic variability and the neurological complications in patients with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Further research is needed to clarify the possible relationship between ACE2 expression and the susceptibility to neurological complications in patients with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Kaletra (an inhibitor of 3-chymotrypsin-like protease of the SARS and MERS), and Ascletis (HIV protease inhibitor) were shown to improve clinical outcomes of COVID-19 (Wang et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, the active form (",
            "CHEMBL2016761",
            ") of Remdesivir showed perfect docking in the overlapping region of the NTP binding motif urging its validation through clinical trials for COVID-19 infection (Chang et al., 2020)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "AccessionNumber",
                "start": 214,
                "end": 227,
                "name": "CHEMBL2016761"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In line with this, several studies have recently explored the repurposing of drugs to find an immediate therapeutic strategy for the deadly COVID-19, by mainly targeting SARS-CoV-2 main protease (Aanouz et al., 2020; Al-Khafaji et al., 2020; Das et al., 2020; Enmozhi et al., 2020; Gyebi et al., 2020; Islam et al., 2020; Joshi et al., 2020; Khan, Jha, et al., 2020; Khan, Zia, et al."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The structure of SARS-CoV-2 Mpro in complex with N3 inhibitor, resolved using X-ray diffraction (resolution of 2.16 Å), was downloaded from ",
            "RCSB Protein Data Bank",
            " (",
            "PDB",
            " ID: ",
            "6LU7",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 933,
                "end": 955,
                "name": "RCSB Protein Data Bank"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 957,
                "end": 960,
                "name": "PDB"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 965,
                "end": 969,
                "name": "6LU7"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T4"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "The structure of Wi-A (CID ",
            "265237",
            "), Wi-N (CID ",
            "21679027",
            ") and CAPE (CID ",
            "5281787",
            ") were downloaded from the ",
            "PubChem",
            " database, while the structure of the N3 inhibitor was extracted from SARS-CoV-2 Mpro-inhibitor complex downloaded from ",
            "PDB",
            " (",
            "PDB",
            " ID: ",
            "6LU7",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 999,
                "end": 1005,
                "name": "265237"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 1018,
                "end": 1026,
                "name": "21679027"
            },
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 1042,
                "end": 1049,
                "name": "5281787"
            },
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 1076,
                "end": 1083,
                "name": "PubChem"
            },
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 1203,
                "end": 1206,
                "name": "PDB"
            },
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 1208,
                "end": 1211,
                "name": "PDB"
            },
            false,
            {
                "id": "T11",
                "type": "AccessionNumber",
                "start": 1216,
                "end": 1220,
                "name": "6LU7"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T8",
                "end": "T5"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T8",
                "end": "T6"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T8",
                "end": "T7"
            },
            {
                "id": "R6",
                "bool": true,
                "head": "T9",
                "end": "T11"
            },
            {
                "id": "R7",
                "bool": true,
                "head": "T10",
                "end": "T11"
            }
        ]
    },
    {
        "sen": [
            "Data presented here predicted that these natural compounds may possess the potential to inhibit the functional activity of SARS-CoV-2 protease (an essential protein for virus survival), and hence (i) may connect to save time and cost required for designing/development, and initial screening for anti-COVID drugs, (ii) may offer some therapeutic value for the management of novel fatal coronavirus disease, (iii) warrants prioritized further validation in the laboratory and clinical tests."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is hard to infer whether the mutations in E protein infect and sicken people deferentially due to COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "From the ",
            "NCBI virus",
            " database, all the protein sequences of 4917 complete SARS-CoV-2 genomes as on date 18th June 2020 as well as other host CoV genomes were fetched."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 120,
                "end": 130,
                "name": "NCBI virus"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The following is the complete list of seventy-four distinct envelope (E) proteins from different host CoVs and their respective protein IDs (Table-2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The E protein is present over all the available 4917 SARS-CoV-2 genomes as on 18th June 2020 in the ",
            "NCBI",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 528,
                "end": 532,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is our belief that various missense mutations in the E protein could weaken the SARS-CoV-2 and would help us gets rid of COVID-19 in future since any virus does not like to destroy its host for its survival for a long to come."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Sixteen sequentially different E -proteins were observed from a total of 4917 available complete SARS-CoV-2 genomes as on 18th June 2020 in the ",
            "NCBI",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 917,
                "end": 921,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At a global level—as excellently elaborated by Prasad et al—4 COVID-19 both unveiled and exacerbated existing inequalities and injustices within a country, making different populations particularly vulnerable to COVID-19 and its sequelae, among them people living in poverty, without shelter, without regular residence, without employment or people living in residential care facilities."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "They were soon identified as being the most vulnerable in these countries with high risk for COVID-19 infection and severe outcomes due to frailty and chronic comorbidities,8 exposed to circumstances with staff shortage, insufficient access to personal protective equipment and limited staff training in infection prevention and control.9",
            "At the beginning of the spread of the COVID-19 pandemic, health authorities, ethicists and the medical community of high-income countries, however, anxiously focused on the ICUs."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In Europe, many hospitals increasingly reported to have quickly maximised resource capacities, reduced postponable interventions and—although challenging—being able to adequately respond to COVID-19 related medical needs of the population."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This is the story of the COVID-19 tragedy observable in many high-income countries in these days, told through the lens of medicine as a social science, focusing history of medicine and social epidemiology: with the pandemic spread of COVID-19, wealthy countries have built their responses informed by natural science and epidemiology,4 focusing the acute setting, personal protective equipment and testing, and establishing ethics guidelines for the expected ‘tough’ triage of lifesaving resources like ventilators or extracorporeal membrane oxygenation (ECMO) in acute hospitals."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As COVID-19 can affect an individual without (initially) being symptomatic, the virus easily spread despite lockdown conditions via healthcare teams and residents’ interactions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In many high-income countries, already before COVID-19, a great ‘viral dying’ can be observable in residential care facilities every winter."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Compared with that, COVID-19 is much deadlier, and we currently have no vaccination and only very limited treatment options."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As the current evidence therefore increasingly reveals,8–14 16 age, frailty and comorbidities are important risk factors, but the social context of nursing homes as well as other communal establishments10 in many high-income countries contributes, according to Virchow’s social hygiene hypothesis, immensely to the death toll itself, with a variation from zero % (Hong Kong) to up to 85% of all COVID-19 related deaths according to official figures (Canada), with excess rates of nursing home deaths not entirely being dependent on the total share of national COVID-19 related deaths."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "17 18 The current evidence strongly suggests that the isolation measures have not been effective in preventing the COVID-19 spread."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For sure, it would be more humane and safer, and, as up to 85% of COVID-19 related deaths in high-income countries are nursing home residents, with the exception of Hong Kong, implementing whole nursing home repeated testing of staff and residents and a short, sharp quarantine for residents, which should be carefully evaluated,8 and approximately 34% of all deaths are people living in communal establishments,10 the next pandemic might not be as deadly, even without having highly effective treatments or a vaccination at hand."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To alleviate the global death toll of COVID-19 with the variety of contextual and local vulnerabilities and populations needing specific protection,4 like people living in refugee camps, undocumented working migrants in agriculture or the meat industry, often accommodated in large lodgings, as well as those living in poor neighbourhoods, we might finally again refer to Dr Virchow, calling for more social justice, as ‘politics is nothing but medicine at a larger scale’."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The incredible fast worldwide spread of the coronavirus disease 2019 (COVID‐19) prompt the World Health Organization (WHO) to declare COVID‐19 as a pandemic on 11 March 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "More than 1 776 867 confirmed cases of COVID‐19 and more than 111 828 fatalities in 185 countries have been attributed to SARS‐CoV‐2 as of 14 April 2020 (",
            "https://who.sprinklr.com/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "URL",
                "start": 329,
                "end": 354,
                "name": "https://who.sprinklr.com/"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Molecular tests (real‐time reverse transcriptase polymerase chain reaction, RT‐qPCR) were generally used to confirm the clinical diagnosis of COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Cardiovascular complications with embolism due to COVID‐19 have been reported recently."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            ", ",
            ", ",
            " Acute myocardial injury associated with COVID‐19 manifested as an increase of high‐sensitivity cardiac troponin levels."
        ],
        "lab": [
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Cardiovascular involvement in COVID‐19 seems to be a notable complication."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "First single case reports could show viral particles in interstitial cytopathic macrophages and their surroundings in EMB of a severe COVID‐19 shock patient by electron microscopic analyses."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on the results of currently published research, it seems important to discuss the manifestations and characteristics of myocardial damage induced by COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, patients with COVID‐19 are known to be at higher risk of acute pulmonary embolism, and elevated d‐dimer levels on admission are predictive of adverse outcomes for patients with COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Bai et al."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            " reported vascular thickening to be significantly associated with COVID‐19 compared with non–COVID‐19 pneumonia (59% vs. 22%, P < 0.001)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, recent histologically post‐mortem analyses in COVID‐10 positive patients revealed lymphocytic endotheliitis in different organs with evidence of direct viral infection, indicating endothelial dysfunction as a possible principle determination of microvascular dysfunction by shifting the vascular equilibrium towards more vasoconstriction with subsequent organ ischaemia and inflammation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although nearly all organs seemed to be affected by COVID‐19, we currently do not know in‐depth details about the organ‐specific infection by SARS‐CoV‐2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this regard, Tavazzi and coworkers have shown recently in their case description using electron microscopy on EMBs of a patient with COVID‐19 in cardiogenic shock that SARS‐CoV‐2 particles could be localized to interstitial macrophages and their surroundings but not in cardiomyocytes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Cardiovascular complications with myocarditis and embolism due to COVID‐19 have been reported."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the same context, the recent outbreak of SARS-CoV 2 (the causative agent of coronavirus disease 2019 (COVID-19)) in December 2019 has inflicted 204 nations, with a total of 896,450 confirmed cases and 45,526 deaths up to 2 April 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "From a structural perspective, the genome of coronaviruses encodes four structural proteins: E (envelope protein, the smallest in size, expressed in abundance inside infected cells during the replication cycle but only partially incorporated into the virion envelope) [8], M (matrix glycoprotein, responsible for the assembly of virions [1,9] and interacting with S proteins, promoting their retention in the endoplasmic reticulum (ER)–Golgi intermediate for their incorporation into new virions) [10], N (nucleocapsid protein, the only protein capable of binding to the virus RNA genome, synthesizing nucleocapsid) [11], S (spike protein, mediating the attachment of the virus to host cell receptors) [12,13,14]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "TMPRSS2 expression and variants served as COVID-19 modulators in Italian patients [31]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Alignment of the template (",
            "PDB",
            " ID: ",
            "5CE1",
            ") and the target protein is shown in Figure 1C."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1067,
                "end": 1070,
                "name": "PDB"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 1075,
                "end": 1079,
                "name": "5CE1"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "",
            "Natural Product Activity and Species Source (NPASS)",
            " is a freely accessible database containing 30,927 natural compounds classified into 18 different superclasses, which include alkaloids and derivatives, lipids and lipid-like molecules, benzenoids, lignans, neolignans and associated compounds, and so on [32]."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 1127,
                "end": 1178,
                "name": "Natural Product Activity and Species Source (NPASS)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In silico screening of large databases is a cost-effective and time-saving approach towards drug discovery."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "",
            "NPASS",
            ", a freely accessible database containing 30,927 compounds, was used to mine the potent inhibitors."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 1546,
                "end": 1551,
                "name": "NPASS"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We screened the ",
            "Natural Product Activity and Species Source database (NPASS",
            ", available at ",
            "http://bidd2.nus.edu.sg/NPASS",
            ") which contains 30,927 compounds [32]."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 1667,
                "end": 1726,
                "name": "Natural Product Activity and Species Source database (NPASS"
            },
            false,
            {
                "id": "T6",
                "type": "URL",
                "start": 1741,
                "end": 1770,
                "name": "http://bidd2.nus.edu.sg/NPASS"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "Based on a report that TMPRSS2 mutation makes some individuals more susceptible to COVID-19, a reported mutation V160M suggestive of changed disease susceptibility [31] was studied with respect to its docking conformation in the presence of the top compound."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To date, there is no specific drug registered to combat the disease it causes, named coronavirus disease 2019 (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Further in vitro and in vivo validation is needed to study and develop an anti-COVID-19 drug based on the structures of the most promising compounds identified in this study."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "They were not considered to be highly pathogenic to humans until the last two decades, which have seen three outbreaks of highly transmissible and pathogenic coronaviruses, including SARS-CoV (severe acute respiratory syndrome coronavirus), MERS-CoV (Middle East respiratory syndrome coronavirus), and SARS-CoV-2 (which causes the disease COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the face of the ongoing COVID-19 pandemic, extensive worldwide research efforts have focused on identifying coronavirus genetic variation and selection [6–8], in order to understand the emergence of host/tissue specificities and to help develop efficient prevention and treatment strategies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Viral genome sequences were downloaded from the ",
            "Genbank",
            " database, as shown in Table 1."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 693,
                "end": 700,
                "name": "Genbank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We set the threshold for prediction of a functional ORF to be XME ≥ 5 (i.e. XME score in the reading frame ≥5), based on our benchmark studies (data not shown) of experimentally validated ORFs in a large set of 80 genomes [15] covering a wide range of viruses (including single-stranded and double-stranded DNA viruses and single-stranded and double-stranded RNA viruses)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To avoid any statistical bias, coronavirus genome sequences were excluded from the benchmark."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This ORF is not annotated in the SARS-CoV-2 reference genome (",
            "MT072688",
            "), but is annotated as ORF3b in the genome of another SARS-CoV-2 strain isolated from the first U.S. case of COVID-19 (",
            "MN985325",
            ").",
            "The datasets analysed during the current study are available in the ",
            "Genbank",
            " viral genomes database, ",
            "https://www.ncbi.nlm.nih.gov/genome/viruses/",
            ""
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 1261,
                "end": 1269,
                "name": "MT072688"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 1388,
                "end": 1396,
                "name": "MN985325"
            },
            false,
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 1467,
                "end": 1474,
                "name": "Genbank"
            },
            false,
            {
                "id": "T5",
                "type": "URL",
                "start": 1499,
                "end": 1543,
                "name": "https://www.ncbi.nlm.nih.gov/genome/viruses/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T4",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "The trained DNNs are the core of our virus-host prediction tool VIDHOP (VIrus Deep learning HOst Prediction)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "VIDHOP also allows the user to train and use models for other viruses.",
            "Availability  VIDHOP is freely available under https://github.com/flomock/vidhop"
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The whole-genome sequence of Wuhan new virus (WH-Human_1) was first released on January 10, 2020 (Zhang, 2020), followed by additional ones released in ",
            "Global Initiative on Sharing All Influenza Data (GISAID)",
            " (Shu and McCauley, 2017)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 152,
                "end": 208,
                "name": "Global Initiative on Sharing All Influenza Data (GISAID)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Sequences of S protein were downloaded for known CoVs from ",
            "UniProt",
            ", and 2019-nCoV sequences were obtained from ",
            "Shanghai Public Health Clinical Center",
            " and ",
            "GISAID",
            " (Supplementary data)."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 294,
                "end": 301,
                "name": "UniProt"
            },
            false,
            {
                "id": "T3",
                "type": "Creator",
                "start": 346,
                "end": 384,
                "name": "Shanghai Public Health Clinical Center"
            },
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 389,
                "end": 395,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The complete genome sequence of 2019-nCoV HKU-SZ-005b was available at ",
            "GenBank",
            " (accession no. ",
            "MN975262",
            ") (Table 1)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 71,
                "end": 78,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 94,
                "end": 102,
                "name": "MN975262"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "Multiple alignment of Spike S1 amino acid sequences of 2019-nCoV HKU-SZ-005b (accession number ",
            "MN975262",
            "), bat SARS-like coronavirus isolates bat-SL-CoVZXC21, bat-SL-CoVZXC45, bat-SL-CoV-YNLF_31C, bat-SL-CoV-YNLF_34C and bat SL-CoV HKU3-1 (accession number ",
            "MG772934.1",
            " and ",
            "MG772933.1",
            ", ",
            "KP886808",
            ", ",
            "KP886809",
            " and ",
            "DQ022305",
            ", respectively), human SARS coronavirus GZ02 and Tor2 (accession number ",
            "AY390556",
            " and ",
            "AY274119",
            ", respectively) and Paguma SARS-CoV (accession number ",
            "AY515512",
            ") was performed and displayed using CLUSTAL 2.1 and BOXSHADE 3.21, respectively."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 210,
                "end": 218,
                "name": "MN975262"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 371,
                "end": 381,
                "name": "MG772934.1"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 386,
                "end": 396,
                "name": "MG772933.1"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 398,
                "end": 406,
                "name": "KP886808"
            },
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 408,
                "end": 416,
                "name": "KP886809"
            },
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 421,
                "end": 429,
                "name": "DQ022305"
            },
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 501,
                "end": 509,
                "name": "AY390556"
            },
            false,
            {
                "id": "T10",
                "type": "AccessionNumber",
                "start": 514,
                "end": 522,
                "name": "AY274119"
            },
            false,
            {
                "id": "T11",
                "type": "AccessionNumber",
                "start": 576,
                "end": 584,
                "name": "AY515512"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We calculated a phylogenetic analysis network of the 160 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) complete genomes submitted to the international ",
            "Global Initiative on Sharing Avian Influenza Data (GISAID)",
            " database by early March 2020, to produce a snapshot of the beginning of the SARS-CoV-2 epidemic (1)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 166,
                "end": 224,
                "name": "Global Initiative on Sharing Avian Influenza Data (GISAID)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Included in the dataset was the closest known nonhuman coronavirus, a bat coronavirus with more than 96% sequence similarity to the human virus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We ran the bat sequence as part of the human dataset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Mavian et al. (8) state that our findings are based on a nonrepresentative dataset of 160 genomes, with no significant correlation between prevalence of confirmed cases and number of sequenced strains per country."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We respond that our data are based on the first 160 high-quality genomes collected, sequenced, and uploaded to the international ",
            "GISAID",
            " database, in order to shed light on the early development of the coronavirus."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 868,
                "end": 874,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The early outbreak was centered on China, and naturally in this early dataset China is well represented."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Focusing on the seed part of miRNA-like sequences having a putative 8 nucleotide hybridization seed inhibition effect [19], [20] (minimum 7), we compare data from different databases",
            "[21], [22], [23], [24], [25], [26] using BLAST [27]."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among the symptoms of the COVID-19 disease, anosmia is frequently described."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This hypothesis is in agreement with numerous studies showing a decrease of adult human hemoglobin blood concentrations in severe COVID-19 cases [46], [47], presenting an increase of the high-sensitivity C-reactive protein as one of the three major predictors of severity [48], like in ß-thalassemia [49] and viral infections [50]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In [63], it is described a release of massive amounts of calprotectin (S100A8/S100A9) in severe cases of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All these probabilities are less than 5 10-2 showing the significance of the corresponding associations, which could be at the origin of the brakes observed on many metabolisms, thus explaining the ubiquitous and inconstant nature of the symptoms of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "They concern indeed many organs, in a sequence and with a duration difficult to anticipate, the cases observed ranging from asymptomatic or mildly affected patients to severe patients suffering from numerous chronic co-morbidities, the worsening of which due to COVID-19 leading sometimes to death."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We compare RNA subsequences of SARS-CoV-2 protein S and RNA-dependent RNA polymerase genes to mRNA sequences of beta-globin and type I interferons; (4) Results: RNA subsequences longer than eight nucleotides from SARS-CoV-2 genome could hybridize subsequences of the mRNA of beta-globin and of type I interferons; (5) Conclusions: Beyond viral protein production, COVID-19 might affect vital processes like host oxygen transport and immune response."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The coronavirus disease 2019 (COVID-19) pandemic created an overwhelming need to define host-derived molecular mediators of disease severity evident in hospitalized patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "One approach to dissect protective and pathological immune responses to COVID-19 infection is to measure plasma biomarkers correlated to various stages of COVID-19 and determine which proinflammatory mediators are modulated in response to therapies improving patient outcomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Analysis of the differential protein regulation patterns within severity classes of COVID-19 cases compared with healthy control (HC) revealed strong dysregulation of IFN-γ, IL-6, IL-10, monocyte chemoattractant protein (MCP)-3, CXCL9, CXCL10, CXCL11, ENRAGE, poly(ADP-ribose) polymerase 1 (PARP-1), and IL-1RA (Fig 1",
            ", A, B-bottom, C)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We observed a 2-fold increase in IL-19 levels and, along with the aforementioned changes in IL-10, MCP-1, -2, and -3, this is consistent with the important role for inflammatory monocytes/macrophages in the immunopathogenesis of patients infected with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A-C, Inflammatory panel (Fig 1, A) or the cardiovascular panel II (Fig 1, B) FC in baseline protein levels, patients with COVID-19 vs HC (n = 20) (bottom)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Baseline samples of patients with COVID-19 were classified on the basis of patients receiving treatment for 2 days or less (n = 25)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Correlations of biomarkers and clinical assessments such as Ordinal Scale, nasopharyngeal viral load (the most sensitive viral target gene, N gene, is shown), and inflammation status (CRP, ferritin, LDH) are shown for each biomarker across all longitudinal time points for patients with COVID-19 treated with baricitinib (top)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our analysis is consistent with a more prominent increase in IFN-γ and IL-10 levels in patients with COVID-19 as seen in the moderate/severe and critical patients who are more likely to suffer from adult respiratory distress syndrome."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This indicates that inflammatory proteins observed in the plasma of patients with COVID-19 could be predictive of disease state and potentially clinical outcomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Pathway mapping of the most prominent biomarkers that are altered in severe patients with COVID-19 (see Table E3 in this article’s Online Repository at ",
            "www.jacionline.org",
            ") suggests changes in cytokines correlated with pneumonia such as IFN-γ and IL-10, along with chemokines such as CXCL10, MCP-3, CCL20, CXCL9, IL-8, ENRAGE, and MCP-2."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "URL",
                "start": 2218,
                "end": 2236,
                "name": "www.jacionline.org"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "In addition to these identified immunologic changes, there is a growing consensus on the thromboembolic risk seen in patients with COVID-19."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severe endothelial injury, vascular thrombosis, and intussusceptive angiogenesis characterizes the lung damage observed, and the incidence of venous thromboembolism among severe and critically ill patients with COVID-19 is higher compared with that reported in other studies including patients with other disease conditions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            " Recent recommendations suggest that all hospitalized patients with COVID-19 should receive thromboprophylaxis or full therapeutic-intensity anticoagulation if such an indication is present."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These changes suggest potential viral-mediated changes in endothelial function that may provide clues to the increased incidence of thromboembolic risks in patients with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Notably, in moderate/severe and critical patients with COVID-19, these plasma markers are elevated relative to mild patients and HCs, which is consistent with thromboembolic risk in these patients potentially attributed to vast changes in the underlying endothelium of the most at-risk patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Likewise, we observed downregulation of GDF-2 in the plasma of patients with COVID-19 (Fig 1, B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In recent work conducted in COVID-19 PBMCs using single-cell RNASeq, it was reported that a reconfiguration of peripheral immune cell phenotype leads to a heterogeneous IFN-stimulated gene signature, HLA class II downregulation, and appearance of a neutrophil population with acute respiratory failure requiring mechanical ventilation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Background  Physicians treating patients with coronavirus disease 2019 (COVID-19) increasingly believe that the hyperinflammatory acute stage of COVID-19 results in a cytokine storm."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The circulating biomarkers seen across the spectrum of COVID-19 have not been characterized compared with healthy controls, but such analyses are likely to yield insights into the pursuit of interventions that adequately reduce the burden of these cytokine storms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Methods  Blood samples from adult patients hospitalized with COVID-19 were analyzed using high-throughput and ultrasensitive proteomic platforms and compared with age- and sex-matched healthy controls to provide insights into differential regulation of 185 markers."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Results  Results indicate a dominant hyperinflammatory milieu in the circulation and vascular endothelial damage markers within patients with COVID-19, and strong biomarker association with patient response as measured by Ordinal Scale."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Despite strict quarantine measures in Wuhan and surrounding areas, the virus, responsible for coronavirus disease (COVID-19), rapidly spread across the globe, leading the World Health Organization (WHO) to declare a pandemic on 11 March 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Soon after the emergence of the virus, a specific syndromic surveillance for COVID-19 was implemented in France."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Strengthened surveillance of COVID-19 cases was implemented in France on 10 January 2020, with the objective of identifying imported cases early to prevent secondary transmission in the community."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As the COVID-19 epidemic progressed in the country, the task of identifying SARS-CoV-2 infections was shared with the NRC-associated laboratory in Lyon and then extended to first line hospital laboratories in the whole country, with the NRC at Institut Pasteur focusing on the northern part of France, including the densely populated capital."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As the virus continued to spread, it became clear that COVID-19 patients could exhibit greatly variable clinical characteristics [4], including a proportion presenting with asymptomatic infection or mild disease [5]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We combined the SARS-CoV-2 genome sequences generated here, including 97 from northern France and three from Algeria with recent history of travel to France, with 338 sequences published and freely available from the ",
            "Global Initiative on Sharing All Influenza Data (GISAID) EpiCoV",
            " database and/or ",
            "GenBank",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 1330,
                "end": 1393,
                "name": "Global Initiative on Sharing All Influenza Data (GISAID) EpiCoV"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 1410,
                "end": 1417,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This dataset enabled to perform a phylogenetic analysis to gain more insight into the initial introductions and spread of the virus in France."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our analysis indicates that the quarantine imposed on the initial imported COVID-19 cases, who were captured by the syndromic surveillance in France, appears to have prevented local transmission."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first European cases, who were originally in Île-de-France (IDF) and who were previously described elsewhere [6], were direct imports from Hubei, China."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "They were sampled on 24 January 2020 and the two derived respective viral genomes, IDF0372 and IDF0373, fall accordingly near the base of the tree, within clade V, according to ",
            "GISAID",
            " nomenclature (Figure 2, Figure 3A)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 2092,
                "end": 2098,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The IDF0372 and IDF0373 genomes were identical and both harboured a G22661T non-synonymous mutation (V367F) in the receptor-binding domain of the spike protein, not observed in other genomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similarly, IDF0515, obtained from a 29 January sample, corresponds to a traveller from Hubei, China."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This basal genome falls outside of the three major ",
            "GISAID",
            " proposed clades V, G, and S (Figure 2), but carries the G11083T mutation associated with putative lineage V1 (Fig. S2), suggesting convergent evolution or a reversion of the V-clade defining G26144T change."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 2479,
                "end": 2485,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Several genomes correspond to patients in GE, Normandie (N), IDF, Hauts-de-France (HF) and B with recent history of travel in Europe (GE3067, N1620, IDF2792), United Arab Emirates (IDF2936), Madagascar (HF1993), Egypt (B1623, B2330) or linked to Paris airports (IDF1980)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Other sequences sampled weeks later (IDF2849, GE1973) are more basal to the clade, highlighting the complexity and risk of inferences based on 1 or 2 nucleotide substitutions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Because of this, and the scarcity of early sequences in many countries in Europe, country and within-country level phylogeographic estimations are unreliable with the current dataset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Crucially, while all early symptomatic suspected COVID-19 cases samples were sent to the NRC for testing, this was no longer the case as the epidemic developed (Figure 1A)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, pauci- or asymptomatic cases are scarcely represented in our dataset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Managing the immediate demands of the current coronavirus disease 2019 (COVID-19) global pandemic has tested many healthcare systems across the world, to their limits."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the months since the initial outbreak of COVID-19 in December 2019, worldwide there have been more than 7.5 millions cases of infection with the severe acute respiratory syndrome coronavirus-2 (SARS-Cov-2) reported."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The treatment needs of COVID-19 survivors are not yet fully appreciated."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It incorporates the cognitive, physical, and psychological dysfunction reported after ICU discharge that can have profound effects on quality of life."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is likely that those surviving critical illness with COVID-19 will be at particular risk of developing chronic pain."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Owing to the severity of COVID-19 critical illness, it is likely that survivors will have undergone multiple pain-associated interventions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 survivors are likely to have sustained a prolonged period of immobilisation, sedation, and ventilation, putting them at high risk of associated ICU-acquired weakness (ICUAW)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Neuromuscular block is now highlighted in several guideline publications as a strategy to improve ventilation in those with acute respiratory distress syndrome (ARDS) associated with COVID-19",
            ",",
            "; although there is no consensus, some recommendations also include use of corticosteroids in certain populations."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The prevalence of ICUAW in the general ARDS population is estimated at 25–96%, and although reported after the Middle East respiratory syndrome (MERS) epidemic it is yet to be determined in those critically ill with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A mainstay of respiratory support through the COVID-19 pandemic has been use of repeated patient proning to improve ventilation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Reports of neurological sequelae of COVID-19 infection are emerging, indicating both central and peripheral nervous system involvement; symptoms such as confusion, headache and dizziness, and anosmia, ageusia, and nerve pain are now described in retrospective cohorts and case reports."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is now clear that COVID-19 itself is associated with painful symptoms, including myalgia, arthralgia, abdominal pain, headache, and chest pain, and even those not admitted to critical care environments may have pain requiring opioids for symptom management."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "An important area to recognise is the psychological impact of COVID-19, with the unique social restrictions likely to create an additional burden."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In COVID-19 this may be augmented by separation from personal protective equipment (PPE) adding to the already alien environment, breakdown of social networks, and fear of mortality; this increases the potential for development of PTSD, anxiety, and depression, as observed in the SARS outbreak."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Even baseline patient characteristics, identified as factors associated with the development of severe COVID-19, overlap with those associated with chronic pain after critical illness, including multi-morbidity and increasing age."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Emerging reports from Wuhan, which is now operating several rehabilitation institutions for COVID-19 survivors, and Italy indicate a significant symptom burden in COVID-19 survivors including anxiety, sleep disorders, fatigue, limited exercise tolerance, and memory and executive function impairment."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There is conflicting evidence on the beneficial effects of post-ICU rehabilitation strategies in general on exercise tolerance and health-related quality of life in the pre-COVID era."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            " Qualitative evaluation suggests increased patient satisfaction and reduced anxiety."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The make-up of such services may also need to be adjusted to address COVID-19-specific sequelae, and this may represent an opportunity to develop better links between pain and ICU survivorship programmes, and improving dialogue with other specialties such as renal, respiratory, and mental health to build existing collaborations and manage multi-morbidity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Pain services are traditionally multidisciplinary, incorporating physical and psychological expertise with the goal of improving function and quality of life, and could therefore have a great deal to offer overwhelmed critical care services."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It causes severe respiratory illness, which the WHO recently named COVID-19 disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A reference dataset of previously published coronavirus whole-genome sequences (WGS) was compiled from the ",
            "Virus Pathogen Resource (VIPR)",
            " database (",
            "www.viprbrc.org",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 192,
                "end": 222,
                "name": "Virus Pathogen Resource (VIPR)"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 233,
                "end": 248,
                "name": "www.viprbrc.org"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "This dataset consisted of 386 WGS of nine important coronavirus species."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To this reference dataset, we added 47 whole genomes of the current Coronavirus 2019 (SARS-CoV-2) outbreak that originated in Wuhan, China, in December 2019."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The SARS-CoV-2 sequences were downloaded from the ",
            "GISAID",
            " database (",
            "https://www.gisaid.org",
            ") together with annotation of its original location, collection date and originating and submitting laboratory."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 532,
                "end": 538,
                "name": "GISAID"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 549,
                "end": 571,
                "name": "https://www.gisaid.org"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "Cluster 5 (virus named SARS-CoV-2 by the ICTV committee and disease named COVID-19 by the WHO) includes three public sequences from the outbreak."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We identified this cluster with many sequences from ",
            "GISAID",
            " but kept only three ones as these were the first ",
            "GenBank",
            " sequences."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 881,
                "end": 887,
                "name": "GISAID"
            },
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 937,
                "end": 944,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Detailed information about the phylogenetic reference datasets is available in Supplementary Table S2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The phylogenetic reference dataset was used to create an automated Coronavirus Typing Tool using the Genome Detective framework (Fonseca ; Vilsker )."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the second step, a query sequence is aligned against the phylogenetic reference dataset using -add alignment option in the MAFFT software (Katoh and Standley, 2013)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This table can be expanded to show nucleotide and amino acid mutations that differentiate a query sequence from their species ",
            "RefSeq",
            " or from a sequence in the phylogenetic reference dataset."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 1504,
                "end": 1510,
                "name": "RefSeq"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Tool also allows a query sequence to be analyzed against a sequence in the phylogenetic reference dataset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "When the SARS-CoV-2 isolated from France (BetaCoV/France/IDF0373/2020) was analyzed with our tool and compared with the SARS-CoV-2 WH_Human1_China_2019Dec strain (Accession: ",
            "MN908947",
            "), this sequence was 99.9% identical and had only two NT mutations (Supplementary Table S4C)."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 1850,
                "end": 1858,
                "name": "MN908947"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We developed and released the Genome Detective Coronavirus Typing tool as a free-of-charge resource in the third week of January 2020 in order to help the rapid characterization of COVID-19 infections."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Abstract   Summary  Genome detective is a web-based, user-friendly software application to quickly and accurately assemble all known virus genomes from next-generation sequencing datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The tool also allows tracking of new viral mutations as the outbreak expands globally, which may help to accelerate the development of novel diagnostics, drugs and vaccines to stop the COVID-19 disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On March 11th, 2020, the World Health Organization (WHO) has officially declared the novel coronavirus (COVID-19) outbreak a global pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Estimates of LOD based on CPE observation on VERO cells were found to be in the range of 1 × 101–1 × 10−2 TCID50 for a wide group of viral families (Gombold et al., 2014)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A dataset of 3.995 SARS-CoV-2 genomic sequences was retrieved from ",
            "GISAID",
            " database (",
            "Elbe and Buckland-Merrett, 2017",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 381,
                "end": 387,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "Creator",
                "start": 398,
                "end": 429,
                "name": "Elbe and Buckland-Merrett, 2017"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The multi-genome alignment including our genome, ",
            "GISAID",
            " genomes and reference genome was obtained using the Purple pipeline (Gona et al., 2020), (available at https://skynet.unimi.it/index.php/tools/purple-tool/)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 481,
                "end": 487,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Phylogenetic analysis (Fig. 3",
            ") revealed that the sequenced strain is closely related to a SARS-CoV-2 strain isolated on March, 3rd, 2020 in Milan (",
            "GISAID",
            " code ",
            "EPI_ISL_413489",
            ")."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 794,
                "end": 800,
                "name": "GISAID"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 806,
                "end": 820,
                "name": "EPI_ISL_413489"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T4",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "Coronavirus disease 2019 (COVID-19) morbidity and mortality has been overwhelmingly concentrated in elderly individuals and those with preexisting comorbidities [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, the mechanisms behind increased mortality among older adults and males with COVID-19 remain speculative."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While genes up-regulated in high viral load samples were dominated by proinflammatory and/or interferon-induced factors such as CXCL9/10, IDO1, and CD80, genes with higher expression in low viral load samples included chemokines for neutrophils (CXCL8, S100A9), and B cell–specific transcripts (FCRL2, IGHG1, IGHM, IGLL5, IGHG2, CD22)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Clinically, COVID-19 cases tend to be more severe for older adults and males [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In men, we found down-regulation of B cell–specific transcripts (IGHG1 and MSA4A/CD20), down-regulation of the NK cell–activating receptor SLAMF6, and an up-regulation of several inhibitors of NFκB signaling (NDRG1, ARRB2, CD300A, and NFKBID) (Fig 5D)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, the reduction in NK cell–activating receptors and up-regulation of negative regulators of immune effector function—and resultant throttling of effector function—is consistent with a more severe manifestation of COVID-19 in males."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "One of the hallmarks of COVID-19 is a dysregulated antiviral immune response."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 patients frequently develop interleukin-6 (IL-6)-driven cytokine release syndrome (CRS), and elevated serum IL-6 correlates with respiratory failure and poor clinical outcomes [37]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Treatment with the IL-6 receptor blocking antibody tocilizumab has effectively treated COVID-19 symptoms in some patients [38]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Notably, the dissection of interferon responses in the lower respiratory tract will be important in light of recent findings that type III interferons in particular can disrupt healing and barrier function of lung epithelial cells following viral infection [39,40], a possible counterindication to the proposed use of type III interferon as treatment for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Immune dysfunctions in older individuals are well-characterized [2,3,32,33] and likely contribute to poorer COVID-19 outcomes; results from clinical trials of type I and III interferons in severely ill patients are likely to further define the role of interferon signaling in older adults [48–50]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The observed increased expression of inhibitors of nuclear factor kappa-B (NF-κB) in males with SARS-CoV-2 may represent either inappropriate throttling of the antiviral immune response or an adaptive mechanism to reduce deleterious inflammation, a hallmark of COVID-19 pathogenesis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Correction for batch effects was incorporated into the design formula and modeling performed using the Wald test with outlier replacement."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Gene expression differences attributable to sex or age were incorporated into the design formula as interaction terms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The viral load was expressed as the equivalent of log10 equivalents per mL (TCID50eq/mL) and compared to that of the pre‐treatment sample."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Each sample was tested in duplicate, and the mean is reported as TCID50eq/mL."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As shown in Table 2, positive controls and pre‐treatment samples from all units had a log10 TCID50eq/mL equivalent to the infectious viral titre determined by plaque assay as shown in Table 1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ongoing outbreak of COVID-19 in the Chinese city of Wuhan (Hubei province) [1] and its alarmingly quick transmission to 25 other countries across the world [2] resulted in the World Health Organization (WHO) declaring a global health emergency on 30 January 2020 [3]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "WHO, in its first emergency meeting [5], estimated the fatality rate of COVID-19 to be around 4%."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 120 whole genome sequences of SARS-CoV-2 were downloaded on 21 February 2020 from the ",
            "GISAID",
            " database (",
            "https://www.gisaid.org/CoV2020/",
            ")",
            "We excluded sequences that likely had spurious mutations resulting from sequencing errors, as indicated in the comment field of the ",
            "GISAID",
            " data."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 467,
                "end": 473,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 484,
                "end": 515,
                "name": "https://www.gisaid.org/CoV2020/"
            },
            false,
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 649,
                "end": 655,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "These nucleotide sequences were aligned to the ",
            "GenBank",
            " reference sequence (accession ID: ",
            "NC_045512.2",
            ") and then translated into amino acid residues according to the coding sequence positions provided along the reference sequence for SARS-CoV-2 proteins (orf1a, orf1b, S, ORF3a, E, M, ORF6, ORF7a, ORF7b, ORF8, N, and ORF10)."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 709,
                "end": 716,
                "name": "GenBank"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 751,
                "end": 762,
                "name": "NC_045512.2"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T4",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "Reference protein sequences for SARS-CoV and MERS-CoV were obtained following the same procedure from ",
            "GenBank",
            " using the accession IDs ",
            "NC_004718.3",
            " and ",
            "NC_019843.3",
            ", respectively."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 1088,
                "end": 1095,
                "name": "GenBank"
            },
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 1120,
                "end": 1131,
                "name": "NC_004718.3"
            },
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 1136,
                "end": 1147,
                "name": "NC_019843.3"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T6",
                "end": "T7"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T6",
                "end": "T8"
            }
        ]
    },
    {
        "sen": [
            "B cell and T cell epitopes were searched on the ",
            "NIAID",
            " ",
            "Virus Pathogen Database and Analysis Resource (ViPR)",
            " (",
            "https://www.viprbrc.org/",
            "; accessed 21 February 2020) [29] by querying for the virus species name: “Severe acute respiratory syndrome-related coronavirus” from “human” hosts."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Creator",
                "start": 1211,
                "end": 1216,
                "name": "NIAID"
            },
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 1217,
                "end": 1269,
                "name": "Virus Pathogen Database and Analysis Resource (ViPR)"
            },
            false,
            {
                "id": "T11",
                "type": "URL",
                "start": 1271,
                "end": 1295,
                "name": "https://www.viprbrc.org/"
            },
            false
        ],
        "rel": [
            {
                "id": "R5",
                "bool": true,
                "head": "T9",
                "end": "T11"
            },
            {
                "id": "R6",
                "bool": true,
                "head": "T10",
                "end": "T11"
            }
        ]
    },
    {
        "sen": [
            "However, for brevity and to be consistent with the terminology used in the ",
            "ViPR",
            " database, we will not make this qualification, and will simply refer to them as epitopes in this study."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 1520,
                "end": 1524,
                "name": "ViPR"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The number of B cell and T cell epitopes obtained from the database following the above procedure is listed in Table 1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We additionally included the Zaria Bat coronavirus strain (accession ID: ",
            "HQ166910.1",
            ") to serve as an outgroup."
        ],
        "lab": [
            false,
            {
                "id": "T13",
                "type": "AccessionNumber",
                "start": 1822,
                "end": 1832,
                "name": "HQ166910.1"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also computed the population coverage of this specific set of epitopes in China, the country most affected by the COVID-19 outbreak, which was estimated to be slightly lower (88.11%), as certain MHC alleles (e.g., HLA-A*02:01) associated with some of these epitopes are less frequent in the Chinese population (Table 3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On the other hand, all 6 SARS-CoV-derived discontinuous B cell epitopes obtained from the ViPR database (Table 5) were derived from the S protein."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A preliminary analysis of linear SARS-CoV-derived B cell epitopes has been reported online on the ",
            "ViPR",
            " database website (",
            "https://www.viprbrc.org/brcDocs/documents/announcements/Corona/2019-nCoV-ViPR-report_24JAN2020.pdf",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T14",
                "type": "Repository",
                "start": 2428,
                "end": 2432,
                "name": "ViPR"
            },
            false,
            {
                "id": "T15",
                "type": "URL",
                "start": 2451,
                "end": 2549,
                "name": "https://www.viprbrc.org/brcDocs/documents/announcements/Corona/2019-nCoV-ViPR-report_24JAN2020.pdf"
            },
            false
        ],
        "rel": [
            {
                "id": "R7",
                "bool": true,
                "head": "T14",
                "end": "T15"
            }
        ]
    },
    {
        "sen": [
            "The beginning of 2020 has seen the emergence of COVID-19 outbreak caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and first reported from Wuhan, Hubei Province, China [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Clinical manifestations of COVID-19 include acute pneumonia detected via computed tomography imaging or radiological examination."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although the medical diagnosis of COVID-19 is rapid and efficient, effective treatments do not yet exist [6]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In China, clinical trials are being conducted with patients at Wuhan hospitals to determine whether high doses of VC can manage COVID-19 [ClinicalTrials.gov Identifier: ",
            "NCT04264533",
            "]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "AccessionNumber",
                "start": 577,
                "end": 588,
                "name": "NCT04264533"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, combining VC with existing medicines or bioactive compounds may enhance the former’s therapeutic effectiveness against COVID-19 while minimizing side effects."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on the potent pharmacological properties of both VC and GA, their combined use may effectively manage COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At this time, no empirical data supports the clinical efficacy of VC + GA treatment against COVID-19 has not been investigated."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, we can perform bioinformatics analysis as a theoretical evaluation of potential anti-COVID-19 molecular mechanisms of VC + GA to support future clinical trials."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "GA treatment against the novel coronavirus, thereby uncovering anti-COVID-19 processes and mechanisms in detail (Figure 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Potential targets were acquired after a thorough analysis of the ",
            "Traditional Chinese Medicine Systems Pharmacology (TCMSP)",
            " [23], ",
            "Drugbank",
            " [24], ",
            "SuperPred",
            ", ",
            "Swiss Target Prediction",
            " [25], ",
            "ChemMapper",
            " [26], ",
            "Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine (BATMAN TCM)",
            " [27] and ",
            "SuperPred",
            " webserver [28] datasets."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 1361,
                "end": 1418,
                "name": "Traditional Chinese Medicine Systems Pharmacology (TCMSP)"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 1425,
                "end": 1433,
                "name": "Drugbank"
            },
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 1440,
                "end": 1449,
                "name": "SuperPred"
            },
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 1451,
                "end": 1474,
                "name": "Swiss Target Prediction"
            },
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 1481,
                "end": 1491,
                "name": "ChemMapper"
            },
            false,
            {
                "id": "T7",
                "type": "Dataset",
                "start": 1498,
                "end": 1595,
                "name": "Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine (BATMAN TCM)"
            },
            false,
            {
                "id": "T8",
                "type": "Dataset",
                "start": 1605,
                "end": 1614,
                "name": "SuperPred"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Functional targets of VC and GA in humans were selected from the ",
            "Swiss-Prot",
            " and ",
            "Uniprot",
            " databases [29]."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 1705,
                "end": 1715,
                "name": "Swiss-Prot"
            },
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 1720,
                "end": 1727,
                "name": "Uniprot"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "",
            "Genecard",
            " [30] and ",
            "Online Mendelian Inheritance in Man (OMIM)",
            " [31] databases were used to screen SARS-CoV-2 pathogenic targets."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Repository",
                "start": 1744,
                "end": 1752,
                "name": "Genecard"
            },
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 1762,
                "end": 1804,
                "name": "Online Mendelian Inheritance in Man (OMIM)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Custom Venn diagrams (http://bioinformatics.psb.ugent.be/webtools/Venn/) were created to show correlative targets of VC and GA against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Cytoscape version 3.7.1 was used to construct visualizations of the component-target-pathway network, GO biological processes and KEGG pathways of VC and GA’s individual and combined effects against COVID-19 [34]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We performed pairwise comparisons on bioinformational data of the top 20 biological processes and KEGG-enriched pathways involved in the separate therapeutic effects of VC and GA against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We used common targets of VC and GA against SARS-CoV-19 as inputs to a STRING database (version 11.0) [36], creating target-to-target network interactions and a target interaction PPI network diagram."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We screened ",
            "Genecard",
            " and ",
            "OMIM",
            " datasets to identify 426 COVID-19-associated genes."
        ],
        "lab": [
            false,
            {
                "id": "T13",
                "type": "Repository",
                "start": 2640,
                "end": 2648,
                "name": "Genecard"
            },
            false,
            {
                "id": "T14",
                "type": "Repository",
                "start": 2653,
                "end": 2657,
                "name": "OMIM"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Venn diagrams revealed 34 VC-intersection (Figure 2A) and 28 GA-intersection (Figure 2B) targets against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The results of GO analysis suggested that the biological processes of core VC targets against COVID-19 were mainly involved in peptidyl-serine phosphorylation, peptidyl-serine modification, regulation of cell–cell adhesion, cellular response to biotic stimulus, positive regulation of nucleocytoplasmic transport, regulation of leukocyte cell–cell adhesion, regulation of T cell activation, response to lipopolysaccharide, T cell activation, blood coagulation, leukocyte cell–cell adhesion, cellular response to external stimulus, hemostasis, coagulation, response to molecule of bacterial origin, platelet activation, fatty acid metabolic process, positive regulation of cell adhesion, regulation of nucleocytoplasmic transport and positive regulation of protein transport (Figure 3A and B and Supplementary Table 1, see Supplementary Data available online at ",
            "https://academic.oup.com/bib",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T15",
                "type": "URL",
                "start": 3686,
                "end": 3714,
                "name": "https://academic.oup.com/bib"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The GO data indicated that functional processes of core GA targets against COVID-19 were associated with response to lipopolysaccharide, cellular response to abiotic stimulus, cellular response to environmental stimulus, response to molecule of bacterial origin, placenta development, peptidyl-serine phosphorylation, reproductive structure development, reproductive system development, peptidyl-serine modification, lipopolysaccharide-mediated signaling pathway, cellular response to external stimulus, platelet activation, regulation of cell–cell adhesion, cellular response to mechanical stimulus, positive regulation of establishment of protein localization, peptidyl-tyrosine autophosphorylation, T cell activation, cellular response to lipopolysaccharide, interaction with host and response to mechanical stimulus (Figure 4A and B and Supplementary Table 3, see Supplementary Data available online at https://academic.oup.com/bib)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We then used the ‘pathview’ package in R to generate network diagrams that highlighted core targets of enriched KEGG pathways for VC against COVID-19 (Supplementary Figure 1, see Supplementary Data available online at ",
            "https://academic.oup.com/bib",
            ") and GA against COVID-19 (Supplementary Figure 2, see Supplementary Data available online at ",
            "https://academic.oup.com/bib",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T16",
                "type": "URL",
                "start": 4873,
                "end": 4901,
                "name": "https://academic.oup.com/bib"
            },
            false,
            {
                "id": "T17",
                "type": "URL",
                "start": 4995,
                "end": 5023,
                "name": "https://academic.oup.com/bib"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We identified 17 intersecting targets of VC and GA against COVID-19: PRKCE, SLC6A4, CYP2D6, PRKCB, MAPK1, EGFR, DPP4, MAPK3, ABCB1, ATP1A1, MAPK14, LCK, CCR5, PTGS2, PTGS1, PRKCA and PTPRC (Figure 5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The top 10 GO terms of VC + GA against COVID-19 were cellular response to external stimulus (0071496), peptidyl-serine modification (0018209), peptidyl-serine phosphorylation (0018105), platelet activation (0030168), regulation of cell–cell adhesion (0022407), response to lipopolysaccharide (0032496), response to molecule of bacterial origin (0002237), T cell activation (0042110), blood coagulation (0007596) and leukocyte cell–cell adhesion (0007159) (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "GA against COVID-19 were AGE-RAGE signaling pathway in diabetic complications (hsa04933), Aldosterone-regulated sodium reabsorption (hsa04960), EGFR tyrosine kinase inhibitor resistance (hsa04960), ErbB signaling pathway (hsa04012), Fc gamma R-mediated phagocytosis (hsa04666), Glioma (hsa05214), GnRH signaling pathway (hsa04912), Human cytomegalovirus infection (hsa04912), Kaposi sarcoma-associated herpesvirus infection (hsa04912), MicroRNAs in cancer (hsa05206), Non-small cell lung cancer (hsa05206), Proteoglycans in cancer (hsa05205), Serotonergic synapse (hsa04726), TCR signaling pathway (hsa04660) and VEGF signaling pathway (hsa04370) (Table 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Respectively, Figure 6A and B shows the heatmaps depicting GO biological processes and KEGG signaling pathways of VC + GA against COVID-19, respectively."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "GA-target-GO-KEGG-COVID-19 using the top 20 enriched GO terms and KEGG pathways (Figure 7)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our result showed that VC and GA shared 10 biological processes and 15 KEGG pathways, representing their combined anti-COVID-19 targets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As the COVID-19 pandemic has spread worldwide, effective management and treatment strategies targeting SARS-CoV-2 are in urgent demand [40]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although VC and GA individually have potent pharmacological efficacy against viral pneumonia [41, 42], no study has investigated their combined effects or potential mechanisms against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we used a potent strategy of network pharmacology and bioinformatics (including GO and KEGG) to uncover the integrative pharmacological mechanism of VC + GA against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "GA may be able to suppress COVID-19 through their combined antioxidative, antiviral and anti-inflammatory effects, along with immune system activation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "GA against COVID-19 involved specific modulations of immune responses, such as Fc gamma R-mediated phagocytosis, TCR signaling pathway, VEGF signaling pathway and human cytomegalovirus infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "When VC + GA activates Fc gamma R-mediated phagocytosis and TCR, these processes may facilitate the host to initiate an immune response against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our molecular functional analysis revealed that key effectors regulate the anti-COVID-19 properties just described."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "GA treatment against COVID-19 is LCK, a tyrosine kinase that contributes to intracellular signaling pathways of lymphocytes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It has been reported that COVID-19 patients with severe and fatal disease had significantly increase in white blood cell number and decreased lymphocyte and platelet counts [67, 68]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "GA treatment should exert potent antiviral and anti-inflammatory effects through the activation of immune system, suggesting the possible use of VC + GA as optional treatment of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In upcoming clinical treatments for COVID-19, VC + GA supplementation may potentiate the therapeutic effectiveness of existing medicines such as Remdesivir."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, more studies are needed to confirm the action of VC + GA on COVID-19, as we currently do not know how the supplements target and influence the virus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We thus find VC + GA, a promising supplementary treatment against COVID-19, which is worth further investigation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Abstract   Objective  Coronavirus disease 2019 (COVID-19) is a fatal and fast-spreading viral infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To date, the number of COVID-19 patients worldwide has crossed over six million with over three hundred and seventy thousand deaths (according to the data from World Health Organization; updated on 2 June 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although COVID-19 can be rapidly diagnosed, efficient clinical treatment of COVID-19 remains unavailable, resulting in high fatality."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We hypothesized that the combination of VC and GA is a potential option for treating COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "GA treatment for COVID-19, using bioinformational network pharmacology."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We uncovered optimal targets, biological processes and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways of VC + GA against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our findings suggested that combinatorial VC and GA treatment for COVID-19 was associated with elevation of immunity and suppression of inflammatory stress, including activation of the T cell receptor signaling pathway, regulation of Fc gamma R-mediated phagocytosis, ErbB signaling pathway and vascular endothelial growth factor signaling pathway."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For the first time, our study uncovered the pharmacological mechanism underlying combined VC and GA treatment for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The initial publications describing genomic features of SARS-CoV-2 [1–4] used Illumina and Oxford nanopore data to elucidate the sequence composition of patient specimens (although only Wu and colleagues [3] explicitly provided the accession numbers for their raw short-read sequencing data)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We preprocessed currently available (as of February 19, 2020) sequencing read data sets for SARS-CoV-2 (S1 Table) by removing adapter contamination and reads derived from human transcripts and combined the resulting data sets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There is no public access to sequence reads that were used to produce these assemblies: as of February 19, 2020—more than 2 months since the beginning of the outbreak—there were only six raw data sets (S1 Table)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Wu and colleagues [3] identified two potential recombination breakpoints within the SARS-CoV-2 S gene with some segments having higher similarity to Bat ZC45 and ZXC21 coronaviruses (accessions ",
            "MG772933",
            " and ",
            "MG772934",
            ", respectively), whereas others were more similar to SARS Tor2 and SZ3 isolates (accessions ",
            "AY274119",
            " and ",
            "AY304486",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "AccessionNumber",
                "start": 927,
                "end": 935,
                "name": "MG772933"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 940,
                "end": 948,
                "name": "MG772934"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 1040,
                "end": 1048,
                "name": "AY274119"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 1053,
                "end": 1061,
                "name": "AY304486"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The goal of our study was to (1) raise awareness of the lack of primary data necessary to effectively respond to global emergencies such as the coronavirus disease 2019 (COVID-19) outbreak and (2) demonstrate that all analyses can be performed transparently with already-existing open-source publicly available tools and computational infrastructure."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, they should have access to computational infrastructure that can execute these tools and apply them to potentially large next-generation sequencing (NGS) data sets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On February 21, 2020 new human data sets ",
            "SRR11092056",
            ", ",
            "SRR11092057",
            ", ",
            "SRR11092058",
            ", and ",
            "SRR11092064",
            " were added to the SARS-CoV-2 archive [22]."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 1631,
                "end": 1642,
                "name": "SRR11092056"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 1644,
                "end": 1655,
                "name": "SRR11092057"
            },
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 1657,
                "end": 1668,
                "name": "SRR11092058"
            },
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 1674,
                "end": 1685,
                "name": "SRR11092064"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our analyses indicate that these data sets contain no useful SARS-CoV-2 data [23]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The current global pneumonia pandemic has been attributed to an outbreak of a novel coronavirus named Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) which causes the infectious disease known as Coronavirus Disease 2019 (COVID-19) [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Symptoms commonly seen in COVID-19 patients include fever, cough, sore throat, dyspnoea [1,4,5]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severe COVID-19 manifests as SARS, lung infections, end-stage renal disease and then, death [5,6]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The virus has also been detected in the faeces and urine of COVID-19 patients, suggesting a faecal-oral transmission route [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 is a tale of the immunopathology of SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, researchers and clinicians should not only look at inhibiting the virus or managing symptoms associated with the disease but also enhance the ability of the immune system both to prevent and combat COVID-19 [7]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The major damage inflicted by COVID-19 is due to the overbearing effect of the immune system on virally infected cells."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "About 80% of COVID-19 patients manifest mild to moderate symptoms of the disease which disappear after about 6-10 days [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Even though the molecular dynamics underlying morbidity and mortality is yet to be fully understood, it is apparent that severe cases of COVID-19 are characterized mainly by an unbalanced immune response [9]",
            "This objective of this case study is to present the pandemic COVID-19 with its associated viremia, cellular oxidation and immune dysfunction."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The World Health Organization advices that adults should reduce sugar and salt intake during the COVID-19 outbreak [21]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The major predilection site of COVID-19 are the lungs and excessive oxidative stress of the pneumocytes would make the lungs unfit to combat the disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Individuals that are constantly on drugs that weaken the immune system especially anticancer chemotherapeutic agents are more likely to have severe COVID-19 [28]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Immunocompromised individuals have a reduced ability to fight COVID-19 and other diseases [31,32]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Mortalities in COVID-19 can be largely predicted by the number of comorbidities as 8 out of 10 deaths are occurring in individuals with at least one underlying disease [34]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Older adults are at high risk for severe illness from COVID-19 [35] and the elderly people are more prone to more serious outcomes when infected with SARS-CoV-2 especially acute respiratory distress syndrome (ARDS) and cytokine storm [36]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Like other coronavirus infections and influenza, diabetes is a risk factor for severe COVID-19 disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Mortality is three-fold higher in patients with diabetes than normal mortalities in COVID-19 [33]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Also, complications of diabetes make the management of COVID-19 more challenging [32]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Individuals with this condition are at risk of having severe forms and complications of COVID-19 [39]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Emerging data suggests that patients with preexisting CVD are at a high risk of mortality from COVID-19 [4,42]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 also causes cardiovascular complications such as myocarditis, arrhythmias, acute heart failure, acute coronary syndromes, cardiogenic shock and death [42]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As found in SARS, there is a suppression of the release of interferons by infected cells which delays immune response in COVID-19 [7]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 also attacks the lymphocytes causing lymphocytopenia which is a common diagnostic marker in COVID-19 patients [50]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, supplementary dietary antioxidants are needed in the management of COVID-19 to improve immunity [30]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The aggressive administration of exogenous antioxidants from natural products would largely impart on clinical outcomes of COVID-19 by improving patient’s health, hastening the immunological process and consequently shortening the hospital admission period."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Innate immune response: the innate immune system serves as the first line of defense in the combat against the viremia associated with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interestingly, the role of NK cells in SARS infections has not been established but they have been reported to be reduced in peripheral blood in patients with severe cases of COVID-19 [50]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interestingly, type 1 IFN is not detected in COVID-19 patients and also not detected in in vitro SARS-CoV-2 infected cells [54]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The administration of type 1 IFN to COVID-19 would trigger interferon-mediated immune responses which could have a positive impact on the clinical outcome of severe cases [55]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This is because as it is with SARS-CoV infection, the acute phase of COVID-19 is characterized by a remarkable reduction in CD4 T cell population and this could be prolonged reaching a lowest point at days 7-9 before returning to normal [50]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In a 47-year-old female patient with mild case of COVID-19, antibodies were detected as early as four days after infection while the virus could be undetected as early as the 7th day and there were progressive increases in plasma SARS-CoV-2-binding IgM and IgG [56]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Individuals with HLA-B*46: 01 are reported to be more vulnerable to COVID-19 [53]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The discovery of the specific HLA molecules and variants involved in COVID-19 would enhance knowledge on the unexplained susceptibility to the disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Unlike in mild cases of COVID-19, severe cases would have an unusually high level of pro-inflammatory cytokines and chemokines such as IL-6, IL-8, MIP-1β, MCP-1 and IFN-γ6, in the plasma."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "T cells are also associated with severe COVID-19 [9]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To enhance a more effective management of COVID-19, the early prediction of severe cases or high-risk individuals is important."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of all cytokine profiles and the cell counts, the Neutrophil to Lymphocyte Ratio (NLR) is the most powerful prognostic indicator in the identification of severe cases of COVID-19 [9,62]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In a study of 245 COVID-19 patients admitted in hospital, NLR of patients in the highest interquartile had 15.04-fold higher risk of death than patients in the lowest interquartile [62]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hyaluronidase can also be administered intranasally [7] and computational approaches present a potential drug discovery option for the COVID-19 [66]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Chloroquine, a double agent: chloroquine (CQ) and its derivative hydroxychloroquine (HCQ) have been reported to show good promise in the treatment of COVID-19 this is because they present a dual advantage of quelling the cytokine storm and inhibiting the coronavirus [67]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "CQ has been used to shorten the course of the disease and it has been enlisted as one of the trial drugs in the guidelines for the diagnosis and treatment of COVID-19 published by national health commission of China [68]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In many countries, clinical trials have been approved to validate the efficacy and to establish the ideal therapeutic dose for the treatment of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recommendations: vaccine and immune development: the race for the development of a vaccine against COVID-19 is on with the first clinical trial presently taking place in the UK."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "An extensive serological survey is also required to determine the antibody titre of post-COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "An idea of an immunity passport has been mooted and it involves the certification of COVID-19 survivors [71]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Apart from the prophylactic benefits, the aggressive consumption of antioxidant beverages has potential therapeutic value in the face of a COVID-19 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Adequate vitamin C supplementation is also good for the management of COVID-19 due to their antioxidant and anti-inflammatory effect."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Clinicians should strive to determine the maximum beneficial dose as research shows that many COVID-19 patients might be under-dosed with vitamin C. Heavy consumption of refined sugar should be avoided as its oxidative effect impairs immune function [18]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Management of COVID-19 patients: on admission of COVID-19 patients, an early determination of the Neutrophil to Lymphocyte Ratio (NLR) would help to determine the degree of severity of cases [64]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this regard, the herbal drink, COVID-organics claimed to combat COVID-19 in Madagascar should be investigated."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Research and testing: the role of NK cells in combating COVID-19 should be investigated since these are the cells responsible for immunosurveillance of virally infected cells [79]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Information on the genetic susceptibility to COVID-19 can be obtained from extensive HLA profiling of patients especially when the severity of the case cannot be associated with any known risk factor [53]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A summary of these recommendations is provided in Table 1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19, caused by SARS-CoV-2 is a tester of the immune system."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This article aims at critically reviewing the key virulence factors of COVID-19 which are the viremia, cellular oxidation and immune dysfunction."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A better understanding of the pathological dynamics of COVID-19 would help the general populace to prepare for possible infection by the invisible enemy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Immunoprophylactic and immunomodulatory strategies are recommended for the different strata of stakeholders combating the pandemic with the hope that morbidities and mortalities associated with COVID-19 would be drastically reduced."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Frail patients, such as elderly people or those with underlying conditions, are at higher risk of complications related to COVID-19.1",
            "Preliminary data suggest an increased risk of developing infection-related severe events (ie, admission to the intensive care unit, mechanical ventilation or death) in the case of antitumour treatment administration within two weeks before COVID-19 diagnosis."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Italian directives for the management of onco-haematological patients on therapy during the COVID-19 pandemic recommend considering treatment delays on a case-by-case basis, taking into account the characteristics of the patient and the disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among these patients, 16 (94%) had symptoms related to COVID-19; eight had severe respiratory symptoms, and 13 (76%) were admitted to hospital (table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At a median follow-up of 15 days since the confirmed diagnosis of SARS-CoV-2 infection, the case fatality rate was 24%: four patients out of 17 died due to severe COVID-19, two of whom were on oncological follow-up (ie, off therapy)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similarly, other patients currently in hospital with mild COVID-19 syndrome might need to resume their therapeutic plan after complete resolution of their symptoms despite SARS-CoV-2 still being detectable potentially for weeks."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on our preliminary experience, we are opening a new unit that will work as a regional cancer hub for the care of patients with cancer affected by COVID-19 within a multidisciplinary team."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The current COVID-19 pandemic has so far affected approximately 2,350,000 people and killed more than 160,000 [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the GHU PARIS Psychiatrie & Neurosciences (Sainte-Anne hospital, Paris, France) we have observed a lower incidence of symptomatic forms of COVID-19 among patients (around 4% in the Pôle Hospitalo-Universitaire de Psychiatrie Paris 15) than among our healthcare staff (around 14% of nurses and doctors in these same wards)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similar observations have been reported by other COVID units in psychiatric wards in France, Spain and Italy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The SARS-CoV-2 coronavirus involved in the current COVID-19 epidemic belongs to the 2b coronavirus family [16] and has many phylogenetic similarities with SARS-CoV-1 [17]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In cases of severe COVID-19, several elements suggest a dysregulation of the immune system, although the precise mechanisms have not yet been elucidated [18]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Because of the respiratory tropism of SARS-CoV-2 [28], this marked pulmonary distribution could be of major interest for COVID-19 treatment."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, due to its lipophilic nature, CPZ can cross the blood-brain barrier [30] and could therefore have a therapeutic or prophylactic effect on the neurological forms of COVID-19 [31]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patients will be randomized in two groups, one receiving standard COVID-19 treatment (standard-of-care, SOC) and the other receiving SOC in combination with CPZ (CPZ + SOC)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The reCoVery study design and its objectives are in line with WHO recommendations for conducting pilot studies in the therapeutic management of COVID-19 [42]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ongoing COVID-19 pandemic has caused approximately 2,350,000 infections worldwide and killed more than 160,000 individuals."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In Sainte-Anne Hospital (GHU PARIS Psychiatrie & Neuroscience, Paris, France) we have observed a lower incidence of symptomatic forms of COVID-19 among patients than among our clinical staff."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We hypothesize that CPZ could reduce the unfavorable course of COVID-19 infection among patients requiring respiratory support without the need for ICU care, and that it could also reduce the contagiousness of SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This repurposing strategy also avoids numerous developmental and experimental steps, and could save precious time to rapidly establish an anti-COVID-19 therapy with well-known, limited and easily managed side effects."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 has become a global public health emergency affecting more than 200 countries and territories resulting in more than 10 million reported cases by June 30 and over 500,000 deaths [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 spreads via the respiratory route to close contacts and social contact patterns are therefore a key factor shaping the spread of COVID-19 and other infectious agents in a population [3, 4]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recruitment of participants occurred via sharing of a survey link on the social media platforms Facebook and Twitter to followers and readers of the science.lu website following the publication of a general interest article on COVID-19 [8]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similar to these estimates, our results explain the rapid decline in SARS-CoV-19 transmission, also resulting in the rapid decline of COVID-19 cases observed since the beginning of the lockdown in Luxembourg."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This increase in social contacts most likely resulted in the increase of the reproduction number followed by growing COVID-19 incidence that had been observed by the end of June."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our results suggest that older individuals are more compliant with restriction measures compared to younger persons, which is expected since the risk of hospitalization and death from COVID-19 increases with age [5]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While the number of social contacts was substantially lower during the lockdown by more than 80% compared to the pre-pandemic period, we observed a more recent 121% increase during the post lockdown period showing an increased potential for COVID-19 spread."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Monitoring social contacts is an important indicator to estimate the possible impact of government interventions on social contacts and the COVID-19 spread in the coming months."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged late in 2019 in the Hubei province, China, as a cause of respiratory disease occasionally leading to acute respiratory distress syndrome and death (COVID-19) (1–4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Four separate data sets of full-length (near-) complete genome sequences of SARS-CoV-2 collected from the start of the pandemic to those most recently deposited on 24 April 2020 were aligned and analyzed (accession numbers listed in Table S1A in the supplemental material)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Each data set showed minimal levels of sequence divergence, with mean pairwise distances ranging from 5.5 to 9.5 nucleotide differences between each sequence."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "First, the ratio of nonsynonymous (amino acid changing) to synonymous substitutions (dN/dS) was high, in the range of 0.57 to 0.73 among the different SARS-CoV-2 data sets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This contrasts with a much lower ratio (consistently below <0.22) in sequence data sets assembled for the other human coronaviruses (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To formally analyze the excess of C→U transitions, we calculated an index of asymmetry (frequency [f][C→U]/f[U→C]) × (fU/fC) and compared this with degrees of sequence divergence and dN/dS ratios in SARS-CoV-2 and other coronavirus data sets (Fig. 2B and C)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This comparison showed that the excess of C→U substitutions was most marked among very recently diverged sequences associated with the SARS-CoV-2 and SARS-CoV outbreaks and was reduced significantly in sequence data sets of the more divergent human coronaviruses (NL63, OC43, 229E, and OC43) as sequences accumulated substitutions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These showed mean levels of within-group sequence divergence of 0.1%, 1.1%, and 0.5%, respectively, spanning the range of divergences in the analyzed SARS-CoV-2 and other coronavirus data sets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Long bars representing more polymorphic sites were frequently shared between replicate data sets, but unique substitutions (occurring once in the data set [short bars]) showed largely separate distributions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Substitutions were not focused toward any particular gene or intergenic region, although all three data sets showed marginally higher frequencies of substitutions in the N gene."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A selection of sequences showing C→U changes in different genome regions was plotted in a phylogenetic tree containing sequences from the SARS-CoV-2 data set (Fig. 4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With the resolution possible in the tree generated from such a minimally divergent data set, many sequences with shared C→U changes were not monophyletic (e.g., those with substitutions at positions 5784, 10319, 21575, 28657, and 28887)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On analysis of amino acid sequence changes, a remarkable 52% of nonsynonymous transitions in the SARS-CoV-2 sequence data set were the consequence of C→U transitions (Fig. 5), compared to 26%, 10%, and 7% for G→A, U→C, and A→C transitions, respectively."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Totals of each transition in the SARS-CoV-2 sequence data set split into subtotals based on the identity of the 5′ (left) and 3′ (right) base."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Comparison of CpG frequencies of SARS-CoV-2, other coronaviruses, and a set of other mammalian RNA viruses; each data point represents an individual currently classified species; accession numbers are listed in Table S1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These accounted for 38% to 42% of all changes in the four SARS-CoV-2 data sets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In seeking alternative nonbiological explanations for this observation, they cannot have arisen through misincorporation errors in the nex-generation sequence methods used to produce the data set because the analysis in the present study was restricted to consensus sequences."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There was, furthermore, no comparable increase in G→A mutations (Fig. 2), and the sequence context in which sequencing errors occur (a 5′ or 3′ C or G [17]) did not match the favored context for mutation observed in our data set (Fig. 6)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By definition, a coronavirus RNA genome descends from any other through an equal number of copies of the positive and negative strands—any tendency to misincorporate a U instead of a C would be reflected in a parallel number of G→A mutations where this error occurred on the minus strand (or vice versa)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The findings of C→U mutations at the consensus genome sequence level have also been observed within virus populations in a recent analysis of intrahost sequence diversity in lung-derived COVID-19 samples (36)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The combination of exceptionally long genomes (≈30,000 bases), an otherwise low mutation rate, and the unprecedented size of the present data set of accurate minimally divergent SARS-CoV-2 sequences assembled postpandemic has enabled these mutational signatures to be so clearly observed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "An RNA editing mechanism of the type discussed above evidently places a huge mutational load on SARS-CoV-2 that may underpin the abnormally high dN/dS ratios recorded in SARS-CoV-2 and SARS-CoV sequence data sets (Fig. 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "An additional data set of 117 well-curated SARS-CoV-2 sequences was downloaded from ",
            "Konsiliarlabor für Coronaviren",
            " (",
            "https://civnb.info/sequences/",
            ") on 13 April 2020 and represents a further independent sample set."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 4885,
                "end": 4915,
                "name": "Konsiliarlabor für Coronaviren"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 4917,
                "end": 4946,
                "name": "https://civnb.info/sequences/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "A listing of further data sets of SARS-CoV, MERS-CoV, and other human coronaviruses is provided in Table 1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In evolutionary terms, the contribution of biased, convergent, and context-dependent mutations to sequence change in SARS-CoV-2 is substantial, and these processes are not incorporated by standard models used in molecular epidemiology investigations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To understand the early evolutionary events following its emergence, a data set of 985 complete SARS-CoV-2 sequences was assembled."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Repeated cycles of mutation and reversion in favored mutational hot spots and the widespread occurrence of amino acid changes with no adaptive value for the virus represent a quite different paradigm of virus sequence change from neutral and Darwinian evolutionary frameworks and are not incorporated by standard models used in molecular epidemiology investigations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In evolutionary terms, the contribution of biased, convergent, and context-dependent mutations to sequence change in SARS-CoV-2 is substantial, and these processes are not incorporated by standard models used in molecular epidemiology investigations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This diversity of RNA strains might be correlated to severity and mortality seen in COVID-19 (Corona Virus disease-2019)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For prediction of human RBPs bound to the UTR of a viral genome, we have used the web-tool ‘RBPmap’ that enabled prediction of RBP binding on genome sequences from a huge list of experimentally validated motifs of RBPmap database."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We have put the reference and mutated 5’- and 3’-UTR sequences separately as query sequence with the in-built human RBP motifs of the database."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For input miRNA sequences, we have obtained a list of all annotated human miRNAs with their sequences in FASTA format from ",
            "miRBase",
            " database [14]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 620,
                "end": 627,
                "name": "miRBase"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The world is going through the critical phase of COVID-19 pandemic, caused by human coronavirus, SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To have an idea of the global changes in 5’ and 3’-UTR sequences, we downloaded 8595 complete and high-coverage SARS-CoV-2 genome sequence information from human host in FASTA format from ",
            "Global Initiative on Sharing All Influenza Data (GISAID)",
            " from 15 different geographical regions."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 940,
                "end": 996,
                "name": "Global Initiative on Sharing All Influenza Data (GISAID)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The homologous protein structures of 2′OMTase with ",
            "PDB",
            " ID: ",
            "3R24",
            " [12,13], ",
            "2XYR",
            " [12,13] from human SARS-CoV and 2′OMTase with ",
            "PDB",
            " ID ",
            "5YN5",
            " from Human betacoronavirus 2c EMC/2012 [Unpublished] were retrieved from ",
            "Protein Data Bank (PDB)",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 51,
                "end": 54,
                "name": "PDB"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 59,
                "end": 63,
                "name": "3R24"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 73,
                "end": 77,
                "name": "2XYR"
            },
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 124,
                "end": 127,
                "name": "PDB"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 131,
                "end": 135,
                "name": "5YN5"
            },
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 209,
                "end": 232,
                "name": "Protein Data Bank (PDB)"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T1",
                "end": "T3"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T4",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "The topology diagram showing the secondary structures present in 2′OMTase was generated by using PDBSum (http://www.ebi.ac.uk/thornton-srv/databases/pdbsum/Generate.html)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All the FDA approved drugs were downloaded from the zinc database and ",
            "DrugBank",
            " and converted into 3D format for high-throughput virtual screening."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 476,
                "end": 484,
                "name": "DrugBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The active site volume of homologous 2′OMTase for PDB ID 3R24_A was 946.75 Å3 and for PDB ID 2XYR was 537.38 Å3."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The coronavirus disease 2019 (COVID-19) pandemic, as declared by the World Health Organization on 11 March 2020 [1], has accumulated 6057.853 confirmed cases globally until June 1 [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The etiologic agent of COVID-19 is a novel beta coronavirus [3], which was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the International Committee on Taxonomy of Viruses [4]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The outbreak of the COVID-19 pandemic shows marked geographic variation in its prevalence and mortality."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It was recently suggested that a renin-angiotensin system (RAS) imbalance impacts all stages of SARS-CoV-2 infection and clinical findings thereof, placing RAS molecules at the center of COVID-19 pathophysiology."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this context, Delanghe et al. [49] analyzed not only the prevalence and mortality data (per 1,000,000 inhabitants) of the COVID-19 infection of several countries but also the frequency of several polymorphisms in genes of some human plasma proteins, including the ACE I/D polymorphism."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The results of this study suggest that the prevalence of COVID-19 is significantly correlated with the ACE1 polymorphism."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In our study, we included only information from the dbSNPs, ",
            "Ensembl Genome Browser",
            ", and ",
            "1000 Genome Project",
            " databases."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1175,
                "end": 1197,
                "name": "Ensembl Genome Browser"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 1203,
                "end": 1222,
                "name": "1000 Genome Project"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Discrete sequence databases of individuals infected with SARS-CoV2 were not analyzed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The prevalence and mortality of the outbreak of the COVID-19 pandemic show marked geographic variation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "immune epitope database (IEDB)",
            " population coverage tool (",
            "Bui et al., 2006",
            ") estimates peptide-HLA binding coverage and the distribution of peptides displayed for a given population but assumes independence between different loci, and thus, does not consider linkage disequilibrium."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 4,
                "end": 34,
                "name": "immune epitope database (IEDB)"
            },
            false,
            {
                "id": "T2",
                "type": "Creator",
                "start": 61,
                "end": 77,
                "name": "Bui et al., 2006"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Immunogenicity data can be incorporated into the peptide scoring process that is used for both vaccine design and evaluation, as shown in italics in Figure 1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using this sliding-window approach, we created peptide sets from the SARS-CoV-2 (COVID-19) and SARS-CoV (human SARS coronavirus) proteomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We obtained the SARS-CoV-2 viral proteome from ",
            "GISAID",
            " (",
            "Elbe and Buckland-Merrett, 2017",
            ") sequence entry Wuhan/IPBCAMS-WH-01/2019, the first documented case."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 631,
                "end": 637,
                "name": "GISAID"
            },
            false,
            {
                "id": "T4",
                "type": "Creator",
                "start": 639,
                "end": 670,
                "name": "Elbe and Buckland-Merrett, 2017"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In EvalVax-Unlinked, we assume independence and use HLA allelic frequencies for 2,392 class I alleles and 280 class II alleles across 15 geographic regions from the ",
            "dbMHC",
            " database (",
            "Helmberg et al., 2004",
            ") obtained from the ",
            "IEDB",
            " population coverage tool (",
            "Bui et al., 2006",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 905,
                "end": 910,
                "name": "dbMHC"
            },
            false,
            {
                "id": "T6",
                "type": "Creator",
                "start": 921,
                "end": 942,
                "name": "Helmberg et al., 2004"
            },
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 962,
                "end": 966,
                "name": "IEDB"
            },
            false,
            {
                "id": "T8",
                "type": "Creator",
                "start": 993,
                "end": 1009,
                "name": "Bui et al., 2006"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We validated our computational models on a dataset of SARS-CoV-2 peptides evaluated for stability (Prachar et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Grifoni et al. (2020b) found that peptides from the S, M, and N proteins produced the majority of the CD4+ (86%) and CD8+ (60%) T cell response in 20 convalescent COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At present the World Health Organization lists 79 COVID-19 vaccine candidates in clinical or preclinical evaluation (WHO, 2020) (accessed May 16, 2020), and the precise designs of most of these vaccines are not public."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We encourage the early publication of vaccine designs to enable collaboration and rapid progress toward safe and effective vaccines for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For SARS-CoV-2, we obtained the most up to date version of the ",
            "GISAID",
            " database (",
            "Elbe and Buckland-Merrett, 2017",
            ") (as of 2:02pm EST May 13, 2020, see Table S4: ",
            "GISAID",
            " acknowledgements) and used ",
            "Nextstrain",
            " (",
            "Hadfield et al., 2018",
            ") to remove genomes with sequencing errors, translate the genome into proteins, and perform multiple sequence alignments (MSAs)."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Dataset",
                "start": 1744,
                "end": 1750,
                "name": "GISAID"
            },
            false,
            {
                "id": "T10",
                "type": "Creator",
                "start": 1761,
                "end": 1792,
                "name": "Elbe and Buckland-Merrett, 2017"
            },
            false,
            {
                "id": "T11",
                "type": "Dataset",
                "start": 1840,
                "end": 1846,
                "name": "GISAID"
            },
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 1874,
                "end": 1884,
                "name": "Nextstrain"
            },
            false,
            {
                "id": "T13",
                "type": "Creator",
                "start": 1886,
                "end": 1907,
                "name": "Hadfield et al., 2018"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We retrieved 24,468 sequences from ",
            "GISAID",
            ", and 19,288 remained after ",
            "Nextstrain",
            " quality processing."
        ],
        "lab": [
            false,
            {
                "id": "T14",
                "type": "Dataset",
                "start": 2071,
                "end": 2077,
                "name": "GISAID"
            },
            false,
            {
                "id": "T15",
                "type": "Repository",
                "start": 2105,
                "end": 2115,
                "name": "Nextstrain"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All peptides from SARS-CoV-2 were scanned against the entire human proteome downloaded from ",
            "UniProt",
            " (Consortium, 2019) under Proteome ID ",
            "UP000005640",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T16",
                "type": "Repository",
                "start": 2228,
                "end": 2235,
                "name": "UniProt"
            },
            false,
            {
                "id": "T17",
                "type": "AccessionNumber",
                "start": 2273,
                "end": 2284,
                "name": "UP000005640"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T16",
                "end": "T17"
            }
        ]
    },
    {
        "sen": [
            "Grifoni et al. (2020b) tested T cell responses from COVID-19 convalescent patients and found that peptides from the S, M, and N proteins of SARS-CoV-2 produce the dominant CD4+ and CD8+ responses when compared to other SARS-CoV-2 proteins."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We validate our computational models on a dataset of SARS-CoV-2 peptides evaluated for stability (Prachar et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For MHC class I alleles, the dataset contains 912 unique peptide-HLA pairs, of which 185 peptides are considered stable (≥ 60% stability)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For MHC class II, the dataset contains 93 total peptides, of which 22 are stable."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While NetMHCIIpan-4.0 with a 50 nM threshold does not identify any peptides in this dataset as binders, we use this stricter threshold in our vaccine designs as it is more conservative and less likely to admit false positive binders."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the database and literature, a single report on Buffalo-originated coronavirus strain collected from Bangladesh (BufCoV-HKU26-M) is available (Lau et al., 2016)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The global risk of the 2019 novel coronavirus (COVID-19 [SARS-CoV-2]) has recently been addressed by many scientists (Bogoch et al., 2020, Chinazzi et al., 2020, Global Health Policy, 2020, Wu et al., 2020, Zhu et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Outside China, COVID-19 transmission has been found in over 210 countries and territories (Global Health Policy, 2020, WHO, 2020c)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As the outbreak of the 2019 novel coronavirus (COVID-19 [SARS-CoV-2]) is spreading rapidly, the analysis of epidemiological data of COVID-19 is necessary to explore the disease burden and associated factors."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Spike (S), membrane (M), envelope (E) and nucleocapsid (N) protein sequences of SARS-CoV-2, HCoV-229E, HCoV-OC43, SARS-CoV, HCoV-NL63, HKU1, MERS-CoV, HKU4, HKU5 and BufCoV-HKU26 were retrieved from the ",
            "ViralZone",
            " root (",
            "https://viralzone.expasy.org/",
            ") and ",
            "UniProt",
            " (",
            "https://www.UniProt.org/",
            ") databases (Supplementary File 1)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 934,
                "end": 943,
                "name": "ViralZone"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 950,
                "end": 979,
                "name": "https://viralzone.expasy.org/"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 985,
                "end": 992,
                "name": "UniProt"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 994,
                "end": 1018,
                "name": "https://www.UniProt.org/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "Additionally, we retrieved epidemiological data for COVID-19 from different websites, such as the ",
            "World Health Organization (WHO)",
            ", ",
            "European Centre for Disease Prevention and Control (ECDC)",
            ", and other online news portals (",
            "WHO",
            ", 2020c; ",
            "ECDC",
            ", 2020; Pharmaceutical-technology, 2020; Reliefweb, 2020; Worldometers."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Creator",
                "start": 1152,
                "end": 1183,
                "name": "World Health Organization (WHO)"
            },
            false,
            {
                "id": "T6",
                "type": "Creator",
                "start": 1185,
                "end": 1242,
                "name": "European Centre for Disease Prevention and Control (ECDC)"
            },
            false,
            {
                "id": "T7",
                "type": "Creator",
                "start": 1275,
                "end": 1278,
                "name": "WHO"
            },
            false,
            {
                "id": "T8",
                "type": "Creator",
                "start": 1287,
                "end": 1291,
                "name": "ECDC"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 Coronavirus outbreak, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, the conservancy pattern of mostly immunogenic B cell peptide sequences of COVID-19 was compared with other homologous sequences retrieved from the ",
            "NCBI",
            " database by using BLASTp (Hasan et al., 2019b)."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 1563,
                "end": 1567,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, homologous sequences of SARS-CoV-2 S, M, E and N proteins were retrieved from the ",
            "NCBI",
            " database (Supplementary File 2) and were subjected to conservancy analysis with the immunogenic epitopes from SARS-CoV-2 proteins."
        ],
        "lab": [
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 1708,
                "end": 1712,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It was found that antigenic sites are almost conserved in all of the homologous protein sequences deposited in the ",
            "NCBI",
            " database (Table 2)."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Repository",
                "start": 1959,
                "end": 1963,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Cross-checked conservancy analysis of COVID-19 antigenic epitopes with SARS-CoV proteins showed that conservancy when cross-checked with other coronaviruses, including BufCoV-HKU26 of Bangladesh origin, was not significant (Table 3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The 3D structures of the SARS-CoV-2 proteins were modeled using the I-TASSER server, where ‘SARS-CoV complex with human neutralizing S230 antibody Fab fragment’ (",
            "PDB",
            " ID: ",
            "6NB6",
            "), ‘Membrane protein complex’ (",
            "PDB",
            " ID: ",
            "5X5Y",
            "), ‘Coronavirus Envelope Proteins’ (",
            "PDB",
            " ID: ",
            "2 MM4",
            ") and ‘SARS CoV Nucleocapsid’ (",
            "PDB",
            " ID: ",
            "1SSK",
            ") acted as the top threading templates of the S, M, E and N proteins, respectively."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 2380,
                "end": 2383,
                "name": "PDB"
            },
            false,
            {
                "id": "T13",
                "type": "AccessionNumber",
                "start": 2388,
                "end": 2392,
                "name": "6NB6"
            },
            false,
            {
                "id": "T14",
                "type": "Repository",
                "start": 2423,
                "end": 2426,
                "name": "PDB"
            },
            false,
            {
                "id": "T15",
                "type": "AccessionNumber",
                "start": 2431,
                "end": 2435,
                "name": "5X5Y"
            },
            false,
            {
                "id": "T16",
                "type": "Repository",
                "start": 2471,
                "end": 2474,
                "name": "PDB"
            },
            false,
            {
                "id": "T17",
                "type": "AccessionNumber",
                "start": 2479,
                "end": 2484,
                "name": "2 MM4"
            },
            false,
            {
                "id": "T18",
                "type": "Repository",
                "start": 2515,
                "end": 2518,
                "name": "PDB"
            },
            false,
            {
                "id": "T19",
                "type": "AccessionNumber",
                "start": 2523,
                "end": 2527,
                "name": "1SSK"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T12",
                "end": "T13"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T14",
                "end": "T15"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T16",
                "end": "T17"
            },
            {
                "id": "R6",
                "bool": true,
                "head": "T18",
                "end": "T19"
            }
        ]
    },
    {
        "sen": [
            "4."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Over two and half months, from its outbreak on 31 December 2019 to 20 March 2020, COVID-19 has spread to up to 182 countries and territories [Fig. 5(i)A] and one cruise ship named ‘Diamond Princess’ in Japan, affecting a total of 253,796persons globally, including in Bangladesh; however, China was the most affected country[Fig."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, COVID-19 resulted in a substantial burden in Iran, Germany, United States of America (USA), France and South Korea infecting 19,644, 17,372, 14,366, 10,995 and 8652 persons, respectively."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Fascinatingly, after 25 February 2020, cases outside China increased more than those in China, which was an alarming signal that COVID-19 became a pandemic [Fig. 5(i)and Supplementary Fig. 1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first death by COVID-19 occurred on 11 January 2000, and by 19 January 2020, another three persons had died."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among 182 countries and territories, 67 countries had experienced deaths from the COVID-19 outbreak by 20 March 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In China, 28 of 34 provinces experienced deaths from COVID-19, and the highest death toll occurred in Hubei (3122) Province, followed by Henan (22) and Heilongjiang (13); in other provinces, the death toll was below ten up until 19 March 2020 (Supplementary File 4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "(A) Cumulative confirmed cases of COVID-19 in globe and China* from January 21, 2020 to March 20, 2020**."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "(B) Cumulative confirmed cases of COVID-19 in Hubei province, China* excluding Hubei and outside china from January 21, 2020 to March 20, 2020**. (C) Cumulative global death toll of COVID-19 from January 11, 2020 to March 20, 2020*."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "(D) Global and country-wise case fatality of COVID-19 up to March 20, 2020*."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19, caused by novel coronavirus SARS-CoV-2, became a pandemic (Jung et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although the causative agent of COVID-19 has already been declared SARS-CoV-2 (Lai et al., 2020, Phan, 2020), we adopted a protein-based phylogenetic study to reveal the phylogenetic relationships and divergent links of SARS-CoV-2 with other human coronavirus strains."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Seven coronaviruses (COVID-19, HCoV-229E, HCoV-OC43, SARS-CoV, HCoV-NL63, HKU1 and MERS-CoV), two bat-originated coronaviruses (HKU4 and HKU5) and one buffalo-originated coronavirus (BufCoV-HKU26) reported from Bangladesh were subjected to phylogenetic analysis of four types of their viral proteins (S, M, E and N proteins)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the ",
            "NCBI",
            " database, the gene sequence of a buffalo coronavirus (BufCoV HKU26) from domestic water buffaloes (Bubalus bubalis) in Bangladesh is available (Lau et al., 2016)."
        ],
        "lab": [
            false,
            {
                "id": "T20",
                "type": "Repository",
                "start": 4947,
                "end": 4951,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 has already spread to all continents except Antarctica."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The temperature could be a factor reducing the risks of COVID-19 to Bangladesh, although the country has a high-risk index (Haider et al., 2020a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The high temperature and high humidity can effectively reduce the environmental persistence and transmission of the COVID-19 (Wang et al., 2020a), and temperature variation and humidity may be important factors affecting the COVID-19 mortality (Ma et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 (SARS-CoV-2) might have different persistence times on inanimate surfaces, but these times should be similar to those of SARS-associated viruses (3-4 days) (Kramer et al., 2006)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recently, the authors established that temperature significantly changed COVID-19 transmission in 429 cities, in which COVID-19 appeared to spread fastest at 8.72°C (Wang et al., 2020b)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, in affected countries, COVID-19 might disappear with rising temperatures when spring comes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Only 20 cases (including one death) of COVID-19 have been confirmed in Bangladesh as of March 20, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Many of the scientists speculated and revealed that high temperature and humidity have a role in restricting the spread of COVID-19, and the spread of disease would be suppressed in hot and humid weather (Sajadi et al., 2020, Zhang and Zeng, 2020), are in the line of our hypothesis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The antigenic sites of COVID-19 were also crosschecked with other coronavirus-corresponding proteins (Table 3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similar to COVID-19, the world experienced an epidemic of severe acute respiratory syndrome (SARS) in 2003 caused by a coronavirus also originating from China (Guangdong Province), which was suggested to be a potential zone of re-emergence of coronaviruses (Lai et al., 2020; WHO, 2020d)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, on March 14, 2020 WHO declared Europe as new epicentre of COVID-19 outbreak (www.who.int)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Within a very short time, COVID-19 was transmitted globally (WHO, 2020c;",
            "COVID-19 Coronavirus outbreak, 2020), infecting 2,53,796 persons globally (WHO, 2020c)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, COVID-19 has already covered approximately 5.52 times more countries than SARS and MERS (WHO, 2020c; Chen et al., 2005)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, up to March 20, 2020, COVID-19 has been attributed 30.03 and 101.76 times more cases, and 12.85 and 12.13 times more deaths globally than SARS and MERS, respectively (Worldometers."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 Coronavirus outbreak, 2020; Chen et al., 2005; WHO, 2020b)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For example, all of Italy has been placed under lockdown due to COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The majority of the cases are in mainland China, followed by Italy, Spain, Iran, Germany, USA, France and Korea and the World Health Organization has formally declared the COVID-19 outbreak a pandemic in March 11, 2020 (WHO, 2020c; Jung et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The case fatality of COVID-19 as of March 19, 2020 was 4.10% and 4.00% globally and in China, respectively."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, the global case fatalities of SARS (9.60%) and MERS (34.40%) were higher than that of COVID-19 (WHO, 2020b; Cameron et al., 2008)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 Coronavirus outbreak, 2020), which supports our estimate."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Despite the lower case fatality than the previous coronaviruses SARS and MERS, COVID-19 poses a great burden across the world in terms of geographical coverage, the occurrence of cases, and the cumulative death toll."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Over 182 countries and territories including Bangladesh reported COVID-19 cases, with more than 2,53,796 people infected globally as of March 20, 2020 (Global Health Policy, 2020, WHO, 2020c)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 coronavirus has spread in the neighboring countries of Bangladesh as well."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Further comprehensive studies that will combine genomic data, outbreak information, surveillance data, travel restrictions will help to generate information that will be necessary for a well-planned long-term strategy to mitigate COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2, a new coronavirus strain responsible for COVID-19, has emerged in Wuhan City, China, and continuing its global pandemic nature."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Descriptive epidemiological analysis on several epidemiological indices was performed on available epidemiological outbreak information from several open databases on COVID-19 (SARS-CoV-2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "•  COVID-19 poses a great burden across the world in terms of geographical coverage, occurrence of cases and death toll."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nidoviruses are a group of lipid-enveloped viruses with nonsegmented RNA genomes and are known to infect animals, including molluscs, arthropods, and vertebrates (1), and apparently also the oomycete Plasmopara (",
            "NCBI",
            " taxonomy ID ",
            "2692091",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 212,
                "end": 216,
                "name": "NCBI"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 229,
                "end": 236,
                "name": "2692091"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "Recently, a novel coronavirus (SARS-CoV-2) was identified as the causative agent of coronavirus disease 2019 (COVID-19), a severe respiratory disease that has been infecting humans since late 2019 (6, 7)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 presents itself with an incubation period ranging from 1 to 24 days followed by the potential development of a constellation of symptoms, including fever, dry cough, fatigue, diarrhea, myalgia, lymphopenia, dyspnea, and bilateral ground-glass opacities in the lungs (10–12)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In most moribund patients, COVID-19 is accompanied by an inflammatory cytokine storm (12), which suggests that virus-induced immunopathological events may play a role in the development of disease severity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, COVID-19’s ability to be transmitted during asymptomatic stages (14) makes prevention challenging."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The similarity plot of SARS-CoV-2-related CoVs compared to the human SARS-CoV-2 Wuhan-Hu-1 genome (",
            "GenBank",
            " accession no. ",
            "NC_045512.2",
            ") is drawn based on a multiple-sequence alignment of the whole genomes."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 1142,
                "end": 1149,
                "name": "GenBank"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 1164,
                "end": 1175,
                "name": "NC_045512.2"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "For the ",
            "NCBI",
            " accession numbers, refer to the Table S2."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 1255,
                "end": 1259,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Consistent with this prediction of being at the interface of a virus-host interaction, several polymorphisms have been reported in the ORF8 region of the genome both over the course of the SARS epidemic and during the current COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Remarkably, a recent study of patients in Singapore pointed to a 382-nt deletion in SARS-CoV-2 (48), suggesting parallel disruption of this gene during the COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We retrieved the SARS-CoV-2-related CoV genomes by searching against the nonredundant (nr) nucleotide database of the ",
            "National Center for Biotechnology Information (NCBI)",
            " with the SARS-CoV-2 genome sequence (",
            "GenBank",
            " accession no."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 1840,
                "end": 1892,
                "name": "National Center for Biotechnology Information (NCBI)"
            },
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 1930,
                "end": 1937,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To collect protein homologs, iterative sequence profile searches were conducted by the programs PSI-BLAST (position-specific iterated BLAST) (35) and JACKHMMER (51), which searched against the nonredundant (nr) protein database of ",
            "NCBI",
            ", with a cutoff E value of 0.005 serving as the significance threshold."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 2183,
                "end": 2187,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By using the HHsearch program (56), we searched with several candidate Ig domains against the Pfam domain database (34), which generated a collection of distinct Ig domains."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ongoing COVID-19 pandemic strongly emphasizes the need for a more complete understanding of the biology and pathogenesis of its causative agent SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was recently identified as the causative agent for the coronavirus disease 2019 (COVID-19) outbreak that has generated a global health crisis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In January, 2020, a cluster of patients with pneumonia of unknown cause was reported in Wuhan, China; the disease was subsequently named COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The clinical spectrum of COVID-19 varies from asymptomatic or mild symptomatic infections to severe respiratory symptoms and death, with older age groups generally presenting with more severe disease and higher death rates.2, 3 Since its identification, SARS-CoV-2 has rapidly spread across the globe."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On June 22, 2020, 177 countries had reported cases of COVID-19, adding up to more than 8·9 million reported cases and 468 000 deaths worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "During the WHO–China Joint Mission on COVID-19, 2055 laboratory confirmed cases were reported in health-care workers from 476 hospitals in China, mostly (88%) from Hubei province."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A follow-up study was done at three hospitals to assess the clinical presentations of COVID-19 of these health-care workers."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "PPE was used according to national guidelines that applied during this period of the outbreak.10, 11 Patients with suspected COVID-19 were nursed under strict isolation precautions and health-care workers applied additional PPE (gowns, gloves, goggles, hair cover, and type IIR surgical masks) on entering the isolation room."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Primers were trimmed using cutadapt, after which a reference-based alignment to the ",
            "GISAID (Global Initiative on Sharing All Influenza Data)",
            " sequence ",
            "EPI_ISL_412973",
            " was done using minimap2."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 1380,
                "end": 1436,
                "name": "GISAID (Global Initiative on Sharing All Influenza Data)"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 1446,
                "end": 1460,
                "name": "EPI_ISL_412973"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "All available full-length SARS-CoV-2 genomes were retrieved from ",
            "GISAID",
            " on March 20, 2020 (appendix 1 pp 8–65), and aligned with the newly obtained SARS-CoV-2 sequences in this study using the multiple sequence alignment software MUSCLE (version 3.8.1551)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 1551,
                "end": 1557,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "One health-care worker (who reported first symptoms on Feb 21, 2020) attended several carnival events while symptomatic but unaware of having COVID-19. 31 (32%) health-care workers reported close contact with an individual with confirmed COVID-19 in the 14 days before onset of symptoms, either a patient (n=3), colleague (n=18), household member (n=1), or another person outside the hospital (n=9)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2=severe acute respiratory syndrome coronavirus 2. ",
            "GISAID=Global Initiative on Sharing All Influenza Data",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 2203,
                "end": 2257,
                "name": "GISAID=Global Initiative on Sharing All Influenza Data"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Most (81–100%) health-care workers testing positive for SARS-CoV-2 at the three hospitals did not work on a ward with patients with confirmed COVID-19 (appendix 1 p 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the present study, we combined epidemiological data with WGS to obtain a deeper understanding of the sources and modes of transmission of SARS-CoV-2 at three hospitals in the south of the Netherlands, which were the first hospitals to identify patients with COVID-19 in the Netherlands."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although possible hospital transmission of SARS-CoV-2 and health-care workers with COVID-19 have been reported,3, 30, 31 to our knowledge, our study is the first to use WGS to analyse possible SARS-CoV-2 nosocomial transmission."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, the sequence-based analysis could be biased when sampling and sequencing is not done systematically and when sequence data in some areas are scarce, as is the case for COVID-19 internationally."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On January 30, 2020, the WHO declared the SARS‐CoV‐2 epidemic (COVID‐19) a public health emergency of international concern."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With a rapid increase in confirmed cases, there is an unmet need of prevention and therapeutic strategies of COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although COVID‐19’s clinical manifestations are dominated by respiratory symptoms, some patients have severe cardiovascular damage3., 4. and kidney disease contributing to multiple organ failure."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For example, COVID‐19 patients with hypertension have an increased mortality and morbidity with hazard ratio ranging from 1.7 to 3.05, depending on the study."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "During the epidemic in China, coagulopathy was reported in severe COVID‐19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coagulopathy was also found in fatal cases of COVID‐19 patients, including a significantly higher proportion of patients with D‐dimers above 500 ng/mL and prolonged prothrombin time (PT) in non‐survivors."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The hypothesis of microthrombi in kidneys was also suggested in COVID‐19 patients because high creatinine level was correlated with D‐dimers above 500 ng/mL."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Circulating endothelial cells (CECs) are considered relevant markers of endothelial lesion or dysfunction and were used to explore the potential vascular dysfunction in COVID‐19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "From March 14, 2020 to March 20, 2020, all consecutive patients aged over 18 years, presenting to the emergency room of the Georges Pompidou European hospital and fulfilling hospitalization criteria or direct in‐patient referral, with an infectious syndrome suspect of COVID‐19 were included."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Suspicion of COVID‐19 was defined by the presence of at least one of the following: fever, headache, myalgia, cough, dyspnea, rhinorrhea, or digestive symptoms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All COVID‐19‐suspected patients had a clinical evaluation, blood tests, and computed tomography (CT) scan, and were tested for SARS‐CoV‐2 infection by nasopharyngeal swab before they were transferred to dedicated hospitalization units: medical department or intensive care unit (ICU)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This model helped assess the extent to which the level of D‐dimers influenced the predictability of COVID‐19 diagnosis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among the 96 COVID‐19‐suspected patients included, 66 were positive for SARS‐CoV‐2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID‐19‐positive patients were more likely to be males (N = 44, 66.7%) than COVID‐19‐negative patients (N = 13, 43.3%; P = .05)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Considering clinical features at admission, COVID‐19‐positive patients were more likely to have fever (P = .02), cough (P = .03), and interstitial pneumonia at CT scan (P = .002)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In terms of biological features (Table 3",
            ") COVID‐19‐positive patients had a significantly lower white blood cell count, including neutrophil count (respectively, P = .008 and 0.02)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Regarding hemostasis, the proportion of COVID‐19‐positive patients with D‐dimers above 500 ng/mL was significantly higher (74.2% versus 43.3%; P = .007)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the context of COVID‐19‐associated coagulopathy with high levels of D‐dimers, fibrinogen, and CRP at admission, the low level of fibrin monomers and normal antithrombin levels allowed us to exclude a disseminated intravascular coagulation (DIC)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "When adding D‐dimers above 500 ng/mL to gender and pneumonia at CT scan, ROC curve area (Figure 1",
            ") significantly increased from AUC 0.73 (95% confidence interval [CI] 0.61‐0.85) to AUC 0.82 (95% CI 0.69‐0.95; P = .02), and confirm the relevance of D‐dimers in diagnosis of COVID‐19 at admission in hospital."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among COVID‐19‐positive patients, 64% were above this threshold, suggesting a SARS‐CoV‐2‐induced endothelial lesion."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For comparison, COVID‐19 negative population had fewer CECs (P = .008; Table 3) with only 27% above the normal range (P = .012)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Because the coagulopathy observed in COVID‐19 patients could be related to this endothelial lesion, we analyzed whether anticoagulation could impact CEC level."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Several Chinese studies found that increased D‐dimer level correlated with in‐hospital mortality,5., 7., 8. suggesting a COVID‐19‐associated DIC.7., 8., 23."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, the increase of D‐dimers largely reported in COVID‐19 patients is probably not related to DIC but might reflect the microthrombi formation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, a recent study using standardized protective ventilation settings in COVID‐19 patients confirmed that oxygenation was severely compromised with a moderate alteration in the respiratory system compliance."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In renal disease associated to COVID‐19, thrombotic lesions were proposed, because high D‐dimers were more commonly observed in patients with elevated baseline serum creatinine."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this context, the International Society on Thrombosis and Haemostasis (ISTH) has recently recommended measuring D‐dimers, PT ratio, and platelet count in all COVID‐19 patients to help stratify those who may benefit from hospitalization and a close monitoring."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, ISTH, the American College of Cardiology, and the French Society for Vascular Medicine suggested the use of prophylactic anticoagulation with low weight molecular heparin (LMWH) for COVID‐19 patients, in the absence of any contraindications."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Indeed, preventive LMWH treatment could be associated with better prognosis in severe COVID‐19 patients meeting sepsis‐induced coagulopathy criteria."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We further hypothesized that COVID‐19‐induced coagulopathy could be a consequence of endothelial injury, based on the rationale that SARS‐CoV‐2 has an endothelial tropism linked to ACE2 expression."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We found that more than 60% of COVID‐19‐positive patients were above this threshold."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Increased mortality and/or morbidity of COVID‐19 in patients with hypertension has been described in China."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, the main scientific societies of cardiology and more specifically of hypertension took the position not to withdraw ACEi or ARB therapy in COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hence, the Council on Hypertension of the European Society of Cardiology recommended that \"patients should continue treatment with their usual anti‐hypertensive therapy because there is no clinical or scientific evidence to suggest that treatment with ACEIs or ARBs should be discontinued because of the COVID‐19 infection.”",
            "Indeed, recent studies did not find any association between ACEi or ARBs therapy and worsening in COVID‐19 patients."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In our population patients treated with curative anticoagulation had a lower level of CECs, so we hypothesized that curative anticoagulation in COVID‐19 patients could decrease thrombotic risk and subsequent mortality."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "First, we are aware that false COVID‐19‐negative patients may exist in our study population due to the imperfect sensitivity of the diagnostic test currently used."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Second, the study population size was necessarily small given the emergency of understanding COVID‐19; indeed we decided to investigate the endothelial dysfunction associated to COVID‐19 in order to consider new therapeutic alternatives."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In conclusion, it therefore seems consistent to open the way to curative anticoagulant treatment as part of the management of COVID‐19 patients in order to limit associated coagulopathy and endothelial dysfunction (Figure 3",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Anticoagulation may not only modify COVID‐19‐associated coagulopathy but also pathophysiology of SARS‐CoV‐2 systemic dissemination."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Curative anticoagulation could decrease mortality observed in COVID‐19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Further studies should evaluate safety and efficacy of curative anticoagulation in COVID‐19 patients to prevent worsening of disease and reduction of admittance in ICUs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Background  Coronavirus disease‐2019 (COVID‐19) has been associated with cardiovascular complications and coagulation disorders."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To explore the coagulopathy and endothelial dysfunction in COVID‐19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The study analyzed clinical and biological profiles of patients with suspected COVID‐19 infection at admission, including hemostasis tests and quantification of circulating endothelial cells (CECs)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Results  Among 96 consecutive COVID‐19‐suspected patients fulfilling criteria for hospitalization, 66 were tested positive for SARS‐CoV‐2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID‐19‐positive patients were more likely to present with fever ( P = .02), cough ( P = .03), and pneumonia at computed tomography (CT) scan ( P = .002) at admission."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Prevalence of D‐dimer >500 ng/mL was higher in COVID‐19‐positive patients (74.2% versus 43.3%; P = .007)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Adding D‐dimers >500 ng/mL to gender and pneumonia at CT scan in receiver operating characteristic curve analysis significantly increased area under the curve for COVID‐19 diagnosis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID‐19‐positive patients had significantly more CECs at admission ( P = .008) than COVID‐19‐negative ones."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID‐19‐positive patients treated with curative anticoagulant prior to admission had fewer CECs ( P = .02) than those without."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Conclusion  Curative anticoagulation could prevent COVID‐19‐associated coagulopathy and endothelial lesion."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In total, 15,721 SARS-CoV-2 genome assemblies available on 12 May, 2020 were downloaded from the ",
            "GISAID",
            " (",
            "Shu and McCauley 2017",
            ") Initiative EpiCoV platform."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 97,
                "end": 103,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "Creator",
                "start": 105,
                "end": 126,
                "name": "Shu and McCauley 2017"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A pdm09 sequences for strains collected between January 2009 and August 2010 that contained segments PB2, PB1, PA, HA, NP, NA, MP, and NS were obtained from ",
            "GISAID",
            " (",
            "Shu and McCauley 2017",
            ") for four segments: RNA polymerase subunit (PB2), hemagglutinin (HA), nucleoprotein (NP), and neuraminidase (NA)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 313,
                "end": 319,
                "name": "GISAID"
            },
            false,
            {
                "id": "T4",
                "type": "Creator",
                "start": 321,
                "end": 342,
                "name": "Shu and McCauley 2017"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Multiple sequence alignment of 1,610 full Ebola virus (EBOV) genomes sampled between March 17, 2014 and October 24, 2015 in West Africa was downloaded from ",
            "EbolaID",
            " database (",
            "Carneiro and Pereira 2016",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 613,
                "end": 620,
                "name": "EbolaID"
            },
            false,
            {
                "id": "T6",
                "type": "Creator",
                "start": 631,
                "end": 656,
                "name": "Carneiro and Pereira 2016"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Phylogenetic tree of 11,204 SARS-CoV-2 isolates was downloaded from the ",
            "COVID-19 Genomics UK Consortium",
            " website (",
            "https://www.cogconsortium.uk/",
            ", version of April 24, 2020)."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 731,
                "end": 762,
                "name": "COVID-19 Genomics UK Consortium"
            },
            false,
            {
                "id": "T8",
                "type": "URL",
                "start": 772,
                "end": 801,
                "name": "https://www.cogconsortium.uk/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T7",
                "end": "T8"
            }
        ]
    },
    {
        "sen": [
            "In order to remove spurious homoplasic sites, a particular worry of this data set because a mix of technologies and methods have been employed by different contributing research groups, these were filtered using a set of parameters and thresholds defined in (van Dorp et al. 2020) to obtain a set of high-confidence homoplasies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Vertebrate virus sequences were retrieved from the ",
            "Virosaurus",
            " database (",
            "Virosaurus",
            " databases 2020_4.1, Release April 2020, file: Virosaurus90v 2020_4.1) (",
            "Gleizes et al. 2020",
            ") (accessed May 7, 2020)."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 1211,
                "end": 1221,
                "name": "Virosaurus"
            },
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 1232,
                "end": 1242,
                "name": "Virosaurus"
            },
            false,
            {
                "id": "T11",
                "type": "Creator",
                "start": 1314,
                "end": 1333,
                "name": "Gleizes et al. 2020"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this database, complete sequences were clustered at 90% to remove redundancy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As in this database, herpesviridae and poxviridae are split in genes rather than full genomes, complete sequences for these viruses were retrieved from ",
            "NCBI RefSeq",
            " database (",
            "Pruitt et al. 2005",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 1592,
                "end": 1603,
                "name": "NCBI RefSeq"
            },
            false,
            {
                "id": "T13",
                "type": "Creator",
                "start": 1614,
                "end": 1632,
                "name": "Pruitt et al. 2005"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For virus sequences obtained from the ",
            "Virosaurus",
            " database, the mean was derived to obtain one value per species."
        ],
        "lab": [
            false,
            {
                "id": "T14",
                "type": "Repository",
                "start": 1673,
                "end": 1683,
                "name": "Virosaurus"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 pandemic has been slow to arrive in the world’s poorest countries, especially in Africa."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To adequately preview the impact of COVID-19 on the continent, however, both weaknesses and strengths must be considered."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The country-to-country effects of COVID-19 could be quite different, and there are resources that may help produce better than expected outcomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The population structure in Africa is relatively protected against serious COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Notably, OO simulations have repeatedly foreshadowed the political distrust and altercations that have increased alongside COVID-19 in the US."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As with COVID-19 (Kupferschmidt, 2020), these super-spreader events accounted for a significant fraction of cases—in the simulation, 30% of all secondary infections were caused by these two participants."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At the time of this report in June 2020, the number of cases in the United States has reached nearly 2.2 million, and the number of deaths has exceeded 100,000, according to the ",
            "Johns Hopkins University",
            " database (3)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Creator",
                "start": 178,
                "end": 202,
                "name": "Johns Hopkins University"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 is the etiologic agent of coronavirus disease 2019 (COVID-19), for which symptoms can vary from mild (e.g., fever, fatigue, dry cough) to severe illness (e.g., dyspnea, persistent pain or pressure in the chest, hypoxia, confusion), and can ultimately lead to death, particularly for those ≥65 years of age and those with certain underlying medical conditions, such as heart disease, lung disease, or diabetes (4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The majority of the SARS-CoV-2 NAATs available today are based on real-time reverse transcription PCR (RT-PCR) methods, including the BioFire Defense COVID-19 test (BioFire) and the Hologic Panther Fusion SARS-CoV-2 assay (Fusion) evaluated in the present study."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The BEI Resources material was provided at a concentration of 4.1 × 109 genome equivalents (GE)/ml (2.8 × 105 50% tissue culture infective doses [TCID50]/ml before inactivation of the virus), from which the following serial dilutions were prepared (in GE/ml): 1,000, 500, 250, 125, 62.5, and 31.3."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Other comparator studies of the Fusion assay have recently been reported, including the following: a study comparing the Fusion assay to the modified CDC assay, GenMark ePlex, and DiaSorin Simplexa (6); a study comparing Cepheid, ID NOW, and GenMark assays using Fusion as the reference standard (7); a study comparing Fusion, Cepheid, DiaSorin, and cobas assays and a laboratory-developed test (LDT) (8); and a study comparing Fusion to an in-house LDT targeting the envelope gene (9)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This study compared three of these assays, the Hologic Panther Fusion SARS-CoV-2 assay (Fusion), the Hologic Aptima SARS-CoV-2 assay (Aptima), and the BioFire Defense COVID-19 test (BioFire), to determine analytical and clinical performance as well as workflow."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This study compared three of these assays, the Hologic Panther Fusion SARS-CoV-2 assay (Fusion), the Hologic Aptima SARS-CoV-2 assay (Aptima), and the BioFire Defense COVID-19 test (BioFire), to determine analytical and clinical performance as well as workflow."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Cold viruses have generally been considered fairly innocuous until the appearance of the severe acute respiratory coronavirus 2 (SARS-CoV-2) in 2019, which caused the coronavirus disease 2019 (COVID-19) global pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In comparison to severe acute respiratory syndrome coronavirus (SARS-CoV), SARS-CoV-2 appears to be more contagious [1], and coronavirus disease 2019 (COVID-19) patients demonstrate varied clinical manifestations distinct from those seen in patients with SARS-CoV and Middle East respiratory syndrome coronavirus infections [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Collective results from the clinical and epidemiological observations suggest a distinct viral–host interaction in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This study was designed to better understand the timing and patterns of humoral immune responses to SARS-CoV-2 in a cohort of COVID-19 patients and evaluate their relationship with the disease course and severity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "37 patients with COVID-19, with a mean±sd age of 52.3±16.3 years, were enrolled in this study."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The enrolled COVID-19 patients consisted of 25 (67.6%) males and 12 (32.4%) females."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to the “Guidelines for the Diagnosis and Treatment of Novel Coronavirus (2019-nCoV) Infection” published by the National Health Commission of China, the enrolled COVID-19 patients were categorised into two groups: 20 (54.1%) severe cases and 17 (46.0%) nonsevere cases [4]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The nonsevere group included patients with mild and moderate symptoms who were also required to be admitted to hospital by the COVID-19 control policy in China."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Critically ill patients met at least one of the extra following conditions in addition to the COVID-19 diagnosis: 1) respiratory failure that required mechanical ventilation; 2) shock; or 3) multiple organ failure that required transfer to the intensive care unit."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In further subgroup analysis, we found a significant positive association between the level of SARS-CoV-2-specific IgA and the Acute Physiology and Chronic Health Evaluation (APACHE)-II score in critically ill patients with COVID-19 (r=0.72, p=0.01), while the level of SARS-CoV-2-specific IgG and IgM did not show correlations with disease severity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Considering the roles of mucosal and systemic IgA in COVID-19, inducing IgA production (using lactoferrin to activate canonical TGF-β signalling [13] or retinoic acid to enhance lactoferrin-induced IgA responses [14]) has been proposed as a novel therapy for severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, as highlighted by our study, enhanced IgA responses observed in severe COVID-19 might confer damaging effects in severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As a result, we hypothesise that severe COVID-19 might be at least in part an IgA-mediated disease (related to IgA deposition and vasculitis), which helps to explain common organ injuries in COVID-19, e.g. acute pulmonary embolism, kidney injury, etc. [15]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Future investigative efforts are certainly needed to explore the functional significance of mucosal and systemic IgA in COVID-19 and whether local interventions at the mucosal level of the nasopharynx/oropharynx could reduce viral load and symptoms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In comparison to severe acute respiratory syndrome coronavirus (SARS-CoV), SARS-CoV-2 appears to be more contagious [1], and coronavirus disease 2019 (COVID-19) patients demonstrate varied clinical manifestations distinct from those seen in patients with SARS-CoV and Middle East respiratory syndrome coronavirus infections [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Collective results from the clinical and epidemiological observations suggest a distinct viral–host interaction in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Humoral immune response to SARS-CoV-2 showed an early response of IgA, instead of IgM, in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As highlighted by this study, enhanced IgA responses observed in severe COVID-19 might confer damaging effects in severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of April 26, 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is known to have infected 2,804,796 persons globally, and 193,710 have had coronavirus disease 2019 (COVID-19) at the time of death (1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Single-cell RNA sequencing (scRNAseq) in human and nonhuman primate respiratory tissues has shown coexpression of ACE2 and TMPRSS2 in pneumocytes in the lungs and goblet secretory cells in the nose (6), indicating that these cell types may serve as foci for infection and potentially explaining the range of respiratory symptoms associated with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coexpression has also been reported in other tissue types, including the ileum, heart, and kidney, for which there are also established COVID-19 symptoms (5, 7, 8, 9, 10, 11)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Given that the clinical features of COVID-19 appear to be largely determined by the tissues with coexpression of ACE2 and TMPRSS2 in their constituent cells, it is conceivable that viral infection could have an impact on reproductive function if cells of the male and/or female reproductive systems also express these genes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Reproductive indices are not typically assessed in the intensive care unit setting, and any effects of COVID-19 on fertility may not be readily apparent until epidemiological data become available."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Understanding whether SARS-CoV-2 has the capacity to infect gametes and embryos produced in vitro is of great importance when considering the risks of natural and assisted reproduction during the COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To visualize “dimensionality” of the dataset, we plotted the principal components using an elbow plot."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This indicated that PC 1 to 13 explained the majority of the variance in both datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of note, these publicly available bulk RNA and protein datasets were generated independently from the previously described scRNAseq datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Published scRNAseq datasets in human testicular (18) and nonhuman primate ovarian (19) tissue were used to assess the cell-type specific expression pattern of SARS-CoV-2 entry receptor ACE2 and entry-associated protease TMPRSS2 and their coexpression."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additionally, a novel RNAseq dataset was available for human cumulus cells and provided supplementary data on gene expression levels in that cell type."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "From scRNAseq datasets, we annotated 11 previously identified cell types of the testes, including somatic niche cells (Leydig cells, endothelial cells, myoid cells, and macrophages) and germ cells (differentiating spermatogonia, early primary spermatocytes, late primary spermatocytes, round spermatids, elongated spermatids, and sperm (Fig. 1A and B",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Proteomic expression of ACE2 (Fig. 4",
            "A), TMPRSS2 (Fig. 4B), BSG (Fig. 4C), and CTSL (Fig. 4D) was queried from two publicly available databases, the ",
            "Human Protein Atlas (HPA)",
            " and the Human Proteome Map."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 2729,
                "end": 2754,
                "name": "Human Protein Atlas (HPA)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Protein expression in ovarian, testicular, endometrial, and placental tissue was correlated with bulk cell RNA expression data from four publicly available datasets: the ",
            "HPA",
            " and ",
            "GTEx",
            " datasets, which both use RNA-seq; the ",
            "FANTOM5",
            " dataset, which uses cap analysis gene expression; and the ",
            "HPA",
            " consensus dataset, a consensus dataset of the other three RNA datasets."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 2953,
                "end": 2956,
                "name": "HPA"
            },
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 2961,
                "end": 2965,
                "name": "GTEx"
            },
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 3004,
                "end": 3011,
                "name": "FANTOM5"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 3070,
                "end": 3073,
                "name": "HPA"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The low sequencing depth of scRNAseq datasets means that many cells will have no expression by chance; therefore, bulk RNAseq datasets, sequenced at higher depths, can serve as a useful point of comparison."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There was general agreement between the expression data from the two protein datasets and the RNA datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In ovarian cells, TMPRSS2 was not detected by either protein profiling platform, which was supported by the external RNA datasets (Fig. 4B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The underrepresentation of Sertoli cells in the scRNAseq data may account for some of the discrepancy in the ACE2 expression profile between these two datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "TMPRSS2 was found to be expressed only at a low level in the RNA datasets and was not detectable by either protein platform (Fig. 4B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is not yet clear what effects, if any, the COVID-19 pandemic will have on male and female fertility."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "More recently, Wagner et al. (24) performed scRNAseq of the outer cortex, containing both germinal and somatic cell types, producing data that could potentially serve as an external validation dataset if expression matrices are made available."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of yet, no autopsy reports in persons with laboratory-confirmed COVID-19 at the time of death have assessed SARS-Cov-2 replication in the reproductive system."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Further experimental data in ovarian tissue from women of reproductive age with COVID-19 is needed to confirm whether the female germ cells can be infected."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Publicly available developmental scRNAseq databases reveal no coexpression of ACE2 and TMPRSS2 in fetal tissues, including liver, thymus, skin, bone marrow, and yolk sac (6)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These conclusions are supported by the lack of ACE2 and TMPRSS2 protein expression in endometrial and placental tissue (",
            "HPA",
            "/IHC datasets) described in this study."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 4860,
                "end": 4863,
                "name": "HPA"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The limited clinical data available have also indicated a lack of vertical transmission in newborns of pregnant women who had confirmed COVID-19 in the third trimester (29)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additionally, obstetric outcomes for babies born to mothers infected with SARS-CoV-2 have not shown any impact of COVID-19 on pregnancy (30)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nonetheless, they add to a growing body of evidence suggesting that most aspects of reproduction during the COVID-19 pandemic are unlikely to be associated with increased risks of clinical complications."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Provided adequate precautions can be instituted to ensure the safety of patients attending fertility clinics, as well as that of clinical staff, it seems reasonable to consider the reintroduction of IVF treatments (at a minimum cycles involving cryopreservation of embryos) in countries where the response to COVID-19 currently includes a severe restriction or denial of patient access to fertility treatments."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There was general agreement between publicly available bulk RNA and protein datasets in terms of ACE2 and TMPRSS2 expression patterns in testis, ovary, endometrial, and placental cells."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 pandemic has caused an unprecedented threat to healthcare delivery worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This has had a marked impact on services and patient care for patients without COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "National guidelines recommended that surgery for malignant tumours should continue during the COVID-19 pandemic providing adjuvant oncology treatment is available."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Data were compared with a baseline MDT workload from the 4 weeks of February (3–28 February 2020) to provide information on the impact of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Project leads were invited to comment with free text on how their unit responded to COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using this free text, we developed three groups that arranged units based on commonly expressed themes of how they managed to mitigate the challenges of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In total, 131 patients (10.7%) had a change in their initial management due to COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Project leads commented that COVID-19 had less impact on their units or were able to cope with the numbers of referrals."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This national study has shown the impact COVID-19 has had on MDT decision making for malignant (gliomas and metastases) brain tumour patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Like other cancers, COVID-19 has impacted on referrals.8",
            "Group analysis identified trends in units that successfully reduced the impact of COVID-19 on MDT management."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our findings complement other studies that have shown that the use of the private sector during this COVID-19 pandemic results in less disruption to services."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "11",
            "Objectives  Pressures on healthcare systems due to COVID-19 has impacted patients without COVID-19 with surgery disproportionally affected."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Each unit decided if management decision for each patient had changed due to COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Conclusion  COVID-19 has had an impact on patients requiring surgery for malignant brain tumours, with patients receiving different treatments—most commonly not receiving surgery or any treatment at all."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This study was registered with the Royal College of Surgeons of England’s COVID-19 Research Group ( https://www.rcseng.ac.uk/coronavirus/rcs-covid-research-group/ )."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In Yichang city, Hubei province, the first outbreak of coronavirus disease 2019 (COVID‐19) commenced on 24 January 2020 in the Yichang Third People's Hospital."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With 931 persons becoming infected and the increasing number of COVID‐19 patients, the medical resources of the Yichang Third People's Hospital were in short supply."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this case, Jiangnan District of Yichang Central People's Hospital has been put into use urgently, and nearly 30% of COVID‐19 confirmed patients in Yichang have been treated in our hospital."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, although there are concerns about whether the use of corticosteroids will slow down the clearance of the coronavirus",
            " and increase the possibility of opportunistic infections",
            ", in severe cases, especially in critically ill COVID‐19 patients, the use of corticosteroids seems to be indispensable."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            ",",
            "A retrospective comparison study was performed on COVID‐19 patients under 50 years old who were admitted between 30 January and 20 February 2020."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Regardless of whether the patient has a positive nucleic acid test result before hospital admission, we re‐tested the nasopharyngeal swabs for COVID‐19 on the first day of admission."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Typology of COVID‐19: Mild: the clinical symptoms are mild and no pneumonia manifestations can be found in imaging."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID‐19 is an animal‐derived virus,",
            " bats may be the host of the virus and intermediate hosts may include pangolins."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To date, 237 cases of COVID‐19 diagnosed patients in Yichang City, Hubei Province have been treated in our hospital."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The age of all the COVID‐19 patients treated in our hospital range from 0.5 to 87 years old, and there is no significant difference in the number of infections based on their gender, which indicates that the entire population is susceptible to COVID‐19, regardless of gender or age."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Unfortunately, there are still no specific drug to treat COVID‐19 at present."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In our retrospective non‐randomized study, 34 patients under 50 years old and diagnosed with coronavirus disease 2019 (COVID‐19) were included."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By comparing the clinical data we concluded that corticosteroids therapy can effectively release COVID‐19 symptoms such as persistent fever and difficult in breathing, improve oxygenation, and prevent disease progression."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Highlights  1. The use of glucocorticoids prolongs the time required for COVID‐19 patients to turn negative consecutively for nucleic acids test."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "2. The use of glucocorticoids in critical and severe COVID‐19 typology patients can prevent the progression of this disease, especially to promote the absorption of CT lesion images  3."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We confirm the safety and necessity of glucocorticoids applications in severe and critical COVID‐19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Methods:  Linear regression, hierarchical clustering, pathway analysis, and network analysis were performed using the E-GEOD-17400 data set."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 pandemic has made brutally clear the need for further research into many aspects of viruses."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To assess the concentration of infectious viruses, researchers typically measure the '50% tissue-culture infectious dose' (TCID50)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Measuring TCID50 involves infecting replicate cultures of susceptible cells with dilutions of the virus and noting the dilution at which half the replicate dishes become infected."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Viral counts reported by TCID50 tend to be much lower than RT-qPCR measurements, which could be one reason why studies relying on RNA measurements (Moriarty et al., 2020) report the persistence of viral RNA on surfaces for much longer times than studies relying on TCID50 (van Doremalen et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For the common cold, for example, ~0.1 TCID50 are sufficient to infect half of the people exposed (Couch et al., 1966)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At the time of writing, such assays are not widely available, and so researchers resort to surrogate datasets generated by testing of foreign citizens returning home from infected countries (Verity et al., 2020; Nishiura et al., 2020), large-scale semi-random testing in countries such as Iceland, near complete testing of passengers on the Diamond Princess ship (Russell et al., 2020), or epidemiological models estimating the number of undocumented cases (Li et al., 2020a; Mizumoto et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "(Godet et al., 1992): \"Based on the estimated molar ratio and assuming that coronavirions bear 100 (J Gen Virol",
            "63: 241–245) to 200 spikes, each composed of 3 s molecules (Virus Research",
            "20:107–120) it can be inferred that approximately 15–30 copies of ORF4 protein are incorporated into TGEV virions (Purdue strain).\"",
            "The COVID-19 pandemic is a harsh reminder of the fact that, whether in a single human host or a wave of infection across continents, viral dynamics is often a story about the numbers."
        ],
        "lab": [
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The World Health Organization declare this 2019-nCoV outbreak as a public health emergency of international concern on January 30th, 2020 (WHO, 2020b) and the disease caused by this specific virus species have recently been designated as COVID-19 (Coronavirus Infectious Disase-19) (WHO, 2020a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Available and comparable complete genome sequences of 81 βCoV strains isolated in China, including SARS-CoV-2 as well as βCoV isolated from different hosts, were obtained from ",
            "GenBank",
            " database (available at: ",
            "http://www.ncbi.nlm.nih.gov",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 472,
                "end": 479,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 504,
                "end": 531,
                "name": "http://www.ncbi.nlm.nih.gov"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "For accession number, strain name, host and date of isolation, see Supplementary material Table 1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The dataset comprised a total of 725,433 codons."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By the same approach, Heatmaps were also constructed, which is a data matrix for visualizing values in the dataset by the use of a color gradient."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The role of host genetics in impacting susceptibility and severity of COVID-19 has been less studied."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For example, in Finland with the national network of biobanks covering each hospital district, it is possible to acquire almost ‘real-time’ updates on COVID-19 status of individuals that are already part of the FinnGen study2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease 2019 (COVID-19) is a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1], which was first identified in Wuhan, China, in December 2019, and has rapidly spread globally, resulting in the ongoing pandemic [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recently, Korean Society for Laboratory Medicine (KSLM) and the Korea Centers for Disease Control and Prevention (KCDC) published guidelines for diagnosing COVID-19 in clinical laboratories in Korea [3]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These guidelines provide appropriate solutions to COVID-19 diagnosis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, many practical and technical issues frequently arise in clinical laboratories conducting COVID-19 testing, including those involving nucleic acid extraction, nucleic acid amplification reagents, and interpretation of test results."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 Diagnosis Test Management Committee was established by the KCDC on Feb 28, 2020, to provide appropriate solutions to such matters in the field through careful review and counseling by specialized experts in the public and private sectors."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On behalf of the COVID-19 Diagnosis Test Management Committee, we present supplementary information to the “Guidelines for Laboratory Diagnosis of COVID-19 in Korea” to provide solutions for practical issues faced when conducting COVID-19 diagnostic testing using real-time reverse transcription (RT)-PCR [3]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These practical guidelines are mostly based on expert opinions regarding samples, nucleic acid extraction, nucleic acid amplification reagents, and interpretation of test results and have been formed with the experience from more than 700,000 COVID-19 tests using five emergency use authorization (EUA) assays in Korea."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since eNAT contains guanidine thiocyanate (a type of chaotropic salt) that prevents the degradation of nucleic acids in the medium, it is a good option when testing microbial nucleic acids only; the same applies to the COVID-19 real-time RT-PCR test."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, heat inactivation of samples through treatment at 56°C for 30 minutes was shown to adversely affect the efficiency of RT-PCR for SARS-CoV-2 detection [8]; therefore, proteinase K treatment at 50–65°C is not recommended for COVID-19 real-time RT-PCR."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The product manual of the DiaPlexQ 2019-nCoV kit (SolGent, Daejeon, Korea) states that a sample can indicate COVID-19 infection if the result for one of the two genes is positive."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This is in contrast with the KSLM guidelines, which specifies that confirmation of COVID-19 requires positive results for all genes [3]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Both Allplex 2019-nCoV (Seegene, Seoul, Korea) and Standard M nCoV Real-Time Detection kits (SD Biosensors, Suwon, Korea) have the advantage of facilitating the observation of the entire process of COVID-19 molecular testing to check nucleic acid extraction, the impact of the PCR inhibitor, and nucleic acid amplification since the IC is directly added to the sample before nucleic acid extraction."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The KCDC’s criteria for the quarantine release of patients with COVID-19 include clinical improvement with negative results from at least two consecutive respiratory samples collected ≥24 hours apart [17]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease 2019 (COVID-19) is a respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Early detection of COVID-19 and immediate isolation of infected patients from the naive population are important to prevent further pandemic spread of the infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Real-time reverse transcription (RT)-PCR to detect SARS-CoV-2 RNA is currently the most reliable diagnostic method for confirming COVID-19 worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Guidelines for clinical laboratories on the COVID-19 diagnosis have been recently published by Korean Society for Laboratory Medicine and the Korea Centers for Disease Control and Prevention."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, these formal guidelines do not address common practical laboratory issues related to COVID-19 real-time RT-PCR testing and their solutions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, this guideline is intended as a practical and technical supplement to the “Guidelines for Laboratory Diagnosis of COVID-19 in Korea”."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease (COVID-19) was caused by severe acute respiratory syndrome coronavirus",
            "2 (SARS-CoV-2), a newly discovered coronavirus with a size of 60–140 nm, located in the SARB",
            "subgene of the Betacoronavirus family [1]."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As on 2:00am CEST, 18 April 2020, there have",
            "been 2,160,207 confirmed cases of COVID-19, including 146,088 deaths globally [3]."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to an analysis of",
            "44,672 confirmed cases out of 72,314 reported cases by the Chinese Center for Disease",
            "Control and Prevention (CDC), the crude case fatality rate of the patients with severe",
            "COVID-19 reached 49%."
        ],
        "lab": [
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "No vaccine for SARS-CoV-2 has been published publicly, and there was no medication specific",
            "for the treatment of COVID-19 so far [6]."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It was",
            "proved that Traditional Chinese Medicine (TCM) could obviously shorten fever duration and",
            "symptomatic relief of the patients with severe COVID-19 [7–9]."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Up to now, ‘three medicines and three formulas’",
            "have been proven effective in treating the COVID-19."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among them, Huashi Baidu formula",
            "(HSBDF) was used as an auxiliary medicine for the treatment of patients with severe",
            "COVID-19."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to the theory of TCM, the core pathogenesis of COVID-19 was the wet epidemic",
            "caused by the cold and humidity outside the lung and spleen, which was transformed into heat",
            "and lead to heat stagnation due to the imbalance of qi mechanism and endogenous stagnated",
            "heat [11]."
        ],
        "lab": [
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The combination of",
            "SARS-CoV-2 and ACE2 was the main cause of COVID-19."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The protein targets associated with active compounds were retrieved from the ",
            "TCMSP",
            "",
            "database (",
            "http://lsp.nwsuaf.edu.cn/tcmsp.php",
            "), which provided information of 6511 drug",
            "molecules and 3987 targets as well as the interactions between them [19]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1529,
                "end": 1534,
                "name": "TCMSP"
            },
            false,
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 1545,
                "end": 1579,
                "name": "http://lsp.nwsuaf.edu.cn/tcmsp.php"
            },
            false,
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "As an authoritative database of protein sequences, ",
            "UniProt Knowledgebase (UniProtKB)",
            " comprised 54,247,468 sequence items [24]."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 1747,
                "end": 1780,
                "name": "UniProt Knowledgebase (UniProtKB)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The targets, including the gene names and gene ID, were further extracted using ",
            "UniProtKB",
            " (",
            "http://www.uniprot.org",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 1903,
                "end": 1912,
                "name": "UniProtKB"
            },
            false,
            {
                "id": "T5",
                "type": "URL",
                "start": 1914,
                "end": 1936,
                "name": "http://www.uniprot.org"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T4",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "Visual component–target network was established based on aforementioned data sets through Cytoscape 3.7.2 (http://www.cytoscape.org/) to reflect the complex relationships between active compounds and their potential targets [25]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "",
            "GeneCards",
            " database (",
            "https://www.genecards.org/",
            ") and ",
            "Therapeutic Target Database (TTD",
            ", ",
            "https://db.idrblab.org/ttd/",
            ") were used to gather the information on",
            "COVID-19-associated target genes [28]."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 2169,
                "end": 2178,
                "name": "GeneCards"
            },
            false,
            {
                "id": "T7",
                "type": "URL",
                "start": 2189,
                "end": 2215,
                "name": "https://www.genecards.org/"
            },
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 2221,
                "end": 2253,
                "name": "Therapeutic Target Database (TTD"
            },
            false,
            {
                "id": "T9",
                "type": "URL",
                "start": 2255,
                "end": 2282,
                "name": "https://db.idrblab.org/ttd/"
            },
            false,
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T6",
                "end": "T7"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T8",
                "end": "T9"
            }
        ]
    },
    {
        "sen": [
            "",
            "GeneCards",
            " is a comprehensive database of functions involving proteomics, genomics, and",
            "transcriptomics [29]."
        ],
        "lab": [
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 2362,
                "end": 2371,
                "name": "GeneCards"
            },
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The keywords ‘novel",
            "coronavirus pneumonia,’ ‘cough,’ and ‘fever’ were utilized to screen the",
            "COVID-19-associated targets."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The names of targets were collected from ",
            "TTD",
            ", which provided",
            "information about the therapeutic protein targets, the corresponding ID of each targets",
            "and the targeted disease."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Repository",
                "start": 2634,
                "end": 2637,
                "name": "TTD"
            },
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The common targets of HSBDF and COVID-19 were then gathered as",
            "the core targets of HSBDF for COVID-19."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 222 active compounds were retrieved in ",
            "TCMSP",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 2921,
                "end": 2926,
                "name": "TCMSP"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 216 possible targets of COVID-19 were screened through ‘novel coronavirus",
            "pneumonia,’ ‘cough,’ and ‘fever.’",
            "The",
            "network contained a total of 53 nodes, which were the core targets of HSBDF in the",
            "treatment of COVID-19."
        ],
        "lab": [
            false,
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since both SARS and COVID-19 were",
            "caused via binding S-protein to ACE2 [37,38], quercetin acted as",
            "a competitive antagonist to inhibit infection of SARS-CoV-2."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Abstract   Purpose  Huashi Baidu formula (HSBDF) was developed to treat the patients with severe COVID-19 in China."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All the components of HSBDF were retrieved from the pharmacology database of TCM system."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The genes corresponding to the targets were retrieved using ",
            "UniProt",
            " and ",
            "GeneCards",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T13",
                "type": "Repository",
                "start": 3591,
                "end": 3598,
                "name": "UniProt"
            },
            false,
            {
                "id": "T14",
                "type": "Repository",
                "start": 3603,
                "end": 3612,
                "name": "GeneCards"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The target protein–protein interaction network was built using STRING database."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Conclusion  Baicalein and quercetin in HSBDF may regulate multiple signaling pathways through ACE2, which might play a therapeutic role on COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The genome sequences of these viruses were obtained from the ",
            "RefSeq",
            " database (",
            "ftp://ftp.ncbi.nlm.nih.gov/genomes/refseq/viral/",
            ") and RNA fragments of 260 base in length were generated based on these viral genomic sequences."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 61,
                "end": 67,
                "name": "RefSeq"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 78,
                "end": 126,
                "name": "ftp://ftp.ncbi.nlm.nih.gov/genomes/refseq/viral/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "Since mRNAs incorporating modified nucleosides such as pseudouridine and methylcytidine may make these RNAs less immunogenic [7], pseudouridine instead of uridine and methylcytidine instead of cytidine were used as substrates for IVT."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also added an anti-reverse cap analog (ARCA) into the substrate mix to act as a modified nucleoside for incorporation as the 5′ cap of the IVT mRNA, to avoid inhibition of translation [8]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To examine whether the identified RNA stabilizing regions are evolutionarily conserved, we compared the genomes of 37 viruses belonging to the Coronaviridae family (Table S6), including human and bat coronaviruses from the ",
            "RefSeq",
            " database (",
            "ftp://ftp.ncbi.nlm.nih.gov/genomes/refseq/viral/",
            ") and SARS-CoV-2 from the ",
            "NCBI Nucleotide",
            " database (",
            "https://www.ncbi.nlm.nih.gov/nuccore/MN908947",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 873,
                "end": 879,
                "name": "RefSeq"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 890,
                "end": 938,
                "name": "ftp://ftp.ncbi.nlm.nih.gov/genomes/refseq/viral/"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 964,
                "end": 979,
                "name": "NCBI Nucleotide"
            },
            false,
            {
                "id": "T6",
                "type": "URL",
                "start": 990,
                "end": 1035,
                "name": "https://www.ncbi.nlm.nih.gov/nuccore/MN908947"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "The genomic sequences of 26 different viral genomes across all groups of the Baltimore classification [6,13] (Table S1) were acquired from the ",
            "RefSeq",
            " database (",
            "ftp://ftp.ncbi.nlm.nih.gov/genomes/refseq/viral/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 1181,
                "end": 1187,
                "name": "RefSeq"
            },
            false,
            {
                "id": "T8",
                "type": "URL",
                "start": 1198,
                "end": 1246,
                "name": "ftp://ftp.ncbi.nlm.nih.gov/genomes/refseq/viral/"
            },
            false
        ],
        "rel": [
            {
                "id": "R4",
                "bool": true,
                "head": "T7",
                "end": "T8"
            }
        ]
    },
    {
        "sen": [
            "Genome sequences of viruses from the Coronaviridae family were obtained from the ",
            "RefSeq",
            " database (",
            "ftp://ftp.ncbi.nlm.nih.gov/genomes/refseq/viral/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 1330,
                "end": 1336,
                "name": "RefSeq"
            },
            false,
            {
                "id": "T10",
                "type": "URL",
                "start": 1347,
                "end": 1395,
                "name": "ftp://ftp.ncbi.nlm.nih.gov/genomes/refseq/viral/"
            },
            false
        ],
        "rel": [
            {
                "id": "R5",
                "bool": true,
                "head": "T9",
                "end": "T10"
            }
        ]
    },
    {
        "sen": [
            "The genome sequence of SARS-CoV-2 was obtained from the ",
            "NCBI Nucleotide",
            " database (",
            "https://www.ncbi.nlm.nih.gov/nuccore/MN908947",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Repository",
                "start": 1454,
                "end": 1469,
                "name": "NCBI Nucleotide"
            },
            false,
            {
                "id": "T12",
                "type": "URL",
                "start": 1480,
                "end": 1525,
                "name": "https://www.ncbi.nlm.nih.gov/nuccore/MN908947"
            },
            false
        ],
        "rel": [
            {
                "id": "R6",
                "bool": true,
                "head": "T11",
                "end": "T12"
            }
        ]
    },
    {
        "sen": [
            "The genomic sequences of SARS-CoV-2 sampled from human hosts were downloaded from the ",
            "GISAID",
            " database [18]."
        ],
        "lab": [
            false,
            {
                "id": "T13",
                "type": "Dataset",
                "start": 1614,
                "end": 1620,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Only genome sequences that had no ‘N’ nucleotides and were incorporated into the ",
            "Nextstrain",
            " website (",
            "https://nextstrain.org/ncov/global",
            "; last access: 2020/0) were selected, resulting in 1,116 SARS-CoV-2 genomes (Table S2)."
        ],
        "lab": [
            false,
            {
                "id": "T14",
                "type": "Repository",
                "start": 1717,
                "end": 1727,
                "name": "Nextstrain"
            },
            false,
            {
                "id": "T15",
                "type": "URL",
                "start": 1737,
                "end": 1771,
                "name": "https://nextstrain.org/ncov/global"
            },
            false
        ],
        "rel": [
            {
                "id": "R7",
                "bool": true,
                "head": "T14",
                "end": "T15"
            }
        ]
    },
    {
        "sen": [
            "Comparative genomic analysis revealed that these RNA sequences and their predicted secondary structures are highly conserved between SARS-CoV and the novel coronavirus, SARS-CoV-2, which is responsible for the global outbreak of the coronavirus-associated disease that emerged in December 2019 (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Abstract   Background  Coronavirus disease 2019 (COVID-19) is a global public health problem that has already caused more than 662,000 deaths worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although the clinical manifestations of COVID-19 are dominated by respiratory symptoms, some patients present other severe damage such as cardiovascular, renal and liver injury or/and multiple organ failure, suggesting a spread of the SARS-CoV-2 in blood."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We herein intended to use the droplet-based digital PCR technology to obtain sensitive detection and precise quantification of plasma SARS-CoV-2 viral load (SARS-CoV-2 RNAaemia) in hospitalized COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Methods  Fifty-eight consecutive COVID-19 patients with pneumonia 8 to 12 days after onset of symptoms and 12 healthy controls were analyzed.",
            "Conclusion  SARS-CoV-2 RNAaemia measured by droplet-based digital PCR constitutes a promising prognosis biomarker in COVID-19 patients"
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Current report conducted careful examination of the sequences of 2019-nCoV, other CoV viruses and HIV-1 as well as ",
            "GenBank",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 115,
                "end": 122,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Blast against viral sequence database also showed these insertion sequences widely exist in all kinds of viruses from bacteriophage, influenza, to giant eukaryotic viruses (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "More hits were found for coronaviruses and a few also hit on HIV-1 sequences than the search against the entire database (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In February 2020, the WHO designated 2019-nCoV–caused pneumonia ‘COVID-19.’",
            "For Bayesian analysis, 777 total 2019-nCoV gene sequences as of 29 February 2020 were downloaded from ",
            "GISAID",
            " [11]."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 178,
                "end": 184,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The outbreak of the COVID-19 pandemia in 2019/2020 has stimulated research on clinical laboratory findings in this condition, as evidenced by two recent papers in this journal [1], [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As this D/I polymorphism shows an important geographical variation [7], we postulated that the variability in D/I genotype distribution might partly explain the variable prevalence of the COVID-19 infection amongst continental European countries."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, we compared the D-allele frequency of the ACE1 gene as obtained in 25 different European countries with the prevalence and mortality of COVID-19, as calculated on March 20, 2020 by ",
            "Johns Hopkins",
            " [8]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Creator",
                "start": 625,
                "end": 638,
                "name": "Johns Hopkins"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The log transformed prevalence of COVID-19 infections inversely correlates with the ACE D allele frequency: log (prevalence; number of cases/106 inhabitants) = 6.358–0.079 (D-allele frequency, %), r2 = 0.378; p = 0.001."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similarly, a significant correlation could be noted between COVID-19 caused mortality (Spearman r = −0.510, p = 0.01) and the prevalence of the ACE1 D-allele."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These data suggest that ACE1 D/I polymorphism may be regarded as a confounder in the spread of COVID-19 and the outcome of the infection in various European populations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We appreciate the constructive comments from Kesici et al. (1) and Zeng et al. (2), which mainly focus on the key points about the optimal procedure of convalescent plasma (CP) transfusion in severe coronavirus disease 2019 (COVID-19) therapy and about how to improve the effectiveness."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Indeed, the adverse effect was minor, whereas a quickly improved outcome of 10 severe COVID-19 patients was observed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Second, the objective for CP transfusion in severe COVID-19 therapy is based on an in-depth understanding of disease mechanisms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Particularly, in severe or critical COVID-19 cases, lung alveolar macrophages or epithelial cells could produce various proinflammatory cytokines and chemokines, which recruit monocytes and neutrophils to the infection site to clear the virus particles and infected cells, resulting in uncontrolled inflammation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, monitoring the dynamic changes of interleukin-6 level, which was significantly elevated in COVID-19, may help to determine the optimal treatment time, generally within 2 wk."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The median duration of hospitalization for COVID-19 patients was 12.0 d (10)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In our study, all of the donors were recovered from the common type of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 is spreading rapidly throughout the world; approximately all developed and developing countries and nations (Amirhossein Takian and Kazempour-Ardebili, 2020; Holshue et al., 2020; Sohrabi et al., 2020; van Doremalen et al., 2020a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In Iran, the first official announcement of death due to COVID-19 was reported by the Ministry of Health and Medical Education on February 19, 2020 (Amirhossein Takian and Kazempour-Ardebili, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On March 31, 2020, Iran with 44,605 COVID-19 cases and 2898 its deaths was the 7th and 6th highest ranking, among 203 countries and territories throughout the world which have experienced COVID-19 outbreak (",
            "https://www.worldometers.info/coronavirus/#countries",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "URL",
                "start": 647,
                "end": 699,
                "name": "https://www.worldometers.info/coronavirus/#countries"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Given the rapid spread of COVID-19 globally, investigations are under way to better understand the potential of airborne transmission mode of the virus as well as the clinical characteristics and severity of the disease (Ghinai et al., 2020; Guan et al., 2020; Holshue et al., 2020; Liu et al., 2020; van Doremalen et al., 2020a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To better manage the risks of COVID-19, particularly for health-care workers (Cheung et al., 2020), it is extremely crucial to address the importance of airborne transmission as one of the most important challenge/question of international COVID-19 outbreak."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We conducted the present study on March 17, 2020 in hospital wards with confirmed COVID-19 at Imam Khomeini Hospital Complex in Tehran, Iran."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On March 31, 2020, Tehran province with the highest confirmed COVID-19 cases ranked the first place among all provinces in Iran."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As a highly efficient approach to sample the airborne viruses, the impinger technique was used in order to collect the air sample of patient rooms with confirmed COVID-19 (Dart and Thornburg, 2008; Verreault et al., 2008)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Table 1",
            "reveals the specifications of all collected samples of SARS-CoV-2 in the air of hospital wards, and Table 2",
            "provides additional information on environmental status of patient rooms with confirmed COVID-19."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As shown in Table 1, there were forty-four patients confirmed with COVID-19 that were receiving oxygen mask (n = 22) and intubation (n = 22) treatments."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It was reported that COVID-19 patients are afflicted with the dry and short cough (Ghinai et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As we had limited access to the wards, the number of collected samples might not be generalized to the all wards of hospital with confirmed COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The coronavirus disease 2019 (COVID-19) emerged in Wuhan city, China, in late 2019 and has rapidly spread throughout the world."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Until now, there has been no evidence for detection of airborne severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and this may have implication for the potential spread of the COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We investigated the air of patient rooms with confirmed COVID-19 in the largest hospital in Iran, on March 17, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Fortunately, in this study all air samples which were collected 2 to 5 m from the patients' beds with confirmed COVID-19 were negative."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We checked the linked original reports from the WHO MERS-CoV disease outbreak news [20] and the Saudi MoH [21] for each human case listed on FluTrackers [19] and extracted data on disease risk factors, including date of notification, date of symptoms onset, date of hospitalization, laboratory confirmation date, complications, death and type of case based on the specified contact history (hospital outbreak-associated case and sporadic case: camel-linked, sheep-linked, community-linked, unknown exposure) to enhance the dataset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We included the remaining 120 complete genome sequences in our dataset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Each sequence contained the basic information of accession number, date of sample collection and location (city)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We classified all the criteria into three groups (Figure S1):",
            "Based on the available information in the two datasets, we matched each sequence with the human case."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Three levels of likelihood of matching were defined (Tables S2 and S3):",
            "Using Geneious v.11.0.4 [22], we annotated all the complete genome sequences with accession numbers."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The majority of sequences (n = 103, 86%) were matched to individuals in the MERS-CoV human cases epidemiological dataset (Tables S1–S3), including 40 (33%) unique matched isolates and 63 (53%) likely matched isolates."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, we linked and used enhanced surveillance datasets for phylogeographic analysis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We enhanced the dataset and identified 12 MERS-CoV isolates from the Al Ahsa hospital outbreak for phylogenetic analysis to minimize the bias caused by the small size of the sequence data."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus is having a global impact with latest ",
            "WHO",
            " data indicating 21,294,845 cases and 761,779 deaths (",
            "WHO",
            " COVID-19 Situation Report 209)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Creator",
                "start": 168,
                "end": 171,
                "name": "WHO"
            },
            false,
            {
                "id": "T2",
                "type": "Creator",
                "start": 225,
                "end": 228,
                "name": "WHO"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The novel coronavirus SARS-CoV-2, the infective agent causing COVID-19, is having a global impact both in terms of human disease as well as socially and economically."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At the time of writing of this article, the world was battling the unprecedented coronavirus pandemic disease, the so-called COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A well-known antimalarial drug chloroquine, its derivative hydroxychloroquine and other antivirals which are known to inhibit viral entry into host cells by increasing endosomal pH have been introduced in an attempt to treat COVID-19 [10]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There are currently 197 clinical trials assessing the role of antimalarials alone or in combination with other agents against COVID-19 infection [12], [13]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These poor results highlight the need to test for G6PD deficiency prior to enrolment in clinical trials evaluating antimalarials and other oxidizing drugs in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first half of the year 2020 has been in the midst of the first wave of COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While P-BEST incorporates a specific Reed-Solomon error-correcting code scheme for pooling, we ran simulations around this band with similar aspects (i.e. each sample contributes to exactly 6 pools in 384-well plate setting) to observe the efficiency gain rates around perfect recovery operating points."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Conducting an effective test, trace & isolate solution might be the key for containing SARS-CoV-2 and an elemental part of fighting against the current COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Currently proposed COVID-19 group testing schemes offer a gain up to no more than 10X and 25X scale-up for medium (0.5%-10%) and low (<0.5%) prevalence respectively [10–12, 16]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although the current popular approach of COVID-19 testing is RT-qPCR based molecular tests, clearly group testing is not limited to PCR based molecular techniques."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On the contrary, we know that COVID-19 sampling is mainly conducted on populations with social contacts, violating the independence assumptions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The capacity of the current molecular testing convention does not allow high-throughput and community level scans of COVID-19 infections."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Currently proposed COVID-19 group testing schemes offer a gain up to 15X-20X scale-up."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The codes, protocols, and datasets used during the current study are available from the corresponding author on reasonable request."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Currently, a total of 14 full‐length sequences of the 2019‐nCoV were released to ",
            "GISAID",
            " and ",
            "GeneBank",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 81,
                "end": 87,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 92,
                "end": 100,
                "name": "GeneBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The newly sequenced Beta‐coronavirus (",
            "MN908947",
            ") genome was downloaded from the ",
            "GenBank",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 140,
                "end": 148,
                "name": "MN908947"
            },
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 181,
                "end": 188,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T4",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "We divided our data set into four clades, the newly discovered 2019‐nCoV sequence was grouped as the query sequence."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interestingly, no similar sequence was found with known sequence in the database, suggesting that a putative recombination parent virus was still unknown."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease 2019 (COVID‐19) outbreak has led to the reorganization of national health systems in many specialties including medical oncology."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The host immune system is crucial in determining the clinical course of COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The severity of COVID‐19 is caused not only by direct viral damage, but also by an impaired immune host reaction, sometimes resulting in an extremely strong inflammatory response leading to airways damage and life‐threatening acute respiratory distress syndrome."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This interaction may worsen the hyperinflammation with CRS observed in severe cases of COVID‐19, but the antagonism of checkpoint axis like PD‐1/PD‐L1 could also potentially participate in accelerating the resolution of viral infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            " Beyond this complexity, SARS‐CoV‐2 infection in patients with cancer poses also issues related to the differential diagnosis between cancer‐related symptoms or immune‐related adverse events (irAEs) and COVID‐19 manifestations."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The survey (Appendix S1) was composed of four sections: (a) demographic, training and employment details of respondents (Q1‐8); (b) perception of the risk related to SARS‐CoV‐2 infection in patients with cancer treated with ICIs (Q9‐11); (c) attitudes towards the administration of ICIs and management of toxicities during COVID‐19 outbreak (Q12‐16); and (d) specific questions focused on attitudes towards the prescription of ICIs for the treatment of different cancer types during COVID‐19 outbreak (Q17‐22)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Figure 2 depicts whether responding physicians have modified their attitudes in the choice of the ICI to administer and its schedule during COVID‐19 outbreak (notably, more than one answer could be selected for this question)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Two clinical situations were explored to assess the issues related to the differential diagnosis between irAEs and COVID‐19 manifestations in cancer patients treated with ICIs: (a) how to manage a patient with onset of dyspnoea and cough (Figure 4A); (b) how to manage a patient whit onset of diarrhoea (Figure 4B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, besides the overlapping between cancer‐related signs/symptoms or side effects of oncological treatments (including irAEs) and COVID‐19 manifestations, additional issues could emerge from the differential diagnosis between radiological findings of lung involvement from SARS‐CoV‐2 and pneumonitis induced by ICIs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "This uncertainty is likely due to the lack of univocal evidence on this regard."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            ", ",
            ", ",
            " Furthermore, 47.1% of respondents supported the hypothesis of a synergism between the mechanism of action of ICIs and the pathogenesis of SARS‐CoV‐2 infections, thus being worried about the potential higher risks of COVID‐19‐related complications in this patient population."
        ],
        "lab": [
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nevertheless, it is comforting that 97.1% of respondents would not deny ICIs as a treatment option at the time of COVID‐19 outbreak only based on the possible risks of infection by SARS‐CoV‐2, considering that so far a clear evidence of a detrimental effect of their administration still lacks."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The European Society for Medical Oncology (ESMO) has created dedicated recommendations for the management of various aspects of oncological care, in order to mitigate the negative impact of COVID‐19 outbreak on patients with cancer."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            " Reducing the number of hospital visits while maintaining treatment effect is a reasonable safety measure that should be taken into account during COVID‐19 outbreak."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The overlapping between clinical manifestations of irAEs and COVID‐19, and the consequent management, is an additional concern."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While immune related pneumonitis is not so frequent in patients with cancer treated with ICIs (1%‐5% with anti‐CTLA‐4 or anti PD‐1/PD‐L1 as monotherapy, 5%‐10% with combination strategies),",
            ", ",
            " it enters in the differential diagnosis list at the time of COVID‐19 outbreak for almost all respondents."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On the contrary, diarrhoea is one of the most frequent irAE,",
            " and despite its overall rate is 10.4% in patients with COVID‐19 in a pooled analysis, only 28.8% of respondents reported to manage a patient with colitis as a SARS‐CoV‐2‐infected patient until otherwise proven, potentially leading to a risk of contagion in the case of underlying infection by SARS‐CoV‐2."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            " Having dedicated facilities where cancer patients could be managed also in the case of suspected SARS‐CoV‐2 infection should be considered of high priority in order to continue providing the needed care in the safest possible environment."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Notably, its use has also been associated with a reduction in the risk of death in patients with COVID‐19‐related pneumonia."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The results of our survey do not demonstrate a significant change in the attitudes of Italian physicians towards the prescription of ICIs during COVID‐19 outbreak."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These data, probably driven by the higher risk of COVID‐19 severe events in the elderly population, deserve a reflection considering the significant benefit associated with ICIs in this setting."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "Abstract   Background  During COVID‐19 outbreak, oncological care has been reorganized."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patients with cancer have been reported to experience a more severe COVID‐19 syndrome; moreover, there are concerns of a potential interference between immune checkpoint inhibitors (ICIs) and SARS‐CoV‐2 pathogenesis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "During COVID‐19 outbreak, to reduce hospital visits, 55.8% and 30.8% opted for the highest labelled dose of each ICI and/or, among different ICIs for the same indication, for the one with the longer interval between cycles, respectively."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These results highlight the uncertainties around the perception of a potential interference between ICIs and COVID‐19, supporting the need of focused studies on this topic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Mutation accumulated in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomes during its pandemic spread can cause unpredictable effects on coronavirus disease 2019 (COVID-19) and further complicate epidemic control efforts (1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We collected 95 SARS-CoV-2 samples from the Sichuan Province of China for amplification-free whole-genome sequencing and acquired 13 whole-genome sequences, which were analyzed for sequence variation and evolution together with 199 SARS-CoV-2 genomes publicly released in the ",
            "GISAID EpiFlu",
            " database (",
            "https://www.gisaid.org/",
            ")",
            "(2) and 7 genomes downloaded from the ",
            "National Genomics Data Center (NGDC)",
            " database (",
            "https://bigd.big.ac.cn/ncov",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 520,
                "end": 533,
                "name": "GISAID EpiFlu"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 544,
                "end": 567,
                "name": "https://www.gisaid.org/"
            },
            false,
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 607,
                "end": 643,
                "name": "National Genomics Data Center (NGDC)"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 654,
                "end": 681,
                "name": "https://bigd.big.ac.cn/ncov"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "To investigate if MERS-CoV can persistently infect cells from an insectivorous bat, we infected big brown bat (Eptesicus fuscus) kidney cells (Efk) at a low multiplicity of infection (MOI; 0.01 TCID50/cell) (Fig. 1a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On re-infecting persistently infected bat cells with W + virus (MOI = 1 TCID50/cell), we did not observe an increase in upE or ORF5 RNA levels in the superinfected cells, suggesting a lack of replication of W+ and ΔORF5 virus at 24 and 48 hpi (Fig. 5a,b)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Graphs were plotted using GraphPad prism version 7."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Dicer-ready siRNA (DsiRNA) specific to big brown bat and human IRF3 was designed and obtained through Integrated DNA Technologies (IDT)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Scrambled non-specific DsiRNA (NC DsiRNA; IDT) was used as a negative control."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Amino acid sequence from CoVs were retrieved from ",
            "NCBI",
            "’s database (accession numbers in supplementary Fig S4d), and multiple sequence alignment was performed using MacVector software."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 792,
                "end": 796,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Coronavirus Disease 2019 (COVID-19) pandemic has led to substantial morbidity and mortality globally, but initial reports suggest historically disadvantaged populations may be most afflicted."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recently, COVID-19 testing results for a subset of participants in England were made available [4]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Individuals were excluded from this analysis if they had enrolled outside England, died prior to 2019, or had an outpatient test positive for COVID-19, in whom the clinical trajectory was uncertain."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additional details are provided in the Additional file 1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 hospitalization was noted in 32 of 7714 (0.4%)",
            "To understand the relationship between socioeconomic status and COVID-19 hospitalization, individuals were stratified at enrollment into deciles of the Townsend Deprivation Index, a previously validated composite metric based on employment status, car or home ownership, and household crowding [5]."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Participants with greater Townsend Deprivation Indices were at substantially higher risk of COVID-19 hospitalization, with a similar pattern observed based on self-reported household income (Fig. 1b, c)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The relationship between race and COVID-19 hospitalization was modestly attenuated in a logistic regression model that additionally adjusted for Townsend Deprivation Index, household income, hypertension, diabetes, heart failure, ischemic stroke, dementia, chronic obstructive pulmonary disease, prior pneumonia, dementia, chronic kidney disease, smoking status, statin use, and body mass index--odds ratios for Black and Asian participants of 2.4 (95%CI 1.5–3.7) and 1.8 (95%CI 1.1–2.9) as compared to White participants respectively."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Within a large population of participants in a national biobank, striking gradients in risk of hospitalization for COVID-19 were noted according to race and a metric of socioeconomic deprivation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With respect to potential biologic factors, ongoing efforts seek to determine whether genetics--known to both vary substantially across racial groups and contribute to pre-existing comorbidities--plays an important role in COVID-19 disease severity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Preliminary reports suggest that the Coronavirus Disease 2019 (COVID− 19) pandemic has led to disproportionate morbidity and mortality among historically disadvantaged populations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We investigate the racial and socioeconomic associations of COVID− 19 hospitalization among 418,794 participants of the ",
            "UK Biobank",
            ", of whom 549 (0.13%) had been hospitalized."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 2395,
                "end": 2405,
                "name": "UK Biobank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We further observed a striking gradient in COVID− 19 hospitalization rates according to the Townsend Deprivation Index − a composite measure of socioeconomic deprivation − and household income."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to ",
            "WHO",
            " Coronavirus Disease 2019 (COVID-19) situation report of 17 February 2020, 71,429 cases have been documented globally [2]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Creator",
                "start": 13,
                "end": 16,
                "name": "WHO"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The outbreak of Coronavirus Disease 2019 (COVID-19) causing novel coronavirus-infected pneumonia (NCIP), has affected the lives of 71,429 people globally."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Clinical presentations of COVID-19 are highly variable, and while the majority of patients experiences mild to moderate symptoms, 10%–20% of patients develop pneumonia and severe disease (Huang et al., 2020a; Wang et al., 2020; Zhou et al., 2020a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This kinetic may suggest a role for secondary immune responses in the development of severe COVID-19 (Ong et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, the exact mechanisms that govern the pathophysiology of the different disease courses of COVID-19 remain ill-defined."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Single-cell studies of bronchoalveolar lavage samples have suggested a complex dysregulation of the pulmonary immune response in severe COVID-19 (Chua et al., 2020; Liao et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Overall, systemic inflammation is linked to an unfavorable clinical course of disease and the development of severe COVID-19 (Giamarellos-Bourboulis et al., 2020; Lucas et al., 2020; Ong et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patients with severe COVID-19 have high systemic levels of inflammatory cytokines, particularly interleukin (IL)-6 and IL-1β",
            "A number of studies and regular clinical observations indicate an increase of neutrophils and a decrease of non-classical (CD14loCD16hi) monocytes in severe COVID-19 (Hadjadj et al., 2020; Merad and Martin, 2020; Sanchez-Cerrillo et al., 2020)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Profound immune dysregulation is commonly observed in severe infections and sepsis, characterized by a progression from hyperinflammatory states to immunosuppression (Remy et al., 2020; Ritchie and Singanayagam, 2020), and similar mechanisms have been proposed for severe COVID-19 (Giamarellos-Bourboulis et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Yet, comprehensive insights into the immunopathology of severe COVID-19 are still missing."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Mitigation of immunodysregulation is therefore viewed as a major therapeutic avenue for the treatment and prevention of severe COVID-19 (Dimopoulos et al., 2020; Jamilloux et al."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In support of this view, a recent multicenter study reported that dexamethasone treatment significantly reduced mortality in hospitalized patients with COVID-19, particularly in patients on mechanical ventilation (Horby et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Previous studies of peripheral blood mononuclear cell (PBMC) transcriptomes in a small number of patients with COVID-19 revealed changes in several cellular compartments, including monocytes, natural killer (NK) cells, dendritic cells (DCs), and T cells (Lee et al., 2020; Wilk et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The heterogeneity of clinical manifestations and the complexity of immune responses to COVID-19 highlight the need for detailed analyses using high-resolution techniques and well-characterized clinical cohorts."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We hypothesized that distinct responses, particularly within the innate immune system, underlie the different clinical trajectories of COVID-19 patients (Chua et al., 2020; Kuri-Cervantes et al., 2020; Mathew et al., 2020; McKechnie and Blish, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we used single-cell transcriptomics and single-cell proteomics to analyze immune responses in blood samples in two independent cohorts of COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In order to probe the divergent immune responses in mild versus severe COVID-19, we analyzed blood samples collected from independent patient cohorts at two university medical centers in Germany."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We analyzed a total of 24 million cells by their protein markers and >328,000 cells by scRNA-seq in 242 samples from 53 COVID-19 patients and 56 controls, including 8 patients with FLI (Figures 1",
            "A, 1B, and S1",
            "A; Table S1)."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "(A) Pipeline for control and COVID-19 blood samples of the two cohorts (see also Table S1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Cells are colored according to donor origin (blue, age-matched controls; gray, FLI; yellow, mild COVID-19; red, severe COVID-19) and major lineage subtypes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "(D) Box and whisker (10–90 percentile) plots of major cell lineage composition in whole blood from FLI (n = 8), COVID-19 patients with mild (n = 8) or severe disease (n = 9), age-matched controls measured by mass cytometry (ctrl CyTOF, n = 9) or by flow cytometry (ctrl flow, n = 19) (Kverneland et al., 2016)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We first characterized alterations of the major leukocyte lineages by mass cytometry on whole blood samples from 20 COVID-19 patients collected between day 4 and day 29 after symptom onset and compared them to 10 age- and gender-matched controls and 8 FLI patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Uniform manifold approximation and projection (UMAP) analysis revealed distinct clustering of samples from COVID-19 patients, FLI, and healthy controls, with marked changes of the monocyte and granulocyte compartment (Figure 1C)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Leukocyte lineages were compared in the earliest available samples in COVID-19 patients (days 4–13), FLI, and controls (Figure 1D; Table S1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Cell counts of the published cohort could therefore be used as a reference to report absolute cell counts for leukocyte lineages in COVID-19 samples."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In line with recent reports (Barnes et al., 2020; Xia et al., 2020), we observed elevated leukocytes and increased proportions of neutrophils in patients with severe COVID-19 (Figure 1D), whereas only proportional increases in neutrophils were evident in FLI and mild COVID-19 patients (Figure 1D)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Total lymphocytes and T cells were strongly reduced in all COVID-19 and FLI patients, whereas non-classical monocytes were specifically depleted in COVID-19 (Figure 1D)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Increased neutrophils in severe COVID-19 and loss of non-classical monocytes in both mild and severe disease were validated in cohort 2 by MCFC (Figure S1C; Tables S1 and S3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Given the dramatic changes in various immune cell populations (Figures 1C and 1D), we next assessed their composition and activation state by droplet-based scRNA-seq in 27 samples from 18 COVID-19 patients (8 mild and 10 severe, cohort 1, Table S1) collected between day 3 and day 20 after symptom onset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 48,266 single-cell transcriptomes of PBMCs were analyzed together with 50,783 PBMCs from publicly available control datasets (21 control donors, Table S1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A distinct subset of CD14",
            " monocytes (cluster 1) (Figure 2A) marked by high expression of HLA-DRA, HLA-DRB1, and co-stimulatory molecule CD83 (Figure S2D), the engagement of which has been linked to prolonged expansion of antigen-specific T cells (Hirano et al., 2006), was selectively detected in mild COVID-19 (Figure 2C)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, upon closer analysis, this cluster was found to originate from a single donor with mild COVID-19 (Figures 2A–2C and S2D)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In patients with severe COVID-19, monocytes showed low expression of HLA-DR and high expression of alarmins S100A8/9/12 (cluster 3, Figures 2A–2C and S2D)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The most prominent change in severe COVID-19 was the appearance of two distinct cell populations (cluster 5+6), absent in PBMCs of patients with mild COVID-19 and control donors (Figure 2A)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "(D) UMAP visualization of scRNA-seq profiles (BD Rhapsody, cohort 2) of 139,848 PBMCs (50 samples of 8 mild, 9 severe COVID-19; 14 samples of 13 controls; different time points), coloring as in (A) (see also Figure S2A and Table S4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the second cohort, PBMCs from 17 COVID-19 patients (8 mild, 9 severe, Table S1), sampled between 2 and 25 days after symptom onset, and 13 controls, were collected for scRNA-seq on a microwell-based platform (BD Rhapsody)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The monocyte compartment is particularly affected by COVID-19, indicated by a loss of CD14loCD16hi non-classical monocytes (Figures 1C and 1D)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We further explored the phenotypic alterations of the monocyte compartment using mass cytometry (Table S2, panel 1) on whole blood samples from COVID-19 patients with a mild or severe disease (n = 8+9), patients with FLI (n = 8), and age- and gender-matched controls (n = 9, all collected within cohort 1, Table S1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Cells are colored according to main cell clusters (1 to 12, colors as in A) as defined in the table, donor origin (blue, controls; gray, FLI; yellow, mild COVID-19; red, severe COVID-19) and expression intensity of HLA-DR, CD11c, CD226, and CD69."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Monocytes from COVID-19 patients separated from those of FLI patients and controls (Figure 3B), mainly based on elevated CD226 and CD69 expression in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Monocytes in mild and severe COVID-19 clustered separately, and monocytes from mild COVID-19 clustered closer to monocytes in FLI."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "FLI patients and mild COVID-19 contained higher proportions of HLA-DRhiCD11chi cells (clusters 3 and 11), and total HLA-DRhiCD11chi monocytes were higher compared to controls and severe COVID-19, reflecting blunted monocyte activation in severe COVID-19, reminiscent of observations in sepsis (Janols et al., 2014) (Figures 3A, 3C, and 3D)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Increased levels of activated HLA-DRhiCD11chi monocytes in mild COVID-19 patients were confirmed by MCFC in cohort 2 (Figure 3E)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In severe COVID-19, we detected increased expression of CD226 and CD69 (cluster 10) and/or decreased expression of HLA-DR, and total CD226+CD69+ monocytes were elevated compared to controls."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, an alternative activation pattern of classical monocytes appeared to be COVID-19-specific and was associated with severe disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Together, this activation pattern may contribute to the reduction of circulating monocytes in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Next, we dissected COVID-19-associated phenotypic alterations of monocytes by scRNA-seq."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Marker genes of the monocyte clusters derived from Figure 2A showed that mild COVID-19 associated clusters 1 and 2 were characterized by an ISG-driven transcriptional program (Figure S3",
            "A), and gene ontology enrichment analysis (GOEA) assigned these clusters to “type I interferon signaling pathway” (Figure S3B)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "S100A",
            ") was strongly associated with severe COVID-19 (Figures 2B, S2D, and S3A)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For further in-depth analysis, we subclustered the monocyte compartment of the PBMC dataset of cohort 2 (Figures 2D and S3C; Table S1) resulting in 7 subclusters (Figure 4",
            "A)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We identified two major clusters (0 and 2) and a smaller cluster (6) with low HLA-DR expression, which were associated with severe COVID-19 (Figures 4B, S3D, and S3E)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, blood monocytes isolated from COVID-19 patients showed a blunted cytokine response to LPS stimulation, particularly monocytes from patients with severe COVID-19 (Figure 4D)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Accordingly, HLA-DR",
            " monocyte clusters (0, 2, and 6) were detected almost exclusively in severe COVID-19 (Figure 4E)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "CD83",
            " monocytes (cluster 1) were found in all cases of mild COVID-19, even at late time points (Figures 4E and 4F)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Expression levels were highest at early time points and consistently decreased over time, clearly indicating that the IFN response in COVID-19 is inversely linked to disease severity and time (Figures S3F and S3G)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In contrast, decreased expression of HLA-DRA and HLA-DRB1 in severe COVID-19 is evident early on and sustained over time."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Transcriptional Differences of Monocytes from Mild and Severe COVID-19, Related to Figure 4",
            "A, Dot plot of the top 10 marker genes sorted by average log fold change of the clusters within the monocyte space of cohort 1 (related to Figure 2, Table S4)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "(A) UMAP visualization of monocytes (43,772 cells; from Figure 2C, cohort 2); 46 samples from controls (n = 6) and COVID-19 (mild, n = 7; severe, n = 8)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Three main clusters defining monocytes in COVID-19 (HLA-DRCD163, HLA-DRS100A, and HLA-DRCD83 monocytes) indicated by dashed areas."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Transcription factor prediction indicated a STAT signaling-driven gene expression program in monocytes in COVID-19 (Figure 4H), with additional regulation by CEBPD and CEBPE, which have been implicated in gene expression programs of sepsis-associated monocytes (Reyes et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "PBMCs derived from blood samples of patients with severe COVID-19 contained two distinct clusters of LDNs (Figures 2A, clusters 5 and 6, and 2D, clusters 5 and 6)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "(A) UMAP representation and clustering of low-density neutrophils (LDNs, 3,154 cells) in PBMCs (cohort 1, clusters 5/6, Figure 2A) from 21 samples (6 mild, 10 severe COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "NETs have recently been implicated in the pathogenesis of COVID-19 (Barnes et al., 2020; Zuo et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, known inhibitors of T cell activation, namely CD274 (PD-L1) and Arginase 1 (ARG1) (Bronte et al., 2003; Li et al., 2018) were highly expressed in neutrophils in COVID-19 patients (Figure 5E)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "ARG1",
            " cells were mainly immature neutrophils (clusters 3–6) and did not overlap with CD274 (PD-L1) expressing cells, indicating different populations of dysfunctional and potentially suppressive neutrophils in severe COVID-19."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Alterations of the neutrophil compartment were further interrogated by mass cytometry of whole blood samples of COVID-19 patients (n = 8 mild + 9 severe, cohort 1), FLI patients (n = 8), and age- and gender-matched controls (n = 9) (Table S1), using a panel designed to detect myeloid cell maturation and activation states as well as markers of immunosuppression or dysfunction (Table S2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Donor origin (blue, controls; gray, FLI; yellow, mild COVID-19; red, severe COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Neutrophils from COVID-19 patients clearly separated from those of controls and also FLI patients in UMAP analysis (Figure 6B), and neutrophils in patients with severe COVID-19 were distinct from those of patients with mild disease (Figure 6B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Neutrophils from COVID-19, particularly from patients with severe disease, primarily occupied immature pre- and pro-neutrophil-like clusters."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In contrast, severe COVID-19 is associated with the appearance of immature pre- and pro-neutrophils (Figures 6D and 6E)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interestingly, immature cell clusters in severe COVID-19 showed signs of recent activation like upregulation of CD64 (Mortaz et al., 2018), RANK, and RANKL (Riegel et al., 2012), as well as reduced CD62L expression (Mortaz et al., 2018)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition to loss of CD62L, immature and mature neutrophils from severe COVID-19 showed elevated PD-L1 expression compared to control samples (Figure 6E)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In both cohorts, we observed a tendency toward (cohort 1) or significantly higher (cohort 2) proportions of granulocytes in severe versus mild COVID-19 patients, both at early and late time points (Figure S5",
            "A)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We observed a persistent release of immature neutrophils (e.g., cluster 6) in severe COVID-19 (Figure S5B) showing high expression of CD64 and PD-L1, but downregulation of CD62L as a sign of activation, dysfunction, and immunosuppression (Figure S5C)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, severe COVID-19 patients show further increased frequencies of mature, partially activated neutrophils (cluster 3) at later time periods (Figure S5B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, the neutrophil compartment of severe COVID-19 patients is characterized by a combination of persistent signs of inflammation and immunosuppression, which is reminiscent of long-term post-traumatic complications (Hesselink et al., 2019)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Non-classical monocytes started to recover in COVID-19 patients during the later stages of the disease (Figure S5A)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "HLA-DRhiCD11chi monocyte cell clusters also declined at later time points in mild COVID-19 (Figures S5D–S5F), which correlates well with the longitudinal changes of IFI6 and ISG15 as well as HLA-DRA and HLA-DRB1 expression profiles (Figures 4G and S3F)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In contrast, overall proportions of HLA-DRhiCD11chi monocytes in severe COVID-19 remained low throughout the course of the disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Proportions of CD10hi macrophage-like cluster 10 and CD226+CD69+ monocytes were generally higher at later stages in severe COVID-19, which resembled the kinetics of HLA-DR",
            "This indicates a prolonged alternative activation of monocytes in severe COVID-19 (Figure S5E)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Whole blood CyTOF analysis (cohort 1) clearly indicated very distinct phenotypic alterations of the neutrophil compartment in mild and severe forms of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Overview of scRNA-Seq Dataset from Cohort 2 and Additional Characterization of Neutrophils, Related to Figure 7",
            "(A) UMAP of 35 fresh blood samples from cohort 2 (122,954 cells, PBMCs, and whole blood): controls (n = 17), mild COVID-19 (early, n = 3; late, n = 3) and severe COVID-19 (early, n = 3, late = 9)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "(B) UMAP visualization of neutrophils (58,383 cells; 34 whole blood samples, cohort 2): controls (n = 16), mild COVID-19 (early, n = 3; late, n = 3), and severe COVID-19 (early, n = 3; late, n = 9)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Seven of the nine neutrophil clusters identified in whole blood in cohort 2 could also be mapped to the fresh PBMC transcriptomes in cohort 1 (Figure S6F), indicating that scRNA-seq of fresh PBMC in COVID-19 patients reveals relevant parts of the neutrophil space."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Heatmap and UMAP visualization of the cell type distribution identified pro- and pre-neutrophils mainly at late time points in severe COVID-19 (Figures 7F and 7G)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, mature neutrophils with a high IFN-signature (cluster 1) were associated with severe COVID-19 (Figures 7E and S6G)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This cluster was also enriched for markers identified by CyTOF as differentially expressed in patients with severe COVID-19 (Figure 6), such as elevated expression of CD274 (PD-L1) and FCGR1A (CD64) (Figure 7H)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Cluster 2 was also enriched for cells from COVID-19 patients, mainly from severe but also mild cases (Figures 7F and 7G)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Gene signatures from granulocytic MDSC (Bayik et al., 2020) and CD274(PD-L1)+ neutrophils after LPS exposure (de Kleijn et al., 2013), both shown to be immunosuppressive, were enriched in clusters 1, 2, and 6, which mainly harbor cells from severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This indicates a suppressive functionality of these cells in severe COVID-19 (Figure 7I)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Predictions of transcription factor (TF)-based regulation of the cluster-specific gene signatures separated mature neutrophils from patients with severe COVID-19 (cluster 1) and control patients (cluster 0) (Figure 7J)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Particularly CD274 (PD-1L) was enriched in cluster 1 compared to cluster 2, supporting the potential of neutrophils to progress toward a suppressive phenotype in severe COVID-19 (Figure S6J)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, we studied whether the persistent emergence of immature, potentially dysfunctional neutrophils in severe COVID-19 patients can be captured under routine diagnostic conditions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, samples of 32 COVID-19 patients (Table S1, cohort 1) were characterized by routine hematology analyses using a clinical flow cytometry system (Sysmex analyzer)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Indeed, the assumption of rescue myelopoiesis in severe COVID-19 was supported by significantly higher counts in the population of immature granulocytes (IG, representing promyelocytes, myelocytes, and metamyelocytes) in this patient group (Figure 7K)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As compared to patients with mild course, severely ill patients displayed increases in width of dispersion of activity and cell volume as surrogates for increased cellular heterogeneity, immaturity, and dysregulation in severe COVID-19 (Figure 7K), resembling previously described alterations in sepsis patients (Stiel et al., 2016)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, neutrophils of severe COVID-19 patients were partially dysfunctional, because their oxidative burst upon stimulation with standardized stimuli (E. coli or PMA) was strongly impaired in comparison to control and mild COVID-19 neutrophils, whereas phagocytic activity was preserved (Figure 7L; Table S1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 infection generally causes mild disease in the majority of individuals, however, ∼10%–20% of COVID-19 patients progress to severe disease with pneumonia and respiratory failure."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Dysregulated immune responses have been described in patients with severe COVID-19 (Chua et al., 2020; Giamarellos-Bourboulis et al., 2020; Lucas et al., 2020; Merad and Martin, 2020; Messner et al., 2020; Wei et al., 2020; Zhou et al., 2020b)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hence, detailed knowledge of the cellular and molecular processes that drive progression from mild disease to potentially fatal courses of COVID-19 is urgently needed to identify predictive biomarkers and therapeutic targets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we employed four complementary technologies at single-cell resolution to assess alterations in the systemic immune response in mild or severe courses of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Combining single-cell transcriptomics with single-cell proteomics, using different technological platforms in two independent patient cohorts, provided a detailed view of the systemic immune responses in COVID-19 and allowed for cross-validation and in-depth interrogation of key findings."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This multipronged approach revealed drastic changes within the myeloid cell compartment during COVID-19, particularly in patients with a severe course of disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "CD83",
            " monocytes with a strong antiviral IFN-signature was a hallmark of mild COVID-19, which receded during the natural course of disease."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In contrast, HLA-DRlo dysfunctional monocytes along with clear evidence of emergency myelopoiesis with release of immature neutrophils including pro- and pre-neutrophils into the circulation marked severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, we identified neutrophils in severe COVID-19 with transcriptional programs reminiscent of dysfunction and immunosuppression not observed in controls or patients with mild COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Previous immunophenotyping studies have reported an increase of inflammatory monocytes with a strong IFN-response in COVID-19 (Liao et al., 2020; Merad and Martin, 2020; Zhou et al., 2020b)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Mononuclear phagocytes and neutrophils appear to dominate inflammatory infiltrates in the lungs, and resident alveolar macrophages are replaced by inflammatory monocyte-derived macrophages in patients with severe COVID-19 (Chua et al., 2020; Liao et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we report substantial time- and disease severity-dependent alterations of the monocyte compartment in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Marked depletion of CD14loCD16hi non-classical monocytes observed in all COVID-19 patients, but not in patients with SARS-CoV-2 negative FLI (Figure 1D), is in line with previous reports on COVID-19, and other severe viral infections (Lüdtke et al., 2016; Naranjo-Gómez et al., 2019)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "CD83",
            ") monocytes in mild COVID-19."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This was similar in patients presenting with common cold or FLI, but absent in severe COVID-19 (Figures 3 and 4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In contrast, in severe COVID-19, monocytes showed low expression of HLA-DR, and high levels of MAFB, PLBD1, and CD163, all of which are associated with anti-inflammatory macrophage functions (Bronte et al., 2016; Cuevas et al., 2017; Fischer-Riepe et al., 2020; MacParland et al., 2018)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In fact, we observed that inflammatory cytokine production, including IL-1β release, was impaired in monocytes from patients with severe COVID-19 (Figure 4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "LDN in PBMC fractions in severe COVID-19 contained immature neutrophils, including pro- and pre-neutrophils, which was not observed in mild cases (Figure 5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Emergence of pro-neutrophils in severe COVID-19 was also detected by single-cell proteomics on whole blood samples."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Neutrophils from patients with severe COVID-19 showed an impaired oxidative burst response, while their phagocytic capacity was preserved (Figure 7)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Single-cell transcriptomics of whole blood samples revealed mature activated neutrophils in both mild and severe COVID-19 (Figure 7B, cluster 2), however, expression of CD274 (PD-L1) was only found in severe COVID-19 (cluster 1), and it increased in later stages of the disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Expression of PD-L1 on neutrophils has been associated with T cell suppression (Bowers et al., 2014; Castell et al., 2019; de Kleijn et al., 2013; Langereis et al., 2017), suggesting that neutrophils in severe COVID-19 might exert suppressive functions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, the expression of CD177 on mature activated neutrophils and the identification of genes associated with anti-inflammatory functions (CD274 and ZC3H12A) suggest a model in which neutrophils emerging prematurely from the bone marrow are programmed toward an anti-inflammatory or even suppressive phenotype in severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The transcriptional programs induced in immature neutrophils, including pro- and pre-neutrophils, as well as in COVID-19-associated mature neutrophil clusters, align with other observations in severe COVID-19 patients, including increased NET formation (Barnes et al., 2020; Zuo et al., 2020), coagulation (Klok et al., 2020; Pfeiler et al., 2014), and immunothrombosis (Stiel et al., 2018; Xu et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In contrast, these transcriptional programs were not observed in patients with mild COVID-19 or in SARS-CoV-2 negative controls, even though the latter exhibited a range of comorbidities (e.g., COPD, type II diabetes)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The pathophysiological consequences of the dysfunctional phenotype of myeloid cells in severe COVID-19 remain unclear at this stage."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While our dual cohort study design provided robust and reproducible results concerning the alterations within the myeloid compartment in COVID-19, it is too early to speculate on the underlying mechanisms driving this response, such as genetics, lifestyle, comorbidities, environmental factors, or initial viral load (Ellinghaus et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Indeed, in future studies it will be interesting to dissect whether the myeloid subsets in COVID-19 are anti-inflammatory or even capable of suppressing other immune cells, and which pathways might be mainly involved."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Samples from patients with COVID-19 were collected within two cohort studies (",
            "Kurth et al., 2020",
            ") designed to allow deep molecular and immunological transcriptomic and proteomic profiling of COVID-19 in blood."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Creator",
                "start": 24905,
                "end": 24923,
                "name": "Kurth et al., 2020"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This study was designed to describe immunological deviations in COVID-19 patients without intention of the development of new treatments or new diagnostics, and therefore sample size estimation was not included in the original study design."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This study includes a subset of patients enrolled between March 2 and July 02 2020 in the Pa-COVID-19 study, a prospective observational cohort study assessing pathophysiology and clinical characteristics of patients with COVID-19 at Charité Universitätsmedizin Berlin (",
            "Kurth et al., 2020",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Creator",
                "start": 25548,
                "end": 25566,
                "name": "Kurth et al., 2020"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The patient population included in all analyses of cohort 1 consists of 10 control donors (samples collected in 2019 before SARS-CoV2 outbreak), 8 patients presenting with flu-like illness but tested SARS-CoV-2-negative, 25 mild and 29 severe COVID-19 patients (Figures 1A and 1B; Table S1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All COVID-19 patients were tested positive for SARS-CoV-2 RNA in nasopharyngeal swabs and allocated to mild (WHO 2-4) or severe (5-7) disease according to the WHO clinical ordinal scale."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also included publicly available single-cell transcriptome data derived from 22 control samples into the analysis; 3 samples were derived from ",
            "10x Genomics",
            ", San Francisco, CA 94111, USA (5k_pbmc_v3: ",
            "https://support.10xgenomics.com/single-cell-gene-expression/datasets/3.0.2/5k_pbmc_v3",
            ", pbmc_10k_v3: ",
            "https://support.10xgenomics.com/single-cell-gene-expression/datasets/3.0.0/pbmc_10k_v3",
            ", pbmc_1k_v3: ",
            "https://support.10xgenomics.com/single-cell-gene-expression/datasets/3.0.0/pbmc_1k_v3",
            "), 19 samples derived from Reyes et al. (2020)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 26194,
                "end": 26206,
                "name": "10x Genomics"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 26250,
                "end": 26335,
                "name": "https://support.10xgenomics.com/single-cell-gene-expression/datasets/3.0.2/5k_pbmc_v3"
            },
            false,
            {
                "id": "T5",
                "type": "URL",
                "start": 26350,
                "end": 26436,
                "name": "https://support.10xgenomics.com/single-cell-gene-expression/datasets/3.0.0/pbmc_10k_v3"
            },
            false,
            {
                "id": "T6",
                "type": "URL",
                "start": 26450,
                "end": 26535,
                "name": "https://support.10xgenomics.com/single-cell-gene-expression/datasets/3.0.0/pbmc_1k_v3"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T3",
                "end": "T4"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T5"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T3",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "After providing written informed consent, 19 control donors and 22 COVID-19 patients (Figures 1A and 1B; Table S1) were included in the study."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 patients who tested positive for SARS-CoV-2 RNA in nasopharyngeal swabs were recruited at the Medical Clinic I of the University Hospital Bonn between March 30 and June 17, 2020 and allocated to mild (WHO 2-4) or severe (5-7) disease according to the WHO clinical ordinal scale."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These individuals were either tested negative for SARS-CoV-2, serologically negative or had no indication for acute COVID-19 disease based on clinical or laboratory parameters."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "1ml of fresh blood from control or COVID-19 donors was treated with 10ml of RBC lysis buffer (Biolegend)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Whitney test was used to report differences in IG count, whereas mixed-effect-analysis and Sidak’s multiple comparison test was applied to report statistical differences of NE-WX, NE-WY and NE-WZ between mild and severe COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Subsequently, the scRNA-seq data from cohort 1 was integrated with publicly available 10x scRNaseq data of healthy controls using the ‘harmony’ algorithm (Korsunsky et al., 2019) based on the first 20 principal components to correct for technical differences in the gene expression counts of the different data sources (Control samples from ",
            "Reyes et al. (2020)",
            ", 10x v3.1 PBMC benchmarking data from healthy controls and 10x v3.1 scRNA-seq data from cohort 1)."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Creator",
                "start": 27877,
                "end": 27896,
                "name": "Reyes et al. (2020)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Cluster marker genes were identified by applying the DE tests for upregulated genes between cells in one cluster to all other clusters in the dataset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To compare shifts in the monocyte and neutrophil populations in the PBMC compartment of COVID-19 patients, the percentages of the cellular subsets - as identified by clustering and cluster annotation explained above for the two independent scRNA-seq datasets (cohort 1 and cohort 2) - of the total number of PBMC in each dataset were quantified per sample and visualized together in boxplots."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The monocyte space was investigated by subsetting the PBMC dataset to those clusters identified as monocytes (cluster 0-4), removing cells with strong multi-lineage marker expressions, and repeating the variable gene selection (top 2,000 variable genes), regression for the number of UMIs and scaling as described above."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Subsequently, the dataset was subsetted for whole blood samples after erythrocyte lysis and clusters identified as neutrophils and immature neutrophils, and re-scaled and regressed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Gene set enrichment was performed on gene sets from the ",
            "Kyoto Encyclopedia of Genes and Genomes (KEGG)",
            " database (",
            "Kanehisa, 2019",
            "), Hallmark gene sets (",
            "Liberzon et al., 2015",
            ") and ",
            "Gene Ontology (GO)",
            " (",
            "Ashburner et al., 2000",
            "; ",
            "Carbon et al., 2019",
            ") using the R package/ClusterProfiler v.3.10.1",
            "Coronavirus disease 2019 (COVID-19) is a mild to moderate respiratory tract infection, however, a subset of patients progress to severe disease and respiratory failure."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 29099,
                "end": 29145,
                "name": "Kyoto Encyclopedia of Genes and Genomes (KEGG)"
            },
            false,
            {
                "id": "T9",
                "type": "Creator",
                "start": 29156,
                "end": 29170,
                "name": "Kanehisa, 2019"
            },
            false,
            {
                "id": "T10",
                "type": "Creator",
                "start": 29193,
                "end": 29214,
                "name": "Liberzon et al., 2015"
            },
            false,
            {
                "id": "T11",
                "type": "Repository",
                "start": 29220,
                "end": 29238,
                "name": "Gene Ontology (GO)"
            },
            false,
            {
                "id": "T12",
                "type": "Creator",
                "start": 29240,
                "end": 29262,
                "name": "Ashburner et al., 2000"
            },
            false,
            {
                "id": "T13",
                "type": "Creator",
                "start": 29264,
                "end": 29283,
                "name": "Carbon et al., 2019"
            },
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The mechanism of protective immunity in mild forms and the pathogenesis of severe COVID-19 associated with increased neutrophil counts and dysregulated immune responses remain unclear."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In a dual-center, two-cohort study, we combined single-cell RNA-sequencing and single-cell proteomics of whole-blood and peripheral-blood mononuclear cells to determine changes in immune cell composition and activation in mild versus severe COVID-19 (242 samples from 109 individuals) over time."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "HLA-DR hi CD11c hi inflammatory monocytes with an interferon-stimulated gene signature were elevated in mild COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severe COVID-19 was marked by occurrence of neutrophil precursors, as evidence of emergency myelopoiesis, dysfunctional mature neutrophils, and HLA-DR lo monocytes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our study provides detailed insights into the systemic immune response to SARS-CoV-2 infection and reveals profound alterations in the myeloid cell compartment associated with severe COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Graphical Abstract      Analysis of patients with mild and severe COVID-19 reveals the presence of dysfunctional neutrophils in the latter that is linked to emergency myelopoiesis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The disease was recognized to be caused by a novel coronavirus (SARS-CoV-2) and termed coronavirus disease-19 (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The symptoms of COVID-19 range from fever, dry cough, fatigue, congestion, sore throat, and diarrhea to severe interstitial bilateral pneumonia with a ground-glass image at the CT scan."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All these data were inserted in a section of the established and certified ",
            "Biobank",
            " and ",
            "Registry of the Medical Genetics Unit of the Hospital",
            " dedicated to COVID-19."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 383,
                "end": 390,
                "name": "Biobank"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 395,
                "end": 448,
                "name": "Registry of the Medical Genetics Unit of the Hospital"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The cohort of COVID-19 patients consists of 131 individuals out of whom 34 females and 97 males belonging to the GEN-COVID MULTICENTER STUDY ([16], Late Breaking Abstract ESHG 2020.2 Virtual Conference “WES profiling of COVID-19”)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The genome aggregation database ",
            "gnomAD",
            " (",
            "https://gnomad.broadinstitute.org/",
            ") was used to assess allele frequency for each variant among different populations."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 736,
                "end": 742,
                "name": "gnomAD"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 744,
                "end": 778,
                "name": "https://gnomad.broadinstitute.org/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "(",
            "PDB",
            " ID code ",
            "1R42",
            ") [24]."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 863,
                "end": 866,
                "name": "PDB"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 875,
                "end": 879,
                "name": "1R42"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "MD simulations were performed using a high parallel computing infrastructure (HPCS) with 660 cpu within 21 different nodes, 190T of RAM, 30T hard disk partition size, and six NVIDIA TESLA gpu with CUDA support."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The c.2158A>G p.(Asn720Asp) substitution was estimated to have a frequency of 0.011 (103/9689 alleles), which is in line with the frequency of the variant reported in the ",
            "gnomAD",
            " database (0.016), and is lower than the frequency reported in ",
            "gnomAD",
            " for the European non-Finnish population (0.025, 2195/87966 analyzed alleles)."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 1269,
                "end": 1275,
                "name": "gnomAD"
            },
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 1338,
                "end": 1344,
                "name": "gnomAD"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition to these variants, 28 rare missense variants were identified, out of which ten had not previously been reported in ",
            "GnomAD",
            " database and nine truncating variants that had not been reported in ",
            "gnomAD",
            " database (Table 1 and Supplementary Table 1)."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 1550,
                "end": 1556,
                "name": "GnomAD"
            },
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 1625,
                "end": 1631,
                "name": "gnomAD"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In order to shed light on the role of ACE2 variants on interindividual variability and susceptibility to COVID-19 in Italian population we performed WES analysis on a cohort of 131 patients and 258 controls who agreed in participating to the study (see “Materials and methods”)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A silent variant the c.2247G>A p.V749V, was also detected in 26 control individuals (allele frequency 0.069) compared with five COVID-19 patients (allele frequency 0.030)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Italy has been the first European country that experienced the COVID-19 outbreak with a rapid increase in the positive cases in a very short-time period and a morbidity and lethality (~10%) definitely higher in comparison with Asian countries, such as China (4%) and South Korea (1.2%) [32]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "WES data generated from a wide cohort of COVID-19 Italian patients revealed a statistically significant (P < 0,029) higher allelic heterogeneity for ACE2 in controls compared with patients with a higher chance to find at least one ACE2 variant in the cohort of controls compared with the cohort of patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A human-to-human transmission was assumed and a previously unrecognized entity, termed coronavirus disease-19 (COVID-19) due to a novel coronavirus (SARS-CoV-2) was described."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These findings suggest that a predisposing genetic background may contribute to the observed interindividual clinical variability associated with COVID-19, allowing an evidence-based risk assessment leading to personalized preventive measures and therapeutic options."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therapeutic efficacy and safety of supplementing ACE2 and Ang (1‐7) with this existing product in non‐critically ill COVID‐19 patients in the hospital and at home is in progress."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By employing an integrated Phase 1 and Phase 2 clinical trial design, this clinical trial addresses an urgent unmet medical need to treat the growing population of COVID‐19 patients and protect them from lung and extra‐pulmonary tissue injury."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the late winter of 2019, emergence of the SARS-CoV-2 virus led to the COVID-19 pandemic, manifesting in a serious illness affecting over a million people around the world, including the United States, during the spring of 2020 [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Not only is there the likelihood of increased morbidity and mortality if these individuals become infected with the virus, but the social and economic consequences of COVID-19 may significantly impact their access to critical healthcare resources."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Each has specific considerations that may be impacted by aspects of the COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Older adults and people of all ages who have serious underlying medical conditions are at higher risk for severe illness from COVID-19 [19]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Inflammation in COVID-19 infection results in a decrease of helper, suppressor and regulatory T cells and of gamma interferon."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The variability in effects of COVID-19 infection rates coupled with the variability in baseline GD disease burden will likely complicate addressing the extent of the vulnerability to infection in this population."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Initial symptoms of COVID-19 include fever, malaise, cough, impairment of sense of smell and/or taste and gastrointestinal disturbance."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The pulmonary involvement prevalent in this group may worsen with COVID-19 disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This “inflammatory storm”, observed in very ill patients with COVID-19, results from excessive and prolonged activation of proinflammatory stimuli. [23,59]",
            "This inflammatory syndrome may occur days to weeks after acute COVID-19 illness, with some patients developing cardiogenic or vasogenic shock requiring intensive care for multiple organ dysfunction.",
            "The response of patients with Gaucher disease to COVID-19 and/or its pharmacological interventions:"
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Subsequently, five additional 2019-nCoV sequences were deposited on the ",
            "GSAID",
            " database on 11th January from institutes across China (Chinese CDC, Wuhan Institute of Virology and Chinese Academy of Medical Sciences & Peking Union Medical College) and allowed researchers around the world to begin analyzing the new CoV [5]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 72,
                "end": 77,
                "name": "GSAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The sequences of these exported cases and several additional 2019-nCoV isolated in China have also been deposited on the ",
            "GSAID",
            " database [5]."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 444,
                "end": 449,
                "name": "GSAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 has infected over 20 million people and has killed more than 737,000 people by mid August 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There are currently no promising antiviral drugs or vaccines to combat COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Developing functional computational models and networks to predict potential SARS-CoV -miRNA/lncRNA association may benefit not only the understanding of COVID-19 mechanism at the noncoding RNA level, but also the detection of disease biomarkers for disease diagnosis, treatment, prognosis, and prevention."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since it is also important to consider the virus-host protein-protein interaction in order to understand its pathogenesis during infection [7,8]; we used ",
            "Viruses- STRING",
            ", a protein–protein interaction database specifically designed to analyze the virus-host interactions [9]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 647,
                "end": 662,
                "name": "Viruses- STRING"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, we used the miRWalk2.0 database to generate a network for a comprehensive overview of miRNA-lncRNA interactions using experimentally verified data [11]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To generate an interactome network of Human SARS coronavirus (SARS-CoV) with human proteins, we used the ",
            "STRING",
            " database ",
            "http://viruses.string-db.org/",
            " (version 10.5) [9]."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 1040,
                "end": 1046,
                "name": "STRING"
            },
            false,
            {
                "id": "T3",
                "type": "URL",
                "start": 1056,
                "end": 1085,
                "name": "http://viruses.string-db.org/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "In order to disclose the most possible miRNAs regulating the selected mRNAs, the ",
            "MiRTarBase",
            " (",
            "http://miRTarBase.cuhk.edu.cn/",
            "), one of the most important experimentally validated miRNA-target interactions (MTIs) databases, was employed."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 1187,
                "end": 1197,
                "name": "MiRTarBase"
            },
            false,
            {
                "id": "T5",
                "type": "URL",
                "start": 1199,
                "end": 1229,
                "name": "http://miRTarBase.cuhk.edu.cn/"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T4",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "Further, miRNA-lncRNA interactions were determined using the ",
            "miRWalk2.0",
            " database (",
            "http://zmf.umm.uni-heidelberg.de/apps/zmf/mirwalk2/",
            "), a database on predicted and published noncoding RNAs; and seed length (SL) ≥ 13 were selected as the most significant interactions [11]."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 1402,
                "end": 1412,
                "name": "miRWalk2.0"
            },
            false,
            {
                "id": "T7",
                "type": "URL",
                "start": 1423,
                "end": 1474,
                "name": "http://zmf.umm.uni-heidelberg.de/apps/zmf/mirwalk2/"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T6",
                "end": "T7"
            }
        ]
    },
    {
        "sen": [
            "Human SARS coronavirus (SARS-CoV) and the Homo sapiens interaction network was downloaded as a vector image from the ",
            "viruses STRING",
            " dataset."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Dataset",
                "start": 1731,
                "end": 1745,
                "name": "viruses STRING"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, we aimed to follow a comprehensive bioinformatics approach to dissect the strongest possible changes in the noncoding RNA network in response to the viral infection in humans using the available online databases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "",
            "STRING",
            " online database as a powerful platform to explore the most significant protein-protein interactions between SARS-CoV viral particles and host proteome."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 1979,
                "end": 1985,
                "name": "STRING"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, it is of utmost important priority to develop novel therapies for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID‐19 pandemic is now rapidly spreading worldwide, notably in Europe and North America where obesity is highly prevalent (10)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All patients were diagnosed with COVID‐19 pneumonia according to World Health Organization interim guidance (11), with SARS symptoms characterized by dyspnea, increased respiratory frequency, decreased blood oxygen saturation, and need for oxygen support therapy for at least 6 L/min."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID‐19 pandemic is rapidly spreading worldwide, notably in Europe and North America where obesity is highly prevalent."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of 28 January 2020, 33 genomes of 2019‐nCoV obtained from humans have been released on ",
            "GISAID",
            " (",
            "http://gisaid.org/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 90,
                "end": 96,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 98,
                "end": 116,
                "name": "http://gisaid.org/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "The final dataset (“dataset_32”) included 32 genomes of 2019‐nCoV from China (n = 25), Thailand (n = 2), and USA (n = 5), with sampling dates between 24 December 2019 and 23 January 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For this dataset, the 2019‐nCoV genomes were aligned using MAFFT v7.222",
            " and then manually curated using BioEdit v7.2.5."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, we subsampled three other datasets, that is, “dataset_14” collected between 24 December 2019 and 1 January 2020, comprising 14 genomes from Wuhan, Hubei Province, China; “dataset_24” collected between 24 December 2019 and 18 January 2020, comprising 24 genomes from China and Thailand; and “dataset_30” collected between 24 December 2019 and 23 January 2020, comprising 30 genomes from China, Thailand, and USA."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To assess the recombination for the full dataset (ie, “dataset_32”), we employed the pairwise homoplasy index (PHI) test to measure the similarity between closely linked sites using SplitsTree v4.15.1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The best‐fit nucleotide substitution model for “dataset_32” was identified according to the Akaike information criterion (AIC), small‐sample corrected AIC (AICc), Bayesian information criterion (BIC), and performance‐based decision theory (DT) method with 3 (24 candidate models) or 11 (88 candidate models) substitution schemes in jModelTest v2.1.10."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To evaluate the phylogenetic signals of the datasets, we performed likelihood‐mapping analysis",
            " using TREE‐PUZZLE v5.3,",
            " with 35 000 to 80 000 randomly chosen quartets for the four datasets."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For each dataset, we employed HKY, as well as a constant size coalescent tree prior and strict molecular clock model to estimate the time to a most recent common ancestor (TMRCA)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We then used two schemes to set the time scale prior for each dataset, that is, constrained evolutionary rate method with a lognormal prior (mean = 1.0 × 10−3 substitutions per site per year; 95% Bayesian credible interval (BCI): 1.854 × 10−4‐4 × 10−3 substitutions per site per year) placed on the evolutionary rate parameter based on previous studies",
            ", ",
            ", ",
            " and the tip‐dating method, for which the evolutionary rate for each dataset was also estimated."
        ],
        "lab": [
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The HIV TRAnsmission Cluster Engine (http://www.hivtrace.org)",
            " was employed to infer transmission network clusters for the full dataset (ie, “dataset_32”)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For “dataset_32”, the HKY model provided the best fit across the four different methods (ie, AIC, AICc, BIC, and DT) and two different substitution schemes (ie, 24 and 88 candidate models), and was thus used in subsequent likelihood‐mapping and phylogenetic analyses for the four datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The PHI test of “dataset_32” did not find statistically significant evidence for recombination (P = 1.0)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Likelihood‐mapping analysis of “dataset_14” revealed that 100% of the quartets were distributed in the center of the triangle, indicating a strong star‐like topology signal reflecting a novel virus, which may be due to exponential epidemic spread (Figure 1A)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Likewise, 91.9%, 81.8%, and 74.7% of the quartets from “dataset_24,” “dataset_30,” and “dataset_32,” respectively, were distributed in the center of the triangle, indicating relatively more phylogenetic signals as additional sequences were analyzed over time (Figure 1B‐D)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "ML phylogenetic analysis of the four datasets also showed star‐like topologies, in accordance with the likelihood‐mapping results (Figure 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Root‐to‐tip regression analyses between genetic divergence and sampling date using the best‐fitting root showed that “dataset_14” had a relatively strong positive temporal signal (R",
            "2 = .2967; correlation coefficient = .5446) (Figure 3A)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In contrast, “dataset_24” had a minor negative temporal signal (R",
            "2 = 4.4428 × 10−2; correlation coefficient = −.2108) (Figure 3B); whereas, “dataset_30” and “dataset_32” both had minor positive temporal signals (R",
            "2 = 1.2155 × 10−2; correlation coefficient = .1102 and R",
            "2 = 1.1506 × 10−2; correlation coefficient = .1073) (Figure 3C,D)."
        ],
        "lab": [
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On the basis of Bayesian time‐scaled phylogenetic analysis using the constrained evolutionary rate method with a lognormal prior (mean = 1.0 × 10−3 substitutions per site per year; 95% BCI: 1.854 × 10−4‐4 × 10−3 substitutions per site per year) placed on the evolutionary rate parameter, we estimated the TMRCA dates for 2019‐nCoV from the four datasets, that is, 1 November 2019 (95% BCI: 21 July 2019 and 29 December 2019), 10 November 2019 (95% BCI: 16 July 2019 and 16 January 2020), 21 October 2019 (95% BCI: 20 May 2019 and 19 January 2020), and 15 October 2019 (95% BCI: 2 May 2019 and 17 January 2020) for “dataset_14,” “dataset_24,” “dataset_30,” and “dataset_32,” respectively (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, based on Bayesian time‐scaled phylogenetic analysis using the tip‐dating method, we also estimated the TMRCA dates and evolutionary rates from “dataset_30” and “dataset_32,” with resulting showing 6 December 2019 (95% BCI: 16 November 2019 and 22 December 2019) and 6 December 2019 (95% BCI: 16 November 2019 and 21 December 2019), respectively; and 1.7926 × 10−3 substitutions per site per year (95% BCI: 7.216 × 10−4‐3.0558 × 10−3) and 1.8266 × 10−3 substitutions per site per year (95% BCI: 7.5813 × 10−4‐3.0883 × 10−3), respectively (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Due to poor convergence in the MCMC chains, we did not obtain the TMRCA date and evolutionary rate from “dataset_14” and “dataset_24.”",
            "This allowed us to identify a single large transmission cluster that included 30 of 32 (93.75%) genomes, thus suggesting low genetic divergence for “dataset_32” (Figure 6A)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This allowed us to identify three transmission clusters that included 15 of 32 (46.875%) genomes for “dataset_32” (Figure 6B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On the basis of “dataset_32,” which included 32 genomes of 2019‐nCoV strains sampled from China (Wuhan, n = 14; Shenzhen, n = 6; Zhuhai, n = 2; Hangzhou, n = 2; Taiwan, n = 1), Thailand (n = 2), and USA (n = 5) with sampling dates between 24 December 2019 and 23 January 2020, and subsampled “dataset_14,” “dataset_24,” and “dataset_30,” which included 14, 24, and 30 2019‐nCoV strain genomes, respectively, our likelihood‐mapping analysis confirmed additional tree‐like signals (from 0% to 8.2%, 18.2%, and 25.4%) over time, thus indicating increasing genetic divergence of 2019‐nCoV in human hosts (Figure 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of note, the strong star‐like signal (100% of quartets were distributed in the center of the triangle) from “dataset_14” at the beginning of the virus outbreak suggests that 2019‐nCoV initially exhibited low genetic divergence, with recent and rapid human‐to‐human transmission."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This result is consistent with the ML phylogenetic analyses, which showed polytomy topology from “dataset_14” (Figure 2A)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The genetic divergence from “dataset_32” and “dataset_30” was higher than that for “dataset_14,” but still demonstrated minor temporal signals (Figure 3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using the constrained evolutionary rate method, the mean TMRCA dates for 2019‐nCoV based on the four datasets ranged from 15 October to 10 November 2019, when using a lognormal prior (mean = 1.0 × 10−3 substitutions per site per year; 95% BCI: 1.854 × 10−4‐4 × 10−3 substitutions per site per year) placed on the evolutionary rate parameter (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using the tip‐dating method, the mean TMRCA date and evolutionary rate for 2019‐nCoV based on the “dataset_30” and “dataset_32” ranged from 16 November to 22 December 2019 and from 1.7926 × 10−3 to 1.8266 × 10−3 substitutions per site per year, respectively (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The X‐ray diffraction experiments were carried out at the Structural Biology Center 19‐ID beamline at the Advanced Photon Source, Argonne National Laboratory."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The data set was processed and scaled with the HKL3000 suite."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The atomic coordinates and structure factors have been deposited in the ",
            "PDB",
            " under accession code ",
            "6VWW",
            " and ",
            "6W01",
            " for Nsp15/apo and Nsp15/cit, respectively."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 293,
                "end": 296,
                "name": "PDB"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 318,
                "end": 322,
                "name": "6VWW"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 327,
                "end": 331,
                "name": "6W01"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T1",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "Coronavirus Disease 2019 (COVID-19) has caused an outbreak in China and is spreading worldwide [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As a result, South Korea could swiftly approve its first real-time reverse transcription (RT) PCR kit for COVID-19 testing on February 4, 2020 [4], following the country’s first reported case of COVID-19 on January 20, 2020 [5]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This issue of Ann Lab Med presents the guidelines for the laboratory diagnosis of COVID-19, which is followed in clinical laboratories in South Korea [6]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As local communities continue to be at risk of the virus spread, on February 23 2020, South Korea raised its national infectious disease alert to the highest level and further mobilized its resources to prevent the spread of COVID-19 [7]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A vast number of real-time RT PCR testing is being carried out thanks to the timely implementation of EUA; however, the country’s diagnostic capacity requires further improvement such as addressing the need to shorten the 6-hr turnaround time for testing in situations such as the current COVID-19 crisis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To reduce the spread of COVID-19, the World Health Organization (WHO) has opened its Emergency Use Listing procedure for new submissions; as of February 12, 2020, 220 IVDs have been listed that will be evaluated for analytical sensitivity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Xpert Xpress SARS-CoV-2 (Cepheid, Sunnyvale, CA) and BioFire COVID-19 Test (BioFire Diagnostics, Salt Lake City, UT), which can be tested within 45 minutes, received EUA from the United States FDA as of March 23, 2020 [9]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first case of COVID-19 in South America was reported in Brazil on February 26, in a 61 years old man traveling from Italy (gob.br, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In Colombia, the first case of COVID-19 was announced on March 6, in a traveler from Italy, after which the number of patients has exceeded 43,000 and over 1500 deaths (INS, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Both N and S proteins are highly immunogenic and most commercial COVID-19 diagnostic tests (molecular and immunologic) target these proteins (Álvarez-Díaz et al., 2020; Lee et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, non-synonymous mutations in the S and N proteins have been reported, their implications in the potential emergence of antigenically distinct and/or more virulent strains remain to be studied, although it was reported that mutations in the receptor-binding domain (RBD) at the S protein of SARS-CoV related viruses disrupt the antigenic structure and binding activity of RBD to ACE2 (Du et al., 2009) Similarly, non-synonymous mutations could impact the antibody response and the specificity and sensitivity of serological tests for COVID-19 diagnosis is unknown."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Reads were mapped to the Wuhan-Hu-1 reference genome (",
            "NC_045512.2",
            ") using BWA (Li et al., 2020) and BBmap (brian-jgi, 2020); then, assembled consensus sequences were submitted to ",
            "GISAID",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "AccessionNumber",
                "start": 1141,
                "end": 1152,
                "name": "NC_045512.2"
            },
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 1265,
                "end": 1271,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Subsequently, 461 SARS-CoV-2 sequences from South American countries, including Argentina, Brazil, Ecuador, Peru, Uruguay and other sequences from Colombia available on the ",
            "GISAID",
            ", ",
            "NCBI",
            ", and ",
            "GSA",
            " databases were analyzed (Supplementary Table S1, and Supplementary Table S2)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 1446,
                "end": 1452,
                "name": "GISAID"
            },
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 1454,
                "end": 1458,
                "name": "NCBI"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 1464,
                "end": 1467,
                "name": "GSA"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first COVID-19 case in Colombia was confirmed on March 6, 2020, from a traveler who entered the country from Italy on February 26, 2020 (",
            "EPI_ISL_418262",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 1687,
                "end": 1701,
                "name": "EPI_ISL_418262"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 is a new member of the genus Betacoronavirus , responsible for the COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Nucleocapsid (N) and Spike (S) are highly immunogenic structural proteins and most commercial COVID-19 diagnostic assays target these proteins."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We used a large database of HLA allele frequencies in world populations (with alleles defined at the second‐field level of resolution, third and fourth‐field levels being recoded to second‐field) including data from both the literature (1992‐2017) and reports of the 11th to 16th International HLA and Immunogenetics Workshops (IHIWs)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For each of the different loci (HLA‐A, ‐B, ‐C, ‐DRB1, ‐DQA1 and ‐DQB1), the dataset comprises between 158 and 374 typed samples, classified according to the hla‐net.eu guidelines,",
            " into 10 sub‐continental regions, that is, Sub‐Saharan Africa (SAF), North Africa (NAF), Europe (EUR), South‐West Asia (SWA), North‐East Asia (NEA), South‐East Asia (SEA), Australia (AUS), Oceania (OCE), North America (NAM) and South America (SAM)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All HLA‐A, ‐B, ‐C, and ‐DRB1 alleles that were observed in at least five populations worldwide (according to our database of allele frequencies), that is 92 HLA‐A, 164 HLA‐B, 55 HLA‐C and 94 HLA‐DRB1 were selected to assess the peptide‐binding affinity of their corresponding proteins HLA‐A, HLA‐B, HLA‐C and HLA‐DR, respectively, the latter representing the HLA‐DRA/DRB1 dimer as HLA‐DRA is here considered monomorphic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A single model including binding kind as a third predictor was considered and provided similar results but, because three‐way interactions were necessary to report the model, we preferred splitting the data set according to binding kind to simplify the presentation of results."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, a recent meta-analysis of six clinical studies involving 1,687 COVID-19 patients provided evidence that individuals with diabetes exhibited a similar prevalence of being infected with SARS-CoV-2 as the overall population, but presence of diabetes was a critical comorbidity that increased the risk of a poor outcome (4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Certain racial groups such as African Americans and Native Americans are highly prone to developing diabetes and experience disparities in health care making them particularly vulnerable to COVID-19 (5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, to date there is a paucity of data regarding comorbidities, COVID-19 outcomes, and mechanisms that modulate viral pathogenesis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this Perspective, we bring attention to specific factors that may complicate COVID-19 in individuals with diabetes including 1) the presence of bone marrow changes (myeloidosis) that predispose those with diabetes to an excessive proinflammatory response (cytokine storm) and contribute to insulin resistance and reduced vascular repair, and worsening function of the heart, kidney, and systemic vasculature as a whole; 2) increased circulating furin levels that could cleave the spike protein and increase infectivity of SARS-CoV-2; 3) dysregulated autophagy that may promote replication and/or reduce viral clearance; and 4) gut dysbiosis that leads to widespread systemic inflammation, increased gut glucose and sodium absorption, and reduced tryptophan and other key amino acid absorption needed for incretin secretion and glucose homeostasis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Central to each of these dysfunctions is the dysregulated RAS, in particular, the global loss of ACE2, which we propose is a unifying mechanism that could lead to the increased risk of morbidity and mortality in individuals with diabetes presenting with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Notably, COVID-19 patients exhibit increased serum levels of Ang-II (6), which would support less cleavage by ACE2 and thus potentially less ACE2 activity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Emerging COVID-19 gastrointestinal disturbances implicate a central role of intestinal pathophysiology in exacerbation of hyperglycemia and blood pressure in individuals with diabetes infected with SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "ACE2 was discovered in 2000 (7), just 2–3 years before the first wave of SARS-CoV coronavirus pandemic, when ACE2 was identified as the major SARS-CoV “receptor” on host cells."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The structure of the hACE2 was replotted from pdb ID: 1R42 (50)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The structure of the hACE2 bound to SARS-CoV-2 receptor binding domain (RBD) was replotted from ",
            "pdb",
            " ID: ",
            "6M0J",
            " (19)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 2490,
                "end": 2493,
                "name": "pdb"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 2498,
                "end": 2502,
                "name": "6M0J"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "High hACE2 expression in the nasal epithelium is consistent with clinical observations that symptomatic individuals with COVID-19 present with a higher viral load in the nasal cavity compared with the throat (10) and that some COVID-19 patients complain of inability to smell (13)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The hACE2-expressing nasal epithelium may provide an “intermediate site” for viral replication before its invasion of the lungs to cause symptomatic COVID-19 and may serve as a sanctuary niche for SARS-CoV-2 survival without spreading to the lungs in human subjects, thus perhaps permitting asymptomatic human-to-human transmission."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The structure of the homotrimeric SARS-CoV-2 spike protein complex was replotted from ",
            "pdb",
            " ID: ",
            "6VYB",
            " (15)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 3210,
                "end": 3213,
                "name": "pdb"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 3218,
                "end": 3222,
                "name": "6VYB"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "As COVID-19 progresses, SARS-CoV-2 may also involve the lytic release pathway for newly produced viral particles, bypassing the budding process utilizing the furin-containing Golgi compartments (Fig. 4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At this stage of COVID-19, extracellular furin may be utilized to complete the cleavage of spike protein’s furin cleavage sites, facilitating the virus spread in the infected host."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additionally, nonstructural protein 6 (nsp6) of SARS-CoV-2 can generate autophagosomes, and an associated mutation in nsp6 is identified in COVID-19 patients (4,24)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Given the strong association between the RAS and autophagy, both may serve as therapeutic targets to ablate SARS-CoV-2 infection and replication, and this may further explain the possible beneficial effects of ACE inhibitors/ATR blockers in the treatment of COVID-19, discussed further below."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Several mechanisms may contribute to increased severity of COVID-19 progression in subjects with diabetes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Diabetes-associated bone marrow dysfunction and loss of vascular reparative cells, such as CACs, may contribute to vascular dysfunction in COVID-19 patients that can be manifested as cardiac disease including arrhythmias, viral myocarditis, heart failure, and cardiac arrest (34–36)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In COVID-19 patients, the prevalence of kidney disease on admission and the development of acute kidney injury during hospitalization is high and associated with in-hospital mortality (37)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The loss of ACE2 via ADAM17 proteolytic cleavage, which is strongly activated in COVID-19 patients, will likely promote further injury to the cardiovascular system and kidneys in patients with diabetes (7,38)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While the lung is not considered a target tissue for diabetic complications, COVID-19 patients with diabetes experience worse pulmonary disease than those without diabetes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "ARDS triggers multiple pulmonary diseases and is observed in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The recent demonstration of SARS-CoV-2 actively infecting human enterocytes and the mounting gastrointestinal symptomology implicate gastrointestinal tract pathophysiology in COVID-19 infection (12,39)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Data coordinates were obtained from ",
            "pdb",
            " ID: ",
            "6M17",
            " (18)."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 5356,
                "end": 5359,
                "name": "pdb"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 5364,
                "end": 5368,
                "name": "6M17"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "In the patient with diabetes infected with COVID-19, developing pneumonia can be devastating, as preexisting systemic inflammation can rapidly lead to multiple organ failure."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Inflammatory cytokine storm is a notable cause of death in critically ill COVID-19 patients and may be driven as much by gut-induced inflammation as lung injury."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These results provide proof of concept for feasibility of using engineered probiotic species as a live vector for delivery of decoy hACE2 for possible treatment of enteric COVID-19 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Collectively, these results show that DIZE downregulates proinflammatory cytokine production by many distinct cell types and suggest that this drug may provide benefit to COVID-19 patients by reducing pulmonary inflammation and fibrosis, gut inflammation, and cytokine storm."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Individuals with diabetes suffering from coronavirus disease 2019 (COVID-19) exhibit increased morbidity and mortality compared with individuals without diabetes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We put forth the hypothesis that during this process, reduced ACE2 could result in clinical deterioration in COVID-19 patients with diabetes via aggravating Ang-II–dependent pathways and partly driving not only lung but also bone marrow and gastrointestinal pathology."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A global pandemic of the coronavirus disease COVID-19, a severe respiratory illness caused by a novel virus from the family Coronaviridae (SARS-CoV-2), has infected millions and caused hundreds of thousands of deaths (World Health Organization 2020a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 manifestation in patients can range from a lack of symptoms to severe pneumonia and death (Huang )."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Despite these measures, the number of confirmed COVID-19 cases has continued to rise (World Health Organization 2020a), highlighting the need for an effective vaccine and antiviral agents."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Synthesized viral coding sequences were incorporated into Gateway Entry plasmids: either pDONR207 (Invitrogen Cat #12213013) or pDONR223 (Rual )."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These clones were made by either PCR-amplifying the whole plasmid with primers that eliminated the stop codon, or by amplifying CDS regions from the first collection, using downstream primers with complementary regions that were internal to each stop codon, and which simultaneously incorporated the flanking sequences necessary for incorporation into a Gateway Entry plasmid [pDONR207, pDONR221 (Invitrogen Cat #12536017) or pDONR223]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The world is facing a global pandemic of COVID-19 caused by the SARS-CoV-2 coronavirus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since its emergence, the 2019 strain of coronavirus (hereafter COVID-19) has been a rising international cause of morbidity and mortality."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This global devastation is partly explained by the nature of viral transmission; the median incubation time from COVID-19 infection to the appearance of symptomatic dyspnea ranges from four to seven days, creating a large window of time for transmission during which patients have few symptoms (Guan et al., 2020; Huang et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Almost all COVID-19 patients who develop ARDS require mechanical ventilation; these patients tend to remain ventilator dependent for 10–14 d, and most ventilated patients ultimately succumb to the disease (Bhatraju et al., 2020; Wu et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There is a compelling case for innate immune hyperactivity in driving the acute lung injury that defines severe COVID-19 infections."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Both DAMPs and PAMPs are likely generated during initial infection and lysis of pneumocytes by COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Significant evidence indicates that a dysregulated innate immune response contributes to the clinical presentation of patients with severe COVID-19 infections."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19–infected patients harbor an expanded population of circulating monocytes that secrete both IL-6 and IL-1β (Wen et al., 2020",
            "Preprint; Zhang et al., 2020",
            "Preprint); as a result, patients with COVID-19 have elevated levels of serum IL-6, as well as lactate dehydrogenase levels, compared with healthy controls (Chen et al., 2020a)."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These elevations in innate immune cytokines have led to the hypothesis that an innate immune-mediated “cytokine storm,” similar to the cytokine release syndrome (CRS) observed in patients receiving treatment with chimeric antigen receptor–transduced T cells (CAR-T), is primarily responsible for the toxicity and end-organ damage mediated by COVID-19 infections (Grupp et al., 2013; Mehta et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A role for cytokine-driven neutrophil mobilization in COVID-associated lung toxicity may explain why neutrophilia, despite the absence of secondary bacterial infections, is associated with mortality (Lagunas-Rangel, 2020), and why administration of monoclonal antibodies targeting IL-6 has shown initial clinical promise (Gritti et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, caution is warranted before invoking IL-6–mediated CRS as the sole pathological driver in severe COVID-19 infections."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "First, COVID-19 patients lacks most of the hallmarks of CRS, including hypotension, capillary leak syndrome, and neurotoxicity (Hay et al., 2017)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Second, the clinical course of CRS is far more acute than that seen in COVID-19 infections, with fever occurring within 2 d and neurotoxicity within 5 d (Neelapu et al., 2018)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Accordingly, serum IL-6 levels are far lower in COVID-19 infections than in CRS, with peak levels typically less than 100 pg/ml in COVID-19, compared with 1,000–10,000 pg/ml in CRS (Chen et al., 2020a; Maude et al., 2014)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Third, deaths in COVID-19–infected patients appear to be due to primary respiratory failure, rather than from distributive shock or status epilepticus, as was predominantly seen in CRS-associated deaths (Lee et al., 2014)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Perhaps most importantly, the clinical results of therapeutic blockade of circulating IL-6 with tocilizumab or siltuximab are thus far mixed; one clinical trial showed evidence of improvement in 33% of patients, at least suggesting that in many cases, a hyperinflammatory response is not primarily responsible for COVID-19–associated morbidity and mortality (Gritti et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the case of viral infections such as COVID-19, however, macrophage activation is occurring as a primary response to viral infection (Tate et al., 2016)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is also worth noting that while many arms of the innate immune response are potently activated by COVID-19, the type I and type III interferon response appears to be muted in response to COVID-19 infection (Blanco-Melo et al., 2020",
            "Preprint), suggesting that some aspects of the innate immune response to COVID-19 might actually benefit from careful amplification (Kotenko et al., 2003)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Regardless of whether innate immune-mediated toxic inflammation contributes to COVID-19–related morbidity and mortality, it is clear that viral dissemination is a key driver of severe disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The rare histopathologic specimens obtained either postmortem or via liver or kidney biopsy in COVID-19–infected patients have almost universally revealed the presence of inclusion bodies, consistent with viral persistence (Chen et al., 2020",
            "Preprint; Diao et al., 2020",
            "Preprint; Yao et al., 2020)."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "What is permitting viral dissemination in patients who succumb to COVID-19 infections?",
            "Is the clinical toxicity observed during COVID-19 infection a product of adaptive immune hyperactivity or suppression?",
            "The clinical presentation of COVID-19 infection is more consistent with a subacute rather than an acute viral illness."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Compared with H1N1 influenza infections, in which the median incubation time was 2 d and the majority of intensive care unit admissions occurred within 24–48 h of admission (Bautista et al., 2010), COVID-19–infected patients present to the hospital with a median incubation time of 5–7 d and are typically hospitalized for an additional 3–4 d before requiring intensive care unit admission and/or mechanical ventilation (Huang et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This subacute pattern of progression raises the possibility that immunosuppression, due both to T cell depletion and exhaustion, contributes to COVID-19 viral persistence and mortality."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Lymphopenia is the most consistent laboratory abnormality in COVID-19–infected patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Notably, progressive lymphodepletion is observed in patients who clinically deteriorate during COVID-19 infection, whereas recovery of lymphocyte counts tends to directly precede clinical recovery (Chen et al., 2020",
            "Preprint)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similar to T cells from both mice and humans with chronic viral infections (Day et al., 2006; Fisicaro et al., 2017; Wherry et al., 2007), both lung-resident and circulating T cells from COVID-19 patients potently up-regulate markers of T cell exhaustion, including PD-1 and Tim-3 (Diao et al., 2020",
            "Preprint)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "T cells from severe COVID-19 patients exhibit transcriptional hallmarks of terminal T cell exhaustion including expression of CCL4 and GZMB; notably, the most expanded T cell population in the bronchoalveolar lavage of severe COVID-19 patients is marked by expression of MKI67 and TYMS, genes that are specifically up-regulated in terminally exhausted CD8+",
            "Conversely, single-cell sequencing of peripheral blood mononuclear cells of patients recovering from COVID-19 infection shows signs of clonal expansion, T cell activation, and T cell memory formation, consistent with an effective adaptive immune response (Wen et al., 2020",
            "Preprint)."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "T cells to inflammation and lung pathology; indeed, it is worth noting that many markers of T cell exhaustion are also up-regulated in effector T cells, and lung-infiltrating T cells from more mild COVID infections significantly up-regulated genes related to T cell activation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A role for the adaptive immune system in suppressing COVID-19 viral dissemination may explain the association of COVID-19 disease severity with age."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A smaller, more restricted T cell repertoire is likely more prone to antigen-mediated exhaustion during chronic viral infections; conversely, the relatively diverse and expanded pool of naive T cells may explain the relatively diminished severity of COVID-19 infections in children (Xu et al., 2020b)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In stark contrast to COVID-19, H1N1 occurred frequently and caused significant morbidity in children; of note, H1N1 infection caused lymphopenia in the majority of pediatric patients (Rhim et al., 2011)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therapeutically, high-dose glucocorticoids are the only strategy used thus far to modulate the adaptive immune system of COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "One commonly used therapeutic strategy in severe viral infections, but not yet in COVID-19–infected patients, is the use of antioxidants such as N-acetylcysteine (N-Ac)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Is there a way to therapeutically balance immune toxicity and immunosuppression to improve outcomes in COVID-19–infected patients?",
            "To answer to this question, we require a deeper understanding of both innate and adaptive immune evolution over the course of COVID-19 illness."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To this end, there is a need to obtain serial peripheral blood, and, when technically feasible and clinically appropriate, bronchoalveolar lavage samples over the course of COVID-19 infection and clearance."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The answer to this question will have key implications for the appropriate design of clinical trials aimed as modulating the anti-COVID immune response."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Longitudinal assessment of anti-COVID immune responses is particularly important in the setting of therapeutic interventions, both antiviral and immune-targeted."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For example, patients who respond to IL-6 blockade have a parallel improvement in lymphocyte counts (Xu et al., 2020a",
            "Preprint), suggesting that in some cases, COVID-19–associated lymphopenia may be a product of bystander inflammation (Stelekati et al., 2014)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Longitudinal sampling of COVID-19–infected patients with either inherent or iatrogenic disruption of host immunity may help identify specific regulators of the anti-COVID immune response (Box 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Second, patients with solid organ transplants require ongoing T cell immunosuppression, offering an opportunity to explore the contribution of the T cell–dependent immune response to COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In either early or late disease, an effective humoral response is a key contributor to viral clearance; here, we draw particular attention to the promise of treating infected patients with serum from convalescent patients that is rich in immunoglobulins targeting COVID-19 (Duan et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "4."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This Perspective explores the contributions of the innate and adaptive immune systems to both viral control as well as toxicity during COVID-19 infections and offers suggestions to both understand and therapeutically modulate anti-COVID immunity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Compared with recent viral outbreaks, COVID-19 infection has a relatively high mortality rate, the reasons for which are not entirely clear."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, treatment options for COVID-19 infection are currently limited."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this Perspective, we explore the contributions of the innate and adaptive immune systems to both viral control as well as toxicity during COVID-19 infections and offer suggestions to both understand and therapeutically modulate anti-COVID immunity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The recent emergence of the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has created a public health emergency across the globe [1–3]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The SARS-CoV-2 virus was isolated from a nasopharyngeal sample of a patient in Sweden and the isolated virus was confirmed as SARS-CoV-2 by sequencing (",
            "Genbank",
            " accession number ",
            "MT093571",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 358,
                "end": 365,
                "name": "Genbank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 383,
                "end": 391,
                "name": "MT093571"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "The raw files were imported to Proteome Discoverer v2.4 (Thermo Scientific) and searched against the Homo sapiens SwissProt (2020_01 release with 20,595 entries) and the pre-leased SARS-CoV-2 ",
            "UniProt",
            " (completed with 14 SARS-CoV-2 sequences of COVID-19 UniProtKB release 2020_04_06) protein databases with Mascot v 2.5.1 search engine (MatrixScience Ltd., UK)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 586,
                "end": 593,
                "name": "UniProt"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The pathway “Antiviral mechanism by IFN-stimulated genes” and two other events it participates were selected from ",
            "Reactome",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 868,
                "end": 876,
                "name": "Reactome"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To further capture the patterns of expression changes in response to the SARS-CoV-2 infection, we performed a weighted co-expression network analysis on both transcriptomic and proteomic datasets using all genes and proteins detected, their functional assignments, and the top genes (Figure 2(a)) and proteins (Figure 2(b)) in key network elements."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To repurpose antiviral drugs targeting host-viral interactions is an attractive strategy to find drugs that might work against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our data indicate a role of Akt/mTOR/HIF-1 in the cellular response to the SARS-CoV-2 infection, suggesting that drugs blocking this pathway could possibly be repurposed for COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The activation of Akt/mTOR signaling during SARS-CoV-2 infection could be to sustain protein synthesis by increased accession to translation components and by overcoming infection-associated stress by blocking autophagy and apoptosis [31]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In COVID-19 patients the severity of the disease is associated with a cytokine storm with markedly increased expression of interleukin 6 (IL-6) in the serum of severe cases [42]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Whether the currently proposed drugs targeting the Akt/mTOR pathway can be indeed repurposed for COVID-19 therapies now needs to be tested carefully in in vitro SARS-CoV-2 infection models and in in vivo COVID-19 disease models as improper regulation may pose a detrimental effect."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ongoing phase I (SirCo-1, ",
            "NCT04371640",
            "), phase II (The SCOPE trials, ",
            "NCT04341675",
            ") and phase III (",
            "NCT04409327",
            ") trials that target mTOR in the severe COVID-19 patients will provide more information."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 2297,
                "end": 2308,
                "name": "NCT04371640"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 2339,
                "end": 2350,
                "name": "NCT04341675"
            },
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 2367,
                "end": 2378,
                "name": "NCT04409327"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Further investigations are required to better understand the molecular sequelae in order to guide potential therapy in the management of severe coronavirus disease 2019 (COVID-19) patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Further extensive global transmission led to the WHO declaring COVID-19 as a pandemic on March 11 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There are thousands of global SARS-CoV-2 whole-genome sequences available on the rapid data sharing service hosted by the ",
            "Global Initiative on Sharing All Influenza Data (GISAID",
            "; ",
            "https://www.epicov.org",
            ")",
            "The extraordinary availability of genomic data during the COVID-19 pandemic has been made possible thanks to a tremendous effort by hundreds of researchers globally depositing SARS-CoV-2 assemblies (Table S1) and the proliferation of close to real time data visualisation and analysis tools including ",
            "NextStrain",
            " (",
            "https://nextstrain.org",
            ") and CoV-GLUE (http://cov-glue.cvr.gla.ac.uk)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 226,
                "end": 281,
                "name": "Global Initiative on Sharing All Influenza Data (GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 283,
                "end": 305,
                "name": "https://www.epicov.org"
            },
            false,
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 608,
                "end": 618,
                "name": "NextStrain"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 620,
                "end": 642,
                "name": "https://nextstrain.org"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "A variant calling pipeline (available at https://github.com/DamienFr/CoV-homoplasy) was used to obtain high-confidence alignments for the 348 (out of 889 as of April 19 2020) ",
            "SRA",
            " genomic datasets both meeting our quality criterions and matching ",
            "GISAID",
            " assemblies."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 865,
                "end": 868,
                "name": "SRA"
            },
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 935,
                "end": 941,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The topology of the Maximum Likelihood phylogeny of these 348 samples was compared to that of the corresponding samples from the ",
            "GISAID",
            " genome assemblies using a Mantel test and the Phytools R package (Revell, 2012) (Figs. S8-S9, see Supplementary text)."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Dataset",
                "start": 1083,
                "end": 1089,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The 7666 SARS-CoV-2 genomes offer an excellent geographical and temporal coverage of the COVID-19 pandemic (Fig. 1a-b)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using TreeDater (Volz and Frost, 2017), we observe an estimated tMRCA, which corresponds to the start of the COVID-19 epidemic, of 6 October 2019–11 December 2019 (95% CIs) (Fig. S4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These dates for the start of the epidemic are in broad agreement with previous estimates performed on smaller subsets of the COVID-19 genomic data using various computational methods (Table 1), though they should still be taken with some caution."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Indeed, the sheer size of the dataset precludes the use of some of the more sophisticated inference methods available."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The SARS-CoV-2 global population has accumulated only moderate genetic diversity at this stage of the COVID-19 pandemic with an average pairwise difference of 9.6 SNPs between any two genomes, providing further support for a relatively recent common ancestor."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Indeed, the earliest available strains were collected in Asia, where the COVID-19 pandemic started, followed by extensive genome sequencing efforts first in Europe and then in the USA."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The SARS-CoV-2 genomic diversity found in most countries (with sufficient sequences) essentially recapitulates the global diversity of COVID-19 from the 7666-genome dataset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This is also to an extent the case for Italy (Fig. S2b), which was an early focus of the COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, this global dataset includes only 35 SARS-CoV-2 genomes from Italy, so some of the genetic diversity of SARS-CoV-2 strains in circulation likely remains unsampled."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The genomic diversity of the global SARS-CoV-2 population being recapitulated in multiple countries points to extensive worldwide transmission of COVID-19, likely from extremely early on in the pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The strongest hit in terms of the inferred minimum number of changes required (Fig. 3b-c) at Orf1ab (11,083, Codon 3606) falls over a region encoding the non-structural protein, Nsp6, and is also observed in our analyses of the ",
            "SRA",
            " dataset (Table S7)."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Dataset",
                "start": 3211,
                "end": 3214,
                "name": "SRA"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Over the last century alone, several global epidemics have claimed millions of lives, including the 1957/58 influenza A (H2N2) pandemic, the sixth (1899–1923) and seventh ‘El Tor’ cholera pandemic (1961–1975), as well as the HIV/AIDS pandemic (1981-today)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 acts as an unwelcome reminder of the major threat that infectious diseases represent in terms of deaths and disruption."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The genetic data available at the time looks staggeringly small in comparison to the amount that has already been generated for SARS-CoV-2 during the early stages of the COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For example, analyses by multiple independent groups place the start of the COVID-19 pandemic towards the end of 2019 (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This site passed our stringent filtering cirteria and was also present in our analysis of the ",
            "SRA",
            " dataset (Table S7)."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Dataset",
                "start": 4033,
                "end": 4036,
                "name": "SRA"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The virus has since spread globally, resulting in the currently ongoing COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We curated a dataset of 7666 public genome assemblies and analysed the emergence of genomic diversity over time.",
            "Highlights     •  Phylogenetic estimates support that the COVID-2 pandemic started sometimes around 6 October 2019 – 11 December 2019.    •"
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severe lung inflammation and tissue damage are hallmarks of COVID-19, significantly contributing to mortality from this infection (Mehta et al., 2020); thus, enhancement of inflammation and cytokine storm must be avoided."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The absence of pro-inflammatory effects in the lungs (Davidson et al., 2016; Forero et al., 2019; Galani et al., 2017) is one of the most important arguments for the specific advantage of IFN-λ over type I IFNs as a treatment option for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, it is very important to establish if immune cells are responsive to IFN-λ in COVID-19, as their activation exacerbates inflammation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, bacterial superinfections can be associated with severe cases of COVID-19 (Zhang et al., 2020",
            "Preprint), although this varies between clinical studies."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although mouse models do not fully recapitulate human diseases with respect to IFN-λ activities, animal studies give a mandate to carefully evaluate the use of IFN-λ as a therapeutic agent against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Viewpoint discusses the benefits and potential limitations of using interferon lambda (IFN-λ, a type III interferon) to prevent, limit, and treat COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With the first reports on coronavirus disease 2019 (COVID-19), which is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the scientific community working in the field of type III IFNs (IFN-λ) realized that this class of IFNs could play an important role in this and other emerging viral infections."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At the time of writing, the outbreak of the highly infectious novel coronavirus disease 2019 (COVID‐19) has swept across all five continents, with >4 million confirmed cases globally (9 May 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patients felt to be at risk can then be identified early and appropriate referral either to a dedicated area for further assessment or to an acute care/COVID‐19 assessment centre can be facilitated."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patients and their caregivers should be reminded of the signs and symptoms of COVID‐19, as well as the importance of hand hygiene and other infection control measures."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Minimising immunosuppressive therapy, wherever possible, has become a key strategy in the face of COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For those patients in whom proceeding with ASCT has been deemed absolutely necessary, increased vigilance will be required in the short‐ and longer‐term, given the increased susceptibility to viral infection that will persist beyond the initial post‐transplant period."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            ", ",
            " Until herd immunity is established, the threat of COVID‐19 infection for this at‐risk population will very likely persist beyond the immediate crisis and may change our recommendations for surveillance and prevention in the post‐transplant period indefinitely."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The very real risk of hospitalisation posed by COVID‐19 has increasingly motivated both patients and treating physicians to actively engage in conversations regarding advance directives, goals of care and end‐of‐life planning, and to document these clearly."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "Despite the fact that at the time of writing there are >3000 published articles on COVID‐19, the data on the true risk posed by this virus to patients with myeloma remain immature."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, there are early suggestions that certain agents used in the treatment of myeloma could be useful against COVID‐19, including selinexor and ixazomib."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            ", ",
            " Angiotensin‐converting enzyme 2 (ACE2) is a co‐receptor for COVID‐19, but it remains unclear whether angiotensin‐converting enzyme inhibitors or receptor blockers, which are commonly co‐prescribed for patients with myeloma, could either aggravate or ameliorate the disease."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            ",",
            "One myeloma physician has suggested things will now be considered in terms of whether they were ‘BC’ (Before COVID‐19) or ‘AC’ (After COVID‐19)."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A global recession in the wake of COVID‐19 seems undeniable and will undoubtedly have a significant impact on healthcare spending regardless of the underlying revenue source and infrastructure."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At the time of writing, estimates suggest that in the USA alone, unemployment resulting from the COVID‐19 pandemic could reach levels of to 52·8 million, more than three‐times worse than the peak of the Great Recession."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Immediate focus is minimising risk of contracting coronavirus disease 2019 (COVID‐19) and the sequelae of infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Healthcare delivery post‐COVID‐19 will not return to how it was, and now is the time to invest in novel strategies to deliver the best possible outcomes for patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The recent pandemic of COVID‐19 is yet another manifestation of the might of natural selection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The recent outbreak of COVID‐19, now categorized as a pandemic, is by all means considerably widespread compared with earlier coronavirus outbreaks."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The findings provide interesting insights into the potential relationship between natural genetic variants in human ACE2 and susceptibility and/or resistance against COVID‐19 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The present investigation highlights candidate alleles of ACE2 that may lead to the variation in the susceptibility and/or resistance against COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, clinical manifestations and recovery rate of COVID‐19 varies significantly between different age groups, nationalities, and race."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            ",",
            "It is possible that in some individuals, if not all, the positive prognosis of the COVID‐19 may be due to the existence of ACE2 variants like rs73635825 (S19P) and rs143936283 (E329G)."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, the findings of this investigation provide clues to screen frequencies of the candidate alleles in different populations to predict the prognosis of COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The recent pandemic of COVID‐19, caused by SARS‐CoV‐2, is unarguably the most fearsome compared with the earlier outbreaks caused by other coronaviruses, SARS‐CoV and MERS‐CoV."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The findings provide direction to the targeted allele screening in COVID‐19 patients, which could further be used in predicting the prognosis of the disease and allocation of the health resources."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first week in the pre‐COVID‐19 era was randomly selected, while the second was chosen during the actual COVID‐19 emergency."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The week between 21 October 2019 and 26 October 2019 was identified as the pre‐COVID‐19 (no closure of the outpatients' surgeries available in our Unit for holidays or meetings)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The days between 12 March 2020 and 18 March 2020 characterized the weekly activity of our emergency service during the COVID‐19 era (days in the run‐up to the Government decree‐law)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the pre‐COVID‐19 era, 106 patients accessed our emergency outpatients' room, whereas just 20 cases were examined after the emergency decree‐law."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The number of unjustified accesses was 60 in pre‐COVID era, and 46 patients showed ‘true’ emergencies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The misuse of the emergency consultation facility is a bad habit and it has been estimated that at least half of the patients do not have a ‘true’ emergency (range 49–82%),",
            ", ",
            ", ",
            ", ",
            ", ",
            ", ",
            " which is confirmed by our study (60 vs. five unjustified accesses, before/after the COVID‐19 pandemic)."
        ],
        "lab": [
            false,
            false,
            false,
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patients suffering from acute myocardial infarction will refer to the ES even in the COVID‐19 era, and the same will occur in the case of dermatological emergencies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A possible bias in our research may be due to the panic related to the COVID‐19 disease, which can explain the drop in the number of consultations (106 vs. 19, for an 81% reduction)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The coronavirus disease 2019 (COVID-19) pandemic has affected most countries in the world."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severe acute respiratory syndrome-related coronavirus (SARS-CoV-2), COVID-19 clinically presents the symptoms with fever and mild respiratory illness, with ~20% of cases requiring hospital intervention, of which 5% require intensive support (Wu and Mc Googan, 2020; Huang et al., 2020; Zhou et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For validation of differential expression of SARS-CoV-2 genes, total RNA was extracted from 70 COVID-19 infected patients using Exgene™ Viral DNA/RNA (GeneAll, Korea) following the manufacturer's instructions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All SARS-CoV-2 whole genome sequences obtained from human hosts with geographical annotations were obtained from ",
            "NCBI",
            " and ",
            "Global initiative on sharing all influenza data (GISAID)",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 629,
                "end": 633,
                "name": "NCBI"
            },
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 638,
                "end": 694,
                "name": "Global initiative on sharing all influenza data (GISAID)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The average fold coverage of viral reads was sufficient to detect low-abundance microbial species genome from metagenomic datasets, implying the reliability of the assembled draft viral genome for SNP determination and further analyses (Albertsen et al., 2013)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The viral RdRP is up regulated during the evolution of RNA viruses, since RdRP is the central enzyme during this process and has the optimal combination of RNA synthesis efficiency and nucleotide incorporation fidelity (Holland et al., 1982; Snijder et al., 2016)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since the branching order of the NJ tree shows location of virus linkage, in principle the NJ tree provides the details that COVID-19 spread from one place to another."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The findings presented did not support the hypothesis, indicating that the COVID-19 may have begun to spread to several regions in the world before its outbreak in Wuhan."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A novel coronavirus related to severe acute respiratory syndrome virus, (SARS-CoV-2) is the causal agent of the COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Four throat swab samples from COVID-19 infected patients were pooled, with RNA-Seq read retrieved from ",
            "SRA NCBI",
            " to detect 21 SNPs and a replacement across the SARS-CoV-2 genomic population."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 1796,
                "end": 1804,
                "name": "SRA NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Aging leads to numerous physiological changes, including the deterioration of the immune system, rendering the elderly more susceptible to infections, such as the COVID-19 pandemic, and poor responses to vaccines (Ciabattini et al., 2018; Alpert et al., 2019; Onder et al., 2020; Verity et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also enrolled young and aged COVID-19 patients in the incipient stage and recovery stage to explore how age influenced the capacity for recovery and prognosis of COVID-19 infection and to better understand the influence of immune dysregulation in aging and infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Most impressively, COVID-19 caused similar immune cell landscape changes to that of aging and further increased aging-induced immune cell polarization and upregulation of inflammatory genes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To generate a comprehensive immune cell atlas reflecting cellular and systemic adaptations resulting from age and/or COVID-19 infection, we integrated scRNA-seq, CyTOF, scATAC-seq and scTCR/BCR-seq of single-cell PBMC suspensions collected from 3 separate cohorts (Fig. 1A, 1B, and Table S1A–G)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In cohort-1, comprising young healthy adults (YA) (20–45 years old) and aged healthy adults (AA) (≥60 years old), we combined CyTOF (n = 10) and scATAC-seq (n = 10) with scRNA-seq (n = 16) and scTCR/BCR-seq (n = 16); in cohort-2, comprising young healthy (YH) individuals (30–45 years old), aged healthy (AH) individuals (≥60 years old), young COVID-19 onset patients (YCO) (30–50 years old) and aged COVID-19 onset patients (ACO) (≥70 years old), we performed CyTOF analysis (n = 8); and in cohort-3, comprising YH individuals, AH individuals, young recovered COVID-19 patients (YCR) (30–50 years old) and aged recovered COVID-19 patients (ACR) (≥70 years old), we performed scRNA-seq (n = 22) (Fig. 1B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In cohort-2, we measured single-cell protein expression using a 26-marker CyTOF panel to discover early cellular changes in incipient COVID-19 patients and how those changes were affected by age."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, in cohort-3, we compared cellular differences between young and aged recovered COVID-19 patients by scRNA-seq analysis (Fig. 1B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To depict how the immune landscape changes with aging and SARS-CoV-2 infection, we enrolled young (YCO, n = 2) and aged (ACO, n = 2) patients with incipient COVID-19 (to assess the acute inflammatory state) in cohort-2 and young (YCR, n = 2) and aged (ACR, n = 2) patients who had recovered from COVID-19 (to assess the recovered state) in cohort-3."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We first compared the peripheral immune cell composition between COVID-19 patients (at the onset stage, CO) and their age-matched healthy controls (HC)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Importantly, the aging-associated increase in MCs and decrease in TCs were amplified by COVID-19 in aged patients compared with healthy aged controls (Fig. 6I)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Notably, we found a higher ratio of MCs, especially inflammatory MCs, and a lower percentage of TCs in aged COVID-19 patients than young COVID-19 patients (Figs. 6O and S12N)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The patients in cohort-2 were diagnosed with severe COVID-19 and presented with similar clinical symptoms and CT findings."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Aged COVID-19 patients had more MCs and fewer TCs than young patients, thus lowering the threshold of developing hyperinflammatory states that may trigger cytokine storms and lymphopenia."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To determine how an increased MCs population and decreased TCs population at the onset of SARS-CoV-2 infection contribute to faster disease progression in the elderly at the cellular and molecular levels, we used scRNA-seq to investigate the association between aging and COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Specifically, we analyzed DEGs to explore whether differentially expressed SARS-CoV-2-related genes in aged patients could explain the impact that aging had on the susceptibility and recovery of COVID-19 patients in cohort-3 (Figs. S13A–C and S14A)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Anti-CD147 antibody has been tested to treat COVID-19 patients with promising effects (Bian et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Altered expression of these molecules in circulating immune cells, especially in CD4 Naive, with age might contribute to increased susceptibility and severity of COVID-19 in the elderly."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our data demonstrated that the inflammatory response was sustained in the blood environment of COVID-19 patients recovering from SARS-CoV-2 infection (Wen et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the recovery stage, the aging-associated increase in MCs and decrease in TCs were amplified by COVID-19 in aged covered patients compared with healthy aged controls."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The results showed that COVID-19 amplifies aging-induced upregulation of inflammatory genes and senescence hallmark genes (CDKN family) (López-Otín et al., 2013)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These findings indicate that aged people have a slower recovery from COVID-19 than young people."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we depicted such an atlas from PBMCs harvested from healthy young and old research subjects and young and old patients with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our data suggest that increased numbers of MCs may contribute to cytokine storms in coronavirus infection, as indicated by increased numbers of MCs during aging and further increases in COVID-19, whereas TCs that are critical for virus clearance (Hickman et al., 2015; Herzig et al., 2019) were decreased during aging and further reduced in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, the polarization from naive to effector cells was further enhanced by SARS-CoV-2 infection in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Inflammatory genes such as IL1B, TNF, and CXCL8 were also increased during aging and were further upregulated in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Collectively, these findings reveal that aging reprograms the landscape of human immune cells toward polarized and inflammatory states and thus increases the susceptibility of COVID-19 in the elderly."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In turn, COVID-19 causes more “aging” of polarization and inflammatory states in immune cells."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, we reveal novel aging-related genes and adaptive immune dysregulation, thus defining the potential contributions of aging-related immune cell disorganization to the high severity rate of aged COVID-19 patients (Fig. 8)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we combined scRNA-seq, mass cytometry and scATAC-seq to compare immune cell types in peripheral blood collected from young and old subjects and patients with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Notably, COVID-19 promoted age-induced immune cell polarization and gene expression related to inflammation and cellular senescence."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, these findings suggest that a dysregulated immune system and increased gene expression associated with SARS-CoV-2 susceptibility may at least partially account for COVID-19 vulnerability in the elderly."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is associated with the current pandemic outbreak of COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "MERS betacoronavirus was used as a control data set as it is well‐studied in both hosts (human and camel), and as their close genetic relationship is well‐characterized."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For the next experiment, based on the alignment and comparison of the structures, MERS has been set as a control data set, due to the well‐characterized close relationship between human‐ and camel‐delivered strains."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "Therefore, our results suggest that the human SARS‐CoV‐2, responsible for the current outbreak of COVID‐19, could also come from yak as an intermediate host."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "During the submission process of this manuscript, the crystal structure of 2019-nCoV Mpro was solved (",
            "PDB",
            " ID: ",
            "6LU7",
            "), of which the lopinavir/ritonavir binding pocket region is nearly identical to our predicted model (Fig. S1)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 102,
                "end": 105,
                "name": "PDB"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 110,
                "end": 114,
                "name": "6LU7"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "Based on these results, we performed virtual docking to screen for commercial medicines in the ",
            "DrugBank",
            " database that could bind to the above mentioned pocket site of 2019-nCoV Mpro, and identified 10 candidate clinical medicines (Table 1",
            "; Figs. 1B and S3)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 321,
                "end": 329,
                "name": "DrugBank"
            },
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "(Coronavirus COVID-19 global cases by the centre for systems science and engineering at Johns Hopkins University) [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 45 confirmed cases of COVID-19 diagnosed at Ramon and Cajal University Hospital between March and May 2020 were included in this pilot study."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this web, frequencies are aggregated by country but reflect the distribution of HLA data available in this Net database."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To the best of our knowledge, this is one of the first works that study the role played by HLA molecules on individual responses to SARS-CoV-2 infection in a cohort of patients from Madrid, the Spanish region with the highest incidence of confirmed cases of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It has been reported to have a low affinity for the virus [13] and to be statistically significantly associated with severe SARS-CoV-1 disease and COVID-19 progression in studies conducted in various regions of China [12,27]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ongoing COVID-19 pandemic caused by the severe acute respiratory syndrome (SARS) coronavirus-2 (SARS-CoV-2) infection has affected over 6.5 million people thus far, resulting in the death of over four hundred thousand individuals worldwide (1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recently, new loss of the sense of smell, either total (anosmia) or partial (hyposmia), has been recognised as a symptom of COVID-19 by the World Health Organisation (WHO) and the US Centres for Disease Control and Prevention (CDC) (www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Accordingly, additional research focus has now been placed on exploring anosmia and the involvement of olfactory receptors (ORs) in COVID-19 (2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of note, the severity of COVID-19 shows a positive association with certain comorbidities which affect these tissues/systems, including asthma, obesity, diabetes and cancer (7)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As such, concentrating on non-neuronal (peripheral) expression of ORs, here we provide a comprehensive analysis of the expression profile of ORs in peripheral tissues, several of which co-express ACE2, TMPRSS2 and CTSL and are correspondingly associated with comorbidities predisposing to severe COVID-19 (Fig. 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Given that cancer is concidered as a comorbididity which predisposes to severe COVID-19, we also investigated the pan-cancer expression of ORs, including data regarding methylation and mutational profiles."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using the ",
            "TCGA",
            " datasets for all cancers, only four ORs appeared to be significantly differentially regulated (Fig. 4)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1404,
                "end": 1408,
                "name": "TCGA"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, despite the extensive data regarding decreased methylation status within an array of data sets, when compared with GEPIA expression data, changes in methylation status of nine ORs did not significantly correlate with changes in gene expression."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, the data from ",
            "cBioPortal",
            " revealed that the highest level of alterations in the data set for these ORs relates to gene amplification or mutation across the cancer panel (Fig. 6)."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 1790,
                "end": 1800,
                "name": "cBioPortal"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The potential involvement of ORs in the loss of smell as one of the COVID-19 presenting symptoms has been hypothesized since the first clinical cases of COVID-19 patients with anosmia (15)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Indeed, given the known expression and involvement of the airway smooth muscle ORs in bronchodilation and airway relaxation (5); such peripheral expression of ORs may have additional implications relating to COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As such, damage and potential interference with signalling pathways associated with OR functions, as noted for nasal epithelial ORs, may contribute to underlying mechanisms predisposing to adverse COVID-19 related clinical outcomes in patients with certain comorbidities (e.g., asthma or cancer) (16)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, our findings suggest potential links which should be explored in the context of male preponderance for severe COVID-19, given that a number of ORs were overexpressed in testes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interestingly, it has been suggested that androgen sensitivity can be a determinant of the severity COVID-19 manifests (24)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The noted high levels of TMPRSS2 and CTSL expression, coupled with the presented data regarding OR expression (e.g., OR51E2) in malignant and healthy tissues suggest additional implications which merit further research; for example, regarding increased expression in the prostate and predisposition to severe COVID-19 documented in male patients (14,25)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "New loss of smell (anosmia/hyposmia) is now recognized as a COVID-19 related symptom, which may be caused by SARS-CoV-2 infection and damage of the olfactory receptor (OR) cells in the nasal neuroepithelium and/or central involvement of the olfactory bulb."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Further in vitro and clinical studies are clearly required to elucidate the role of ORs, both at the olfactory level and the periphery, in the context of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At the end of December 2019, an outbreak of a respiratory disease affecting humans in China was reported., A few days after the outbreak was announced, the causal agent of coronavirus disease 2019 (COVID-19) was identified as severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), a novel betacoronavirus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 affects people of all ages, most of whom will develop mild to moderate symptoms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Most people with COVID-19 (84%) develop a mild or uncomplicated illness."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For COVID-19 patients admitted to ICU, the disease can be complicated by acute respiratory disease syndrome (ARDS), sepsis and septic shock, and multi-organ failure."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The WHO has published detailed guidelines for clinical management of patients with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For mild COVID-19 cases, patients can be provided with antipyretics for fever."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The management of severe COVID-19 cases includes immediate oxygen therapy and monitoring, it may be necessary to proactively prevent complications and secondary infections, treat underlying diseases and provide organ function support., Treatment of co-infections relies on empirical antimicrobial therapy to treat all likely pathogens causing severe acute respiratory infection (SARI) and sepsis (Figure 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patients suspected to have COVID-19 should be administered appropriate empirical antimicrobials within 1 h of identification of sepsis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Administration of antimicrobials in different hospital situations during the COVID-19 pandemic and the implications for AMR in One Health sectors."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There is no current evidence to recommend any specific treatment for patients with confirmed COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While a variety of antiviral agents, including antiviral peptides (e.g. favipiravir) and corticosteroids have been used in COVID-19 patients, their role and mode of action has yet to be established., Dexamethasone, a corticosteroid, has shown benefits in critically ill patients with COVID-19, reducing the mortality by about one-fifth or one-third in patients requiring oxygen or ventilator support, respectively."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The antiviral agent remdesivir is the most promising treatment for COVID-19, as it inhibits the activity of the viral RNA-dependent RNA polymerase.,",
            "Information on antimicrobial treatments given to patients with SARS-CoV-2 infection is scarce."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For example, Chen et al. reported that 15% of COVID-19 patients received antifungal treatment and 71% received antibiotic treatment, 25% of whom were treated with a single antibiotic and 45% with combination therapy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The administration of antibiotics was also reported in a case of a neonate with non-specific symptoms of COVID-19 infection; this neonate received fluid therapy, oxygen therapy and antibiotic therapy with vancomycin and amikacin."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Other studies did not describe the antimicrobial types used, reporting only the administration of IV antibiotic and antifungal medications in 57% and 3% of COVID-19 patients, respectively, or that all of 41 patients (100%) received antibiotics and 93% received antiviral treatments."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Other antibiotic therapeutics proposed for the treatment of COVID-19 disease are azithromycin, quercetin, rapamycin and doxycycline."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, the combination of hydroxychloroquine (an analogue of chloroquine considered an old antimalarial drug) and azithromycin appeared to be even more effective in COVID-19 treatment."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 pandemic has the potential to become a sustained major public health emergency."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the COVID-19 pandemic, it is important to warn of the unreported amounts of antibiotics and antifungals that have been administered worldwide in just a few months."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Rawson et al. highlighted several factors and potential impacts during the COVID-19 pandemic, as well as potential interventions in the AMR area."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Regardless of the COVID-19 pandemic, AMR could force up to 24 million people into extreme poverty by 2030 and drug-resistant diseases could cause 10 million deaths each year by 2050, as described in a United Nations report for urgent action to avert the AMR crisis., A sustained One Health approach is essential to engage and unite all stakeholders around a shared vision and common goals, since this global crisis includes humans, animals, plants, food and the environment and knows no borders (Figure 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Multisectoral and multifaceted actions on AMR are crucial because human medicine, and the food and agricultural sectors use antibiotics daily.,",
            "Abstract  COVID-19 is caused by the SARS-CoV-2 virus, which has infected more than 4 million people with 278 892 deaths worldwide as of 11 May 2020."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This article highlights the administration of antimicrobials in COVID-19 patients worldwide, during the 2019–20 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Primary sequence of Saudi Arabia isolate MERS-COVS protein was retrieved from ",
            "NCBI",
            " database using accession number ",
            "ALW82742.1",
            " [18]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 78,
                "end": 82,
                "name": "NCBI"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 115,
                "end": 125,
                "name": "ALW82742.1"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "Experimentally known 3D structure of MERS-COV S protein was retrieved by using ",
            "PDB",
            " ID: ",
            "5X59",
            " from ",
            "Protein-Data-Bank",
            " [19]."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 211,
                "end": 214,
                "name": "PDB"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 219,
                "end": 223,
                "name": "5X59"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 229,
                "end": 246,
                "name": "Protein-Data-Bank"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "This method relies on surface accessibility and amino acid statistics in a collected form dataset of discontinuous epitopes found out by X-ray crystallography of antigen/antibody protein buildings."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Aller Hunter server compares peptide’s query sequences opposed to the database of previously reported allergens to give significant outcomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "S protein sequences of 8 distinctive countries were taken from an open access ",
            "Genbank",
            " database [38]."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 671,
                "end": 678,
                "name": "Genbank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All the predicted peptides 3D structures were modelled via PEPFOLD server at RPBS MOBYL portal [41], from ",
            "Protein databank",
            " (",
            "PDB",
            " ID: ",
            "3VCL",
            ") at a resolution of 1.7 Å, the 3D structure of human HLA-B7 allele crystallized was taken [42] and utilized for further molecular docking purpose."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 800,
                "end": 816,
                "name": "Protein databank"
            },
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 818,
                "end": 821,
                "name": "PDB"
            },
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 826,
                "end": 830,
                "name": "3VCL"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T8",
                "end": "T9"
            }
        ]
    },
    {
        "sen": [
            "3D structure of S protein (",
            "PDB",
            " ID: ",
            "5X59",
            ") [19] was used for discontinuous epitopes prediction, 90% specificity, − 3.700 threshold and 22.000 Angstroms propensity score radius."
        ],
        "lab": [
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 1005,
                "end": 1008,
                "name": "PDB"
            },
            false,
            {
                "id": "T11",
                "type": "AccessionNumber",
                "start": 1013,
                "end": 1017,
                "name": "5X59"
            },
            false
        ],
        "rel": [
            {
                "id": "R4",
                "bool": true,
                "head": "T10",
                "end": "T11"
            }
        ]
    },
    {
        "sen": [
            "Crystal structure of human HLA-B7 (",
            "PDB",
            " ID: ",
            "3VCL",
            ") protein was previously accessible with co-crystallized peptide in ",
            "PDB",
            " [42]."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 1188,
                "end": 1191,
                "name": "PDB"
            },
            false,
            {
                "id": "T13",
                "type": "AccessionNumber",
                "start": 1196,
                "end": 1200,
                "name": "3VCL"
            },
            false,
            {
                "id": "T14",
                "type": "Repository",
                "start": 1268,
                "end": 1271,
                "name": "PDB"
            },
            false
        ],
        "rel": [
            {
                "id": "R5",
                "bool": true,
                "head": "T12",
                "end": "T13"
            }
        ]
    },
    {
        "sen": [
            "Peptide ‘WPRPIDVSK’ was docked (dock score -20.4007 kcal/mol) inside the catalytic pocket of receptor protein through 4 hydrogen bonds with Arg-62, Glu-152, Glu-163 and Trp-167 (Fig. 6b)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since the initial outbreak of COVID-19 and identification of a novel enveloped RNA betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), reports suggest the virus might be evolving, albeit at a lower rate than influenza viruses.1, 2, 3 Nevertheless, in light of the rapid and pandemic-scale spread of COVID-19, mutations in SARS-CoV-2 raise new diagnostic challenges, including the redesign of the oligonucleotide sequences in use in RT-qPCR assays to circumvent potential primer–sample mismatches."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We report an analysis of all high-coverage SARS-CoV-2 genome sequences (1825 in total) deposited in the ",
            "Global Initiative on Sharing All Influenza Data (GISAID)",
            " database as of March 30, 2020."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 628,
                "end": 684,
                "name": "Global Initiative on Sharing All Influenza Data (GISAID)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Oligonucleotide optimisation will be facilitated by global sharing of SARS-CoV-2 genomes and the frequently updated reports on sequence analysis that are available on the ",
            "GISAID",
            " website."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 887,
                "end": 893,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This particular disease has been named as COVID-19, with common symptoms such as loss of smell, muscle ache, shortness of breath and fever with cough (Aanouz et al., 2020; Alagaili et al., 2014; Bhakkiyalakshmi et al., 2016; Bonkowski & Sinclair, 2016)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 has the capability to spread human to human through droplet exchange while coughing, talking, and sneezing (Chan et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Experimentally solved 3D structures of the proteins non-structural protein 15 (nsp15) (",
            "PDB",
            " ID:",
            "6VWW",
            ") and RNA-dependent polymerase (RdRp) (",
            "PDB",
            " ID: ",
            "6YYT",
            "), human angiotensin receptor (ace2) (",
            "PDB",
            " ID:",
            "6M1D",
            ", chain B) were used for this study."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 478,
                "end": 481,
                "name": "PDB"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 485,
                "end": 489,
                "name": "6VWW"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 528,
                "end": 531,
                "name": "PDB"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 536,
                "end": 540,
                "name": "6YYT"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 578,
                "end": 581,
                "name": "PDB"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 585,
                "end": 589,
                "name": "6M1D"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "100,000 compounds) was obtained from ",
            "ZINC",
            " database (",
            "Sterling & Irwin, 2015",
            ") for the best optimal hit against these mentioned targets."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 663,
                "end": 667,
                "name": "ZINC"
            },
            false,
            {
                "id": "T8",
                "type": "Creator",
                "start": 678,
                "end": 700,
                "name": "Sterling & Irwin, 2015"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The independence of the endonuclease activity marks our third protein target which is RdRp, known as RNA-dependent polymerase (",
            "PDB",
            " ID: ",
            "6M17",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 887,
                "end": 890,
                "name": "PDB"
            },
            false,
            {
                "id": "T10",
                "type": "AccessionNumber",
                "start": 895,
                "end": 899,
                "name": "6M17"
            },
            false
        ],
        "rel": [
            {
                "id": "R4",
                "bool": true,
                "head": "T9",
                "end": "T10"
            }
        ]
    },
    {
        "sen": [
            "The protein on the human side (ACE2 receptor – ",
            "PDB",
            " ID ",
            "6M1D",
            ") is the first entry point for the SARS-CoV-2 to playing the crucial role for the host cells allowing the entry of the viral genome (Yan et al., 2020)."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Repository",
                "start": 949,
                "end": 952,
                "name": "PDB"
            },
            false,
            {
                "id": "T12",
                "type": "AccessionNumber",
                "start": 956,
                "end": 960,
                "name": "6M1D"
            },
            false
        ],
        "rel": [
            {
                "id": "R5",
                "bool": true,
                "head": "T11",
                "end": "T12"
            }
        ]
    },
    {
        "sen": [
            "The ongoing pandemic COVID-19 (COrona Virus Immuno Deficiency-2019) which is caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome–CoronaVirus-2) has emerged as a pandemic with 400,000 plus deaths till date."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The expedition for searching a potential drug or vaccine against COVID-19 will be of massive potential and favor."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our studies propose Baicalin and Limonin in combination to be studied in vitro and in vivo against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The age of COVID-19 cases in urban areas ranged from 19 to 90 years, averaging 51.89 years (51.89 ± 15.79 years), whereas the age of COVID-19 cases in suburban areas ranged from 9 to 90 years, averaging 47.89 years (47.89 ± 17.12)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The distribution of COVID-19 cases by age is shown in Table 1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of all of the COVID-19 cases in Tianjin, 72 were male and 63 were female, accounting for 53.33% and 46.67%, respectively."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The distribution of COVID-19 cases by gender is shown in Table 1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of the total COVID-19 cases, 101 (74.81%) cases belonged to family or social setting (including workplace and public place) clusters."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Figure 1 shows the familial clustering of COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of the 135 COVID-19 cases in Tianjin, 26 (29.55%) came into contact with the epidemic area before the onset of symptoms, but 109 (80.74%) had no history of contact with the epidemic area before the onset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of January 31, COVID-19 cases with no history of sojourning in Hubei began to account for the majority of the new cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among urban residents, there were 14 (31.10%) COVID-19 cases of people who had visited Hubei Province and 31 (68.90%) COVID-19 cases of people who had not."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among suburban residents, there were 6 (7.14%) COVID-19 cases of people who had visited Hubei Province and 78 (92.86%) COVID-19 cases of people who had not."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This study describes the epidemiologic features of an outbreak of the coronavirus disease (COVID-19) in Tianjin caused by a novel coronavirus and provides the scientific basis for prevention and control measures."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Methods:  Data from COVID-19 cases were collected from daily notifications given to the ",
            "National Health Commission of the People’s Republic of China",
            " and ",
            "Tianjin Health Committee",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Creator",
                "start": 1621,
                "end": 1681,
                "name": "National Health Commission of the People’s Republic of China"
            },
            false,
            {
                "id": "T2",
                "type": "Creator",
                "start": 1686,
                "end": 1710,
                "name": "Tianjin Health Committee"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The incidence of COVID-19 was 8.65/1 000 000 with a 2.22% case fatality rate."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A familial clustering was the most important characteristic of COVID-19 (accounting for 74.81%)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Conclusions:  Current information suggests that people are generally susceptible to COVID-19, which has shown a familial clustering in Tianjin."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thanks to next‐generation sequencing approach, a new coronavirus was quickly identified as the causative agent of the new coronavirus disease 2019 (COVID‐19)",
            "; moreover, due to the rapid global diffusion, WHO declared the pandemic status on 11 March 2020."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID‐19 related virus was classified as a betacoronavirus and, considering its close correlation to SARS‐CoV, it was renamed SARS‐CoV‐2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Low‐quality reads bases were trimmed out using Trimmomatic software,",
            " using 13 different parameter sets (LEADING:3 TRAILING:3 SLIDINGWINDOW:4:15 MINLEN:36, LEADING:3 TRAILING:3 SLIDINGWINDOW:4:20 MINLEN:36, LEADING:3 TRAILING:3 SLIDINGWINDOW:4:25 MINLEN:36, LEADING:3 TRAILING:10 SLIDINGWINDOW:4:15 MINLEN:36, LEADING:3 TRAILING:10 SLIDINGWINDOW:4:20 MINLEN:36, LEADING:3 TRAILING:10 SLIDINGWINDOW:4:25 MINLEN:36, LEADING:3 TRAILING:20 SLIDINGWINDOW:4:15 MINLEN:36, LEADING:3 TRAILING:20 SLIDINGWINDOW:4:20 MINLEN:36, LEADING:3 TRAILING:20 SLIDINGWINDOW:4:25 MINLEN:36, MAXINFO:50:0.3, MAXINFO:50:0.5, MAXINFO:50:0.7, MAXINFO:50:0.9)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Then, single‐nucleotide polymorphism (SNP) calling was performed following the GATK Best Practice procedure,",
            " using the Wuhan‐Hu‐1 strain genome (accession ",
            "MN908947.3",
            ") as reference."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T1",
                "type": "AccessionNumber",
                "start": 1189,
                "end": 1199,
                "name": "MN908947.3"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A dataset of 41 genome assemblies of SARS‐CoV‐2 strains isolated in Italy between 20 February 2020 and 30 March 2020 was retrieved from ",
            "Global Initiative on Sharing All Influenza Data (GISAID)",
            " database (Table S1)."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 1351,
                "end": 1407,
                "name": "Global Initiative on Sharing All Influenza Data (GISAID)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A global dataset including these 41 ",
            "GISAID",
            " genome assemblies and the 20 genome assemblies generated in this study was produced and aligned using MAFFT."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 1465,
                "end": 1471,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The 20 SARS‐CoV‐2 genome assemblies are available on the ",
            "GISAD",
            " database (Table 1)."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 1638,
                "end": 1643,
                "name": "GISAD"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Lombardy had the highest prevalence of COVID‐19 in Italy, thus being the likely epicenter of country outbreak."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A phylogenetic analysis was conducted on 20 full‐length genomes from patients addressing to several Lombard hospitals (20 February to 4 April 2020), aligned with 41 Italian viral genome assemblies from ",
            "GISAID",
            " database as of 30 March 2020."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 1977,
                "end": 1983,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These amino‐acid changes appear to coexist, being always found together in the dataset, as well as present almost exclusively in ",
            "GISAID",
            " 20B clade."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 2143,
                "end": 2149,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thereafter Lombardy has reported the highest prevalence of COVID‐19 cases in the country, especially in Milano, Brescia and Bergamo provinces."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The aim of this study was to assess the potential presence of different viral clusters belonging to the six main provinces involved in Lombardy COVID‐19 cases in order to highlight peculiar province‐dependent viral characteristics."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A phylogenetic analysis was conducted on 20 full length genomes obtained from patients addressing to several Lombard hospitals from February 20th to April 4th, 2020, aligned with 41 Italian viral genome assemblies available on ",
            "GISAID",
            " database as of 30th March, 2020: two main monophyletic clades, containing 8 and 53 isolates, respectively, were identified."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Dataset",
                "start": 2763,
                "end": 2769,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, upon entering into cells, exogenous RNAs need to escape from endosomal trapping and/or degradation by large classes of intracellular ribonucleases or RNases (e.g., endonucleases, and 5′ and 3′ exonucleases), become incorporated into specific complex, and get access to the targets (Fig. 1) to exercise pharmacological effects."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although IVT is unable to specifically assemble post-transcriptionally modified or natural nucleosides into an mRNA molecule at particular sites, and the effects of such modifications on the efficiency of intracellular translation remain obscure, systemic incorporation of pseudouridine (Karikó et al., 2008) or N1-methyl-pseudouridine (Svitkin et al., 2017) into mRNA substances could be achieved by IVT reactions, leading to an improvement of translational capacity and biological stability, as compared with unmodified counterparts."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Entrapment of a ligand can stabilize the incorporation of the switching sequence into the aptamer domain, and thus the expression platform is induced to fold into a specific structure to modulate the expression of genes controlling the biosynthesis and transport of metabolites (Serganov and Nudler, 2013; Hallberg et al., 2017)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease 2019 (COVID-19), a deadly disease induced by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first discovered in China, and is accompanied by a high degree of morbidity and mortality [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Clinical features of COVID-19 may include pyrexia, asthenia, dyspnea, as well as acute respiratory distress syndrome, septic shock, and coagulation dysfunction in critically ill patients [3]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, the medical pharmacotherapy to treat COVID-19 is still insufficient [7]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Accordingly, it is necessary to explore and develop bioactive compounds to treat COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All these pieces of evidence suggest that vitamin A may be an optional treatment for COVID-19; however, to date there has been no investigation of VA against SARS-CoV-2, especially its pharmacological mechanism."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this report, we aimed to determine and identify the curative effect of VA for treating COVID-19 and to utilize a network pharmacology approach to uncover the mechanisms underlying the therapeutic role of VA."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We assayed and identified 393 SARS-CoV-2-associated genes from the ",
            "Genecard",
            " and ",
            "OMIM",
            " datasets."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1103,
                "end": 1111,
                "name": "Genecard"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 1116,
                "end": 1120,
                "name": "OMIM"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These findings suggest that vitamin A could be a potential treatment for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, there are few existing drug treatments for COVID-19, and some of the immunotherapy treatments and antiviral drugs used in clinical practice have shown limited therapeutic effectiveness [18]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "VA may exert potent, beneficial pharmacological activity for the treatment of COVID-19 via associated cytoprotection, anti-viral and anti-inflammatory effects, and immunoregulation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In further bioinformatics and computational assays, the therapeutic mechanisms of VA for managing COVID-19 could be conjunctively actualized through collective regulation of the FoxO signaling pathway, GnRH signaling pathway, PD-L1 expression, and PD-1 checkpoint pathway."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Adjuvant supplementation of VA may enhance the therapeutic efficacy of current clinical anti-viral agents and immunotherapy to treat potentially fatal COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "More importantly, VA may be used clinically for the treatment of COVID-19, as evidenced by the identified biological processes—which indicate pharmacological functions—and the signaling pathways, which suggest therapeutic mechanisms (Figure 6)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By using online datasets, in particular ",
            "TCMSP",
            ", ",
            "Drugbank",
            ", ",
            "SuperPred",
            ", ",
            "Swiss Target Prediction",
            ", ",
            "ChemMapper",
            ", and ",
            "BATMAN TCM",
            ", all target genes activated by VA were obtained."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 2315,
                "end": 2320,
                "name": "TCMSP"
            },
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 2322,
                "end": 2330,
                "name": "Drugbank"
            },
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 2332,
                "end": 2341,
                "name": "SuperPred"
            },
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 2343,
                "end": 2366,
                "name": "Swiss Target Prediction"
            },
            false,
            {
                "id": "T7",
                "type": "Dataset",
                "start": 2368,
                "end": 2378,
                "name": "ChemMapper"
            },
            false,
            {
                "id": "T8",
                "type": "Dataset",
                "start": 2384,
                "end": 2394,
                "name": "BATMAN TCM"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The genes activated by VA were collected for target correction from reviewed (",
            "Swiss-Prot",
            ") and ",
            "Uniprot",
            " databases."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 2522,
                "end": 2532,
                "name": "Swiss-Prot"
            },
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 2538,
                "end": 2545,
                "name": "Uniprot"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "Genecard",
            " and ",
            "OMIM",
            " datasets were employed to harvest SARS-CoV-2 genes."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Repository",
                "start": 2561,
                "end": 2569,
                "name": "Genecard"
            },
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 2574,
                "end": 2578,
                "name": "OMIM"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19), an epidemic disease characterized by rapid infection and a high death toll."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The clinical diagnosis of patients with COVID-19 has risen sharply, especially in Western countries."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Globally, an effective treatment for COVID-19 is still limited."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, bioinformatics analysis and computation assays using a network pharmacology method were conducted to explore and uncover the therapeutic targets and mechanisms of VA for treating COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, seven core targets of VA against COVID-19, including MAPK1, IL10, EGFR, ICAM1, MAPK14, CAT , and PRKCB were identified."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With this bioinformatics-based report, we reveal, for the first time, the anti-SARS-CoV-2 functions and mechanisms of VA and suggest that VA may act as a potent treatment option for COVID-19, a deadly global epidemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In December 2019, the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in the city of Wuhan in Hubei province, People’s Republic of China, as the etiologic agent of coronavirus disease 2019 (COVID-19), which has hence spread worldwide causing a global pandemic (1–3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Megahit generated in all cases 7 contigs with more than 1,000 bp and 100× coverage; all of these assembled contigs were compared (using BLASTn) against the entire nonredundant (nr) nucleotide and protein databases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The longer sequences were named hCoV-19/Italy/FVG/ICGEB_S1, _S5, _S8, and _S9 and were deposited in ",
            "GISAID",
            " (see below)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 621,
                "end": 627,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Phylogenetic trees were inferred using the maximum likelihood method implemented in the MEGAX program using the ",
            "GISAID",
            " sequences available at 03-16-2020 (6)."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 753,
                "end": 759,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Bootstrap support values were calculated from 500 pseudoreplicate trees of the whole data set (Fig. 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Despite a high burden of COVID-19 in Italy, very little information is available to date from full-length high-quality sequences."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first sequences deposited in ",
            "GISAID",
            " (",
            "EPI_ISL_410545",
            " and ",
            "EPI_ISL_410546",
            ") were collected in Rome from a Chinese tourist from Hubei province who got infected before visiting Italy, and another one (",
            "EPI_ISL_412974",
            ") was from a test-positive Italian citizen returning from China."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 1066,
                "end": 1072,
                "name": "GISAID"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 1074,
                "end": 1088,
                "name": "EPI_ISL_410545"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 1093,
                "end": 1107,
                "name": "EPI_ISL_410546"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 1232,
                "end": 1246,
                "name": "EPI_ISL_412974"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T3",
                "end": "T4"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T5"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T3",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "The longer sequences were named hCoV-19/Italy/FVG/ICGEB_S1, _S5, _S8, and _S9 and were deposited in ",
            "GISAID",
            " (",
            "https://www.gisaid.org/",
            ") with accession numbers ",
            "EPI_ISL_417418",
            ", ",
            "EPI_ISL_417419",
            ", ",
            "EPI_ISL_417421",
            ", and ",
            "EPI_ISL_417423",
            ", respectively (9)."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Dataset",
                "start": 1411,
                "end": 1417,
                "name": "GISAID"
            },
            false,
            {
                "id": "T8",
                "type": "URL",
                "start": 1419,
                "end": 1442,
                "name": "https://www.gisaid.org/"
            },
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 1467,
                "end": 1481,
                "name": "EPI_ISL_417418"
            },
            false,
            {
                "id": "T10",
                "type": "AccessionNumber",
                "start": 1483,
                "end": 1497,
                "name": "EPI_ISL_417419"
            },
            false,
            {
                "id": "T11",
                "type": "AccessionNumber",
                "start": 1499,
                "end": 1513,
                "name": "EPI_ISL_417421"
            },
            false,
            {
                "id": "T12",
                "type": "AccessionNumber",
                "start": 1519,
                "end": 1533,
                "name": "EPI_ISL_417423"
            },
            false
        ],
        "rel": [
            {
                "id": "R4",
                "bool": true,
                "head": "T7",
                "end": "T8"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T7",
                "end": "T9"
            },
            {
                "id": "R6",
                "bool": true,
                "head": "T7",
                "end": "T10"
            },
            {
                "id": "R7",
                "bool": true,
                "head": "T7",
                "end": "T11"
            },
            {
                "id": "R8",
                "bool": true,
                "head": "T7",
                "end": "T12"
            }
        ]
    },
    {
        "sen": [
            "According to data presented by the COVID-19 situation report from ",
            "World Health Organization (WHO)",
            ", as of May 15, 2020, the virus has infected more than 4,347,935 people around the world including a staggering 297,241 deaths, with a cumulative mortality rate of >6.8% and exponentially increased in between March and April [2]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Creator",
                "start": 66,
                "end": 97,
                "name": "World Health Organization (WHO)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Despite the instantaneous and monumental research efforts from the scientific community around the globe at present, no effective antiviral treatment or vaccine is available for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recently several repurposing studies on SARS-CoV-2 have been performed using clinically approved drugs [20], among which a very new study comes out on a clinical trial of Lopinavir–Ritonavir drug for COVID-19, which was indicated on top of our drug repurposing study [21]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To this end, a recently elucidated X-ray crystal structure of SARS-CoV-2 Mpro (",
            "PDB",
            " ID: ",
            "6Y2F",
            ") which have been shown with an α-ketoamide as a potent inhibitor in the enzyme’s active site, was chosen and screened for several FDA approved antiviral drugs to simulate the Mpro–α-ketoamide interactions and thereby blocking the active pocket [16]."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 867,
                "end": 870,
                "name": "PDB"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 875,
                "end": 879,
                "name": "6Y2F"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "The crystal structure of SARS-CoV-2 Mpro in the apo form (",
            "PDB",
            " ID: ",
            "6Y2E",
            ") and α-ketoamide bound form (",
            "PDB",
            " ID: ",
            "6Y2F",
            ") shows that the protein makes a crystallographic dimer composed of two monomers of identical conformations."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 1188,
                "end": 1191,
                "name": "PDB"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 1196,
                "end": 1200,
                "name": "6Y2E"
            },
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 1230,
                "end": 1233,
                "name": "PDB"
            },
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 1238,
                "end": 1242,
                "name": "6Y2F"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T4",
                "end": "T5"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T6",
                "end": "T7"
            }
        ]
    },
    {
        "sen": [
            "For analysis, all the closely related and complete reference genome sequences of SARS-CoV-2 were downloaded from the ",
            "NCBI GenBank",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 1468,
                "end": 1480,
                "name": "NCBI GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The recently elucidated X-ray crystal structure coordinates of SAR-CoV-2 Mpro was downloaded from ",
            "RCSB PDB",
            " (",
            "PDB",
            " ID: ",
            "6Y2F",
            "), having 1.75 Å resolution."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 1589,
                "end": 1597,
                "name": "RCSB PDB"
            },
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 1599,
                "end": 1602,
                "name": "PDB"
            },
            false,
            {
                "id": "T11",
                "type": "AccessionNumber",
                "start": 1607,
                "end": 1611,
                "name": "6Y2F"
            },
            false
        ],
        "rel": [
            {
                "id": "R4",
                "bool": true,
                "head": "T9",
                "end": "T11"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T10",
                "end": "T11"
            }
        ]
    },
    {
        "sen": [
            "To further identify the potent inhibitors for SAR-CoV-2 Mpro among the FDA approved antiviral drugs, we have downloaded more than 75 drug compounds from the ",
            "PubChem",
            " chemical database [24]."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 1797,
                "end": 1804,
                "name": "PubChem"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the present study, the docked complexes of virtually screened top three drugs Lopinavir–Ritonavir, Tipranavir, and Raltegravir with the X-ray crystal structure of SARS-CoV-2 Mpro(",
            "PDB",
            " ID: ",
            "6Y2F",
            ") were analyzed through MD simulations."
        ],
        "lab": [
            false,
            {
                "id": "T13",
                "type": "Repository",
                "start": 2011,
                "end": 2014,
                "name": "PDB"
            },
            false,
            {
                "id": "T14",
                "type": "AccessionNumber",
                "start": 2019,
                "end": 2023,
                "name": "6Y2F"
            },
            false
        ],
        "rel": [
            {
                "id": "R6",
                "bool": true,
                "head": "T13",
                "end": "T14"
            }
        ]
    },
    {
        "sen": [
            "The rapidly spreading disease caused by the novel SARS-CoV-2 is now called COVID-19 [43]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This drug is mainly used for HIV-AIDS to control HIV infection by inhibiting the protease and help to decrease the amount of HIV in the body by promoting the function of the body’s natural immune system to work better [48]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This drug could also be used with other combinations like Raltegravir and Lopinavir for the treatment of COVID-19, if found producing desirable inhibitory effect against SARS-CoV-2 protease in biochemical activity assay or cell-based assays."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This MD simulation analysis shows the promising binding stability of the drug compounds with the binding pocket of CoV-2 Mpro (",
            "PDB",
            " ID: ",
            "6Y2F",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T15",
                "type": "Repository",
                "start": 2746,
                "end": 2749,
                "name": "PDB"
            },
            false,
            {
                "id": "T16",
                "type": "AccessionNumber",
                "start": 2754,
                "end": 2758,
                "name": "6Y2F"
            },
            false
        ],
        "rel": [
            {
                "id": "R7",
                "bool": true,
                "head": "T15",
                "end": "T16"
            }
        ]
    },
    {
        "sen": [
            "The rapidly enlarging COVID-19 pandemic caused by the novel SARS-corona virus-2 is a global public health emergency of an unprecedented level."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The recently concluded α-ketoamide ligand-bound X-ray crystal structure of SARS-CoV-2 M pro (",
            "PDB",
            " ID: ",
            "6Y2F",
            ") from Zhang et al. has revealed the potential inhibitor binding mechanism and the molecular determinants responsible for substrate binding."
        ],
        "lab": [
            false,
            {
                "id": "T17",
                "type": "Repository",
                "start": 2997,
                "end": 3000,
                "name": "PDB"
            },
            false,
            {
                "id": "T18",
                "type": "AccessionNumber",
                "start": 3005,
                "end": 3009,
                "name": "6Y2F"
            },
            false
        ],
        "rel": [
            {
                "id": "R8",
                "bool": true,
                "head": "T17",
                "end": "T18"
            }
        ]
    },
    {
        "sen": [
            "The AFCD of Hong Kong stated: ‘Although there is no evidence yet that pets can transmit the virus to other pets or back to humans, we strongly advise that mammalian pets including dogs and cats from households with persons confirmed as infected with COVID-19 or as close contacts of COVID-19 infected persons should be put under quarantine in AFCD facilities to safeguard public and animal health."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Neither dog showed any signs of being ill with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The dog was 17 years old and had ongoing health issues that were likely responsible for the death of this dog, rather than COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On March 19, the AFCD reported that a third dog, a German Shepherd Dog living with an owner testing positive for COVID-19, had also tested positive."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The decision to test will be made collaboratively between local, state, and federal animal and public health officials’, ‘After the decision is made to test, state animal health officials will designate a state-appointed veterinarian, USDA-accredited veterinarian, or foreign animal disease diagnostician to collect the sample using appropriate personal protective equipment (PPE) and sample collection methods’, ‘While we are recommending these as good practices, it is important to remember that, to date, there have not been any reports of pets or other animals becoming ill with SARS-CoV-2, and there is currently no evidence that pets can spread COVID-19 to other animals, including people’ (8)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Further studies are needed to understand if and how different animals could be affected by COVID-19 virus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, because animals and people can sometimes share diseases (known as zoonotic diseases), it is still recommended that people who are sick with COVID-19 limit contact with companion and other animals until more information is known about the virus’ (9)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "CDC advise ‘You should restrict contact with pets and other animals while you are sick with COVID-19, just like you would around other people."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although there have not been reports of pets or other animals becoming sick with COVID-19, it is still recommended that people sick with COVID-19 limit contact with animals until more information is known about the virus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "If you are sick with COVID-19, avoid contact with your pet, including petting, snuggling, being kissed or licked, and sharing food."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We studied 8612 genomes obtained from ",
            "GISAID’s EpiCoV™",
            " presenting less than 1% non-DNA characters (high coverage only option) (",
            "Elbe and Buckland-Merrett, 2017",
            "; ",
            "Shu and McCauley, 2017",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 38,
                "end": 54,
                "name": "GISAID’s EpiCoV™"
            },
            false,
            {
                "id": "T2",
                "type": "Creator",
                "start": 127,
                "end": 158,
                "name": "Elbe and Buckland-Merrett, 2017"
            },
            false,
            {
                "id": "T3",
                "type": "Creator",
                "start": 160,
                "end": 182,
                "name": "Shu and McCauley, 2017"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The final, high-quality dataset had 4,333 genomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Shortly, we made an R script that takes a sequence (the query) from the dataset, determines which sequences are identical to it, put these together in an identity cluster, and record the size (number of sequences, interpreted as SV abundance) of the cluster."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The process was repeated until all the sequences in the dataset were processed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Once aligned, our high-quality dataset presented 2713 polymorphic sites of which 885 were parsimony informative."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The dataset was phylogenetically analyzed with IQTREE (Minh et al., 2020) using the GTR +",
            "The database used in this study is the major SARS-CoV-2 sequence repository and can be considered reliable."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The given name to the disease associated with the coronavirus was COVID19, while novel CoV was named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID19 is milder but a highly transmissible infectious disease compared with SARS (severe acute respiratory syndrome) and MERS (Middle East respiratory syndrome) outbreaks, according to morbidity and mortality rates [2, 3]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Today, the involvement of the Huanan market with COVID19 origin seems controversial [12, 13]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Maximum likelihood phylogenetic analysis involved 87 amino acid sequences from CoV S protein obtained from ",
            "NCBI Protein",
            " database (",
            "www.ncbi.nlm.nih.gov/protein/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 592,
                "end": 604,
                "name": "NCBI Protein"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 615,
                "end": 644,
                "name": "www.ncbi.nlm.nih.gov/protein/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "Malayan pangolin ",
            "MT084071",
            " sequence was translated from annotated coding region obtained from ",
            "NCBI",
            " ",
            "Genbank",
            " database (",
            "www.ncbi.nlm.nih.gov/genbank/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 664,
                "end": 672,
                "name": "MT084071"
            },
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 740,
                "end": 744,
                "name": "NCBI"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 745,
                "end": 752,
                "name": "Genbank"
            },
            false,
            {
                "id": "T6",
                "type": "URL",
                "start": 763,
                "end": 792,
                "name": "www.ncbi.nlm.nih.gov/genbank/"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T5",
                "end": "T3"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "Accession codes were included in each taxon name."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There were a total of 1494 positions in the final dataset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All amino acids sequences were obtained by ",
            "NCBI Protein",
            " database (",
            "www.ncbi.nlm.nih.gov/protein/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 947,
                "end": 959,
                "name": "NCBI Protein"
            },
            false,
            {
                "id": "T8",
                "type": "URL",
                "start": 970,
                "end": 999,
                "name": "www.ncbi.nlm.nih.gov/protein/"
            },
            false
        ],
        "rel": [
            {
                "id": "R4",
                "bool": true,
                "head": "T7",
                "end": "T8"
            }
        ]
    },
    {
        "sen": [
            "All sequences were obtained from ",
            "NCBI Protein",
            " database (",
            "www.ncbi.nlm.nih.gov/protein/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 1035,
                "end": 1047,
                "name": "NCBI Protein"
            },
            false,
            {
                "id": "T10",
                "type": "URL",
                "start": 1058,
                "end": 1087,
                "name": "www.ncbi.nlm.nih.gov/protein/"
            },
            false
        ],
        "rel": [
            {
                "id": "R5",
                "bool": true,
                "head": "T9",
                "end": "T10"
            }
        ]
    },
    {
        "sen": [
            "R. sinicus ASM188883v1 sequence was translated based on genome assembly obtained from ",
            "NCBI Genome",
            " database (",
            "www.ncbi.nlm.nih.gov/genome/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Repository",
                "start": 1176,
                "end": 1187,
                "name": "NCBI Genome"
            },
            false,
            {
                "id": "T12",
                "type": "URL",
                "start": 1198,
                "end": 1226,
                "name": "www.ncbi.nlm.nih.gov/genome/"
            },
            false
        ],
        "rel": [
            {
                "id": "R6",
                "bool": true,
                "head": "T11",
                "end": "T12"
            }
        ]
    },
    {
        "sen": [
            "Accession codes were included in each taxon name."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There were a total of 829 positions in the final dataset",
            "An emergence of a novel coronavirus, causative agent of COVID19, named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), occurred due to cross-species transmission."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All the data obtained from ",
            "NCBI Protein",
            " and ",
            "NCBI",
            " ",
            "GenBank",
            " databases included in this research study presented accession code/numbers for research or reanalysis."
        ],
        "lab": [
            false,
            {
                "id": "T13",
                "type": "Repository",
                "start": 1543,
                "end": 1555,
                "name": "NCBI Protein"
            },
            false,
            {
                "id": "T14",
                "type": "Repository",
                "start": 1560,
                "end": 1564,
                "name": "NCBI"
            },
            false,
            {
                "id": "T15",
                "type": "Repository",
                "start": 1565,
                "end": 1572,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The rapid emergence of COVID-19 has sent shockwaves through healthcare systems globally, with cancer patients at increased risk."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As a corollary, the pangolin trade has very recently been pinpointed as posing a serious threat to human health, pangolins being potentially involved in the COVID-19 pandemic [5, 6]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We used the Multilocus tagging option in GenAlex to detect identical genotypes in our dataset (sub-option ‘Matches’)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The 20 loci were successfully amplified (with 100% PCR success rate), with only 0.84% missing data in our final multilocus dataset (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Pangolins, or scaly anteaters, have recently been flagshiped as one of the most illegally traded mammals, and as a corollary, as potential intermediate hosts at the origin of the COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The novel coronavirus was named 2019‐nCoV by the World Health Organization (WHO) on January 12, 2020, and was later named severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) by the International Classification Committee of Viruses on February 11, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            " Now, the associated disease has been named coronavirus disease 2019 (COVID‐19) by the WHO."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "The transmission mode for COVID‐19 has been shown to be human to human."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID‐19 is currently a global pandemic, and over 2 740 000 cases of COVID‐2019 and 191 000 deaths have been reported globally as of April 24, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We hypothesized that HLA variation in the population may be associated with the occurrence of COVID‐19, because HLA plays a pivotal role in the immune response to pathogens."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we report HLA allele frequencies in Chinese Han individuals with COVID‐19 and a comparison between HLA allele distribution in COVID‐19 patients and healthy individuals."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Eighty‐two Han individuals from Zhejiang with confirmed COVID‐19 were tested."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All patients had mild or severe COVID‐19, with none in a critical condition."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Individuals were recruited for plasma donation after recovery and the plasma was used for treatment of other COVID‐19 patients with severe or critical symptoms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The allele distributions of HLA‐A, ‐C, ‐B, ‐DRB1, ‐DQB1, and ‐DPB1 loci were compared between COVID‐19 patients and control individuals."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The frequencies and ORs of the HLA alleles, with uncorrected significance, for COVID‐19 patients are listed in Table 1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "HLA‐C*07:29, C*08:01G (including C*08:01 and C*08:22), B*15:27, B*40:06, DRB1*04:06, and DPB1*36:01 frequencies were higher in COVID‐19 patients than in the control population, with uncorrected statistical significance (P < .05)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Meanwhile, the frequencies of the DRB1*12:02 and DPB1*04:01 alleles were significantly lower in COVID‐19 patients (Pc < .05), with ORs of 0.44 and 0.40, respectively."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the present study, HLA‐C*07:29 was found in one COVID‐19 patient, but in no individuals in the control group."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Two alleles, B*07:02 (1.38%) and B*27:04 (1.92%), with frequencies greater than 1% in the control group, were not found in COVID‐19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, the association of HLA alleles with COVID‐19 warrants further research."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "In the present study, these SARS‐susceptibility alleles were not found to occur at a significantly different frequency in COVID‐19 patients after P‐value correction."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We found that B*15:27 alleles may be associated with the occurrence of COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Prediction of the peptide‐binding groove of these alleles may help to explain their association with COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although the number of samples in the present study was small, these data will still be useful for exploring the influence of HLA gene polymorphisms on susceptibility to COVID‐19 and patient outcomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID‐19 is a respiratory disease caused by a novel coronavirus and is currently a global pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "HLA variation is associated with COVID‐19 because HLA plays a pivotal role in the immune response to pathogens."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, 82 individuals with COVID‐19 were genotyped for HLA‐A, ‐B, ‐C, ‐DRB1, ‐DRB3/4/5, ‐DQA1, ‐DQB1, ‐DPA1, and ‐DPB1 loci using next‐generation sequencing (NGS)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Frequencies of the HLA‐C*07:29 , C*08:01G , B*15:27 , B*40:06 , DRB1*04:06 , and DPB1*36:01 alleles were higher, while the frequencies of the DRB1*12:02 and DPB1*04:01 alleles were lower in COVID‐19 patients than in the control population, with uncorrected statistical significance."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These data suggested that some HLA alleles may be associated with the occurrence of COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "X-ray data were collected on crystals of the PLpro-ISG15 complex at 100 K using a Dectris Eiger 9M detector (a 2°/s spindle rate) on beamline 21-ID-D at the Life Sciences-Collaborative Access Team (LS-CAT)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To determine the initial phases for the PLpro-ISG15 complex, the PLpro domain from the bound PLpro-Ub complex (",
            "PDB",
            " accession code: ) was used as a search model and the programs Phaser (McCoy et al., 2007) and Phenix were used to identify a molecular replacement solution."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 318,
                "end": 321,
                "name": "PDB"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Free human ISG15 (Narasimhan et al., 2005) with the ",
            "PDB",
            " accession code of  was manually positioned into the corresponding residual electron density using the program Coot (Emsley and Cowtan, 2004)."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 531,
                "end": 534,
                "name": "PDB"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The wild-type pEVL8-his8-TEVp-MERS-CoV PLpro-ΔUbl2 plasmid was used as a template and primers were designed and synthesized using Integrated DNA Technologies (IDT)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Three complete X-ray datasets were collected on crystals of the MERS-CoV PLpro-ISG15 complex that were grown at three different citrate concentrations (0.2, 0.3 and 0.35 M)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To identify potential residues of MERS-CoV PLpro that dictate substrate specificity for ISG15 versus Ub, the MERS-CoV PLpro-ISG15 structure was superimposed with the Ub-bound structure (",
            "PDB",
            " accession code ) and the result is shown in Fig. 3",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 1202,
                "end": 1205,
                "name": "PDB"
            },
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The outbreak of a novel coronavirus disease (COVID-19, caused by the 2019-nCoV infection) in December 2019 is one of the most severe public health emergencies since the founding of People’s Republic of China in 1949."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Sadly, as of February 20, 2020, over two thousand COVID-19 cases are confirmed among HCP from 476 hospitals nationwide, with nearly 90% of them from Hubei Province."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The experience and lessons learned should be a valuable asset for international health community to contain the ongoing COVID-19 epidemic around the world."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Identifying the first introduction of the virus is of epidemiological interest, for the tracking and mapping of COVID-19 spread in a country."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In Italy, and elsewhere, there have been speculations to the effect that COVID-19 had been silently circulating before the first case was identified."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In France, where the COVID-19 epidemic was believed to have started in late January 2020, a retrospective analysis of a stored respiratory sample from a patient hospitalised in December 2019, demonstrated that the patient was positive for SARS-CoV-2, suggesting that, in France, the epidemic started much earlier than previously thought (Deslandes et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is known that gastrointestinal symptoms are seen in patients with COVID-19 (between 16% to 33% in most studies), and that approximately 50% of patients with COVID-19 have detectable virus in their stool (Ouali et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The viral load in the faeces of COVID-19 patients was estimated between 103 and 107 copies/mL, depending on the infection course (reviewed in Foladori et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Sequences were submitted to ",
            "NCBI",
            " ",
            "GenBank",
            " with the following accession numbers: ",
            "MT843229",
            "-",
            "MT843240",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1077,
                "end": 1081,
                "name": "NCBI"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 1082,
                "end": 1089,
                "name": "GenBank"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 1128,
                "end": 1136,
                "name": "MT843229"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 1137,
                "end": 1145,
                "name": "MT843240"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T2",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "A sustained local transmission has been documented, so that by 11th August 2020, 250.973 COVID-19 cases were diagnosed, with 35.6441 deaths (",
            "https://www.epicentro.iss.it/en/coronavirus/sars-cov-2-dashboard",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "URL",
                "start": 1288,
                "end": 1352,
                "name": "https://www.epicentro.iss.it/en/coronavirus/sars-cov-2-dashboard"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As far as we know, COVID-19 first affected Lombardy and Veneto and, later on, all the other regions of Italy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A genomic characterisation and phylogenetic analysis performed on complete SARS-CoV-2 genomes isolated from patients involved in the first outbreak of COVID-19 in Lombardy, suggested that SARS-CoV-2 entered Northern Italy weeks before the first reported case of infection (Zehender et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, after mid-December 2019, SARS-CoV-2 had already been circulating in major urban centres surrounding the area (Codogno, in the province of Lodi) where the first case of COVID-19 was reported in February 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Significantly, all of these regions documented COVID-19 cases starting from 25th February (Protezione Civile, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Considering the incubation period of COVID-19 - 6.4 days on average (Wang et al., 2020) - as well as evidence showing that viral shedding may occur in asymptomatic patients (Jiang et al., 2020; Park et al., 2020; Tang et al., 2020), it is conceivable that the virus was circulating and being released into the sewage in the Paris area roughly at the same time as in northern Italy, as indicated by our positive sewage samples."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A Spanish study in the region of Murcia detected SARS-CoV-2 RNA in wastewater before the first COVID-19 cases were declared by the local authorities in many of the cities where wastewaters have been sampled (Randazzo et al., 2020), revealing that members of the community were shedding SARS-CoV-2 RNA before the first cases were reported."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The hypothesis of SARS-CoV-2 circulation before the identification of the first clinical cases is supported by other epidemiological approaches as well: a seroprevalence study, conducted on healthy blood donors in the province of Milan during the COVID-19 epidemic showed that, between 12 and 17 February 2020, 2.0% of donors displayed IgG for SARS-CoV-2 (Percivalle et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recently, van Dorp and co-workers analysed the genomic diversity of SARS-CoV-2 in the global population since the beginning of the COVID-19 pandemic by comparing 7666 SARS-CoV-2 genomes covering a vast geographical area (van Dorp et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease COVID-19, a public health emergency worldwide, and Italy is among the most severely affected countries."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first autochthonous Italian case of COVID-19 was documented on February 21, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Clinical specimens from a case-patient who had acquired COVID-19 during travel to China and who was identified in Washington, USA, were collected as described ()."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A nearly full-length viral contig obtained in each sample had 100% identity to the 2019-nCoV/USA-WA1/2020 strain (",
            "GenBank",
            " accession no."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 277,
                "end": 284,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A patient was identified with confirmed COVID-19 in Washington State on January 22, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We sequenced viral RNA from SARS-CoV-2 passage 4 stock and confirmed it to have no nucleotide mutations compared with the original reference sequence (",
            "GenBank",
            " accession no. ",
            "MN985325",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 540,
                "end": 547,
                "name": "GenBank"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 562,
                "end": 570,
                "name": "MN985325"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "Similar to SARS-CoV, SARS-CoV-2 replicated rapidly in Vero cells after an initial eclipse phase, achieving 105 TCID50/mL by 24 h postinfection and peaking at >106 TCID50/mL."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Replication in HUH7.0 cells also increased quickly after an initial eclipse phase but plateaued by 24 h postinoculation in the intracellular compartment at 2 × 103 TCID50/mL and decreased after 66 h postinoculation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Major SARS-CoV-2 worldwide clades have been proposed by nomenclature systems including ",
            "Nextstrain",
            " [8] and the ",
            "global initiative on sharing all influenza data (GISAID",
            ", ",
            "https://www.gisaid.org",
            ") [9]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 87,
                "end": 97,
                "name": "Nextstrain"
            },
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 110,
                "end": 165,
                "name": "global initiative on sharing all influenza data (GISAID"
            },
            false,
            {
                "id": "T3",
                "type": "URL",
                "start": 167,
                "end": 189,
                "name": "https://www.gisaid.org"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "These are based on viral genomes from >57,000 sequences submitted in ",
            "GISAID",
            " [9]."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 265,
                "end": 271,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Clade annotations were attained from ",
            "Nextstrain",
            " [8], who identify variants that define clades of interest from sequences submitted to ",
            "GISAID",
            " by labs worldwide and updates them periodically in clades.tsv (",
            "https://github.com/nextstrain/ncov/blob/master/defaults/clades.tsv",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 314,
                "end": 324,
                "name": "Nextstrain"
            },
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 411,
                "end": 417,
                "name": "GISAID"
            },
            false,
            {
                "id": "T7",
                "type": "URL",
                "start": 481,
                "end": 547,
                "name": "https://github.com/nextstrain/ncov/blob/master/defaults/clades.tsv"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T5",
                "end": "T7"
            }
        ]
    },
    {
        "sen": [
            "These conclusions are further supported by a larger-scale phylogenetic tree including the ICVL workers and family member samples in addition to 25 randomly chosen Israel-based samples downloaded from ",
            "GISAID",
            ", wherein S7 is placed with non-ICVL samples with 88% confidence (Figure S1)."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Dataset",
                "start": 750,
                "end": 756,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This novel coronavirus has now been named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) while the disease it causes is known as coronavirus disease 2019 (COVID-19) (2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Cases have now been identified, and deaths due to COVID-19 reported, on all 6 populated continents (3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Centers for Disease Control and Prevention (CDC) confirmed the first case of COVID-19 in the United States on 21 January."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "No additional cases of COVID-19 were identified in Washington State until 28 February when two new cases were confirmed, one in Snohomish County and one in neighboring King County, where Seattle is located (6, 7)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since 28 February, the number of cases of COVID-19 in Washington has steadily increased and currently stands at 2,096 (3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For all of the above primer-probe sets, real-time RT-PCR assays were performed using the AgPath-ID One Step RT-PCR kit (Life Technologies)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Known cases of COVID-19 have now exceeded 375,000 worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A major lesson that the coronavirus disease 2019 (COVID-19) pandemic has already taught the scientific community is that timely international data sharing and collaborative data analysis is absolutely vital to navigate through policy decisions that have life-or-death consequences."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Some of the most pressing issues about COVID-19 infections require urgent sharing of high-quality data concerning, for example, risk factors that influence infection, prognosis, and predictions of drug response from phenotypic, genotypic, and epigenetic data."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To generate or test scientific hypotheses, we need large-scale and well-characterized patient-level datasets to provide sufficient statistical power."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Building and sharing massive datasets containing personal health information have numerous legal and ethical implications that hinder new discoveries and prevent the scientific community from assessing their validity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this respect, the case of 2 COVID-19 related articles published by The Lancet and The New England Journal of Medicine serves as an example."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These instances reinforce the need for a robust privacy- and confidentiality-compliant data-processing and sharing system to address these challenges in the era of COVID-19 and future pandemics."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Numerous data-driven projects have been launched across the globe to combat COVID-19, as summarized below."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On the 1 hand, several data-sharing projects on COVID-19 are based on a decentralized approach, employing the computation of local statistics (sometimes obfuscated to hide small numbers) that are subsequently shared and aggregated through meta-analysis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On the other hand, other projects aim to centralize patient-level data from COVID-19 at a single site and then perform the analysis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With this goal in mind, we have established an international consortium for Secure Collective Research (SCOR) to deploy the next-generation distributed infrastructure and tools for secure data sharing, analysis, and mining while respecting patient privacy and maximizing data utility during global disease outbreaks like the current COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SCOR is a new initiative that complements existing multicentric data-sharing efforts to face the COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 research moves rapidly with new initiatives announced daily."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In Table 1 we summarize the major initiatives we are aware of (as of June 2020) and compare them to SCOR along the following axes:",
            "Comparison of fully automated systems for COVID-19 data sharing is reported in Table 2 below."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This issue is alleviated when safe settings are used to create large (protected) virtual datasets compared to applying data obfuscation to local datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By using MedCo, health professionals and scientists can query data scattered among diverse institutions as if it were stored in a single location (virtual collective dataset) but without the need of seeing nor moving the data (see Figure 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Existing health informatics systems do not incorporate the latest progress in modern security and federated machine learning algorithms, which are poised to offer solutions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A",
            "recent study indicated that SARS-CoV-2 was 96% identical to a bat coronavirus RaTG13",
            "(accession: ",
            "MN996532",
            ") at the genomic level, suggesting that bat might be a natural host of",
            "SARS-CoV-2 [7]."
        ],
        "lab": [
            false,
            false,
            false,
            {
                "id": "T1",
                "type": "AccessionNumber",
                "start": 99,
                "end": 107,
                "name": "MN996532"
            },
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "",
            "GISAID",
            " is a platform for sharing",
            "genetic data of influenza."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 194,
                "end": 200,
                "name": "GISAID"
            },
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Currently, a rapidly increasing number of SARS-CoV-2 genomic",
            "sequences are being deposited into this database from laboratories around the world [8]."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 343 full-length SARS-CoV-2 genomes available in the ",
            "GISAID",
            " platform (",
            "https://platform.gisaid.org/",
            ") as of 10 March 2020 with 5 March 2020 as",
            "cut-off date were downloaded [8]."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 467,
                "end": 473,
                "name": "GISAID"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 484,
                "end": 512,
                "name": "https://platform.gisaid.org/"
            },
            false,
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "A total of",
            "247 sequences with high sequence quality as noted in the ",
            "GISAID",
            " database were included for",
            "further analysis after removing sequences containing little temporal signal and thus are",
            "not unsuitable for inference using phylogenetic molecular clock models."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 657,
                "end": 663,
                "name": "GISAID"
            },
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Information",
            "regarding the date and country of isolation were also retrieved from the ",
            "GISAID",
            " platform."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 937,
                "end": 943,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The annotated reference genome sequence of the SARS-CoV-2 isolate Wuhan-Hu-1 (accession:",
            "",
            "NC_045512.2",
            ") was downloaded from the ",
            "NCBI GenBank",
            " database."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 1043,
                "end": 1054,
                "name": "NC_045512.2"
            },
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 1080,
                "end": 1092,
                "name": "NCBI GenBank"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T8",
                "end": "T7"
            }
        ]
    },
    {
        "sen": [
            "A total of 22 such genome",
            "sequences were reported so far, accounting for 9% of the 247 SARS-CoV-2 sequences",
            "documented in the ",
            "GISAID",
            " database as of 5 March 2020."
        ],
        "lab": [
            false,
            false,
            false,
            {
                "id": "T9",
                "type": "Dataset",
                "start": 1229,
                "end": 1235,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Viruses in SS4 were",
            "responsible for the explosive increase in incidence of COVID-19 in Europe in March (Table 4)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Upon completion of analysis of SARS-CoV-2 sequences available in the ",
            "GISAID",
            " database as",
            "of 5 March 2020 and identification of the four “super-spreader” type strains, we",
            "investigated if viral strains of the four super-spreaders were responsible for the vast",
            "majority of subsequent infections."
        ],
        "lab": [
            false,
            {
                "id": "T10",
                "type": "Dataset",
                "start": 1448,
                "end": 1454,
                "name": "GISAID"
            },
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We conducted detailed and comprehensive analyses of 247 high quality SARS-CoV-2 sequences",
            "deposited in the ",
            "GISAID",
            " database during the period December 2019 to 5 March 2020 to provide",
            "insight into the evolution and transmission of this novel virus (Figure 3)."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T11",
                "type": "Dataset",
                "start": 1778,
                "end": 1784,
                "name": "GISAID"
            },
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This second dataset",
            "showed that viruses of SS4 have since been transmitted to other parts of world including",
            "Africa, Asia, North America and Oceania."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To trace the evolution route and probe the transmission dynamics of this virus, we performed phylodynamic analysis of 247 high quality genomic sequences available in the ",
            "GISAID",
            " platform as of 5 March 2020."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "Dataset",
                "start": 2249,
                "end": 2255,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The virus was soon identified as novel CoV 2019 (2019-nCoV), more recently designated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), while the associated disease is referred to as coronavirus disease 2019 (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of 15 June 2020, there were almost 8 million confirmed COVID-19 cases and 431,541 deaths globally (2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "(A) Schematic diagram of the genomes of SARS-CoV-2 isolates Wuhan-Hu-1 (",
            "GenBank",
            " accession no. ",
            "MN908947",
            ") and human CoV-19/Singapore/12/2020 (hCoV-19/Singapore/12/2020) Δ382 (",
            "GISAID",
            ": ",
            "EPI_ISL_414378",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 410,
                "end": 417,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 432,
                "end": 440,
                "name": "MN908947"
            },
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 511,
                "end": 517,
                "name": "GISAID"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 519,
                "end": 533,
                "name": "EPI_ISL_414378"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "To investigate the possible origin and evolutionary relationships of these Δ382 viruses, a maximum likelihood (ML) phylogeny of SARS-CoV-2 full genomes was inferred from serially sampled data sets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We then tested residual diagnostic samples from COVID-19 patients in Singapore for the presence of Δ382 viruses to understand the epidemiological fitness of Δ382 viruses."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Full complete genomes of SARS-CoV-2 wild-type and Δ382 viruses generated in Singapore were deposited in the ",
            "GISAID",
            " database (see Table S1 in the supplemental material)."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 1013,
                "end": 1019,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All available genomes of SARS-CoV-2 with associated virus sampling dates were downloaded from the ",
            "GISAID",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 1172,
                "end": 1178,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To reduce bias from locations with higher virus sampling and genome availability, data sets were subsampled randomly based on geographical location and collection month using in-house scripts."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To reconstruct a time-scaled phylogeny, we analyzed serially sampled data sets of 419 complete genomes (Table S5) using an uncorrelated lognormal relaxed-clock (UCLN) model with an exponential growth coalescent prior and the HKY85+Γ substitution model in BEAST program v1.10.4 (29) to simultaneously estimate phylogenies, divergence times, and rates of nucleotide substitution."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The strict and UCLN models were recently tested by Duchene et al. (30), who showed that the UCLN model is preferred over a strict clock for analyzing large (>122) SARS-CoV-2 genome data sets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Cells were washed with phosphate-buffered saline (PBS), and SARS-CoV-2 viral antigens were detected using a COVID-19 convalescent human serum at a 1:400 dilution in PBS for 30 min at 37°C."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Supernatant was harvested daily for 6 days following infection and 50% tissue culture infective doses (TCID50) titers were determined."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Sequences generated in this study have been deposited in the ",
            "GISAID",
            " database (see Table S1 for accession numbers)."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Dataset",
                "start": 2337,
                "end": 2343,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2, first isolated in Wuhan, China, in December 2019 [1] is a new coronavirus responsible for the severe pulmonary/systemic disease called COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, the first COVID-19 patient was diagnosed by the Virology Laboratory of Ancona University Hospital on the 25 February 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Several research centres started sequencing programs on different platforms and some results are already available [2,4,5,6] in databases such as ",
            "Global Initiative on Sharing All Influenza Data (GISAID",
            ", ",
            "https://www.gisaid.org/",
            ") or ",
            "GenBank",
            " (",
            "https://www.ncbi.nlm.nih.gov/genbank/sars-cov-2-seqs/",
            "), which will continue to accumulate sequencing data from around the world."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 432,
                "end": 487,
                "name": "Global Initiative on Sharing All Influenza Data (GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 489,
                "end": 512,
                "name": "https://www.gisaid.org/"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 517,
                "end": 524,
                "name": "GenBank"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 526,
                "end": 579,
                "name": "https://www.ncbi.nlm.nih.gov/genbank/sars-cov-2-seqs/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "Reads were aligned with the Wuhan-Hu-1 ",
            "NCBI",
            " Reference Genome (Accession number: ",
            "MN908947.3",
            ") on the Torrent Suite v. 5.10.1."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 694,
                "end": 698,
                "name": "NCBI"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 735,
                "end": 745,
                "name": "MN908947.3"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "The following plugins were used: Coverage Analysis (v5.10.0.3), Variant Caller ( v.5.10.1.19) both with “Generic - S5/S5XL (510/520/530) - Somatic - Low Stringency” and “Generic-S5/S5XL (510/520/530)-Germ Line-Low Stringency” default parameters and COVID19AnnotateSnpEff (v.1.0.0), a plugin specifically developed for Sars-Cov-2 that can predict the effect of a base substitution."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In December 2019, the first cases of coronavirus disease (COVID-19) were reported in Wuhan, China, a megacity with a population of approximately 11 million people."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, despite these efforts, COVID-19 spread to many countries across the world, reaching pandemic levels, and continues to be a serious public health concern due to its high mortality rate."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With internet search as an important source of epidemiologic information on COVID-19 [4], we performed a combined analysis of the infection rates of these population samples using publicly available data (Table 1), instead of a simple pooled calculation, considering potential differences in lifestyles and pathogen exposure across different populations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The coronavirus disease (COVID-19) pandemic began in Wuhan, China, in December 2019."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "One major hitch in developing a COVID-19 vaccine is that no medically proven predecessor exists for any type of human coronavirus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While influenza, like COVID-19, causes morbidity among all ages, those most vulnerable to its serious complications, such as pneumonia, are the elderly [17, 18]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The mechanisms of the ‘cytokine storm’ and how they contribute to fatalities reported for COVID-19 are still under investigation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In a study of 41 patients hospitalized with COVID-19, high levels of pro-inflammatory cytokines were found, including IL-2, IL-7, G-CSF, IP-10, MCP-1, MIP-1A, and TNF-α, in the most severe cases [119]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The fight against COVID-19 will be difficult and lengthy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "During the current COVID-19 pandemic, the global ratio between the dead and the survivors is approximately 1 to 10, which has put humanity on high alert and provided strong motivation for the intensive search for vaccines and drugs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The experience accumulated dealing with the biology of zoonotic RNA viruses suggests that the fight against COVID-19 will be difficult and lengthy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Unfortunately, RNA viruses constantly sweep their tracks and perhaps one of the most promising solutions in the fight against the COVID-19 pandemic is the creation of 'universal' vaccines based on conservative SARS-CoV-2 genome sequences (antigen-presenting) and unmethylated CpG dinucleotides (adjuvant) in the composition of the phosphorothioate backbone of single-stranded DNA oligonucleotides (ODN), which can be effective for long periods of use."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Di Giambenedetto et al."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            " described their experience with intravenous tocilizumab (TCZ) in treating severe coronavirus disease 2019 (COVID‐19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Results of this case series appear to support efficacy and tolerability of TCZ given subcutaneously in patients with COVID‐19, at least in those with pneumonia not requiring mechanical ventilation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Particularly, it has to be seen whether SC TCZ at single dose in early stages of COVID‐19 is equally effective to intravenous TCZ given at standard doses."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In particular, since SC TCZ was not administered further for rapid improvement of patient conditions, this suggest the possibility of reducing the dosage of TCZ, at least in patients with less severe COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We then aligned our complete genome sequences with other related coronavirus sequences archived from ",
            "GenBank",
            "/",
            "GISAID",
            " using Mafft software version 7.452."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 101,
                "end": 108,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 109,
                "end": 115,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This was later attributed to a novel coronavirus (the COVID-19 virus), and represents the third major zoonotic human coronavirus of this century [31]:",
            "On February 28, 2020, the World Health Organization set the COVID-19 risk assessment for regional and global levels to “Very High” [32]."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "From analyses employing whole genome to viral protein-based comparisons, the COVID-19 virus is thought to belong to lineage B (Sarbecovirus) of Betacoronavirus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "From phylogenetic analysis of the RdRp protein, spike proteins, and full genomes of the COVID-19 virus and other coronaviruses, it was found that the COVID-19 virus is most closely related to two bat SARS-like coronaviruses, bat-SL-CoVZXC21 and bat-SL-CoVZC45, found in Chinese horseshoe bats Rhinolophus sinicus [12, 33–37]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Along with the phylogenetic data, the genome organization of the COVID-19 virus was found to be typical of lineage B (Sarbecovirus) Betacoronaviruses [33]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "From phylogenetic analysis of full genome alignment and similarity plots, it was found that the COVID-19 virus has the highest similarity to the bat coronavirus RaTG13 [38]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Within the COVID-19 virus sequences, over 99% sequence similarity and a lack of diversity within these strains suggest a common lineage and source, with support for recent emergence of the human strain [12, 31]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There is ongoing debate whether the COVID-19 virus arose following recombination with previously identified bat and unknown coronaviruses [39] or arose independently as a new lineage to infect humans [38]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In combination with the identification that the angiotensin converting enzyme 2 (ACE2) protein is a receptor for COVID-19 virus, as it is for SARS and other Sarbecovirus strains, the hypothesis that the COVID-19 virus originated from bats is deemed very likely [12, 33, 35, 38, 40–44]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, we use MLDSP [50] and MLDSP-GUI [51] with CGR as a numerical representation of DNA sequences to assess the classification of the COVID-19 virus from the perspective of machine learning-based alignment-free whole genome comparison of genomic signatures."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using MLDSP and MLDSP-GUI, we confirm that the COVID-19 virus belongs to the Betacoronavirus, while its genomic similarity to the sub-genus Sarbecovirus supports a possible bat origin."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Wuhan seafood market pneumonia virus (COVID-19 virus/SARS-CoV-2) isolate Wuhan-Hu-1 complete reference genome of 29903 bp was downloaded from the ",
            "National Center for Biotechnology Information (NCBI)",
            " database on January 23, 2020."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 2412,
                "end": 2464,
                "name": "National Center for Biotechnology Information (NCBI)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All of the available 28 sequences of COVID-19 virus and the bat Betacoronavirus",
            "RaTG13 from the ",
            "GISAID",
            " platform, and two additional sequences (bat-SL-CoVZC45, and bat-SL-CoVZXC21) from the ",
            "NCBI",
            ", were downloaded on January 27, 2019."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 2591,
                "end": 2597,
                "name": "GISAID"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 2684,
                "end": 2688,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Accession numbers for all the sequences used in this study can be found in S1 File of S2 and S3 Tables."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The trained machine learning models are then used to test the COVID-19 virus sequences."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To determine whether there is a correlation between k-mer frequencies in COVID-19 virus genomes and specific taxonomic groups, a Spearman’s rank correlation coefficient test is conducted for k = 1 to k = 7."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Table 1 provides the details of three datasets Test-1, Test-2, Test-3a and Test-3b used for analyses with MLDSP-GUI."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Each dataset’s composition (clusters with number of sequences), the respective sequence length statistics, and results of MLDSP-GUI after applying 10-fold cross-validation as classification accuracy scores are shown."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As shown in Table 1, for the first test (Test-1), we organized the dataset of sequences into 12 clusters (11 families, and Riboviria realm)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "After filtering out the sequences, our pre-processed dataset is left with 3273 sequences organized into 12 clusters (Adenoviridae, Anelloviridae, Caudovirales, Geminiviridae, Genomoviridae, Microviridae, Ortervirales, Papillomaviridae, Parvoviridae, Polydnaviridae, Polyomaviridae, and Riboviria)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All six classification models trained on 3273 sequences were used to classify (predict the labels of) the 29 COVID-19 virus sequences."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Test-1 classified the COVID-19 virus as belonging to the realm Riboviria."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The second test (Test-2) is designed to classify the COVID-19 virus among the families of the Riboviria realm."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We completed the dataset pre-processing using the same rules as in Test-1 and obtained a dataset of 2779 sequences placed into the 12 families (Betaflexiviridae, Bromoviridae, Caliciviridae, Coronaviridae, Flaviviridae, Peribunyaviridae, Phenuiviridae, Picornaviridae, Potyviridae, Reoviridae, Rhabdoviridae, and Secoviridae), see Table 1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "MLDSP-GUI with CGR at k = 7 as the numerical representation was used for the classification of the dataset in Test-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All six classification models trained on 2779 sequences were used to classify (predict the label of) the 29 COVID-19 virus sequences."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Test-2 correctly predicted the family of the COVID-19 virus sequences as Coronaviridae."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The third test (Test-3a) is designed to classify the COVID-19 virus sequences at the genus level."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "MLDSP-GUI with CGR at k = 7 as the numerical representation was used for the classification of the dataset in Test-3a."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All six classification models trained on 208 sequences were used to classify (predict the label of) the 29 COVID-19 virus sequences."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All six classification models trained on 60 sequences were used to classify the 29 COVID-19 virus sequences."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Given confirmation that the COVID-19 virus belongs to the Betacoronavirus genus, there now is a question of its origin and relation to the other viruses of the same genus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To examine this question, we preprocessed our dataset from our third test to keep the sub-clusters of the Betacoronavirus with at least 10 sequences (Test-4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All six classifiers trained on 124 sequences predicted the label as Sarbecovirus, when used to predict the labels of 29 COVID-19 virus sequences."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For Test-5, we added the COVID-19 virus with 29 sequences as the fifth cluster, see Table 3."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the MoDMap3D plot from Test-5, COVID-19 virus sequences are placed in a single distinct cluster, see Fig 2(b)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As visually suggested by the MoDMap3D (Fig 2(b)), the average inter-cluster distances confirm that the COVID-19 virus sequences are closest to the Sarbecovirus (average distance 0.0556), followed by Merbecovirus (0.0746), Embecovirus (0.0914), and Nobecovirus (0.0916)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The three closest sequences based on the average distances from all COVID-19 virus sequences are RaTG13 (0.0203), bat-SL-CoVZC45 (0.0418), and bat-SL-CoVZXC21 (0.0428)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For Test-6, we classified Sarbecovirus (47 sequences) and COVID-19 virus (29 sequences) clusters and achieved separation of the two clusters visually apparent in the MoDMap3D, see Fig 2(c)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We generated phylogenetic trees (UPGMA and neighbor-joining) based on all pairwise distances for the dataset in Test-6 that show the separation of the two clusters and relationships within the clusters (Figs 3 and 4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As observed in Test-5, the phylogenetic trees show that the COVID-19 virus sequences are closer to the Betacoronavirus",
            "RaTG13 sequence collected from a bat host."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The CGR plots visually suggest and the pairwise distances confirm that the genomic signature of the COVID-19 virus Wuhan-Hu-1 (Fig 5(a)) is closer to the genomic signature of the BetaCov-RaTG13 (Fig 5(b); distance: 0.0204), followed by the genomic signatures of bat-SL-CoVZC45 (Fig 5(c); distance: 0.0417), bat-SL-CoVZXC21(Fig 5(d); distance: 0.0428), Alphacoronavirus /",
            "DQ811787",
            " PRCV",
            "ISU-1 (Fig 5(e); distance: 0.0672), Gammacoronavirus / Infectious bronchitis virus NGA /A116E7/2006/",
            "FN430415",
            " (Fig 5(f); distance: 0.0791), and Deltacoronavirus / PDCoV / USA / Illinois121 /2014/",
            "KJ481931",
            " (Fig 5(g); distance: 0.0851)."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 7421,
                "end": 7429,
                "name": "DQ811787"
            },
            false,
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 7535,
                "end": 7543,
                "name": "FN430415"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 7629,
                "end": 7637,
                "name": "KJ481931"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first test in Fig 6 shows COVID-19 virus being compared to the four genera; Alphacoronavirus, Betacoronavirus, Gammacoronavirus and Deltacoronavirus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 virus showed the highest k-mer frequency correlation to Betacoronavirus at k = 7 (Table 4), which is consistent with the MLDSP results in Test-3 (Table 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 virus was then compared to all sub-genera within the Betacoronavirus genus: Embecovirus, Merbecovirus, Nobecovirs and Sarbecovirus seen in Fig 7."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These tests confirm the findings in MLDSP and are consistent with the COVID-19 virus as part of the sub-genus Sarbecovirus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The strongest correlation value was found between Betacoronavirus and Sarbecovirus when using the data sets from Test 3a from Table 2 and Test 4 from Table 3, respectively."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Prior work elucidating the evolutionary history of the COVID-19 virus had suggested an origin from bats prior to zoonotic transmission [12, 33, 35, 38, 41, 62]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Most early cases of individuals infected with the COVID-19 virus had contact with the Huanan South China Seafood Market [26–31]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Still, the early COVID-19 virus genomes that have been sequenced and uploaded are over 99% similar, suggesting these infections result from a recent cross-species event [12, 31, 40]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These prior analyses relied upon alignment-based methods to identify relationships between the COVID-19 virus and other coronaviruses with nucleotide and amino acid sequence similarities."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "When analyzing the conserved replicase domains of ORF1ab for coronavirus species classification, nearly 94% of amino acid residues were identical to SARS-CoV, yet overall genome similarity was only around 70%, confirming that the COVID-19 virus was genetically different [64]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Within the RdRp region, it was found that another bat coronavirus, RaTG13, was the closest relative to the COVID-19 virus and formed a distinct lineage from other bat SARS-like coronaviruses [38, 40]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Other groups found that two bat SARS-like coronaviruses, bat-SL-CoVZC45 and bat-SL-CoVZXC21, were also closely related to the COVID-19 virus [12, 33–37]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There is a consensus that these three bat viruses are most similar to the COVID-19 virus, however, whether or not the COVID-19 virus arose from a recombination event is still unknown [38–40]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Regardless of the stance on recombination, current consensus holds that the hypothesis of the COVID-19 virus originating from bats is highly likely."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Whether or not the COVID-19 virus was transmitted directly from bats, or from intermediary hosts, is still unknown, and will require identification of the COVID-19 virus in species other than humans, notably from the wet market and surrounding area it is thought to have originated from [30]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Snakes had been proposed as an intermediary host for the COVID-19 virus based on relative synonymous codon usage bias studies between viruses and their hosts [39], however, this claim has been disputed [79]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "China CDC released information about environmental sampling in the market and indicated that 33 of 585 samples had evidence of the COVID-19 virus, with 31 of these positive samples taken from the location where wildlife booths were concentrated, suggesting possible wildlife origin [80, 81]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Viral outbreaks like COVID-19 demand timely analysis of genomic sequences to guide the research in the right direction."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The main advantage alignment-free methodology offers is the ability to analyze large datasets rapidly."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study we confirm the taxonomy of the COVID-19 virus and, more generally, propose a method to efficiently analyze and classify a novel unclassified DNA sequence against the background of a large dataset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We namely use a “decision tree” approach (paralleling taxonomic ranks), and start with the highest taxonomic level, train the classification models on the available complete genomes, test the novel unknown sequences to predict the label among the labels of the training dataset, move to the next taxonomic level, and repeat the whole process down to the lowest taxonomic label."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The objective is to train the classification models with the known viral genomes and then predict the labels of the COVID-19 virus sequences."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The trained models are then used to predict the labels of 29 COVID-19 virus sequences."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As expected, all classification models correctly predict that the COVID-19 virus sequences belong to the Riboviria realm, see Table 2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "When the COVID-19 virus sequences are tested using the models trained on Test-2, all of the models correctly predict the COVID-19 virus sequences as Coronaviridae (Table 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All trained classification models correctly predict the COVID-19 virus as Betacoronavirus, see Table 2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "MLDSP-GUI obtains 100% classification accuracy for this additional test and still predicts all of the COVID-19 virus sequences as Betacoronavirus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These tests confirm that the COVID-19 virus sequences are from the genus Betacoronavirus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All of the classification models trained on the dataset in Test-4 predicted the label of all 29 COVID-19 virus sequences as Sarbecovirus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This suggests substantial similarity between the COVID-19 virus and the Sarbecovirus sequences."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Test-5 and Test-6 (see Table 3) are designed to verify that the COVID-19 virus sequences can be differentiated from the known species in the Betacoronavirus genus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This shows that although the COVID-19 virus and Sarbecovirus are closer on the basis of genomic similarity (Test-4), they are still distinguishable from known species."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, these results suggest that the COVID-19 virus may represent a genetically distinct species of Sarbecovirus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All the COVID-19 virus sequences are visually seen in MoDMap3D generated from Test-5 (see Fig 2(b)) as a closely packed cluster and it supports a fact that there is 99% similarity among these sequences [12, 31]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The MoDMap3D generated from the Test-5 (Fig 2(b)) visually suggests and the average distances from COVID-19 virus sequences to all other sequences confirm that the COVID-19 virus sequences are most proximal to the RaTG13 (distance: 0.0203), followed by the bat-SL-CoVZC45 (0.0418), and bat-SL-CoVZX21 (0.0428)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The phylogenetic trees placed the RaTG13 sequence closest to the COVID-19 virus sequences, followed by the bat-SL-CoVZC45 and bat-SL-CoVZX21 sequences."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We further confirm our results regarding the closeness of the COVID-19 virus with the sequences from the Betacoronavirus genus (especially sub-genus Sarbecovirus) by a quantitative analysis based on the Spearman’s rank correlation coefficient tests."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 virus was compared to all genera under the Coronaviridae family and the k-mer frequencies showed the strongest correlation to the genus Betacoronavirus, and more specifically Sarbecovirus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Spearman’s rank tests corroborate that the COVID-19 virus is part of the Sarbecovirus sub-genus, as shown by CGR and MLDSP."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Attributes of the COVID-19 virus genomic signature are consistent with previously reported mechanisms of innate immunity operating in bats as a host reservoir for coronaviruses."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Spearman’s rank correlation data and the patterns observed in the CGR images from Fig 5, of the coronavirus genomes, including the COVID-19 virus identify patterns such as CG underepresentation, also present in vertebrate and, importantly, bat host genomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Due to the high amino acid similarities between the COVID-19 virus and SARS-CoV main protease essential for viral replication and processing, anticoronaviral drugs targeting this protein and other potential drugs have been identified using virtual docking to the protease for treatment of COVID-19 [29, 43, 44, 92–95]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The human ACE2 receptor has also been identified as the potential receptor for the COVID-19 virus and represents a potential target for treatment [41, 42]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "MLDSP-GUI took just 10.55 seconds to compute a pairwise distance matrix (including reading sequences, computing magnitude spectra using DFT, and calculating the distance matrix using PCC combined) for the Test-1 (largest dataset used in this study with 3273 complete genomes)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All of the tests combined (Test-1 to Test-6) are doable in under 10 minutes including the computationally heavy 10-fold cross-validation, and testing of the 29 COVID-19 virus sequences."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The 2019 novel coronavirus (renamed SARS-CoV-2, and generally referred to as the COVID-19 virus) has spread to 184 countries with over 1.5 million confirmed cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This paper identifies an intrinsic COVID-19 virus genomic signature and uses it together with a machine learning-based alignment-free approach for an ultra-fast, scalable, and highly accurate classification of whole COVID-19 virus genomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These tools are used to analyze a large dataset of over 5000 unique viral genomic sequences, totalling 61.8 million bp, including the 29 COVID-19 virus sequences available on January 27, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our results support a hypothesis of a bat origin and classify the COVID-19 virus as Sarbecovirus , within Betacoronavirus ."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our method achieves 100% accurate classification of the COVID-19 virus sequences, and discovers the most relevant relationships among over 5000 viral genomes within a few minutes, ab initio , using raw DNA sequence data alone, and without any specialized biological knowledge, training, gene or genome annotations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also examined how many seropositive children had received RT-PCR viral tests for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Over a third of children in our study had received at least one viral test (Table 1; note that administration of a viral test does not imply that a child was suspected of having COVID-19, since tests were routinely administered before hospital admission or procedures such as surgery)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A detailed chart review revealed that only the two seropositive children with a RT-PCR-confirmed viral infection had documented COVID-19 symptoms (Supplementary Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additional RT-PCR-confirmed COVID-19 pediatric cases were actively recruited to enroll in another approved study at Seattle Children’s Hospital during this study period."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Children are strikingly underrepresented in COVID-19 case counts."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Most seropositive children (6/8) were not suspected of having had COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 disease is less common in children than adults, but the extent to which SARS-CoV-2 infections are missed through symptom-driven testing is not well understood."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, the authors show that approximately 1% of children seeking care for reasons other than COVID-19 at a Seattle hospital in March/April 2020 were seropositive for SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Full raw data for all serological assays, as well as much demographic and viral-testing data that can be provided without compromising sample and patient de-identification, are available in Supplementary Data files 1–4."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Emerging viral infections represent a threat to global health, and the recent outbreak of novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, novel coronavirus, 2019-nCoV) exemplifies the risks (, )."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To assess whether RNA editing could be involved in human host responses to SARS-CoV-2 infections, we started from publicly available RNA sequencing datasets from bronchoalveolar lavage fluids (BALF) obtained from patients diagnosed with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The low editing frequencies we observe resembles the editing present on human transcripts containing Alu sequences, which were found in a limited number in those early datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There is no evidence of a sequence context preference if we use a larger dataset such as ",
            "REDIportal",
            " (), which includes >1.5 M sites in Alu repeats (fig. S3)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 775,
                "end": 785,
                "name": "REDIportal"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A comparison of the SNV datasets from the transcriptomic and genomic analyses reveals a different weight of A-to-I and C-to-U changes (Figs. 2B and 4A), with an underrepresentation of A-to-I in the viral genomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We used REDItools 2 (, ) and JACUSA () to call the SNVs using the following command line:",
            "Bcftools () has been used to calculate total allelic depths on the forward and reverse strand (ADF and ADR) for AS_StrandOddsRatio calculation, with the following command line:",
            "Logo alignments were calculated using ggseqlogo, using either the pooled dataset or the dataset of recurring SNVs."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 genomic sequences were downloaded from ",
            "GISAID",
            " (",
            "https://www.gisaid.org/",
            ") and aligned with MUSCLE ()."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 1489,
                "end": 1495,
                "name": "GISAID"
            },
            false,
            {
                "id": "T3",
                "type": "URL",
                "start": 1497,
                "end": 1520,
                "name": "https://www.gisaid.org/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "The COVID-19 outbreak has become a global health risk, and understanding the response of the host to the SARS-CoV-2 virus will help to combat the disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This report describes the epidemiological and clinical features of coronavirus disease (COVID-19) among three members of a family following SARS-CoV-2 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The coronavirus disease (COVID-19) outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Wuhan, China, in late 2019 and has affected more than 1 270 000 people worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our observations suggest the importance of preventing family transmission and the efficacy of current integrated treatment for mild/moderate pneumonia in COVID-19 cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To identify all relevant variants of ACE2, we performed a search in multiple databases and created workflow for assembling the variants in complex with the SARS-CoV-2 RBD (Fig. 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "XXXX stands for the ",
            "PDB",
            " ID from which the model was extracted, R1 is the one-letter residue code of the native residue of the ACE2 receptor, NUM is the residue number according to the ",
            "Uniprot",
            " sequence of human ACE2 receptor and R2 is the one-letter residue code of the variant to which the residue R1 was changed."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 201,
                "end": 204,
                "name": "PDB"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 365,
                "end": 372,
                "name": "Uniprot"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Variants in the 3 datasets are distinct, showing minor overlap in terms of amino acid substitution (Fig. 2a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The computational alanine scanning shows a minor overlap with reported mutagenesis studies, where only 13% of the total mutations can be found in both datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The experimental ",
            "Procko",
            " dataset ",
            "(PROCKO)",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 783,
                "end": 789,
                "name": "Procko"
            },
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 798,
                "end": 806,
                "name": "(PROCKO)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interestingly, overlap of those data with the 3 datasets described above is minor (78 common out of 242 mutations) (Fig. 4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Due to the higher risk of severe COVID-19 symptoms manifesting in cancer patients, we have specifically focused on retrieving genetic variants of ACE2 available in COSMIC v91 (Fig. 4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "ACE2 mutations from COVID-19 patients included in LOVD 3.0 (Fig. 4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "LOVD 3.0 reports additional variants for the ACE2 receptor and includes the N720D mutation which has been identified as a variant in COVID-19 patients in the Italian population."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "N720D is found in genomic data (",
            "gnomAD",
            "), cancer (",
            "COSMIC",
            " v91) and COVID-19 patients (",
            "LOVD",
            " 3.0)."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 1397,
                "end": 1403,
                "name": "gnomAD"
            },
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 1414,
                "end": 1420,
                "name": "COSMIC"
            },
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 1449,
                "end": 1453,
                "name": "LOVD"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Another ACE2 protein variation identified in COVID-19 patients is the K26R, which is also included in the ",
            "gnomAD",
            " data, but not in cancer patients."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 1566,
                "end": 1572,
                "name": "gnomAD"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our dataset includes 140 variants of human ACE2 representing missense mutations found in genome-wide studies, 39 mutants with reported effects on the recognition of the RBD, and 63 predictions after computational alanine scanning mutagenesis of ACE2-RBD interface residues."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This dataset will help accelerate the design of therapeutics against SARS-CoV-2, as well as contribute to prevention of possible future coronaviruses outbreaks."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "From Bangladesh, the very first complete genome of SARS‐CoV‐2 (hCoV‐19/Bangladesh/CHRF_nCOV19_0001/2020 under ",
            "GISAID",
            " Accession no: ",
            "EPI/ISL/437912",
            ") was published by the Child Health Research Foundation (CHRF) on 12 May 2020."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 110,
                "end": 116,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 131,
                "end": 145,
                "name": "EPI/ISL/437912"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "First, Bangladesh reported the first case of COVID‐19 on 8 March 2020 having a travel history from Italy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Secondly, the sequence is showing 99.99% identity to the strains of European, Arabian, and Asian countries (Table 1 listing the representative countries with the strain ID) considering a good number of the aligned sequences of the ",
            "NCBI",
            " and ",
            "GISAID",
            " databases."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 561,
                "end": 565,
                "name": "NCBI"
            },
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 570,
                "end": 576,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As ",
            "Nextstrain",
            " or ",
            "GISAID",
            " deals with a large number of data set (25,246 as of 14th April 2020) and generates an updated picture of the evolutionary timeframe using the maximum clade credibility (MCC) tree, at this stage, these results can be considered more reliable."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 591,
                "end": 601,
                "name": "Nextstrain"
            },
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 605,
                "end": 611,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We have found, considering this literature and online resources, that the Bangladeshi strain fell within the clade A2a containing a mutation at the 614th position of the spike protein changing amino acid aspartate to glycine (synonymous to G clade according to ",
            "GISAID",
            " phylogenetic tree) and another mutation at the 323rd position of NSP12 (proline to leucine)."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Dataset",
                "start": 1115,
                "end": 1121,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "It was also claimed in the report of Ayub",
            " as of 9th April 2020 that the predominant presence of SARS‐CoV‐2a substrain in a particular city or country, such as United Kingdom (26%), Belgium (31%), Netherland (50%), Portugal (60%), can be a cause of reduced cases of COVID‐19."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among them, mutation E261D (glutamic acid to aspartic acid) in the NSP13 protein (RNA helicase and/or 5′ triphosphatase activity) was found only in one Austrian strain (hCoV‐19/Austria/CeMM0004/2020) collected on 3rd March 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            " Remarkably, another mutation (I120F: isoleucine to phenylalanine) in the NSP2 (predicted role in viral pathogenicity)",
            " is not found in any other sequences available in the ",
            "GISAID",
            " database."
        ],
        "lab": [
            false,
            false,
            false,
            {
                "id": "T8",
                "type": "Dataset",
                "start": 1898,
                "end": 1904,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This may be explained by the fact of the return of a lot of immigrants to Bangladesh from other countries, some of which were declared as the COVID‐19 epicenters."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 pandemic is the first pandemic where WGS capacity has been widely available to the public health sector from the beginning."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since the first genomes were published in January 2020 [1-4], the number of available sequences has rapidly increased to more than 63,000 complete genome sequences available in ",
            "GISAID",
            " as at 10 July [5]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 314,
                "end": 320,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The World Health Organization (WHO) European Region has been an active contributor, with around 39,000 complete genome sequences from 35 countries published in ",
            "GISAID",
            ", with a median time of 40 days from sample collection to publication according to the ",
            "GISAID",
            " collection and submission dates."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 500,
                "end": 506,
                "name": "GISAID"
            },
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 593,
                "end": 599,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Several nomenclatures have been introduced for SARS-CoV-2 (strains in ",
            "GISAID",
            " use the name hCoV-19), including by ",
            "Nextstrain",
            " [6], ",
            "GISAID",
            " [7] and ",
            "Rambaut et al.",
            " (",
            "cov-lineages.org",
            ") [8-10]."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 703,
                "end": 709,
                "name": "GISAID"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 746,
                "end": 756,
                "name": "Nextstrain"
            },
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 762,
                "end": 768,
                "name": "GISAID"
            },
            false,
            {
                "id": "T7",
                "type": "Creator",
                "start": 777,
                "end": 791,
                "name": "Rambaut et al."
            },
            false,
            {
                "id": "T8",
                "type": "URL",
                "start": 793,
                "end": 809,
                "name": "cov-lineages.org"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T7",
                "end": "T8"
            }
        ]
    },
    {
        "sen": [
            "While ",
            "Nextstrain",
            " and ",
            "GISAID",
            " clade nomenclatures aim at providing a broad-brush categorisation of globally circulating diversity, the lineages (",
            "cov-lineages.org",
            ") are meant to correspond to outbreaks."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 825,
                "end": 835,
                "name": "Nextstrain"
            },
            false,
            {
                "id": "T10",
                "type": "Dataset",
                "start": 840,
                "end": 846,
                "name": "GISAID"
            },
            false,
            {
                "id": "T11",
                "type": "URL",
                "start": 962,
                "end": 978,
                "name": "cov-lineages.org"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The tree is shaded to correspond to the major lineages and all ",
            "Nextstrain",
            " and ",
            "GISAID",
            " clades."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 1081,
                "end": 1091,
                "name": "Nextstrain"
            },
            false,
            {
                "id": "T13",
                "type": "Dataset",
                "start": 1096,
                "end": 1102,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Between ",
            "Nextstrain",
            " clades 20A and 20C and ",
            "GISAID",
            " clades G and GH, there are differences in the position where clades are divided (shown as grey in the main tree and lineage columns, and grey stripes in the ",
            "Nextstrain",
            " and ",
            "GISAID",
            " column)."
        ],
        "lab": [
            false,
            {
                "id": "T14",
                "type": "Repository",
                "start": 1119,
                "end": 1129,
                "name": "Nextstrain"
            },
            false,
            {
                "id": "T15",
                "type": "Dataset",
                "start": 1153,
                "end": 1159,
                "name": "GISAID"
            },
            false,
            {
                "id": "T16",
                "type": "Repository",
                "start": 1317,
                "end": 1327,
                "name": "Nextstrain"
            },
            false,
            {
                "id": "T17",
                "type": "Dataset",
                "start": 1332,
                "end": 1338,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, the grey is shown as stripes in the ",
            "Nextstrain",
            " and ",
            "GISAID",
            " clade columns to reflect how they are categorised by each methodology."
        ],
        "lab": [
            false,
            {
                "id": "T18",
                "type": "Repository",
                "start": 1390,
                "end": 1400,
                "name": "Nextstrain"
            },
            false,
            {
                "id": "T19",
                "type": "Dataset",
                "start": 1405,
                "end": 1411,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The sequence data available from ",
            "GISAID",
            " were curated using the Pangolin data preparation pipeline [8]."
        ],
        "lab": [
            false,
            {
                "id": "T20",
                "type": "Dataset",
                "start": 1516,
                "end": 1522,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There was an initial period in January 2020 when the 19A/L/V/O clades (",
            "Nextstrain",
            "/",
            "GISAID",
            " nomenclatures) were more prevalent in total than the 20A/G clades, However, this could partially be an effect of small numbers of sequenced viral genomes in Europe early in the pandemic as well as the widespread sampling strategy focusing on cases with travel history to East Asia."
        ],
        "lab": [
            false,
            {
                "id": "T21",
                "type": "Repository",
                "start": 1657,
                "end": 1667,
                "name": "Nextstrain"
            },
            false,
            {
                "id": "T22",
                "type": "Dataset",
                "start": 1668,
                "end": 1674,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "Nextstrain",
            " 20C clade peaked at ca 20% of the sequences in early April 2020 and has since then slowly declined and almost disappeared, while the ",
            "GISAID",
            " GH clade peaked at ca 30% in May 2020 and has rapidly declined since then."
        ],
        "lab": [
            false,
            {
                "id": "T23",
                "type": "Repository",
                "start": 1961,
                "end": 1971,
                "name": "Nextstrain"
            },
            false,
            {
                "id": "T24",
                "type": "Dataset",
                "start": 2105,
                "end": 2111,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "From top to bottom: ",
            "Nextstrain",
            ", ",
            "GISAID",
            " and ",
            "cov-lineages.org",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T25",
                "type": "Repository",
                "start": 2207,
                "end": 2217,
                "name": "Nextstrain"
            },
            false,
            {
                "id": "T26",
                "type": "Dataset",
                "start": 2219,
                "end": 2225,
                "name": "GISAID"
            },
            false,
            {
                "id": "T27",
                "type": "URL",
                "start": 2230,
                "end": 2246,
                "name": "cov-lineages.org"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Shaded areas: interquartile ranges obtained by bootstrap resampling the dataset by country."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The geographical distribution of ",
            "Nextstrain",
            " and ",
            "GISAID",
            " clades shows that in general, clade 19B/S has been very rare, except in Spain and Kazakhstan, and frequencies of the other clades were varied for most countries in the WHO European Region (Figure 3)."
        ],
        "lab": [
            false,
            {
                "id": "T28",
                "type": "Repository",
                "start": 2373,
                "end": 2383,
                "name": "Nextstrain"
            },
            false,
            {
                "id": "T29",
                "type": "Dataset",
                "start": 2388,
                "end": 2394,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The grey areas represent sequences called differently by the ",
            "GISAID",
            " and ",
            "Nextstrain",
            " methodologies, and correspond to the grey-shaded partition of the tree in Figure 1."
        ],
        "lab": [
            false,
            {
                "id": "T30",
                "type": "Dataset",
                "start": 2656,
                "end": 2662,
                "name": "GISAID"
            },
            false,
            {
                "id": "T31",
                "type": "Repository",
                "start": 2667,
                "end": 2677,
                "name": "Nextstrain"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The proportion of clades found in each country was calculated using all available full-length, high-quality (> 27,000 bases, < 3,000 undetermined bases) sequences available on ",
            "GISAID",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T32",
                "type": "Dataset",
                "start": 2938,
                "end": 2944,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Clade membership for each sequence was determined by given ",
            "GISAID",
            " annotation or via the ",
            "Nextstrain",
            " clades script, and proportions were calculated for all sequences from a given country."
        ],
        "lab": [
            false,
            {
                "id": "T33",
                "type": "Dataset",
                "start": 3005,
                "end": 3011,
                "name": "GISAID"
            },
            false,
            {
                "id": "T34",
                "type": "Repository",
                "start": 3034,
                "end": 3044,
                "name": "Nextstrain"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first three also depend to a large degree on data completeness, which is a limitation in the currently available dataset where the number of sequences per country ranges from four to 28,000."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2, which causes the disease known as COVID-19, was first reported in late 2019 (Coronaviridae Study Group of the International Committee on Taxonomy of V., 2020, Lu et al., 2020, Paules et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 is characterized by pneumonia, fever, cough, and occasional diarrhea (Guan et al., 2020, Holshue et al., 2020, Huang et al., 2020), and SARS-CoV-2 RNA has been reliably detected in nasopharyngeal swabs, sputum, and stool samples (Wang et al., 2020, Wölfel et al., 2020, Zou et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Early models of COVID-19 transmission dynamics estimate one infectious individual infects slightly over two individuals; travel restrictions reduce that spread to one individual, although these figures might evolve as more accurate epidemiological data become available (Kucharski et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, using published and unpublished datasets (all from non-SARS-CoV-2-infected samples), we analyze human, NHP, and mouse tissues that have been clinically identified to harbor virus in patients exhibiting COVID-19 symptoms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we focus our analysis and discussion on the specific subsets where ACE2 and TMPRSS2 are enriched and on relative comparisons within each dataset, rather than between datasets or equivalence to absolute numbers of total cells."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Human influenza infection also induces broader expression of ACE2 in upper airway epithelial cells and is corroborated by publicly available databases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The dynamic, species-specific and multifaceted role of IFN raises implications for pre-clinical COVID-19 disease modeling."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To investigate which cells within human and NHP tissues represent likely SARS-CoV-2 targets, we analyzed new and existing scRNA-seq datasets to assess which cell types express ACE2, alone or with TMPRSS2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In a previously unpublished dataset consisting of NHP (Macaca mulatta) lung tissue collected after necropsy of healthy adult animals and analyzed by using Seq-Well v1 (",
            "Gierahn et al., 2017",
            "), we recovered at least 17 distinct major cell types, including various lymphoid, myeloid, and stromal populations (Figures 1A–1C; Table S1; STAR Methods)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Creator",
                "start": 1911,
                "end": 1931,
                "name": "Gierahn et al., 2017"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To assess whether the findings from NHP lung cells were similarly present in humans, we analyzed a previously unpublished scRNA-seq dataset derived from surgical resections of fibrotic lung tissue collected with Seq-Well S3 (",
            "Hughes et al., 2019",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Creator",
                "start": 2313,
                "end": 2332,
                "name": "Hughes et al., 2019"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of note, we also observed TRIM28 co-expressed with ACE2 and TMPRSS2 among type II pneumocytes in this dataset (FDR-adjusted p = 2.34E−9), which might play a role in potentiating an IFN response in lung epithelial cells (Krischuns et al., 2018)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Next, using a previously unpublished scRNA-seq dataset consisting of granuloma and adjacent, uninvolved lung samples from Mtb-infected NHPs (Macaca fascicularis) collected with Seq-Well S3, we identified subsets of epithelial cells expressing ACE2 and TMPRSS2 (Figure S1; Table S3; STAR Methods)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Next, we examined several other tissues for ACE2-expressing cells on the basis of the location of hallmark symptoms of COVID-19, focusing on the gastrointestinal tract due to reports of clinical symptoms and viral shedding (",
            "Xiao et al., 2020",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Creator",
                "start": 3101,
                "end": 3118,
                "name": "Xiao et al., 2020"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Shown on the right is a tSNE plot of 13,689 epithelial cells selected from original dataset generated by 10x 3′ v2 (see Figure S2), colored by cellular subsets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "(E)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In an additional dataset consisting of endoscopic biopsies from the terminal ileum of a human pediatric cohort (n = 13 donors, ranging in age from 10 to 18 years old), collected with 10X 3′ v2, we confirmed a large abundance of ACE2+ cells with selective expression within absorptive enterocytes (29.7% ACE2+, FDR-adjusted p = 2.46E−100) (Figures 3D and 3E; Table S5; STAR Methods)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To identify potential viral target cells in nasal and sinus tissue, two regions that are frequently primary sites of exposure for coronaviruses, we analyzed existing scRNA-seq datasets from the human upper airway (inferior turbinate and ethmoid sinus mucosa) across a spectrum of healthy donors and individuals with allergic inflammation due to chronic rhinosinusitis (CRS) collected with Seq-Well v1 (Figure 4A; STAR Methods) (",
            "Ordovas-Montanes et al., 2018",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Creator",
                "start": 4098,
                "end": 4127,
                "name": "Ordovas-Montanes et al., 2018"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We next utilized IFN-inducible gene sets of relevance to human airway epithelial cells, which we derived from a prior study by performing differential expression on a published dataset where air-liquid interface cultures from primary human nasal epithelial cells were treated with IFN-αA/D, IFN-β1a, IFN-γ, IL-4, or IL-13 (",
            "Giovannini-Chami et al., 2012",
            ", ",
            "Ordovas-Montanes et al., 2018",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Creator",
                "start": 4453,
                "end": 4482,
                "name": "Giovannini-Chami et al., 2012"
            },
            false,
            {
                "id": "T6",
                "type": "Creator",
                "start": 4484,
                "end": 4513,
                "name": "Ordovas-Montanes et al., 2018"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Next, using a publicly available resource (",
            "interferome.org",
            ") that hosts genomic and transcriptomic data from cells or tissues treated with IFN, we queried ACE2 expression within human and mouse cells, searching for datasets with a log2-fold-change of >1 or < −1 compared with untreated samples, including all IFN types (Rusinova et al., 2013)."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "URL",
                "start": 4559,
                "end": 4574,
                "name": "interferome.org"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We recovered 21 datasets spanning 8 distinct primary tissues or cell lines with non-trivial changes in ACE2 expression after both type I and type II IFN treatment (Figure S4A)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Immune cell types, such as CD4 T cells and macrophages, were noticeably absent from datasets with a significant change in ACE2 expression after IFN stimulation or were even found to downregulate ACE2 (e.g., primary CD4 T cells + type I IFN) (Figure S4A, and in our analysis of scRNA-seq peripheral blood mononuclear cell data from Butler et al., (2018); data not shown)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Generated from ",
            "TRANSFAC",
            " data using the ",
            "interferome.org",
            " database (",
            "Matys et al., 2003",
            ", ",
            "Rusinova et al., 2013",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 5422,
                "end": 5430,
                "name": "TRANSFAC"
            },
            false,
            {
                "id": "T9",
                "type": "URL",
                "start": 5446,
                "end": 5461,
                "name": "interferome.org"
            },
            false,
            {
                "id": "T10",
                "type": "Creator",
                "start": 5472,
                "end": 5490,
                "name": "Matys et al., 2003"
            },
            false,
            {
                "id": "T11",
                "type": "Creator",
                "start": 5492,
                "end": 5513,
                "name": "Rusinova et al., 2013"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, using both ",
            "Transcription Factor database (TRANSFAC)",
            " data hosted by the ",
            "interferome",
            " database, as well as chromatin immunoprecipitation sequencing (ChIP-seq) data (provided by the ",
            "ENCODE Factorbook",
            " repository), we found evidence for STAT1, STAT3, IRF8, and IRF1 binding sites within −1500–500 bp of the transcription start site of ACE2 (all in human studies, Figure S4B) (Gerstein et al., 2012, Matys et al., 2003, Wang et al., 2012, Wang et al., 2013)."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 5540,
                "end": 5580,
                "name": "Transcription Factor database (TRANSFAC)"
            },
            false,
            {
                "id": "T13",
                "type": "Dataset",
                "start": 5600,
                "end": 5611,
                "name": "interferome"
            },
            false,
            {
                "id": "T14",
                "type": "Repository",
                "start": 5707,
                "end": 5724,
                "name": "ENCODE Factorbook"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We collected from both tissue sites because of early reports of anosmia in COVID-19 (Lechien et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We re-analyzed a publicly available dataset of RNA-seq from human lung explants isolated after surgical resections that were infected with influenza A virus ex vivo for 24 h."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To review the data presented: (1) we found that expression of the cellular entry receptor for SARS-CoV-2, ACE2, is primarily restricted to type II pneumocytes in the lung, absorptive enterocytes within the gut, and goblet secretory cells of the nasal mucosa; (2) ACE2 and TMPRSS2 co-expression in respiratory tissues is consistently found only among a rare subset of epithelial cells; (3) we observed similarities in the cellular identities and frequencies of putative SARS-CoV-2 target cells across human and NHP cohorts; (4) we observe increased expression of ACE2 during SHIV and TB infection of NHPs, and HIV/TB co-infection and influenza infection of humans compared with that in matched controls but caution that none of the datasets presented here were designed to answer this specific query."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also present datasets separately, given that each study differed in its methods of tissue processing and collection, which can influence the frequency of recovered cell subsets (STAR Methods)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We provide Table S9 as a summary of ACE2+ and ACE2+TMPRSS2+ cells across various datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This is based on several lines of evidence: (1) we identified a human goblet secretory cell subset in upper airway nasal epithelium enriched for ACE2 expression to have the highest IFN-α-induced gene signature; (2) we found that IFN-α, and to a lesser extent IFN-β or IFN-γ, induced ACE2 expression in a published dataset of air-liquid interface cultures derived from human nasal epithelial cells (Giovannini-Chami et al., 2012, Ordovas-Montanes et al., 2018); (3) we extended our search through the ",
            "Interferome",
            " database (",
            "Rusinova et al., 2013",
            ") and found that, in epithelial barrier tissues, type I IFNs upregulate ACE2 in multiple studies, especially in primary bronchial cells and keratinocytes (Rusinova et al., 2013); (4) we found two STAT1 binding sites in the promoter of ACE2; (5) in our unpublished atlas of SHIV-infected macaques, known to have elevated amounts of chronic IFN signaling, we found ACE2 upregulation in absorptive enterocytes; (6) we directly provided evidence for IFN-α, and to some extent IFN-γ, inducing ACE2 expression in primary human upper airway basal cells; and (7) influenza infection in humans, a known inducer of the IFN pathway, leads to increased ACE2 expression in goblet secretory cells of the nasal epithelium (Cao et al., 2020)."
        ],
        "lab": [
            false,
            {
                "id": "T15",
                "type": "Dataset",
                "start": 7851,
                "end": 7862,
                "name": "Interferome"
            },
            false,
            {
                "id": "T16",
                "type": "Creator",
                "start": 7873,
                "end": 7894,
                "name": "Rusinova et al., 2013"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Altogether, our own and publicly available data highlight that ACE2 might have been missed as a canonical ISG because of its notable absence in peripheral blood mononuclear cell datasets and in lung-derived transformed cell lines such as the A549 cell line (Butler et al., 2018, Letko et al., 2020, Rusinova et al., 2013)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Importantly, other groups have independently analyzed publicly available datasets, some referenced in our work, and observed ACE2’s behavior as an ISG (Wang and Cheng, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Whether IFNs upregulate ACE2 in putative target cell subsets in vivo will be of significant interest to define in future work once current COVID-19-related restrictions on basic scientific inquiry are lifted (Qian et al., 2013)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For example, examining the efficacy of recombinant human ACE2 to act as a decoy receptor or the effect of “ACE inhibitors” in patients with, or at risk for, COVID-19 will require careful experimentation in appropriate models together with well-controlled clinical trials (Hofmann et al., 2004, Monteil et al., 2020, Vaduganathan et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, another study appeared on medRxiv profiling bronchoalveolar lavage fluid from 3 severe and 3 mild COVID-19 patients, though they were unable to profile sufficient numbers of epithelial cells (Liao et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our study highlights the power of scRNA-seq datasets, both existing and novel, to derive hypotheses relevant to human disease that might differ from paradigms established by using cell lines."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In Table S9, we provide a guide to all datasets analyzed in this paper as well as links to each individual dataset for download with the main landing page here: ",
            "https://singlecell.broadinstitute.org/single_cell?scpbr=the-alexandria-project",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T17",
                "type": "URL",
                "start": 10270,
                "end": 10348,
                "name": "https://singlecell.broadinstitute.org/single_cell?scpbr=the-alexandria-project"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Downloadable datasets include both raw and normalized cell x gene matrices, as well as relevant metadata."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These datasets are additionally available here to facilitate downloading: ",
            "https://drive.google.com/drive/folders/1bxCIqNeZ7wLuVOT16gphwj98_cc9KhrV?usp=sharing",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T18",
                "type": "URL",
                "start": 10530,
                "end": 10614,
                "name": "https://drive.google.com/drive/folders/1bxCIqNeZ7wLuVOT16gphwj98_cc9KhrV?usp=sharing"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We have also posted these cell x gene matrices to Chan Zuckerberg Initiative cellxgene (https://chanzuckerberg.github.io/cellxgene/posts/cellxgene_cziscience_com) and the Broad Institute Single Cell COVID-19 portal (https://singlecell.broadinstitute.org/single_cell/covid19) as leading community efforts."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "FASTQ files and cell x gene matrices for NHP and murine datasets, and cell x gene matrices for human datasets, are available at ",
            "GEO",
            ": ",
            "GSE148829",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T19",
                "type": "Repository",
                "start": 11049,
                "end": 11052,
                "name": "GEO"
            },
            false,
            {
                "id": "T20",
                "type": "AccessionNumber",
                "start": 11054,
                "end": 11063,
                "name": "GSE148829"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T19",
                "end": "T20"
            }
        ]
    },
    {
        "sen": [
            "Full information related to subject age/developmental stage and sex found in metadata associated with provided raw datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Full information related to subject age/developmental stage and sex found in metadata associated with provided raw datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Expression data for epithelial cells and enterocytes included in this dataset can be visualized and downloaded here: ",
            "https://singlecell.broadinstitute.org/single_cell/study/SCP807?scpbr=the-alexandria-project#study-summary.",
            "",
            "Sub-clusters (i.e., clusters within broad cell type classifications) were annotated by cross-referencing cluster-defining genes with curated gene lists and online databases SaVanT (http://newpathways.mcdb.ucla.edu/savant-dev/) and ",
            "GSEA/MsigDB",
            " (",
            "https://www.gsea-msigdb.org/gsea/msigdb/index.jsp",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T21",
                "type": "URL",
                "start": 11432,
                "end": 11538,
                "name": "https://singlecell.broadinstitute.org/single_cell/study/SCP807?scpbr=the-alexandria-project#study-summary."
            },
            false,
            false,
            {
                "id": "T22",
                "type": "Dataset",
                "start": 11770,
                "end": 11781,
                "name": "GSEA/MsigDB"
            },
            false,
            {
                "id": "T23",
                "type": "URL",
                "start": 11783,
                "end": 11832,
                "name": "https://www.gsea-msigdb.org/gsea/msigdb/index.jsp"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T22",
                "end": "T23"
            }
        ]
    },
    {
        "sen": [
            "Expression data for epithelial cells included in this dataset can be visualized and downloaded here: ",
            "https://singlecell.broadinstitute.org/single_cell/study/SCP814?scpbr=the-alexandria-project#study-summary",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T24",
                "type": "URL",
                "start": 11936,
                "end": 12041,
                "name": "https://singlecell.broadinstitute.org/single_cell/study/SCP814?scpbr=the-alexandria-project#study-summary"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Expression data for epithelial cells included in this dataset can be visualized and downloaded here:",
            "Libraries corresponding to 4 mice, with 2 Seq-Well arrays per mouse were sequenced using Illumina NextSeq as described (Gierahn et al., 2017, Hughes et al., 2019)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This dataset can be visualized and downloaded here:",
            "Libraries corresponding to 14 mice were aligned to a custom reference genome encompassing both murine (mm10) and herpes virus genes: 84 known genes from MHV68 were retrieved from ",
            "NCBI",
            " (",
            "NCBI",
            ": ",
            "txid33708",
            ") and added to the mm10 mouse genome."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T25",
                "type": "Repository",
                "start": 12539,
                "end": 12543,
                "name": "NCBI"
            },
            false,
            {
                "id": "T26",
                "type": "Repository",
                "start": 12545,
                "end": 12549,
                "name": "NCBI"
            },
            false,
            {
                "id": "T27",
                "type": "AccessionNumber",
                "start": 12551,
                "end": 12560,
                "name": "txid33708"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T26",
                "end": "T27"
            }
        ]
    },
    {
        "sen": [
            "Type I Pneumocytes were excluded from this analysis based on uniformly negative expression of Ace2, resulting in a final dataset subset of 5,558 cells."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There is pressing urgency to understand the pathogenesis of the severe acute respiratory syndrome coronavirus clade 2 (SARS-CoV-2), which causes the disease COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we leverage human, non-human primate, and mouse single-cell RNA-sequencing (scRNA-seq) datasets across health and disease to uncover putative targets of SARS-CoV-2 among tissue-resident cell subsets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Graphical Abstract      Highlights     •  Meta-analysis of human, non-human primate, and mouse single-cell RNA-seq datasets for putative SARS-CoV-2 targets    •",
            "Type II pneumocytes, nasal secretory cells, and absorptive enterocytes are ACE2 + TMPRSS2 +    •  Interferon and influenza increase ACE2 in human nasal epithelia and lung tissue    •  Mouse Ace2 is not upregulated by interferon, raising implications for disease modeling      Analysis of single-cell RNA-seq datasets from human, non-human primate, and mouse barrier tissues identifies putative cellular targets of SARS-CoV-2 on the basis of ACE2 and TMPRSS2 expression."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of note, the recent outbreak of Corona virus Disease 2019 (COVID-19), a cluster of pneumonia in humans caused by SARS-CoV-2, turned into a public health emergency of international concern (Sun et al. 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although our discrete phylogeographic inference results currently do not implicate geographic distance or hog population sizes in farms as drivers of spatial spread, more comprehensive sampling and incorporating additional predictors at different levels (county, prefecture, or province) may elucidate important spatial dynamics in the future."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The continuous phylogeographic reconstruction that incorporates a directional tendency suggests a southern origin for PDCoV spread in China."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 119 genome sequences and 220 S gene sequences were used, along with 21 newly sequenced genomes (",
            "GenBank",
            " accession numbers in supplementary table S2, Supplementary Material online) and 29 newly sequenced S gene (",
            "GenBank",
            " accession numbers: ",
            "MN058045",
            "–",
            "MN058073",
            ") sequences, respectively."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 799,
                "end": 806,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 914,
                "end": 921,
                "name": "GenBank"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 941,
                "end": 949,
                "name": "MN058045"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 950,
                "end": 958,
                "name": "MN058073"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T2",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "We first assessed temporal signal in our data sets using TempEst (Rambaut et al. 2016) and continued to assess the best fitting model through marginal likelihood estimation using path-sampling and stepping-stone estimation approaches."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since its emergence from Wuhan, China, in late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19), has already claimed the lives of more than 70,000 individuals worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "With the number of COVID-19 cases and deaths increasing with each passing day, there is perhaps no more pressing need in medicine than to identify safe and efficacious therapies to prevent SARS-CoV-2 infections as well as to attenuate the severity of the resulting COVID-19 illness."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although there are no proven US Food and Drug Administration (FDA)–approved drugs to prevent or treat COVID-19, a number of promising novel (eg, remdesivir) and repurposed (eg, hydroxychloroquine, potentially together with azithromycin) pharmacological agents, reported to inhibit the growth of SARS-CoV-2 in vitro,",
            ",",
            " are being evaluated in randomized clinical trials."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In light of (1) the need for this practice to continue in the absence of viable, evidence-based therapies and (2) the proclivity of many promising COVID-19 pharmacotherapies—specifically antimalarial agents such as hydroxychloroquine—to prolong the QTc, thereby increasing the risk of drug-induced torsades de pointes (DI-TdP) and drug induced-sudden cardiac death (DI-SCD), this document was assembled to help health care professionals safely use these medications and minimize concomitant risks."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "Based on this in vitro data, it has been hypothesized that hydroxychloroquine, more so than chloroquine, may have therapeutic efficacy in the COVID-19 pandemic by (1) preventing SARS-CoV-2 infection by inhibiting angiotensin-converting enzyme 2–mediated viral entry (ie, preinfection prophylaxis) and (2) attenuating the postviral cytokine storm observed in severe COVID-19 cases via a multitude of immunomodulatory mechanisms (ie, treatment of active infection/postviral sequelae)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Promising in vitro data",
            ",",
            " as well as anecdotal in vivo evidence of therapeutic benefit have led many institutions, including Mayo Clinic, to consider the use of hydroxychloroquine as a first-line COVID-19 pharmacotherapy for the time being and spurred an array of clinical trials designed to assess the efficacy of repurposed hydroxychloroquine in both the prevention and treatment of COVID-19."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Torsadogenic Potential and Postmarketing Adverse Events Associated With Possible COVID-19 Repurposed Pharmacotherapiesa",
            "Although some might argue that DI-SCDs in the setting of widespread chloroquine/hydroxychloroquine use represents acceptable “friendly fire” in the war on SARS-CoV-2/COVID-19, we believe that with the institution of a few simple and safe precautions, the risk of DI-TdP and DI-SCD can be mitigated."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although the percentage of individuals at risk is small, given the pandemic nature of COVID-19, in absolute terms the number of individuals potentially at risk for lethal adverse drug effects is large (at least 10,000 individuals of the >1,000,000 COVID-19–positive patients worldwide are expected to be at increased risk for DI-TdP/DI-SCD if treated with these medications)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Unfortunately, in the context of the COVID-19 pandemic, acquisition of the patient’s QTc by the 12-lead ECG, which requires additional personnel exposure (ie, ECG technician), and a necessity for serial ECGs, which requires exposure of complex equipment (multiple ECG wires), could further strain the already limited supply of personal protective equipment (PPE) in many countries."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To this end, AliveCor, Inc, just received emergency clearance from the FDA for use of the KardiaMobile 6L device (FDA-approved for atrial fibrillation detection) for QTc monitoring of patients with COVID-19 treated with QT-prolonging medications such as chloroquine/hydroxychloroquine (March 20, 2020, 1:15 PM CST)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For patients with COVID-19 about to be treated with medications with the increased potential for DI-TdP/DI-SCD (Figure 1), baseline QTc status should be obtained either by a traditional 12-lead ECG or perhaps preferably with the use of a smartphone-enabled mobile QTc meter using the simple infection control measures outlined in Figure 2",
            "to limit personnel exposures and conserve critical PPE."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For patients with QTc values less than the 99th percentile for age/sex (ie, 460 ms in prepubertal males/females, 470 ms in postpubertal males, and 480 ms in postpubertal females [Figure 1 “green light” status]), the risk of DI-TdP/DI-LQTS is low, and chloroquine/hydroxychloroquine (or other QTc-prolonging COVID-19 pharmacotherapies) should be initiated without delay as outlined in the QTc monitoring algorithm."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Remember, whether by 12-lead ECG, telemetry, or smartphone-enabled acquisition of the ECG, if the noted QT interval is less than one-half the preceding RR interval, then the calculated QTc will always be less than 460 ms and the patient can be “green light go” for COVID-19 treatments that may have QTc-prolonging potential."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For example, in younger patients with COVID-19 (ie, <40 years) who have only mild symptoms and a QTc of 500 ms or greater, it may be reasonable to avoid treatment altogether because the arrhythmia risk may outweigh the risk of developing COVID-19–related acute respiratory distress syndrome."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, in patients with a QTc of 500 ms or greater presenting with progressively worsening respiratory symptoms or at greater risk (eg, >65 years of age, immunosuppressed, and/or high-risk comorbid conditions) for respiratory complications, the potential benefit of QTc-prolonging COVID-19 pharmacotherapies may exceed the arrhythmia risk."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, the ultimate goal of QTc surveillance in the COVID-19 pandemic should  be to identify those who cannot receive these medications but to identify those with compromised or reduced “repolarization reserve” in whom increased QTc countermeasures can and should be taken to mitigate the risk of drug-related death from DI-TdP/DI-SCD."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The timing of on-therapy QTc surveillance will be dictated not only by the pharmacokinetics of the COVID-19 therapies used but also by the practical logistics of an institution’s method of QTc monitoring."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As the coronavirus disease 19 (COVID-19) global pandemic rages across the globe, the race to prevent and treat this deadly disease has led to the “off-label” repurposing of drugs such as hydroxychloroquine and lopinavir/ritonavir, which have the potential for unwanted QT-interval prolongation and a risk of drug-induced sudden cardiac death."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With the possibility that a considerable proportion of the world’s population soon could receive COVID-19 pharmacotherapies with torsadogenic potential for therapy or postexposure prophylaxis, this document serves to help health care professionals mitigate the risk of drug-induced ventricular arrhythmias while minimizing risk of COVID-19 exposure to personnel and conserving the limited supply of personal protective equipment."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of May 13, 2020, more than 4·1 million confirmed cases of COVID-19 have been reported with more than 280 000 attributable deaths worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The clinical situation in both parents also deteriorated during the primary case's stay in Germany and both were laboratory-confirmed with COVID-19 later."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "After Spanish authorities were informed, patient 12 was isolated in hospital on Jan 30 and diagnosed with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In December, 2019, the newly identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, causing COVID-19, a respiratory disease presenting with fever, cough, and often pneumonia."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Case interviews were done to describe timing of onset and nature of symptoms and to identify and classify contacts as high risk (had cumulative face-to-face contact with a confirmed case for ≥15 min, direct contact with secretions or body fluids of a patient with confirmed COVID-19, or, in the case of health-care workers, had worked within 2 m of a patient with confirmed COVID-19 without personal protective equipment) or low risk (all other contacts)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These results suggest that although the outbreak was controlled, successful long-term and global containment of COVID-19 could be difficult to achieve."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Emerging epidemiological studies have brought the attentions towards liver injury and liver impairment as a potential outcome of COVID19 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similarly, in COVID-19, more than half of patients developed abnormal levels of alanine aminotransferase and aspartate aminotransferase (AST) (Zhang et al. 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, higher liver dysfunction was observed with more severe presentations of COVID-19 and more admission to intensive care units (Guan et al. 2020; Huang et al. 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the COVID-19, the resulting hepatic dysfunction is accompanied by abnormal coagulation and fibrinolytic pathways leading to worse outcomes (Tang et al. 2020; Thachil et al. 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Liver impairment during COVID-19 infection could be due to several factors including the direct infection of liver cells with SARS-CoV-2 (Wang et al. 2020; Zhao et al. 2020), cytokine storm and inflammation, and drug-induced toxicity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Understanding that may reflect how such medications may affect the level of infectivity and permissibility of the liver following COVID-19 infection (Boeckmans et al. 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Not all medications present in Fig. 1b were available in this dataset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Within the analgesics, acetaminophen revealed a dose-dependent reduction in expression level of ACE2, while the effect of non-steroidal anti-inflammatory drugs (NSAIDs) ranged between no expression change with ibuprofen and meloxicam and mixed effect of decreased ACE2 and increased TMPRSS2 expressions with diclofenac, naproxen, and nimesulide (Fig. 1b; Supplementary Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our results are based on public gene expression datasets and thus they may or may not reflect changes in protein expression."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although the increased risk of developing severe COVID-19 infections should not be correlated solely with the use of medications, data presented here suggest that we should be vigilant about the potential medication effects."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Publicly available gene expression datasets available via ",
            "Toxicogenomics Project-Genomics Assisted Toxicity Evaluation System (Open TG-GATEs)",
            " (",
            "Igarashi et al. 2015",
            "), ",
            "National Center for Biotechnology Information",
            " ",
            "Gene Expression Omnibus",
            " (",
            "NCIB",
            " ",
            "GEO",
            ", ",
            "https://www.ncbi.nlm.nih.gov/geo",
            ") and the ",
            "European Bioinformatics Institute (EMBL-EBI",
            ", ",
            "https://www.ebi.ac.uk",
            ") were used."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 1934,
                "end": 2017,
                "name": "Toxicogenomics Project-Genomics Assisted Toxicity Evaluation System (Open TG-GATEs)"
            },
            false,
            {
                "id": "T2",
                "type": "Creator",
                "start": 2019,
                "end": 2039,
                "name": "Igarashi et al. 2015"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 2042,
                "end": 2087,
                "name": "National Center for Biotechnology Information"
            },
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 2088,
                "end": 2111,
                "name": "Gene Expression Omnibus"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 2113,
                "end": 2117,
                "name": "NCIB"
            },
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 2118,
                "end": 2121,
                "name": "GEO"
            },
            false,
            {
                "id": "T7",
                "type": "URL",
                "start": 2123,
                "end": 2155,
                "name": "https://www.ncbi.nlm.nih.gov/geo"
            },
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 2165,
                "end": 2208,
                "name": "European Bioinformatics Institute (EMBL-EBI"
            },
            false,
            {
                "id": "T9",
                "type": "URL",
                "start": 2210,
                "end": 2231,
                "name": "https://www.ebi.ac.uk"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T4",
                "end": "T7"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T6",
                "end": "T7"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T8",
                "end": "T9"
            }
        ]
    },
    {
        "sen": [
            "Medication treatments were extracted from ",
            "TG-GATEs",
            " database using the high and middle concentrations."
        ],
        "lab": [
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 2286,
                "end": 2294,
                "name": "TG-GATEs"
            },
            false
        ],
        "rel": [
            {
                "id": "R4",
                "bool": true,
                "head": "T10",
                "end": "T11"
            }
        ]
    },
    {
        "sen": [
            "The data for chloroquine derivative medication were extracted from the ",
            "GSE30351",
            " dataset."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "AccessionNumber",
                "start": 2417,
                "end": 2425,
                "name": "GSE30351"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The rat in-invitro treatments were obtained from ",
            "DrugMatrix",
            " toxicogenomic database (",
            "GSE57805",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 2484,
                "end": 2494,
                "name": "DrugMatrix"
            },
            false,
            {
                "id": "T13",
                "type": "AccessionNumber",
                "start": 2519,
                "end": 2527,
                "name": "GSE57805"
            },
            false
        ],
        "rel": [
            {
                "id": "R5",
                "bool": true,
                "head": "T12",
                "end": "T13"
            }
        ]
    },
    {
        "sen": [
            "Emerging epidemiological studies brought the attentions towards liver injury and impairment as a potential outcome of COVID19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Understanding that may reflect how such medications may affect the level of infectivity and permissibility of the liver following COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using transcriptomic datasets, ",
            "Toxicogenomic Project-Genomics Assisted Toxicity Evaluation System (Open TG-GATEs)",
            " and ",
            "GSE30351",
            ", we have tested the ability of ninety common medications to regulate COVID-19 receptors expression in human primary hepatocytes."
        ],
        "lab": [
            false,
            {
                "id": "T14",
                "type": "Dataset",
                "start": 2828,
                "end": 2910,
                "name": "Toxicogenomic Project-Genomics Assisted Toxicity Evaluation System (Open TG-GATEs)"
            },
            false,
            {
                "id": "T15",
                "type": "AccessionNumber",
                "start": 2915,
                "end": 2923,
                "name": "GSE30351"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To confirm the observed effects on primary human hepatocytes, rat hepatocyte treatments data was obtained from ",
            "DrugMatrix",
            " toxicogenomic database (",
            "GSE57805",
            "), which showed a similar ACE2 and TMPRSS2 expression pattern."
        ],
        "lab": [
            false,
            {
                "id": "T16",
                "type": "Repository",
                "start": 3164,
                "end": 3174,
                "name": "DrugMatrix"
            },
            false,
            {
                "id": "T17",
                "type": "AccessionNumber",
                "start": 3199,
                "end": 3207,
                "name": "GSE57805"
            },
            false
        ],
        "rel": [
            {
                "id": "R6",
                "bool": true,
                "head": "T16",
                "end": "T17"
            }
        ]
    },
    {
        "sen": [
            "More research is needed to determine the effect of different medications on COVID-19 receptors."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since its emergence, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19, has become a global health threat."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of July 22, 2020, more than 15 million cases of COVID-19 have been documented worldwide, with nearly 618 000 deaths."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Guidelines from the UK and the USA recommend mask use for health-care workers caring for people with COVID-19.9, 10 However, global shortages of masks, respirators, face shields, and gowns, caused by surging demand and supply chain disruptions, have led to efforts to conserve PPE through extended use or reuse, and disinfection protocols have been developed, for which scientific consensus on best practice is scarce."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "11, 12, 13",
            "Although addressing the needs of front-line health-care workers during the COVID-19 pandemic is a high priority,6, 14 data to inform such efforts are scarce, and particularly so among Black, Asian, and minority ethnic communities."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, we did a prospective population-based study using data from a smartphone-based application (app) to investigate the risk of testing positive for COVID-19, the risk of developing symptoms associated with SARS-CoV-2 infection, or both, among individuals in the UK and the USA."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We did a prospective, observational cohort study using the COVID Symptom Study app."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our study was approved by the Partners Human Research Committee (protocol 2020P000909) and King's College London ethics committee (REMAS ID 18210, LRS-19/20-18210)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Information obtained through the COVID Symptom Study app has been described in detail."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Briefly, on first use, participants were asked to provide demographic factors and were questioned separately about a series of COVID-19 risk factors (appendix pp 4–8)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Participants were also asked if they had been tested for COVID-19 and the results (none, negative, pending, or positive)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our primary outcome was a report of a positive COVID-19 test."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Follow-up started when participants first reported on the COVID Symptom Study app and continued until a report of a positive COVID-19 test or the time of last data entry, whichever occurred first."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We used standard calculations to determine the minimum detectable hazard ratio (HR) for our primary categorical exposure (health-care worker status) and risk of reporting a positive COVID-19 test with 80% power."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Because our primary outcome (positive COVID-19 test) required a participant to receive a test, we did several prespecified secondary analyses."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "First, we tested a symptom-based classifier predictive of positive COVID-19 testing."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Briefly, using logistic regression and symptoms preceding testing, we have previously described that loss of smell or taste, fatigue, persistent cough, and loss of appetite predicted COVID-19 positivity with high specificity (appendix p 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To assess factors associated with PPE adequacy, work in especially high-risk clinical settings, or greater exposure to patients with COVID-19 (including a post-hoc analysis of race and ethnicity), we used multivariable logistic regression models to estimate adjusted odds ratios (ORs) and 95% CIs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Between March 24 and April 23, 2020, we enrolled 2 810 103 consecutive users of the COVID Symptom Study app to our study."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The prevalence of COVID-19 was 2747 cases per 100 000 front-line health-care workers compared with 242 cases per 100 000 people in the general community (figure",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "After excluding 670 298 participants with less than 24 h of follow-up and 4615 individuals who reported a positive COVID-19 test at baseline, we included 2 135 190 participants in our prospective inception cohort, of whom 99 795 (4·7%) identified as front-line health-care workers (appendix p 14)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on this cohort, we had 80% power to detect a minimum HR of 1·16 for risk of reporting a positive COVID-19 test between health-care workers and the general community."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We recorded 5545 incident reports of positive COVID-19 testing over 34 435 272 person-days."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In a prespecified secondary analysis, a validated model was used based on a combination of symptoms predictive of COVID-19 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Compared with the general community, health-care workers initially free of symptoms had an increased risk of predicted COVID-19 (adjusted HR 2·05, 95% CI 1·99–2·10), which was higher in the UK (2·09, 2·02–2·15) than in the USA (1·31, 1·14–1·51; pdifference<0·0001)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In a post-hoc analysis, compared with individuals in the general community from a non-Hispanic white ethnic background, the risk for a positive COVID-19 test was increased for individuals from Black, Asian, and minority ethnic backgrounds in the general community (adjusted HR 2·51, 95% CI 2·18–2·89), for Black, Asian, and minority ethnic health-care workers (21·88, 17·78–26·94), and for non-Hispanic white health-care workers (12·58, 11·42–13·86; table 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In post-hoc analyses, the association of race and health-care worker status with risk of COVID-19 was assessed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Black, Asian, and minority ethnic health-care workers had an increased risk of COVID-19 (adjusted HR 1·81, 95% CI 1·45–2·24) compared with non-Hispanic white health-care workers."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among front-line health-care workers, availability and use of PPE, COVID-19 patient exposures, and subsequent risk for testing positive were assessed in prespecified analyses."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Compared with health-care workers who reported adequate PPE, front-line health-care workers reporting PPE reuse had an increased risk of a positive COVID-19 test (adjusted HR 1·46, 95% CI 1·21–1·76), with inadequate PPE associated with a comparable increase in risk after multivariable adjustment (1·31, 1·10–1·56; table 3",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In a prespecified secondary analysis, front-line health-care workers with inadequate PPE caring for patients with documented COVID-19 had an increased risk for COVID-19 after multivariable adjustment (adjusted HR 5·91, 95% CI 4·53–7·71) compared with those with adequate PPE not caring for patients with suspected or documented COVID-19 (table 3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Risk for front-line health-care workers reusing PPE and exposed to patients with documented COVID-19 was also increased (adjusted HR 5·06, 95% CI 3·90–6·57)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Notably, even among front-line health-care workers reporting adequate PPE, the risk for COVID-19 was increased for those caring for patients with suspected COVID-19 (adjusted HR 2·39, 95% CI 1·90–3·00) and for those caring for patients with documented COVID-19 (4·83, 3·99–5·85), compared with health-care workers who did not care for either group (table 3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In a post-hoc analysis, differences were noted in PPE adequacy according to race and ethnicity, with non-white health-care workers more frequently reporting reuse of or inadequate access to PPE, even after adjusting for exposure to patients with COVID-19 (adjusted OR 1·49, 95% CI 1·36–1·63; table 4",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In a prespecified secondary analysis, risk of COVID-19 by practice location was assessed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In a post-hoc analysis, compared with non-Hispanic white health-care workers, Black, Asian, and minority ethnic health-care workers were more likely to work in higher risk clinical settings, including inpatient hospital or nursing homes (adjusted OR 1·13, 95% CI 1·03–1·23) and to care for patients with suspected or documented COVID-19 (1·20, 1·09–1·30)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our findings could help provide greater context for previous cross-sectional reports from public health authorities suggesting 10–20% of SARS-CoV-2 infections occur among health-care workers.6, 7 Our results offer individual-level data additionally accounting for workplace risk factors that complement these limited reports by providing a more precise assessment of the magnitude of increased risk among health-care workers during the initial phases of the COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Taken in the context of the requirement for testing to establish a COVID-19 diagnosis, our range of results based on either reporting a positive test for COVID-19 or symptoms predictive of COVID-19 offer several complementary estimates for risk among front-line health-care workers."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also provide evidence that sufficient availability of PPE, quality of PPE, or both reduce the risk of COVID-19, but reuse of PPE or inadequate PPE might confer comparably increased risk, which is compatible with findings from one of the first studies to specifically investigate PPE reuse."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, even with adequate PPE, health-care workers who cared for patients with COVID-19 remained at increased risk, highlighting the importance of not only ensuring PPE quality and availability but also other aspects of appropriate use, including correct application and removal of PPE and clinical situation (practice location)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, health-care workers were at greater risk of developing symptoms predictive of eventual COVID-19, which does not reflect access to testing."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Second, we obtained information from participants who did not have a positive COVID-19 test, which offered an opportunity to prospectively assess risk factors with minimal recall bias."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, we gathered information on a wide range of known or suspected risk factors for COVID-19 generally not available in existing registries or population-scale surveillance efforts."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our primary outcome was based on the report of a positive COVID-19 test."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Background  Data for front-line health-care workers and risk of COVID-19 are limited."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We sought to assess risk of COVID-19 among front-line health-care workers compared with the general community and the effect of personal protective equipment (PPE) on risk."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We did a prospective, observational cohort study in the UK and the USA of the general community, including front-line health-care workers, using self-reported data from the COVID Symptom Study smartphone application (app) from March 24 (UK) and March 29 (USA) to April 23, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Participants were voluntary users of the app and at first use provided information on demographic factors (including age, sex, race or ethnic background, height and weight, and occupation) and medical history, and subsequently reported any COVID-19 symptoms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We used Cox proportional hazards modelling to estimate multivariate-adjusted hazard ratios (HRs) of our primary outcome, which was a positive COVID-19 test."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID Symptom Study app is registered with ClinicalTrials.gov , ",
            "NCT04331509",
            " ."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "AccessionNumber",
                "start": 10185,
                "end": 10196,
                "name": "NCT04331509"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Findings  Among 2 035 395 community individuals and 99 795 front-line health-care workers, we recorded 5545 incident reports of a positive COVID-19 test over 34 435 272 person-days."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Compared with the general community, front-line health-care workers were at increased risk for reporting a positive COVID-19 test (adjusted HR 11·61, 95% CI 10·93–12·33)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To account for differences in testing frequency between front-line health-care workers and the general community and possible selection bias, an inverse probability-weighted model was used to adjust for the likelihood of receiving a COVID-19 test (adjusted HR 3·40, 95% CI 3·37–3·43)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the UK and the USA, risk of reporting a positive test for COVID-19 was increased among front-line health-care workers."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Health-care systems should ensure adequate availability of PPE and develop additional strategies to protect health-care workers from COVID-19, particularly those from Black, Asian, and minority ethnic backgrounds."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 is the respiratory illness caused by the SARS-CoV-2 virus that is currently affecting millions of people worldwide and putting extraordinary pressure on public health systems everywhere."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This process is vital for the entry of SARS-CoV-2 into human host cells, and thus it plays an integral role in COVID-19 infection and disease progression."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 also has a strong immunological component, where poor outcomes have recently been associated with cytokine storms and a hyperinflammatory immune system [6]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Case studies of COVID-19 patients show that previous and current smokers experience more severe infections than non-severe infections [7]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since ACE2 is also an immunomodulator, its dysregulation could be essential for COVID-19 outcomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Cigarette smoke has been associated with an increased susceptibility to COVID-19 [15], although the mechanism for this is unclear."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This paper aims to investigate the expression of TMPRSS2, ACE2, and related genes in smokers and determine if the link between smoking and these genes could help explain smokers’ apparent increased vulnerability to COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "TMPRSS2 expression was correlated to the enrichment of ARRB2, CDK6, ID2, and EP300, as shown in Figure 4B."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of the core enriched genes with the most interactions with other core enriched genes in androgen pathways, ARRB2, CDK6, and ID2 were all upregulated in smokers."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 pandemic is marked by a wide range of clinical disease courses, ranging from asymptomatic to deadly."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There have been many studies seeking to explore the correlations between COVID-19 clinical outcomes and various clinical variables, including age, sex, race, underlying medical problems, and social habits."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In particular, the relationship between smoking and COVID-19 outcome is controversial, with multiple conflicting reports in the current literature."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These data provide a potential model for the increased susceptibility of smoking patients to COVID-19 and encourage further exploration into the androgen and tobacco upregulation of ACE2 to understand the potential clinical ramifications."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For instance, as different countries review and test archived specimens from cases of severe pneumonia or influenza-like illness for SARS-CoV-2, it is expected that additional cases may be identified, such as in France where a patient without travel history to China was identified to have COVID-19 in late December concurrent with the initial reported cases from Wuhan."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The trimeric and monomeric structures of the Spike protein were generated using Illustrate (https://ccsb.scripps.edu/illustrate/) by rendering a protein structure from the ",
            "Protein Data Bank",
            " with ID ",
            "6vsb",
            " (",
            "https://www.rcsb.org/structure/6vsb",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 543,
                "end": 560,
                "name": "Protein Data Bank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 569,
                "end": 573,
                "name": "6vsb"
            },
            false,
            {
                "id": "T3",
                "type": "URL",
                "start": 575,
                "end": 610,
                "name": "https://www.rcsb.org/structure/6vsb"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T1",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "The COVID-19 pandemic, caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), was declared on March 11, 2020 by the World Health Organization."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of the 31st of May, 2020, there have been more than 6 million COVID-19 cases diagnosed worldwide and over 370,000 deaths, according to Johns Hopkins."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The genomic sequence of SARS-CoV-2 isolated from the bronchoalveolar lavage fluid of a patient from Wuhan, China showed a length of 29,903 nucleotides [",
            "GenBank",
            " accession number ",
            "NC_045512",
            "]",
            "BepiPred 1.0 Linear Epitope Prediction module incorporated in ",
            "Immune Epitope Database (IEDB)",
            " was used to predict potential epitopes within the S protein (Haste Andersen et al., 2006; Larsen et al., 2006; Ponomarenko and Bourne, 2007; Vita et al., 2019)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 152,
                "end": 159,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 177,
                "end": 186,
                "name": "NC_045512"
            },
            false,
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 250,
                "end": 280,
                "name": "Immune Epitope Database (IEDB)"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "The S glycoprotein sequence is 1273 amino acids long, except for that of the virus isolated from Kerala (India), which is a 1272 amino acid long S glycoprotein (",
            "GenBank",
            " accession number ",
            "MT012098",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 603,
                "end": 610,
                "name": "GenBank"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 628,
                "end": 636,
                "name": "MT012098"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T4",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "The potential epitope regions were predicted using the sequence of the S protein of SARS-CoV-2 that showed the least variability (",
            "GenBank",
            " accession number ",
            "NC_045512",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 769,
                "end": 776,
                "name": "GenBank"
            },
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 794,
                "end": 803,
                "name": "NC_045512"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T6",
                "end": "T7"
            }
        ]
    },
    {
        "sen": [
            "Also, identified T-cell epitopes might be considered for incorporation in vaccine designs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Does remdesivir provide a benefit on clinical status for patients hospitalized with moderate coronavirus disease 2019 (COVID-19) pneumonia?",
            "In this randomized, open-label, phase 3 trial that included 584 patients with moderate COVID-19, the day 11 clinical status distribution measured on a 7-point ordinal scale was significantly better for those randomized to a 5-day course of remdesivir (median length of treatment, 5 days) compared with those randomized to standard care."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Meaning  Hospitalized patients with moderate COVID-19 randomized to a 5-day course of remdesivir had a statistically significantly better clinical status compared with those randomized to standard care at 11 days after initiation of treatment, but the difference was of uncertain clinical importance."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Importance  Remdesivir demonstrated clinical benefit in a placebo-controlled trial in patients with severe coronavirus disease 2019 (COVID-19), but its effect in patients with moderate disease is unknown."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Design, Setting, and Participants  Randomized, open-label trial of hospitalized patients with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and moderate COVID-19 pneumonia (pulmonary infiltrates and room-air oxygen saturation >94%) enrolled from March 15 through April 18, 2020, at 105 hospitals in the United States, Europe, and Asia."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Conclusions and Relevance  Among patients with moderate COVID-19, those randomized to a 10-day course of remdesivir did not have a statistically significant difference in clinical status compared with standard care at 11 days after initiation of treatment."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of 26 March 2020, 72 genes of SARS‐CoV‐2 strains obtained from humans have been collected on ",
            "GISAID",
            " (",
            "http://gisaid.org/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 96,
                "end": 102,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 104,
                "end": 122,
                "name": "http://gisaid.org/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "To eliminate the recombination in the dataset, we used splitstreev4.15.1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to the Bayesian information criterion (BIC) method implemented in the jModelTest v2.1.10 software,",
            ", ",
            " the most suitable nucleotide substitution model for this genomic data set is HKY +",
            "To set the time scale prior for the dataset, we used a constrained evolution rate with a Log‐normal prior averaged at 10−3 by substitution per site per year."
        ],
        "lab": [
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For the SARS‐CoV‐2 genomic dataset from the three geographic locations (Shanghai, Italy, and Spain) the most suitable model was HKY + 4 according to the BIC method."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Phylogenetic analyzes of the SARS‐CoV‐2 dataset, using the Bayesian multi‐type birth‐death model and molecular clock calibration, showed an estimate of the rate of evolution of whole genome sequences SARS‐CoV‐2 at 2.11 × 10−3 substitutions per site per year (95% highest posterior density [HPD]: 1.56 × 10−3 to 3.89 × 10−3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To do this, we reported the phylodynamic and phylogeographic results, proposing the implementation of molecular modeling based on the multi‐type birth‐death model implemented in Beast2, using heterochromatic genomic data retrieved from the ",
            "GISAID",
            " repository."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 1283,
                "end": 1289,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A tree of maximum credibility was constructed using the 72 entire genome sequences of this virus, from the three countries (China, Italy, and Spain) available as of 26 March 2020 on the ",
            "GISAID",
            " reference frame."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 1488,
                "end": 1494,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of June 18, 2020, over 8.4 million cases and 450,000 deaths resulting from infection by a novel SARS coronavirus, SARS-CoV-2 (also termed Coronavirus Disease 2019 or COVID-19), have now been confirmed worldwide; furthermore, there have been more than 2.2 million confirmed cases and over 110,000 deaths due to the COVID-19 pandemic in the USA alone [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Morbidity and mortality due to COVID-19 rise dramatically with age and co-existing health conditions, including cancer and cardiovascular diseases, and while most infected individuals recover, even very young and otherwise healthy patients may unpredictably succumb to this disease [3]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These observations beg the question of how much of the variation in COVID-19 disease severity may be explained by genetic susceptibility."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Development of new preventive and/or therapeutic strategies for COVID-19 will be greatly facilitated by systematic identification of host genetic pathways and DNA polymorphisms (variants) which modulate the risk of infection and severe illness, including the overexuberant immune response to the virus that often portends a poor outcome."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Not only has the COVID-19 pandemic had huge health and economic impacts in 188 countries/regions across the world, but the disease has also struck in different racial/ethnic subpopulations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Clinical studies have reported that incidence and mortality rates are significantly different between male and female COVID-19 patients, and the disease is associated with pre-existing conditions, such as cancer and cardiovascular disorders, in particular individuals with hypertension receiving anti-hypertensive medications [8]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, a systematic investigation of the functional polymorphisms in ACE2 and TMPRSS2 among different populations could pave the way for precision medicine and personalized treatment strategies for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we investigated genetic susceptibility to COVID-19 by examining DNA polymorphisms in ACE2 (OMIM 300335) and TMPRSS2 (OMIM 602060) genes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We assembled a total of 437 non-synonymous single-nucleotide variants (SNVs) in the protein-coding regions of ACE2 and TMPRSS2 (Fig. 1a) from three databases: (i) ",
            "Genome Aggregation Database (gnomAD",
            " v3: ",
            "gnomad.broadinstitute.org",
            ", covering 9 geographical areas), (ii) ",
            "Exome Sequencing Project (ESP",
            ": ",
            "evs.gs.washington.edu/EVS/",
            "), and (iii) ",
            "1000 Genomes Project (1KGP",
            ", ",
            "www.internationalgenome.org",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 2159,
                "end": 2194,
                "name": "Genome Aggregation Database (gnomAD"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 2199,
                "end": 2224,
                "name": "gnomad.broadinstitute.org"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 2263,
                "end": 2292,
                "name": "Exome Sequencing Project (ESP"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 2294,
                "end": 2320,
                "name": "evs.gs.washington.edu/EVS/"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 2333,
                "end": 2359,
                "name": "1000 Genomes Project (1KGP"
            },
            false,
            {
                "id": "T6",
                "type": "URL",
                "start": 2361,
                "end": 2388,
                "name": "www.internationalgenome.org"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "We further inspected the expression quantitative trait loci (eQTL) for ACE2 using the ",
            "GTEx",
            " [13] and ",
            "QTLbase",
            " [14] databases."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Dataset",
                "start": 2477,
                "end": 2481,
                "name": "GTEx"
            },
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 2491,
                "end": 2498,
                "name": "QTLbase"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We found 6 germline deleterious variants (p.Val160Met, p.Gly181Arg, p.Arg240Cys, p.Gly259Ser, p.Pro335Leu, and p.Gly432Ala) in the TMPRSS2 coding region, which are also identified as somatic mutations occurring in different cancer types from ",
            "TCGA",
            " and ",
            "COSMIC",
            " databases (",
            "https://cancer.sanger.ac.uk/cosmic",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 2757,
                "end": 2761,
                "name": "TCGA"
            },
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 2766,
                "end": 2772,
                "name": "COSMIC"
            },
            false,
            {
                "id": "T11",
                "type": "URL",
                "start": 2784,
                "end": 2818,
                "name": "https://cancer.sanger.ac.uk/cosmic"
            },
            false
        ],
        "rel": [
            {
                "id": "R4",
                "bool": true,
                "head": "T10",
                "end": "T11"
            }
        ]
    },
    {
        "sen": [
            "We further evaluated the eQTL profile of TMPRSS2 using the ",
            "GTEx",
            " [13] and ",
            "QTLbase",
            " databases [14] as well."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "Dataset",
                "start": 2880,
                "end": 2884,
                "name": "GTEx"
            },
            false,
            {
                "id": "T13",
                "type": "Repository",
                "start": 2894,
                "end": 2901,
                "name": "QTLbase"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We found two eQTLs associated with TMPRSS2 non-synonymous SNPs (rs12329760 (encoding p.Val160Met), p = 4.54 × 10−5; rs75603675, p = 0.009) in the kidney and bone, respectively, using the ",
            "QTLbase",
            " database [14], while there are no known eQTLs associated with TMPRSS2 non-synonymous SNPs from ",
            "GTEx",
            " [13]."
        ],
        "lab": [
            false,
            {
                "id": "T14",
                "type": "Repository",
                "start": 3113,
                "end": 3120,
                "name": "QTLbase"
            },
            false,
            {
                "id": "T15",
                "type": "Dataset",
                "start": 3216,
                "end": 3220,
                "name": "GTEx"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These unique but prevalent polymorphisms in TMPRSS2 offer potential explanations for differential genetic susceptibility to COVID-19 as well as for risk factors, including those with cancer and the high-risk group of male patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Because TMPRSS2 is located on 21q22.3, we could speculate that individuals with Down syndrome would be at high risk for COVID-19 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, oncogenic roles of TMPRSS2 may be linked to poor outcomes with COVID-19 as well [16], which should be studied in the future."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This observation suggests that developmental regulation of TMPRSS2 may link the relative protection of infants and children from COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There are currently no approved effective medications against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Several national and international research groups are working on the development of vaccines to prevent COVID-19, but effective vaccines not likely to be available for many months."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Several potentially repurposable drugs (Fig. 2c), including melatonin [19], hydroxychloroquine, and chloroquine, are under investigation for treatment of COVID-19 [20]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, further pharmacogenomic studies that integrate drug response and genetic data from patients with COVID-19 are urgently needed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Current analysis examined massive genomic data from general population, not COVID-19 patient-specific populations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All genetic associations identified in current study are urgently needed to be tested in COVID-19 patients in the near future."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We anticipate that large-scale genome-wide association studies (GWAS) are urgently needed to identify likely causal host genetic risk factors for severe COVID-19 outcomes using genetic data from patients with COVID-19; such knowledge will improve risk stratification of individuals exposed to or testing positive for SARS-CoV-2 and allow for precision medicine interventions for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A COVID-19 host genetics initiative is already underway to bring together the human genetics research community to generate, share, and analyze data in a search for the genetic determinants of COVID-19 susceptibility, severity, and outcomes [27]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first COVID-19 GWAS identified the 3p21.31 gene cluster (including SLC6A20, LZTFL1, CCR9, FYCO1, CXCR6, and XCR1) as a genetic susceptibility locus in severe patients with COVID-19 and respiratory failure [28]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Yet, our study aims to look for SNPs associated with disease severity of COVID-19, but not disease susceptibility."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In summary, systematic identification of the genetic determinants of COVID-19 susceptibility, severity, and clinical outcome, including both virus and host factors (e.g., ACE2 and TMPRSS2 polymorphisms), could guide personalized treatment in the emerging COVID-19 pandemic and even explain current epidemiologic observations (i.e., males, elderly at high risk, and clinical comorbidities) and natural history."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Background  Coronavirus Disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has now been confirmed worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Yet, COVID-19 is strangely and tragically selective."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Morbidity and mortality due to COVID19 rise dramatically with age and co-existing health conditions, including cancer and cardiovascular diseases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, we investigated genetic susceptibility to COVID-19 by examining DNA polymorphisms in ACE2 and TMPRSS2 (two key host factors of SARS-CoV-2) from ~ 81,000 human genomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Unique but prevalent polymorphisms (including p.Val160Met (rs12329760), an expression quantitative trait locus (eQTL)) in TMPRSS2 , offer potential explanations for differential genetic susceptibility to COVID-19 as well as for risk factors, including those with cancer and the high-risk group of male patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We further discussed that polymorphisms in ACE2 or TMPRSS2 could guide effective treatments (i.e., hydroxychloroquine and camostat) for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This study suggested that ACE2 or TMPRSS2 DNA polymorphisms were likely associated with genetic susceptibility of COVID-19, which calls for a human genetics initiative for fighting the COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All population genetic data used in this study are free and available at three databases: (i) ",
            "Genome Aggregation Database (gnomAD",
            " v3: ",
            "gnomad.broadinstitute.org",
            ", covering 9 geographical areas), (ii) ",
            "Exome Sequencing Project (ESP",
            ": ",
            "evs.gs.washington.edu/EVS/",
            "), and (iii) ",
            "1000 Genomes Project (1KGP",
            ", ",
            "www.internationalgenome.org",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T16",
                "type": "Repository",
                "start": 7351,
                "end": 7386,
                "name": "Genome Aggregation Database (gnomAD"
            },
            false,
            {
                "id": "T17",
                "type": "URL",
                "start": 7391,
                "end": 7416,
                "name": "gnomad.broadinstitute.org"
            },
            false,
            {
                "id": "T18",
                "type": "Repository",
                "start": 7455,
                "end": 7484,
                "name": "Exome Sequencing Project (ESP"
            },
            false,
            {
                "id": "T19",
                "type": "URL",
                "start": 7486,
                "end": 7512,
                "name": "evs.gs.washington.edu/EVS/"
            },
            false,
            {
                "id": "T20",
                "type": "Repository",
                "start": 7525,
                "end": 7551,
                "name": "1000 Genomes Project (1KGP"
            },
            false,
            {
                "id": "T21",
                "type": "URL",
                "start": 7553,
                "end": 7580,
                "name": "www.internationalgenome.org"
            },
            false
        ],
        "rel": [
            {
                "id": "R5",
                "bool": true,
                "head": "T16",
                "end": "T17"
            },
            {
                "id": "R6",
                "bool": true,
                "head": "T18",
                "end": "T19"
            },
            {
                "id": "R7",
                "bool": true,
                "head": "T20",
                "end": "T21"
            }
        ]
    },
    {
        "sen": [
            "With respect to the origin of this COVID-19 pandemic, of further interest is the fact that the S protein has a specific FCS that is absent in coronaviruses of the same clade as SARS-CoV-2 [8,[14], [15], [16]]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the midst of this COVID-19 pandemic, FCS is reportedly linked to a natural-selection, instead of purposeful-manipulation, −based hypothesis of the origin of this COVID-19 outbreak [9,[17], [18], [19], [20], [21]]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Regardless of this COVID-19-origin hypothesis [9], to date (Thu Jun 25 09:39:392020), it still remains not clear what the actual structural consequence is of the polybasic FCS's insertion into the S protein of SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In fact, however, the structural search led to a Cryo-EM structure (",
            "PDB",
            " ID: ",
            "6VSB",
            ") with a range of EUTs [24], representing the three-dimensional structure of the prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up [1]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 717,
                "end": 720,
                "name": "PDB"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 725,
                "end": 729,
                "name": "6VSB"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "From an amino acid sequence alignment (Fig. 1.2 in supplementary file supplement.pdf), it is obvious that those EUTs are widely scattered throughout the homotrimeric structure (",
            "PDB",
            " ID ",
            "6VSB",
            ") [1]."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 1072,
                "end": 1075,
                "name": "PDB"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 1079,
                "end": 1083,
                "name": "6VSB"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "Yet, with another amino acid sequence alignment (Fig. 1.1 in supplementary file supplement.pdf), it was revealed that the sequence similarity between the Cryo-EM structure (",
            "PDB",
            " ID ",
            "6VSB",
            ") and ",
            "QHD43416.1",
            " is as high as 99.26%, making ",
            "PDB",
            " ID ",
            "6VSB",
            " rather suitable to be used as a structural template for the subsequent homology structural modelling of the S protein of the SARS-CoV-2."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 1263,
                "end": 1266,
                "name": "PDB"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 1270,
                "end": 1274,
                "name": "6VSB"
            },
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 1280,
                "end": 1290,
                "name": "QHD43416.1"
            },
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 1320,
                "end": 1323,
                "name": "PDB"
            },
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 1327,
                "end": 1331,
                "name": "6VSB"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T8",
                "end": "T9"
            }
        ]
    },
    {
        "sen": [
            "Therefore, the Cryo-EM ",
            "PDB",
            " ID ",
            "6VSB",
            " structure was used as the template by the SwissModel [23] homology modelling server to build a structural model with as less EUTs [24] as possible of the S protein of SARS-CoV-2."
        ],
        "lab": [
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 1492,
                "end": 1495,
                "name": "PDB"
            },
            false,
            {
                "id": "T11",
                "type": "AccessionNumber",
                "start": 1499,
                "end": 1503,
                "name": "6VSB"
            },
            false
        ],
        "rel": [
            {
                "id": "R5",
                "bool": true,
                "head": "T10",
                "end": "T11"
            }
        ]
    },
    {
        "sen": [
            "With SwissModel [23] and UCSF Chimera [25], a homology homotrimeric structural model (supplementary file model.pdb) of the spike protein of SARS-CoV-2 was built with only two EUTs (Fig. 1.3 in supplementary file supplement.pdf) [24], one at its N-terminal and another at its C-terminal, as compared (Fig. 1.2 in supplementary file supplement.pdf) with the widely scattered EUTs [24] inside its Cryo-EM structural template ",
            "PDB",
            " ID ",
            "6VSB",
            " [1]."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 2105,
                "end": 2108,
                "name": "PDB"
            },
            false,
            {
                "id": "T13",
                "type": "AccessionNumber",
                "start": 2112,
                "end": 2116,
                "name": "6VSB"
            },
            false
        ],
        "rel": [
            {
                "id": "R6",
                "bool": true,
                "head": "T12",
                "end": "T13"
            }
        ]
    },
    {
        "sen": [
            "In this figure, the three (A, B and C) chains of the spike protein of SARS-CoV-2 is shown as green, cyan and purple cartoons, the residue naming scheme is Chain ID, residue name, residue number, the four salt bridges are shown here with four dotted yellow lines, with the lengths of the four inter-chain salt bridges being 2.6, 2.6, 3.3 and 3.5 Å, respectively."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Incorporating currently available structural data (as of Thu Jun 25 09:39:402020) of the S protein [22], and in the hope of pushing a little bit forward the boundary of our scientific knowledge on COVID-19, this short article presents a comprehensive structural characterization of the FCS inserted into the S protein of SARS-CoV-2, and puts forward a set of structural analysis as below,",
            "the polybasic FCS is spatially located at a random coil loop region, mostly distantly solvent-exposed (Fig. 1, instead of deeply buried), with no structural proximity to the other part of the S protein of SARS-CoV-2."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "the S1 and S2 subunits of the S protein will still be strongly bonded together, at least electrostatically [31] from a structural and biophysical point of view, even if the FCS is actually cleaved by furin protease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nevertheless, in the midst of this COVID-19 pandemic [32] with more than 5.5 million (as of Thu Jun 25 09:39:402020) confirmed cases globally, this short article puts forward a set of analysis that the net structural consequence of FCS here is the insertion of a furin cleavage site into the S protein of SARS-CoV-2, and is thus of only limited structural biophysical relevance here."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The coronavirus disease 2019 (COVID-19) pandemic, and our knowledge about the virus, has exponentially grown since media reports of a cluster of acute respiratory infections in Wuhan, Hubei Province, China, were first reported in December 2019 [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The demanding pace and large volume of COVID-19 science generated in the last 3 months, however, has made timely scientific communication through the conventional route of published biomedical journals at best challenging, and at worst obsolete."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We propose that Twitter has played a fundamental—but often precarious—role in permitting real-time global communication between scientists during the COVID-19 epidemic, on a scale not seen before."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This discussion also serves as a succinct primer on some of the pivotal epidemiological analyses (and their communication) during the early phases of the COVID-19 outbreak, as seen through the lens of a Twitter feed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similarly, concerns of malignant misinformation about COVID-19 deliberately spread through this medium are beyond the scope of this commentary [8]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As with other outbreaks, early estimation of epidemic parameters during the first month of the COVID-19 epidemic has been critical to predict the epidemic trajectory and inform decision making."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Indeed, such open-source line-list data remain more comprehensive than what is currently published by some other countries now experiencing major COVID-19 epidemics."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Accurate approximation and interpretation of the COVID-19 case-fatality ratio (CFR) has been critical for resource planning and risk messaging."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These discussion points were vital to frame any early comparisons of COVID-19 morbidity and mortality with that of seasonal or pandemic influenza [33–35]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is important to acknowledge, however, the continued importance of rigorously peer-reviewed journal publications of COVID-19 clinical and epidemiological characteristics, especially when accompanied by expert editorials, and particularly given the exponential rise of preprint publications, which may vary in quality [36]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Twitter has and continues to serve as a valuable medium to discuss the caveats and future directions in applying infectious disease models in COVID-19 decision making [41–44]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Still, Twitter remains the double-edged sword of rapid scientific communication during the ongoing COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The human and social toll of the coronavirus disease 2019 (COVID-19) pandemic has already spurred several major public health “lessons learned,” and the theme of effective and responsible scientific communication is among them."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We propose that Twitter has played a fundamental—but often precarious—role in permitting real-time global communication between scientists during the COVID-19 epidemic, on a scale not seen before."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This discussion also serves as a succinct primer on some of the pivotal epidemiological analyses (and their communication) during the early phases of the COVID-19 outbreak, as seen through the lens of a Twitter feed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Twitter remains the double-edged sword of rapid scientific communication during the ongoing COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of 19 January 2020, 13 genome sequences of 2019‐nCoV have been released on ",
            "GISAID",
            " (",
            "http://gisaid.org/",
            ") and one strain (virus name: BetaCoV/Wuhan‐Hu‐1/2019; accession ID: ",
            "EPI_ISL_402125",
            ") has been released on ",
            "GenBank",
            " (",
            "https://www.ncbi.nlm.nih.gov/nuccore/MN908947",
            ") by the ",
            "Shanghai Public Health Clinical Center & School of Public Health",
            ", Fudan University, Shanghai, China."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 78,
                "end": 84,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 86,
                "end": 104,
                "name": "http://gisaid.org/"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 173,
                "end": 187,
                "name": "EPI_ISL_402125"
            },
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 210,
                "end": 217,
                "name": "GenBank"
            },
            false,
            {
                "id": "T5",
                "type": "URL",
                "start": 219,
                "end": 264,
                "name": "https://www.ncbi.nlm.nih.gov/nuccore/MN908947"
            },
            false,
            {
                "id": "T6",
                "type": "Creator",
                "start": 273,
                "end": 337,
                "name": "Shanghai Public Health Clinical Center & School of Public Health"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T1",
                "end": "T3"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T4",
                "end": "T5"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T4",
                "end": "T7"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T6",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "In this study, we used the latest version (",
            "MN908947.3",
            "), and therefore the genome sequence of strain BetaCoV/Wuhan‐Hu‐1/2019 from ",
            "GISAID",
            " (",
            "EPI_ISL_402125",
            ") was excluded."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 417,
                "end": 427,
                "name": "MN908947.3"
            },
            false,
            {
                "id": "T8",
                "type": "Dataset",
                "start": 503,
                "end": 509,
                "name": "GISAID"
            },
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 511,
                "end": 525,
                "name": "EPI_ISL_402125"
            },
            false
        ],
        "rel": [
            {
                "id": "R6",
                "bool": true,
                "head": "T8",
                "end": "T9"
            }
        ]
    },
    {
        "sen": [
            "The final dataset included 12 genome sequences of 2019‐nCoV with known sampling date and city (10 from individuals in Wuhan, Hubei Province, China, with samples collected between 24 and 30 December 2019, and two from Chinese individuals in Bangkok, Thailand, who had recently traveled from Wuhan, with samples collected between 8 and 13 January 2020) (Table S1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For this dataset, the 2019‐nCoV genome sequences were aligned using MAFFT v7.222",
            " and then manually curated using BioEdit v7.2.5."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To study the amount of evolutionary information contained in the dataset, likelihood‐mapping analysis",
            " was performed using TREE‐PUZZLE v5.3,",
            " with 30 000 randomly chosen quartets for the entire tree."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As no temporal signal was present in the dataset, we employed HKY+G, as well as a constant size coalescent tree prior and strict molecular clock model assuming an evolutionary rate of 4.59 × 10−4 substitutions per site per year to estimate the time to most recent common ancestor (TMRCA) for this dataset based on previous genetic analysis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To perform ancestral reconstruction of the unobserved sampling locations (k = 2), discrete phylogeographic analyses",
            " were performed using the empirical tree distributions generated for our 2019‐nCoV dataset."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Bayesian analysis was run using BEAST v1.8.4",
            " and BEAGLE library v2.1.2",
            " for an MCMC chain of 100 million iterations, with 10 000 samples of all parameters and 10 000 trees for our dataset."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For this dataset, our likelihood‐mapping analysis revealed a strong star‐like topology signal (Figure 1), indicating very limited genetic diversity for 2019‐nCoV as of now."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also used an assumed evolutionary rate range (95% Bayesian credible interval: 1.178 × 10−4 to 3 × 10−3 substitutions per site per year) for this dataset based on previous studies,",
            ", ",
            ", ",
            " and estimated that the TMRCA for 2019‐nCoV was 3 September 2019 (95% Bayesian credible interval: 25 March 2019 and 20 December 2019)."
        ],
        "lab": [
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The outbreak of SARS-CoV-2 (the cause of the disease known as COVID-19) was first reported in Wuhan city (Hubei province), China, in December 2019, and swept across the nation and then around the world within 2 months, leading to its declaration as a pandemic by the World Health Organisation (WHO) on 11 March 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of 20 May 2020, the worldwide COVID-19 death toll has reached 318 789, and nearly 5 million confirmed cases have been reported across all continents [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Several studies using mathematical modeling of COVID-19 and other coronavirus transmission have suggested that measures such as social distancing and city lockdown may be effective methods of disease control [5,6], but these seldom assess individual transmission chains."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This is seen in the SARS-CoV-2 dataset used by ",
            "Lu et al.",
            " [7], which has relatively few genomes from outside Guangdong province (e.g., only 32 genomes from Hubei province, which had >60000 cases at the time)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Creator",
                "start": 792,
                "end": 801,
                "name": "Lu et al."
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Notably, the SARS-CoV-2 genome dataset publicly available at time of writing remains highly uneven across different countries."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For instance, the ",
            "GISAID (Global Initiative on Sharing All Influenza Data",
            "; ",
            "https://www.gisaid.org",
            ") database had only five full genome sequences from Iran where >120000 cases have been reported; by contrast, it has ~1300 genomes from ~7000 cases reported in Australia."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 1098,
                "end": 1153,
                "name": "GISAID (Global Initiative on Sharing All Influenza Data"
            },
            false,
            {
                "id": "T3",
                "type": "URL",
                "start": 1155,
                "end": 1177,
                "name": "https://www.gisaid.org"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "The transmission and progression of this disease (COVID-19) imply that a great number of infected individuals will need hospitalization and possibly admission to intensive care units [2, 3]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On May 11, over 168,000 individuals in Brazil had a confirmed COVID-19 infection and around 11,500 had died from the disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The management of early breast cancer (EBC), a disease with well-established treatment protocols [6–8], also had to be adjusted in order to free up hospital beds and vital hospital supplies for individuals infected by COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This online survey aimed to evaluate how Brazilian breast specialists have managed EBC (stage I/II and clinically negative axilla) following publication of emergency treatment protocols [12–14, 23, 24], at the beginning and during the COVID-19 pandemic, according to EBC subtypes [26] and oncoplastic surgery."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The results were stratified by degree of priority in accordance with the COVID-19 Pandemic Breast Cancer Consortium: Priority A patients have a condition that is immediately life threatening and for whom a delay would alter prognosis, while Priority B patients are those who do not have an immediately life threatening condition, but for whom treatment should not be delayed until the end of the pandemic, and Priority C patients are those for whom treatment could be deferred [13]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, there is no statistically significant difference when the southeastern and northeastern regions, those most affected by COVID-19 in Brazil, are evaluated together (p = 0.746) (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Overall, 498 respondents (99%) lived/worked in a city/town with confirmed cases of COVID-19 and 258 (51.3%) reported that there were COVID-free medical establishments in their cities."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Being board-certified, having COVID-free hospitals available and working in an academic institute associated with cancer treatment had no significant effect either at the beginning or during the pandemic (Table 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The availability of hospital supplies and beds is greater in the southeast of the country where the concentration of COVID-19 cases is greater."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In agreement with the ",
            "SBM",
            " database, most respondents live in state capitals or in cities with more than 500,000 inhabitants, which are also those most affected by COVID-19 [34]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 2098,
                "end": 2101,
                "name": "SBM"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The onset of the COVID-19 epidemic in Brazil occurred relatively late compared to Europe and North America."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The demographic characteristics most associated with a change in management at the beginning of the pandemic were living in the southeast of the country and in a state capital city, coinciding with the areas in which the incidence of COVID-19 infection was greatest, with an increasing demand for hospital beds and the implementation of restrictive measures by the government."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On the other hand, during the pandemic, various state capital cities made an effort to reserve COVID-free hospitals or wards so as to guarantee the admission of elective patients, particularly cancer patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to the advice provided in the Ontario Health Pandemic Planning Clinical Guideline for Patients with Cancer [37], cases of luminal tumors were classified as Priority B, while the COVID-19 Pandemic Breast Cancer Consortium stratified such tumors as Priority B3 (T2 or N1) or C1 (T1N0) [13]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Indeed, 67% of respondents considered that chemotherapy increases the risk of developing COVID-19-related complications."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 pandemic has impacted early breast cancer (EBC) treatment worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) across the globe has led to an outbreak of life-threatening respiratory disease, termed COVID-19 (Zhou et al., 2020; Zhu et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While adults have suffered the highest rates of morbidity and mortality of COVID-19, children were thought to be spared (Dong et al., 2020; Ludvigsson, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The concentration of this disease to regions of high local SARS-CoV-2 transmission but, with an onset weeks after the peak COVID-19 caseload, suggests MIS-C is a secondary consequence of SARS-CoV-2 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To estimate the average time between initial infection and MIS-C onset, we determined the temporal delay between peak COVID-19 and MIS-C admissions at our institution."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We performed high-dimensional cytokine profiling of 92 analytes using the Olink platform to define the secreted immune response in MIS-C patient plasma and compared it with plasma from age-matched healthy controls, a pediatric patient treated with IVIG with an unrelated infection (urinary tract infection [UTI]), and cases of active pediatric and young adult COVID-19 infection that did not develop MIS-C."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As otherwise healthy children rarely experience clinically apparent COVID-19 infections, we used samples from children with immunocompromising comorbidities (Pediatric COVID 1 and 3–6, details in Table S2) and one otherwise-healthy child (Pediatric COVID 2) who did experience acute COVID-19 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While some of these MIS-C cytokine signatures resembled that of acute or convalescent SARS-CoV-2 infection, a unique MIS-C cytokine profile could be distinguished from that of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To more finely characterize the cytokine profile differences between MIS-C patients and pediatric COVID-19 patients, we conducted PCA analysis restricted to pediatric patients (Figure S3",
            "A)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "PC1 loading analysis identified components that separated the healthy pediatric controls from all disease patients, while PC2 resolved the profiles of pediatric COVID-19 and MIS-C (Figure 2H)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Elevations in unique chemokines (CXCL5, CXCL11, CXCL1, and CXCL6) and cytokines (including IL-17A, CD40, and IL-6) appear to distinguish MIS-C patients from pediatric COVID-19 patients (Figure S3B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "High-Throughput Cytokine Analysis of Pediatric Patient Samples, Related to Figure 2",
            "Next, we performed CyTOF (Cytometry by Time-Of-Flight)-based immunophenotyping on nine MIS-C patients, five age-matched healthy controls, and seven young adults with acute COVID-19 infection."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These findings suggest that no active peripheral B or T expansion was underway at the time of sampling and distinguish MIS-C from acute COVID-19 for which an active bias toward effector populations was readily observed (Figures 3C and 3D)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among innate cells, CD56lo NK cells were also decreased in MIS-C but not in acute COVID-19 peripheral blood (Figure 3E), while non-classical monocytes and pDCs (plasmacytoid DC) frequencies were lower in both groups (Figure 3F)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This antibody response demonstrated typical IgG class switching, absence of circulating IgM but elevated IgA, and effective virus neutralization, resembling, but not identical to, serologies from convalescent COVID-19 adults."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Clinical criteria detailed in Table S1 were used to recruit and classify samples as MIS-C or pediatric COVID."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Demographic and clinical data of recruited MIS-C patients and pediatric COVID patients are detailed in Tables 1 and S2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Samples related to young adults were obtained from the Mount Sinai Health System’s COVID-19 Biobank."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Under the age of 35, found to be SARS-COV-2 positive by PCR test and classified with severe/moderate COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Diluted plasma was then incubated in a 1:1 volumetric ratio with SARS-CoV-2 virus (USA-WA1/2020; ",
            "GenBank",
            ": ",
            "MT020880",
            ") at a concentration of 100 TCID50 (50% tissue culture infectious dose) in 1 × MEM for 1 h at room temperature."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 3742,
                "end": 3749,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 3751,
                "end": 3759,
                "name": "MT020880"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "Serology assays assessing plasma reactivity against SARS-CoV-2 spike protein were perfomed on samples from healthy patients (pediatric: N = 4, adults: N = 7), patients hospitalized for active COVID-19 (pediatric: N = 1, young adult: N = 4; adult: N = 3), convalescent COVID-19 patients (young adult: N = 2, adult: N = 6), active MIS-C patients (N = 9) and convalescent (recovered) MIS-C patients (N = 2; MIS-C 4 and MIS-C 7)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Samples for mass cytometry analyses were performed on samples from age-matched healthy controls (n = 5), acute COVID infection in young adults (n = 7) and MIS-C patients (n = 9)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There is obvious interest in gaining insights into the epidemiology and evolution of the virus that has recently emerged in humans as the cause of the coronavirus disease 2019 (COVID-19) pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This is particularly true for the work of Forster et al., since their findings are based on a nonrepresentative dataset of 160 genomes, with no significant correlation between prevalence of confirmed cases and number of sequenced strains per country (7, 8)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The essential role of representative sampling is well documented in the literature (9), but was not acknowledged by the authors, who, instead, claim that their “network faithfully traces routes of infections for documented [COVID-19] cases,” without taking into consideration missing viral diversity, or evaluating multiple transmission hypotheses that would be consistent with sequence data, or even providing any support on the robustness of the branching pattern in their network."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Vero cells were inoculated with equivalent virus titres, and supernatants were collected every 12 h for 120 h and titrated by TCID50."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Peak titre of full-length viruses ranged from 105 to 106 TCID50 ml−1, whereas deletion mutants ranged from 5×104−1×105 TCID50 ml−1 (Fig. 2a), suggesting that these deletions may confer some growth inhibition, but not abrogate it."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hu/Riyadh_KSA_2959_2015 cell-associated titre peaked at 5×106 TCID50 ml−1 with supernatant peaking at 5×104 TCID50 ml−1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similarly, Hu/Riyadh_KSA-4050_2015 cell-associated titre peaked at 1×106 TCID50 ml−1 with supernatant peaking at 5×104 TCID50 ml−1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus is of particular concern for people with rheumatic disease or those who are immunosuppressed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In general, immunosuppression and the presence of comorbidities are associated with an increased risk of serious infection in people with rheumatic diseases1 therefore, people with rheumatic disease may be at higher risk for a more severe course with COVID-19, including hospitalisation, complications and death."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Importantly, some medications used to treat rheumatic diseases, such as hydroxychloroquine and interleukin-6 (IL-6) inhibitors, are being studied for the prevention and/or treatment of COVID-19 and its complications including cytokine-storm."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At present, the implications of COVID-19 for people living with rheumatic diseases remain poorly understood."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To address this knowledge gap, a global network of rheumatologists, scientists and patients developed a physician-reported case registry of people with rheumatic diseases diagnosed with COVID-19.5 6",
            "This report aims to (1) describe the demographic and clinical characteristics of the first 600 patients submitted to the ",
            "COVID-19 Global Rheumatology Alliance (C19-GRA)",
            " physician registry and (2) identify factors associated with hospitalisation for COVID-19 in this population."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1181,
                "end": 1228,
                "name": "COVID-19 Global Rheumatology Alliance (C19-GRA)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "5–7 Briefly, ",
            "C19-GRA",
            " data regarding individuals with rheumatic diseases diagnosed with COVID-19 are captured from rheumatology physicians via two parallel international data entry portals for regulatory reasons: one limited to European countries (",
            "eular.org/eular_covid19_database.cfm",
            "; hosted by The University of Manchester, UK) and a second for all other sites (",
            "rheum-covid.org/provider-global/",
            "; hosted by the University of California, San Francisco, California, USA)."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 1351,
                "end": 1358,
                "name": "C19-GRA"
            },
            false,
            {
                "id": "T3",
                "type": "URL",
                "start": 1585,
                "end": 1621,
                "name": "eular.org/eular_covid19_database.cfm"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 1701,
                "end": 1733,
                "name": "rheum-covid.org/provider-global/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T2",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "COVID-19 diagnoses were predominately made through PCR testing (437, 73%), followed by laboratory assay of unknown type (58, 10%), CT scan (42, 7%) or other (31, 5%) (individuals could be tested using more than one method)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The median number of days from COVID-19 symptom onset to resolution or death was 13 (IQR: 8–17)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "NSAID use was reported less frequently among hospitalised patients than non-hospitalised patients (16% vs 25%, p=0.02), while there was a higher proportion of patients receiving high doses of glucocorticoids among those who were hospitalised than not hospitalised (16% vs 7% for doses ≥10 mg/day, p=0.01)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Treatment with b/tsDMARD monotherapy just prior to COVID-19 diagnosis was significantly associated with a lower odds of hospitalisation compared with no DMARD therapy (OR=0.46, 95% CI 0.22 to 0.93; p=0.03)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We found no significant association between antimalarial therapy and hospitalisation (OR=0.94, 95% CI 0.57 to 1.57; p=0.82) after adjusting for sex, age over 65 years, rheumatic disease, smoking status, comorbidities, other csDMARD monotherapy, b/tsDMARD monotherapy, csDMARD-b/tsDMARD combination therapy (excluding antimalarials), NSAID use and glucocorticoid dose."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A significant inverse association between any anti-TNF therapy and hospitalisation was found (OR=0.40, 95% CI 0.19 to 0.81; p=0.01), after controlling for sex, age over 65 years, rheumatic disease, smoking, comorbidities, csDMARD monotherapy, other b/tsDMARD monotherapy, csDMARD-b/tsDMARD combination therapy (excluding anti-TNF), NSAID use and glucocorticoid dose."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Prior to this report, there had been several small case series of COVID-19 in patients with rheumatic disease reported from Europe."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With few exceptions,12 13 prior large descriptive studies of patients with COVID-19 from China, Europe and the USA have not included rheumatic disease in their baseline comorbidities."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These studies have not allowed for further inference on the characteristics of patients with rheumatic disease and their associations with COVID-19 severity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In accordance with previous studies of COVID-19 in different populations, we found that patients with comorbidities such as hypertension, cardiovascular disease and diabetes had higher odds of hospitalisation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The use of hydroxychloroquine for the treatment of COVID-19, which was based on in vitro studies, has had mixed results."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "23 24 Two randomised controlled trials of hydroxychloroquine had conflicting findings.25 26 A phase IIb randomised controlled trial comparing two doses of chloroquine among patients hospitalised with COVID-19 with historical controls from Wuhan detected a negative safety signal—QTc prolongation—but no clinical benefit."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also did not detect a significant association between NSAID use and hospitalisation in adjusted analyses."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although no prior data in patients with COVID-19 have supported a deleterious effect of NSAIDs on clinical outcomes, early reports cautioned against the use of NSAIDs suggesting harm when used during the clinical course of COVID-19.30",
            "These observations, while anecdotal, may also relate to confounding by indication, since NSAIDs are also often sold over-the-counter and may not be documented in hospital records with the same accuracy as prescription medications, leading to a reporting bias."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although we caution against causal inference regarding drug effects given significant potential for residual confounding in our study, we also note that there is biological plausibility for the potential benefit of biologic medications in treating COVID-19, as evidenced by those with more severe disease having higher levels of cytokines, including IL-6 and TNF.31 32 The use of IL-6 inhibitors is being investigated for COVID-19, particularly in cases complicated by aberrant inflammatory responses or ‘cytokine storm’."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "33 34 Anti-TNFs have also been suggested as a potential therapy in COVID-19, but this has been based solely on preclinical data.35 Randomised, placebo-controlled trials are needed to clarify potential benefits or harms of biologic therapies in treating COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Strengths of our study include the first large analysis of patients with rheumatic diseases and COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The registry collects information on specific rheumatic disease diagnoses, which to date have not been captured in large, published case series of COVID-19.15",
            "This series of cases demonstrates that the majority of patients with rheumatic diseases captured in our registry recover from COVID-19."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Results support the guidance issued by the American College of Rheumatology and the European League Against Rheumatism, which suggest continuing rheumatic medications in the absence of COVID-19 infection or SARS-CoV-2 exposure.36 37",
            "Objectives  COVID-19 outcomes in people with rheumatic diseases remain poorly understood."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The aim was to examine demographic and clinical factors associated with COVID-19 hospitalisation status in people with rheumatic disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Methods  Case series of individuals with rheumatic disease and COVID-19 from the ",
            "COVID-19 Global Rheumatology Alliance",
            " registry: 24 March 2020 to 20 April 2020."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 6835,
                "end": 6872,
                "name": "COVID-19 Global Rheumatology Alliance"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Non-steroidal anti-inflammatory drug (NSAID) use was not associated with hospitalisation status (OR 0.64, 95% CI 0.39 to 1.06)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Neither exposure to DMARDs nor NSAIDs were associated with increased odds of hospitalisation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thecoronavirus disease-19 (COVID-19) caused by SARS-CoV-2 infection can lead to a series of clinical settings from non-symptomatic viral carriers/spreaders to severe illness characterized by acute respiratory distress syndrome (ARDS)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "1, 2, 3 A sizable part of patients with COVID-19 have mild/moderate clinical symptoms at the early stage of infection, but the disease progression may become quite rapid in the later stage with ARDS as the common manifestation and followed by critical multiple organ failure, causing a high mortality rate of 7-10% in the elderly population with non-communicable chronic disease (NCD). [1,2,4]",
            "The pathological evidences in the lung of fatal cases are fundamental for the mechanistic understanding and treatment of severe patients with COVID-19."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, we investigated the critical pathological changes in the lung of severe COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We hope this work may contribute in a significant way to the understanding of the mechanisms underlying the phenotype of severe cases in COVID-19 and appropriate development of treatment strategies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The two deceased COVID-19 patients, with the diagnosis confirmed by reverse transcriptase-polymerase chain reaction (RT-PCR) for SARS-CoV-2, were a 53 years old female (Patient No 1) and a 62 years old male (Patient No 2) (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The pathological investigations of severe patients are pivotal for the understanding of pathogenesis of COVID-19 and assessment of clinical treatments."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Special attention was given to the abnormalities in lungs, which are the main damaged organ in severe COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is one of common manifestations in the diffuse alveolar damage (DAD) that existed in acute respiratory distress syndrome (ARDS) not only in COVID19 but also in SARS and MERS."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "9, 10, 11, 12, 13 Though the endothelial injury and thrombosis were not common in our cases, resent studied showed the high incidence of thromboembolic events in segmental/subsegmental pulmonary arterial vessels [14], pulmonary embolism and deep venous thrombosis [15], and microvascular thrombosis [16], suggested coagulopathy in severe COVID-19 infection patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, the pathology of lungs in COVID-19 also exhibited unique features as compared to SARS."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In COVID-19, we found mucous plugs in all respiratory tracts, terminal bronchioles and pulmonary alveoli, which was not described in SARS."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Another unique feature of COVID-19 was the excessive mucus secretion with serous and fibrinous exudation, which could aggravate the dysfunction of ventilation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, the pathogenic mechanisms responsible for the hypoxemia could be somehow different between COVID-19 and SARS patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We assumed these lesions could play a part in the sputum suction failure in very severe COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, the differences between COVID-19 and SARS could be found at the level of immune cell involvement."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the case of COVID-19, the viral infection of aggregated alveolar macrophages was obvious from early phase to the late stage, according to our study and the results in recent reports of pulmonary pathology [17,20]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The spectacular infiltration and activation of alveolar macrophages in COVID-19 might represent the shift of classically activated phenotype (M1) to alternatively activated phenotype (M2) of these cells, whereas this shift, particularly in the case of antibody-dependent enhancement (ADE), could contribute to the inflammatory injuries and fibrosis of respiratory tracts. [21]",
            "Recently, the Tocilizumab therapy was recommended in the Guideline of Diagnosis and Treatment of COVID-19 (version 7) by the National Health Commission in China to control the CRS."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While potential benefits of this treatment still require definite evidence, our pathological findings tend to support the clinical practice of the anti-IL-6/IL-6R antibody treatment among severe COVID-19 patients in order to inhibit the vicious cycle of alveolar macrophage activation and inflammatory injuries."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On the other hand, the use of anti-viral effect of convalescent plasma from recovered patients has been shown to be effective in the treatment of severe cases of COVID-19. [24]",
            "The novel coronavirus pneumonia COVID-19 caused by SARS-CoV-2 infection could lead to a serious of clinical symptoms and severe illness, including acute respiratory distress syndrome (ARDS) and fatal organ failure."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We report the fundamental pathological investigation in the lungs and other organs of fatal cases for the mechanistic understanding of severe COVID-19 and the development of specific therapy in these cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The autopsy and pathological investigations of specimens were performed on bodies of two deceased cases with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to the mean expression of ACE2, the mucosa of oral cavity could express ACE2, and the results were validated by the data of normal tissues from the ",
            "FANTOM5 CAGE",
            " dataset (Fig. 1b)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 158,
                "end": 170,
                "name": "FANTOM5 CAGE"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To investigate the potential route of 2019-nCov infection on the mucosa of oral cavity, bulk RNA-seq profiles from two public databases including ",
            "The Cancer Genome Atlas (TCGA)",
            " and ",
            "Functional Annotation of The Mammalian Genome Cap Analysis of Gene Expression (FANTOM5 CAGE)",
            " dataset were collected."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 336,
                "end": 366,
                "name": "The Cancer Genome Atlas (TCGA)"
            },
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 371,
                "end": 463,
                "name": "Functional Annotation of The Mammalian Genome Cap Analysis of Gene Expression (FANTOM5 CAGE)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A case-patient in the Riyadh region who reported no high-risk exposures had a 66-nt in-frame deletion in ORF1a (Figure; ",
            "GenBank",
            " accession no. ",
            "MK462255",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 120,
                "end": 127,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 142,
                "end": 150,
                "name": "MK462255"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "An accurate grasp of COVID-19 situation is considered highly important."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The website we launched provides graphs of COVID-19 cases and deaths per one million population over time including trajectory analysis, and one can easily grasp the COVID-19 trend and adequately compare the situation between countries through this interactive graph system."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Importantly, data suggest that the severity and mortality risk of nosocomial transmission may be greater than for community-acquired COVID-19 (McMichael et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Protection of HCWs and their families from the acquisition of COVID-19 in hospitals is paramount, and underscored by rising numbers of HCW deaths nationally and internationally (Cook et al., 2020; CDC COVID-19 Response Team, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The clinical presentation of COVID-19 can include minimal or no symptoms (WHO, 2020a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Asymptomatic or pre-symptomatic transmission is clearly reported and is estimated to account for around half of all cases of COVID-19 (He et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recent modelling has suggested that weekly testing of asymptomatic HCWs could reduce onward transmission by 16–23%, on top of isolation based on symptoms, provided results are available within 24 hr (Imperial College COVID-19 Response Team, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The need for widespread adoption of an expanded screening programme for asymptomatic, as well as symptomatic HCWs, is apparent (Imperial College COVID-19 Response Team, 2020; Black et al., 2020; Gandhi et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "21 individuals underwent repeat testing for a variety of reasons, including evolving symptoms (n = 3) and scoring ‘medium’ probability on clinical COVID-19 criteria (Tables 1–2) (n = 11)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Table 3 outlines the total number of SARS-CoV-2 tests performed in each screening group (HCW asymptomatic, HCW symptomatic, and HCW symptomatic household contact) categorised according to the ward with the highest anticipated risk of exposure to COVID-19 (‘red’, high; ‘amber’, medium; ‘green’, low; Tables 4–5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Each individual in the HCW asymptomatic screening group was contacted by telephone to establish a clinical history, and COVID-19 probability criteria (Table 1) were retrospectively applied to categorise any symptoms in the month prior to testing (Figure 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Individuals captured by the HCW asymptomatic screening group were generally asymptomatic at the time of screening, however could be divided into three sub-groups: (i) HCWs with no symptoms at all, (ii) HCWs with (chiefly low-to-medium COVID-19 probability) symptoms commencing ≤7 days prior to screening and (iii) HCWs with (typically high COVID-19 probability) symptoms commencing >7 days prior to screening (Figure 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Wards are coloured (‘green’, ‘amber’, ‘red’) according to risk of anticipated exposure to COVID-19 (Table 4)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Ward F is an elderly care ward, designated as a ‘green’ area with Scenario 0 PPE (Tables 4–5), with a high proportion of COVID-19 vulnerable patients due to age and comorbidity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It was subsequently found that two further staff members from ward F had previously been admitted to hospital with severe COVID-19 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Ward Q is a general medical ward designated as a ‘red’ clinical area for the care of COVID-19 positive patients, with a Scenario 1 PPE protocol (Tables 4–5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The majority of individuals who tested positive for SARS-CoV-2 after screening due to the presence of symptoms had high COVID-19 probability (Table 7)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Whilst temporally associated, it cannot be assumed that these symptoms necessarily resulted from COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "12/30 (40%) individuals from the HCW asymptomatic screening group reported symptoms > 7 days prior to testing, and the majority experiencing symptoms consistent with a high probability of COVID-19 had appropriately self-isolated during that period."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patients with COVID-19 can remain SARS-CoV-2 PCR positive for a median of 20 days (IQR 17–24) after symptom onset (Zhou et al., 2020), and the limited data available suggest viable virus is not shed beyond eight days (Wölfel et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This approach was based on the following: low seasonal incidence of alternative viral causes of high COVID-19 probability symptoms in the UK (Public Health England, 2018), the high potential for SARS-CoV-2 exposure during the pandemic and the potential for prolonged, non-infectious shedding of viral RNA (Zhou et al., 2020; Wölfel et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "More comprehensive data will parametrise workforce depletion and COVID-19 transmission models."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The incorporation of additional information including staffing levels, absenteeism, and changes in proportions of staff self-isolating before and after the introduction of widespread testing will better inform the impact of screening at a national and international level."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Such models will be critical for optimising the impact on occupationally-acquired COVID-19, and reducing the likelihood that hospitals become hubs for sustained COVID-19 transmission."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first (HCW symptomatic, and HCW symptomatic household contact screening groups) allowed any patient-facing or non-patient-facing hospital employee (HCW) to refer themselves or a household contact, including children, should they develop symptoms suggestive of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "High throughput clinical areas where staff might be exposed to large numbers of suspected COVID-19 patients were also prioritised for staff screening."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These included the Emergency Department, the COVID-19 Assessment Unit, and a number of ‘red’ inpatient wards."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We devised a scoring system to determine the clinical probability of COVID-19 based on symptoms from existing literature (Wang et al., 2020; Giacomelli et al., 2020; Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Self-isolation and household quarantine advice was determined by estimating the pre-test probability of COVID-19 (high, medium or low) in those with symptoms, based on the presence or absence of typical features (Tables 1–2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Pauci-symptomatic individuals were defined as those with low-probability clinical COVID-19 criteria (Table 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Samples were sequenced as part of the COVID-19 Genomics UK Consortium, COG-UK), a partnership of NHS organisations, academic institutions, UK public health agencies and the Wellcome Sanger Institute."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "12/30 (40%) had experienced symptoms compatible with coronavirus disease 2019 (COVID-19)>7 days prior to testing, most self-isolating, returning well."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "eLife digest  Patients admitted to NHS hospitals are now routinely screened for SARS-CoV-2 (the virus that causes COVID-19), and isolated from other patients if necessary."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Over 1,000 staff members at a large UK hospital who felt they were well enough to work, and did not fit the government criteria for COVID-19 infection, were tested."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On closer questioning, around one in five reported no symptoms, two in five very mild symptoms that they had dismissed as inconsequential, and a further two in five reported COVID-19 symptoms that had stopped more than a week previously."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In parallel, healthcare workers with symptoms of COVID-19 (and their household contacts) who were self-isolating were also tested, in order to allow those without the virus to quickly return to work and bolster a stretched workforce."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, the rates of infection were examined to probe how the virus could have spread through the hospital and among staff – and in particular, to understand whether rates of infection were greater among staff working in areas devoted to COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Despite wearing appropriate personal protective equipment, healthcare workers in these areas were almost three times more likely to test positive than those working in areas without COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The main phase and that is more pathologically relevant to COVID‐19 is, however, the delayed pneumonia which itself could vary depending on the disease severity level (Li et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Inhibiting TMPRSS2 could exert a dual effect on COVID‐19, that of limiting viral entry by reducing the cleavage of the spike protein in ACE2 receptor mediated viral entry as shown by Hoffmann et al. (2020) and that of inhibiting NF‐kB pathway leading to a weaker pro‐inflammatory response with less severe lung pathology as shown by Iwata‐Yoshikawa et al. (2019) on SARS and MERS‐CoV, with celastrol likely mediating both mechanisms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Even though application of antiinflammatory agents in COVID‐19 may be debatable or one should say highly dependent on the disease stage, a trial of compounds like celastrol with promising effect in a variety of related lung diseases is highly encouraged."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover recent studies have shown that smokers have lower risk of contracting COVID-19, and one explanation could be the interference between the nicotine which downregulates the ACE2 receptor."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As no approved therapeutics exists to treat COVID-19, the disease associated to SARS-Cov-2, there is an urgent need to propose molecules that could quickly enter into clinics."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19, caused by SARS-CoV-2, was first reported in several cases with unexplained pneumonia from Wuhan, China, in late December 2019."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of Feb 24, 2020, a total of 77,262 COVID-19 cases have been confirmed in mainland China with 2595 deaths, and 2069 cases outside China with 23 deaths (WHO, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The nucleocapsid protein gene (N gene) of SARS-CoV-2 downloaded from the ",
            "Global Initiative on Sharing All Influenza Data (GISAID)",
            " was chosen as the target region."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 376,
                "end": 432,
                "name": "Global Initiative on Sharing All Influenza Data (GISAID)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Only the extracts from SARS-CoV-2 strain and COVID-19 patient's samples showed positive reactions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The current outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in China firstly."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of eight variants of hACE2 that map to the interaction surface are described in the ",
            "gnomAD",
            " database (Fig. 4",
            "A)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 92,
                "end": 98,
                "name": "gnomAD"
            },
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The spread of COVID-19 caused by the SARS-CoV-2 outbreak has been growing since its first identification in December 2019."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By calculating the binding energy score between RBD and ACE2, we highlighted the putative jump in the affinity from a progenitor form of SARS-CoV-2 to the current virus responsible for COVID-19 outbreak."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There are no known medicines or vaccines to control the COVID-19 pandemic caused by SARS-CoV-2 (nCoV)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Antiviral peptides are superior to conventional drugs and may also be effective against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Second, peptides from five antibacterial peptide databases that block nCoV-RBD are identified; finally, a chimeric peptide design approach is used to design peptides that can bind to key nCoV-RBD residues."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We found that: (i) three amino acid stretches in hACE2 interact with nCoV-RBD; (ii) effective peptides must bind to three key positions of nCoV-RBD (Gly485/Phe486/Asn487, Gln493, and Gln498/Thr500/Asn501); (iii) Phe486, Gln493, and Asn501 are critical residues; (iv) AC20 and AC23 derived from hACE2 may block two key critical positions; (iv) DBP6 identified from databases can block the three sites of the nCoV-RBD and interacts with one critical position, Gln498; (v) seven chimeric peptides were considered promising, among which cnCoVP-3, cnCoVP-4, and cnCoVP-7 are the top three; and (vi) cnCoVP-4 meets all the criteria and is the best peptide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Results  Using RNA extracted from cells infected by SARS coronavirus as a positive control, these assays were shown to have a dynamic range of at least seven orders of magnitude (2x10 −4 -2000 TCID 50 /reaction)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to the study reporting kidney injury cases, direct effect of virus was suspected (Wang et al., 2020), and Academician Nanshan, Zhong, leader of high‐level steering team dealing with outbreak of COVID‐19 in China, declared that virus of COVID‐19, SARS‐Cov‐2, was separated from patients’ urine sample (Le, Knoedler, & Roberge, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, based on public databases, single‐cell RNA sequencing (scRNA‐seq) technology was used to obtain evidences of potential route of SARS‐Cov‐2 entry and underlying pathogenesis of kidney injury in COVID‐19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Significantly top 200 ACE2 co‐expressed genes (p value <0.05) were collected for following downstream Gene Ontology (GO) as well as Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis (p value <0.05), with the corresponding databases of Carlson M (2019)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although the exact evidence for kidney injury caused by COVID‐19 has not been estimated, several infected patients’ studies revealed the potential risk of kidney vulnerable to be damaged due to SARS‐Cov‐2 virus direct effect."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hypothesis of virus direct effect resulting in kidney damage was suspected within the abovementioned case‐studies and, more importantly, based on our study results of scRNA‐seq in human kidney, potential route for COVID‐19 leading kidney damage via ACE2 was estimated."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "From our GO & KEGG analysis, RAS was a significant pathway in ACE2 co‐expressed gene enrichment, which might indicate one of the potential mechanisms of COVID‐19 damage to kidney."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To the best of our knowledge, no specific medication could be used to against COVID‐19 but symptomatic treatment would be the predominant strategy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Occurrence of AKI is the most frequent renal‐related complication in COVID‐19 patients, which increases the risk factor for mortality."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recombinant ACE2 was reported to be effective in slowing the progression of kidney disease by reducing albumin excretion and modulating RAS depressor arm (AT2R, ACE2, Ang 1–7) by ACE2 activator or AT2R agonist might protect the kidney from renal injury (Oudit et al., 2010; Sharma, Malek, Mulay, & Gaikwad, 2019), which may provide potential clues for clinicians encountering COVID‐19 patients, especially complicated with kidney injury."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, the abovementioned mechanism of kidney injury in COVID‐19 infection should be verified in experiment under precise experimental design."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Several organs are vulnerable to COVID‐19 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Acute kidney injury (AKI) was reported in parts of case‐studies reporting characteristics of COVID‐19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Method  Single‐cell RNA sequencing (scRNA‐seq) technology was used to obtain evidence of potential route and ACE2 expressing cell in renal system for underlying pathogenesis of kidney injury caused by COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "From Gene Ontology (GO) & KEGG enrichment analysis, imbalance of ACE2 expression, renin‐angiotensin system (RAS) activation, and neutrophil‐related processes were the main issue of COVID‐19 leading kidney injury."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Several organs are vulnerable to potential infection of COVID‐19 except lung, such as liver, digestive system, reproductive system and urinary system, and SARS‐CoV‐2 was separated from patients’ urine."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Consequently, we hypothesized that COVID‐19 might invade human kidney causing renal injury, and this is the first study investigating the potential route of COVID‐19 leading kidney injury."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is the cause of the respiratory disease coronavirus disease 2019 (COVID-19) has resulted in tens of thousands of deaths globally since it was first identified in Wuhan, China, at the end of 2019 (1, 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Clinical manifestations of COVID-19 range from mild symptoms to severe illness and even death."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Viral RNA is detectable not only from respiratory specimens but also in the urine, serum, and stool using reverse transcription-PCR (RT-PCR), and viral RNA has been detected in COVID-19 patients for more than 30 days (8–13)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To clarify the correlation between the culturability of the virus from clinical specimens and the RNA copy number, in the present study, we investigated the culturability of a total of 60 specimens from 50 laboratory-confirmed COVID-19 patients that were collected from 25 January to the end of March 2020 in Taiwan."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As a reference laboratory of the Taiwan Centers for Disease Control (CDC; https://www.cdc.gov.tw/En/), we have been performing viral diagnosis for suspected COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Specimens of suspected COVID-19 cases collected by border control systems and different hospitals around Taipei county are routinely sent to our clinical virology laboratory."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 cDNA was prepared using RNA extracted from the specimens of the first patient with confirmed COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Detection of SARS-CoV-2 by RT-PCR remains the gold standard test for confirming COVID-19, and two negative tests at least 24 h apart in a clinically recovered patient are one of the important criteria for hospital discharge as recommended by the World Health Organization (22)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A previous study indicated that 6 log10 genome copies/ml sample might be required for virus isolation based on analysis of a series of specimens from patients hospitalized for COVID-19, and no virus could be isolated from specimens collected after day 8 of illness irrespective of the high viral loads (9)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Real-time reverse transcription-PCR (RT-PCR) is currently the most sensitive method to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "ABSTRACT  Real-time reverse transcription-PCR (RT-PCR) is currently the most sensitive method to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Most COVID-19 studies have focused on its epidemiological and clinical characteristics (Ghinai et al., 2020, Guan et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "They usually recover with, or even without, conventional medical treatment and therefore are classified as mild or moderate COVID-19 (Thevarajan et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These molecular changes may shed light on therapy development for COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To test this hypothesis, we applied proteomic (Aebersold and Mann, 2016, Li et al., 2020) and metabolomic (Hou et al., 2020, Lee et al., 2019) technologies to analyze the proteome and metabolome of sera from COVID-19 patients and several control groups."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We procured a cohort of patients (Zheng et al., 2020) containing 28 severe COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These controls were 28 healthy subjects, 25 non-COVID-19 patients (negative for the SARS-CoV-2 nucleic acid test) with similar clinical characteristics as COVID-19 patients, and 25 non-severe COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We analyzed 12 clinical measurements of the COVID-19 and non-COVID-19 patients (Figure S1",
            "), including white blood cell count, lymphocyte count, monocyte count, platelet count, C-reactive protein (CRP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), glutamyltransferase (GGT), total bilirubin (TBIL), direct bilirubin (DBIL), creatinine, and glucose."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "(A) Summary of COVID-19 patients, including non-severe (n = 37) and severe (n = 28) patients with more details in Table S1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Twelve Clinical Parameters of COVID-19 Patients and Non-COVID-19 Patients, Related to Figure 1",
            "We next investigated the possibility of identifying the severe cases from COVID-19 patients based on the molecular signatures of proteins and metabolites (Table S3)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This model reached an area under curve (AUC) of 0.957 in the training set (Figure 2C)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To further validate this classifier, we developed targeted mass spectrometric assays for the 22 proteins and 7 metabolites (Figure 2A) and analyzed these 29 molecules in a second test cohort containing 19 COVID-19 patients (Figure 1; Table 1; Tables S1 and S5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We found that 105 proteins were differentially expressed in the sera of COVID-19 patients but not the non-COVID-19 patients (Figures S3",
            "and S4",
            ")."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It was found that 373 metabolites were significantly changed in COVID-19 patients (Figure S4B), whereas the change of 204 metabolites was correlated with disease severity as evaluated by mFuzz (Figure S5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Differentially Expressed Proteins and Metabolites in Different Patient Groups in the Training Cohort, Related to Figure 4 and 5",
            "Proteins and Metabolites Regulated in COVID-19 Patients but Not in Non-COVID-19 Patients, Related to Figure 4 and 5",
            "Identification of Specific Clusters of Proteins and Metabolites in COVID-19 Patients, Related to Figure 4 and 5",
            "Pathway Analysis of 93 Differentially Expressed Proteins in COVID-19 Patients, Related to Figure 4 and 5",
            "Our data uncovered dysregulation of multiple apolipoproteins including APOA1, APOA2, APOH, APOL1, APOD, and APOM (Figure 3A)."
        ],
        "lab": [
            false,
            false,
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Decrease of APOA1 in serum has been reported during the transition of COVID-19 patients from mild to severe illness (Nie et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The APOM in sera of severe patients was downregulated compared with healthy and non-severe COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Accumulation of 11 steroid hormones in COVID-19 patients may contribute to macrophage modulation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Metabolites of kynurenate, kynurenine, and 8-methoxykynurenate were enriched in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our data showed decreased sphingolipids in both non-severe and severe COVID-19 patients (Figure 4",
            "A)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our data suggest severe COVID-19 patients might benefit from this therapeutic strategy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Choline and its derivatives were downregulated in COVID-19 patients (Figure 4B), particularly in severe cases, while phosphocholine, the intermediate product for producing phosphatidylcholine (PC) was upregulated (Figure 4A)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among the most significantly upregulated proteins in the sera of the severe COVID-19 patients are APPs, including serum amyloid A-1 (SAA1), serum amyloid A-2 (SAA2), serum amyloid A-4 (SAA4), CRP, alpha-1-antichymotrypsin (SERPINA3), and serum amyloid P-component (SAP/APCS) (Figure 3B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although CRP has been associated with COVID-19, the other proteins have not previously been reported in COVID-19 (Liang et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Low platelet count is also reported to be associated with severe COVID-19 and mortality (Lippi et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In a proteomic investigation of sera in SARS patients, decreasing PF4 was found to be associated with poor prognosis (Poon et al., 2012), which is in consistent with our findings in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Serotonin level decreases as the severity of COVID-19 increases (Figure 4B) and so does the platelet count (Zheng et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Compared with the healthy group, serotonin in non-severe and severe COVID-19 patients decreased by 2.07-fold (p = 1.86e-04) and 3.31-fold (p = 9.07e-07), respectively."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Compared with the healthy controls, more than 100 metabolites, amino acids and their derivatives, in the sera of COVID-19 patients were significantly decreased, whereas their levels were either unchanged or even increased in the sera of non-COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, some arginine derivatives such as argininate, asymmetric dimethylarginine, symmetric dimethylarginine, homoarginine, and N-acetylarginine were also significantly decreased in the sera of non-severe COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although COVID-19 can be diagnosed effectively by nucleic-acid-based methods at an early stage, it is equally critical to identify severe COVID-19 patients before the manifestation of severe symptoms to minimize mortality."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We achieved an overall accuracy of 93.5% in the training set (C1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this training set (C1), five severe patients were correctly identified based on the analysis of their serum samples collected 1 to 4 days before they were clinically diagnosed as severe patients (Figure 1), suggesting that their serum protein and metabolite signatures at the sampling time may already point to further deterioration into severe state even when severe clinical symptoms have not started to appear yet."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The proteins and metabolites used in our classifier (Figure 2A) contain several known biomarkers for viral infections, such as SAA2, SAA1, and CRP, which have already been used empirically to monitor the severity of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our data suggest potential benefits of broader testing of these proteins in newly diagnosed cases to identify which COVID-19 patients are likely to progress to severe disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our data shed light on the molecular changes reflected in COVID-19 sera, which could potentially yield critical diagnostic markers or therapeutic targets for managing severe COVID-19 patients (Figure 5",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A recent necropsy report revealed alveolar macrophage infiltration and activation in severe COVID-19 patients (Liao et al., 2020), supporting our findings."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To date, few other therapies are proven effective for severe COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Corticosteroid treatment was effective in suppressing MERS-CoV and SARS-CoV (Arabi et al., 2018) but showed negligible effect on COVID-19 patients and may even have induced lung injury (Russell et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The molecular changes revealed in this study in the COVID-19 sera might be useful for prioritizing therapeutic strategies for the severe patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our data suggest that severe COVID-19 patients might benefit from suppression of complement system."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our metabolomics results showed that more than 100 lipids including glycerophospholipid, sphingolipids, and fatty acids were downregulated in COVID-19 patient sera, probably because of damage to the liver, which is also reflected in aberrancy in bilirubin and bile acids."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Drugs inhibiting lipid synthesis such as statin have been proposed to treat HCV (Heaton and Randall, 2011) and COVID-19 (Fedson et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our data suggest these potential therapeutics might be helpful in the treatment of severe COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Upon COVID-19 outbreak, limited information of this pathogen was available, which restricted the collection of a large number of clinical specimens for this study mainly because of biosafety constraints."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our team procured serum samples from 65 COVID-19 patients who visited Taizhou Hospital from January to March 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "They were diagnosed as COVID-19 according to the Chinese Government Diagnosis and Treatment Guideline (Trial 5th version) (NHCPRC, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For diagnosing COVID-19, nucleic acid from sputum or throat swab was extracted using nucleic acid extractor (Shanghai Zhijiang, China, EX3600) and virus nucleic acid extraction reagent (Shanghai Zhijiang, China, NO. P20200201) was used to extract nucleic acid."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to the abovementioned guideline, COVID-19 patients are classified into four subgroups: 1) Mild: mild symptoms without pneumonia; 2) Typical: fever or respiratory tract symptoms with pneumonia; 3) Severe: fulfill any of the three criteria: respiratory distress, respiratory rate ≥ 30 times/min; means oxygen saturation ≤ 93% in resting state; arterial blood oxygen partial pressure/oxygen concentration ≤ 300 mmHg (1 mmHg = 0.133 kPa); 4) Critical: fulfill any of the three criteria: respiratory failure and require mechanical ventilation; shock incidence; admission to ICU with other organ failure."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, we included both severe and non-severe patients, with the latter composed of mild and typical COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also procured 25 non-COVID-19 patients with similar clinical characteristics including fever and/or cough as COVID-19 patients however negative in the nucleic acid test."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on the Chinese Government Diagnosis and Treatment Guideline (Trial 5th version) (NHCPRC, 2020), patients are defined as suspected COVID-19 cases when they meet the following three clinical criteria: 1) fever or respiratory symptoms, 2) imaging manifestation of pneumonia, and 3) optional reduction of white blood cell or lymphocyte count at early stage."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The patients only need to meet at least two of the above three criteria if they have been exposed to COVID-19 individuals."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Most non-COVID-19 patients exhibited fever and cough."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The samples from this study are from a clinical trial that our team initiated and registered in the ",
            "Chinese Clinical Trial Registry",
            " with an ID of ",
            "ChiCTR2000031365",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 10146,
                "end": 10177,
                "name": "Chinese Clinical Trial Registry"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 10192,
                "end": 10208,
                "name": "ChiCTR2000031365"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "The resultant mass spectrometric data were analyzed using Proteome Discoverer (Version 2.4.1.15, Thermo Fisher Scientific) using a protein database composed of the Homo sapiens fasta database downloaded from UniProtKB on 07 Jan 2020, containing 20412 reviewed protein sequences, and the SARS-CoV-2 virus fasta downloaded from ",
            "NCBI",
            " (version ",
            "NC_045512.2",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 10536,
                "end": 10540,
                "name": "NCBI"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 10550,
                "end": 10561,
                "name": "NC_045512.2"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "IDA mode (rolling collision energy, +2 to +5 charge states with intensity criteria above 2,000,000 cps to guarantee all untargeted peptides will not be acquired) for time-scheduling was set up for 51 peptides including 10 iRT peptides (Escher et al., 2012) with a mass tolerance of 50 ppm."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Early detection and effective treatment of severe COVID-19 patients remain major challenges."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Here, we performed proteomic and metabolomic profiling of sera from 46 COVID-19 and 53 control individuals."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Targeted proteomics and metabolomics assays were employed to further validate this molecular classifier in a second test cohort of 19 COVID-19 patients, leading to 16 correct assignments."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We identified molecular changes in the sera of COVID-19 patients compared to other groups implicating dysregulation of macrophage, platelet degranulation, complement system pathways, and massive metabolic suppression."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This study revealed characteristic protein and metabolite changes in the sera of severe COVID-19 patients, which might be used in selection of potential blood biomarkers for severity evaluation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Graphical Abstract      Proteomic and metabolomic analysis of COVID-19 sera identifies differentially expressed factors that correlate with disease severity and highlights dysregulation of multiple immune and metabolic components in clinically severe patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The outbreak of a novel coronavirus (SARS-CoV-2) and the associated disease (COVID-19) began in Wuhan, China, near the end of 2019."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 continues to pose a severe threat to public health and economic prosperity in China [1,2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 was more severe in Wuhan soon after its appearance, with severe/critical and fatality rates of approximately 32% and 11%, respectively [8,9]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Subsequent data as the disease spread revealed a milder form of COVID-19 in Zhejiang province [10] and nationwide [11]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, the observation of a similar viral load in symptomatic and asymptomatic COVID-19 patients revealed the capacity of SARS-CoV-2 for occult transmission [14]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Changes in the epidemiological and clinical features of COVID-19 relate to the virologic changes of SARS-CoV-2, in which the spike (S) surface envelope protein plays an important role [15]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, it is valuable to focus on the sequence mutation and conformation change in S protein for SARS-CoV-2 evolution in an established model with the aim of explaining the related changes in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This retrospective study investigating the epidemiological, clinical and virologic features of COVID-19 was performed at designated hospitals in Zhejiang province between 17 January and 7 February 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We subsequently calculated the time period of positive COVID-19 nucleic acid in our hospital."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All patients were diagnosed with COVID-19 according to the World Health Organization interim guidance [17] and the preliminary data were promptly reported to the authority of Zhejiang province."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The subtypes of COVID-19 were categorized as mild, severe and critical, as recently described [11]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "One strain of SARS-CoV-2 was successfully isolated from a single sputum sample of a patient with a mild COVID-19 case at the time of admission in our hospital."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Normalization and principal component analysis (PCA) were performed using the R package Seurat [24], with different dataset-based data processing methods."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Depending on the expression level of cell markers provided in the original article corresponding to the single-cell RNA (scRNA)-seq datasets, we further estimated which cell types the cell clusters belonged to."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The rates of mild, severe and critical types of COVID-19 were 90.1%, 7.74% and 2.16%, respectively."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "He visited outpatient clinics one day after symptom onset and was admitted to the hospital with COVID-19 on the same day following the PCR result."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Consistent with other COVID-19 patients, his symptoms included fever, cough and sputum production, with bilateral pneumonia evident in the CT scan."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The patient had mild type COVID-19, with normal results for routine blood parameters and inflammation markers (C-reactive protein and procalcitonin)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among the eight strains collected in Wuhan, Guangdong, and Hangzhou, six were collected at the early stage of COVID-19 (26 December 2019 to 2 January 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the scRNA-seq datasets, ACE2, Furin and TMPRSS2 showed higher expression levels in the liver and colon than in the lung (Figure 7(E))."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recently, elevated plasmin was reported in COVID-19 with comorbidities such as hypertension, diabetes, et al while plasmin or other proteases may be able to cleave FCS [35]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 rapidly spread throughout China and has causing enormous damage."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To provide clarity, we selected a COVID-19 patient who experienced a mild disease and isolated the causative virus (ZJ01) for comparative analysis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our hypothesis is consistent with changes in the clinical characteristics of COVID-19 from published data and our observations, including detection of virus in faeces [38] and conjunctival secretions [39], decreased severity/fatality, increased liver/kidney damage and symptoms of the gastrointestinal tract, increased transmissibility, and prolonged period of nucleic acid positivity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The mutations in the SARS-CoV-2 virus genome during COVID-19 dissemination are unclear."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In 788 COVID-19 patients from Zhejiang province, we observed decreased rate of severe/critical cases compared with patients in Wuhan."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For mechanisms exploration, we isolated one strain of SARS-CoV-2 (ZJ01) from a mild COVID-19 patient."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The evolutionary pattern of SARS-CoV-2 towards FCS formation may result in its clinical symptom becoming closer to HKU-1 and OC43 caused mild flu-like symptoms, further showing its potential in differentiating into mild COVID-19 subtypes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although limited data are available regarding sepsis induced by COVID-19, pathogenic coronaviruses-induced sepsis is observed with Middle East respiratory syndrome [3]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using the ",
            "Traditional Chinese Medicine Systems Pharmacology (TCMSP)",
            " [17], ",
            "Drugbank",
            " [18], ",
            "SuperPred",
            " [19] and ",
            "Swiss Target Prediction",
            " [20] databases, well-reported pharmacological targets of VC were obtained."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 179,
                "end": 236,
                "name": "Traditional Chinese Medicine Systems Pharmacology (TCMSP)"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 243,
                "end": 251,
                "name": "Drugbank"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 258,
                "end": 267,
                "name": "SuperPred"
            },
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 277,
                "end": 300,
                "name": "Swiss Target Prediction"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Likewise, the ",
            "DisGeNET",
            " [21], ",
            "Drugbank",
            ", and ",
            "Genecard",
            " [22] databases were used to screen pathological targets of sepsis."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 390,
                "end": 398,
                "name": "DisGeNET"
            },
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 405,
                "end": 413,
                "name": "Drugbank"
            },
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 419,
                "end": 427,
                "name": "Genecard"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using a STRING database, the mapped target of VC action against sepsis were reassayed to harvest a target-to-target function-related protein network, protein–protein interaction (PPI) network, and tsv. data."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The inclusion criteria for sepsis screening through ",
            "DisGeNET",
            " database was a gene-disease association score > 0.1 and for sepsis screening through ",
            "GeneCards",
            " database was a gene score >",
            "VC drug targets were screened and identified through both the ",
            "TCMSP",
            " and ",
            "Swiss Target Prediction",
            " databases, and 161 VC targets were identified (after removing duplicates) using Uniprot database."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 755,
                "end": 763,
                "name": "DisGeNET"
            },
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 849,
                "end": 858,
                "name": "GeneCards"
            },
            false,
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 949,
                "end": 954,
                "name": "TCMSP"
            },
            false,
            {
                "id": "T11",
                "type": "Repository",
                "start": 959,
                "end": 982,
                "name": "Swiss Target Prediction"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using a minimum required interaction score set to 0.700 (high confidence), a STRING database was used to collect function-related PPI data from the 63 targets (Supplementary Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Abstract  Sepsis is a life-threatening complication of pneumonia, including coronavirus disease-2019 (COVID-19)-induced pneumonia."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To date, 11 million have been infected with SARS-CoV-2, and 0.52 million have died from coronavirus disease 2019 (COVID-19) (Organization WH, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As Japan continues to battle a second wave of COVID-19 epidemic, more than 1,000 newly infected patients are being confirmed daily."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The World Health Organization (WHO) has raised a global warning and announced the need for a test system for COVID-19-suspected patients (World Health Organization, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The development of a more cost-effective and high-throughput test system will be important for preventing viral spread and monitoring infection levels in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to the protocol developed by the National Institute of Infectious Diseases (NIID) in Japan (Shirato et al., 2020), we performed one-step RT-qPCR to detect SARS-CoV-2 (Hirotsu et al., 2020d)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The clusters of COVID-19 are reported in closed environments, which could contribute to secondary transmission and promote super-spreading events (Nishiura et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this context, our results showed that the antigen test could be used to identify COVID-19-infected individuals who pose a high risk of transmission."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), which causes the disease COVID-19, was initially described near the end of 20191 2 and has caused a global pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "3 COVID-19 is characterized predominately by fever, cough, and pneumonia, with some patients presenting with diarrhea and other symptoms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "12 Analyses of ACE2 protein expression by organ system have suggested high levels in epithelia of the lung and small intestine, consistent with presenting symptoms of patients with COVID-19.13",
            "Patients with cancer may be at increased risk for SARS-CoV-2 infection and deleterious outcomes to COVID-19 disease though reports have varied by geography and cancer histology."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In a single hospital study from Wuhan, China, patients with cancer made up 1% of the overall prevalence of COVID-19,19 substantially higher than the overall incidence of cancer in the Chinese population at 0.29%.20",
            "Outcomes to COVID-19 appeared to be worse in patients with cancer with increased intensive care unit admission, mechanical ventilation, and mortality, especially those who had recently received chemotherapy or surgery."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "22 Particularly, there has been concern that patients being treated with cancer immunotherapy drugs might be at increased risk given the possible overlapping immune-related toxicities for checkpoint blocking antibodies with the pneumonitis and diarrheal syndromes seen in COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This remains an area of open investigation with analyses even from the same institution giving conflicting results about the risk of immunotherapy, notably in advanced lung cancer.25 26 Multiple societies, including the Society for Immunotherapy of Cancer, have issued guidance for cancer care during the pandemic as well as the use of immunomodulatory agents such as anti-IL6.27",
            "Several clinical associations have arisen from a smaller series of patients infected with COVID-19."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To the authors’ knowledge, only two tumor types had diabetes status information (pancreatic adenocarcinoma (PAAD) and uterine corpus endometrial carcinoma (UCEC)), which was retrieved from clinical XML files on ",
            "GDC",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 2102,
                "end": 2105,
                "name": "GDC"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Macrophage M1/M2 and T cells were included in the model based on emerging evidence suggesting an important role of macrophage and proinflammatory phenotype39 in COVID-19 disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Given the purpose of this analysis was to evaluate the relative importance of features rather than training and validating a predictive model, we did not split samples into training and test sets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Given the association between COVID-19 disease and various organ-specific symptoms, we investigated the distribution of ACE2 and TMPRSS2 expression in tumor and normal tissues across 34 tumor types consisting of 15 tissue types (online supplementary tables 1–3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A full description of each cancer ID is provided in online supplementary table 1. LAML, acute myeloid leukemia."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Several clinical observations on COVID-19 indicated clinical factors such as BMI might be associated with severity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Last, we examined a public scRNAseq cohort from patients with COVID-19 infection (",
            "https://doi.org/10.5281/zenodo.3747336",
            ") and confirmed that ACE2 was not expressed in immune cells, and TMPRSS2 was present in 6 out of 140,956 cells total by one read count."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 3056,
                "end": 3094,
                "name": "https://doi.org/10.5281/zenodo.3747336"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The mortality of COVID-19 disease has been substantially greater than that seen with seasonal influenza and led to the identification of or hypothesis that certain clinical factors may be associated with outcomes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "An initial hypothesis when considering the deleterious outcomes for patients with cancer and COVID-19 disease was that cancer tissues themselves might have higher expression of viral entry related genes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Observing higher ACE2 levels in T cell-inflamed tumors may be relevant to the administration of cancer immunotherapy during the COVID-19 pandemic, especially in patients with tumors of the aerodigestive tract such as head and neck, lung, and colorectal/anal tracts."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "49 However, if ACE2 and TMPRSS2 levels are high, making viral infection potentially more likely, concomitant treatment with checkpoint blockade may potentially change antiviral host response50 or possibly obscure rapidly delineation of symptoms such as fatigue, dyspnea, diarrhea,51 and complicate irAE management, especially given emerging evidence that corticosteroids may worsen COVID-19 disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To date, it remains unclear whether immune-checkpoint blockade increases risk of SARS-CoV-2 infection or subsequent impact of COVID-19.25 26",
            "Direct infection or dysregulation of immune cell populations is an additional area of concern in patients with cancer and more broadly in infected patients."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 can manifest with lymphopenia with some autopsy series suggesting lymph node or splenic atrophy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Studies have raised the possibility that SARS-CoV-2 infects lymphocytes17 or macrophages,53 leading to COVID-19 associate findings."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In our study, we investigated the expression of ACE2 and TMPRSS2 across multiple single-cell sequencing databases encompassing nine independent studies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additionally, multiple other known pathologies associated with sepsis and extreme illness could explain these lymph node and splenic findings, and few patients with COVID-19 have been documented to have an extreme viremia consistent with what would be required as a prerequisite to such histologic findings."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In our analysis, we found strong correlations of specific bacterial flora and high expression of ACE2 in COVID-19 related organs, including colorectal and kidney."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, this observation suggests that further investigation of the commensal microbiome in COVID-19 and possibly that bacterial antibiosis related to coronavirus infection might be of relevance in the future."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Rather we sought to investigate factors correlated with viral cell engagement via ACE2 and viral entry via TMPRSS2 as possible associative risk factors that might be entertained on a clinical or translational level when considering risk for patients with cancer and otherwise of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, we believe our analysis to be the most comprehensive catalog of ACE2 and TMPRSS2 correlates to date (34 tumor types from 15 tissue types across 10 038 subjects including both tumor samples and matched normal tissues as well as scRNAseq databases consisting of patients with cancer and healthy donors)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, these source data constitute the largest collection of microbiota communities identified from patients with cancer, have previously been used in this manner to build prediction algorithms, and the data were optimized via rigorous methodology to control for noise across the data set.35",
            "We also note that we are unable in this analysis to comment on respiratory or fecal samples from patients infected with COVID-19 and very much look forward to better understanding the functional mechanisms associated with those commensal and pathogenic microbiota related to COVID-19."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Last, our work does not determine a causal role of those correlates in driving response or severity of COVID-19 disease and would require further mechanistic studies as well as prospective clinical trials in patients to further develop or investigate interventional approaches."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Background  Pandemic COVID-19 by severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) infection is facilitated by the ACE2 receptor and protease TMPRSS2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Modestly sized case series have described clinical factors associated with COVID-19, while ACE2 and TMPRSS2 expression analyses have been described in some cell types."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patients with cancer may have worse outcomes to COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We performed an integrated study of ACE2 and TMPRSS2 gene expression across and within organ systems, by normal versus tumor, across several existing databases (",
            "The Cancer Genome Atlas,",
            " ",
            "Census of Immune Single Cell Expression Atlas",
            ", ",
            "The Human Cell Landscape",
            ", and more)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 7699,
                "end": 7723,
                "name": "The Cancer Genome Atlas,"
            },
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 7724,
                "end": 7769,
                "name": "Census of Immune Single Cell Expression Atlas"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 7771,
                "end": 7795,
                "name": "The Human Cell Landscape"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, was first identified in the Hubei province of China in December 2019 and has now spread worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The etiologic agent of COVID-19 is a β-coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1] that is closely related to severe acute respiratory syndrome coronavirus (SARS-CoV), the virus that caused the much more limited SARS outbreak of 2002–2003, and to Middle East respiratory syndrome coronavirus (MERS-CoV), the etiologic agent for MERS."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The case fatality rate for COVID-19 is considerably lower than that reported for SARS (17%) or MERS (40%) [2]; however, SARS-CoV-2 spread much more rapidly, quickly causing many more total deaths than infection with both previous coronaviruses combined."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Currently, there are no effective treatments for COVID-19 and our understanding of the immunological response to SARS-CoV-2 is limited."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The nucleocapsid N-terminal residues (N-NTD) interact with genomic RNA of SARS-CoV-2 and incorporate it into progeny particles (Tang et al."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This study will provide a better understanding of rapid drug designing to control the global epidemic of SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "",
            "PDB",
            " is a database of biomolecule structure, providing crystal structure for proteomics and in silico studies."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 257,
                "end": 260,
                "name": "PDB"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The crystal structure of nucleocapsid N-terminal domain (N-NTD) was retrieved from ",
            "Protein Data Bank",
            " (",
            "PDB",
            " ID: ",
            "6yi3",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 450,
                "end": 467,
                "name": "Protein Data Bank"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 469,
                "end": 472,
                "name": "PDB"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 477,
                "end": 481,
                "name": "6yi3"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "Crystal structure of N-NTD (",
            "PDB",
            " ID ",
            "6M3M",
            ") and dsRNA (",
            "PDB",
            " structure ",
            "2LK2",
            "), a 21-base pair-long dsRNA(Liu et al."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 512,
                "end": 515,
                "name": "PDB"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 519,
                "end": 523,
                "name": "6M3M"
            },
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 536,
                "end": 539,
                "name": "PDB"
            },
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 550,
                "end": 554,
                "name": "2LK2"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T5",
                "end": "T6"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T7",
                "end": "T8"
            }
        ]
    },
    {
        "sen": [
            "Considering the consensus sequences, two non-synonymous changes with respect to the Wuhan-Hu-1 ",
            "NCBI",
            " Reference Genome (Accession number: ",
            "MN908947.3",
            ") [2] were observed in the sequence from the clinical sample from patient 1: G11083T, leading to L3606F change in Orf1a, and G26144T, leading to G251V change in Orf3a."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 95,
                "end": 99,
                "name": "NCBI"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 136,
                "end": 146,
                "name": "MN908947.3"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "For the phylogenetic analysis, 87 full-genome SARS-CoV-2 sequences were retrieved from the ",
            "Global Initiative on Sharing All Influenza Data (GISAID)",
            ", along with ",
            "WH-01_MN908947.3",
            " from ",
            "GenBank",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 405,
                "end": 461,
                "name": "Global Initiative on Sharing All Influenza Data (GISAID)"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 474,
                "end": 490,
                "name": "WH-01_MN908947.3"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 496,
                "end": 503,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T5",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "All the genomes carrying this mutation are included in a significant phylogenetic cluster (bootstrap 87%), suggesting a common origin (Fig. 1",
            "); in fact, the G251V substitution in Orf3a has recently been defined as the marker variant of the ‘V’ clade (",
            "GISAID",
            ")."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 757,
                "end": 763,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Likewise, in December of 2019, a novel coronavirus, SARS-CoV-2, causing the Coronavirus Infection Disease 2019 (COVID-19) pandemic, represents the third coronavirus to jump the species barrier to cause severe fatal disease in humans, leading to an unprecedented devastating global pandemic that has left the world paralyzed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The receptor binding domain (RBD) of the spike protein of SARS-CoV-2 (residues 319–529) (",
            "GenBank",
            ": ",
            "MN975262.1",
            "), of SARS-CoV-1 (residues 306–515) (Urbani strain; ",
            "AAP13441.1",
            "), and of CoV-HKU1 (residues 310–677) (Accession #: ",
            "AY597011",
            ") were cloned into a pVRC vector with a C-terminal SBP-tag and expressed in HEK293F cells and purified as previously published Bajic et al., 2019."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 414,
                "end": 421,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 423,
                "end": 433,
                "name": "MN975262.1"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 485,
                "end": 495,
                "name": "AAP13441.1"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 547,
                "end": 555,
                "name": "AY597011"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T1",
                "end": "T3"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T1",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "To confirm that RBD-specific responses can differentiate individuals that have been previously exposed to SARS-CoV-2 from those that have not been exposed, RBD-specific IgM, IgG, and IgA responses were probed in a group of convalescent (individuals who were previously diagnosed with COVID-19 and later recovered, as confirmed by two negative RNA tests) and negative community controls."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Critical to managing the spread of COVID-19 is the ability to diagnose infection and define the acquired immune response across the population."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the early phase of the epidemic, COVID‐19 was not widely distributed in children."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Later on, 1391 children from Wuhan who had contact with COVID‐19 patients were screened."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A similar situation was observed in Italy which is, after China, the second hotspot of the COVID‐19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "One special problem should still be mentioned in this context: in Italy, paediatric hospitalization decreased substantially during the COVID‐19 epidemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "An increased number of deaths occurred in Italy due to delayed arrival of children in hospitals, while no child died from COVID‐19 in Italy (Lazzerini et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The statistics for the COVID‐19 epidemic have shown that the older population has suffered the greatest loss of life, and that nursing homes have been hotspots for transmission."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At the end of February 2020, a cluster of 167 epidemiologically linked COVID‐19 cases were reported in several long‐term care facilities in Washington state."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "One in 10 of >1300 accredited nursing facilities reported COVID‐19 cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A cluster of COVID‐19 cases in Munich, Germany was analysed in detail."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The dynamics of viral shedding was also evaluated in 94 Chinese COVID‐19 patients who provided 414 throat swabs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It was deduced from this observation that the infectiousness of COVID‐19 patients peaked on, or slightly before, symptom onset and that 44% of the secondary infections occurred in the pre‐symptomatic phase of the index patient."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Increased personal hygiene and social distancing for everyone are, therefore, key instruments for COVID‐19 disease control in the community (He et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At the height of the UK COVID‐19 epidemic asymptomatic health care workers (HCW) from London were repeatedly tested for viral RNA over 6 weeks."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The infection rate in asymptomatic HCW was 7% at the peak of the epidemic, and it decreased to 1% with the lessening of the epidemic in the population, suggesting that infection was contracted in the community, and not in the hospital, since HCW remained exposed to COVID‐19 patients during work (Treibel et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Viruses from 53 patients were sequenced and compared with 177 SARS‐CoV‐2 sequences deposited in the database."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first case of COVID‐19 in the United States was reported on January 19 at the northwest coast of Washington State and was imported from China."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Epidemiologists investigated the first nine COVID‐19 cases on the East coast (Connecticut) that were observed in mid‐March with genome sequencing."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In Wuhan, 105 index cases of patients suffering from moderate COVID‐19 symptoms (fever, cough, fatigue) were investigated for secondary transmission to 392 household contacts."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Adding viral‐specific IgG antibody tests to the toolbox of COVID‐19 epidemiology have allowed the connection between three previously separated infections clusters in Singapore."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since most COVID‐19 transmission seems to occur through close contact, droplets have been considered to be the more likely vehicles."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The environment of three COVID‐19 patients from a ventilated hospital infection ward in Singapore was tested for viral RNA presence by RT‐PCR."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The control measures that stopped the epidemic locally have included: intense infection surveillance of incoming travellers; isolation of COVID‐19 cases in hospitals; contact tracing and quarantine in holiday camps; and school closure but no lock‐down, thus preventing the crisis from having a negative economic impact."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Unfortunately, the full effect of school closure is still unknown because the susceptibility of children for COVID‐19 and their capacity to transmit the infection has not yet been established (Cowling et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "China has contained the COVID‐19 epidemic through a combination of different measures including drastic ones."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on these data and on a mathematical infection model, the authors concluded that social distancing alone is sufficient to control COVID‐19 spread."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The definition for a confirmed case of COVID‐19 was changed five times in China, which accounts for the increase in knowledge about the epidemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID‐19 deaths at care homes were three times as high as COVID‐19 deaths in hospitals (Burki, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In comparison, the global death toll of COVID‐19 is now 315′000 (status May 18)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A direct comparison of these two figures is difficult for two reasons: death levels are affected by vaccination campaigns against seasonal influenza and by strict containment measures for COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It seems plausible that without any containment measures COVID‐19 mortality would surpass greatly the number of deaths from seasonal influenza."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The presumption that the COVID‐19 mortality is comparable to that of seasonal influenza deaths is fundamentally flawed because it compares numbers which are obtained by different methods."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The death rate for COVID‐19, which has just crossed the 100 000 figure in the United States, is an actual count of dead patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Expressed as deaths per peak week, influenza claimed a maximum 1616 deaths per week, while COVID‐19 took about 15 000 lives per week at its peak in the United States (Faust and del Rio, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Epidemiologists from Harvard University derived projections from model calculations about the future dynamics of the COVID‐19 epidemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In contrast to the case fatality rate (CFR) which expresses the number of deaths per clinically ill patients (which varies from 1.4% to 15% for COVID‐19), IFR is the number of deaths per infected individual."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While we know, approximatively, the number of COVID‐19 deaths and COVID‐19 cases, we do not definitively know the number of infected persons, since this would require large and systematic seroprevalence studies, but which are lacking."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Anosmia (loss of smell) appeared as a strong predictor of COVID‐19, while fever was not a diagnostic criterion unless combined with other symptoms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Also, long‐term effects of the disease, and the impact of the COVID‐19 epidemic on social relations, mental health, and financial outcome can be evaluated with this tool."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A preliminary evaluation of a COVID‐19 Symptom Tracker smartphone app from UK users showed that the loss of smell was reported by 59% of people with respiratory infection who tested positive for SARS‐CoV‐2, compared with 18% of respiratory patients who tested negative."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Clinical criteria that allow a diagnosis of COVID‐19 without a viral RNA test would be welcome for mass screening and telemedicine in an epidemic situation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "French physicians have also reported that many COVID‐19 patients reported loss of smell and loss of taste, without nasal congestion."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "When these criteria were combined in a retrospective questionnaire this combination of signs had a sensitivity of 42% and a specificity of 95% for detecting COVID‐19 patients (Bénézit et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "U.S. physicians even suspected that SARS‐CoV‐2 might, in addition to the respiratory and alimentary tract, also infect cranial nerves (i.e. being neurotropic), which potentially explains the observation of neurological signs in 9% of COVID‐19 patients (Chu et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These datasets cannot be extrapolated to the population at large."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the United States, the COVID‐19 epidemic has taken more lives in 1 month than over 8 years during the Vietnam War."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With more than 1.7 million cases, and more than 100 000 deaths, the ‘America first’ slogan has become sadly ironic in the context of COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The CDC, once a pillar and international reference for combating diseases worldwide, instrumental in eradicating smallpox and coping with AIDS or Ebola, has lost its technical competence and public trust due to contradictory scientific messages and the undermining of trust in scientific evidence by the current U.S. administration."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At the end of May, the United Kingdom directly follows the United States in the international mortality ranking list with more than 38 000 COVID‐19 deaths."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The European Centre for Disease Prevention and Control (ECDC), which was established in 2004 to create a complement to the U.S. CDC, failed to become a hub in Europe of knowledge for COVID‐19 and a coordination centre for Europe‐wide epidemic counter‐strategies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Even the city‐state of Singapore, where the early handling of the COVID‐19 was lauded as exemplary public health action, had ‘blind spots’ on their screen in overlooking the miserable living conditions of migrant workers that became hotspots of COVID‐19 transmission."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It will be important that they also find the money needed for COVID‐19 containment among migrant workers, refugees and populations at risk in developing countries."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "When the leading nation of the western hemisphere leaves now the WHO, this is a disastrous signal for global public health at this crucial moment of the COVID‐19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the absence of an efficient drug treatment or a vaccine, the control of the COVID‐19 pandemic relies on classic infection control measures."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The 2019 novel coronavirus disease (COVID-19) is highly infectious 1, 2, outbreak of which has been announced as a global pandemic by the World Health Organization on 11 March 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The pathogen contributed to COVID-19 is Severe Acute Respiratory Syndrome Coronavirus 2(SARS-CoV-2), a sister of SARS-CoV 3, 4."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The RNA binding domain of SARS-CoV-2 spike protein binds to ACE2 with a 20-30-fold higher affinity than SARS-CoV 6-9, which may contribute to the rapid transmission of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To comprehensively investigate the mRNA expression of ACE2 in human tissues, we collected the transcriptome datasets in three public databases, including the ",
            "Tissue Atlas of Human Protein Atlas (HPA)",
            ", ",
            "Genotype-Tissue Expression (GTEx)",
            ", and ",
            "Functional Annotation of Mammalian Genomes 5 (FANTOM5) Cap Analysis of Gene Expression (CAGE)",
            " 18-22."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 646,
                "end": 687,
                "name": "Tissue Atlas of Human Protein Atlas (HPA)"
            },
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 689,
                "end": 722,
                "name": "Genotype-Tissue Expression (GTEx)"
            },
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 728,
                "end": 821,
                "name": "Functional Annotation of Mammalian Genomes 5 (FANTOM5) Cap Analysis of Gene Expression (CAGE)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Given the minor difference between these three data sets, we analyzed the overlapped tissues among them using a Venn diagram."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Indeed, such results were further supported by the transcriptome in other different databases, including ",
            "Monaco",
            " scaled dataset and ",
            "Schmiedel",
            " dataset 25, 26",
            "(."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Creator",
                "start": 1060,
                "end": 1066,
                "name": "Monaco"
            },
            false,
            {
                "id": "T5",
                "type": "Creator",
                "start": 1086,
                "end": 1095,
                "name": "Schmiedel"
            },
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With the global outbreak of COVID-19, the development of the drugs against SARS-CoV-2 had become an urgent work."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, the comprehensive investigation of ACE2 expression in human tissues has implications for understanding the transmission routes of SARS-CoV-2 and the development of anti-COVID-19 drugs."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, given the great heterogeneity among humans, the transcriptome and proteomic dataset with a larger number of samples and a wider range of tissues such as blood cells should be collected to analyze."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, we made a comprehensive investigation of the mRNA and protein expression of ACE2 in human tissues using public transcriptome, proteomic datasets, and antibody-based protein profiles."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Despite all these databases utilized in this study based on RNA-seq, there is a minor difference among the transcriptome result obtained from different databases, which may be caused by tissue source, technical artifacts inherent in the respective methodologies, and gene model annotation issues among them."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The high expression level of ACE2 in the gastrointestinal tract may explain why most of COVID-19 patients show gastrointestinal symptoms in the early stage of the infection 41."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Given there was a divergence toward the potential of intrauterine vertical transmission in women who develop COVID-19 pneumonia during pregnancy 42-44, we also paid attention to the expression of ACE2 in the female reproduction-associated tissues."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of note, all the transcriptome in different database revealed no ACE2 mRNA and protein in the common blood cells, including basophil, eosinophil, neutrophil, classical monocytes, non-classical monocyte, Treg, gd-T cell, MAIT T-cell, memory CD4 T-cell, naïve CD4 T-cell, memory B-cell, naïve B-cell, plasmacytoid DC, myeloid DC, NK cell, and total PBMC, suggesting the potential of resistance of immune cell against SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 infection also caused a remodeling myeloid in severe COVID-19 patients 45."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interestingly, a prior study reported that COVID-19 susceptibility seems to be related to blood group, whereas whether such results are associated with the level of ACE2 remains uncertain 46."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The way the tissue is fixed or processed can affect the result of IHC or proteomics of these databases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To obtain the comprehensive information regarding the transcriptome of human tissues, we collected the transcriptome from three public databases, including the ",
            "Human Protein Atlas (HPA) tissues atlas",
            ", ",
            "Genotype-Tissue Expression (GTEx)",
            " project, and ",
            "Functional Annotation of Mammalian Genomes 5 (FANTOM5)",
            " project."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 3529,
                "end": 3568,
                "name": "Human Protein Atlas (HPA) tissues atlas"
            },
            false,
            {
                "id": "T7",
                "type": "Dataset",
                "start": 3570,
                "end": 3603,
                "name": "Genotype-Tissue Expression (GTEx)"
            },
            false,
            {
                "id": "T8",
                "type": "Dataset",
                "start": 3617,
                "end": 3671,
                "name": "Functional Annotation of Mammalian Genomes 5 (FANTOM5)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All these databases update irregularly and the version of them we analyzed is the latest."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "HIPED is an integrated proteomics platform residing within GeneCards, which involved 69 normal anatomical entities (tissues, cells, and fluids) from four databases including ",
            "ProteomicsDB",
            ", ",
            "MOPED",
            ", ",
            "PaxDb",
            ", and ",
            "MaxQB",
            " 51."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 3945,
                "end": 3957,
                "name": "ProteomicsDB"
            },
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 3959,
                "end": 3964,
                "name": "MOPED"
            },
            false,
            {
                "id": "T11",
                "type": "Repository",
                "start": 3966,
                "end": 3971,
                "name": "PaxDb"
            },
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 3977,
                "end": 3982,
                "name": "MaxQB"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The public transcriptome datasets from ",
            "Schmiedel B.J.",
            " 25 and ",
            "Monaco G.",
            " 26 were also collected to analyze the mRNA expression of ACE2 in human common blood cells."
        ],
        "lab": [
            false,
            {
                "id": "T13",
                "type": "Creator",
                "start": 4026,
                "end": 4040,
                "name": "Schmiedel B.J."
            },
            false,
            {
                "id": "T14",
                "type": "Creator",
                "start": 4048,
                "end": 4057,
                "name": "Monaco G."
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Given the heterogeneity among humans, the datasets covering more tissues with a larger size of samples should be analyzed."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The bulk RNA-seq profiles from three separate public datasets including ",
            "HPA tissue Atlas",
            ", ",
            "GTEx",
            ", and ",
            "FANTOM5 CAGE",
            " were also obtained to determine the expression of ACE2 in human tissues."
        ],
        "lab": [
            false,
            {
                "id": "T15",
                "type": "Dataset",
                "start": 4344,
                "end": 4360,
                "name": "HPA tissue Atlas"
            },
            false,
            {
                "id": "T16",
                "type": "Dataset",
                "start": 4362,
                "end": 4366,
                "name": "GTEx"
            },
            false,
            {
                "id": "T17",
                "type": "Dataset",
                "start": 4372,
                "end": 4384,
                "name": "FANTOM5 CAGE"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The pandemic of coronavirus disease 2019 (COVID-19) caused by the 2019 novel coronavirus (2019-nCoV or SARS-CoV-2) infection has become a Public Health Emergency of International Concern (PHEIC) with more than 6 million cases and 376,320 deaths as of June 2, 2020 (WHO, 2020, https://covid19.who.int)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 infection causes disorder of natural and adaptive immunity, leading to tissue damage and systemic inflammation, which is the main reason for death of COVID-19 patients (Huang et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To study the gene function of new coronavirus, SARS-CoV-2 ORFs of the structural genes (S, E, M, and N) and the accessory genes (3a, 6, 7a, 8 and 10) (",
            "GenBank",
            " ID ",
            "MN908947.3",
            ") were synthesized by Sangon Biotechnology Co., Ltd. (Shanghai, China), and then cloned into pCAGGS vector with a tag encoding hemagglutinin (HA) at the N-terminus of each protein (Fig. 1",
            "A)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 654,
                "end": 661,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 665,
                "end": 675,
                "name": "MN908947.3"
            },
            false,
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "ORF3b is not performed in this study, since the first sequence published in the database did not annotate the ORF3b gene."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel human coronavirus causing the pandemic of severe pneumonia (Coronavirus Disease 2019, COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Innate immune response is critical for the host defense against viral infection and the dysregulation of the host innate immune responses probably aggravates SARS-CoV-2 infection, contributing to the high morbidity and lethality of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The complete genomes of 15 2019‐nCoV sequences have been downloaded from ",
            "GISAID",
            " (",
            "https://www.gisaid.org/",
            ") and ",
            "GenBank",
            " (",
            "http://www.ncbi.nlm.nih.gov/genbank/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 73,
                "end": 79,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 81,
                "end": 104,
                "name": "https://www.gisaid.org/"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 110,
                "end": 117,
                "name": "GenBank"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 119,
                "end": 155,
                "name": "http://www.ncbi.nlm.nih.gov/genbank/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "A dataset has been built using five highly similar sequences for SARS, two sequences for the Middle East respiratory syndrome (MERS), and five highly similar sequences for bat SARS‐like coronavirus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The percentage of similarity has been identified using a basic local alignment search tool (https://blast.ncbi.nlm.nih.gov/Blast.cgi); eventually duplicated sequences have been excluded from the datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The dataset including 27 sequences has been aligned using multiple sequence alignment online tool",
            " and manually edited using BioEdit program v7.0.5."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ability to rapidly connect with scientists in spite of institutional shutdowns has, on top of this, facilitated the engagement of researchers in collaborative activities targeted against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "European COVID-19 Data Portal",
            " [6], announced by the European Commission President Ursula von der Leyen on 20 April 2020, for example, is setting out to help scientists coordinate the sharing of research data related to the fight against COVID-19 using the European Open Science Cloud."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 205,
                "end": 234,
                "name": "European COVID-19 Data Portal"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additional activities include new global efforts that aim to sequence SARS-CoV-2 viral genomes along with patient-matched host genomes or to utilize existing cohorts such as the ",
            "UK Biobank",
            " [7], in order to dissect the role of host genetics in the COVID-19 disease course."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 668,
                "end": 678,
                "name": "UK Biobank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On top of this, new international platforms such as ",
            "Crowdfight COVID-19",
            " [8] or ",
            "data against COVID-19",
            " [9] aim to empower scientists to work together in fighting SARS-CoV-2, by connecting expertise from different fields with data resources."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 814,
                "end": 833,
                "name": "Crowdfight COVID-19"
            },
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 841,
                "end": 862,
                "name": "data against COVID-19"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Another example is a regular workshop series hosted by the European Laboratory of Intelligent Systems (ELLIS), which seeks to connect the expertise of leading researchers in machine learning and artificial intelligence for the fight against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although 49% of scientists reported that their research hours have been reduced during the COVID-19 outbreak, many indicated that they are using the times of shutdown to devote more time to data analysis (43%), manuscript or thesis writing (45%), or developing grant applications (11%) (see Fig. 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Indeed, there are early signs that manuscript submissions to scientific journals have already been increasing since COVID-19-related restrictions have emerged [4]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "And somewhat impressively, over a hundred respondents (102, 18% of the total) indicated that they shifted the regular scientific activities to be able to directly contribute to research with the aim to combat COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A recent inquiry circulated among members of the European Molecular Biology Organization (EMBO) provides an independent testament of the willingness of life scientists to contribute to fighting COVID-19 (",
            "https://www.data-against-covid.org",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "URL",
                "start": 2139,
                "end": 2173,
                "name": "https://www.data-against-covid.org"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A novel coronavirus SARS‐CoV‐2 leading to COVID‐19 was identified for the first time in December 2019 and as of today has infected already more than 5.0 million and killed more than 320 000 people worldwide (as of 20th of May 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "An anti‐CD147 antibody that blocks infection with SARS‐CoV‐2 in vitro and its humanized drug (meplazumab) has been already used in a clinical trial in patients with COVID‐19 pneumonia."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The percentage of improvement in patients with severe and critical COVID‐19 presentations seemed higher in weekly meplazumab treatment compared to patients on the conventional treatment."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "They can be incorporated to the viral capsid and released, which further enables virus binding to CD147 and subsequent infection of CD147‐expressing cells."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since cyclophilins are regulators of NFAT activation, the extracellular binding of the virus through cyclophilin‐CD147 complex, as well as intracellular interactions of cyclophilins with the virus proteins might be important in COVID‐19 development."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We analyzed gene expression of SARS‐CoV‐2 receptors and related molecules’ (Table S1) in a broad range of tissues and immune cells from the human RNA‐seq databases generated by our ex vivo and in vitro approaches in the ",
            "Swiss Institute of Asthma and Allergy Research (SIAF)",
            ", by our collaborators or from the ",
            "Gene Expression Omnibus",
            " (",
            "http://www.ncbi.nlm.nih.gov/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1231,
                "end": 1284,
                "name": "Swiss Institute of Asthma and Allergy Research (SIAF)"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 1319,
                "end": 1342,
                "name": "Gene Expression Omnibus"
            },
            false,
            {
                "id": "T3",
                "type": "URL",
                "start": 1344,
                "end": 1372,
                "name": "http://www.ncbi.nlm.nih.gov/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "We further investigated different expression patterns of ACE2‐, CD147‐, and CD26‐related genes in the context of potential COVID‐19 risk factors, namely age, gender, smoking status, diagnosis of asthma, chronic obstructive pulmonary disease (COPD), hypertension, obesity, and atopic dermatitis (AD) (Table S3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Genes of interest were extracted from all datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Clinical evidence from COVID‐19 patients worldwide clearly demonstrates an association between disease severity and morbidity with age."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We analyzed expression of ACE2‐, CD147‐, and CD26‐related genes from different cells and tissues in various comorbidities and risk factors, which have been shown, or are suspected to predispose to SARS‐CoV‐2 infection and/or COVID‐19 progression."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Next, we analyzed the ACE2‐, CD147‐, and CD26‐related gene expression in our controls, asthma and COPD patients according to the additional clinical features, which have been reported as risk factors for COVID‐19, such as hypertension, smoking, gender, and obesity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "In summary, these findings suggest that higher BMI and older age lead to higher expression of CD147‐related genes on immune cells, but not on the barrier cells, which potentially can influence the development and the course of COVID‐19."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As we found a high expression of ACE2‐, CD147‐, and CD26‐related genes in the skin biopsies of healthy subjects, and since COVID‐19‐related skin lesions have been recently reported,",
            " we also analyzed the skin biopsies of healthy subjects and AD patients."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID‐19 pandemic is developing at such a pace that extraordinary actions are being initiated to learn quickly about its biology, transmission, and potential means of prevention and treatment."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this spirit, we first performed an extensive literature and database search and curated a list of proven and potential receptors for SARS‐CoV‐2 and interaction partners, whose expression in different tissues and cells might be involved in the course of immunological response in COVID‐19 (Figure 6)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While interesting associations were observed to be age‐dependent, these findings must be further explored and repeated due to the possibility of batch‐specific systematic variations in the gene expression values between in‐house and public datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Despite our efforts in applying identical data analysis workflow for the datasets produced by our group and those available in public repositories, different sequencing facilities and experiment protocols can lead to altered gene expression values, especially for genes with extreme gene length and G/C content."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, we analyzed gene expression in adults with known and potential COVID‐19 comorbidities and risk factors such as COPD, asthma, hypertension, obesity, smoking, male gender, and AD."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interestingly, we observed high expression of ACE2 and TMPRSS2 in bronchial airway epithelium: in HBECs ALI cultures in vitro, as well as in vivo in humans in bronchial biopsies, indicating that they can be as important in initiation and progression of COVID‐19, as recently shown for type II pneumocytes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On the other hand, ACE2 and the angiotensin II type 2 receptor (AT2) were reported to protect from severe acute lung injury in mice,",
            " therefore an importance of ACE2 in SARS‐CoV‐2 infection and COVID‐19 progression should be further explored."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Even though initially asthma was not reported to be a significant comorbidity for COVID‐19, more observations from Europe and the US seem to show otherwise."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, it is possible that ACE2 expression in the airways of allergic patients, even if slightly protective in terms of infection with SARS‐CoV‐2, might also predispose to faster progression of COVID‐19 to more severe forms, especially in case of higher TMPRSS2 expression."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We found that immune cells do not express ACE2, TMPRSS2, or SLC6A19, which has also been observed by others."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            " Importantly though, we found that CD147 and its extracellular agonists and transmembrane partners are highly expressed in innate and adaptive immune cells in the lungs and in the periphery, suggesting that they should be further investigated in SARS‐CoV‐2 spread and COVID‐19 pathology."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Obesity is one of the main comorbidities reported in patients with severe COVID‐19,",
            " and since CD147 expression in the whole blood correlates positively with BMI in our cohort, it certainly needs further attention in relation to COVID‐19."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Importantly, CD147 expression is upregulated by high glucose concentrations,",
            " which might reflect its correlation with obesity, and potentially also with diabetes, another very important COVID‐19 comorbidity."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, our results suggest a possible role of CD147 and its extracellular and intracellular ligands in COVID‐19 pathogenesis via regulation of cell metabolism, motility, and activation, especially in patients with comorbidities."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A clinical trial with anti‐CD147 in COVID‐19 patients seems to confirm its pleiotropic role in SARS‐CoV‐2 infection, but it requires further research to investigate the involved mechanisms and molecules."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recent studies reported that many COVID‐19 cases developed nonpruritic, erythematous rashes, urticaria, or varicella‐like lesions,",
            ", ",
            " but so far it is not known if they are a place of viral replication or just a local reaction to systemic infection."
        ],
        "lab": [
            false,
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Similarly, not much is yet known about the potential connections between AD and the course of COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Abstract   Background  Morbidity and mortality from COVID‐19 caused by novel coronavirus SARS‐CoV‐2 is accelerating worldwide, and novel clinical presentations of COVID‐19 are often reported."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The aim of our study was to analyze the expression of known and potential SARS‐CoV‐2 receptors and related molecules in the extensive collection of primary human cells and tissues from healthy subjects of different age and from patients with risk factors and known comorbidities of COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We performed RNA sequencing and explored available RNA‐Seq databases to study gene expression and co‐expression of ACE2, CD147 ( BSG ), and CD26 ( DPP4 ) and their direct and indirect molecular partners in primary human bronchial epithelial cells, bronchial and skin biopsies, bronchoalveolar lavage fluid, whole blood, peripheral blood mononuclear cells (PBMCs), monocytes, neutrophils, DCs, NK cells, ILC1, ILC2, ILC3, CD4 + and CD8 +",
            "We analyzed the material from healthy children and adults, and from adults in relation to their disease or COVID‐19 risk factor status."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Altered expression of these receptors related to age, gender, obesity and smoking, as well as with the disease status, might contribute to COVID‐19 morbidity and severity patterns."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The recognition in 2019 of the first outbreak in Wuhan, China, of a respiratory disease (COVID‐19) associated with a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) triggered an international response unparalleled in its scale and tempo.1, 2, 3, 4, 5, 6 In particular, the rapid sharing and integration of clinical and epidemiological data has facilitated understanding of the spectrum of clinical disease caused by SARS‐CoV‐2 and the extent of its global spread, although there are still many unanswered questions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In China, he had had no contact with live food markets, people known to have COVID‐19, or hospitals."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our sequences are available at ",
            "GenBank",
            " (accession number, ",
            "MT007544.1",
            "), and the genome was rapidly uploaded to the ",
            "Global Initiative of Sharing All Influenza (GISAID)",
            " (accession number, ",
            "EPI_ISL_406844",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 680,
                "end": 687,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 707,
                "end": 717,
                "name": "MT007544.1"
            },
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 763,
                "end": 814,
                "name": "Global Initiative of Sharing All Influenza (GISAID)"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 834,
                "end": 848,
                "name": "EPI_ISL_406844"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "We have described the first reported case of COVID‐19 in Australia, with rapid diagnosis, and isolation, imaging, and sharing of the causative agent, SARS‐CoV‐2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Major outcomes  Clinical course and laboratory features of the first reported case of COVID ‐19 (the illness caused by SARS ‐CoV‐2) in Australia; isolation, whole genome sequencing, imaging, and rapid sharing of virus from the patient."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel RNA virus of the Coronaviridae family, caused an outbreak of coronavirus disease 2019 (COVID-19) in China in late December 2019, and has been rapidly spreading to more than 214 countries and areas since then [1], [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 is the third pandemic caused by coronavirus in the last 20 years; and it has resulted in more than 4,993,470 infections and claimed nearly 327,738 lives as of May 22, 2020, exceeding any other epidemic caused by betacoronaviruses in the human history, for example, SARS in 2002–2003 and the Middle East respiratory syndrome (MERS) in 2012 (https://www.ecdc.europa.eu/en/2019-ncov-background-disease)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among the extensive studies conducted on COVID-19, one essential question is to trace the origin and transmission between humans, shedding light on the molecular mechanism underlying epidemiological and pathological characteristics of the virus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "One example of an infection cluster is the COVID-19 outbreak in the Diamond Princess cruise [9]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The dataset used for this study includes 12,909 genomic sequences as of May 4, 2020, of which 487 genomes are from China (15 provinces and regions) and 12,422 genomes are from 72 other countries of the world."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Second, from Jan 10, 2020 to Feb 29, 2020, only 11 out of the 718 samples in the public databases, i.e., ",
            "2019 Novel Coronavirus Resource (2019nCoVR)",
            " [14] and ",
            "Global Initiative on Sharing All Influenza Data (GISAID)",
            ", were collected from Wuhan."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1359,
                "end": 1402,
                "name": "2019 Novel Coronavirus Resource (2019nCoVR)"
            },
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 1412,
                "end": 1468,
                "name": "Global Initiative on Sharing All Influenza Data (GISAID)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Third, before Dec 24, 2019, no sequence was collected in the databases during this early stage."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Fifteen of the 68 (22.06%) H1 haplotypes were collected only from patients near WSM showing severe symptoms of COVID-19 in a short time interval (Dec 30, 2019–Jan 7, 2020), which was the initial period of COVID-19 outbreak."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "WSM was widely considered as the source of the COVID-19 outbreak since it was first identified around late December, 2019."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, some studies claimed COVID-19 might originate at an earlier time point and outside of WSM (e.g., [15])."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The estimated TMRCA and the associated 95% CIs are both earlier than the outbreak time of COVID-19 in WSM."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We observe remarkable changes in the prevalence of L lineage during the COVID-19 pandemic (Figure S3A)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 12,909 SARS-CoV-2 genomes available on May 4, 2020 were downloaded from ",
            "GISAID",
            " (",
            "http://www.gisaid.org",
            ") and ",
            "National Genomics Data Center",
            " (",
            "https://bigd.big.ac.cn/ncov/",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 2347,
                "end": 2353,
                "name": "GISAID"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 2355,
                "end": 2376,
                "name": "http://www.gisaid.org"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 2382,
                "end": 2411,
                "name": "National Genomics Data Center"
            },
            false,
            {
                "id": "T6",
                "type": "URL",
                "start": 2413,
                "end": 2441,
                "name": "https://bigd.big.ac.cn/ncov/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T3",
                "end": "T4"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "A novel RNA virus, the severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ), is responsible for the ongoing outbreak of coronavirus disease 2019 ( COVID-19 )."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Population genetic analysis could be useful for investigating the origin and evolutionary dynamics of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The results indicate that COVID-19 might originate earlier than and outside of Wuhan Seafood Market."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 65 SARS-CoV-2 patient isolate sequences were collected from ",
            "NCBI",
            " and ",
            "GISAID",
            " databases and aligned against SARS-CoV-2 reference sequence ",
            "NC_045512.2",
            " (Table S1)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 71,
                "end": 75,
                "name": "NCBI"
            },
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 80,
                "end": 86,
                "name": "GISAID"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 147,
                "end": 158,
                "name": "NC_045512.2"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "Using databases and published data, we filtered our considered miRNA to those with documented expression in SARS-CoV-2 target cells, and additionally focused on miRNAs that have been reported as components of the anti-viral miRNA-mediated defence system."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It is well established that patients with cardiovascular disease are overrepresented in symptomatic COVID-19 cohorts and have a higher mortality rate [55]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nsp4 A9259G is present in a sequence obtained from Vietnam (",
            "GISAID",
            ": ",
            "EPI_ISL_416429",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 642,
                "end": 648,
                "name": "GISAID"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 650,
                "end": 664,
                "name": "EPI_ISL_416429"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T4",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "However, further investigations into the interactions of miR-197-5p expression, the C3037U mutation, and COVID-19 disease severity in this cardiovascular patients are required."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The tree structure was validated by running the analysis on 100 bootstrapped input datasets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Briefly, this analysis finds the eigenvectors describing the highest variance within a categorical dataset, like ours."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our dataset derived from the MUSCLE MSA of 70 genomes and generated 32 206 positions: the categories in each coordinate could be A (Adenine), C (Cytosine), G (Guanine; T [Thymine], although being an single strand RNA virus, it would be more appropriate to use U [Uracil]), N (Nucleotide, uncertain location: very rare in this dataset, and accounting for only nine positions, or 0.0004% of all the data)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "So, we searched for ORF8 homologous substrates in the Mammalia ",
            "NCBI",
            " nr protein database, but could not find matches within the E‐value threshold of 1."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 679,
                "end": 683,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In summary, we found that all data sets, including both the on-going outbreak of SARS-CoV-2 in China and the 2003 SARS-CoV epidemic in China and worldwide, were well fitted to the Boltzmann function (Fig. 1 and S1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The world is facing a dire situation of global public health emergency due to a viral pandemic of severe febrile pneumonia like respiratory syndrome caused by a novel coronavirus, named SARS-CoV-2, causing the COVID-19 disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Clinical onset of infection in COVID-19 is characterized by symptoms as headache, dry cough, and fever; in severe cases multi-organ failure, and even deaths (3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Additionally, neutralizing monoclonal antibody-based therapeutics are also being developed to combat COVID-19 crisis (13, 14)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This study has identified potential anti-SARS-CoV-2 agents, which can be directly tested for in vitro and in vivo studies, to combat a global threat of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Drug molecules targeting the S-protein has the potential to cure COVID-19 infections and to tackle the pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since the newly published structure of SARS-CoV-2 S-protein (",
            "PDB",
            " ID: ",
            "6VSB",
            ") lacks important loop residues of S-RBD domain proposed to be involved in receptor binding, therefore a homology model was generated utilizing it as a template (Figures 3A,B)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 853,
                "end": 856,
                "name": "PDB"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 861,
                "end": 865,
                "name": "6VSB"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "A 3D model of S1 subunit of SARS-CoV-2 S-protein, was predicted using SWISS MODEL (",
            "NCBI",
            " reference sequence: ",
            "MN908947.3",
            ") and the pre-fusion structure of SARS-CoV-2 spike glycoprotein (",
            "PDB",
            " ID: ",
            "6VSB",
            ") was used as template (Figure 3)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 1125,
                "end": 1129,
                "name": "NCBI"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 1150,
                "end": 1160,
                "name": "MN908947.3"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 1225,
                "end": 1228,
                "name": "PDB"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 1233,
                "end": 1237,
                "name": "6VSB"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "The predicted homology model for S1 subunit of S-protein was submitted in ",
            "PMDB",
            " database (",
            "PMDB",
            " ID: ",
            "PM0082972",
            "), and the HADDOCK tool was used to identify interacting residues between receptor and S-RBD of S-protein (Figure S2)."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 1346,
                "end": 1350,
                "name": "PMDB"
            },
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 1361,
                "end": 1365,
                "name": "PMDB"
            },
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 1370,
                "end": 1379,
                "name": "PM0082972"
            },
            false
        ],
        "rel": [
            {
                "id": "R4",
                "bool": true,
                "head": "T7",
                "end": "T9"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T8",
                "end": "T9"
            }
        ]
    },
    {
        "sen": [
            "Crystal structure of S-protein of SARS-CoV-2 (",
            "PDB",
            " ID: ",
            "6VSB",
            "), published recently, lacks residues present in the S-RBD region of SARS-CoV-2. Chimeric S-RBD of SARS-CoV-2 (",
            "PDB",
            " ID: ",
            "6VW1",
            ") has been reported, but the structure comprises majorly of SARS-CoV residues and contains only S-RBM of SARS-CoV-2."
        ],
        "lab": [
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 1544,
                "end": 1547,
                "name": "PDB"
            },
            false,
            {
                "id": "T11",
                "type": "AccessionNumber",
                "start": 1552,
                "end": 1556,
                "name": "6VSB"
            },
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 1667,
                "end": 1670,
                "name": "PDB"
            },
            false,
            {
                "id": "T13",
                "type": "AccessionNumber",
                "start": 1675,
                "end": 1679,
                "name": "6VW1"
            },
            false
        ],
        "rel": [
            {
                "id": "R6",
                "bool": true,
                "head": "T10",
                "end": "T11"
            },
            {
                "id": "R7",
                "bool": true,
                "head": "T12",
                "end": "T13"
            }
        ]
    },
    {
        "sen": [
            "The datasets presented in this study can be found in online repositories."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The names of the repository/repositories and accession number(s) can be found in the article/Supplementary Material."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The rapidly spreading, highly contagious and pathogenic SARS-coronavirus 2 (SARS-CoV-2) associated Coronavirus Disease 2019 (COVID-19) has been declared as a pandemic by the World Health Organization (WHO)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The repurposing of drugs can provide a rapid and potential cure toward exponentially expanding COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Timely identification and determination of an effective drug to combat and tranquilize the COVID-19 global crisis is the utmost need of hour."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "(Gorbalenya et al., 2020; Jiang et al., 2020) causing human pneumonia (i.e., COVID-19), was first reported in Wuhan, Hubei, Central China (Wu et al., 2020a; Zhou et al., 2020; Zhu et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since the outbreak of COVID-19 was first identified in Wuhan in mid-December 2019, the first infected individuals identified in other provinces and regions of China, and other countries, during January 2020, have been assumed to have been infected in Wuhan or through contact with people from Wuhan (Chan et al., 2020; Holshue et al., 2020; Phan et al., 2020; Rothe et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, we used 93 genomes of SARS-CoV-2 from the ",
            "GISAID",
            " EpiFluTM database (Shu & McCauley, 2017) (access date 12 February 2020) to decode the evolution and transmissions of SARS-CoV-2 in the first two months of its spread."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 633,
                "end": 639,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To decode the evolutionary history of SARS-CoV-2, we retrieved 96 complete genomes from ",
            "GISAID",
            " (Supplementary Table S1, access by 12 February 2020) (Shu & McCauley, 2017)."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 895,
                "end": 901,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The genome ",
            "EPI_ISL_402131",
            " (bat-RaTG13-CoV, hereafter) from ",
            "GISAID",
            " was also included as the outgroup, because it is the closest sister betacoronavirus available to SARS-CoV-2 (Zhou et al., 2020)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 990,
                "end": 1004,
                "name": "EPI_ISL_402131"
            },
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 1038,
                "end": 1044,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T4",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "We carefully used three datasets (i.e., four core substitution sites, 120 substitution sites, and 1 235 substitution sites, Supplementary Datasets) to evaluate the relationship between bat-RaTG13-CoV and four associated/central haplotypes of SARS-CoV-2 (H1, H3, H13, and H38)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Three different datasets were used to infer evolutionary networks, which consistently supported H13 and H38 as the potentially ancestral haplotypes, i.e., the outgroup bat-RaTG13-CoV could connect to both H13 and H38, or H38 alone, or through a medium vector mv1 (an intermediate host or the first infected humans) connected to both H13 and H38 by single mutations at positions 18067 (S, synonymous substitution) and/or 29102 (S), referring to the numbering of the alignment length 29 910 bp (Figure 5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Five main groups can be recognized in the network using the dataset of 120 substitution sites (Figure 3A)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The outbreak of COVID-19 started in mid-December 2019 in Wuhan, China."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, we used 93 complete genomes of SARS-CoV-2 from the ",
            "GISAID",
            " EpiFlu TM database to investigate the evolution and human-to-human transmissions of SARS-CoV-2 in the first two months of the outbreak."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 2199,
                "end": 2205,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The dataset of four core substitution sites is the four variable sites shared among bat-RaTG13-CoV and the four central node haplotypes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The dataset of 120 substitution sites refers to all variable sites of coding regions in SARS-CoV-2 haplotypes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The dataset of 1235 substitution sites refers to all variable sites of coding regions among bat-RaTG13-CoV and SARS-CoV-2 haplotypes."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 is the causative agent of current pandemic of novel coronavirus disease (COVID-19) which has infected millions of people and is responsible for more than 200,000 deaths worldwide in a span of just 4 months."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In both cases, the Severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1 as reference genome (Accession ",
            "NC_045512.2",
            ") was used as the reference sequence."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "AccessionNumber",
                "start": 335,
                "end": 346,
                "name": "NC_045512.2"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Five individuals had contact with COVID-19 patients in particular; both S2 and S3 had contact with the same patient (table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All the nine sequences have been submitted in the ",
            "Global Initiative on Sharing All Influenza Data (GISAID)",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 561,
                "end": 617,
                "name": "Global Initiative on Sharing All Influenza Data (GISAID)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Phylogenetic tree analysis of the sequences, along with other complete viral genome sequences submitted from India in ",
            "GISAID",
            ", revealed that seven of these sequences belonged to the A2a clade while only one sequence belonged to clade B4 (figure 1 and table 1)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 746,
                "end": 752,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To understand transmission histories of these nine SARS-CoV-2 isolates from West Bengal, we aligned these sequences with more than 6000 global sequences, including thirty sequences submitted in ",
            "GISAID",
            " from India (at the time of our analysis) to identify specific mutations that occur at the highest level of the tip in a branch leading to the specific subtype."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 1082,
                "end": 1088,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Out of these, two sequences were obtained from individuals with contact history of a COVID-19 patient who had travelled from Italy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interestingly, two out of three sequences harbouring these mutations obtained by us belonged to Kolkata and with contact history with one COVID-19 patient who had travelled from London (UK)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The third sequence was obtained from a COVID-19 patient from Darjeeling, India who had history of travel from Chennai, India."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, we used the ",
            "TissueAtlas",
            " database to analyse the presence and correlation of these miRNAs in body fluids."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 1721,
                "end": 1732,
                "name": "TissueAtlas"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "When Ser202 is phosphorylated which incorporates a large negative group tethered to the sidechain of Ser, as seen in many other substrates of kinases, it is likely that charge neutralization takes place involving positively charged sidechains in the sequential and spatial vicinity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Substantial uncertainties surround the trajectory of the recent epidemic of COVID-19 in India."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interestingly, while two out the three sequences harbouring these mutations were from individuals who shared contact history with a COVID-19 patient with history of travel from Italy, two out of the three samples from West Bengal shared contact history with the same COVID-19 patient with history of travel from UK."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This correlates with the fact that these two individuals had also been known to have contact with the same COVID-19 patient."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interestingly, both these individuals belonged to the same district of East Medinipur, had history of contact with COVID-19 patients and did not exhibit any clinical symptom."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interesting correlation was observed between these mutations and travel or contact history of COVID-19 positive cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recent correspondence in this Journal has highlighted the current threat posed by recently-emerging corona virus disease 2019 (COVID-19) in the world."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 is infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is characterized by fever, dry cough, weak, and so on."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Recently, COVID-19 epidemic in China has been well controlled, whereas the risk of imported COVID-19 cases has increased dramatically."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, limited studies on full-length genome characterization of SARS-CoV-2 from COVID-19 cases imported from abroad."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Eight COVID-19 patients imported from overseas were admitted to Yunnan Provincial Infectious Disease Hospital from March 15, 2020 to March 26, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Two cases YN_Im01 and YN_Im03 were from Spain to Yunnan, YN_Im02 from France, YN_Im04 from Cambodia, YN_Im05 from Sri Lanka, and YN_Im06-08, a family cluster of COVID-19 patients from the United States (Fig. 1A)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "YN_Im06 was severe, YN_Im01, YN_Im05, YN_Im07, and YN_Im08 were moderate, YN_Im02 was mild, and YN_Im03 and YN_Im04 were asymptomatic according to the latest COVID-19 diagnostic criteria (5th edition) published by the National Health Commission of China (Fig. 1B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "So far, three main clades involving G, V, and S have been identified based on marker mutations in the complete SARS-CoV-2 genome according to the latest genotyping rules recommended by the ",
            "GISAID",
            " databas."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 1382,
                "end": 1388,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Further, phylogenetic trees for SARS-CoV-2 full-length nucleotide sequences were constructed based on the obtained datasets with the maximum-likelihood method using IQ-tree."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, three novel mutations, including D1962V in nsp3 from the strain YN_Im03, L1375F in nsp3 and A829T in S protein from the isolate YN_Im04 were first identified in this study according to the comparison with 11,231 genomic sequences available at ",
            "GISAID",
            " on 4/26/2020.10",
            "Given that the three COVID-19 patients were diagnosed on the same day and the viruses originated from the same strain, indicated that the strain is replicating and mutating rapidly in different individuals."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 1825,
                "end": 1831,
                "name": "GISAID"
            },
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "After being interviewed by quarantine officers, she was transferred to Bamrasnaradura Infectious Disease Institute (BIDI) Hospital, Nonthaburi, for isolation and laboratory investigations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Genomic sequencing analysis included Sanger and next generation sequencing were performed by the Emerging Infectious Diseases Health Science Center, the Thai Red Cross Society and the Thai National Institute of Health, Department of Medical Sciences and the sequence shared via the ",
            "Global Initiative on Sharing All Influenza Data (GISAID) EpiCoV",
            " database (",
            "EPI_ISL_403962",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 471,
                "end": 534,
                "name": "Global Initiative on Sharing All Influenza Data (GISAID) EpiCoV"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 545,
                "end": 559,
                "name": "EPI_ISL_403962"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "Subsequent genome sequencing was again compatible with the SARS-CoV-2 and shared via the ",
            "GISAID EpiCoV",
            " database (",
            "EPI_ISL_403963",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 651,
                "end": 664,
                "name": "GISAID EpiCoV"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 675,
                "end": 689,
                "name": "EPI_ISL_403963"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "The genomes of the two separate cases of coronavirus disease 2019 (COVID-19) are identical over the full length of close to 30 kb and are furthermore identical to five other sequences (four from Wuhan and one from Zhejiang); together these sequences form the largest cluster of identical cases within the early outbreak, comprising a core of at least indirectly linked cases (Figure 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to the cases’ history, the two imported COVID-19 cases described here are not directly linked, yet their genomes are identical."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The missing link to the market, the time of travel and onset of symptoms in the two COVID-19 cases together with the incubation period of mean 6.4 days (range: 5.6–7.7) [16] and the time of closest genome neighbours obtained from sequences in Wuhan, suggest that transmission within Wuhan beyond the Huanan Seafood Market is likely to have occurred in the first week of January or earlier."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, while one cannot exclude the possibility that asymptomatic cases in their incubation period would be missed and become infectious later, screening of incoming travellers from an affected area proved successful at least in these two instances, when COVID-19 cases were detected, isolated, observed and only discharged once they tested negative for SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Rapid response including genome sequencing and sharing via ",
            "GISAID",
            " [18,19] (",
            "https://www.gisaid.org/",
            ") enabled fast dissemination of results and provided a glimpse of early transmission patterns in this outbreak."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 2036,
                "end": 2042,
                "name": "GISAID"
            },
            false,
            {
                "id": "T6",
                "type": "URL",
                "start": 2052,
                "end": 2075,
                "name": "https://www.gisaid.org/"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "We report two cases of coronavirus disease 2019 (COVID-19) in travellers from Wuhan, China to Thailand."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Probably started in December 2019 from a zoonotic transmission from traded wild animals in a Wuhan market (Hubei Province, China) [1,2], the coronavirus disease 2019 (COVID-19) quickly reached a planetary dimension forcing billions of people into lockdown, grinding to a halt most of the world economies, and killing in excess of 375,000 of the 6.1 million people known to be infected (as of 2 June 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Initially catalogued as a respiratory disease (severe acute respiratory syndrome, SARS), the investigation of severe COVID-19 cases progressively revealed their association with a dysfunctional pro-inflammatory response leading to severe lung damages [3], but also cardiovascular complications [4] and multi-organ failures [5]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The unexpected severity and dimension of the COVID-19 pandemic prompted national research organizations to ask their scientists, even without prior knowledge on coronaviruses, to use their expertise to contribute to the solution of this formidable challenge."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this paper, I present a bioinformatic investigation of publicly available sequence data, in an attempt to identify which molecular processes might be responsible of the specific clinical picture of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Several coincidental findings examined in the light of the rich pre-existing bibliographical information strongly suggest that virus-induced de-mono-ADP-ribosylation (de-MARylation) of STAT1 might be one of the key steps leading to the inflammatory cytokine storm seen in the most severe COVID-19 cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Due to the lockdown constraints imposed during the COVID-19 epidemic, all the bioinformatics analyses presented in this article were performed on publicly accessible bioinformatic platforms."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As previously noticed, the most similar isolate is bat coronavirus RaTG13 with 96.7% similarity (Accession # ",
            "QHR63299",
            ") [1], followed by two other bat isolates (# ",
            "AVP78030",
            ", # ",
            "AVP78041",
            ", 93.5% and 92.5% identical, respectively) [9], and several similar pangolin isolates (e.g., # ",
            "QIQ54046",
            ", 85.4% identical) (Cao et al., unpublished)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "AccessionNumber",
                "start": 1808,
                "end": 1816,
                "name": "QHR63299"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 1861,
                "end": 1869,
                "name": "AVP78030"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 1873,
                "end": 1881,
                "name": "AVP78041"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 1976,
                "end": 1984,
                "name": "QIQ54046"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It turns out that this protein plays a significant role in the regulation of the inflammatory response that is out of control in severe cases of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By following the natural incentive of all viruses to maximize their infectivity, hereby increasing the density of its receptor, SARS-CoV-2 triggers a cytokine storm as an unfortunate side-effect of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As more cases of COVID-19 are studied and treated worldwide, it had become apparent that the lethal and most severe cases of pneumonia are due to an out-of-control inflammatory response to the SARS-CoV-2 virus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A number of convergent findings suggest de-mono-ADP-ribosylation (de-MARylation) of STAT1 by the SARS-CoV-2 nsp3 as a putative cause of the cytokine storm observed in the most severe cases of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Incorporation of the nitrogen atom in the course of evolution allowed the synthesis of amino acids, as well as nucleic acids."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In contrast, SARS-CoV-2 was rapidly identified following the onset of the COVID-19 epidemic, as viruses appear to be identified only by the infectious diseases that they cause."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Viruses, including the SARS-CoV-2 virus responsible for the current COVID-19 epidemic, are a key to the understanding of life and evolution."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nitrogen incorporation in the primordial cell chemistry allowed synthesis of amino acids and nucleic acids, a prelude to RNA and subsequently DNA."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This classification is consistent with estimations on case fatality ratio of MERS, SARS and COVID-19, which is 35%, 9% and 2.4% respectively and with our observations on odds ratio of CG in their ORFS, which is 0.56, 0.44 and 0.39 respectively (Table S1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The outbreak of COVID-19 has brought great threat to human health."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The disease caused by SARS-CoV-2, coronavirus disease 2019 (COVID-19), has affected millions of people, with a death toll amounting to hundreds of thousands worldwide (, )."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As the coronavirus disease 2019 (COVID-19) pandemic continues to cause devastation, scientists race to increase their understanding of the disease-causing severe acute respiratory syndrome coronavirus 2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The binding pocket on the ribosome may be a target for drugs to treat COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the current coronavirus disease 2019 (COVID-19) pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A major reason for the failure to know when or where the virus first appeared seems to have been the widespread occurrence of asymptomatic cases of COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Importantly, there appear to be observations that suggest that a virus causing severe cases of atypical pneumonia already existed in mid‐December 2019 in China (Guo et al., 2020), possibly even in Italy, in France, and in the United States in January 2020 not initially ascribed to COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It could well be that early ancestors of SARS‐CoV‐2, producing asymptomatic infections had already spread before causing clinical—COVID‐19—disease (Forster et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In Wuhan hospitals, the healthcare personnel observed that the clinical characteristics of COVID‐19 patients at the onset of the disease became progressively different, possibly as new coronavirus variants emerged and spread over time and generations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We have tried to summarize here reasons to hope for a positive outcome of the outbreak of COVID‐2, namely via progressive attenuation of the virus (Armengaud et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, besides this optimistic exit from the COVID‐19 epidemic, we should be concerned by the high recombination potential of the virus, which may erase the mutations that allowed it to evolve towards attenuation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Monitoring as a function of time the genome sequences in closely related cases is critical to anticipate the future of SARS‐CoV‐2 and hence of COVID‐19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The coronavirus disease 2019 (COVID-19) pandemic has spread globally and caused massive loss of life and economic hardship."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Treatment strategies for critically ill COVID-19 patients are lacking, with only limited evidence available for a battery of antiviral, antibiotic, and anti-inflammatory agents, and aggressive supportive therapy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There are early anti–COVID-19 efficacy data with remdesivir."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "New therapies are needed to improve outcomes for critically ill COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Several small observational studies published during the COVID-19 pandemic suggest convalescent plasma is part of an effective treatment strategy for patients with severe disease.17, 18, 19, 20 The first report describing administration of convalescent plasma to five patients early in the COVID-19 outbreak in Wuhan was recently published."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Symptomatic patients with a high degree of clinical suspicion for COVID-19 disease were tested in the Molecular Diagnostics Laboratory at Houston Methodist Hospital using a validated assay applied for under Emergency Use Authorization from the US Food and Drug Administration."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Twenty-five patients with severe and/or life-threatening COVID-19 disease were enrolled in the study from March 28, 2020, to April 14, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of nine donors provided plasma that was used to transfuse COVID-19 patients; two donors gave plasma on multiple occasions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The observed thrombotic complications are consistent with findings reported for COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The current study was performed to evaluate the safety and potential benefit of transfusing convalescent plasma to patients with severe COVID-19 disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To date, this is the largest cohort assessed for outcomes pertaining to convalescent plasma transfusion for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Several case studies investigating the use of convalescent plasma to treat severe COVID-19 have recently been published,17, 18, 19, 20, 21 and the overall findings presented herein are consistent with these reports."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The results from this study support the existing data from the COVID-19 literature that point to underlying medical conditions, such as obesity, type 2 diabetes, and hypertension, playing a large role in patients' COVID-19 disease course and outcomes.36, 37, 38 Of transfused patients in this study, 68% (17/25) had a body mass index in the obese category and 84% were considered overweight."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Despite inconclusive data on ribavirin's efficacy in the treatment of SARS during the 2003 epidemic, proven safety and ready availability supported its use in the treatment of our COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Tocilizumab was recently shown to reduce mortality in a retrospective analysis of 20 severe COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The patient outcomes in the current study are similar to those recently published describing treating COVID-19 patients with remdesivir on a compassionate-use basis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Initial donors, who donated repeatedly, were blood type O. Because ABO compatibility was a requirement for recipient selection early in the study, many of our early recipients were also type O. Zhao et al have reported that of the 2173 patients analyzed in their study of COVID-19 patients in China, most had type A blood."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Regardless, our data do not reflect a higher rate of blood type A in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, has spread globally, and no proven treatments are available."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patients ( n = 25) with severe and/or life-threatening COVID-19 disease were enrolled at the Houston Methodist hospitals from March 28, 2020, to April 14, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The data indicate that administration of convalescent plasma is a safe treatment option for those with severe COVID-19 disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "21,789 complete SARS-CoV2 genomes were downloaded from ",
            "GISAID",
            " (",
            "Shu and McCauley 2017",
            ") (May 28, 2020)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 55,
                "end": 61,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "Creator",
                "start": 63,
                "end": 84,
                "name": "Shu and McCauley 2017"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We observed 8,427 SNPs in the current dataset (May 28, 2020) and we defined five major clades which contains 15 subclades (Fig.1",
            ", Fig.S2) compared to the prototype (",
            "MN908947.3",
            ")."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 268,
                "end": 278,
                "name": "MN908947.3"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "(Rambaut et al. 2020) and ",
            "GISAID",
            " (Shu and McCauley 2017)."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 307,
                "end": 313,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We have tested this protocol on 24 RNA samples from COVID-19 patients, and generated the barcode information from the publicly accessible Python script (https://github.com/raeece/sarscov2barcode)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "(A) The structure of the SARS-CoV-2 spike trimer in its open conformation (chains are cyan, magenta and grey) bound to the human receptor ACE2 (black) modeled based on ",
            "PDB",
            " accessions ",
            "6m17",
            " and ",
            "6vyb",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 704,
                "end": 707,
                "name": "PDB"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 719,
                "end": 723,
                "name": "6m17"
            },
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 728,
                "end": 732,
                "name": "6vyb"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T5",
                "end": "T6"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T5",
                "end": "T7"
            }
        ]
    },
    {
        "sen": [
            "In this study, we have defined 5 major clades (G614, S84, V251, I378 and D392) of fully-sequenced SARS-CoV-2 genomes available until May 28, 2020 in the ",
            "GISAID",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Dataset",
                "start": 887,
                "end": 893,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This is due to biases of genome data deposits from the sequencing laboratories based mainly in the Northern hemisphere and new datasets may define new clades or subclades in the near future from other regions, including Africa, the Indian subcontinent and Latin America from where there are comparably few genomes available at present."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The U.S. Food and Drug Administration (USFDA) has authorised Illumina COVIDSeq test which is intended for the detection of SARS-CoV-2 virus RNA for research use (https://www.illumina.com/products/by-type/ivd-products/covidseq.html)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to the COVIDseq instructions, up to 384 results per lane can be processed on the NovaSeq 6000 System for whole-genome sequecing."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our methodology is complementary to the COVIDSeq test and aimed at revealing the major clades of the virus in a given sample."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A total of 21,789 complete genomes were downloaded from ",
            "GISAID",
            " on May 28, 2020 for analyses."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Dataset",
                "start": 1794,
                "end": 1800,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The current coronavirus disease 2019 (COVID-19) pandemic has created challenges for the treatment of patients with cancer."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These patients are at a high risk of contracting COVID-19 because of the following factors: older age (≥65 years), medical comorbidities, and Eastern Cooperative Oncology Group status ≥2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "Furthermore, the SGO has stated that use of neoadjuvant chemotherapy may be effective in delaying surgery and hospitalization during the COVID-19 pandemic."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In both cases, the patients underwent 3 cycles of chemotherapy followed by repeat imaging with plans for possible IDS."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although IDS has been shown to be less morbid than primary cytoreductions, there are still inherent surgical risks."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The viral titers of the control mixtures (mixtures containing DMSO) were 103.25-6.75 50% tissue culture infective dose (TCID50)/mL. Solutions with virus and SS-derived components were incubated at 25 °C for varying periods of time, from 10 s to 48 h."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The log10 TCID50/mL was calculated using the Behrens–Kärber method [20]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The concentration of SS-derived samples was 250 µg/mL in the mixture containing purified IAV (8.25 log10 TCID50/mL)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The concentration of SS-derived samples was 250 µg/mL in the mixture containing purified IAV (8.25 log10 TCID50/mL), FCV (7.25 log10 TCID50/mL), and MNV (7.25 log10 TCID50/mL)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The concentration of Fr 1C was 250 µg/mL in the mixture containing SARS-CoV-2 (4.75 log10 TCID50/mL)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Fr 1C (250 µg/mL) or DMSO diluent was added to a PBS containing purified IAV (200 µg/mL, 5.75 log10 TCID50/mL)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The virucidal activity of Fr 1C was the most potent of this set; incubation with Fr 1C resulted in >99.98% inactivation of IAV (i.e., a reduction ≥3.83 log10 TCID50/mL; Table 2A)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All fractions except Fr 1A inactivated FCV within 1 min; >99.79% of FCV was inactivated within this time frame (reduction ≥2.67 log10 TCID50/mL; Table 2B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Overall, MNV inactivation of >98.52% was observed in response to these fractions (reduction ≥1.83 log10 TCID50/mL; Table 2C)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Compound Nos. 2–4 (25 µg/mL) had virucidal activity against both of IAV and FCV at 1 min, with >93.24% inactivation of IAV and FCV (reduction ≥1.17 log10 TCID50/mL; Table 3A,B)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We found that the aqueous extract and Fr 1B–E (all at 25 µg/mL) had significant virucidal activity against SARS-CoV-2 within 1 min of exposure; >99% of the virus was inactivated by components within these fractions (i.e., reduction of ≥2 log10 TCID50/mL)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We found that >99.53% of the virus was inactivated by Fr 1C within 10 s of exposure (reduction of ≥2.33 log10 TCID50/mL; Table 4A)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We found that 25 µg/mL of Fr 1C inactivated >99.6% of SARS-CoV-2 within 10 s (reduction of ≥2.33 log 10 TCID 50 /mL)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease‐2019 (COVID‐19), which is caused by a novel coronavirus termed severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is a respiratory disease that officially started in the Chinese city of Wuhan Hubei Province during December 2019 and has since spread globally as a pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of 13 May 2020, the total COVID‐19 world cases have surpassed four million with more than 250 000 deaths."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All 79 COVID‐19 whole genome sequences isolated from Italian patients from 29 January 2020 to 27 April 2020 (53, 11, 6, 6, 2, and 1 isolates from regions Abruzzo, Lazio, Friuli Venezia Giulia, Lombardy, Veneto, and Marche, respectively) (Table 1) and 48 COVID‐19 sequences from 24 December 2019 to 17 January 2020 in China have been downloaded from ",
            "GISAID",
            " (",
            "https://www.gisaid.org/",
            ") database."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 762,
                "end": 768,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 770,
                "end": 793,
                "name": "https://www.gisaid.org/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "The data set has been aligned using multiple sequence alignment (MAFFT) online tool",
            " and manually edited using Bioedit program v7.0.5."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In fact, recent evidence",
            " strongly suggests that the virus was circulating unrecognized in Lombardy since at least mid‐January, while the first official COVID‐19 Italian case was notified in Codogno (Lombardy) only the 21st of February."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For this and the additional reason that many efforts to generate a safe and efficacious COVID‐19 vaccine focus upon the spike component, changes in its composition and structure are particularly relevant."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nucleocapsid protein was also proposed to be important in COVID‐19 infectivity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This new coronavirus disease (COVID‐19) has caused more than 3100 deaths, mainly in continental China and mostly on elderly people, who are affected by fever and serious respiratory diseases like pneumonia."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            ",",
            "SARS‐CoV‐2 has a single‐stranded RNA genome and its length is similar to other related coronaviruses, with an extension near 29 890 bp (",
            "GenBank",
            " ",
            "NC_045512.2",
            ")."
        ],
        "lab": [
            false,
            false,
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 348,
                "end": 355,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 356,
                "end": 367,
                "name": "NC_045512.2"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "The most related genomes available in public databases were bat‐SL‐CoVZC45 (",
            "GenBank",
            " ",
            "MG772933",
            ") with an 87.99% sequence identity and bat‐SL‐CoVZXC21 (",
            "GenBank",
            " ",
            "MG772934",
            ") with an 87.23% sequence identity,",
            " followed by the human viruses SARS‐CoV‐Tor2 (",
            "GenBank",
            " ",
            "NC_004718",
            ") and MERS‐CoV (",
            "GenBank",
            " ",
            "NC_019843",
            ") with a 79.0% and 51.8% of nucleotide identity, respectively."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 446,
                "end": 453,
                "name": "GenBank"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 454,
                "end": 462,
                "name": "MG772933"
            },
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 518,
                "end": 525,
                "name": "GenBank"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 526,
                "end": 534,
                "name": "MG772934"
            },
            false,
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 616,
                "end": 623,
                "name": "GenBank"
            },
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 624,
                "end": 633,
                "name": "NC_004718"
            },
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 649,
                "end": 656,
                "name": "GenBank"
            },
            false,
            {
                "id": "T10",
                "type": "AccessionNumber",
                "start": 657,
                "end": 666,
                "name": "NC_019843"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T7",
                "end": "T8"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T9",
                "end": "T10"
            }
        ]
    },
    {
        "sen": [
            "There are also at least six predicted ORFs as hypothetical proteins with no associated function."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            ",",
            "Near 286 complete genomes of SARS‐CoV‐2 and related viruses, has been submitted to the ",
            "GISAID",
            " database (",
            "www.gisaid.org/CoV2020",
            ") collecting genetic information of the outbreak worldwide."
        ],
        "lab": [
            false,
            false,
            false,
            {
                "id": "T11",
                "type": "Dataset",
                "start": 918,
                "end": 924,
                "name": "GISAID"
            },
            false,
            {
                "id": "T12",
                "type": "URL",
                "start": 935,
                "end": 957,
                "name": "www.gisaid.org/CoV2020"
            },
            false
        ],
        "rel": [
            {
                "id": "R6",
                "bool": true,
                "head": "T11",
                "end": "T12"
            }
        ]
    },
    {
        "sen": [
            "Recently Tang et al",
            " and ",
            "GISAD",
            " database in the SARS‐CoV‐2 portal defined three subtypes: S, G, and V, according to nucleotide variants that produce amino acid changes."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T13",
                "type": "Dataset",
                "start": 1042,
                "end": 1047,
                "name": "GISAD"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID‐19 cases in Spain started to be reported since February 1st with a very low number of cases for about a month, where the reported cases may be underestimated, and after a month the infected people started to raise over a hundred patients.",
            ","
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In 2020, SARS‐CoV‐2, first reported from Hubei province of China in December 2019, has become the first coronavirus to cause a pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            " Most patients with coronavirus disease 2019 (COVID‐19) present with respiratory symptoms, while 18% exhibit gastrointestinal symptoms."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Radiologically, COVID‐19 is characterized by multifocal and peripheral ground‐glass opacities, but 2.9% of severe cases did not show any abnormalities in their lung computed tomography."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            " Complications include acute respiratory distress syndrome, arrhythmia, secondary bacterial infection, and multiorgan failure."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ", ",
            " Pathologically, COVID‐19 was characterized by diffuse alveolar damage, endothelialitis interstitial lymphocyte infiltrates, and multinucleated syncytial cells in the lung, and microvascular steatosis in the liver."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            ",",
            "The importance of diagnostic testing is well demonstrated with COVID‐19."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Many groups have shared their in‐house real‐time reverse transcription‐polymerase chain reaction (RT‐PCR) protocol with the World Health Organization during the early period of COVID‐19, which have tremendously helped clinical microbiology laboratories around the world in the detection of SARS‐CoV‐2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to an analysis by ",
            "GISAID",
            ", 0.02% to 0.53% of the genomes contain mutations in the last five nucleotides of the 3′ ends of the published RT‐PCR primer regions."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 1215,
                "end": 1221,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These specimens included 101 clinical specimens collected from COVID‐19 patients admitted to Queen Mary Hospital, or from COVID‐19 patients admitted to Princess Margaret Hospital for whom specimens were sent to Queen Mary Hospital for viral load testing."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The consensus sequences of five specimens from four patients (HKU‐902a, HKU‐903a, HKU‐903b, HKU‐907b, and HKU‐908a) were previously deposited into ",
            "NCBI GenBank",
            " (accession number: ",
            "MT114412",
            ", ",
            "MT114414",
            ", ",
            "MT114415",
            ", ",
            "MT114417",
            ", ",
            "MT114418",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 1757,
                "end": 1769,
                "name": "NCBI GenBank"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 1789,
                "end": 1797,
                "name": "MT114412"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 1799,
                "end": 1807,
                "name": "MT114414"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 1809,
                "end": 1817,
                "name": "MT114415"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 1819,
                "end": 1827,
                "name": "MT114417"
            },
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 1829,
                "end": 1837,
                "name": "MT114418"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T2",
                "end": "T4"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T2",
                "end": "T5"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T2",
                "end": "T6"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T2",
                "end": "T7"
            }
        ]
    },
    {
        "sen": [
            "The consensus sequences of HKU‐904a, HKU‐905a, HKU‐911a, HKU‐913a, and HKU‐915a have been deposited into ",
            "NCBI GenBank",
            " (accession number: ",
            "MT365028",
            "‐",
            "MT365032",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 1945,
                "end": 1957,
                "name": "NCBI GenBank"
            },
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 1977,
                "end": 1985,
                "name": "MT365028"
            },
            false,
            {
                "id": "T10",
                "type": "AccessionNumber",
                "start": 1986,
                "end": 1994,
                "name": "MT365032"
            },
            false
        ],
        "rel": [
            {
                "id": "R6",
                "bool": true,
                "head": "T8",
                "end": "T9"
            },
            {
                "id": "R7",
                "bool": true,
                "head": "T8",
                "end": "T10"
            }
        ]
    },
    {
        "sen": [
            "Raw reads, after excluding human reads, have been deposited into BioProject (Bioproject ID: ",
            "PRJNA627286",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "AccessionNumber",
                "start": 2089,
                "end": 2100,
                "name": "PRJNA627286"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The concentration of the virus culture stock was 1.8 × 107 50% tissue culture infective doses (TCID50)/mL. Triplicates were performed for each dilution in two independent experiments."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nucleotide sequences were downloaded from ",
            "NCBI Genbank",
            " and ",
            "GISAID",
            " (Table S2)."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 2329,
                "end": 2341,
                "name": "NCBI Genbank"
            },
            false,
            {
                "id": "T13",
                "type": "Dataset",
                "start": 2346,
                "end": 2352,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Specific primers and probes targeting SARS‐CoV‐2 were selected by aligning more than 7000 SARS‐CoV‐2 sequences downloaded from ",
            "GISAID",
            " on 22 April 2020, other human Betacoronaviruses, and a bat SARS‐like coronavirus (Figure 1)."
        ],
        "lab": [
            false,
            {
                "id": "T14",
                "type": "Dataset",
                "start": 2492,
                "end": 2498,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of these 101 COVID‐19 patients, SARS‐CoV‐2 was detected by at least one of nsp1, N or E gene RT‐PCR assays in 99 patients (98.0%), and 85 patients (84.2%) were detected by all three RT‐PCR assays (Table 2)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Together with the analysis done by ",
            "GISAID",
            ",",
            " which showed higher mutation rate in the published N gene primers/probe region, nsp1 can serve as an alternative target for the detection of SARS‐CoV‐2."
        ],
        "lab": [
            false,
            {
                "id": "T15",
                "type": "Dataset",
                "start": 2834,
                "end": 2840,
                "name": "GISAID"
            },
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Shortly after the announcement of SARS‐CoV‐2 as the causative pathogen of COVID‐19, Shirato et al",
            " has reported the use of a conventional nested RT‐PCR targeting nsp1 gene, but require Sanger sequencing for confirmation."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Abstract  Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has caused the coronavirus disease 2019 (COVID‐19) pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Accurate detection of SARS‐CoV‐2 using molecular assays is critical for patient management and the control of the COVID‐19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using sequence‐independent single‐primer amplification and nanopore whole‐genome sequencing, we have found that the nonstructural protein 1 (nsp1) gene, located at the 5′ end of the SARS‐CoV‐2 genome, was highly expressed in the nasopharyngeal or saliva specimens of 9 COVID‐19 patients of different clinical severity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), genus Betacoronavirus, subgenus Sarbecovirus, family Coronaviridae, is a positive-polarity single-stranded RNA virus that probably originated in bats (Andersen et al., 2020, Lu et al., 2020, Gorbalenya et al., 2020) and is the causative agent of coronavirus disease of 2019 (COVID-19) (Li et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The dynamics of the COVID-19 pandemic have proven to be complex."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Many challenges remain pertaining to a better understanding of the epidemiology, pathology, and transmission of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For example, the clinical manifestations of COVID-19 range from an asymptomatic infection, mild respiratory illness to pneumonia, respiratory failure, multiorgan failure, and death (Guan et al., 2020, Jiang et al., 2020, Zhu et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, SARS-CoV-2 genomic RNA has been detected in airborne material collected by air samplers positioned distal to COVID-19 patients (Liu et al., 2020, Guo et al., 2020, Santarpia et al., 2020, Chia et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Because efforts to isolate virus in cell cultures in the aforementioned air sampling studies in hospital wards were not made (Guo et al., 2020, Chia et al., 2020), or failed when they were attempted due to overgrowth by faster replicating respiratory viruses (Lednicky et al., 2020), and so far only one has provided evidence of virus isolation (Santarpia et al., 2020), uncertainties about the role of aerosols in COVID-19 transmission remain."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Because, we previously collected SARS-CoV-2 from the air of a respiratory illness ward within a clinic but were unable to isolate the virus in cell cultures due to out-competition by other respiratory viruses (Lednicky et al., 2020), we sought to perform air sampling tests in a hospital room reserved for COVID-19 patients, to lessen the probability of collecting other airborne human respiratory viruses."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We thus collected aerosols containing SARS-CoV-2 in a room housing COVID-19 patients using our VIVAS air samplers that collect virus particles without damaging them, thus conserving their viability."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Air samples were collected in a room that was part of a designated COVID-19 ward (Figure 1",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Following the removal of host sequences (Chlorocebus sabaeus; ",
            "GenBank",
            " assembly accession number ",
            "GCA_000409795.2",
            ") using Kraken 2 (wood et al., 2019), de novo assembly of paired-end reads was performed in SPAdes v3.13.0 with default parameters (Bankevich et al., 2012)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 2221,
                "end": 2228,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 2255,
                "end": 2270,
                "name": "GCA_000409795.2"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            }
        ]
    },
    {
        "sen": [
            "Whereas the concentration of SARS-CoV-2 genome equivalents per liter of air were estimated (Table 2), the determination of the specific infectivity (ratio of SARS-CoV-2 genome equivalents present for every one able to infect a cell in culture) required the performance of a plaque assay or a standard 50% endpoint dilution assay (TCID50 assay)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Plaque assays could not be performed due to a nationwide nonavailability of some critical media components (due to COVID-19 pandemic-related temporary lockdown of production facilities), so TCID50 assays were performed in Vero E6 cells to estimate the percentage of the collected virus particles that were viable."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Estimates ranged from 2 to 74 TCID50 units/L of air (Table 4",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The nearly complete genome sequence (and the virus isolate) was designated SARS-CoV-2/human/UF-19/2020, and this genome sequence has been deposited in ",
            "GenBank",
            " (accession no. ",
            "MT668716",
            ") and in ",
            "GISAID",
            " (accession no. ",
            "EPI_ISL_480349",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 3301,
                "end": 3308,
                "name": "GenBank"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 3324,
                "end": 3332,
                "name": "MT668716"
            },
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 3341,
                "end": 3347,
                "name": "GISAID"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 3363,
                "end": 3377,
                "name": "EPI_ISL_480349"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T5",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "This complete genome sequence of the virus collected by the air samplers (and the virus therein) was considered the same isolate and designated SARS-CoV-2/Environment/UF-20/2020, and this genome sequence has been deposited in ",
            "GenBank",
            " (accession no. ",
            "MT670008",
            ") and in ",
            "GISAID",
            " (accession no. ",
            "EPI_ISL_477163",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 3606,
                "end": 3613,
                "name": "GenBank"
            },
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 3629,
                "end": 3637,
                "name": "MT670008"
            },
            false,
            {
                "id": "T9",
                "type": "Dataset",
                "start": 3646,
                "end": 3652,
                "name": "GISAID"
            },
            false,
            {
                "id": "T10",
                "type": "AccessionNumber",
                "start": 3668,
                "end": 3682,
                "name": "EPI_ISL_477163"
            },
            false
        ],
        "rel": [
            {
                "id": "R4",
                "bool": true,
                "head": "T7",
                "end": "T8"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T9",
                "end": "T10"
            }
        ]
    },
    {
        "sen": [
            "The virus’ genomic sequence currently falls within ",
            "GISAID",
            " clade B.1(GH), which is characterized by mutations C241T, C3037T, A23403G, G25563T, S-D614G, and NS3-Q57H relative to reference genome WIV04 (",
            "GenBank",
            " accession no."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Dataset",
                "start": 3736,
                "end": 3742,
                "name": "GISAID"
            },
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 3885,
                "end": 3892,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As reported in air sampling tests performed by others (Liu et al., 2020, Wang et al., 2020, Holshue et al., 2020, Santarpia et al., 2020) and in our previous report (Lednicky et al., 2020), airborne SARS-CoV-2 was present in a location with COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Unlike previous studies, we have demonstrated that the virus in aerosols can be viable, and this suggests that there is an inhalation risk for acquiring COVID-19 within the vicinity of people who emit the virus through expirations including coughs, sneezes, and speaking."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The amount of airborne virus detected per liter of air was small, and future studies should address (a) whether this is typical for COVID-19, (b) if this represented virus production relative to the phase of infection in the patient, (c) if this was a consequence of active air flow related to air exchanges within the room, (d) or if the low number of virus was due to technical difficulties in removing small airborne particles from the air (Pan et al., 2019)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our findings reveal that viable SARS-CoV-2 can be present in aerosols generated by a COVID-19 patient in a hospital room in the absence of an aerosol-generating procedure, and can thus serve as a source for transmission of the virus in this setting."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Moreover, the public health implications are broad, particularly as current best practices for limiting the spread of COVID-19 center on social distancing, wearing of face coverings while in proximity to others and hand washing."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "With the current surge of cases, to help stem the COVID-19 pandemic, clear guidance on control measures against SARS-CoV-2 aerosols are needed, as recently voiced by other scientists (Morawska and Milton, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Air samples collected in the hospital room of two coronavirus disease-2019 (COVID-19) patients, one ready for discharge and the other newly admitted, were subjected to RT-qPCR and virus culture."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Estimates of viable viral concentrations ranged from 6 to 74 TCID 50 units/L of air."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Conclusions  Patients with respiratory manifestations of COVID-19 produce aerosols in the absence of aerosol-generating procedures that contain viable SARS-CoV-2, and these aerosols may serve as a source of transmission of the virus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The disease caused by SARS-CoV-2 was called “coronavirus disease 2019” (COVID-19) [7]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The complete genomic sequences of SARS-CoV-2 were obtained from ",
            "2019 Novel Coronavirus Resource (2019nCoVR)",
            " [12] and two databases, including the ",
            "National Center for Biotechnology Information (NCBI)",
            " [13] and ",
            "Global Initiative on Sharing All Influenza Data (GISAID)",
            " [14]."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 151,
                "end": 194,
                "name": "2019 Novel Coronavirus Resource (2019nCoVR)"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 233,
                "end": 285,
                "name": "National Center for Biotechnology Information (NCBI)"
            },
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 295,
                "end": 351,
                "name": "Global Initiative on Sharing All Influenza Data (GISAID)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The differences and similarities of clinical characteristics between COVID-19 and SARS were summarized in Table 1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The main timeline of SARS and COVID-19 epidemic development were shown in Figure 1a,b, respectively."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In comparison, COVID-19 showed similar trends with SARS patients [28]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Beijing Centers for Diseases Control and Prevention indicated that the typical case of COVID-19 has a progressive aggravation process."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 can be classified into light, normal, severe, and critical types based on the severity of the disease [31]: (1) Mild cases—the clinical symptoms were mild, and no pneumonia was found on the chest computed tomography (CT); (2) normal cases—fever, respiratory symptoms, and patients found to have imaging manifestations of pneumonia; (3) severe cases—one of the following three conditions: Respiratory distress, respiratory rate ≥ 30 times/min (in resting state, refers to oxygen saturation ≤ 93%), partial arterial oxygen pressure (PaO2)/oxygen absorption concentration (FiO2) ≤ 300 mmHg (1 mmHg = 0.133 kPa); (4) critical cases—one of the following three conditions: Respiratory failure and the need for mechanical ventilation, shock, or the associated failure of other organs requiring the intensive care unit [32]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It has been demonstrated that the latency of COVID-19 varies from 3–7 days on average, for up to 14 days [35]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By comparison, we found that the average latency of COVID-19 is slightly longer than that of SARS."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Li et al. reported that people who have not been exposed to SARS-CoV-2 are all susceptible to COVID-19 [41]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among the 8,866 patients who have been confirmed with COVID-19, nearly half of the patients have been aged 50 years or older (47.7%) [36]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, severe COVID-19 cases and deaths have mostly been in the middle-aged adults and the elderly with long smoking histories or other basic diseases, such as heart disease and hypertension [43,44]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At the time that this paper was been submitted, COVID-19 patients mortality rate was 2.1% [45]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "According to the latest data on Feb. 14th, 2020 [55,56], there have been a total of 67,081 clinically diagnosed cases of COVID-19 in worldwide, with 1,526 deaths."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As the origin area of COVID-19, Hubei province has been the most severely infected area, with 54,406 cumulative diagnosis cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At present, the COVID-19 outbreak has been spread to all parts of China and around the world, including the United States, Thailand, and Japan."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The distribution of COVID-2019 patients in China (including Hong Kong, Macao and Taiwan) and Hubei Province is shown in Figure 3."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As the number of COVID-19 patients in China has been growing rapidly, preventing the spread of SARS-CoV-2 is the most important and urgent task [57]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The possible pathogens of SARS and COVID-19 are both derived from wild animals [63]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The early symptoms of SARS and COVID-19 are very similar to winter influenza, and the most important way to distinguish flu and pneumonia is to take throat swabs for viral testing [68]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Both SARS-CoV and SARS-CoV-2 are CoVs; hence, the treatment strategies of SARS could be relevant for COVID-19 [74]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Now, isolation, antiviral, and symptomatic treatments are still mainly adopted for COVID-19 treatment."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As effective drugs for SARS, hormones and interferons can also be used to treat COVID-19 [74]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Lopinavir/ritonavir has also been clinically tested in treatment of COVID-19, and showed wonderfully effective treatment for some patients, but the general clinical effect has not been determined [78]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A high-resolution crystal structure of SARS-CoV-2 coronavirus 3CL hydrolase (Mpro) was announced after the outbreak of COVID-19 in the world [80], and human coronaviruses (HCoVs) have been treated as severe pathogens in respiratory tract infections."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Clinical trials of remdesivir for treatment of COVID-19 just started on Feb. 5th and 12th, 2020 in Wuhan and Beijing, respectively, and the experimental results remain unclear [85,86]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As a large number of people have left Wuhan, the control of the epidemic situation is extremely urgent, and the treatments of COVID-19 are imminent."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Hence, clinical drugs and therapies for treating SARS may be used as a reference for COVID-19 treatment [74]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although more and more studies for SARS-CoV-2 have sprung up since the outbreak of this epidemic COVID-19, based on our comparison, we propose some key questions to be clarified in future studies (Table 3)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In-depth understanding the underlying pathogenic mechanisms of SARS-CoV-2 will reveal more targets for better therapy of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This virus causes acute lung symptoms, leading to a condition that has been named as “coronavirus disease 2019” (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To date, Covid-19 associated pneumonia accounts (as of 14th July 2020, source: www.who.int, “COVID-19 Situation report - 176”) almost 13 Million confirmed cases and more than 550′000 deaths since its first reported discovery in the Hubei province in China in December 2019 [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Reference coronavirus genomes were obtained either from ",
            "NCBI GenBank",
            " (",
            "https://www.ncbi.nlm.nih.gov/genbank/",
            ") or from ",
            "GISAID",
            " (",
            "https://www.gisaid.org/",
            ") databases as suggested from the recent discoveries on the proximal origins of SARS-CoV-2 [2,3]",
            "(Detailed accession numbers in Supplementary Table 1)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 334,
                "end": 346,
                "name": "NCBI GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 348,
                "end": 385,
                "name": "https://www.ncbi.nlm.nih.gov/genbank/"
            },
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 395,
                "end": 401,
                "name": "GISAID"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 403,
                "end": 426,
                "name": "https://www.gisaid.org/"
            },
            false,
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "Although little information is available on lung epithelium ageing-dependent mechanisms, we hypothesize that E protein significantly increase this dysfunction, especially in elderly people as evidenced by COVID-19 epidemiological data."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We compared the genomic sequences of E protein of SARS-CoV-2, SARS-CoV and the closely related genomes of bats and pangolins obtained from the ",
            "GISAID",
            " and ",
            "GenBank",
            " databases."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 957,
                "end": 963,
                "name": "GISAID"
            },
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 968,
                "end": 975,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Large scale testing is essential, but estimates indicate that large numbers of mild, asymptomatic or pre-symptomatic COVID-19 cases are not detected by current testing efforts (Kobayashi et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the U.S., one estimate suggest that only 1.6% of COVID-19 cases have been detected (Vollmer, 2020), while another study estimates that about 17.9% of individuals infected with SARS-CoV-2 are asymptomatic at their first positive test and may not develop symptoms for up to two weeks (Mizumoto et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, most symptoms associated with COVID-19, such as fever and cough, are non-specific and do not distinguish COVID-19 cases from individuals with other respiratory infections (Guan et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nucleic acid tests employing RT-PCR, are the primary means employed to diagnose COVID-19 using respiratory samples (CDC, 2020; Udugama et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A recently deployed isothermal assays for COVID-19 that uses the Abbott ID Now system requires less expensive equipment and less training, but also produces less definitive results."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, RT-qPCR assays are still the gold-standard for COVID-19 diagnosis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Rapid and ultrasensitive COVID-19 diagnostic assays that are capable of high-throughput analyses and which do not require a high degree of technical expertise or sophisticated equipment are required to expand COVID-19 testing capacity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "One recently published report, incorporated RT-LAMP with CRISPR-Cas12a to allow detection of SARS-CoV-2 in respiratory swab RNA extracts in a colorimetric lateral flow assay (Broughton et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 CRISPR-FDS assay we describe uses a streamlined approach that does not require any special equipment beyond that found in most clinical and research laboratories."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 CRISPR-FDS assays performed with RT-PCR and RT-RPA amplified samples, detected samples spiked with ≥2 copies of the target RNA sequence, regardless of the method used in the pre-amplification step (Fig. 3",
            "A and B), in good agreement with our calculated estimate for its LOD."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For the analysis of clinical samples, a COVID-19 CRISPR-FDS assay result was considered positive if it was equal or greater than a cut-off threshold equal to the mean signal of the negative control samples plus three times its standard deviation (Kim et al., 2016)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although RT-qPCR is the most widely used diagnostic method for COVID-19, its sensitivity has not proven satisfactory, resulting in a relatively high number of false-negative results, so that a substantial number of infected individuals do not receive proper diagnoses and treatment."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In a study of more than 1000 patients, 75% of COVID-19 suspects had negative RT-qPCR test results but positive chest computerized tomograph results, and 48% of these patients were considered highly likely to have had COVID-19, with an additional 33% considered probable cases (Ai et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Various isothermal amplification methods, such as RPA and LAMP, have been reported for the detection of COVID-19 (Ding et al., 2020; Lucia et al., 2020; Yu et al., 2020), but many problems were identified upon detailed analysis of these methods, including low sensitivity and low throughput."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We do not see this as a major drawback given the clear need for rapid, sensitive, and robust assays to diagnose COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "CRISPR assay diagnostic results obtained nasal swab samples of individuals with suspected COVID-19 cases were comparable to paired results from a CDC-approved quantitative RT-PCR (RT-qPCR) assay performed in a state testing lab, and superior to those produced by same assay in a clinical lab, where the RT-qPCR assay exhibited multiple invalid or inconclusive results."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Based on these findings, we believe that a CRISPR-based fluorescent application has potential to improve current COVID-19 screening efforts."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Highlights     •  Integrated CRISPR for COVID-19 clinical diagnosis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "•  Detection environment friendly and compatible for high throughput COVID-19 screening in hospital."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "•  Improve diagnosis of individuals with suspected COVID-19 infections."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A new coronavirus SARS-CoV-2 capable to infect humans, emerged in mid-December 2019 in Wuhan, China, causing the novel disease COVID-19 (Wu et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A recent study which analyzed COVID-19 symptoms in monozygotic and dizygotic twins, reported that 50 (95% confidence intervals 29–70)% of the variance of ‘predicted COVID-19’ phenotype is due to genetic factors (Williams et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "It has been shown that plasmin is also capable to cleave furin sites (Zhao et al., 2020) and that individuals with elevated plasmin demonstrated higher susceptibility to COVID-19 (Ji et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "At the beginning of May 2020, in the full swing of COVID-19 pandemic, the data on genetic susceptibility or resistance to SARS-CoV-2 which would be based on the genotyping of individuals infected by SARS-CoV-2 are still lacking."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, we can learn from clinical experiences of the SARS-CoV-2 infection which showed that plasmin and other airway proteases could also be important for patients experiencing more severe form of COVID-19 (Ji et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To systematically examine the coding variants in selected genes and differences in the allele frequency between populations, we performed comparative analysis of 22 variants found in FURIN, PLG, PRSS1, TMPRSS11a, MBL2 and OAS1 genes from Serbian population database with different European populations and super-populations extracted from ",
            "1kGP",
            " database (",
            "Genomes Project et al., 2015",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1388,
                "end": 1392,
                "name": "1kGP"
            },
            false,
            {
                "id": "T2",
                "type": "Creator",
                "start": 1403,
                "end": 1431,
                "name": "Genomes Project et al., 2015"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Having in mind that individuals with elevated plasmin had greater susceptibility to COVID-19 and more severe clinical manifestations (Ji et al., 2020), rare variants in PLG, such as p.Arg261His and p.Ala494Val may be recognized as potential markers of inter-individual differences in susceptibility to coronavirus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Having in mind the MAF difference between Spanish and East Asian populations, it would be interesting to further investigate whether it also reflects the remarkable differences in susceptibility and morbidity to COVID-19 between these populations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While variant p.Gln293Arg was described as a cumulative risk factor for esophageal squamous cell carcinoma (Suo et al., 2019), its effect on the protease activity and COVID-19 susceptibility remains to be elucidated."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "New coronavirus SARS-CoV-2 is capable to infect humans and cause a novel disease COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Aiming to understand a host genetic component of COVID-19, we focused on variants in genes encoding proteases and genes involved in innate immunity that could be important for susceptibility and resistance to SARS-CoV-2 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This has been made evident by the ongoing pandemic of severe acute respiratory syndrome (SARS), officially named COVID-19, caused by the betacoronavirus SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Most important in the context of the COVID-19 pandemic, four betacoronaviruses, SARS-CoV, SARS-CoV-2, MERS-CoV, and SCH 1 014-CoV, a bat coronavirus, were significantly crippled by TOP3B KO (Fig. 2C)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As of April 30th, 2020 there were approximately 3.1 M confirmed cases of COVID-19 worldwide and more than 217.000 infection-related deaths."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, in our study, CFR was calculated as the ratio between the death cases due to COVID-19, over the total number of SARS-CoV-2 reported cases 14 days before, as previously described [11]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Mortality calculations during the epidemics are difficult, mostly due to calculation biases: during the initial period of the epidemic, many patients were diagnosed with COVID-19 only after developing critical illness or even at the time of death, whereas asymptomatic or paucisymptomatic patients were untested, leading to an underestimation of the denominator [11]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We chose to analyze the Country-specific data relative to the number of COVID-19 deaths in April 2020, when some of the initial biases were likely attenuated, using the method described [11]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, even if the daily number of death patients divided per age is available for each Country, we could not provide in this study a further normalization of the CFR taking into account patients age, since a similar daily database of infected people divided per age is not publicly available."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A database of 487 genome sequences isolated from patients infected with SARS-CoV-2 in Italy, Spain, Germany, France, UK, Sweden and USA has been randomly collected from the ",
            "GISAID",
            " database, aligned and compared to the SARS-CoV-2 reference genome."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 1364,
                "end": 1370,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The only significant difference is the newly emerged mutation nt24368, that in our database was detected only in the genomes analyzed in Sweden."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Background  Severe acute respiratory syndrome CoV-2 (SARS-CoV-2) caused the first coronavirus disease 2019 (COVID-19) outbreak in China and has become a public health emergency of international concern."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Case fatality rate was calculated as the ratio between the death cases due to COVID-19, over the total number of SARS-CoV-2 reported cases 14 days before."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also analyzed 487 genomic sequences from the ",
            "GISAID",
            " database derived from patients infected by SARS-CoV-2 from January 2020 to April 2020 in Italy, Spain, Germany, France, Sweden, UK and USA."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 1989,
                "end": 1995,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 reference genome was obtained from the ",
            "GenBank",
            " database (",
            "NC_045512.2",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 2186,
                "end": 2193,
                "name": "GenBank"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 2204,
                "end": 2215,
                "name": "NC_045512.2"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "We calculated case fatality rates by dividing the death number of a specific day by the number of patients with confirmed COVID-19 infection observed 14 days before and normalized by a ρ factor which takes into account the diagnostic PCR testing capability of each Country and the number of positive cases detected."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Data available in the ",
            "GISAID",
            " database and in a public repository that does not issue datasets with DOIs."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 2556,
                "end": 2562,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Chemoinformatics searches from the IUPHAR/BPS Guide to Pharmacology (2020–3-12) and the ChEMBL25 database on the human interactors yielded 16 approved drugs, 3 investigational new drugs (clinical), and 18 pre-clinical candidates (Supplementary Table 4); while target- and pathway-specific literature search revealed 13 approved drugs, 9 investigational new drugs (clinical), and 10 preclinical candidates (Supplementary Table 5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Two classes of molecules emerged as effectively reducing viral infectivity: protein biogenesis inhibitors (zotatifin, ternatin-4, and PS3061; Fig. 6b, Extended Data Fig. 9) and ligands of the Sigma1 and Sigma2 receptors: haloperidol, PB28, PD-144418 and hydroxychloroquine, which is undergoing clinical trials in COVID-19 patients; we also subsequently found the SigmaR1/R2 active drugs clemastine, cloperastine, and progesterone (Fig. 6c, Extended Data Fig. 9) and the clinical molecule siramesine (Extended Data Figure 9) to be antiviral."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "TCID50 assays on supernatants from infected cells treated with PB28 (IC90 0.278 μM) and zotatifin (IC90 0.037 μM) revealed a more potent inhibition than was observed in the NP-staining assay (Fig. 6d)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A critical question going forward is whether these or related inhibitors of viral protein biogenesis will show therapeutic benefit in COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Plitidepsin is currently under consideration by the Spanish Medicines Agency for a Phase II trial in hospitalized COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "By the same standard, we find that the widely used antitussive dextromethorphan harbors proviral activity and therefore its use should merit caution and further study in the context of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, this area of pharmacology has great promise for repurposing and for the optimization of new agents in the fight against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To identify drugs and reagents that modulate the 332 host factors interacting with SARS-CoV-2-HEK293T/17 (MiST >= 0.70), we used two approaches: 1) a chemoinformatic analysis of open-source chemical databases and 2) a target- and pathway-specific literature search, drawing on specialist knowledge within our group."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Chemoinformatically, we retrieved 2,472 molecules from the IUPHAR/BPS Guide to Pharmacology (2020–3-12) (Supplementary Table 7) that interacted with 30 human “prey” proteins (38 approved, 71 in clinical trials), and found 10,883 molecules (95 approved, 369 in clinical trials) from the ",
            "ChEMBL",
            "25 database (Supplementary Table 8)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 2397,
                "end": 2403,
                "name": "ChEMBL"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For both approaches, molecules were prioritized on their FDA approval status, activity at the target of interest better than 1 μM, and commercial availability, drawing on the ",
            "ZINC",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 2615,
                "end": 2619,
                "name": "ZINC"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Complete methods can be found here (https://github.com/momeara/BioChemPantry/tree/master/vignette/COVID19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The analysis is based on 2,784 sequences obtained from ",
            "GISAID",
            " on April 4, 2020."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 2793,
                "end": 2799,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The novel coronavirus SARS-CoV-2, the causative agent of COVID-19 respiratory disease, has infected over 2.3 million people, killed over 160,000, and caused worldwide social and economic disruption 1 , 2 ."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Further studies of these host factor targeting agents, including their combination with drugs that directly target viral enzymes, could lead to a therapeutic regimen to treat COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The dataset used for phylogenetic analysis included (n = 54) genomes sequences from the current 2019‐nCoV epidemic plus (n = 2) closely related bat strains (SARS‐like CoV) retrieved from ",
            "NCBI",
            " (",
            "http://www.ncbi.nlm.nih.gov/genbank/",
            ") and ",
            "GISAID",
            " (",
            "https://www.gisaid.org/",
            ") databases."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 187,
                "end": 191,
                "name": "NCBI"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 193,
                "end": 229,
                "name": "http://www.ncbi.nlm.nih.gov/genbank/"
            },
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 235,
                "end": 241,
                "name": "GISAID"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 243,
                "end": 266,
                "name": "https://www.gisaid.org/"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "Both SS and PS estimators indicated the uncorrelated relaxed molecular clock (Bayes factor = 4.3) as the best‐fitted model to the dataset under analysis."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A maximum clade credibility tree has been built using a dataset of 54 genome sequences of 2019‐nCoV plus two closely related bat strains (SARS‐like CoV) available in ",
            "GenBank",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 599,
                "end": 606,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "During the cruise, a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak occurred among the passengers and crew members, ultimately resulting in 712 confirmed coronavirus disease 2019 (COVID-19) cases with 13 deaths [1], the largest disease outbreak involving a cruise ship to date."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Investigation into the Diamond Princess outbreak provides further evidence of the case fatality ratio (CFR) of COVID-19 in isolation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Epidemiological findings on COVID-19 are increasingly linked to information from whole-genome sequencing of SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The outbreak of the coronavirus disease 2019 (COVID-19), caused by a novel (new) coronavirus (SARS-CoV-2), has been characterized as a global pandemic [1–5]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 is rapidly spreading across the world and affecting all populations."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Thus, it’s important to systematically characterize and evaluate potentially deleterious variants in ACE2, which may affect SARS-CoV-2 recognition and infection, and COVID-19 susceptibility and treatment."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A recent genome-wide association study (GWAS) including 835 patients with COVID-19 and severe disease (defined as respiratory failure) and 1255 control participants from Italy, plus 775 patients and 950 control participants from Spain was conducted by the Severe COVID-19 GWAS Group [22]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "They identified multiple genetic variants and genes associated with COVID-19 with respiratory failure."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Although our study has characterized the putative functional and structurally related variants in ACE2 with top allele frequencies in various populations, the lack of phenotypes of COVID-19 prevents us from identifying susceptibility variants associated with a phenotype of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, our findings, together with other ACE2 genetic studies [17, 19], can prioritize the promising variants in ACE2 for further fast-track genotyping in blood samples from COVID-19 patients, which could provide a great opportunity to identify susceptibility variants in ACE2 related to symptoms of COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The outbreak of coronavirus disease (COVID-19) was caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), through its surface spike glycoprotein (S-protein) recognition on the receptor Angiotensin-converting enzyme 2 (ACE2) in humans."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These findings provide novel insight into the genetic variation in ACE2 which may affect the SARS-CoV-2 recognition and infection, and COVID-19 susceptibility and treatment."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The coronavirus disease 2019 (COVID‐19) outbreak has become a public health emergency globally.1, 2 Until 26 May 2020, there were 7126 confirmed cases reported in Australia (",
            "https://coronavirus.jhu.edu/map.html",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "URL",
                "start": 174,
                "end": 210,
                "name": "https://coronavirus.jhu.edu/map.html"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Panel A: Deletions and mutations in the primary, secondary and tertiary structures of the coronavirus disease 2019 (COVID‐19) s2m RNA genetic element based on the three‐dimensional crystal structure of the SARS virus.",
            "Up to 29 April, 1319 sequences of the Australian SARS‐CoV‐2 isolates are available in the website of the ",
            "Global Initiative on Sharing All Influenza Data (GISAID)",
            ".3"
        ],
        "lab": [
            false,
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 536,
                "end": 592,
                "name": "Global Initiative on Sharing All Influenza Data (GISAID)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "GenBank",
            " accession numbers of these viruses are recorded in Table S1."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 4,
                "end": 11,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, we compared the pan-CoV assay’s performance to the US Center for Disease Control and Prevention’s 2019-nCoV RT-PCR assay [11] against a set of clinical specimens from COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As the COVID-19 pandemic is currently surging, pathogen discovery of novel CoVs now seems even more important than before."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To assess the assay's clinical performance, we tested a large panel of previously studied specimens: 192 human respiratory specimens from pneumonia patients, 5 clinical specimens from COVID-19 patients, 81 poultry oral secretion specimens, 109 pig slurry specimens, and 31 aerosol samples from a live bird market."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We apply genomic alignment analysis to observe SARS-CoV-2 sequences from ",
            "GenBank",
            " ( ",
            "http://www.ncbi.nim.nih.gov/genebank",
            "/ ): ",
            "MN 908947",
            " (China, C1); ",
            "MN985325",
            " (United States: WA, UW); ",
            "MN996527",
            " (China, C2); ",
            "MT007544",
            " (Australia: Victoria, A1); ",
            "MT027064",
            " (United States: CA, UC); ",
            "MT039890",
            " (South Korea, K1); ",
            "MT066175",
            " (Taiwan, T1); ",
            "MT066176",
            " (Taiwan, T2); ",
            "LC528232",
            " (Japan, J1); and ",
            "LC528233",
            " (Japan, J2) and ",
            "Global Initiative on Sharing All Influenza Data",
            " database ( ",
            "https://www.gisaid.org",
            " )."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 73,
                "end": 80,
                "name": "GenBank"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 83,
                "end": 119,
                "name": "http://www.ncbi.nim.nih.gov/genebank"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 124,
                "end": 133,
                "name": "MN 908947"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 147,
                "end": 155,
                "name": "MN985325"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 181,
                "end": 189,
                "name": "MN996527"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 203,
                "end": 211,
                "name": "MT007544"
            },
            false,
            {
                "id": "T7",
                "type": "AccessionNumber",
                "start": 239,
                "end": 247,
                "name": "MT027064"
            },
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 273,
                "end": 281,
                "name": "MT039890"
            },
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 301,
                "end": 309,
                "name": "MT066175"
            },
            false,
            {
                "id": "T10",
                "type": "AccessionNumber",
                "start": 324,
                "end": 332,
                "name": "MT066176"
            },
            false,
            {
                "id": "T11",
                "type": "AccessionNumber",
                "start": 347,
                "end": 355,
                "name": "LC528232"
            },
            false,
            {
                "id": "T12",
                "type": "AccessionNumber",
                "start": 373,
                "end": 381,
                "name": "LC528233"
            },
            false,
            {
                "id": "T13",
                "type": "Dataset",
                "start": 398,
                "end": 445,
                "name": "Global Initiative on Sharing All Influenza Data"
            },
            false,
            {
                "id": "T14",
                "type": "URL",
                "start": 457,
                "end": 479,
                "name": "https://www.gisaid.org"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T1",
                "end": "T3"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T1",
                "end": "T4"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T1",
                "end": "T5"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T1",
                "end": "T6"
            },
            {
                "id": "R6",
                "bool": true,
                "head": "T1",
                "end": "T7"
            },
            {
                "id": "R7",
                "bool": true,
                "head": "T1",
                "end": "T8"
            },
            {
                "id": "R8",
                "bool": true,
                "head": "T1",
                "end": "T9"
            },
            {
                "id": "R9",
                "bool": true,
                "head": "T1",
                "end": "T10"
            },
            {
                "id": "R10",
                "bool": true,
                "head": "T1",
                "end": "T11"
            },
            {
                "id": "R11",
                "bool": true,
                "head": "T1",
                "end": "T12"
            },
            {
                "id": "R12",
                "bool": true,
                "head": "T13",
                "end": "T14"
            }
        ]
    },
    {
        "sen": [
            "We analyze database by genome alignment search for nonstructural ORFs and structural E, M, N, and S proteins."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Because the disease, COVID-19, spread across China and beyond (Phan, 2020), WHO was obliged to declare as pandemic on March 11 and reported a total of confirmed 4,617,176 cases and 307,988 deaths until May 15, 22:41 GMT (WHO, 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, this study was conducted to unfold SARS-CoV-2 virus genome to identify regulatory elements such as CpG islands, transcription factors (TFs) and their corresponding binding sites (TFBSs) involved in the regulation of its gene expression so that it provide baseline information for designing COVID-19 disease control strategy and for further detail molecular characterization of SARS-CoV-2 virus genome."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this analysis all eleven SARS-CoV-2 gene coding sequences, available in ",
            "NCBI",
            " database with the start codon at the beginning of the sequence and only functional genes (protein coding) were considered."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 721,
                "end": 725,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The output of TOMTOM includes LOGOS representing the alignment of the candidate motif and TF with the p-value and q-value (a measure of false discovery rate) of the match, and links back to the parent transcription database for more detailed information about it (Bailey et al., 2006; Bailey et al., 2009)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The GOMO output is HTML and shows the GO terms, GO name and Gene ID."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Buttons on the GOMO HTML output allow one or all of the Gene ID to be forwarded for further analysis, to ascertain which molecular and biological functions are associated with the candidate motif."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "MVI was compared to registered motifs in publically available databases such as Prokaryote DNA to see if they are similar to known regulatory motifs for transcription factor using the TOMTOM web application (Reese, 2001)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The output from TOMTOM also links the parent TF database for more detail information for activation, repression or dual regulatory effects on the matched motif."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As a result, MVI matched with 10 out of 84 known motifs found in the databases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As we tried to check the role of CRP TFs in UniProt protein database, they can act as an activator, repressor, co-activator or co-repressor in Escherichia coli and Yersinia pestis where similar function was revealed for CcpA transcription factor in Lactococcus lactis and Streptococcus pneumoniae."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In ",
            "UniProt",
            " protein database LexA transcription factor is also named as LexA repressor functioning as a repressor of a number of genes in bacteria such as Rhizobium meliloti."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 2186,
                "end": 2193,
                "name": "UniProt"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "But, further investigation about ArcA transcription factor from UniProt protein data base revealed it is a protein with two component signal transduction system controlling aerobic respiration response regulator with gene ontology (molecular function) of mainly serving as DNA-binding transcription activator activity in bacteria."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 is a new virus responsible for an outbreak of respiratory illness known as COVID-19, which has spread to several countries around the world and a global effort is being undertaken to characterize the molecular features and evolutionary origins of this virus."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For this purpose, we first computationally surveyed all SARS-CoV-2 virus genes with the open reading frames from ",
            "NCBI",
            " database and found eleven sequences to accomplish the mentioned features by using bioinformatics tools.",
            "Highlights     •  Computationally surveyed all SARS-CoV-2 genes with the open reading frames from ",
            "NCBI",
            " database showed eleven gene sequences    •"
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 3071,
                "end": 3075,
                "name": "NCBI"
            },
            false,
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 3278,
                "end": 3282,
                "name": "NCBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The risk of morbidity and mortality from COVID-19 as a consequence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is not uniform across the UK population."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The evidence to support this claim is scarce and limited to retrospective series arising from China, the epicentre of the COVID-19 pandemic, and involving small numbers of patients.2, 3, 4 However, despite these severe limitations, the promulgation of this hypothesis has led to widespread global changes to patterns of prescribing chemotherapy and anticancer treatment."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In a global health emergency, oncologists must secure evidence from a large dataset, which can then inform their risk-benefit analyses for individual patients in terms of the use of anticancer treatments.6, 7",
            "On March 18, 2020, we launched the ",
            "UK Coronavirus Cancer Monitoring Project (UKCCMP)",
            ", with widespread support across our national cancer network."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 797,
                "end": 846,
                "name": "UK Coronavirus Cancer Monitoring Project (UKCCMP)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Within 5 weeks, the ",
            "UKCCMP",
            " had generated the largest prospective database of COVID-19 in patients with cancer that had been generated to date."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 928,
                "end": 934,
                "name": "UKCCMP"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We aimed to describe the clinical and demographic characteristics and COVID-19 outcomes in this cohort of patients with cancer and symptomatic COVID-19, and attempted to assess how the presence of cancer and the receipt of cytotoxic chemotherapy and other anticancer treatments affects the COVID-19 disease phenotype."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "UKCCMP",
            " database of UK patients COVID-19 who have cancer with was launched with the support of the UK oncology professional bodies, including the ",
            "Association of Cancer Physicians",
            ", the ",
            "Royal College of Radiologists",
            ", the ",
            "National Oncology Trainees Research Collaborative for Healthcare Research",
            ", patient support groups including ",
            "Macmillan Cancer Support",
            ", and charities including ",
            "Action Radiotherapy",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 1373,
                "end": 1379,
                "name": "UKCCMP"
            },
            false,
            {
                "id": "T4",
                "type": "Creator",
                "start": 1518,
                "end": 1550,
                "name": "Association of Cancer Physicians"
            },
            false,
            {
                "id": "T5",
                "type": "Creator",
                "start": 1556,
                "end": 1585,
                "name": "Royal College of Radiologists"
            },
            false,
            {
                "id": "T6",
                "type": "Creator",
                "start": 1591,
                "end": 1664,
                "name": "National Oncology Trainees Research Collaborative for Healthcare Research"
            },
            false,
            {
                "id": "T7",
                "type": "Creator",
                "start": 1699,
                "end": 1723,
                "name": "Macmillan Cancer Support"
            },
            false,
            {
                "id": "T8",
                "type": "Creator",
                "start": 1749,
                "end": 1768,
                "name": "Action Radiotherapy"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The database was designed as a public health surveillance registry to support rapid clinical decision making, in accordance with the UK Policy Framework for Health and Social Care Research, the UK National Research Ethics Service, and the UK Governance Arrangement for Research Ethic Committees."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Case reporting was led by a COVID-19 emergency response reporting individual (ERRI), supported by a local emergency response reporting group (LERRG) at each centre."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The data fields were then updated as soon as treatment and outcomes had been identified and also to reflect the worse COVID-19 severity categories during hospitalisation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Patient demographics, treatment details, COVID-19 disease course, and cancer features were obtained by the direct assessment of the ERRI and LERRG, or through hospital medical records."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 severity category was determined according to WHO guidelines."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This definition included deaths described as related to COVID-19 during admission, as well as deaths reported as a consequence of any other cause during admission, such as due to cancer progression or treatment toxicity."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "55 cancer centres had appointed a COVID-19 LERRG and formed part of this clinical network of cancer centres."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our patient cohort consisted of the first 800 patients with active cancer who had documented SARS-CoV-2 infection presenting as symptomatic COVID-19 disease."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The median time from identification of documented COVID-19 disease until study endpoints were met (death or discharge from hospital) was 5 days (range 0–38)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A mild COVID-19 severity category was recorded in 412 (52%) patients, with 96 (12%) patients not requiring hospital admission."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "226 (28%) patients died, with reports stating that the death was principally attributable to COVID-19 in most patients (211 [93%])."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To explore this relationship in greater detail, we did an in-depth analysis of the 281 patients who had received recent chemotherapy (ie, within 4 weeks of testing positive for COVID-19; figure 3",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, we did a multivariate analysis with adjustment for age, gender, and comorbidities and found that deaths in patients with COVID-19 who have cancer who had received recent chemotherapy were still no more likely than in those who had not (table 3",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, we analysed the use of other forms of anticancer therapies within 4 weeks of testing positive for SARS-CoV-2 infection and presenting with COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Second, many oncologists are being redeployed to general or acute medicine roles to support the many COVID-19 admissions requiring intensive medical support and input."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Third, two small studies2, 3 reporting COVID-19 outcomes in patients with cancer have resulted in the community being fearful of giving effective anticancer treatments."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These studies concluded that cancer patients are not only more susceptible to contracting the virus compared with the general population, but also at risk of developing more severe sequelae.3, 4 In the largest cohort of 105 cancer patients, consisting of only 17 on chemotherapy, six patients on immunotherapy, and four on targeted therapies, strong recommendations were made about the COVID-19 risk from anticancer treatments."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To clarify the relationship between cancer, anticancer treatments, and COVID-19, larger-scale datasets are necessary."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We described the demographics of patients with COVID-19 who have cancer and explored the effect of cytotoxic chemotherapy and other anticancer treatments on the trajectory of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We identified that the phenotype of diagnosed COVID-19 disease in over half of cancer patients is mild, but death from COVID-19 in this cohort was observed in a substantial proportion of patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using our dataset, we are unable to answer the question as to whether this finding might arise as a result of advance patient health-care directives, hospital and ITU admission policies, a reluctance of treating physicians to use ITU resources for patients with cancer, or historically fewer ITU beds available in the UK."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Our analysis is partly dependent on the UK national COVID-19 testing policy, which is less permissive than that of other nations,18, 19 and also relies on RT-PCR, which has a well described false-negative result."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The project might therefore under-report total COVID-19 cases in patients with cancer, particularly those with no or mild symptoms and who do not require treatment at or present to health-care centres."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "A selection bias might exist, in that those patients who were not on chemotherapy might have stopped chemotherapy because of a poor performance status, thus increasing the risk of death from COVID-19 disease, and reducing our ability to assess the real risk of anticancer treatments in a population with a better performance status."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, we have not commented on overall incidence of COVID-19 positivity among cancer patients because we do not yet have secure numerators and denominators for that calculation."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Background  Individuals with cancer, particularly those who are receiving systemic anticancer treatments, have been postulated to be at increased risk of mortality from COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We aimed to describe the clinical and demographic characteristics and COVID-19 outcomes in patients with cancer."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "UKCCMP",
            " is the first COVID-19 clinical registry that enables near real-time reports to frontline doctors about the effects of COVID-19 on patients with cancer."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Dataset",
                "start": 6994,
                "end": 7000,
                "name": "UKCCMP"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We excluded patients with a radiological or clinical diagnosis of COVID-19, without a positive RT-PCR test."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Findings  From March 18, to April 26, 2020, we analysed 800 patients with a diagnosis of cancer and symptomatic COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "412 (52%) patients had a mild COVID-19 disease course."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "281 (35%) patients had received cytotoxic chemotherapy within 4 weeks before testing positive for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "After adjusting for age, gender, and comorbidities, chemotherapy in the past 4 weeks had no significant effect on mortality from COVID-19 disease, when compared with patients with cancer who had not received recent chemotherapy (1·18 [0·81–1·72]; p=0·380)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Interpretation  Mortality from COVID-19 in cancer patients appears to be principally driven by age, gender, and comorbidities."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We are not able to identify evidence that cancer patients on cytotoxic chemotherapy or other anticancer treatment are at an increased risk of mortality from COVID-19 disease compared with those not on active treatment."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In December 2019, reports emerged of a cluster of cases of pneumonia of unknown cause in Wuhan City, China, culminating in the identification of a novel coronavirus on 12 January 2020, denoted as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the associated disease as coronavirus disease 2019 (COVID-19) [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All COVID-19 papers drew heavily or exclusively on data and experience from China."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Abbreviations: COVID-19, coronavirus disease 2019; HDAS, Healthcare Databases Advanced Search; MERS-CoV, Middle East respiratory syndrome coronavirus; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses; SARS-CoV, severe acute respiratory syndrome coronavirus; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; WHO, World Health Organization."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Children are affected by COVID-19, but extant data (largely case series from China) suggest they are less likely to be affected than adults."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Report of the WHO-China Joint Mission on COVID-19 [7] concludes that “we cannot determine the extent of infection among children, what role children play in transmission, whether children are less susceptible or whether they simply present differently.”",
            "In an early epidemiological analysis of 507 COVID-19 cases, mainly from China, 13 (2.6%) were younger than 15 years, and the relative risk of COVID-19 in children was less than 0.5 compared with the population average [10]."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Symptoms of COVID-19 are nonspecific and disease presentation ranges from asymptomatic to severe pneumonia and death [7]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Wei et al [9] identified all hospitalized infants in China diagnosed with COVID-19 infection between 8 December 2019 and 6 February 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In Singapore, a well 6-month-old infant with COVID-19 and high viral load was detected as part of a cluster and was also asymptomatic throughout admission [16]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Asymptomatic cases are also reported in the English abstract of a Chinese paper, which reports clinical data and CT chest images of 15 children (aged 4–14 years old) diagnosed with COVID-19 in Shenzhen."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Report of the WHO-China Joint Mission on COVID-19 stated that 2.5% of the cases among those under 19 years old were severe and 0.2% were critical [7]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Among the 105 children admitted to Wuhan’s Children’s Hospital, the sole hospital for treating COVID-19 in children in Wuhan, 8 (7.6%) were reported to have severe disease [18]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Both parents developed symptomatic COVID-19 days after they looked after the sick infant without personal protective measures [12]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nevertheless, we identify that children appear to be less affected by COVID-19 than adults by observed rate of infection; while 17.8% of the population were aged 0–15 years old, only 2.1% of reported cases in a large case series from China were in the 0–19-year age group [23]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Reliable evidence about clinical features and outcomes of COVID-19 in children is limited to small case series and case reports."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We detected only a weak signal that children with comorbidities are at increased risk or are overrepresented among pediatric COVID-19 cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Given that poor COVID-19 outcomes have been seen in adults with underlying conditions, a similar issue in children might be anticipated when sufficient data are available."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "One study attempts to assess the impact of Hong Kong’s public health measures and population behavior change on COVID-19 transmission, using routine influenza surveillance data as a proxy, assuming that influenza and COVID-19 are likely transmitted in similar ways [25]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The authors demonstrate the substantial impact that familiar public health measures (including school closure), social distancing, and behavioral change could have in slowing down COVID-19 transmission, although questions remain about whether these measures can avoid fatigue and be sustained in the long term."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While the evidence we reviewed related mainly to data from China, as the COVID-19 pandemic spreads worldwide data are beginning to emerge from other countries, including Italy [26], South Korea [27], Iceland [28], and the United States [29]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Abstract   Background  Few pediatric cases of coronavirus disease 2019 (COVID-19) have been reported and we know little about the epidemiology in children, although more is known about other coronaviruses."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We searched 3 databases and the COVID-19 resource centers of 11 major journals and publishers."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Twenty-four studies relating to COVID-19 were included in the review."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Children appear to be less affected by COVID-19 than adults by observed rate of cases in large epidemiological studies."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Conclusions  Children appear to have a low observed case rate of COVID-19 but may have rates similar to adults of infection with SARS-CoV-2."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This discrepancy may be because children are asymptomatic or too mildly infected to draw medical attention and be tested and counted in observed cases of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Initial reports from China observed low rates of COVID-19 in children compared with adults."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Coronavirus disease 2019 (COVID-19) pandemic fatalities are rare before adrenarche/puberty (<10 years of age), and the vulnerability of males to severe disease has been constantly reported over the past months of pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Theoretically, the hyperandrogenic phenotype might correlate with COVID-19 increased viral load, increased viral dissemination, and severity of lung involvement (Infographic 1",
            ")."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The SARS outbreak of 2002–2004, the MERS outbreaks since 2012 and the current COVID‐19 outbreak since 2019 demonstrate the potential of coronaviruses, especially bat‐derived betacoronaviruses (Zhou et al., 2020), to cause PHEICs, with COVID‐19 having escalated to a global pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For the ongoing COVID‐19 outbreak, as illustrated in Figure 1, applying in silico approaches can rapidly provide answers to questions like:",
            "Is the first sequenced SARS‐CoV‐2 genome (often called the ‘reference genome’ in ",
            "GISAID",
            ", ",
            "GenBank",
            ", etc.) closest to the original or ‘true reference’ strain which entered humans (which may not have been sequenced and/or which may still be circulating with minimal mutations)?",
            "All available viral sequences were downloaded from ",
            "GISAID",
            " (on 05/03/2020, see Appendix S3 (Elbe, & Buckland‐Merrett, 2017)), filtering for complete sequences of human origin (187 genomes in total)."
        ],
        "lab": [
            false,
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 504,
                "end": 510,
                "name": "GISAID"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 512,
                "end": 519,
                "name": "GenBank"
            },
            false,
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 748,
                "end": 754,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also included one recently reported viral sequence from the ",
            "European Virus Archive",
            " global (Ref‐SKU: ",
            "026V‐03883",
            ") and the two Australian sequences in the full data set."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 958,
                "end": 980,
                "name": "European Virus Archive"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 998,
                "end": 1008,
                "name": "026V‐03883"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T4",
                "end": "T5"
            }
        ]
    },
    {
        "sen": [
            "This data set of 181 sequences was aligned against each other using Muscle (v3.8.31) (Madeira et al., 2019)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The C1 cluster mainly represents Wuhan and isolates captured early on; C2 and C3 contain later isolates, such as Sydney/3, Australia/VIC01 and France/IDF0372 in C2 and Australia/NSW01, Australia/QLD01‐3, Australia/VIC02 and USA/WA1 in C3."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "There may also be three additional clusters emerging (C4‐6) with C4 capturing the suspected community spread from Lombardy (‘Narrative: Genomic analysis of COVID‐19 spread’, n.d.), C5 regionally mixed (Asia and North Amerika) and C6 from Australia and Asia, notably Australia/NSW05‐7 (see fully annotated tree in Figure S5)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Their analysis was only on 103 ",
            "GISAID",
            " isolates and includes betacoronaviruses from bats, which roots the tree differently and merges C1 and C2."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 1769,
                "end": 1775,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, this alignment‐free method positions isolates with deletions (viz. Australia/VIC01 and Canada/ON‐VIDO‐01) further away from Wuhan‐Hu‐1 than in the phylogenetic tree, demonstrating the ability of the K‐mer method to represent deletions accurately (see Supplemental Table 7)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "While ",
            "Nextstrain",
            " ('Narrative: Genomic analysis of COVID‐19 spread', n.d.) is a powerful aid in visualizing the available strains in real time, it currently relies on phylogeny only and thus may be hampered in its conclusions."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 2171,
                "end": 2181,
                "name": "Nextstrain"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "C2 is represented by Australia/VIC01 and France/IDF0372, and C3 is represented by USA/WA1."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The central location of Germany/BavPat1 and France/IDF0372 may reflect a broad representation across multiple clusters, in contrast to Canada/ON‐VIDO‐01 and Australia/VIC01, which are located further away from the SARS‐CoV‐2 centre marked by the rectangle in Figure 4b inset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The vertical lines hence cluster isolates with a similar number of ‘missing’ bases; for example, Australia/VIC01 and Canada/ON‐VIDO‐01 have 10‐bp deletions, while Korea/KCDC05 and Australia/Sydney02 have a 40‐bp shorter sequence and 42‐bp deletion, respectively."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Furthermore, releasing the full high‐throughput sequencing data sets rather than the consensus sequences would allow a more detailed exploration of the existing quasispecies to further improve isolate selection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We discuss the currently chosen SARS‐CoV‐2 strains for international coronavirus disease (COVID‐19) models in the context of their phylogeny as well as in a novel alignment‐free bioinformatic approach."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ongoing pandemic of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causing the coronavirus disease 2019 (COVID-19) has imposed an increasing demand on daily diagnostic screening."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Given the high specificity of the RT-qPCR (Alcoba-Florez et al., 2020), focus was on evaluating the rate of false negatives (FN) and assay sensitivity using the same 98 COVID-19 patient samples."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since all samples were COVID-19 positive for at least one solution/viral target, results with threshold cycle (Ct) values >40 or those that remained undetected during the 45 cycles of the experiments were considered FN observations (Fig. 1",
            ", Table 1)."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Attending to individual targets, it was found that the most sensitive solution was the LightMix® Modular SARS-CoV (COVID19) (TIB MOLBIOL, Berlin, Germany) used in combination with a primer-probe set for the E-gene (97.9% [92.8–99.7]) (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Finally, because the LightMix® Modular SARS-CoV (COVID19) kit with primer-probes for the E-gene showed the highest sensitivity, it was tested on samples that were preheated at 70 °C for 10 minutes in a substitution of the RNA extraction (Alcoba-Florez et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "RT-qPCR for selected target genes of SARS-CoV-2 has been key in the global response to the COVID-19 pandemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Given the rapid spread of the virus at this time, it is likely that the RT-qPCR assays will continue to be a central tool for controlling COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, as happened in the past due to supply chain issues, policy decisions and laboratory testing capacities (Alcoba-Florez et al., 2020), it is predictable that the diagnosis of COVID-19 will continue relying on a variety of solutions among laboratories and countries (Vogels et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These findings will help to assess the impact of the selected solution on FN diagnoses of COVID-19 (Ramdas et al., 2020) and to choose a solution that minimizes misdiagnoses of an active SARS-CoV-2 infection."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ongoing COVID-19 pandemic continues to impose demands on diagnostic screening."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Six different RT-qPCR alternatives were evaluated for SARS-CoV-2/COVID-19 diagnosis based on standard RNA extractions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "These results will help to calibrate the impact of false negative diagnoses of COVID-19, and to detect and control new SARS-CoV-2 outbreaks and community transmissions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The coding sequences of the N genes along with their accession numbers were obtained from the ",
            "GenBank",
            " database (Supplementary file)."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 94,
                "end": 101,
                "name": "GenBank"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "COVID-19 has launched our community of practice into a new reality of digital care."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As highlighted by the COVID-19 pandemic, digital solutions are becoming essential for the provision of clinical genetics services."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We assume that upon the end of the COVID-19 pandemic, the structure of scientific meetings will be re-examined."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The recent coronavirus disease 2019 (COVID-19) pandemic has caused worldwide disruption which also extends to the arena of scientific meetings around the world."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the current coronavirus outbreak, the global community is mounting a large-scale public health response to understand the pathogen, SARS-CoV-2, and combat coronavirus disease 2019 (COVID-19)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Below we briefly outline the response—including actions taken by national Nodes—and note that this strategy directly answers to priority action 8 (“Access to research infrastructures”) and action 9 (“Research data sharing platform”) in the EU action plan for COVID-19 [10]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "",
            "ELIXIR",
            " provides updated information on services run by ",
            "ELIXIR",
            " Nodes that can be used by researchers working on COVID-19 via ",
            "elixir-europe.org/services/covid-19-resources",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 469,
                "end": 475,
                "name": "ELIXIR"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 524,
                "end": 530,
                "name": "ELIXIR"
            },
            false,
            {
                "id": "T3",
                "type": "URL",
                "start": 593,
                "end": 638,
                "name": "elixir-europe.org/services/covid-19-resources"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "National infrastructures provide important focal points for the efforts around COVID-19 and many ",
            "ELIXIR",
            " Nodes are tasked with coordinating national data spaces for health, clinical and epidemiological data."
        ],
        "lab": [
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 737,
                "end": 743,
                "name": "ELIXIR"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "National infrastructures also provide the bulk of data processing capabilities for the many COVID-19 research projects now underway."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This federated model provides the coordination across Europe to ensure consistent discovery and access to relevant human genetic datasets for research."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As much of the COVID-19 host data will come directly from clinical care it will likely be subject to national laws and regulations and therefore, for example, much of the data is unlikely to be consented to leave national jurisdictions."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As part of the COVID-19 response ",
            "ELIXIR",
            " will accelerate implementation of the ",
            "Federated European Genome-phenome Archive (FEGA)",
            " to provide the necessary infrastructure and coordination between European national initiatives and ensure rapid sharing of COVID-19 host data in full compliance with national regulations (e.g. GDPR)."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Repository",
                "start": 1402,
                "end": 1408,
                "name": "ELIXIR"
            },
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 1447,
                "end": 1495,
                "name": "Federated European Genome-phenome Archive (FEGA)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In addition, the rapid response to the COVID-19 pandemic provides a blueprint for European data access in projects such as ",
            "1 Million European Genomes",
            " [12]."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 1819,
                "end": 1845,
                "name": "1 Million European Genomes"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The federated EGA nodes forms a set of connected European COVID-19 Data Spaces, that bring together national health informatics infrastructure [13] and European archives such as those at EMBL–EBI [14]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This interconnected ecosystem will allow data from ongoing European projects as well as the many re-focussed national research programmes to be widely accessed, reused and linked to global COVID-19 initiatives."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Public databases are key to ensuring that datasets—from short-read sequence data to protein structures—are stored over the long-term and accessed by scientists in academia and industry."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "",
            "ELIXIR",
            " is an open data infrastructure and advocates the open sharing—wherever possible for reasons of personal privacy and public health—of COVID-19 data."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 2451,
                "end": 2457,
                "name": "ELIXIR"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "",
            "ELIXIR",
            "’s response aims to ensure that COVID-19 data are well annotated and accessible for reuse by the research community and society."
        ],
        "lab": [
            false,
            {
                "id": "T9",
                "type": "Repository",
                "start": 2606,
                "end": 2612,
                "name": "ELIXIR"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "",
            "EMBL–EBI",
            " has a dedicated page to assist deposition and sharing of SARS-CoV-2 data into molecular databases."
        ],
        "lab": [
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 2741,
                "end": 2749,
                "name": "EMBL–EBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In the first weeks of teh European response ",
            "ELIXIR",
            " has further reached out to the data generation underway in the facilities of the ESFRI Research Infrastructures and ensure that data is deposited in existing archives where possible (e.g. ",
            "EMBL–EBI",
            " COVID19 Portal, ENA, IDR, Biostudies etc.) and are made FAIR for the research community at large."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Repository",
                "start": 2893,
                "end": 2899,
                "name": "ELIXIR"
            },
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 3088,
                "end": 3096,
                "name": "EMBL–EBI"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "National infrastructures—some of which already form part of EOSC—are also providing open-access biocomputing resources with COVID-19 workflows and toolkits."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Via the EOSC-Life project3 we are also investigating if resources can be made available to resource-poor countries in the fight against COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "As projects on COVID-19 research studies emerge from many initiatives driven from ",
            "ELIXIR",
            " Nodes, ",
            "ELIXIR",
            " has launched the ",
            "ELIXIR",
            " support for SARS-CoV-2 research webpage to display the services that ELIXIR Nodes offer to scientists (Fig. 1)."
        ],
        "lab": [
            false,
            {
                "id": "T13",
                "type": "Repository",
                "start": 3580,
                "end": 3586,
                "name": "ELIXIR"
            },
            false,
            {
                "id": "T14",
                "type": "Repository",
                "start": 3594,
                "end": 3600,
                "name": "ELIXIR"
            },
            false,
            {
                "id": "T15",
                "type": "Repository",
                "start": 3618,
                "end": 3624,
                "name": "ELIXIR"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The webpage focuses on Node services that enable European researchers to carry out research into COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "",
            "ELIXIR",
            ", the European research infrastructure for life science data, provides open access to data, tools and workflows in the response to the COVID-19 pandemic."
        ],
        "lab": [
            false,
            {
                "id": "T16",
                "type": "Repository",
                "start": 3844,
                "end": 3850,
                "name": "ELIXIR"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "1. Connecting national COVID-19 data platforms to create federated European COVID-19 Data Spaces; 2. Fostering good data management to make COVID-19 data open, FAIR and reusable over the long term; 3. Providing open tools, workflows and computational resources to drive reproducible and collaborative science."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Some Nodes have prioritised access to their national cloud and compute facilities for all COVID-19 research projects, while others have developed tools to search, access and share all data related to the pandemic in a national healthcare setting."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The first coronavirus diasease 2019 (COVID‐19) case in South America was reported on 25 February 2020, in Sao Paulo, Brazil, and since has spread so that as of 20 March, cases of SARS‐CoV‐2 infection have been reported from all Latin American countries."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, genomic epidemiology studies must be in place to understand the dynamics of COVID‐19 epidemic."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Colombia, the fifth largest country in South America is the fourth country in number of confirmed new COVID‐19 cases in the region by 30th July 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Following identification of the first COVID‐19 case in Colombia, on 6 March 2020, in a female traveler returning from Milan, Italy, the Colombian government implemented early control measures."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Comparative genome analysis of our 88 cases and three previously reported Colombian cases was carried out relative to publicly available background data from 2744 cases sampled from the ",
            "GISAID EpiCoV",
            " database to obtain a full representation of global lineage diversity."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 889,
                "end": 902,
                "name": "GISAID EpiCoV"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Consensus viral sequences from each case were also submitted to ",
            "GISAID",
            " (accessions: ",
            "EPI_ISL_447734",
            "‐",
            "EPI_ISL_447817",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 1037,
                "end": 1043,
                "name": "GISAID"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 1057,
                "end": 1071,
                "name": "EPI_ISL_447734"
            },
            false,
            {
                "id": "T4",
                "type": "AccessionNumber",
                "start": 1072,
                "end": 1086,
                "name": "EPI_ISL_447817"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T2",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "Whole genome sequences for the samples included in each dataset were aligned using MAFFT v7.40755",
            " with FFT‐NS‐2 algorithm and default parameter settings."
        ],
        "lab": [
            false,
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The genome sequence of 88 samples isolated from patients with COVID‐19 from different regions of Colombia allowed identifying 11 independent lineages, suggesting a massive introduction of the virus in the country (Figure 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The novel coronavirus SARS-CoV-2 that causes COVID-19 and first identified in the Wuhan region of China [1] is an enveloped positive sense RNA virus of the family Coronaviridae and genus Betacoronavirus ([2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In view of the potential application of IFITM proteins’ induction to target SARS-CoV-2 infection that causes COVID-19, this article layout insights into the known antiviral mechanisms and therapeutic agents related to IFITM."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Though by 14 March 2020, fewer than 500 SARS-CoV-2 genomes were published on public databases including ",
            "China National GeneBank DataBase (CNGBdb)",
            ", ",
            "NCBI",
            " ",
            "GenBank",
            ", and the ",
            "Global Initiative on Sharing All Influenza Data (GISAID)",
            ", and much remains unknown about the epidemiology and evolution of the virus."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 104,
                "end": 145,
                "name": "China National GeneBank DataBase (CNGBdb)"
            },
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 147,
                "end": 151,
                "name": "NCBI"
            },
            false,
            {
                "id": "T3",
                "type": "Repository",
                "start": 152,
                "end": 159,
                "name": "GenBank"
            },
            false,
            {
                "id": "T4",
                "type": "Dataset",
                "start": 169,
                "end": 225,
                "name": "Global Initiative on Sharing All Influenza Data (GISAID)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For metatranscriptomic and hybrid capture sequencing data, total reads were first processed using Kraken v0.10.5 [20] (default parameters) with a self-built database of Coronaviridae genomes (including SARS, MERS, and SARS-CoV-2 genome sequences downloaded from ",
            "GISAID",
            ", ",
            "NCBI",
            ", and ",
            "CNGB",
            ") to identify Coronaviridae-like reads in a loose manner."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 565,
                "end": 571,
                "name": "GISAID"
            },
            false,
            {
                "id": "T6",
                "type": "Repository",
                "start": 573,
                "end": 577,
                "name": "NCBI"
            },
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 583,
                "end": 587,
                "name": "CNGB"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Nucleotide positions with sequencing depth < 100× or < 5-fold higher than that of negative controls were masked as ambiguous base N."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The Coronaviridae-like reads from metatranscriptomic and hybrid capture sequencing data were aligned against the SARS-CoV-2 reference genome (",
            "GISAID",
            " accession: ",
            "EPI_ISL_402119",
            ") [27] with BWA aln (v0.7.16) [28]."
        ],
        "lab": [
            false,
            {
                "id": "T8",
                "type": "Dataset",
                "start": 920,
                "end": 926,
                "name": "GISAID"
            },
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 938,
                "end": 952,
                "name": "EPI_ISL_402119"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T8",
                "end": "T9"
            }
        ]
    },
    {
        "sen": [
            "SARS-CoV-2 reads of metatranscriptomic and hybrid capture sequencing data were identified by aligning the Coronaviridae-like reads against the SARS-CoV-2 reference genome (",
            "GISAID",
            " accession: ",
            "EPI_ISL_402119",
            ") [27] with BWA in a strict manner of coverage ≥ 95% and identity ≥ 90%."
        ],
        "lab": [
            false,
            {
                "id": "T10",
                "type": "Dataset",
                "start": 1160,
                "end": 1166,
                "name": "GISAID"
            },
            false,
            {
                "id": "T11",
                "type": "AccessionNumber",
                "start": 1178,
                "end": 1192,
                "name": "EPI_ISL_402119"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T10",
                "end": "T11"
            }
        ]
    },
    {
        "sen": [
            "To estimate the minimum data required for genome assembly and genome variation analysis, we applied gradient-based sampling to the SARS-CoV-2 genome alignments (referred to BAM files) to each dataset using SAMtools (v1.9) [29]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For metatranscriptomic sequencing of clinical samples, raw sequencing data of a single sequence lane (approximately 60–75 Gb per sample) was used to simultaneously assess the RNA expression patterns of human, bacteria, and viruses in clinical samples from COVID-19 patients."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Next, we applied Kraken 2 [39] (version 2.0.8-beta, parameters: --threads 24 --confidence 0) to assign microbial taxonomic ranks to non-human RNA reads against the large reference database MiniKraken2 (April 2019, 8 GB) built from the ",
            "Refseq",
            " bacteria, archaea, and viral libraries and the h38 human genome."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 2003,
                "end": 2009,
                "name": "Refseq"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We sampled eight specimens from COVID-19 patients in February 2020, including throat swab, nasal swab, anal swab, and sputum specimens, and the corresponding cycle threshold (Ct) value of SARS-CoV-2 qRT-PCR ranges from 18 to 32 (Table 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To ensure the confidence of the datasets, we included serial dilutions of the cultured isolate and negative controls prepared from nuclease-free water and human nucleic acids since the 1st PCR."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All samples in ~ 400 bp amplicon-based sequencing exhibited > 99.5% coverage of 1× depth across the SARS-CoV-2 genome except for 1E+01 (95.23%), GZMU0031 (73.65%), HNA (6.17%), and water (60.24%) and > 97.00% coverage of 100× depth across the SARS-CoV-2 genome except for GZMU0030 (94.15%), GZMU0042 (88.17%), GZMU0014 (71.66%), D7 (39.49%), GZMU0031 (0.00%), HNA (0.00%), and water (0.00%), suggesting the primers were well designed and the positive datasets were reliable (Fig. 3a)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Considering the costs for sequencing, storage, and analysis increase substantially with larger datasets, we tried to estimate how much sequencing data must be produced for each approach in order to achieve 10× depth across 95% of the SARS-CoV-2 genome, and the results can be found in Additional file 2 Table 3."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "a SNVs detected between clinical samples against a reference genome (",
            "GISAID",
            " accession: ",
            "EPI_ISL_402119",
            ") [27]."
        ],
        "lab": [
            false,
            {
                "id": "T13",
                "type": "Dataset",
                "start": 3374,
                "end": 3380,
                "name": "GISAID"
            },
            false,
            {
                "id": "T14",
                "type": "AccessionNumber",
                "start": 3392,
                "end": 3406,
                "name": "EPI_ISL_402119"
            },
            false
        ],
        "rel": [
            {
                "id": "R3",
                "bool": true,
                "head": "T13",
                "end": "T14"
            }
        ]
    },
    {
        "sen": [
            "For serial dilutions of the cultured isolate, the minor allele frequencies detected in capture sequencing datasets were generally approximate to meta sequencing, while most allele frequencies in amplicon sequencing datasets deviated with those in meta sequencing (Fig. 4c)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Background  COVID-19 (coronavirus disease 2019) has caused a major epidemic worldwide; however, much is yet to be known about the epidemiology and evolution of the virus partly due to the scarcity of full-length SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) genomes reported."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The data that support the findings of this study have been deposited into ",
            "CNSA (CNGB Nucleotide Sequence Archive",
            ", ",
            "https://db.cngb.org/cnsa/",
            ") of ",
            "CNGBdb",
            " with project IDs ",
            "CNP0000951",
            " [50] and ",
            "CNP0000955",
            " [51]; into ",
            "GISAID",
            " (",
            "https://www.gisaid.org/",
            ", registration required) with accession numbers ",
            "EPI_ISL_414663",
            ", ",
            "EPI_ISL_414686",
            ", ",
            "EPI_ISL_414687",
            ", ",
            "EPI_ISL_414688",
            ", ",
            "EPI_ISL_414689",
            ", ",
            "EPI_ISL_414690",
            ", ",
            "EPI_ISL_414691",
            ", and ",
            "EPI_ISL_414692",
            " [52]; and into ",
            "NCBI",
            " with accession numbers ",
            "MT568634",
            ", ",
            "MT568635",
            ", ",
            "MT568636",
            ", ",
            "MT568637",
            ", ",
            "MT568638",
            ", ",
            "MT568639",
            ", ",
            "MT568640",
            ", ",
            "MT568641",
            " [53] and ",
            "PRJNA637515",
            " [54]."
        ],
        "lab": [
            false,
            {
                "id": "T15",
                "type": "Repository",
                "start": 4053,
                "end": 4091,
                "name": "CNSA (CNGB Nucleotide Sequence Archive"
            },
            false,
            {
                "id": "T16",
                "type": "URL",
                "start": 4093,
                "end": 4118,
                "name": "https://db.cngb.org/cnsa/"
            },
            false,
            {
                "id": "T17",
                "type": "Repository",
                "start": 4123,
                "end": 4129,
                "name": "CNGBdb"
            },
            false,
            {
                "id": "T18",
                "type": "AccessionNumber",
                "start": 4147,
                "end": 4157,
                "name": "CNP0000951"
            },
            false,
            {
                "id": "T19",
                "type": "AccessionNumber",
                "start": 4167,
                "end": 4177,
                "name": "CNP0000955"
            },
            false,
            {
                "id": "T20",
                "type": "Dataset",
                "start": 4189,
                "end": 4195,
                "name": "GISAID"
            },
            false,
            {
                "id": "T21",
                "type": "URL",
                "start": 4197,
                "end": 4220,
                "name": "https://www.gisaid.org/"
            },
            false,
            {
                "id": "T22",
                "type": "AccessionNumber",
                "start": 4268,
                "end": 4282,
                "name": "EPI_ISL_414663"
            },
            false,
            {
                "id": "T23",
                "type": "AccessionNumber",
                "start": 4284,
                "end": 4298,
                "name": "EPI_ISL_414686"
            },
            false,
            {
                "id": "T24",
                "type": "AccessionNumber",
                "start": 4300,
                "end": 4314,
                "name": "EPI_ISL_414687"
            },
            false,
            {
                "id": "T25",
                "type": "AccessionNumber",
                "start": 4316,
                "end": 4330,
                "name": "EPI_ISL_414688"
            },
            false,
            {
                "id": "T26",
                "type": "AccessionNumber",
                "start": 4332,
                "end": 4346,
                "name": "EPI_ISL_414689"
            },
            false,
            {
                "id": "T27",
                "type": "AccessionNumber",
                "start": 4348,
                "end": 4362,
                "name": "EPI_ISL_414690"
            },
            false,
            {
                "id": "T28",
                "type": "AccessionNumber",
                "start": 4364,
                "end": 4378,
                "name": "EPI_ISL_414691"
            },
            false,
            {
                "id": "T29",
                "type": "AccessionNumber",
                "start": 4384,
                "end": 4398,
                "name": "EPI_ISL_414692"
            },
            false,
            {
                "id": "T30",
                "type": "Repository",
                "start": 4414,
                "end": 4418,
                "name": "NCBI"
            },
            false,
            {
                "id": "T31",
                "type": "AccessionNumber",
                "start": 4442,
                "end": 4450,
                "name": "MT568634"
            },
            false,
            {
                "id": "T32",
                "type": "AccessionNumber",
                "start": 4452,
                "end": 4460,
                "name": "MT568635"
            },
            false,
            {
                "id": "T33",
                "type": "AccessionNumber",
                "start": 4462,
                "end": 4470,
                "name": "MT568636"
            },
            false,
            {
                "id": "T34",
                "type": "AccessionNumber",
                "start": 4472,
                "end": 4480,
                "name": "MT568637"
            },
            false,
            {
                "id": "T35",
                "type": "AccessionNumber",
                "start": 4482,
                "end": 4490,
                "name": "MT568638"
            },
            false,
            {
                "id": "T36",
                "type": "AccessionNumber",
                "start": 4492,
                "end": 4500,
                "name": "MT568639"
            },
            false,
            {
                "id": "T37",
                "type": "AccessionNumber",
                "start": 4502,
                "end": 4510,
                "name": "MT568640"
            },
            false,
            {
                "id": "T38",
                "type": "AccessionNumber",
                "start": 4512,
                "end": 4520,
                "name": "MT568641"
            },
            false,
            {
                "id": "T39",
                "type": "AccessionNumber",
                "start": 4530,
                "end": 4541,
                "name": "PRJNA637515"
            },
            false
        ],
        "rel": [
            {
                "id": "R4",
                "bool": true,
                "head": "T15",
                "end": "T16"
            },
            {
                "id": "R5",
                "bool": true,
                "head": "T17",
                "end": "T16"
            },
            {
                "id": "R6",
                "bool": true,
                "head": "T17",
                "end": "T18"
            },
            {
                "id": "R7",
                "bool": true,
                "head": "T17",
                "end": "T19"
            },
            {
                "id": "R8",
                "bool": true,
                "head": "T20",
                "end": "T21"
            },
            {
                "id": "R9",
                "bool": true,
                "head": "T20",
                "end": "T22"
            },
            {
                "id": "R10",
                "bool": true,
                "head": "T20",
                "end": "T23"
            },
            {
                "id": "R11",
                "bool": true,
                "head": "T20",
                "end": "T24"
            },
            {
                "id": "R12",
                "bool": true,
                "head": "T20",
                "end": "T25"
            },
            {
                "id": "R13",
                "bool": true,
                "head": "T20",
                "end": "T26"
            },
            {
                "id": "R14",
                "bool": true,
                "head": "T20",
                "end": "T27"
            },
            {
                "id": "R15",
                "bool": true,
                "head": "T20",
                "end": "T28"
            },
            {
                "id": "R16",
                "bool": true,
                "head": "T20",
                "end": "T29"
            },
            {
                "id": "R17",
                "bool": true,
                "head": "T30",
                "end": "T31"
            },
            {
                "id": "R18",
                "bool": true,
                "head": "T30",
                "end": "T32"
            },
            {
                "id": "R19",
                "bool": true,
                "head": "T30",
                "end": "T33"
            },
            {
                "id": "R20",
                "bool": true,
                "head": "T30",
                "end": "T34"
            },
            {
                "id": "R21",
                "bool": true,
                "head": "T30",
                "end": "T35"
            },
            {
                "id": "R22",
                "bool": true,
                "head": "T30",
                "end": "T36"
            },
            {
                "id": "R23",
                "bool": true,
                "head": "T30",
                "end": "T37"
            },
            {
                "id": "R24",
                "bool": true,
                "head": "T30",
                "end": "T38"
            },
            {
                "id": "R25",
                "bool": true,
                "head": "T30",
                "end": "T39"
            }
        ]
    },
    {
        "sen": [
            "The present outbreak of the coronavirus-associated acute respiratory disease is named coronavirus disease 19 (COVID-19) by WHO."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Since the pandemic of COVID-19, more than 332, 930 people from 147 countries and territories have been confirmed sicked and more than 14, 510 have died from the rapidly-spreading SARS-CoV-2 virus as of March 23, 2020 [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Total 558 complete genome sequences of the SARS-CoV-2 strains from the infected individuals are retrieved from the ",
            "GISAID",
            " database [26] as of March 23, 2020."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Dataset",
                "start": 465,
                "end": 471,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Only the complete genomes of high-coverage and having no stretches of’NNNNN’ are included in the dataset."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ",
            "GISAID",
            " Ids of SARS-CoV-2 isolates are listed in the supplementary material."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Dataset",
                "start": 618,
                "end": 624,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This study retrieved the SNP genotypes of 558 SARS-CoV-2 strains in ",
            "GISAID",
            " database from the globe."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 762,
                "end": 768,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The emerging global infectious COVID-19 disease by novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) presents critical threats to global public health and the economy since it was identified in late December 2019 in China."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "This virus was labeled severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and defined as the causal agent of Coronavirus Disease 2019 (COVID-19) [2]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "On 5 March 2020, the first COVID-19 case was reported in KwaZulu-Natal, South Africa, from a traveler from Italy."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Reads are then filtered and sorted, on a protein level, into “bins” corresponding to recognized viral species, using DIAMOND [16] and the ",
            "UniRef90",
            " database (",
            "https://www.uniprot.org/help/uniref",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 412,
                "end": 420,
                "name": "UniRef90"
            },
            false,
            {
                "id": "T2",
                "type": "URL",
                "start": 431,
                "end": 466,
                "name": "https://www.uniprot.org/help/uniref"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All of the sequences were deposited in ",
            "GISAID",
            " (",
            "https://www.gisaid.org/",
            ")",
            "(Accession IDs in Table S2)."
        ],
        "lab": [
            false,
            {
                "id": "T3",
                "type": "Dataset",
                "start": 508,
                "end": 514,
                "name": "GISAID"
            },
            false,
            {
                "id": "T4",
                "type": "URL",
                "start": 516,
                "end": 539,
                "name": "https://www.gisaid.org/"
            },
            false,
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T3",
                "end": "T4"
            }
        ]
    },
    {
        "sen": [
            "Moreover, 10,959 ",
            "GISAID",
            " reference genomes (all authors acknowledged in Table S3) and 54 whole genomes generated at KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP) were aligned in Mafft v7·313 (FF-NS-2) [19], followed by manual inspection and editing in the Geneious Prime software suite (Biomatters Ltd., New Zealand)."
        ],
        "lab": [
            false,
            {
                "id": "T5",
                "type": "Dataset",
                "start": 587,
                "end": 593,
                "name": "GISAID"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "All of the data produced have been deposited in the ",
            "GISAID",
            " (consensus genomes) (Accession IDs in Table S2) and at the FASTQ short reads deposited at the ",
            "Short Read Archive (SRA)",
            " with accession code ",
            "PRJNA636748",
            "."
        ],
        "lab": [
            false,
            {
                "id": "T6",
                "type": "Dataset",
                "start": 959,
                "end": 965,
                "name": "GISAID"
            },
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 1060,
                "end": 1084,
                "name": "Short Read Archive (SRA)"
            },
            false,
            {
                "id": "T8",
                "type": "AccessionNumber",
                "start": 1105,
                "end": 1116,
                "name": "PRJNA636748"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T7",
                "end": "T8"
            }
        ]
    },
    {
        "sen": [
            "In addition, 13 samples delivered from the hospital outbreak were sequenced, but the patient or healthcare worker from the sample ID, or the sample ID, has been lost, or the sample itself was lost during transport or in storage, before coming to the laboratories."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In total, 108 COVID-19 positive individuals were sequenced in less than three weeks."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The COVID-19 pandemic has spread very fast around the world."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The ongoing COVID-19 pandemic caused by SARS-CoV-2 has raised worldwide alert."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The atomic coordinates of HKU2 spike and SADS-CoV spike have been deposited in the ",
            "Worldwide Protein Data Bank",
            " with the accession codes ",
            "6M15",
            " and ",
            "6M16",
            ", respectively; the corresponding maps have been deposited in the ",
            "Electron Microscopy Data Bank",
            " with the accession codes ",
            "EMD-30037",
            " and ",
            "EMD-30038",
            ", respectively."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 162,
                "end": 189,
                "name": "Worldwide Protein Data Bank"
            },
            false,
            {
                "id": "T2",
                "type": "AccessionNumber",
                "start": 215,
                "end": 219,
                "name": "6M15"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 224,
                "end": 228,
                "name": "6M16"
            },
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 294,
                "end": 323,
                "name": "Electron Microscopy Data Bank"
            },
            false,
            {
                "id": "T5",
                "type": "AccessionNumber",
                "start": 349,
                "end": 358,
                "name": "EMD-30037"
            },
            false,
            {
                "id": "T6",
                "type": "AccessionNumber",
                "start": 363,
                "end": 372,
                "name": "EMD-30038"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T1",
                "end": "T2"
            },
            {
                "id": "R2",
                "bool": true,
                "head": "T1",
                "end": "T3"
            },
            {
                "id": "R3",
                "bool": true,
                "head": "T4",
                "end": "T5"
            },
            {
                "id": "R4",
                "bool": true,
                "head": "T4",
                "end": "T6"
            }
        ]
    },
    {
        "sen": [
            "In addition, a combined approach using both HbA1c and FPG measurement was evaluated in the Pregnancy and Infant Development (PRIDE) Study cohort (4303 women): HbA1c levels ≥ 5.7% (39 mmol/mol) and/or FPG levels ≥ 92 mg/dL had a detection rate of 51% for HIP, as defined by UK National Institute for Health and Care Excellence (NICE) criteria, and a 12% rate of false-positive cases."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, in the absence of additional evidence, we recommend that this guidance be followed only for the duration of the COVID-19 pandemic, with a return back to the usual French recommended screening procedure when it appears to be safe and feasible to do so."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), a recent pandemic outbreak, which was first reported in Wuhan (Hubei province), China, causing novel coronavirus pneumonia (COVID-19), resulted in more than 298,000 deaths, as on 14th May 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Even though COVID-19 presents relatively mild symptoms compared to the recent outbreaks like Ebola or Middle East Respiratory Syndrome (MERS), they are highly transmissible and can lead to severe pneumonia and death (Boopathi et al., 2020; DiMaio et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In this study, we have modeled SARS-CoV-2 N7-MTase protein structure in order to decipher the molecular architecture of the substrate-binding site and to perform virtual screening and docking analysis to identify an attractive and novel lead compound from ",
            "TCM@Taiwan",
            " database, which can assist researchers in designing a potent antiviral drug against COVID-19 by blocking the SARS-CoV-2’s RNA capping mechanism required for evading the host defense."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 774,
                "end": 784,
                "name": "TCM@Taiwan"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Amino acid flipping is incorporated for side-chains angles of amino acids (Asn, Gln, and His) and it may influence the hydrogen bond formation and generate tautomer/ionized states (Sastry et al., 2013)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For ligand preparation, the substrate of the Guanine-N7 methyltransferase namely G3A (Guanosine-P3-Adenosine-5′,5′-Triphosphate) is downloaded from the ",
            "PubChem",
            " (ID: ",
            "135450590",
            ") and for screening approaches, 22122 molecules from ",
            "TCM Database@Taiwan",
            " is used (",
            "Ma et al., 2016",
            "; ",
            "Wang et al., 2018",
            ")."
        ],
        "lab": [
            false,
            {
                "id": "T2",
                "type": "Repository",
                "start": 1323,
                "end": 1330,
                "name": "PubChem"
            },
            false,
            {
                "id": "T3",
                "type": "AccessionNumber",
                "start": 1336,
                "end": 1345,
                "name": "135450590"
            },
            false,
            {
                "id": "T4",
                "type": "Repository",
                "start": 1398,
                "end": 1417,
                "name": "TCM Database@Taiwan"
            },
            false,
            {
                "id": "T5",
                "type": "Creator",
                "start": 1427,
                "end": 1442,
                "name": "Ma et al., 2016"
            },
            false,
            {
                "id": "T6",
                "type": "Creator",
                "start": 1444,
                "end": 1461,
                "name": "Wang et al., 2018"
            },
            false
        ],
        "rel": [
            {
                "id": "R1",
                "bool": true,
                "head": "T2",
                "end": "T3"
            }
        ]
    },
    {
        "sen": [
            "In order to identify the appropriate compounds that perfectly fits the substrate-binding site of the G3A, the Glide incorporated virtual screening protocol is used (Grover et al., 2012; Kawatkar et al., 2009; Muralidharan et al., 2020)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The whole database is initially screened with High Throughput Virtual Screening (HTVS), for identifying appropriate compounds that fit in the substrate-binding site (Lobo-Galo et al., 2020; Patidar et al., 2016)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The experimental structure of the Guanine-N7 methyltransferase enzyme is unavailable in the ",
            "PDB",
            " and BLASTp results suggest the crystal structure of the SARS-CoV nsp14-nsp10 complex (",
            "PDB",
            " ID: ",
            "5c8s",
            ") as the template for structure modeling."
        ],
        "lab": [
            false,
            {
                "id": "T7",
                "type": "Repository",
                "start": 2006,
                "end": 2009,
                "name": "PDB"
            },
            false,
            {
                "id": "T8",
                "type": "Repository",
                "start": 2096,
                "end": 2099,
                "name": "PDB"
            },
            false,
            {
                "id": "T9",
                "type": "AccessionNumber",
                "start": 2104,
                "end": 2108,
                "name": "5c8s"
            },
            false
        ],
        "rel": [
            {
                "id": "R2",
                "bool": true,
                "head": "T8",
                "end": "T9"
            }
        ]
    },
    {
        "sen": [
            "To disturb the G3A binding towards the Asn388, the whole ",
            "TCM",
            " database is searched for a suitable compound using the HTVS method."
        ],
        "lab": [
            false,
            {
                "id": "T10",
                "type": "Repository",
                "start": 2207,
                "end": 2210,
                "name": "TCM"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The XP docking and Prime MM/GBSA provides the TCM 57025 (5a), TCM 3495 (5b), TCM 20111 (5c), TCM 31007 (5d) and TCM 5376 (5e) from the TCM database as the best compounds that can bind with the substrate-binding site of SARS-CoV-2 N7-MTase as shown in Figure 5(a–e)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For tackling Coronavirus Disease 2019 (COVID-19), researchers from around the world are swiftly working on designing and identifying inhibitors against all possible viral key protein targets."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "For an in-depth understanding of these substrate specificities, we tried to screen and identify inhibitors from the ",
            "Traditional Chinese Medicine (TCM)",
            " database."
        ],
        "lab": [
            false,
            {
                "id": "T11",
                "type": "Repository",
                "start": 2853,
                "end": 2887,
                "name": "Traditional Chinese Medicine (TCM)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We strongly believe the final compounds can become COVID-19 therapeutics, with huge international support."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Therefore, our study proposes the top hit compounds from the ",
            "Traditional Chinese Medicine (TCM)",
            " database using a combination of several computational approaches."
        ],
        "lab": [
            false,
            {
                "id": "T12",
                "type": "Repository",
                "start": 3066,
                "end": 3100,
                "name": "Traditional Chinese Medicine (TCM)"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The recent outbreak of the novel coronavirus disease 2019 (COVID-19) and the associated need for vital social practices that reduce further spread have disrupted clinical research functions worldwide [1]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Ironically, this interruption coincides with an especially critical need for human biospecimen research to better understand the biology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the pathology of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Building a COVID-19 biorepository is a delicate and complex task that requires maximum biosafety measures and minimum interruption in an overburdened clinical delivery system."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We also feature the earliest outcome of this pipeline, which is the recently reported genomic characterization linking the US and European viral strains, a crucial development in our efforts to combat COVID-19 [3]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The CBRD adheres to all biosafety level-3 guidelines for COVID-19 collections as outlined by the Center for Disease Control [4]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "To maximize COVID-19 collections, we modified this protocol to prospectively enroll all patients presenting to NYULH with a COVID-19 nasopharyngeal diagnostic test performed into Labvantage."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The clinical information from enrolled patients is extracted from the electronic medical record and recorded in 107 discrete demographic, medical, and COVID-19-specific data fields (Additional file 1: Appendix S1) in a ",
            "REDCap",
            " [5] database."
        ],
        "lab": [
            false,
            {
                "id": "T1",
                "type": "Repository",
                "start": 1367,
                "end": 1373,
                "name": "REDCap"
            },
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The protocol for COVID-19 biospecimen collections for research at NYULH minimizes interruptions in the delivery of care, includes vital biosafety measures, and maximizes the research potential for banked COVID-19 biospecimens (Fig. 1)."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "NYULH saw its first confirmed case of COVID-19 on March 11, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "In accordance with national and international policies, the IRB approved a waiver of consent to permit COVID-19 biospecimen collection on March 28, 2020."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Of the first 11,120 patients accrued to the COVID-19 database, 4267 (38.4%) tested positive and approximately 10% required hospitalization."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "We therefore suggest establishing a main biorepository with institutional governance for all patients tested for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The creation of this resource at NYULH has enriched the community with high-quality patient-linked COVID-19 specimens, which has already contributed to novel findings about SARS-CoV-2 epidemiology [3]."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "The outbreak of the novel coronavirus disease 2019 (COVID-19) and consequent social distancing practices have disrupted essential clinical research functions worldwide."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Ironically, this coincides with an immediate need for research to comprehend the biology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the pathology of COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "However, building a COVID-19 biorepository amidst the active pandemic is a complex and delicate task."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    },
    {
        "sen": [
            "Using an amended institutional biobanking protocol, these efforts led to accrual of 11,120 patients presenting for SARS-CoV-2 testing, 4267 (38.4%) of whom tested positive for COVID-19."
        ],
        "lab": [
            false
        ],
        "rel": [
            "No Relation"
        ]
    }
]